Citrus Sinensis ID: 002461

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------92
Protein Sequence
MGSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR
Secondary Structure (PSIPRED)
cccccccccccccHHHHHHHHHHHHHHHHHccEEEcccccccccccccccccccccccccccccEEEEcccccccccccccccEEEEcccccccccccEEcccccccccccccccEEEEEcccccEEEEEccccccccEEEEEEEEEcccccccccccEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccEEEEEccccccccEEEEEEEEEccccccccccccEEEEEEEEEcccccccccccccccccEEEcccccccccccccccEEccccccccccHHHHHHHccccccccccEEEEEEccccccccEEEEEEEcccccccccEEEEEEEEcccccccccccccccccEEEEEEccccccEEEEEEccccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHcccccccccccccccccccEEEEcccccccccEEEEEEEcccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHEEcccccccccccccccccccccccccccHHHHHHHHcccccEEEEEcccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEcccccccHHHHccccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEcccccccccccccccEEEEEEEcccccccHHHHHHcccccccccEEHHHHHHHHHHcccccccccccccHHHHHHHHHHcccccEEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHcHHHHHHHcccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHEcccccccEEEEEccccccccccccccccEEEcccccccccccccccHHHccccccccccEEEEcccccccEEEEccccccccEEEEEEEEEEccccccccccEEEEEEccccEEEEEEccccccEEEEEEEEcccccEEEEEEEccccccEEEEEEEccccccccccccccEEEEEEEccccccccEEEccccccccEEEcccccccccEEcccccccccccccccccHHHHHHccccccccccEEEEEccccccccEEEEEEEHEHHccccccEEEEEEEEcccEccccccccHccccEEEccccccccEEEEEEEEccccccccEEEEEEEEEEEEcccccccHHHHHHHHHHHHHcccccccccccccccccccccEEEccccccccEEEEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHHccccEEEEEEcccccccccccccccccccEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEccHHHHHHHHHHHHHHEccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEcccccccEcccccccEEEEEEccccccccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHccccHHcEccHccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEEcccccccccc
Coil and Loop (DISEMBL)
mgskckssraYDLMMRFIFISLFAICVCIEKQtvlasdatssgksekfvghkharrklddiggdisidcgvpagfmyldektqlsyksDEEFIRTGVNKNISSKFMSANlqntyatvrsfpegnrncyslrppegkaktYLTRASfmygdyddedklpefdlyigvnrwdsikfdnasHVVIKEIIHSALMDEINVCllntgkgtpfiSALELRHFHNATYRTQSGALVLYrrldvgstttqiirfkddhydriwvpypgfpgsasintSFIIDSLVdsqyrlpsavMKTAvkpmnvndsldfdfeigdptLQFYVYMHFAELesrqgnqyrEFSIELNgnlweksvvpeylqsktisstqpargsklnfslcktsnstlppiLNAIEIYILtdtlqeptdqddvnaIMDIKLsydlgkgwqgdpcspmyyswdglncsyngykppkiislnltsegltgkispslsnlkslenldlsnnsltgsipeflsqlpllrvlnldgnklsgsvptslvarsQNGSLLlsigrnpdlclsapckkekrnsvmpVVAASVSLLVILIALLVFWTYKRKRaarlnvdnshskkegslksdnqqfTYSEIVDITNNFHRilgkggfgtvyhgyladGSEVAIKMLSasssqgpkQFRTEAQLLMRVHHRNLASLVGycndggnvgLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLeylhhgckppiihrdVKTANILLNEKMQAKLadfgfskifpaeseshistsivgtvgyldpeyyasnrlteksdvYSFGIVLLELITGLPAiirgynnthivnrvcpflergdvrsivdprleanfdtnSVWKVAETAMecvpsisfqrptmsHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVetemgpear
Flexible Loop (DISEMBL)
mgskckssrayDLMMRFIFISLFAICVCIEKQTVlasdatssgksekfvghkharrklddiggdiSIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYAtvrsfpegnrncyslrppegkaktYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATyrtqsgalvlyrRLDVGSTTTqiirfkddhydrIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKtisstqpargsKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRaarlnvdnshskkegslksdnqqfTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFpaeseshistsivGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVpsisfqrptmsHVVTELKKCLEMETAREQIQrtksqmlslsssvdisavevetemgpear
Low Complexity Region (SEG)
MGSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLddiggdisidcgVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKIspslsnlkslenldlsnnslTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPvvaasvsllviliallvFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR
Disordered region (IsUnstruct)
*********AYDLMMRFIFISLFAICVCIEKQTVLA*****************ARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLR***GKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQ**************LNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGL************************TGSIPEFLSQLPLLRVLNLDGNKLSGSV*TSLVA***NGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAA*********************FTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKM**************EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL***************************************
Disordered Region (DISOPRED)
********RAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRK*DDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTG***************NTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL************SVMPVVAASVSLLVILIALLVFWTYKR************************QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKM************RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL***************************************
Disordered Region (DISEMBL)
********RAYDLMMRFIFISLFAICVCIEKQTVL*******************RRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQS***********SKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVD************DNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML********KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVE**********
Disordered Region (DISPRO)
*GSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKR******************SDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ**********************E********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	919	2.2.26 [Sep-21-2011]
O65924	881	Putative leucine-rich rep	no	no	0.922	0.962	0.483	0.0
O64556	877	Putative leucine-rich rep	no	no	0.880	0.922	0.496	0.0
O64483	876	Senescence-induced recept	no	no	0.919	0.964	0.475	0.0
C0LGD6	852	Probable LRR receptor-lik	no	no	0.911	0.983	0.473	0.0
Q9FZB1	872	Probable LRR receptor-lik	no	no	0.909	0.958	0.466	0.0
C0LGG4	890	Probable LRR receptor-lik	no	no	0.915	0.944	0.450	0.0
C0LGR6	913	Probable LRR receptor-lik	no	no	0.886	0.892	0.480	0.0
C0LGG6	876	Probable LRR receptor-lik	no	no	0.905	0.949	0.445	0.0
C0LGD9	871	Probable LRR receptor-lik	no	no	0.910	0.960	0.444	0.0
Q9FZB8	871	Probable LRR receptor-lik	no	no	0.891	0.940	0.445	0.0

>sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1

 Score =  838 bits (2165), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/873 (48%), Positives = 574/873 (65%), Gaps = 25/873 (2%)

Query: 57  KLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYAT 116
           +  D  G +SIDCG+P    Y DE T + Y SD  F+ +G   +I  +F +++L+  +  
Sbjct: 24  RAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQN 83

Query: 117 VRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDN 176
           VRSFPEGNRNCY ++PP+GK   YL R  FMYG+YD+  K P+FDLY+G N WDS+  DN
Sbjct: 84  VRSFPEGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDN 143

Query: 177 ASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDV 236
           A+ +V KEIIH+   D ++VCL++  +GTPF+SALE+R   + TY T   +L+L++R D+
Sbjct: 144 ATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLILFKRWDL 203

Query: 237 GSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMN 296
           G      +R+KDD +DRIW+P   FP     N S  IDS  +  ++    VM TA  P +
Sbjct: 204 GGLGALPVRYKDDVFDRIWIPL-RFPKYTIFNASLTIDSNNNEGFQPARFVMNTATSPED 262

Query: 297 VNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELN-GNLWEKSVVPEYLQSK 355
           ++  + F +E  DPT +++VYMHFAE+     N+ REF + LN   +   S  P YL + 
Sbjct: 263 LSQDIIFSWEPKDPTWKYFVYMHFAEVVELPSNETREFKVLLNEKEINMSSFSPRYLYTD 322

Query: 356 TISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSY 415
           T+    P  G KL F L +T  STLPPI+NAIE Y + + LQ PTDQ DV+AIM IK  Y
Sbjct: 323 TLFVQNPVSGPKLEFRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKY 382

Query: 416 DLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENL 475
            + K W GDPC+P+ Y W  +NCSY   + P+IIS+NL+S GLTG+I  + SNL  L  L
Sbjct: 383 GVKKSWLGDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLLHIL 442

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCL 535
           DLSNNSLTG IP+FL  L  L  LNL+GNKLSG++P  L+ RS    +LL I  NPDLC+
Sbjct: 443 DLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCV 502

Query: 536 SAPCK----KEKRNS-VMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGS 590
           SA C+    K K+N  ++P+VA+ V +L +++A+ +F  YK KR  R     S   + G 
Sbjct: 503 SASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLYK-KRHRR---GGSGGVRAGP 558

Query: 591 LKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR 650
           L +  + + YSE+V +TNNF R+LG+GGFG VYHG L D  +VA+K+LS SS+QG K+FR
Sbjct: 559 LDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND-DQVAVKILSESSAQGYKEFR 617

Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
            E +LL+RVHH+NL +L+GYC++G  + L+YE+MA G L  YL  E    LSW++RLQI+
Sbjct: 618 AEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQIS 677

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
           +DAAQGLEYLH+GCKPPI+ RDVK ANIL+NEK+QAK+ADFG S+    +  +  +T++ 
Sbjct: 678 LDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVA 737

Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN---NTHIVNRVCPFLE 827
           GT+GYLDPEY+ + +L+EKSD+YSFG+VLLE+++G P I R      N HI +RV   L 
Sbjct: 738 GTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLS 797

Query: 828 RGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
            GD+R IVDP+L   FD  S WK+ E AM C  S S  RPTMSHVV ELK         E
Sbjct: 798 TGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELK---------E 848

Query: 888 QIQRTKSQMLSLSSSV-DISAVEVETEMGPEAR 919
            + R ++   S +SSV D +    ++ M P+AR
Sbjct: 849 SVSRARAGGGSGASSVTDPAMTNFDSGMFPQAR 881

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3

 Score =  825 bits (2131), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/829 (49%), Positives = 555/829 (66%), Gaps = 20/829 (2%)

Query: 60  DIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRS 119
           D  G +SIDCG+P    Y DEKT + Y SD  F+ +G   +I SKF   NL+  +  VRS
Sbjct: 26  DQSGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTIHSIDSKFQKKNLEKQFQKVRS 85

Query: 120 FPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASH 179
           FPEG +NCY ++PP+GK   YL R  FMYG+YD+  K P+FDLY+GVN WDS+  +N++ 
Sbjct: 86  FPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGVNLWDSVTLENSTT 145

Query: 180 VVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGST 239
           +V KEII++   D+++VCL++  +GTPF+S LELR   N  Y T S +L+LYRR D+G+T
Sbjct: 146 IVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLKNNIYETASDSLMLYRRWDLGAT 205

Query: 240 TTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVN- 298
                R+KDD +DR W+P   FP    +NTS +ID    + +  PS VM TAV PMN + 
Sbjct: 206 GDLPARYKDDIFDRFWMPL-MFPNFLILNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSI 264

Query: 299 DSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVV--PEYLQSKT 356
           + +   +E  DP  +FY+Y+HFAE+E    N+ REFS+ LN    + + V  P YL + T
Sbjct: 265 EQIMVYWEPRDPNWKFYIYIHFAEVEKLPSNETREFSVFLNKEQIDTTSVFRPSYLYTDT 324

Query: 357 ISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYD 416
           +    P  G  L F L +   ST PPI+NAIE Y   + L  PTDQ+DV+AIM IK  Y 
Sbjct: 325 LYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYK 384

Query: 417 LGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLD 476
           + K W GDPC+P  Y W G+NCSY    PP+IIS+NL+  GLTG+I P    L  L+ LD
Sbjct: 385 VKKNWLGDPCAPFGYPWQGINCSYTANNPPRIISVNLSFSGLTGQIDPVFITLTPLQKLD 444

Query: 477 LSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLS 536
           LSNN LTG++P+FL+ LP L  LNL+ NKL+G +P  L+ RS++GSL L +G NPDLC+S
Sbjct: 445 LSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRVGGNPDLCVS 504

Query: 537 APC---KKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKS 593
             C   K E++  ++P VA+   L  +L+AL+ FW +K+++          S K G L +
Sbjct: 505 DSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQ---------QSVKTGPLDT 555

Query: 594 DNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEA 653
             + + YSEIV+ITNNF R+LG+GGFG VY+G L  G +VAIKMLS SS+QG K+FR E 
Sbjct: 556 -KRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVAIKMLSKSSAQGYKEFRAEV 613

Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
           +LL+RVHH+NL +L+GYC++G  + L+YEY+  G L  YL  +    LSW++RLQI++DA
Sbjct: 614 ELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLSGKNSSILSWEERLQISLDA 673

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           AQGLEYLH+GCKPPI+HRDVK  NIL+NEK+QAK+ADFG S+ F  E +S +ST + GT+
Sbjct: 674 AQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTI 733

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN--NTHIVNRVCPFLERGDV 831
           GYLDPE+Y+  + +EKSDVYSFG+VLLE+ITG P I R     N HI +RV   L +GD+
Sbjct: 734 GYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDI 793

Query: 832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +SIVDP+L   F+    WK+ E A+ C    +  R TMS VV ELK+ L
Sbjct: 794 KSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTMSQVVAELKESL 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64483|SIRK_ARATH Senescence-induced receptor-like serine/threonine-protein kinase OS=Arabidopsis thaliana GN=SIRK PE=2 SV=1

 Score =  798 bits (2060), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/866 (47%), Positives = 550/866 (63%), Gaps = 21/866 (2%)

Query: 60  DIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRS 119
           D  G ISIDCG+P    Y DE T + Y SD  F+ +G  K I+++F S+        VRS
Sbjct: 26  DQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHLLNVRS 85

Query: 120 FPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASH 179
           FP+  R+CY +  P GK   YL R  FMYG+YDD  ++PEFDLY+GVN WDS+K D+A+ 
Sbjct: 86  FPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKLDDATT 145

Query: 180 VVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGST 239
           ++ KEII   L+D + VC+++   GTPF+S LE+R   N TY T   AL L RRLD   T
Sbjct: 146 ILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIRLLLNTTYETPYDALTLLRRLDYSKT 205

Query: 240 TTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVND 299
                R+KDD YDRIW P         +NTS  +D  +++ Y+  S VM TA    N + 
Sbjct: 206 GKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQPASTVMSTAETARNESL 265

Query: 300 SLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISS 359
            L   F   DP  +FYVYMHFAE+E  + NQ REFSI LN ++   S    YL + T  +
Sbjct: 266 YLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREFSIWLNEDVISPSFKLRYLLTDTFVT 325

Query: 360 TQPARGSKLNFSLCKTSNS-TLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLG 418
             P  G  +NFSL +      LPPI+NA+E+Y + + LQ PT   DV+A+  IK +Y + 
Sbjct: 326 PDPVSGITINFSLLQPPGEFVLPPIINALEVYQVNEFLQIPTHPQDVDAMRKIKATYRVK 385

Query: 419 KGWQGDPCSPMYYSWDGLNC-SYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDL 477
           K WQGDPC P+ YSW+G++C   +    P+++SLN++   L G+I P+ SNL S+  LDL
Sbjct: 386 KNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDL 445

Query: 478 SNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSA 537
           S N+LTG IP FL+ LP L  LN++GNKL+G VP  L  RS+NGSL L  GRNPDLCLS 
Sbjct: 446 SGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSD 505

Query: 538 PC---KKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSD 594
            C   KK+ +N  +  +     ++V+L AL +F  +K+K+        +  ++ G LK+ 
Sbjct: 506 SCSNTKKKNKNGYIIPLVVVGIIVVLLTALALFRRFKKKQQR-----GTLGERNGPLKTA 560

Query: 595 NQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQ 654
            + F YSE+V+ITNNF R++GKGGFG VYHG + +G +VA+K+LS  S+QG K+FR E  
Sbjct: 561 KRYFKYSEVVNITNNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVD 619

Query: 655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA 714
           LLMRVHH NL SLVGYCN+  ++ L+YEYMA  NL  YL  +    LSW++RL+I++DAA
Sbjct: 620 LLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFILSWEERLKISLDAA 679

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           QGLEYLH+GCKPPI+HRDVK  NILLNEK+QAK+ADFG S+ F  E    IST + G++G
Sbjct: 680 QGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIG 739

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRG-YNNTHIVNRVCPFLERGDVRS 833
           YLDPEYY++ ++ EKSDVYS G+VLLE+ITG PAI        HI + V   L  GD+R 
Sbjct: 740 YLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIASSKTEKVHISDHVRSILANGDIRG 799

Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTK 893
           IVD RL   +D  S WK++E A+ C    S QRPTMS VV ELK+ +      ++     
Sbjct: 800 IVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQIVYGIVTDQENYDDS 859

Query: 894 SQMLSLSSSVDISAVEVETEMGPEAR 919
           ++ML+         V ++TEM P AR
Sbjct: 860 TKMLT---------VNLDTEMVPRAR 876

Involved in innate immune response of plants.

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1

 Score =  788 bits (2035), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/883 (47%), Positives = 566/883 (64%), Gaps = 45/883 (5%)

Query: 14  MMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPA 73
            +  I+ + FA+C+ +   +VLA D +                      G ISIDCG+P+
Sbjct: 6   FLYLIYSAAFALCLVV---SVLAQDQS----------------------GFISIDCGIPS 40

Query: 74  GFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPP 133
           G  Y D+ T ++Y SD  F+ TGV+K+I        LQN    +RSFPEG+RNCY+L P 
Sbjct: 41  GSSYKDDTTGINYVSDSSFVETGVSKSIPFT-AQRQLQN----LRSFPEGSRNCYTLIPI 95

Query: 134 EGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDE 193
           +GK K YL RASFMYG+YD E+  PEFDL++G N WD++   N S +V KE+++ +  + 
Sbjct: 96  QGKGKKYLIRASFMYGNYDGENGSPEFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSEN 155

Query: 194 INVCLLNTGKGTPFISALELRHF--HNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHY 251
           I VCL N GKGTPFIS LELR     N TY + +GAL   RR D+ S     +R+ DD Y
Sbjct: 156 IFVCLGNKGKGTPFISTLELRFLGNDNTTYDSPNGALFFSRRWDLRSLMGSPVRYDDDVY 215

Query: 252 DRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPT 311
           DRIW+P   F     INTS  + S  ++ Y L S VM TA+ P+N    +    E  DP 
Sbjct: 216 DRIWIPR-NFGYCREINTSLPVTS-DNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPN 273

Query: 312 LQFYVYMHFAELE--SRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLN 369
           ++++VYMHFAE+E  S + NQ REF I +NG        P+YLQ+ T     P   SK+ 
Sbjct: 274 VRYFVYMHFAEVEDLSLKPNQTREFDISINGVTVAAGFSPKYLQTNTFF-LNPESQSKIA 332

Query: 370 FSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPM 429
           FSL +T  STLPPI+NA+EIY+     Q  T+Q+D +A+  +K SY + K W GDPC P 
Sbjct: 333 FSLVRTPKSTLPPIVNALEIYVANSFSQSLTNQEDGDAVTSLKTSYKVKKNWHGDPCLPN 392

Query: 430 YYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
            Y W+GLNCSY+   PP+I SLNL+S GLTG IS S SNL  ++ LDLSNN LTG IPEF
Sbjct: 393 DYIWEGLNCSYDSLTPPRITSLNLSSSGLTGHISSSFSNLTMIQELDLSNNGLTGDIPEF 452

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEK-RNSVM 548
           LS+L  LRVLNL+ N L+GSVP+ L+ RS  GS  L +G NP LC    C+K   +  V+
Sbjct: 453 LSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFSLRLGENPGLCTEISCRKSNSKKLVI 512

Query: 549 PVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQ-FTYSEIVDIT 607
           P+VA+  +L ++L+   VFW  + +R   +N   S  +     KS+N+  FT+++++ +T
Sbjct: 513 PLVASFAALFILLLLSGVFWRIRNRRNKSVN---SAPQTSPMAKSENKLLFTFADVIKMT 569

Query: 608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           NNF ++LGKGGFGTVYHG+  D  +VA+K+LS +S+QG K+FR+E ++L+RVHH NL +L
Sbjct: 570 NNFGQVLGKGGFGTVYHGFY-DNLQVAVKLLSETSAQGFKEFRSEVEVLVRVHHVNLTAL 628

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +GY ++G  +GL+YE+MA GN+  +L  + +  LSW+ RLQIA+DAAQGLEYLH GCKPP
Sbjct: 629 IGYFHEGDQMGLIYEFMANGNMADHLAGKYQHTLSWRQRLQIALDAAQGLEYLHCGCKPP 688

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           I+HRDVKT+NILLNEK +AKLADFG S+ F  ES SH+ST + GT GYLDP  + +N L 
Sbjct: 689 IVHRDVKTSNILLNEKNRAKLADFGLSRSFHTESRSHVSTLVAGTPGYLDPLCFETNGLN 748

Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLER-GDVRSIVDPRLEANFDT 845
           EKSD+YSFG+VLLE+ITG   I        H+ + V   L    DV +++D ++  +FD 
Sbjct: 749 EKSDIYSFGVVLLEMITGKTVIKESQTKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDV 808

Query: 846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
           NSVWKV E A+  V      RP M H+V  L +CL+ E + + 
Sbjct: 809 NSVWKVVELALSSVSQNVSDRPNMPHIVRGLNECLQREESNKN 851

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1

 Score =  771 bits (1991), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/866 (46%), Positives = 568/866 (65%), Gaps = 30/866 (3%)

Query: 63  GDISIDCG-VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFP 121
           G IS+DCG VP    Y ++ T ++YKSD  +I +G+   IS+++  A LQ    TVRSFP
Sbjct: 28  GFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEY-KAQLQQQTWTVRSFP 86

Query: 122 EGNRNCYSLRPPEGKAKT-YLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHV 180
           EG RNCY+       AK+ YL RA+F YG+YD   ++P+FD++IG ++W S+K D   + 
Sbjct: 87  EGERNCYNFNL---TAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTSVKLDGVGNG 143

Query: 181 VIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTT 240
            + E+IH    D + +CL+ TGKG PFIS+LELR  +N TY TQSG+L+ + R+   +T 
Sbjct: 144 AVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQSGSLIGFARVFFSATP 203

Query: 241 TQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDS 300
           T  IR+ +D +DR+WV   G  G  SI+T  ++D+   + Y +P AV KTA  P N +  
Sbjct: 204 T-FIRYDEDIHDRVWVRQFG-NGLKSISTDLLVDT--SNPYDVPQAVAKTACVPSNASQP 259

Query: 301 LDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVV-PEYLQSKTISS 359
           L FD+ + + T Q YVYMHFAE+++ + N  REF+I  NG     S + PE  +  T+  
Sbjct: 260 LIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNGGQNVYSYLRPEKFEISTLFD 319

Query: 360 TQPARGSKLNFSL--CKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDL 417
           ++P      +FSL   KT NSTLPP++N +EIY + D L+  TDQD+V+A+++IK +YDL
Sbjct: 320 SKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLELETDQDEVSAMINIKATYDL 379

Query: 418 GK--GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENL 475
            K   WQGDPC+P  Y W+GLNCSY     P+IISLNL    LTG I+P +S L  L  L
Sbjct: 380 SKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAENKLTGTITPEISKLTQLIEL 439

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGN-KLSGSVPTSLVARSQNGSLLLSIGRNPDLC 534
           DLS N L+G IPEF + + LL+++NL GN  L+ ++P S+  R  + SL+L + +     
Sbjct: 440 DLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIPDSIQQRLDSKSLILILSKTVTKT 499

Query: 535 LSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSD 594
           ++    K K+  ++P+VA+   +  +L+ L +F+  +RK         S+     S+ + 
Sbjct: 500 VTLK-GKSKKVPMIPIVASVAGVFALLVILAIFFVVRRKNG------ESNKGTNPSIITK 552

Query: 595 NQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQ 654
            ++ TY E++ +TNNF R+LGKGGFGTVYHG L D ++VA+KMLS SS+QG K+F+ E +
Sbjct: 553 ERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVE 611

Query: 655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDA 713
           LL+RVHHRNL  LVGYC+DG N+ L+YEYMA G+LK+ +  +     L+W++R+QIAV+A
Sbjct: 612 LLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGNVLTWENRMQIAVEA 671

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           AQGLEYLH+GC PP++HRDVKT NILLNE+  AKLADFG S+ FP + ESH+ST + GT 
Sbjct: 672 AQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTP 731

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           GYLDPEYY +N L+EKSDVYSFG+VLLE++T  P   +    THI   V   L +GD++S
Sbjct: 732 GYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRERTHINEWVGSMLTKGDIKS 791

Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTK 893
           I+DP+L  ++DTN  WK+ E A+ CV   S +RPTM+HVVTEL +C+ +E AR Q     
Sbjct: 792 ILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALENARRQ----G 847

Query: 894 SQMLSLSSSVDISAVEVETEMGPEAR 919
            + +  S  VD S     +E  P AR
Sbjct: 848 REEMHTSGYVDFSRSSA-SEFSPGAR 872

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2

 Score =  739 bits (1908), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/881 (45%), Positives = 561/881 (63%), Gaps = 40/881 (4%)

Query: 62  GGDISIDCG-VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSF 120
            G IS+DCG VP    Y ++ T ++YKSD ++I +G+   I+  + +   Q  +A VRSF
Sbjct: 27  AGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVWA-VRSF 85

Query: 121 PEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHV 180
           P G RNCY++         YL R +F+YG+YD  ++ P FDL+IG N+W S+K    ++ 
Sbjct: 86  PVGQRNCYNVNLTANNK--YLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNT 143

Query: 181 VIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTT 240
            + EIIH    D + VCL+ TG  TPFIS+LE+R  +N +Y TQSG+L+L+ R+   S++
Sbjct: 144 SMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGSLMLFARVYFPSSS 203

Query: 241 TQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDS 300
           +  IR+ +D +DR+W  +     +  I+T   ID+   + Y +P +VMKTA  P N ++ 
Sbjct: 204 SSFIRYDEDIHDRVWNSFTD-DETVWISTDLPIDT--SNSYDMPQSVMKTAAVPKNASEP 260

Query: 301 LDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNL-WEKSVVPEYLQSKTISS 359
               + + + T Q YVYMHFAE+++   N+ REF+I  NG L W   + P  L   TI +
Sbjct: 261 WLLWWTLDENTAQSYVYMHFAEVQNLTANETREFNITYNGGLRWFSYLRPPNLSISTIFN 320

Query: 360 TQPARGSK--LNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDL 417
            +    S    NF+   T NSTLPP+LNA+EIY + D LQ  T++D+V+A+M+IK +Y L
Sbjct: 321 PRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGL 380

Query: 418 GK--GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENL 475
            K   WQGDPC+P  Y W+GLNCSY   +  +IISLNL    LTG I+  +S L  L  L
Sbjct: 381 SKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLTVL 440

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGN---KLSGSVPTSLVARSQNGSLLLSIGRNPD 532
           DLSNN L+G IP F +++  L+++NL GN    L+ ++P SL  R  + SL L +G N  
Sbjct: 441 DLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLT-AIPDSLQQRVNSKSLTLILGEN-- 497

Query: 533 LCLSAPCKKEKRNSVMPVVAASVS-LLVILIALLVFWTYKRKRAARLN------------ 579
             L+   KKE +   M  +AASV+ +  +L+ L +F+  KRK                  
Sbjct: 498 --LTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGI 555

Query: 580 VDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLS 639
           V +       S+ +  ++ TY E++ +TNNF R+LGKGGFGTVYHG L DG+EVA+KMLS
Sbjct: 556 VKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLS 614

Query: 640 ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK- 698
            SS+QG K+F+ E +LL+RVHHR+L  LVGYC+DG N+ L+YEYMA G+L++ +  +   
Sbjct: 615 HSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGG 674

Query: 699 EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP 758
             L+W++R+QIAV+AAQGLEYLH+GC+PP++HRDVKT NILLNE+  AKLADFG S+ FP
Sbjct: 675 NVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFP 734

Query: 759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHI 818
            + E H+ST + GT GYLDPEYY +N L+EKSDVYSFG+VLLE++T  P I +     HI
Sbjct: 735 IDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHI 794

Query: 819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
            + V   L +GD++SIVDP+L  ++DTN  WK+ E A+ CV   S +RPTM+HVV EL  
Sbjct: 795 NDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELND 854

Query: 879 CLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR 919
           C+ +E AR Q      +M S+  SVD S +   ++  P AR
Sbjct: 855 CVALENARRQ---GSEEMYSM-GSVDYS-LSSTSDFAPGAR 890

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGR6|Y4291_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g29180 OS=Arabidopsis thaliana GN=At4g29180 PE=2 SV=2

 Score =  736 bits (1899), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/847 (48%), Positives = 548/847 (64%), Gaps = 32/847 (3%)

Query: 62  GGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKF---MSANLQNTYATVR 118
            G ISIDCG P    Y+D  T +SY  D  FI  GVN N+S ++    +  L    A VR
Sbjct: 26  AGFISIDCGSPPNINYVDTDTGISYTWDAPFINAGVNLNVSEEYGYPKNPVLPFPLADVR 85

Query: 119 SFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNAS 178
           SFP+GNRNCY+L P +GK   YL RASFMYG+YD ++ LPEFDLY+ VN W S+K  NAS
Sbjct: 86  SFPQGNRNCYTLTPSDGKGNLYLIRASFMYGNYDGKNALPEFDLYVNVNFWTSVKLRNAS 145

Query: 179 HVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSG---ALVLYRRLD 235
             VIKEI+  A  D I VCL+N GKGTPFISALELR  +++ Y T+ G   +LVLY+R D
Sbjct: 146 ENVIKEILSFAESDTIYVCLVNKGKGTPFISALELRPMNSSIYGTEFGRNVSLVLYQRWD 205

Query: 236 VGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPM 295
            G       R++ D YDRIW PY     + ++ T +I   +  S YR P  V+KTA  P 
Sbjct: 206 TG-YLNGTGRYQKDTYDRIWSPYSPVSWNTTMTTGYI--DIFQSGYRPPDEVIKTAASPK 262

Query: 296 NVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSK 355
           + ++ L+  +   DP  +FY Y++FAELE+ + N+ RE  I  NG+    +  P    S 
Sbjct: 263 SDDEPLELSWTSSDPDTRFYAYLYFAELENLKRNESREIKIFWNGSPVSGAFNPSPEYSM 322

Query: 356 TISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSY 415
           T+S+++   G     S+ KT+ ST PPILNAIEI+      +  T  DDV AI  IK +Y
Sbjct: 323 TVSNSRAFTGKDHWISVQKTAESTRPPILNAIEIFSAQSLDEFYTRIDDVQAIESIKSTY 382

Query: 416 DLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENL 475
            + K W GDPCSP  + W+G+ CSYN     +I SLNL+S GL G I+ +  NL  LE+L
Sbjct: 383 KVNKIWTGDPCSPRLFPWEGIGCSYNT-SSYQIKSLNLSSSGLHGPIAFAFRNLSLLESL 441

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCL 535
           DLSNN+L G +PEFL+ L  L+ LNL GN L+G +P SL  R+    L LS+    ++C 
Sbjct: 442 DLSNNNLKGIVPEFLADLKYLKSLNLKGNNLTGFIPRSLRKRATANGLALSVDEQ-NICH 500

Query: 536 SAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDN 595
           S  C+   R  ++P+V   VS LVI++   +      +R +++    ++S     L S  
Sbjct: 501 SRSCRDGNR-IMVPIV---VSTLVIILIAALAIICIMRRESKIMYSGAYSGP--LLPSGK 554

Query: 596 QQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLS-------------ASS 642
           ++FTYSE+  ITNNF++++GKGGFG VY G L DG+E+A+KM++             +SS
Sbjct: 555 RRFTYSEVSSITNNFNKVIGKGGFGIVYLGSLEDGTEIAVKMINDSSFGKSKGSSSSSSS 614

Query: 643 SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
           SQ  K+F+ EA+LL+ VHHRNLAS VGYC+DG ++ L+YEYMA GNL+ YL  E  E LS
Sbjct: 615 SQVSKEFQVEAELLLTVHHRNLASFVGYCDDGRSMALIYEYMANGNLQDYLSSENAEDLS 674

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
           W+ RL IA+D+AQGLEYLHHGC+PPI+HRDVKTANILLN+ ++AK+ADFG SK+FP +  
Sbjct: 675 WEKRLHIAIDSAQGLEYLHHGCRPPIVHRDVKTANILLNDNLEAKIADFGLSKVFPEDDL 734

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN--THIVN 820
           SH+ T+++GT GY+DPEYY + +L EKSDVYSFGIVLLELITG  +I++  +    ++V+
Sbjct: 735 SHVVTAVMGTPGYVDPEYYNTFKLNEKSDVYSFGIVLLELITGKRSIMKTDDGEKMNVVH 794

Query: 821 RVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
            V PFL+ GD+  +VDPRL  +F +NS WK  E AM CV      RP  + +V++LK+CL
Sbjct: 795 YVEPFLKMGDIDGVVDPRLHGDFSSNSAWKFVEVAMSCVRDRGTNRPNTNQIVSDLKQCL 854

Query: 881 EMETARE 887
             E ARE
Sbjct: 855 AAELARE 861

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2

 Score =  731 bits (1886), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/884 (44%), Positives = 549/884 (62%), Gaps = 52/884 (5%)

Query: 60  DIGGDISIDCG-VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVR 118
           D  G IS+DCG VP    Y+++ T ++Y+SD  +I +GV   I+  + +   Q  +A +R
Sbjct: 21  DQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPGKINEVYRTQFQQQIWA-LR 79

Query: 119 SFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNAS 178
           SFPEG RNCY+        + YL R +F+YG+YD  ++LP FDLYIG N+W S+      
Sbjct: 80  SFPEGQRNCYNFS--LTAKRKYLIRGTFIYGNYDGLNQLPSFDLYIGPNKWTSVSIPGVR 137

Query: 179 HVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGS 238
           +  + E+IH    D + +CL+ TG+ TPFIS+LELR  +N TY T+SG+L++  RL   S
Sbjct: 138 NGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYVTKSGSLIVVARLYF-S 196

Query: 239 TTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVN 298
            T   +R+ +D +DRIW+P+     S  ++T   +D+   + Y +P  V KTA  P+N  
Sbjct: 197 PTPPFLRYDEDVHDRIWIPFLDNKNSL-LSTELSVDT--SNFYNVPQTVAKTAAVPLNAT 253

Query: 299 DSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNL-WEKSVVPEYLQSKTI 357
             L  ++ + D T Q Y+YMHFAE+E+ + N+ REF+I  NG   W     P   +  T+
Sbjct: 254 QPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGENWFSYFRPPKFRITTV 313

Query: 358 SSTQPARGSKL----NFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKL 413
            +  PA  S L    NF+   T NST PP++N +EIY + +  Q  T QD+V+A+M+IK 
Sbjct: 314 YN--PAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDTYQDEVSAMMNIKT 371

Query: 414 SYDLGK--GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKS 471
            Y L K   WQGDPC+P  Y W+GLNCSY  + PP+IISLNL+   L+G I+  +S L  
Sbjct: 372 IYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAPPQIISLNLSGSNLSGTITSDISKLTH 431

Query: 472 LENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK-LSGSVPTSLVARSQNGSLLL---SI 527
           L  LDLSNN L+G IP   S +  L ++NL GNK L+ SVP +L  R  N SL L     
Sbjct: 432 LRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQKRIDNKSLTLIRDET 491

Query: 528 GRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKK 587
           G+N               +V+ + A+  S+  +L+ L + +   RK+          S  
Sbjct: 492 GKN-------------STNVVAIAASVASVFAVLVILAIVFVVIRKKQRTNEASGPRSFT 538

Query: 588 EGSLKSD-----------NQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIK 636
            G++KSD            ++FTYSE++ +T NF R+LGKGGFGTVYHG L D ++VA+K
Sbjct: 539 TGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNL-DDTQVAVK 597

Query: 637 MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
           MLS SS+QG K+F+ E +LL+RVHHR+L  LVGYC+DG N+ L+YEYM  G+L++ +  +
Sbjct: 598 MLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGK 657

Query: 697 -TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
            +   LSW+ R+QIAV+AAQGLEYLH+GC+PP++HRDVK  NILLNE+ QAKLADFG S+
Sbjct: 658 HSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSR 717

Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN 815
            FP + ESH+ T + GT GYLDPEYY +N L+EKSDVYSFG+VLLE++T  P + +    
Sbjct: 718 SFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNRER 777

Query: 816 THIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE 875
            HI   V   L  GD++SIVDP+L  ++DTN VWKV E A+ CV   S +RPTM HVV E
Sbjct: 778 PHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVME 837

Query: 876 LKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR 919
           L +CL +E  R+Q     SQ   +  SV+ S     ++  P AR
Sbjct: 838 LNECLALEIERKQ----GSQATYIKESVEFSPSSA-SDFSPLAR 876

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1

 Score =  706 bits (1821), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/858 (44%), Positives = 541/858 (63%), Gaps = 21/858 (2%)

Query: 57  KLDDIGGDISIDCGVPAG-FMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYA 115
           +  D  G IS+DCG+ A    Y +  T+L++ SD +FI++G +  I +          Y 
Sbjct: 23  RAQDQQGFISLDCGLQADESPYTEPLTKLTFTSDADFIKSGKSGKIQN-VPGMEYIKPYT 81

Query: 116 TVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFD 175
            +R FP+G RNCY+L   +G    YL  A F YG+YD+ +  P+FDLY+G N W ++   
Sbjct: 82  VLRYFPDGVRNCYTLIVIQGT--NYLIVAMFTYGNYDNLNTHPKFDLYLGPNIWTTVDLQ 139

Query: 176 NASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLD 235
              +    EIIH      + +CL+ TG  TP ISALELR   N TY  QSG+L    R+ 
Sbjct: 140 RNVNGTRAEIIHIPRSTSLQICLVKTGTTTPLISALELRPLRNNTYIPQSGSLKTLFRVH 199

Query: 236 VGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPM 295
           + + + + +R+ +D +DR+W P+   P    + TS  +++  D+ Y +P  V+ TA  P 
Sbjct: 200 L-TDSKETVRYPEDVHDRLWSPF-FMPEWRLLRTSLTVNTSDDNGYDIPEDVVVTAATPA 257

Query: 296 NVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSK 355
           NV+  L   + +  P    Y Y+H AE++S + N  REF+I    ++    V P+     
Sbjct: 258 NVSSPLTISWNLETPDDLVYAYLHVAEIQSLRENDTREFNISAGQDVNYGPVSPDEFLVG 317

Query: 356 TISSTQPAR--GSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKL 413
           T+ +T P +  G   +  L KT  STLPP+LNAIE +I  +  Q  T+ +DV AI  I+ 
Sbjct: 318 TLFNTSPVKCEGGTCHLQLIKTPKSTLPPLLNAIEAFITVEFPQSETNANDVLAIKSIET 377

Query: 414 SYDLGK-GWQGDPCSPMYYSWDGLNCSY-NGYKPPKIISLNLTSEGLTGKISPSLSNLKS 471
           SY L +  WQGDPC P    WDGL C Y N   PP+I SL+L+S  LTG I P + NL  
Sbjct: 378 SYGLSRISWQGDPCVPQQLLWDGLTCEYTNMSTPPRIHSLDLSSSELTGIIVPEIQNLTE 437

Query: 472 LENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNP 531
           L+ LD SNN+LTG +PEFL+++  L V+NL GN LSGSVP +L+ + +NG L L+I  NP
Sbjct: 438 LKKLDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNKVKNG-LKLNIQGNP 496

Query: 532 DLCLSAPCKKEKRNSVMPVVA--ASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEG 589
           +LC S+ C K+K + ++PVVA  AS++ ++ +IALL F   KR+ ++R       S  + 
Sbjct: 497 NLCFSSSCNKKKNSIMLPVVASLASLAAIIAMIALL-FVCIKRRSSSR----KGPSPSQQ 551

Query: 590 SLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQF 649
           S+++  +++TY+E++ +T  F R+LGKGGFG VYHGY+    EVA+K+LS SS+QG K+F
Sbjct: 552 SIETIKKRYTYAEVLAMTKKFERVLGKGGFGMVYHGYINGTEEVAVKLLSPSSAQGYKEF 611

Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
           +TE +LL+RV+H NL SLVGYC++  ++ L+Y+YM  G+LK++        +SW DRL I
Sbjct: 612 KTEVELLLRVYHTNLVSLVGYCDEKDHLALIYQYMVNGDLKKHF--SGSSIISWVDRLNI 669

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           AVDAA GLEYLH GCKP I+HRDVK++NILL++++QAKLADFG S+ FP   ESH+ST +
Sbjct: 670 AVDAASGLEYLHIGCKPLIVHRDVKSSNILLDDQLQAKLADFGLSRSFPIGDESHVSTLV 729

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
            GT GYLD EYY +NRL+EKSDVYSFG+VLLE+IT  P I    +  HI   V   L RG
Sbjct: 730 AGTFGYLDHEYYQTNRLSEKSDVYSFGVVLLEIITNKPVIDHNRDMPHIAEWVKLMLTRG 789

Query: 830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ- 888
           D+ +I+DP+L+  +D+ S WK  E AM CV   S +RP MSHVV ELK+CL  E  R + 
Sbjct: 790 DISNIMDPKLQGVYDSGSAWKALELAMTCVNPSSLKRPNMSHVVHELKECLVSENNRTRD 849

Query: 889 IQRTKSQMLSLSSSVDIS 906
           I  ++S  ++LS   D++
Sbjct: 850 IDTSRSMDINLSFGTDVN 867

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1

 Score =  704 bits (1818), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/858 (44%), Positives = 543/858 (63%), Gaps = 39/858 (4%)

Query: 53  HARRKLDDIGGDISIDCGVP-AGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQ 111
           H  +  D IG  I++DCG+   G  Y +  T L+Y SD+ F+++G    I+ +  S   +
Sbjct: 16  HLVQAQDPIGF-INLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITKELESL-YK 73

Query: 112 NTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDS 171
               T+R FP+G RNC+SL    G    YL + +F+YG+YD  + +P+FDLYIG N W +
Sbjct: 74  KPERTLRYFPDGVRNCFSLNVTRGTK--YLIKPTFLYGNYDGRNVIPDFDLYIGPNMWIT 131

Query: 172 IKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLY 231
           +  DN     IKEI+H +  + + VCL+ TG   P+I+ LELR   +  Y  +SG+L   
Sbjct: 132 VNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNESGSLNYL 187

Query: 232 RRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTA 291
            R+   S     I + DD +DRIW     +     + T+  I+  V + Y LP  VMKTA
Sbjct: 188 FRVYY-SNLKGYIEYPDDVHDRIWKQILPYQDWQILTTNLQIN--VSNDYDLPQRVMKTA 244

Query: 292 VKPMNVNDS-LDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPE 350
           V P+  + + ++F + +  PT QFY+++HFAEL+S Q N+ REF++ LNGN+  KS  P+
Sbjct: 245 VTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREFNVVLNGNVTFKSYSPK 304

Query: 351 YLQSKTISSTQPAR--GSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAI 408
           +L+ +T+ ST P +  G K    L KTS STLPP++NA+E Y + D  Q  T+ D+V AI
Sbjct: 305 FLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAI 364

Query: 409 MDIKLSYDLGKG-WQGDPCSPMYYSWDGLNCS-YNGYKPPKIISLNLTSEGLTGKISPSL 466
            +I+ +Y L K  WQGDPC P  + WDGLNC+  +   PP I SLNL+S GLTG I  ++
Sbjct: 365 KNIQSTYGLSKTTWQGDPCVPKKFLWDGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTI 424

Query: 467 SNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLS 526
            NL +L+ LDLSNN+L+G +PEFL+ +  L V+NL GN LSG VP  L+ +     L L+
Sbjct: 425 QNLANLQELDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKM---LKLN 481

Query: 527 IGRNPDL-CLSAPC-------KKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKR---- 574
           I  NP L C    C        ++ ++  +P+VA+  S++   +AL++F   ++      
Sbjct: 482 IEGNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASIGSVVAFTVALMIFCVVRKNNPSND 541

Query: 575 ----AARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADG 630
               +  L  D+  S  E ++ + N++FTY+E++ +TNNF +ILGKGGFG VY+G +   
Sbjct: 542 EAPTSCMLPADSRSS--EPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNGT 599

Query: 631 SEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK 690
            +VA+KMLS SS+QG KQF+ E +LL+RVHH+NL  LVGYC +G  + L+YEYMA G+L 
Sbjct: 600 EQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLD 659

Query: 691 QYLFDETKEA-LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA 749
           +++  +   + L+W  RL+IA++AAQGLEYLH+GCKP ++HRDVKT NILLNE    KLA
Sbjct: 660 EHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLA 719

Query: 750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
           DFG S+ FP E E+H+ST + GT+GYLDPEYY +N LTEKSDVYSFG+VLL +IT  P I
Sbjct: 720 DFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPVI 779

Query: 810 IRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTM 869
            +     HI   V   L +GD++SI DP L  ++++ SVWK  E AM C+   S  RPTM
Sbjct: 780 DQNREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTM 839

Query: 870 SHVVTELKKCLEMETARE 887
           S VV ELK+CL  E++RE
Sbjct: 840 SQVVFELKECLASESSRE 857

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	919
255549760	1234	Serine/threonine-protein kinase-transfor	0.959	0.714	0.636	0.0
297743150	918	unnamed protein product [Vitis vinifera]	0.994	0.995	0.613	0.0
356557314	875	PREDICTED: putative leucine-rich repeat	0.912	0.958	0.611	0.0
359482547	896	PREDICTED: putative leucine-rich repeat	0.963	0.987	0.527	0.0
225442394	879	PREDICTED: putative leucine-rich repeat	0.930	0.972	0.543	0.0
147800914	809	hypothetical protein VITISV_044244 [Viti	0.874	0.993	0.512	0.0
297743155	873	unnamed protein product [Vitis vinifera]	0.937	0.987	0.508	0.0
255549700	884	BRASSINOSTEROID INSENSITIVE 1-associated	0.930	0.967	0.531	0.0
255549714	915	BRASSINOSTEROID INSENSITIVE 1-associated	0.909	0.913	0.519	0.0
255549712	884	BRASSINOSTEROID INSENSITIVE 1-associated	0.926	0.962	0.513	0.0

>gi|255549760|ref|XP_002515931.1| Serine/threonine-protein kinase-transforming protein raf, putative [Ricinus communis] gi|223544836|gb|EEF46351.1| Serine/threonine-protein kinase-transforming protein raf, putative [Ricinus communis]

 Score = 1180 bits (3052), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 565/888 (63%), Positives = 705/888 (79%), Gaps = 6/888 (0%)

Query: 35  LASDATSSGKSE-KFVGHKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFI 93
           +AS ++    SE K +   H RRKLDDI G I+IDCG+       + KT + Y SD  + 
Sbjct: 1   MASGSSRFRNSEAKSIVQMHTRRKLDDIAGSINIDCGLSEDSSSTEVKTGMHYISDTLYT 60

Query: 94  RTGVNKNISSKFMS-ANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYD 152
            TGVNK ISS F S A    +  TVRSF +G RNCY+LRPPEGKA  YL RASFMYG+YD
Sbjct: 61  NTGVNKKISSNFSSDAQFPVSLMTVRSFSQGIRNCYTLRPPEGKASIYLIRASFMYGNYD 120

Query: 153 DEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALE 212
           + ++LP+F LY+GVN WD++KFDNASHVVIKEIIH   +++I VCLLNTG GTPFISALE
Sbjct: 121 NLNQLPQFSLYLGVNLWDTVKFDNASHVVIKEIIHVPALNDIYVCLLNTGSGTPFISALE 180

Query: 213 LRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFI 272
           LRHFHN+TYRT+SG+LVL++RLD GSTT +I+R+ DD YDRIW PY   P  A+++TSF 
Sbjct: 181 LRHFHNSTYRTESGSLVLFQRLDFGSTTNEIVRYHDDAYDRIWFPY-NCPQYAALSTSFA 239

Query: 273 IDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYR 332
           +DSL  + + LPS VM+TAV+PMN N+SL+F+F+IG P + FY+YMHFAE+ES Q NQYR
Sbjct: 240 VDSLKTTDFNLPSKVMQTAVEPMNANESLNFEFDIGTPNMNFYIYMHFAEVESIQRNQYR 299

Query: 333 EFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYIL 392
            F+I LNG L+ + VV +YLQS TIS+ QP RG+K++ SL K  NSTLPPILNA+EIY++
Sbjct: 300 GFNIALNGKLFNEGVVLKYLQSMTISTMQPMRGAKISISLNKLPNSTLPPILNAMEIYLM 359

Query: 393 TDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLN 452
            +  Q+PT Q+D N+I DI  SY++GKGWQGDPC P   +WDGLNCS NGY PP+IISLN
Sbjct: 360 NEFWQQPTYQEDANSIEDIMSSYNVGKGWQGDPCLPAP-AWDGLNCSDNGYDPPRIISLN 418

Query: 453 LTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPT 512
           L+S G+TG+IS SLSNLK L++LDLSNNSLTG++PEFLSQLP L++LNL GN+LSGS+P+
Sbjct: 419 LSSIGITGQISSSLSNLKFLQHLDLSNNSLTGAVPEFLSQLPDLKILNLGGNRLSGSIPS 478

Query: 513 SLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLVFWTYKR 572
           +L+ +S N SLLL +  NP+LCL + C+KEK++  +P+VA  V L  I +AL++ W YKR
Sbjct: 479 ALMEKSNNQSLLLRLDGNPELCLLSTCEKEKKSVFVPIVATVVPLAAIFLALIILWRYKR 538

Query: 573 KRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE 632
           ++  R +V NS  ++  SLKSD +QFTY++IV ITNNF  ++GKGGFGTVYHG+L DG++
Sbjct: 539 RKVPRRSV-NSQKEEGSSLKSDKRQFTYAKIVRITNNFSTVIGKGGFGTVYHGHLTDGTQ 597

Query: 633 VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQY 692
           VA+KMLSA+S+QG  QFRTEA LLMRVHHRNLAS +GYCN+G N+G++YEYMA GNL+QY
Sbjct: 598 VAVKMLSATSAQGSNQFRTEAHLLMRVHHRNLASFIGYCNEGTNIGIIYEYMACGNLEQY 657

Query: 693 LFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG 752
           L D++ E L+WK+RLQIA+DAAQGLEYLHHGCKPPIIHRDVK ANILLNE +QAK+ADFG
Sbjct: 658 LSDKSIEPLTWKERLQIALDAAQGLEYLHHGCKPPIIHRDVKCANILLNENLQAKVADFG 717

Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRG 812
           FSK  P+ES SH+ST++VGTVGYLDPEYY+SNRLTEKSDVYSFGIVLLELITG PAI+R 
Sbjct: 718 FSKCLPSESRSHMSTAVVGTVGYLDPEYYSSNRLTEKSDVYSFGIVLLELITGQPAIMRN 777

Query: 813 YN-NTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSH 871
            + N HIV+ V PF+ERGD+RS  DPRL+   DTNS WK  E AM CVP I   RPTM+H
Sbjct: 778 RDENIHIVHWVRPFIERGDIRSAADPRLQGKLDTNSAWKFMEIAMSCVPPIMIHRPTMNH 837

Query: 872 VVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAVEVETEMGPEAR 919
           VV ELK+CL  E AREQ  R + Q + LS+S ++ AV++ETEMGPEAR
Sbjct: 838 VVAELKECLGTEIAREQNCRMEGQAMRLSNSFEMIAVDLETEMGPEAR 885

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297743150|emb|CBI36017.3| unnamed protein product [Vitis vinifera]

 Score = 1166 bits (3017), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 566/923 (61%), Positives = 710/923 (76%), Gaps = 9/923 (0%)

Query: 1   MGSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDD 60
           M  +C+ + A+   +  IF+ +FA+ + +E+   LASD    G SE  +  K ARRKLDD
Sbjct: 1   MFVECRGTYAWSSKVCLIFLQVFALTISMEESVALASDGVF-GNSESVINRKPARRKLDD 59

Query: 61  IGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSF 120
           I G I+IDCG+P    Y+D +T L Y SD  FIR+G+NKNISSKF S  L  +   VRSF
Sbjct: 60  IAGSINIDCGLPEDCKYIDAETGLQYTSDASFIRSGINKNISSKFSSTTLHKSLTNVRSF 119

Query: 121 PEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHV 180
           P+G RNCY+LRPPEG    YL RASFMYG+YD+ +++P+FDLYIGVN WDS+K DNASH+
Sbjct: 120 PQGKRNCYTLRPPEGHGTMYLIRASFMYGNYDELNQVPQFDLYIGVNMWDSVKLDNASHL 179

Query: 181 VIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTT 240
           V+KEI+H+   D+I VCL+N G G PFIS+LE+RHFH+++Y+T+SG+L LYRRLD GSTT
Sbjct: 180 VMKEILHAPSDDDIYVCLVNIGYGEPFISSLEVRHFHDSSYKTESGSLALYRRLDAGSTT 239

Query: 241 TQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDS 300
            +I+RFKDD YDRIW PY   P   S+NT+  IDS  +++Y+LPS VM TA++PMN + S
Sbjct: 240 NEIVRFKDDAYDRIWFPY-NLPDCESLNTTVPIDSHAETEYKLPSKVMTTAIRPMNSSAS 298

Query: 301 LDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLW-EKSVVPEYLQSKTISS 359
           LDFDF+IGD TL+FYVYMHFAELE  Q NQ R FSI LNGN W E ++VP+YL S+T+++
Sbjct: 299 LDFDFDIGDSTLEFYVYMHFAELEGLQENQTRNFSITLNGNPWGEANIVPKYLHSRTVNN 358

Query: 360 TQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK 419
            QP RGSKL FS+ KT NS+LPPILNA+EIY++   LQ PT Q+DVN I  IK  Y + K
Sbjct: 359 KQPVRGSKLKFSIYKTLNSSLPPILNAMEIYMVKGLLQAPTCQEDVNGISRIKSFYLVEK 418

Query: 420 GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSN 479
            WQGDPC+P+   WDGL CS NGY+ P+IISL L+S GL G ISPSL NL +L+ LDLSN
Sbjct: 419 NWQGDPCAPVQ-PWDGLTCSNNGYESPRIISLKLSSSGLRGTISPSLLNLTALQFLDLSN 477

Query: 480 NSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPC 539
           NSLTG +PEFLS+L  L  LN+ GNKLSGSVP  L+ARS+ GSL LS+  NPDLC SA C
Sbjct: 478 NSLTGELPEFLSRLSFLTALNVTGNKLSGSVPPDLIARSEKGSLSLSVANNPDLCPSAQC 537

Query: 540 KKEKRNSVMPVVAASVS-LLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQF 598
           K E +NSV P+VAA VS L++I +AL++ W+ KR++ A  ++  S  ++  SLK +NQ+F
Sbjct: 538 K-ENKNSVGPIVAAVVSSLVIIFLALVIIWSLKRRKKATKSLVRS-PEETWSLKMENQRF 595

Query: 599 TYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMR 658
            Y EIV ITN+F  +LG GGFGTVYHG + +G++VAIKMLS SS QG K+FR EA+LLMR
Sbjct: 596 RYLEIVSITNDFQTVLGTGGFGTVYHGCMLNGTQVAIKMLSQSSKQGMKEFRNEARLLMR 655

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQG 716
           VHHRNLASLVGYC++G N+GL+YEYMA GNL+ YL   D +   LSW +RLQIAVDAAQG
Sbjct: 656 VHHRNLASLVGYCHEGTNMGLIYEYMAGGNLQNYLSGADISTSPLSWIERLQIAVDAAQG 715

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           LEY+H GCKPPIIHRDVKTANILL+EK+QAK+ADFGFS+ F  ESE+H +T++VGT+GY+
Sbjct: 716 LEYMHCGCKPPIIHRDVKTANILLSEKLQAKIADFGFSRFFSIESETHATTAVVGTIGYI 775

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
           DPEYY SNRLTEKSDVYSFGIVLLELITG PAII+  +N HIV  V  F+ERGD+ SIVD
Sbjct: 776 DPEYYISNRLTEKSDVYSFGIVLLELITGKPAIIKDEDNIHIVQWVRSFVERGDIGSIVD 835

Query: 837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQM 896
           PRL+ N +TNSVW+V ETAM C+P IS QR TMSHVV +LK+CLE E A +Q +R + Q 
Sbjct: 836 PRLQGNLNTNSVWRVLETAMACLPPISIQRVTMSHVVMQLKECLEEEKAHDQTRRMEEQA 895

Query: 897 LSLSSSVDISAVEVETEMGPEAR 919
              S+ +D+ ++++E EMGPEAR
Sbjct: 896 TKSSNLIDLYSLDLELEMGPEAR 918

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557314|ref|XP_003546962.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Glycine max]

 Score = 1077 bits (2786), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 528/864 (61%), Positives = 644/864 (74%), Gaps = 25/864 (2%)

Query: 51  HKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANL 110
           HK  RRKLDD+ G I IDCG+  G  Y D+KTQ+ Y SD +FI TG +K+IS KF+S   
Sbjct: 10  HKQGRRKLDDVTGSICIDCGIAEGLDYTDDKTQIHYTSDAQFIGTGTSKSISHKFISDTP 69

Query: 111 QNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWD 170
           Q T+  VRSFPEG +NCY+LR PEG+   YL RASFMYG+YDD +KLP+FDLYIGVN WD
Sbjct: 70  QRTFTNVRSFPEGKKNCYTLRHPEGRNTIYLIRASFMYGNYDDLNKLPQFDLYIGVNLWD 129

Query: 171 SIKFDNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVL 230
           ++ F+NA+HVVIKEI+H   +DE+ VCLLNT KGTPFISALE+RHF +++YRT+S  L L
Sbjct: 130 TVMFENATHVVIKEILHVPSLDELYVCLLNTDKGTPFISALEVRHFDHSSYRTKSELLSL 189

Query: 231 YRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKT 290
           YRR D+GSTT +I+R+  D YDR+W PY   P S  +NTSF +DSL  + Y LPSAVMKT
Sbjct: 190 YRRFDIGSTTNEIVRYDKDVYDRMWYPY-NLPDSTPLNTSFTVDSLNHTAYHLPSAVMKT 248

Query: 291 AVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPE 350
           AV+P N NDSL+F+F+ G PT + YVYMHFAE+E    N+ R F I LNG LW + V P 
Sbjct: 249 AVRPTNENDSLEFEFDTGQPTSESYVYMHFAEIEVLNENECRAFDITLNGKLWAEYVTPT 308

Query: 351 YLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMD 410
           YLQS TI   Q  RGSKL FS+ K  NST PPILNA+EIYI+ + L  PT+QDDV AI+D
Sbjct: 309 YLQSNTIDGNQSIRGSKLKFSMHKKPNSTHPPILNAMEIYIVKEFLHSPTNQDDVKAIID 368

Query: 411 IKLSYDL----GKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSL 466
           IK  Y L    GK WQGDPC+P  YSW+GLNCS NGY PP I +L L S GL G I  S 
Sbjct: 369 IKSHYKLTSSVGKSWQGDPCAPSKYSWNGLNCSNNGYNPPTITALYLASSGLGGTIIASF 428

Query: 467 SNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLS 526
             LK LE+LDLSNNSLTG +P+F SQL  L+ LNL GN+LSG +P+ L  RS NGSLLLS
Sbjct: 429 LELKFLESLDLSNNSLTGPLPDF-SQLQHLKALNLSGNRLSGEIPSLLKERSNNGSLLLS 487

Query: 527 IGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLVILIALLV----FWTYK------RKRAA 576
           +  N DLC   PC+++K N + P+VA  +S++V  I L +     W  +       K+A 
Sbjct: 488 VDGNLDLCREGPCEEDKMN-IAPLVAGILSVVVFFIVLGIVLNIIWRRRCNRKPASKQAV 546

Query: 577 RLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIK 636
           RLN       +E  LK++N QFTYS+I  ITNNF +++GKGG G VY G L DG++VA+K
Sbjct: 547 RLN-------EEVVLKTNNTQFTYSQISTITNNFDKMIGKGGCGIVYLGSLQDGTQVAVK 599

Query: 637 MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
           ML     QG +QF+TEAQLLMRVHH+NLAS VGYCN+ G+ G++YEYMAYGNL++YL D 
Sbjct: 600 MLLPKCPQGSQQFQTEAQLLMRVHHKNLASFVGYCNEVGHTGIIYEYMAYGNLEEYLSDA 659

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            +E LSW+ R+QIAVDAAQG+EYLHHGCKPPIIHRD+KTANILLNEKMQAK+ADFGFSK+
Sbjct: 660 RREPLSWRQRIQIAVDAAQGIEYLHHGCKPPIIHRDIKTANILLNEKMQAKVADFGFSKL 719

Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT 816
           F AE+ESH+ST ++GT+GYLDPEYY S+RLTEKSDVYSFGIVLLELITG PAII+G+ NT
Sbjct: 720 FSAENESHVSTVVIGTLGYLDPEYYTSSRLTEKSDVYSFGIVLLELITGQPAIIKGHQNT 779

Query: 817 HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
           HI   V  FL +GD++ IVDPRL  +FD  SVWK  E A+ CVPSIS QRP+MS++V EL
Sbjct: 780 HIAQWVNNFLAKGDIQQIVDPRLRGDFDFGSVWKALEAAIACVPSISIQRPSMSYIVGEL 839

Query: 877 KKCLEMETAREQIQRTKSQMLSLS 900
           K+ LEME ARE I  T S  ++LS
Sbjct: 840 KESLEMEAARE-ITMTFSSKVALS 862

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482547|ref|XP_002277236.2| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Vitis vinifera]

 Score =  951 bits (2457), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 481/911 (52%), Positives = 627/911 (68%), Gaps = 26/911 (2%)

Query: 14  MMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPA 73
           ++R IF+ LF I        ++A     +  + +   H   RR   D  G ISIDCG+  
Sbjct: 7   LVRLIFV-LFTIISSGNNPELVAGKPHHTASTFQH-NHPSPRRLAADTQGFISIDCGIAP 64

Query: 74  GFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPP 133
           G  Y D+KTQ+ Y SD +F  TG+N N+S    S N       VRSFPEG RNCY+L P 
Sbjct: 65  GSYYTDDKTQIPYTSDADFTDTGINYNVSR---SENPSKQLMNVRSFPEGARNCYTLEPE 121

Query: 134 EGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDE 193
           +GK   YL RA FMYG+YD +++LP F L++GV+ WD+I F+N+S  V KEIIH    D 
Sbjct: 122 KGKGNKYLIRAFFMYGNYDSKNQLPVFKLHLGVDEWDTINFNNSSQTVRKEIIHVPKTDY 181

Query: 194 INVCLLNTGKGTPFISALELRHFHNATY-RTQSGALVLYRRLDVGSTTTQI-IRFKDDHY 251
           I+VCL+N G GTPFISALELR   N++Y +T+SG+L+L+ R D+GS   ++ +R+KDD  
Sbjct: 182 IDVCLVNNGSGTPFISALELRPLGNSSYNKTESGSLLLFNRWDIGSEQEKLQVRYKDDAL 241

Query: 252 DRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPT 311
           DRIW  Y       SI   F   S  +++++LP  +M TA  P N ++ L F  ++ DP+
Sbjct: 242 DRIWNSYMS-TSWESITAGFESYSYSETRFKLPGIIMSTAATPKNESEPLRFFLDMDDPS 300

Query: 312 LQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFS 371
            +FY+YMHF+E+   QGNQ R F+I LNGNLW  +V PE L S TI ST   RGS+L+FS
Sbjct: 301 QRFYLYMHFSEVLQLQGNQSRVFTIWLNGNLWSDAVAPERLTSTTIFSTNSVRGSRLSFS 360

Query: 372 LCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYY 431
           L KT  S LPPI+NA+E+Y++ +  Q  TDQ+DV AI  IK  Y + + WQGDPC PM Y
Sbjct: 361 LQKTGESMLPPIINALEVYVIKEFSQSTTDQEDVEAIKKIKSVYMVRRNWQGDPCLPMDY 420

Query: 432 SWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS 491
            WDGL CS NG   P +ISLNL+   LTGKI PS SNLKSL+NLDLS N+LTGS+PEFL+
Sbjct: 421 QWDGLKCSDNG--SPTLISLNLSYSNLTGKIHPSFSNLKSLQNLDLSYNNLTGSVPEFLA 478

Query: 492 QLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCK-KEKRNSVMPV 550
           +L  L  LNL+GN L+GSVP +L+ + QNG+L LS+  NP+LCLS  CK K+ +N ++PV
Sbjct: 479 ELSSLTFLNLEGNNLTGSVPQALMEKYQNGTLSLSLRENPNLCLSVSCKGKQNKNFIVPV 538

Query: 551 VAASVSLLVI--LIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITN 608
           +A+ +S+LV+  LIA+ + W +KRK            +  GSLKS N +FTYSE+V IT 
Sbjct: 539 LASIISVLVLFLLIAVGIIWNFKRK------------EDTGSLKSGNSEFTYSELVAITR 586

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           NF   +G+GGFG V+ G L DG++VA+K+ S SS QG K+FR EA+LLMRVHH+NL  LV
Sbjct: 587 NFTSTIGQGGFGNVHLGTLVDGTQVAVKLRSQSSMQGSKEFRAEAKLLMRVHHKNLVRLV 646

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           GYCNDG N+ L+YEYM+ GNL+Q L +   + L WK+RLQIAVDAAQGLEYLH+GCKPPI
Sbjct: 647 GYCNDGTNMALIYEYMSNGNLRQRLSERDTDVLHWKERLQIAVDAAQGLEYLHNGCKPPI 706

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+KT+NILLNEK+QAK+ADFG S+    ES   +ST   GT GYLDPEYY+S  L +
Sbjct: 707 IHRDLKTSNILLNEKLQAKIADFGLSRDLATESGPPVSTVPAGTPGYLDPEYYSSGNLNK 766

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           +SDVYSFGIVLLELITG PAII    N HIV  + P +ERGD++++VDPRL+ +F+TNS 
Sbjct: 767 RSDVYSFGIVLLELITGQPAIITP-GNIHIVQWISPMIERGDIQNVVDPRLQGDFNTNSA 825

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAV 908
           WK  ETA+ CVPS + QRP MSHV+ +LK CLE+E    + QR  S  +  S+++   AV
Sbjct: 826 WKALETALACVPSTAIQRPDMSHVLADLKDCLEIEVGAMRTQRIDSYKMGSSNTLKSCAV 885

Query: 909 EVETEMGPEAR 919
           ++E EM P  R
Sbjct: 886 DLENEMAPHVR 896

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225442394|ref|XP_002276980.1| PREDICTED: putative leucine-rich repeat receptor-like protein kinase At2g19210-like [Vitis vinifera]

 Score =  936 bits (2420), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/864 (54%), Positives = 616/864 (71%), Gaps = 9/864 (1%)

Query: 60  DIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRS 119
           D  G ISIDCG+  G  Y D  T + Y SD +FI TG NK+IS    S NL    ++VR+
Sbjct: 21  DQSGFISIDCGMAEGTDYNDATTSILYTSDAQFIDTGTNKSISPDLESENLPKYLSSVRA 80

Query: 120 FPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASH 179
           FPEG +NCY+ +  +G    YL R+ FMYG+YD +++ PEF LY+  + WDS+K +N+S 
Sbjct: 81  FPEGLKNCYTFKLVQGNK--YLIRSVFMYGNYDSKNQAPEFGLYLNADEWDSVKLENSSD 138

Query: 180 VVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGST 239
           VV+KEIIH    +  +VCL+NTG GTPFISALELR  ++  Y+TQS +LVL  RLD+GST
Sbjct: 139 VVVKEIIHVQETNYSHVCLVNTGLGTPFISALELRLLNSTIYKTQSASLVLATRLDIGST 198

Query: 240 TTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVND 299
           +   IRFKDD YDRIW PY        ++  +  D L  + + LP  VM TAV P N + 
Sbjct: 199 SNDTIRFKDDDYDRIWKPYTSSSWEL-VSLRYASDLLSANPFILPPRVMTTAVTPKNGSR 257

Query: 300 SLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISS 359
           SL+  ++  D T QFYVYMHFAE+E      YR F+I LNG+ W   +  +YL   T+ S
Sbjct: 258 SLELQYDPDDATKQFYVYMHFAEVEELGDGGYRNFTILLNGDFWYGPMSVQYLSPVTVYS 317

Query: 360 TQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK 419
                G+ L  SL + ++S  PPILNA+E+Y + + LQ PT+Q DV AI ++K  Y + +
Sbjct: 318 QYTVSGTSLELSLVQANDSKFPPILNAVELYWVKEFLQSPTEQSDVEAIRNVKSVYGVKR 377

Query: 420 GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSN 479
            WQGDPC+P  + WDGL CSYNGY  P+IISL+L+S GL+GKI  SLSNL+SL+ LDLSN
Sbjct: 378 NWQGDPCAPKKHLWDGLECSYNGYNSPRIISLDLSSSGLSGKIDSSLSNLESLQYLDLSN 437

Query: 480 NSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPC 539
           NSLTG +P+FLSQLPLL+ LNL GN+ +GSVP+ L+ RS+NGSL LS+  NP+LC+ A C
Sbjct: 438 NSLTGEVPDFLSQLPLLKTLNLSGNEFTGSVPSLLIQRSKNGSLSLSVDGNPNLCVMASC 497

Query: 540 KKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDN-SHSKKEGSLKSDNQQF 598
              K++ V+PV+A+   +LV+LIA L+ W  KR+R  R  +++ ++ +++G L+S N QF
Sbjct: 498 NN-KKSVVIPVIASIAVVLVLLIAFLILWGLKRRRQQRQVLESKANYEEDGRLESKNLQF 556

Query: 599 TYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMR 658
           TYSE+V+ITNNF ++LGKGGFG+VY GYL DG++VA+KMLS  S+QG K+FR+EAQLL +
Sbjct: 557 TYSELVNITNNFQKVLGKGGFGSVYGGYLNDGTQVAVKMLSEQSAQGFKEFRSEAQLLTK 616

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
           VHHRNLA L+GYCN+G   G+VYEYMA GNL+++L  +    LSW+ RLQIAVDAAQ  E
Sbjct: 617 VHHRNLAPLIGYCNEGRYKGIVYEYMANGNLREHLSGKDTPVLSWEQRLQIAVDAAQAFE 676

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH GCKPPIIHRDVKT+NILL+ K+QAK+ADFG S+  P+ES + +ST + GT GYLDP
Sbjct: 677 YLHEGCKPPIIHRDVKTSNILLDGKLQAKVADFGLSRFMPSESRTIVSTQVAGTPGYLDP 736

Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
           EYY SN L EKSDVY+FGIVLLEL+TG PAII G+ NTH+V+ + P L  G++RSIVD R
Sbjct: 737 EYYISNNLNEKSDVYAFGIVLLELVTGHPAIIPGHENTHLVDWLSPRLAGGEIRSIVDSR 796

Query: 839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQI---QRTKSQ 895
           L  +F+ NS WK+ ETAM CVP  S QRPTMS VV +LK+CL+ME  R +     RT   
Sbjct: 797 LNGDFNPNSAWKLVETAMACVPRSSIQRPTMSQVVADLKECLQMEMHRNKSASQSRTYQD 856

Query: 896 MLSLSSSVDISAVEVETEMGPEAR 919
             S ++S+D+ AVE++  M P AR
Sbjct: 857 TASSANSIDLFAVELDVSM-PHAR 879

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147800914|emb|CAN68923.1| hypothetical protein VITISV_044244 [Vitis vinifera]

 Score =  905 bits (2339), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 474/924 (51%), Positives = 605/924 (65%), Gaps = 120/924 (12%)

Query: 1   MGSKCKSSRAYDLMMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDD 60
           M  +C+ + A+   +  IF+ +FA+ + +E+   LASD    G SE  +  K ARRKLDD
Sbjct: 1   MFVECRGTYAWSSKVCLIFLQVFALTISMEESVALASDGVF-GDSESVINRKPARRKLDD 59

Query: 61  IGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSF 120
           I G I+IDCG+P    Y+D +T L Y SD  FIR+G+NKNISSKF S  L  +   VRSF
Sbjct: 60  IAGSINIDCGLPEDCKYIDAETGLQYTSDASFIRSGINKNISSKFSSTTLHKSLTNVRSF 119

Query: 121 PEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHV 180
           P+G RNCY+LRPPEG    YL RASFMYG+YD+ +++P+FDLYIGVN WDS+K DNASH+
Sbjct: 120 PQGKRNCYTLRPPEGHGTMYLIRASFMYGNYDELNQVPQFDLYIGVNMWDSVKLDNASHL 179

Query: 181 VIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTT 240
           V+KEI+H+   D+I VCL+N G G PFIS+LE+RHFH+++Y+T+SG+L LYRRLD GSTT
Sbjct: 180 VMKEILHAPSDDDIYVCLVNIGYGEPFISSLEVRHFHDSSYKTESGSLALYRRLDAGSTT 239

Query: 241 TQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDS 300
            +I+RFKDD YDRIW PY   P   S+NT+  IDS  +++Y+LPS VM TA++PMN + S
Sbjct: 240 NEIVRFKDDAYDRIWFPY-NLPDCESLNTTVPIDSHAETEYKLPSKVMTTAIRPMNSSAS 298

Query: 301 LDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLW-EKSVVPEYLQSKTISS 359
           LDFDF+IGD TL+FYVYMHFAELE  Q NQ R FSI LNGN W E ++VP+YL S+T+++
Sbjct: 299 LDFDFDIGDSTLEFYVYMHFAELEGLQENQTRNFSITLNGNPWGEANIVPKYLHSRTVNN 358

Query: 360 TQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK 419
            QP RGSKL FS+ KT NS+LPPILNA+EIY++ D LQ PT Q+DVN I  IK  Y + K
Sbjct: 359 KQPVRGSKLKFSIYKTLNSSLPPILNAMEIYMVKDLLQAPTCQEDVNGISRIKSFYLVEK 418

Query: 420 GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSN 479
            WQGDPC+P+   WDGL CS NGY+ P+IISLNL+S G                      
Sbjct: 419 NWQGDPCAPVQ-PWDGLTCSNNGYESPRIISLNLSSSG---------------------- 455

Query: 480 NSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPC 539
             L G+I   L  L  L+ L+L  N L+             G L   + R   L      
Sbjct: 456 --LRGTISPSLLNLTALQFLDLSNNSLT-------------GELPEFLSRLSFLTALNVT 500

Query: 540 KKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFT 599
             +   SV P + A                    R+ + ++     ++  SLK +NQ+F 
Sbjct: 501 GNKLSGSVPPDLIA--------------------RSEKGSLSLRSPEETWSLKMENQRFR 540

Query: 600 YSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           YSEI                                                 A+LLMRV
Sbjct: 541 YSEI-------------------------------------------------ARLLMRV 551

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQG- 716
           HHRN+ASLVGYC++G N+GL+YEYMA GNL+ YL   D +   LSW +RLQIAVDAAQG 
Sbjct: 552 HHRNVASLVGYCHEGTNMGLIYEYMAGGNLQNYLSGADISTSPLSWIERLQIAVDAAQGV 611

Query: 717 -LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            LEY+H GCKPPIIHRDVKTANILL+EK+QAK+ADFGFS+ F  ESE+H +T++VGT+GY
Sbjct: 612 GLEYMHCGCKPPIIHRDVKTANILLSEKLQAKIADFGFSRFFSIESETHATTAVVGTIGY 671

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV 835
           +DPE      LTEKSDVYSFGIVLLELITG PAII+  +N HIV  V  F+ERG++ SIV
Sbjct: 672 IDPE------LTEKSDVYSFGIVLLELITGKPAIIKDEDNIHIVQWVRSFVERGNIGSIV 725

Query: 836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQ 895
           DPRL+ N +TNSVW+V ETAM C+P I+ QR TMSHVV +LK+CLE E A +Q +R + Q
Sbjct: 726 DPRLQGNLNTNSVWRVLETAMACLPPIAIQRVTMSHVVMQLKECLEEEKAHDQTRRMEEQ 785

Query: 896 MLSLSSSVDISAVEVETEMGPEAR 919
               S+S+D+ ++++E EMGPEAR
Sbjct: 786 ATESSNSIDLYSLDLELEMGPEAR 809

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297743155|emb|CBI36022.3| unnamed protein product [Vitis vinifera]

 Score =  897 bits (2318), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 463/911 (50%), Positives = 605/911 (66%), Gaps = 49/911 (5%)

Query: 14  MMRFIFISLFAICVCIEKQTVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPA 73
           ++R IF+ LF I        ++A     +  + +   H   RR   D  G ISIDCG+  
Sbjct: 7   LVRLIFV-LFTIISSGNNPELVAGKPHHTASTFQH-NHPSPRRLAADTQGFISIDCGIAP 64

Query: 74  GFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPP 133
           G  Y D+KTQ+ Y SD +F  TG+N N+S    S N       VRSFPEG RNCY+L P 
Sbjct: 65  GSYYTDDKTQIPYTSDADFTDTGINYNVSR---SENPSKQLMNVRSFPEGARNCYTLEPE 121

Query: 134 EGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDE 193
           +GK   YL RA FMYG+YD +++LP F L++GV+ WD+I F+N+S  V KEIIH    D 
Sbjct: 122 KGKGNKYLIRAFFMYGNYDSKNQLPVFKLHLGVDEWDTINFNNSSQTVRKEIIHVPKTDY 181

Query: 194 INVCLLNTGKGTPFISALELRHFHNATY-RTQSGALVLYRRLDVGSTTTQI-IRFKDDHY 251
           I+VCL+N G GTPFISALELR   N++Y +T+SG+L+L+ R D+GS   ++ +R+KDD  
Sbjct: 182 IDVCLVNNGSGTPFISALELRPLGNSSYNKTESGSLLLFNRWDIGSEQEKLQVRYKDDAL 241

Query: 252 DRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPT 311
           DRIW  Y       SI   F   S  +++++LP  +M TA  P N ++ L F  ++ DP+
Sbjct: 242 DRIWNSYMS-TSWESITAGFESYSYSETRFKLPGIIMSTAATPKNESEPLRFFLDMDDPS 300

Query: 312 LQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFS 371
                                             +V PE L S TI ST   RGS+L+FS
Sbjct: 301 -------------------------------QSDAVAPERLTSTTIFSTNSVRGSRLSFS 329

Query: 372 LCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYY 431
           L KT  S LPPI+NA+E+Y++ +  Q  TDQ+DV AI  IK  Y + + WQGDPC PM Y
Sbjct: 330 LQKTGESMLPPIINALEVYVIKEFSQSTTDQEDVEAIKKIKSVYMVRRNWQGDPCLPMDY 389

Query: 432 SWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS 491
            WDGL CS NG   P +ISLNL+   LTGKI PS SNLKSL+NLDLS N+LTGS+PEFL+
Sbjct: 390 QWDGLKCSDNG--SPTLISLNLSYSNLTGKIHPSFSNLKSLQNLDLSYNNLTGSVPEFLA 447

Query: 492 QLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCK-KEKRNSVMPV 550
           +L  L  LNL+GN L+GSVP +L+ + QNG+L LS+  NP+LCLS  CK K+ +N ++PV
Sbjct: 448 ELSSLTFLNLEGNNLTGSVPQALMEKYQNGTLSLSLRENPNLCLSVSCKGKQNKNFIVPV 507

Query: 551 VAASVSLLVI--LIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITN 608
           +A+ +S+LV+  LIA+ + W +KRK    + +      KEGSLKS N +FTYSE+V IT 
Sbjct: 508 LASIISVLVLFLLIAVGIIWNFKRKEDTAMEM----VTKEGSLKSGNSEFTYSELVAITR 563

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           NF   +G+GGFG V+ G L DG++VA+K+ S SS QG K+FR EA+LLMRVHH+NL  LV
Sbjct: 564 NFTSTIGQGGFGNVHLGTLVDGTQVAVKLRSQSSMQGSKEFRAEAKLLMRVHHKNLVRLV 623

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           GYCNDG N+ L+YEYM+ GNL+Q L +   + L WK+RLQIAVDAAQGLEYLH+GCKPPI
Sbjct: 624 GYCNDGTNMALIYEYMSNGNLRQRLSERDTDVLHWKERLQIAVDAAQGLEYLHNGCKPPI 683

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+KT+NILLNEK+QAK+ADFG S+    ES   +ST   GT GYLDPEYY+S  L +
Sbjct: 684 IHRDLKTSNILLNEKLQAKIADFGLSRDLATESGPPVSTVPAGTPGYLDPEYYSSGNLNK 743

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           +SDVYSFGIVLLELITG PAII    N HIV  + P +ERGD++++VDPRL+ +F+TNS 
Sbjct: 744 RSDVYSFGIVLLELITGQPAIITP-GNIHIVQWISPMIERGDIQNVVDPRLQGDFNTNSA 802

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDISAV 908
           WK  ETA+ CVPS + QRP MSHV+ +LK CLE+E    + QR  S  +  S+++   AV
Sbjct: 803 WKALETALACVPSTAIQRPDMSHVLADLKDCLEIEVGAMRTQRIDSYKMGSSNTLKSCAV 862

Query: 909 EVETEMGPEAR 919
           ++E EM P  R
Sbjct: 863 DLENEMAPHVR 873

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549700|ref|XP_002515901.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544806|gb|EEF46321.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  886 bits (2290), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 459/863 (53%), Positives = 594/863 (68%), Gaps = 8/863 (0%)

Query: 60  DIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRS 119
           D  G ISIDCG+PA   Y DE T L+Y SD  FI  G+   I+ K  + +      +VRS
Sbjct: 27  DQSGFISIDCGLPANSSYTDETTSLNYISDASFIDVGIITTITPKVTTNSTDRQQLSVRS 86

Query: 120 FPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASH 179
           FPEG+RNC+++     K   YL RA F +GDYD  ++LPEFDL++G N+W ++K  NAS 
Sbjct: 87  FPEGDRNCFNVE--LAKNTKYLIRAIFAHGDYDGSNELPEFDLHLGPNKWVTVKILNASI 144

Query: 180 VVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGST 239
            VIKEIIH+  ++ I++CL+NT  G PFISALELR   N TY  QSGALV   RLD+GS 
Sbjct: 145 PVIKEIIHTPTLNYIHICLVNTDSGMPFISALELRPLKNTTYVAQSGALVKSTRLDLGSL 204

Query: 240 TTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVND 299
           T + +R+ DD +DRIW P   F     ++T   +D+     ++ PS VM+TA  P N ++
Sbjct: 205 TNKTVRYPDDVFDRIWTP-DHFHKWTDLSTPDTVDAQNHIDFQPPSVVMRTANMPTNASE 263

Query: 300 SLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISS 359
           +++F  +I D T  FYVYMHFAE+   Q NQ R F+I LNG +W   V+P +L S T+ S
Sbjct: 264 NMEFYIDIDDTTSLFYVYMHFAEIVELQANQSRLFNISLNGTIWYGPVIPNHLSSGTVYS 323

Query: 360 TQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK 419
             P  G    FSL K   STLPP+LNAIEIY + D  Q  TDQDDV+AIM IK +Y + K
Sbjct: 324 QFPIIGGNNMFSLFKIEGSTLPPLLNAIEIYFVVDLSQSETDQDDVDAIMKIKSTYGITK 383

Query: 420 GWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSN 479
            WQGDPC+P  Y W GLNCSY+   PP + SLNL+S GL G+I   ++NL+SLE LDLSN
Sbjct: 384 NWQGDPCAPQAYVWHGLNCSYSDDDPPTVKSLNLSSSGLRGEIVSEIANLRSLELLDLSN 443

Query: 480 NSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPC 539
           NSL+GS+P+FLS++  L+VLNL GNKL+G++P  L  RSQ GSLLLS+  NP+LC S  C
Sbjct: 444 NSLSGSLPDFLSRMTSLKVLNLTGNKLTGTIPADLFERSQQGSLLLSVSGNPELCPSVSC 503

Query: 540 KKEKRNSVMPVVAASVSLLVILIALLVFWTY--KRKRAARLNVDNSH-SKKEGSLKSDNQ 596
            K+K++ V+PVVA+ V+  ++  AL+V   Y   R +A       S+ +  E  ++S  +
Sbjct: 504 TKKKKSVVVPVVASVVAFFILAAALVVILRYFFVRSQAKTNEAKISYETNDEPLVESKKR 563

Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLL 656
           QF+YSEI+ ITNNF +ILGKGGFGTVYHG L DG++VA+K+LS SS+QG K+F+ E +LL
Sbjct: 564 QFSYSEILKITNNFDKILGKGGFGTVYHGTLNDGTQVAVKVLSLSSAQGYKEFQAEVKLL 623

Query: 657 MRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
           +RVHHRNL +LVGYCN+G N+GL+YEYMA GNL+ YL D     LSW+ RL+IA +AAQG
Sbjct: 624 LRVHHRNLTTLVGYCNEGTNLGLIYEYMANGNLEDYLSDSCLNTLSWEIRLRIATEAAQG 683

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           LEYLH+GCKP I+HRDVKT NILLN+K QAKLADFG S+IFP +  +HIST + GT GYL
Sbjct: 684 LEYLHNGCKPQIVHRDVKTTNILLNDKFQAKLADFGLSRIFPVDGSTHISTVVAGTPGYL 743

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
           DPEYY +N LT+KSDV+SFG+VLLE+ITG PAI +    THI   V   LE+GD+  IVD
Sbjct: 744 DPEYYVNNWLTDKSDVFSFGVVLLEIITGRPAIAQTRERTHISQWVSSMLEKGDIHGIVD 803

Query: 837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQM 896
           PRL  +F+ NSVWK AE AM CV + S +RPTM+  V EL  CL +E  R   +  +S  
Sbjct: 804 PRLNGDFEINSVWKAAELAMGCVSASSARRPTMNQAVVELNDCLNIEMGRT--REGQSSQ 861

Query: 897 LSLSSSVDISAVEVETEMGPEAR 919
              S+S+++  V V TE  P AR
Sbjct: 862 SFNSNSIELMTVNVHTEASPLAR 884

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549714|ref|XP_002515908.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544813|gb|EEF46328.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  868 bits (2244), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/842 (51%), Positives = 580/842 (68%), Gaps = 6/842 (0%)

Query: 63  GDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPE 122
           G ISIDCG+     Y D  T + Y SD  FI TG +K+I++++   N+      VRSF E
Sbjct: 57  GFISIDCGISENATYTDSTTSIDYVSDAAFIDTGKSKSIAAEYTRYNINQQLQNVRSFAE 116

Query: 123 GNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVI 182
           G RNCY +   +G    YL RA F+YG+YD ++K P FDLY+G ++W+++   N++ ++ 
Sbjct: 117 GVRNCYKIGLKKGAK--YLIRAEFLYGNYDGQNKAPIFDLYLGSSKWETVDTINSTMIIT 174

Query: 183 KEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQ 242
           KEIIH      I+VCL+NTG GTPF+S LELR    + Y T  G+L  + R DVGSTT +
Sbjct: 175 KEIIHLINTSYIDVCLVNTGSGTPFMSKLELRPIRISAYSTSLGSLARFSRSDVGSTTNR 234

Query: 243 IIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLD 302
            +R+ DD YDRIW P   F   A I+TS  ID+L  + YR PS VM+TA  P N N+ + 
Sbjct: 235 TLRYADDVYDRIWTPNHFFKW-AEISTSETIDALAQNDYRPPSIVMRTAGIPANDNEPMT 293

Query: 303 FDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQP 362
              +  D T +F VYMHFAE+   + N+ R+F+I LNG  W   + P+YL + T+ S   
Sbjct: 294 VSIDFEDTTFRFLVYMHFAEILKLEANESRQFNISLNGEHWFGPLRPDYLYTTTVFSPTV 353

Query: 363 ARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQ 422
             G +  FS+ KT NSTLPP+LNAIEIY + D  Q  ++Q+DV+AI +IK SY + + WQ
Sbjct: 354 LSGGQYEFSIYKTENSTLPPLLNAIEIYYILDLSQPQSNQEDVDAITNIKSSYGIKRNWQ 413

Query: 423 GDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSL 482
           GDPC+P  Y W+GLNCSY+G   P+IISLNL+S GLTG+I  S+S+L SLE+LDLSNN L
Sbjct: 414 GDPCAPQAYLWEGLNCSYSGNVMPRIISLNLSSSGLTGEIPSSISSLTSLESLDLSNNYL 473

Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKE 542
           TGS+P+FLSQLP L VL L GN+LSGSVP SLV +S+   L+LS+G N +LCL + CK E
Sbjct: 474 TGSVPDFLSQLPSLNVLILTGNRLSGSVPPSLVEKSEQNLLVLSVGGNANLCLKSSCKNE 533

Query: 543 KRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSE 602
           K+N+V+  V AS++ ++I+I+ L    Y RKR  +   D   S   G L+S  +QFTYSE
Sbjct: 534 KKNNVVVPVVASIAGVLIIISALAAILYTRKRRKQQEEDTKTSNIYGPLESKERQFTYSE 593

Query: 603 IVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR 662
           I++ITNNF R+LGKGGFGTVYHGYL D ++VA+K+LS  S+QG K+F  E +LL+RVHHR
Sbjct: 594 ILNITNNFERVLGKGGFGTVYHGYL-DDTQVAVKILSPLSAQGYKEFHAEVKLLLRVHHR 652

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           NL SLVG+CN+G  +GL+YEYMA G+L+  L    +  L W+ RL IAV+AA+GLEYLH+
Sbjct: 653 NLTSLVGFCNEGTKMGLIYEYMANGDLEHLLSGRNRHVLKWERRLDIAVEAAKGLEYLHN 712

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           GCKPPI+HRD+KTANILLN++ QA+LADFG SK FP E  +H+ST + GT GYLDPEY  
Sbjct: 713 GCKPPIVHRDIKTANILLNDQFQARLADFGLSKSFPVEGGTHVSTVVAGTPGYLDPEYSM 772

Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAI-IRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
           +N LTEKSDVYSFG+VLL++ITG P I +    + HI + V   +  GD+++++DP L  
Sbjct: 773 TNWLTEKSDVYSFGVVLLKIITGRPVIAVIDERSIHISHWVSSLVANGDIKTVIDPCLGG 832

Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAR-EQIQRTKSQMLSLS 900
           +FD NSVWK  E AM C    S  RPTM+ VV EL + L  ETAR E+  +TKS ++   
Sbjct: 833 DFDINSVWKAVEVAMACTSPTSAGRPTMNQVVRELIESLAEETARAEEGHKTKSIVMMTE 892

Query: 901 SS 902
           S+
Sbjct: 893 ST 894

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255549712|ref|XP_002515907.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223544812|gb|EEF46327.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  868 bits (2242), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/866 (51%), Positives = 590/866 (68%), Gaps = 15/866 (1%)

Query: 60  DIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRS 119
           D  G ISIDCG+PA   Y D  T L+Y SD  FI TG+  N++    ++++     +VRS
Sbjct: 28  DQSGFISIDCGLPANSSYTDATTGLNYVSDAAFIDTGIINNLAPGLNTSSIDRQQLSVRS 87

Query: 120 FPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASH 179
           FPEG+RNCY +    G    YL RA F+Y +YD   KLP FDL++G N+W ++K  NA+ 
Sbjct: 88  FPEGDRNCYQVELTRGTK--YLIRAIFLYRNYDGLSKLPHFDLHLGPNKWITVKILNATI 145

Query: 180 VVIKEIIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRTQS-GALVLYRRLDVGS 238
            VI EII++ +++ I+VCL+NTG GTPFISALELR   N TY  +S GAL  + RLD GS
Sbjct: 146 PVITEIIYTPILNYIHVCLVNTGLGTPFISALELRPLKNTTYEIRSEGALAKFARLDFGS 205

Query: 239 TTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVN 298
            T + +R+ DD YDRIW P   +  +  ++T   ID+   + ++ PS VM TA  P N +
Sbjct: 206 VTNKTVRYPDDVYDRIWTPDHYYKWT-DLSTPETIDAQFHNDFQPPSIVMSTANVPTNAS 264

Query: 299 DSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTIS 358
           + + F  +  D +LQFY YMHFAE+   + NQ R+F+I LNG ++   V+P+YL + ++ 
Sbjct: 265 EDMQFFIDNEDTSLQFYFYMHFAEIVKLEANQSRQFNISLNGTIFFGPVIPDYLYTSSVY 324

Query: 359 STQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLG 418
           +  P       FSL K   STLPP+LNAIEIY   D  Q  TDQDDV+AI  IK +Y + 
Sbjct: 325 NGLPINAGSNVFSLFKIGGSTLPPLLNAIEIYFFVDLSQSQTDQDDVDAITKIKSTYGIT 384

Query: 419 KGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLS 478
           + WQGD C+P  Y W GLNCSY+   PPKI SLNL+S GLTG+I   ++NLKSLE LDLS
Sbjct: 385 RNWQGDACAPQAYVWQGLNCSYSDNDPPKITSLNLSSSGLTGEIVSDIANLKSLEFLDLS 444

Query: 479 NNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAP 538
           NNSL+G +P+FLSQ+P L+VLNL GNKL+G +P  L  R+Q GSLLLS+  NP+LC S  
Sbjct: 445 NNSLSGPVPDFLSQMPSLKVLNLTGNKLTGRIPVDLFERTQKGSLLLSVSGNPELCPSVS 504

Query: 539 CKKEKRNSVMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDN--SHSKKEGSLKSDNQ 596
           CKK++++  +PVVA+  S+ ++  A+ V   Y+  R+     +   SH   E  ++  N+
Sbjct: 505 CKKKEKSIAVPVVASVASVFILAAAVAVILRYRILRSVSETGETKLSHESNE-PMELKNK 563

Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLL 656
           QFTYSE++ ITNNF ++LGKGGFGTVY+G LADG++VA+K+LS SS QG K+F  E +LL
Sbjct: 564 QFTYSEVLKITNNFEKVLGKGGFGTVYYGTLADGTQVAVKILSQSSVQGYKEFLAEVKLL 623

Query: 657 MRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
           MRVHHRNL +LVG C +G N+GL+YEYMA GNL+ YL       LSW+ RL+IA++A QG
Sbjct: 624 MRVHHRNLTTLVGCCIEGTNMGLIYEYMANGNLEDYLSGSNLNTLSWEARLRIALEAGQG 683

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           LEYLH GCK PI+HRDVKT NILLN+K QAK++DFG S+IFPA+  +H+ST + GT GYL
Sbjct: 684 LEYLHGGCKLPIVHRDVKTTNILLNDKFQAKISDFGLSRIFPADGGTHVSTIVAGTPGYL 743

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAII--RGYNNTHIVNRVCPFLERGDVRSI 834
           DPEYY +N LT+KSDVYSFG+VLLE+IT  P I   R + N+HI   V   +E GDV SI
Sbjct: 744 DPEYYVTNWLTDKSDVYSFGVVLLEIITCRPVIAQNRNHENSHISQWVSSMIENGDVNSI 803

Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAR-EQIQRTK 893
            DPRL   ++ NSVWK+ E AMEC+ + S +RPTM+ VV EL +CL+ E AR  + Q T+
Sbjct: 804 ADPRLNGEYEVNSVWKIVELAMECLSTTSARRPTMNQVVIELNECLKTEMARTREGQSTQ 863

Query: 894 SQMLSLSSSVDISAVEVETEMGPEAR 919
           S       S+++  V V+TE  P AR
Sbjct: 864 SYY-----SIELVTVNVDTESSPLAR 884

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	919
TAIR|locus:2126540	876	AT4G29990 [Arabidopsis thalian	0.909	0.954	0.471	3.6e-208
TAIR|locus:2047675	881	AT2G19210 [Arabidopsis thalian	0.907	0.946	0.463	5.4e-205
TAIR|locus:2059093	876	FRK1 "FLG22-induced receptor-l	0.907	0.952	0.454	3e-195
TAIR|locus:2195850	890	AT1G51860 [Arabidopsis thalian	0.907	0.937	0.432	8.5e-184
TAIR|locus:2118344	863	AT4G29450 [Arabidopsis thalian	0.867	0.923	0.459	3.3e-182
TAIR|locus:2066158	884	AT2G28990 [Arabidopsis thalian	0.903	0.938	0.430	2.5e-177
TAIR|locus:2195855	876	AT1G51910 [Arabidopsis thalian	0.870	0.913	0.439	4e-177
TAIR|locus:2028446	888	AT1G49100 [Arabidopsis thalian	0.907	0.939	0.416	5.9e-176
TAIR|locus:2059804	892	AT2G04300 [Arabidopsis thalian	0.900	0.928	0.430	2e-175
TAIR|locus:2017572	882	AT1G51790 [Arabidopsis thalian	0.875	0.912	0.419	4.7e-174

TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)]

 Score = 2013 (713.7 bits), Expect = 3.6e-208, P = 3.6e-208
 Identities = 404/856 (47%), Positives = 543/856 (63%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             +P    Y DEKT + Y SD  F+ +G + +I S   + +L+  +  VRSFPEG RNCY +
Sbjct:    34 IPDDSSYTDEKTNMKYVSDLGFVESGTSHSIVSDLQTTSLERQFQNVRSFPEGKRNCYDI 93

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
             RP +GK   YL R  FMYG+YD   K PEFDLYIG N W+S+   N + ++ KEII++  
Sbjct:    94 RPQQGKGFKYLIRTRFMYGNYDGFSKTPEFDLYIGANLWESVVLINETAIMTKEIIYTPP 153

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDH 250
              D I+VCL++  +GTPF+S LE+R   N TY T   AL+L RR D G+ T   IR+KDD 
Sbjct:   154 SDHIHVCLVDKNRGTPFLSVLEIRFLKNDTYDTPYEALMLGRRWDFGTATNLQIRYKDDF 213

Query:   251 YDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDP 310
             YDRIW+PY   P   ++NTS  ID    + +R  S VM++A+ P N ++ L F++   DP
Sbjct:   214 YDRIWMPYKS-PYQKTLNTSLTIDETNHNGFRPASIVMRSAIAPGNESNPLKFNWAPDDP 272

Query:   311 TLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLN- 369
               +FY+YMHFAE+   Q N+ REF I +N  +  ++  P YL + T S+  P  G K+N 
Sbjct:   273 RSKFYIYMHFAEVRELQRNETREFDIYINDVILAENFRPFYLFTDTRSTVDPV-GRKMNE 331

Query:   370 FSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPM 429
               L +T  STLPPI+NAIEIY + + LQ PTDQ DV+A+  IK  Y + K WQGDPC P+
Sbjct:   332 IVLQRTGVSTLPPIINAIEIYQINEFLQLPTDQQDVDAMTKIKFKYRVKKNWQGDPCVPV 391

Query:   430 YYSWDGLNCSYNGYKP-PKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPE 488
               SW+GL C ++     PK I+LNL+S GLTG+I                    TG +P+
Sbjct:   392 DNSWEGLECLHSDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPD 451

Query:   489 FLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCK---KEKRN 545
             FL+ LP L  LNL+GNKL+GS+P  L+ +S++GSL L  G NPDLC S  C+   K+K  
Sbjct:   452 FLASLPNLTELNLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIG 511

Query:   546 SVMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSH-SKKEGSLKSDNQQFTYSEIV 604
              ++P                  W +K KR+ R  + N       G L +  + F YSE+V
Sbjct:   512 YIVPVVASLAGLLIVLTALALIWHFK-KRSRRGTISNKPLGVNTGPLDTAKRYFIYSEVV 570

Query:   605 DITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
             +ITNNF R+LGKGGFG VYHG+L +G +VA+K+LS  S+QG K+FR E +LLMRVHH NL
Sbjct:   571 NITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNL 629

Query:   665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
              SL+GYCN+  ++ L+YEYMA GNL  YL  ++   LSW++RLQI++DAAQGLEYLH+GC
Sbjct:   630 TSLIGYCNEDNHMALIYEYMANGNLGDYLSGKSSLILSWEERLQISLDAAQGLEYLHYGC 689

Query:   725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
             KPPI+HRDVK ANILLNE +QAK+ADFG S+ FP E  S +ST + GT+GYLDPEYYA+ 
Sbjct:   690 KPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATR 749

Query:   785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNT-HIVNRVCPFLERGDVRSIVDPRLEANF 843
             ++ EKSDVYSFG+VLLE+ITG PAI      + H+ ++V   L  GD++ IVD RL   F
Sbjct:   750 QMNEKSDVYSFGVVLLEVITGKPAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRF 809

Query:   844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSV 903
             +  S WK+ E A+ C    S QRPTMS VV ELK+ +          +   +M++++   
Sbjct:   810 EVGSAWKITELALACASESSEQRPTMSQVVMELKQSIFGRVNNRSDHKDPVRMVTMN--- 866

Query:   904 DISAVEVETEMGPEAR 919
                   ++TEM P AR
Sbjct:   867 ------LDTEMVPRAR 876

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1983 (703.1 bits), Expect = 5.4e-205, P = 5.4e-205
 Identities = 398/859 (46%), Positives = 539/859 (62%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             +P    Y DE T + Y SD  F+ +G   +I  +F +++L+  +  VRSFPEGNRNCY +
Sbjct:    38 IPEDSSYNDETTDIKYVSDAAFVESGTIHSIDPEFQTSSLEKQFQNVRSFPEGNRNCYDV 97

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
             +PP+GK   YL R  FMYG+YD+  K P+FDLY+G N WDS+  DNA+ +V KEIIH+  
Sbjct:    98 KPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYLGFNIWDSVTIDNATTIVTKEIIHTLR 157

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDH 250
              D ++VCL++  +GTPF+SALE+R   + TY T   +L+L++R D+G      +R+KDD 
Sbjct:   158 SDHVHVCLVDKNRGTPFLSALEIRLLKSNTYETPYDSLILFKRWDLGGLGALPVRYKDDV 217

Query:   251 YDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDP 310
             +DRIW+P   FP     N S  IDS  +  ++    VM TA  P +++  + F +E  DP
Sbjct:   218 FDRIWIPLR-FPKYTIFNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDP 276

Query:   311 TLQFYVYMHFAELESRQGNQYREFSIELNGN-LWEKSVVPEYLQSKTISSTQPARGSKLN 369
             T +++VYMHFAE+     N+ REF + LN   +   S  P YL + T+    P  G KL 
Sbjct:   277 TWKYFVYMHFAEVVELPSNETREFKVLLNEKEINMSSFSPRYLYTDTLFVQNPVSGPKLE 336

Query:   370 FSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPM 429
             F L +T  STLPPI+NAIE Y + + LQ PTDQ DV+AIM IK  Y + K W GDPC+P+
Sbjct:   337 FRLQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWLGDPCAPV 396

Query:   430 YYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPEF 489
              Y W  +NCSY   + P+IIS+NL+S GLTG+I                    TG IP+F
Sbjct:   397 KYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDF 456

Query:   490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCK----KEKRN 545
             L  L  L  LNL+GNKLSG++P  L+ RS    +LL I  NPDLC+SA C+    K K+N
Sbjct:   457 LGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKN 516

Query:   546 S-VMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIV 604
               ++P                 F  YK KR  R     S   + G L +  + + YSE+V
Sbjct:   517 VYIIPLVASVVGVLGLVLAIALFLLYK-KRHRR---GGSGGVRAGPLDTTKRYYKYSEVV 572

Query:   605 DITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
              +TNNF R+LG+GGFG VYHG L D  +VA+K+LS SS+QG K+FR E +LL+RVHH+NL
Sbjct:   573 KVTNNFERVLGQGGFGKVYHGVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNL 631

Query:   665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
              +L+GYC++G  + L+YE+MA G L  YL  E    LSW++RLQI++DAAQGLEYLH+GC
Sbjct:   632 TALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSYVLSWEERLQISLDAAQGLEYLHNGC 691

Query:   725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
             KPPI+ RDVK ANIL+NEK+QAK+ADFG S+    +  +  +T++ GT+GYLDPEY+ + 
Sbjct:   692 KPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQ 751

Query:   785 RLTEKSDVYSFGIVLLELITGLPAIIRGYN---NTHIVNRVCPFLERGDVRSIVDPRLEA 841
             +L+EKSD+YSFG+VLLE+++G P I R      N HI +RV   L  GD+R IVDP+L  
Sbjct:   752 KLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGE 811

Query:   842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSS 901
              FD  S WK+ E AM C  S S  RPTMSHVV ELK         E + R ++   S +S
Sbjct:   812 RFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELK---------ESVSRARAGGGSGAS 862

Query:   902 SV-DISAVEVETEMGPEAR 919
             SV D +    ++ M P+AR
Sbjct:   863 SVTDPAMTNFDSGMFPQAR 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1891 (670.7 bits), Expect = 3.0e-195, P = 3.0e-195
 Identities = 389/855 (45%), Positives = 519/855 (60%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             +P    Y DE T + Y SD  F+ +G  K I+++F S+        VRSFP+  R+CY +
Sbjct:    37 IPDDSSYNDETTGIKYVSDSAFVDSGTTKRIAAQFQSSGFDRHLLNVRSFPQSKRSCYDV 96

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
               P GK   YL R  FMYG+YDD  ++PEFDLY+GVN WDS+K D+A+ ++ KEII   L
Sbjct:    97 PTPRGKGFKYLIRTRFMYGNYDDLGRVPEFDLYLGVNFWDSVKLDDATTILNKEIITIPL 156

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDH 250
             +D + VC+++   GTPF+S LE+R   N TY T   AL L RRLD   T     R+KDD 
Sbjct:   157 LDNVQVCVVDKNAGTPFLSVLEIRLLLNTTYETPYDALTLLRRLDYSKTGKLPSRYKDDI 216

Query:   251 YDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDP 310
             YDRIW P         +NTS  +D  +++ Y+  S VM TA    N +  L   F   DP
Sbjct:   217 YDRIWTPRIVSSEYKILNTSLTVDQFLNNGYQPASTVMSTAETARNESLYLTLSFRPPDP 276

Query:   311 TLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNF 370
               +FYVYMHFAE+E  + NQ REFSI LN ++   S    YL + T  +  P  G  +NF
Sbjct:   277 NAKFYVYMHFAEIEVLKSNQTREFSIWLNEDVISPSFKLRYLLTDTFVTPDPVSGITINF 336

Query:   371 SLCKTSNS-TLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPM 429
             SL +      LPPI+NA+E+Y + + LQ PT   DV+A+  IK +Y + K WQGDPC P+
Sbjct:   337 SLLQPPGEFVLPPIINALEVYQVNEFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPV 396

Query:   430 YYSWDGLNC-SYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPE 488
              YSW+G++C   +    P+++SLN++   L G+I                    TG IP 
Sbjct:   397 DYSWEGIDCIQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPA 456

Query:   489 FLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPC---KKEKRN 545
             FL+ LP L  LN++GNKL+G VP  L  RS+NGSL L  GRNPDLCLS  C   KK+ +N
Sbjct:   457 FLANLPNLTELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKN 516

Query:   546 SVMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVD 605
               +                  F  +K+K+        +  ++ G LK+  + F YSE+V+
Sbjct:   517 GYIIPLVVVGIIVVLLTALALFRRFKKKQQR-----GTLGERNGPLKTAKRYFKYSEVVN 571

Query:   606 ITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
             ITNNF R++GKGGFG VYHG + +G +VA+K+LS  S+QG K+FR E  LLMRVHH NL 
Sbjct:   572 ITNNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLT 630

Query:   666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
             SLVGYCN+  ++ L+YEYMA  NL  YL  +    LSW++RL+I++DAAQGLEYLH+GCK
Sbjct:   631 SLVGYCNEINHMVLIYEYMANENLGDYLAGKRSFILSWEERLKISLDAAQGLEYLHNGCK 690

Query:   726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             PPI+HRDVK  NILLNEK+QAK+ADFG S+ F  E    IST + G++GYLDPEYY++ +
Sbjct:   691 PPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQ 750

Query:   786 LTEKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPRLEANFD 844
             + EKSDVYS G+VLLE+ITG PAI        HI + V   L  GD+R IVD RL   +D
Sbjct:   751 MNEKSDVYSLGVVLLEVITGQPAIASSKTEKVHISDHVRSILANGDIRGIVDQRLRERYD 810

Query:   845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVD 904
               S WK++E A+ C    S QRPTMS VV ELK+ +      ++     ++ML+      
Sbjct:   811 VGSAWKMSEIALACTEHTSAQRPTMSQVVMELKQIVYGIVTDQENYDDSTKMLT------ 864

Query:   905 ISAVEVETEMGPEAR 919
                V ++TEM P AR
Sbjct:   865 ---VNLDTEMVPRAR 876

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016045 "detection of bacterium" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)]

 Score = 1783 (632.7 bits), Expect = 8.5e-184, P = 8.5e-184
 Identities = 376/869 (43%), Positives = 538/869 (61%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             VP    Y ++ T ++YKSD ++I +G+   I+  + +   Q  +A VRSFP G RNCY++
Sbjct:    37 VPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAYKTQFQQQVWA-VRSFPVGQRNCYNV 95

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
                      YL R +F+YG+YD  ++ P FDL+IG N+W S+K    ++  + EIIH   
Sbjct:    96 NLTANNK--YLIRGTFVYGNYDGLNQFPSFDLHIGPNKWSSVKILGVTNTSMHEIIHVVP 153

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDH 250
              D + VCL+ TG  TPFIS+LE+R  +N +Y TQSG+L+L+ R+   S+++  IR+ +D 
Sbjct:   154 QDSLEVCLVKTGPTTPFISSLEVRPLNNESYLTQSGSLMLFARVYFPSSSSSFIRYDEDI 213

Query:   251 YDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDP 310
             +DR+W  +     +  I+T   ID+   + Y +P +VMKTA  P N ++     + + + 
Sbjct:   214 HDRVWNSFTD-DETVWISTDLPIDT--SNSYDMPQSVMKTAAVPKNASEPWLLWWTLDEN 270

Query:   311 TLQFYVYMHFAELESRQGNQYREFSIELNGNL-WEKSVVPEYLQSKTISSTQPARGSK-- 367
             T Q YVYMHFAE+++   N+ REF+I  NG L W   + P  L   TI + +    S   
Sbjct:   271 TAQSYVYMHFAEVQNLTANETREFNITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGI 330

Query:   368 LNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK--GWQGDP 425
              NF+   T NSTLPP+LNA+EIY + D LQ  T++D+V+A+M+IK +Y L K   WQGDP
Sbjct:   331 FNFTFAMTGNSTLPPLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDP 390

Query:   426 CSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGS 485
             C+P  Y W+GLNCSY   +  +IISLNL    LTG I                    +G 
Sbjct:   391 CAPQLYRWEGLNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGD 450

Query:   486 IPEFLSQLPLLRVLNLDGN-KLS-GSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEK 543
             IP F +++  L+++NL GN  L+  ++P SL  R  + SL L +G N  L L+ P K+ K
Sbjct:   451 IPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGEN--LTLT-PKKESK 507

Query:   544 RNSVMPXXXXXXXXXXXXXXXXXFWTYKRK--RAARL---------NVDNSHSKKEG-SL 591
             +  ++                  F+  KRK  +A +           +  S ++    S+
Sbjct:   508 KVPMVAIAASVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSI 567

Query:   592 KSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRT 651
              +  ++ TY E++ +TNNF R+LGKGGFGTVYHG L DG+EVA+KMLS SS+QG K+F+ 
Sbjct:   568 ITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKA 626

Query:   652 EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIA 710
             E +LL+RVHHR+L  LVGYC+DG N+ L+YEYMA G+L++ +  +     L+W++R+QIA
Sbjct:   627 EVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIA 686

Query:   711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
             V+AAQGLEYLH+GC+PP++HRDVKT NILLNE+  AKLADFG S+ FP + E H+ST + 
Sbjct:   687 VEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVA 746

Query:   771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             GT GYLDPEYY +N L+EKSDVYSFG+VLLE++T  P I +     HI + V   L +GD
Sbjct:   747 GTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPHINDWVGFMLTKGD 806

Query:   831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQ 890
             ++SIVDP+L  ++DTN  WK+ E A+ CV   S +RPTM+HVV EL  C+ +E AR Q  
Sbjct:   807 IKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQ-- 864

Query:   891 RTKSQMLSLSSSVDISAVEVETEMGPEAR 919
                 +M S+ S VD S +   ++  P AR
Sbjct:   865 -GSEEMYSMGS-VDYS-LSSTSDFAPGAR 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2118344 AT4G29450 [Arabidopsis thaliana (taxid:3702)]

 Score = 1768 (627.4 bits), Expect = 3.3e-182, P = 3.3e-182
 Identities = 381/830 (45%), Positives = 512/830 (61%)

Query:    79 DEKTQLSYKSDEEFIRTGVNKNISSKF-MSAN--LQNTYATVRSFPEGNRNCYSLRPPEG 135
             D  T ++Y SDE FI TGVN  +S ++    N  L +T A VR+FP+GNRNCY+L+  +G
Sbjct:    42 DTMTNINYVSDEAFITTGVNFKVSEEYGYPKNPVLLSTLAEVRAFPQGNRNCYTLKLSQG 101

Query:   136 KAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEIN 195
             K   YL RASFMYG+YD +  LPEFDLY+ VN W ++KF NAS  V KEI+  A  D I 
Sbjct:   102 KDHLYLIRASFMYGNYDGKKALPEFDLYVNVNFWSTVKFKNASDQVTKEILSFAESDTIY 161

Query:   196 VCLLNTGKGTPFISALELRHFHNATYRTQSG---ALVLYRRLDVGSTTTQIIRFKDDHYD 252
             VCL+N GKGTPFIS LELR  +++ Y T+ G   +LVLYRR D+G       R++DD +D
Sbjct:   162 VCLVNKGKGTPFISGLELRPVNSSIYGTEFGRNVSLVLYRRWDIGYLNGTG-RYQDDRFD 220

Query:   253 RIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTL 312
             RIW PY       SI TS  ID +  + Y  P  V+KTA  P NV+D L+  +   DP +
Sbjct:   221 RIWSPYSSNISWNSIITSGYID-VFQNGYCPPDEVIKTAAAPENVDDPLELFWTSDDPNV 279

Query:   313 QFYVYMHFAELESRQGNQYREFSIELNGN-LWEKSVVPEYLQSKTISSTQPARGSKLNFS 371
             +FY Y++FAELE+ + N+ R+  I  NG+ + E S  P    S T S+ +   G     S
Sbjct:   280 RFYAYLYFAELETLEKNETRKIKILWNGSPVSETSFEPSSKYSTTFSNPRAFTGKDHWIS 339

Query:   372 LCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYY 431
             + KT +STLPPILNAIEI+      +  T  +D++AI  IK +Y + K W GDPCSP  +
Sbjct:   340 IQKTVDSTLPPILNAIEIFTAQSLDEFSTTIEDIHAIESIKATYKVNKVWSGDPCSPRLF 399

Query:   432 SWDGLNCSYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPEFLS 491
              W+G+ CS N     +I SLNL+S GL G I                      ++PEFL+
Sbjct:   400 PWEGVGCSDNNNNH-QIKSLNLSSSGLLGPIVLAFRNLSLLESLDLSNNDLQQNVPEFLA 458

Query:   492 QLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVMPXX 551
              L  L+VLNL GN  +G +P SL+ + + G L LS     +LC S   KK+K++ V+P  
Sbjct:   459 DLKHLKVLNLKGNNFTGFIPKSLMKKLKAGLLTLSADEQ-NLCNSCQEKKKKKSMVVPIA 517

Query:   552 XXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFH 611
                             W   R+R        ++S     L S  ++FTY+E+  ITNNF+
Sbjct:   518 VAASVIVLVVVLVI-IWIILRQRKK-----GAYSGP--LLPSGKRRFTYNEVSSITNNFN 569

Query:   612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK------------QFRTEAQLLMRV 659
             +++GKGGFG VY G L DG+++A+KM++ SS   PK            QF+ EA+LL+ V
Sbjct:   570 KVIGKGGFGIVYLGSLEDGTKIAVKMINDSSLAKPKGTSSSSLSRASNQFQVEAELLLTV 629

Query:   660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
             HHRNLAS VGYC+D  ++ L+YEYMA GNL+ YL  E  E LSW+ RL IA+D+AQGLEY
Sbjct:   630 HHRNLASFVGYCDDDRSMALIYEYMANGNLQAYLSSENAEDLSWEKRLHIAIDSAQGLEY 689

Query:   720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             LH GC+P I+HRDVKTANIL+N+ ++AK+ADFG SK+FP +  SH+ T+++GT GY+DPE
Sbjct:   690 LHDGCRPAIVHRDVKTANILINDNLEAKIADFGLSKVFPEDDLSHVVTTVMGTPGYVDPE 749

Query:   780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY--NNTHIVNRVCPFLERGDVRSIVDP 837
             YY +  L EKSDVYSFG+VLLELITG  AII+    +N  +++ V PF E  ++  +VDP
Sbjct:   750 YYRTFVLNEKSDVYSFGVVLLELITGQRAIIKTEEGDNISVIHYVWPFFEARELDGVVDP 809

Query:   838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
              L  +F  +S WK  + AM CV      RPTM+ +V ELK+CL  E  RE
Sbjct:   810 LLRGDFSQDSAWKFVDVAMSCVRDKGSNRPTMNQIVAELKQCLAAELDRE 859

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)]

 Score = 1722 (611.2 bits), Expect = 2.5e-177, P = 2.5e-177
 Identities = 370/859 (43%), Positives = 517/859 (60%)

Query:    77 YLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGK 136
             Y D    L++ SD  FI+TG   ++  K ++ NL   Y T+R FPEG RNCYSL    G 
Sbjct:    39 YDDSFNGLTFTSDSTFIQTGKIDSVD-KDLNINLSKQYLTLRYFPEGKRNCYSLDVKRGT 97

Query:   137 AKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINV 196
               TYL   SF+YG+YD  ++ P FD+++G N+W  I  D       +EIIH A  + +++
Sbjct:    98 --TYLIVVSFVYGNYDGLNRDPNFDIHLGPNKWKRIDLDGEKEGTREEIIHKARSNSLDI 155

Query:   197 CLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRIWV 256
             CL+ TG+  P ISA+E+R   N TY TQSG+L++  R+ + ++   I R+ DD +DRIW 
Sbjct:   156 CLVKTGETLPIISAIEIRPLRNNTYVTQSGSLMMSFRVYLSNSDASI-RYADDVHDRIWS 214

Query:   257 PYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYV 316
             P+ G      I T   I++   + Y +P  +++TA  P N +  L   ++      + Y+
Sbjct:   215 PFNG-SSHTHITTDLNINN--SNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYL 271

Query:   317 YMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQPAR-GSK-LNFSLCK 374
             YMHFAE+++ + N+ R+F + L GN       P  L+  T+ + +P + GS+     L K
Sbjct:   272 YMHFAEIQTLEANETRQFDVILRGNFNHSGFSPTKLKVFTLYTEEPMKCGSEGCYLQLVK 331

Query:   375 TSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK-GWQGDPCSPMYYSW 433
             T NSTLPP++NAIE Y + +  Q  T   DV+AI +IK +Y L K  WQGDPC P   SW
Sbjct:   332 TPNSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQGDPCLPQDLSW 391

Query:   434 DGLNCSY-NGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPEFLSQ 492
             + + C+Y +G   P IISL+L+  GL G I                    TG +P FL+ 
Sbjct:   392 ESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLAN 451

Query:   493 LPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNS-VMPXX 551
             +  L ++NL GN LSGSVP +L+ + + G L+L +  NPDLC S+ C  EK+N  ++P  
Sbjct:   452 MKTLSLINLSGNNLSGSVPQALLDKEKEG-LVLKLEGNPDLCKSSFCNTEKKNKFLLPVI 510

Query:   552 XXXXXXXXXXXXXXXFWTYKRKRAARLN--------VDN-SH-SKKEGSLKSDNQQFTYS 601
                            F+ +++K+A+  N        V N  H S+ E S  S   +FTYS
Sbjct:   511 ASAASLVIVVVVVALFFVFRKKKASPSNLHAPPSMPVSNPGHNSQSESSFTSKKIRFTYS 570

Query:   602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
             E+ ++TNNF + LG+GGFG VYHG++    +VA+K+LS SSSQG K F+ E +LLMRVHH
Sbjct:   571 EVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLLSQSSSQGYKHFKAEVELLMRVHH 630

Query:   662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKE-ALSWKDRLQIAVDAAQGLEYL 720
              NL SLVGYC++G ++ L+YEYM  G+LKQ+L  +     LSW+ RL+I +DAA GLEYL
Sbjct:   631 INLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGKHGGFVLSWESRLKIVLDAALGLEYL 690

Query:   721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
             H GC PP++HRD+KT NILL++ +QAKLADFG S+ FP  +E ++ST + GT GYLDPEY
Sbjct:   691 HTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSRSFPIGNEKNVSTVVAGTPGYLDPEY 750

Query:   781 YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
             Y +N LTEKSD+YSFGIVLLE+I+  P I +     HIV  V   + +GD+RSI+DP L 
Sbjct:   751 YQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSREKPHIVEWVSFMITKGDLRSIMDPNLH 810

Query:   841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLS 900
              ++D  SVWK  E AM CV   S +RP MS VV ELK+CL  ET+R    R      S+ 
Sbjct:   811 QDYDIGSVWKAIELAMSCVSLSSARRPNMSRVVNELKECLISETSRIGEGRDMESKGSME 870

Query:   901 SSVDISAVEVETEMGPEAR 919
              S DI       E+ P+AR
Sbjct:   871 FSRDIY-----NEVIPQAR 884

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195855 AT1G51910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
 Identities = 366/833 (43%), Positives = 510/833 (61%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             +P    Y ++ T ++Y SD ++I +G+ + IS  + S   Q T+ T+RSFPEG RNCY+ 
Sbjct:    37 IPKDTTYTEQITNITYISDADYIDSGLTERISDSYKSQLQQQTW-TLRSFPEGQRNCYNF 95

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
                +   K YL R +F+YG+YD  +++P+FDL+IG N+W S+  +  ++  I EIIH   
Sbjct:    96 NL-KANLK-YLIRGTFVYGNYDGLNQMPKFDLHIGPNKWTSVILEGVANATIFEIIHVLT 153

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDH 250
              D + VCL+ TG+ TPFIS+LELR  +N TY TQ G+L+ + R+    T    +R+ DD 
Sbjct:   154 QDRLQVCLVKTGQTTPFISSLELRPLNNDTYVTQGGSLMSFARIYFPKTA-YFLRYSDDL 212

Query:   251 YDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDP 310
             YDR+WVP+     + S++T+  +D+  +S Y +P  V  +A+ P      L+  +++ + 
Sbjct:   213 YDRVWVPFSQNE-TVSLSTNLPVDTSSNS-YNVPQNVANSAIIPAEATHPLNIWWDLQNI 270

Query:   311 TLQFYVYMHFAELESRQGNQYREFSIELNGN-LWEKSVVPEYLQSKTISSTQPARGSK-- 367
                 YVYMHFAE+++ + N  REF+I  NG  +WE S+ P  L   TISS      S   
Sbjct:   271 NAPSYVYMHFAEIQNLKANDIREFNITYNGGQVWESSIRPHNLSITTISSPTALNSSDGF 330

Query:   368 LNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK--GWQGDP 425
              NF+   T+ STLPP++NA+E+Y L + L   T QD+V+A+M+IK +Y L K   WQGDP
Sbjct:   331 FNFTFTMTTTSTLPPLINALEVYTLVENLLLETYQDEVSAMMNIKKTYGLSKKISWQGDP 390

Query:   426 CSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGS 485
             CSP  Y W+GLNC Y     P I SLNL + GLTG I                    +G 
Sbjct:   391 CSPQIYRWEGLNCLYLDSDQPLITSLNLRTSGLTGIITHDISNLIQLRELDLSDNDLSGE 450

Query:   486 IPEFLSQLPLLRVLNLDGN-KLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKR 544
             IP+FL+ + +L ++NL GN KL+ +VP S+  R  N SL L I  N           EK 
Sbjct:   451 IPDFLADMKMLTLVNLKGNPKLNLTVPDSIKHRINNKSLKLIIDENQS--------SEKH 502

Query:   545 NSVMPXXXXXXXXXXXXXXXXXFWT---YKRKRA----ARLNVDNSHSKKEGSLKSDNQQ 597
                 P                 F     +KR++     A   V+        S+++ +++
Sbjct:   503 GIKFPLVAILASVAGVIALLAIFTICVIFKREKQGSGEAPTRVNTEIRSSYQSIETKDRK 562

Query:   598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSS-QGPKQFRTEAQLL 656
             FTYSEI+ +TNNF R+LGKGG+G VY+G L D +EVA+KML  SS+ Q  K F+ E +LL
Sbjct:   563 FTYSEILKMTNNFERVLGKGGYGRVYYGKL-DDTEVAVKMLFHSSAEQDYKHFKAEVELL 621

Query:   657 MRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-DETKEALSWKDRLQIAVDAAQ 715
             +RVHHR+L  LVGYC+DG N  L+YEYMA G+LK+ +  + +   LSW++R+QIA++AAQ
Sbjct:   622 LRVHHRHLVGLVGYCDDGDNFALIYEYMANGDLKENMSGNRSGHVLSWENRMQIAMEAAQ 681

Query:   716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
             GLEYLH+G +PP++HRDVKT NILLNE  QAKLADFG S+  P + ES++ST + GT GY
Sbjct:   682 GLEYLHNGSRPPMVHRDVKTTNILLNELYQAKLADFGLSRSSPVDGESYVSTIVAGTPGY 741

Query:   776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV 835
             LDPE   +N L+EK+DVYSFG+VLLE+IT  P I       HI + V   L  GD+R+I+
Sbjct:   742 LDPE---TNLLSEKTDVYSFGVVLLEIITNQPVIDTTREKAHITDWVGFKLMEGDIRNII 798

Query:   836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
             DP+L   FDTN VWK  E A+ CV   S  RPTM HVV ELK+CL+ E AR+Q
Sbjct:   799 DPKLIKEFDTNGVWKAVELALSCVNPTSNHRPTMPHVVMELKECLDSEIARKQ 851

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1709 (606.7 bits), Expect = 5.9e-176, P = 5.9e-176
 Identities = 361/866 (41%), Positives = 516/866 (59%)

Query:    71 VPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSL 130
             +P G  Y +  T L++ SD  FI +G N  +S K    N +  + T+R FP+G RNCY+L
Sbjct:    38 LPDGSPYTNPSTGLTFTSDSSFIESGKNGRVS-KDSERNFEKAFVTLRYFPDGERNCYNL 96

Query:   131 RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSAL 190
                +G    YL RA+F+YG+YD  + +P FDL+IG N+  ++ F+     V  EIIH + 
Sbjct:    97 NVTQGT--NYLIRAAFLYGNYDGLNTVPNFDLFIGPNKVTTVNFNATGGGVFVEIIHMSR 154

Query:   191 MDEINVCLLNTGKGTPFISALELRHFHNATYRTQSGA-LVLYRRLDVGSTTTQIIRFKDD 249
                +++CL+ TG  TP IS LELR   + TY +  G+ L+LY R  +  +   ++R+ DD
Sbjct:   155 STPLDICLVKTGTTTPMISTLELRPLRSDTYISAIGSSLLLYFRGYLNDSGV-VLRYPDD 213

Query:   250 HYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGD 309
               DR W P+  +     + T+  +++   + + LP   M +A   +N N + +F + + D
Sbjct:   214 VNDRRWFPF-SYKEWKIVTTTLNVNT--SNGFDLPQGAMASAATRVNDNGTWEFPWSLED 270

Query:   310 PTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTIS----STQPARG 365
              T +F++Y+HFAEL++   N+ REF++ LNG ++     P+ L   T+S    ST   +G
Sbjct:   271 STTRFHIYLHFAELQTLLANETREFNVLLNGKVYYGPYSPKMLSIDTMSPQPDSTLTCKG 330

Query:   366 SKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK-GWQGD 424
                   L KT+ STLPP++NAIE++ + +  Q  T+QD+V AI  I+L+Y L +  WQGD
Sbjct:   331 GSCLLQLVKTTKSTLPPLINAIELFTVVEFPQSETNQDEVIAIKKIQLTYGLSRINWQGD 390

Query:   425 PCSPMYYSWDGLNCS-YNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXT 483
             PC P  + W GL CS  N   PP I  LNL+S GLTG I                    T
Sbjct:   391 PCVPEQFLWAGLKCSNINSSTPPTITFLNLSSSGLTGIISPSIQNLTHLQELDLSNNDLT 450

Query:   484 GSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL-CLSAPCKKE 542
             G +PEFL+ +  L ++NL GN  SG +P  L+ + +   L L++  NP L C   PC  +
Sbjct:   451 GDVPEFLADIKSLLIINLSGNNFSGQLPQKLIDKKR---LKLNVEGNPKLLCTKGPCGNK 507

Query:   543 -------KRNSVMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKK-EGSLKSD 594
                    K++ ++P                 F   ++K  +R   +   S+  E    + 
Sbjct:   508 PGEGGHPKKSIIVPVVSSVALIAILIAALVLFLVLRKKNPSRSKENGRTSRSSEPPRITK 567

Query:   595 NQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQ 654
              ++FTY E+ ++TNNF  +LGKGGFG VYHGY+    +VA+K+LS +S  G KQF+ E +
Sbjct:   568 KKKFTYVEVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVE 627

Query:   655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDA 713
             LL+RVHH+NL SLVGYC  G  + LVYEYMA G+LK++   +   + L W+ RLQIAV+A
Sbjct:   628 LLLRVHHKNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEA 687

Query:   714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
             AQGLEYLH GC+PPI+HRDVKTANILL+E  QAKLADFG S+ F  E ESH+ST + GT+
Sbjct:   688 AQGLEYLHKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTI 747

Query:   774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
             GYLDPEYY +N LTEKSDVYSFG+VLLE+IT    I R     HI   V   + +GD+R 
Sbjct:   748 GYLDPEYYRTNWLTEKSDVYSFGVVLLEIITNQRVIERTREKPHIAEWVNLMITKGDIRK 807

Query:   834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTK 893
             IVDP L+ ++ ++SVWK  E AM CV   S  RPTM+ VVTEL +C+ +E +R      K
Sbjct:   808 IVDPNLKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLENSRGG----K 863

Query:   894 SQMLSLSSSVDISAVEVETEMGPEAR 919
             SQ +  +SS +++ +  +TE+ P AR
Sbjct:   864 SQNMGSTSSSEVT-MTFDTEVNPVAR 888

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1704 (604.9 bits), Expect = 2.0e-175, P = 2.0e-175
 Identities = 371/862 (43%), Positives = 512/862 (59%)

Query:    77 YLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGK 136
             Y+D  T L+Y +D +F+++G    I  K + +        +R FPEG RNCY+L    G 
Sbjct:    46 YVDAATDLTYTTDNDFVQSGKTGTID-KELESTYNKPILQLRYFPEGVRNCYTLNVTLGT 104

Query:   137 AKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDN--ASHVVIKEIIHSALMDEI 194
                YL RASF+YG+YD  +K  EFDLY+G N W ++       + V  +EIIHS     +
Sbjct:   105 --NYLIRASFVYGNYDGLNKELEFDLYLGPNLWANVNTAVYLMNGVTTEEIIHSTKSKVL 162

Query:   195 NVCLLNTGKGTPFISALELRHFHNATYRTQSGAL-VLYRRLDVGSTTTQIIRFKDDHYDR 253
              VCL+ TG+  P I++LELR   N TY TQSG+L  L+R  +  ST+ +IIR+ +D  DR
Sbjct:   163 QVCLIKTGESIPIINSLELRPLINDTYNTQSGSLKYLFR--NYFSTSRRIIRYPNDVNDR 220

Query:   254 IWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQ 313
              W P+        + T+  ++S   + Y  P  VM +A  P++ N   +F + +   T +
Sbjct:   221 HWYPFFDEDAWTELTTNLNVNS--SNGYDPPKFVMASASTPISKNAPFNFTWSLIPSTAK 278

Query:   314 FYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTISSTQP--ARGSKLNFS 371
             FY YMHFA++++ Q N+ REF + LNGNL  +   P+   + TI   +P    G +    
Sbjct:   279 FYSYMHFADIQTLQANETREFDMMLNGNLALERYRPKTFATGTIYFIKPQICEGGQCIIE 338

Query:   372 LCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGK-GWQGDPCSPMY 430
             L KTS STLPP+ +A+E++ + D  +  T+QDDV AI +I+ +Y + K  WQGDPC P  
Sbjct:   339 LLKTSKSTLPPLCSALEVFTVIDFPELETNQDDVIAIKNIQNTYGVSKTSWQGDPCVPKR 398

Query:   431 YSWDGLNCSYNGY--KPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSIPE 488
             + WDGLNC+ N Y   PP I  LNL+S  LTG I                    TG +PE
Sbjct:   399 FMWDGLNCN-NSYISTPPTITFLNLSSSHLTGIIASAIQNLTHLQNLDLSNNNLTGGVPE 457

Query:   489 FLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRN-----PD-LCLSAPCK-- 540
             FL+ L  L V+NL GN LSGSVP +L+   Q   L L++  N     PD  C+S      
Sbjct:   458 FLAGLKSLLVINLSGNNLSGSVPQTLL---QKKGLKLNLEGNIYLNCPDGSCVSKDGNGG 514

Query:   541 KEKRNSVMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTY 600
              +K+N V+                  F  +++++  R  V  +    + ++ + N++FTY
Sbjct:   515 AKKKNVVVLVVVSIALVVVLGSALALFLVFRKRKTPRNEVSRTSRSLDPTITTKNRRFTY 574

Query:   601 SEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
             SE+V +TNNF +ILGKGGFG VYHG + D  +VA+KMLS SSSQG K+F+ E +LL+RVH
Sbjct:   575 SEVVKMTNNFEKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVH 634

Query:   661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-DETKEALSWKDRLQIAVDAAQGLEY 719
             H+NL  LVGYC++G N+ L+YEYMA G+LK+++  ++    L WK RL+I  ++AQGLEY
Sbjct:   635 HKNLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEY 694

Query:   720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             LH+GCKPP++HRDVKT NILL+E  QAKLADFG S+ FP E E+ + T + GT GYLDPE
Sbjct:   695 LHNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPE 754

Query:   780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
             YY +N L EKSDVYSFGIVLLE+IT    I +     HI   V   L +GD++SI+DP+ 
Sbjct:   755 YYRTNWLNEKSDVYSFGIVLLEIITNQHVINQSREKPHIAEWVGVMLTKGDIKSIIDPKF 814

Query:   840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSL 899
               ++D  SVW+  E AM CV   S  RPTMS VV EL +CL  E +R    R  SQ +  
Sbjct:   815 SGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVIELNECLASENSR----RGMSQNMES 870

Query:   900 SSSVDISAVEVE--TEMGPEAR 919
               S+  + V     TE  PEAR
Sbjct:   871 KGSIQYTEVSTNFGTEYTPEAR 892

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2017572 AT1G51790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1691 (600.3 bits), Expect = 4.7e-174, P = 4.7e-174
 Identities = 349/831 (41%), Positives = 502/831 (60%)

Query:    72 PAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRNCYSLR 131
             P    Y +  T + Y SD  +  TG +  ++ +    N++ +  +VRSFPEG RNCY++ 
Sbjct:    38 PENSSYTETSTDIKYVSDSSYTDTGTSYFVAPENRQ-NMKQSMWSVRSFPEGIRNCYTIA 96

Query:   132 PPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALM 191
                  +  YL RA FMYG+YD  +++P FDL++G N+WD+++  +    V KEII+  L 
Sbjct:    97 V--NSSTKYLIRADFMYGNYDSRNEIPGFDLHLGPNKWDTVELVSPLQTVSKEIIYYVLT 154

Query:   192 DEINVCLLNTGKGTPFISALELRHFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHY 251
             D I VCL+NTG GTPFIS LELR   N++Y  QS +L L++RLD GSTT   +R+ +D +
Sbjct:   155 DTIQVCLVNTGNGTPFISVLELRQLPNSSYAAQSESLQLFQRLDFGSTTNLTVRYPNDVF 214

Query:   252 DRIWVPYPGFP-GSASINT-SFIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGD 309
             DRIW  +P  P G+  ++  S  + S     +RLP  VM+T + P N    +DF +   D
Sbjct:   215 DRIW--FPATPNGTKPLSDPSTSLTSNSTGNFRLPQVVMRTGIVPDNPRGFVDFGWIPDD 272

Query:   310 PTLQFYVYMHFAELES-RQGN-QYREFSIELNGNLWEKSVVPEYLQSKTISSTQPARGSK 367
             P+L+F+ Y++F EL+    G  + REF I LNG  + + +   Y ++  + ++ P +   
Sbjct:   273 PSLEFFFYLYFTELQQPNSGTVETREFVILLNGKSFGEPLSLNYFRTLALFTSNPLKAES 332

Query:   368 LNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCS 427
               FSL +T +S+LPP++NA+E Y +    Q  TD +D++A+ +IK +Y + + W+GD C 
Sbjct:   333 FQFSLRQTQSSSLPPLINAMETYFVNKLPQSSTDPNDLSAMRNIKSAYKVKRNWEGDVCV 392

Query:   428 PMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTG-SI 486
             P  Y+W+GLNCS+NG   P++I+LNL+S GLTG+I                    +G ++
Sbjct:   393 PQAYTWEGLNCSFNGTNMPRVIALNLSSAGLTGEITSDISRLSQLQILDLSNNNLSGPAV 452

Query:   487 PEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCK-----K 541
             P FL+QL  LRVL+L  N+LSG +P+SL+ R      L S   NP +C +  C+     +
Sbjct:   453 PAFLAQLQFLRVLHLANNQLSGPIPSSLIER------LDSFSGNPSICSANACEEVSQNR 506

Query:   542 EKRNS----VMPXXXXXXXXXXXXXXXXXFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQ 597
              K+N     V+P                  +    ++  +    N  +     L+  N++
Sbjct:   507 SKKNKLPSFVIPLVASLAGLLLLFIISAAIFLILMRKKKQDYGGNETAVDAFDLEPSNRK 566

Query:   598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLM 657
             FTY+EIV+ITN F R  GK GFG  Y G L DG EV +K++S+ SSQG KQ R E + L 
Sbjct:   567 FTYAEIVNITNGFDRDQGKVGFGRNYLGKL-DGKEVTVKLVSSLSSQGYKQLRAEVKHLF 625

Query:   658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL 717
             R+HH+NL +++GYCN+G  + ++YEYMA GNLKQ++ + +    SW+DRL IAVD AQGL
Sbjct:   626 RIHHKNLITMLGYCNEGDKMAVIYEYMANGNLKQHISENSTTVFSWEDRLGIAVDVAQGL 685

Query:   718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
             EYLH GCKPPIIHR+VK  N+ L+E   AKL  FG S+ F A   SH++T+I GT GY+D
Sbjct:   686 EYLHTGCKPPIIHRNVKCTNVFLDESFNAKLGGFGLSRAFDAAEGSHLNTAIAGTPGYVD 745

Query:   778 PEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP 837
             PEYY SN LTEKSDVYSFG+VLLE++T  PAII+     HI   V   L R ++  I+DP
Sbjct:   746 PEYYTSNMLTEKSDVYSFGVVLLEIVTAKPAIIKNEERMHISQWVESLLSRENIVEILDP 805

Query:   838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
              L  ++D NS +K  E A+ CV   S  RP MS VVT LK+ L +E  R++
Sbjct:   806 SLCGDYDPNSAFKTVEIAVACVCRNSGDRPGMSQVVTALKESLAVEVERKK 856

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	919
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	1e-119
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-49
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-49
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-28
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-27
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-23
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-23
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-23
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-23
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-22
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-22
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-20
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  365 bits (938), Expect = e-119
 Identities = 151/337 (44%), Positives = 206/337 (61%), Gaps = 17/337 (5%)

Query: 67  IDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFPEGNRN 126
           IDCG+P+   Y D  T +++ SD  FI TG + NIS +  S+ L   Y T+RSFP+G RN
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFPDGKRN 60

Query: 127 CYSLRPPEGKAKTYLTRASFMYGDYDDEDKL---PEFDLYIGVNRWDSIKFDNAS-HVVI 182
           CY+L    GK   YL RA+F+YG+YD  + +   P FDLY+GVN W ++   N S   V+
Sbjct: 61  CYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSVV 120

Query: 183 KE-IIHSALMDEINVCLLNTGKGTPFISALELRHFHNATYRT--QSGALVLYRRLDVGST 239
           KE IIH    D ++VCL+NTG GTPFISALELR   ++ Y +   S AL L  RL+ G  
Sbjct: 121 KEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARLNFGG- 179

Query: 240 TTQIIRFKDDHYDRIWVPYPGFPGSASINTSF-IIDSLVDSQYRLPSAVMKTAVKPMNVN 298
           +   IR+ DD YDRIW P+   PG + I+TS  +  S  ++ Y  PSAV++TAV P N +
Sbjct: 180 SEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTPTNAS 239

Query: 299 DSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKSVVPEYLQSKTIS 358
             L+F +++ DP  ++YVY+HFAE++S    + REF I +NG      V P+YL + T +
Sbjct: 240 APLNFTWDLVDPNFEYYVYLHFAEIQS---LETREFDIYINGKTVYGDVSPKYLGTDTGA 296

Query: 359 STQPA-----RGSKLNFSLCKTSNSTLPPILNAIEIY 390
                      G  LN SL  TS STLPP+LNA+EI+
Sbjct: 297 LYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIF 333

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (447), Expect = 3e-50
 Identities = 76/194 (39%), Positives = 110/194 (56%), Gaps = 12/194 (6%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYC 671
           LG+GGFGTVY       G +VAIK++    S    +    E ++L +++H N+  L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIH 730
            D  ++ LV EY   G+LK  L +   + LS  + L+I +   +GLEYLH +G    IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNG----IIH 115

Query: 731 RDVKTANILLNEK-MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR-LTE 788
           RD+K  NILL+    + KLADFG SK+    S+  +  +IVGT  Y+ PE        +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 789 KSDVYSFGIVLLEL 802
           KSD++S G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  176 bits (450), Expect = 5e-50
 Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 29/276 (10%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
             + LG+G FG VY G L    E     VA+K L   +S+  ++ F  EA ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           +  L+G C  G  + +V EYM  G+L  +L     E L+ KD LQ+A+  A+G+EYL   
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                 +HRD+   N L+ E +  K++DFG S+    +            + ++ PE   
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 783 SNRLTEKSDVYSFGIVLLELITG--LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
             + T KSDV+SFG++L E+ T    P    G +N  ++      LE G        RL 
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEVLE----LLEDG-------YRLP 224

Query: 841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
              +     ++ E  ++C       RPT S +V +L
Sbjct: 225 RPENCPD--ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  175 bits (445), Expect = 2e-49
 Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 11/201 (5%)

Query: 610 FHRILGKGGFGTVYHGYLADGS-----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRN 663
             + LG+G FG VY G L         EVA+K L   +S Q  ++F  EA+++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+G C +   + +V EYM  G+L  YL    +  LS  D L  A+  A+G+EYL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
                IHRD+   N L+ E +  K++DFG S+    + + +        + ++ PE    
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T KSDV+SFG++L E+ T
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  173 bits (440), Expect = 9e-49
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 610 FHRILGKGGFGTVYHGYLADGS-----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRN 663
             + LG+G FG VY G L         EVA+K L   +S Q  ++F  EA+++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+G C +   + +V EYM  G+L  YL     + LS  D L  A+  A+G+EYL   
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG--TVGYLDPEYY 781
                IHRD+   N L+ E +  K++DFG S+      +        G   + ++ PE  
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKGGKLPIRWMAPESL 176

Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
              + T KSDV+SFG++L E+ T
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (433), Expect = 1e-47
 Identities = 70/205 (34%), Positives = 102/205 (49%), Gaps = 15/205 (7%)

Query: 612 RILGKGGFGTVYHGYLADGS----EVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLAS 666
           + LG+G FG VY G L        EVA+K L    S +  K F  EA+++ ++ H N+  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYL-------FDETKEALSWKDRLQIAVDAAQGLEY 719
           L+G C +   + LV EYM  G+L  YL           K  LS KD L  A+  A+G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           L        +HRD+   N L+ E +  K++DFG S+    +      T     + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
                  T KSDV+SFG++L E+ T
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  169 bits (431), Expect = 2e-47
 Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 12/201 (5%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASL 667
               LG+G FG VY       G  VAIK++      +  ++   E ++L ++ H N+  L
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
                D   + LV EY   G+L   L  + +  LS  +           LEYLH  G   
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKG--- 117

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I+HRD+K  NILL+E    KLADFG ++           T+ VGT  Y+ PE       
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 787 TEKSDVYSFGIVLLELITGLP 807
            +  D++S G++L EL+TG P
Sbjct: 174 GKAVDIWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score =  176 bits (449), Expect = 1e-46
 Identities = 147/522 (28%), Positives = 235/522 (45%), Gaps = 71/522 (13%)

Query: 116 TVRSFP--EGNRNCYSL-RPPEGKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSI 172
           T+R FP  +G  NCY++ R P+G    Y  R  F      + D  P FD+ +   +  S+
Sbjct: 71  TLRYFPLSDGPENCYNINRVPKGH---YSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSL 127

Query: 173 KFDNASH---VVIKEIIHSALMD-EINVCLLNTGKGTPFISALELRHFHNATYRTQSGA- 227
           K   +SH   V  + ++   L D   ++C  +TG G P I ++E+    +  Y       
Sbjct: 128 KSGWSSHDEQVFAEALVF--LTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWG 185

Query: 228 ----LVLYRRLDVGSTTTQI-IRFKDDHY--DRIWVPYPGFPGSA--SINTSFIIDSLVD 278
               L   +RL  G+  ++    +  DH+  DR W     F   +  +I+T  +I    +
Sbjct: 186 QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASN 245

Query: 279 SQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELE-SRQGNQYREFSIE 337
           +    P ++ ++A+   +    L +  ++ DP   + V++HFAE++ S      R F + 
Sbjct: 246 APNFYPESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVL 304

Query: 338 LNGNLWEKSV-----VPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIY-I 391
           +NG+   K V       E   +  ++ T    G  L   L     +    I+NAIE++ I
Sbjct: 305 INGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTH--AIINAIEVFEI 362

Query: 392 LTDTLQEPTDQDDVNAIMDIK--LSYDLGKGWQGDPCSPMYYSWDGLNCSYN-------- 441
           +T   +  T  ++V+A+  +K  L   L  GW GDPC P  + W G +C ++        
Sbjct: 363 IT--AESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFI 420

Query: 442 -----------GYKPPKII------SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG 484
                      G+ P  I       S+NL+   + G I PSL ++ SLE LDLS NS  G
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 485 SIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSA---PCKK 541
           SIPE L QL  LR+LNL+GN LSG VP +L  R  + +   +   N  LC       C  
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA-SFNFTDNAGLCGIPGLRACGP 539

Query: 542 EKRNSVMPVVAASVSL-LVILIALLVFWTYKRK----RAARL 578
                    +A  VS+  + L+   + W +KR+    RA R+
Sbjct: 540 HLSVGAKIGIAFGVSVAFLFLVICAMCW-WKRRQNILRAQRI 580

Length = 623

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (421), Expect = 4e-46
 Identities = 79/203 (38%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLAS 666
             R LG G FGTVY       G  VA+K+L   S  S+  +  R E ++L R+ H N+  
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCK 725
           L+    D  ++ LV EY   G+L  YL       LS  +  +IA+   +GLEYLH +G  
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             IIHRD+K  NILL+E    K+ADFG +K       S   T+ VGT  Y+ PE      
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 786 L-TEKSDVYSFGIVLLELITGLP 807
               K DV+S G++L EL+TG P
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKP 197

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  139 bits (353), Expect = 5e-37
 Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 20/201 (9%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG--Y 670
           +GKGGFG VY   +   G EVAIK++   S +  ++   E Q+L +  H N+    G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLH-HGCKP 726
             D   + +V E+ + G+LK  L   T + L      QIA    +  +GLEYLH +G   
Sbjct: 68  KKD--ELWIVMEFCSGGSLKD-LLKSTNQTL---TESQIAYVCKELLKGLEYLHSNG--- 118

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            IIHRD+K ANILL    + KL DFG S      S++    ++VGT  ++ PE       
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 175 DYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  130 bits (329), Expect = 9e-34
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 34/213 (15%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            +LG+G FG+VY     D G  +A+K   LS  S +  +    E ++L  + H N+    
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 669 GYC--NDGGNVGLVYEYMAYGNLKQYL-----FDE------TKEALSWKDRLQIAVDAAQ 715
           G     +   + +  EY++ G+L   L       E      T++ L             +
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------E 112

Query: 716 GLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           GL YLH +G    I+HRD+K ANIL++     KLADFG +K          + S+ GT  
Sbjct: 113 GLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           ++ PE          +D++S G  ++E+ TG P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  139 bits (351), Expect = 1e-33
 Identities = 122/473 (25%), Positives = 214/473 (45%), Gaps = 57/473 (12%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            +++ L L+   L+G+I   LS+ K L +LDLS+N L+G IP   S++P+L  L+L  N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558

Query: 506 LSGSVPTSL--------VARSQN---GSL-----LLSIGR-----NPDLCLS------AP 538
           LSG +P +L        V  S N   GSL      L+I       N DLC         P
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618

Query: 539 CKKEKRNSVMPVVAAS--VSLLVILIALLVFWTYKRKRAARLN-VDNSHSKKEGSLKSD- 594
           CK+ ++             + LV+ +    F   + +    L  V+N     E       
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678

Query: 595 -NQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTE 652
            ++  T ++I+        ++ +G  G  Y G  + +G +  +K ++  +S  P     +
Sbjct: 679 VSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-PSSEIAD 736

Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
              + ++ H N+  L+G C       L++EY+   NL + L       LSW+ R +IA+ 
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIG 788

Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
            A+ L +LH  C P ++  ++    I+++ K +  L       +   +++  IS++    
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---- 843

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL-PAIIRGYNNTHIVN--RVCPFLERG 829
             Y+ PE   +  +TEKSD+Y FG++L+EL+TG  PA      +  IV   R C      
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC--YSDC 899

Query: 830 DVRSIVDP--RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
            +   +DP  R + + + N + +V   A+ C  +    RP  + V+  L+   
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             R LG G FG V+ G   + + VA+K L   +   PK F  EAQ++ ++ H  L  L  
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + +V E M YG+L +YL      AL     + +A   A G+ YL        I
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNRL 786
           HRD+   N+L+ E    K+ADFG +++     +  I  +  G    + +  PE    NR 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTAPEAALYNRF 181

Query: 787 TEKSDVYSFGIVLLELIT 804
           + KSDV+SFGI+L E++T
Sbjct: 182 SIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 2e-32
 Identities = 65/189 (34%), Positives = 102/189 (53%), Gaps = 10/189 (5%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           +GKG FG V  G    G +VA+K L   S+   + F  EA ++  + H NL  L+G    
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
           G  + +V EYMA G+L  YL    +  ++   +L  A+D  +G+EYL    +   +HRD+
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
              N+L++E + AK++DFG +K     S+   S  +   V +  PE     + + KSDV+
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFSTKSDVW 183

Query: 794 SFGIVLLEL 802
           SFGI+L E+
Sbjct: 184 SFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  125 bits (315), Expect = 8e-32
 Identities = 77/238 (32%), Positives = 124/238 (52%), Gaps = 32/238 (13%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHR 662
           F   LG+G FG VY G L   +E      VAIK L  ++    +Q FR EA+L+  + H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF--------------DETKEALSWKDRLQ 708
           N+  L+G C       +++EY+A+G+L ++L               +  K +L   D L 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 709 IAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHI 765
           IA+  A G+EYL  HH      +HRD+   N L+ E +  K++DFG S+ I+ A+     
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRV 822
           S S++  V ++ PE     + T +SD++SFG+VL E+ + GL     G++N  ++  +
Sbjct: 184 SKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 1e-31
 Identities = 65/196 (33%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           R LG G FG V+ G     ++VA+K L    +  P+ F  EAQ++ ++ H  L  L   C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           ++   + +V EYM+ G+L  +L     + L     + +A   A+G+ YL        IHR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNRLTE 788
           D+   NIL+ E +  K+ADFG +++     E    T+  G    + +  PE     R T 
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI----EDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 789 KSDVYSFGIVLLELIT 804
           KSDV+SFGI+L E++T
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (314), Expect = 6e-31
 Identities = 88/309 (28%), Positives = 136/309 (44%), Gaps = 21/309 (6%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRV-HHRNL 664
              R LG+G FG VY     D   VA+K+L+    S S+  ++F  E Q+L  + H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
             L  +  D G++ LV EY+  G+L+  L     K  LS  + L I       LEYLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 724 CKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESES----HISTSIVGTVGYLDP 778
               IIHRD+K  NILL+      KL DFG +K+ P    +     + ++ VGT GY+ P
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 779 EYYASNRL---TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV 835
           E      L   +  SD++S GI L EL+TGLP      N++     +   LE       +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--PSL 235

Query: 836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT-ELKKCLEMETAREQIQRTKS 894
              L  +         ++   + +      R + S  ++ +L   L+++ +         
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 895 QMLSLSSSV 903
               L  S+
Sbjct: 296 DSAPLRLSL 304

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (306), Expect = 1e-30
 Identities = 62/196 (31%), Positives = 92/196 (46%), Gaps = 12/196 (6%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G  G VY   +   G   A+K +      +  KQ   E + L       +    G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL--QIAVDAAQGLEYLHHGCKPPII 729
              G + +V EYM  G+L   L    K+     + +   IA    +GL+YLH      II
Sbjct: 69  YKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKRH--II 122

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           HRD+K +N+L+N K + K+ADFG SK+   E+      + VGTV Y+ PE       +  
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 790 SDVYSFGIVLLELITG 805
           +D++S G+ LLE   G
Sbjct: 181 ADIWSLGLTLLECALG 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (307), Expect = 1e-30
 Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 20/235 (8%)

Query: 610 FHRILGKGGFGTVY---HGYLAD--GSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRN 663
           F + LG+G FG V    +  L D  G +VA+K L+ S   Q    F  E ++L  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 664 LASLVGYCNDGGNVG--LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           +    G C   G     L+ EY+  G+L+ YL    ++ ++ K  L  +    +G++YL 
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEY 780
                  IHRD+   NIL+  +   K++DFG +K+ P + + +       + + +  PE 
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 781 YASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNRVCPFLER 828
             +++ +  SDV+SFG+ L EL T            +R          V   LE 
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  121 bits (305), Expect = 1e-30
 Identities = 68/215 (31%), Positives = 101/215 (46%), Gaps = 36/215 (16%)

Query: 612 RILGKGGFGTVYHGYLA----DGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           + +GKG FG VY   L     DG    +K   LS  S +  +    E ++L +++H N+ 
Sbjct: 6   KQIGKGSFGKVY---LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI- 61

Query: 666 SLVGYCN---DGGNVGLVYEYMAYGNLKQYL---------FDETKEALSWKDRLQIAVDA 713
             + Y     + G + +V EY   G+L Q +         F E ++ L W   +Q+ +  
Sbjct: 62  --IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDW--FVQLCL-- 114

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
              L+YLH      I+HRD+K  NI L      KL DFG SK+    S   ++ ++VGT 
Sbjct: 115 --ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTP 167

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPA 808
            YL PE   +     KSD++S G VL EL T    
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 3e-30
 Identities = 72/216 (33%), Positives = 108/216 (50%), Gaps = 13/216 (6%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGY 670
             +GKG FG VY G L   +EVA+K   ++     K+ F  EA++L +  H N+  L+G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           C     + +V E +  G+L  +L  + K  L+ K  LQ+++DAA G+EYL        IH
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT----VGYLDPEYYASNRL 786
           RD+   N L+ E    K++DFG S+    E E  I T   G     + +  PE     R 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T +SDV+S+GI+L E  +       G +N     R+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  119 bits (300), Expect = 6e-30
 Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 5/193 (2%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           R LG G FG V+ G   +   VAIK+L +      + F+ E Q L R+ H++L SL   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           + G  V ++ E M  G+L  +L     + L     + +A   A+G+ YL    +   IHR
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSD 791
           D+   NIL+ E +  K+ADFG +++   +        I     +  PE  +    + KSD
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSD 186

Query: 792 VYSFGIVLLELIT 804
           V+SFGI+L E+ T
Sbjct: 187 VWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 4e-29
 Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 29/207 (14%)

Query: 614 LGKGGFGTVY---HGYLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASL 667
           LGKG FG V          G   A+K+L        +  +   TE  +L R++H  +  L
Sbjct: 1   LGKGSFGKVLLVRK--KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQ-IAVDAAQGLEYLH 721
                    + LV EY   G L  +L     F E        +R +  A +    LEYLH
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--------ERARFYAAEIVLALEYLH 110

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
             G    II+RD+K  NILL+     KL DFG +K   +E     + +  GT  YL PE 
Sbjct: 111 SLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEV 164

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
                  +  D +S G++L E++TG P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 1e-28
 Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           ++G+G FG VY G  L  G  VAIK +S      +  K    E  LL  + H N+   +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                 ++ ++ EY   G+L+Q +  F    E+L      Q+     QGL YLH   +  
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH---EQG 119

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+K ANIL  +    KLADFG +      S+     S+VGT  ++ PE    +  +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGAS 177

Query: 788 EKSDVYSFGIVLLELITGLP 807
             SD++S G  ++EL+TG P
Sbjct: 178 TASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 3e-28
 Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 12/216 (5%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           F + LG G FG V+ G      +VAIKM+    +     F  EA+++M++ H NL  L G
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + +V EYMA G L  YL  E K  L  +  L +  D  + +EYL        I
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNRL 786
           HRD+   N L+ E    K++DFG ++ +  + +    TS  GT   V +  PE +  +R 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + KSDV+SFG+++ E+ +        ++N+ +V  V
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (288), Expect = 3e-28
 Identities = 72/247 (29%), Positives = 107/247 (43%), Gaps = 37/247 (14%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLS-ASSSQGPKQFRTEAQLLMRVHHR 662
             R LG+G FG V+ G             VA+K L   +S+   K F  EA+LL    H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL------------FDETKEALSWKDRLQIA 710
           N+    G C +G    +V+EYM +G+L ++L             D     L+    LQIA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 711 VDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
           V  A G+ YL   H      +HRD+ T N L+   +  K+ DFG S+         +   
Sbjct: 129 VQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183

Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN-------- 820
            +  + ++ PE     + T +SDV+SFG+VL E+ T       G +N  ++         
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243

Query: 821 ---RVCP 824
              R CP
Sbjct: 244 QRPRTCP 250

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  113 bits (285), Expect = 5e-28
 Identities = 71/205 (34%), Positives = 110/205 (53%), Gaps = 13/205 (6%)

Query: 612 RILGKGGFGTVYHGYLADGS----EVAIKMLSA-SSSQGPKQFRTEAQLLMRVHHRNLAS 666
           R++GKG FG VYHG L D        A+K L+  +  +  +QF  E  ++    H N+ S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 667 LVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
           L+G C    G+  +V  YM +G+L+ ++  ET    + KD +   +  A+G+EYL     
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEYYAS 783
              +HRD+   N +L+E    K+ADFG ++ I+  E  S H  T     V ++  E   +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 784 NRLTEKSDVYSFGIVLLELIT-GLP 807
            + T KSDV+SFG++L EL+T G P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  112 bits (283), Expect = 1e-27
 Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 12/203 (5%)

Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+++  + F  E ++L  + H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ LV EY+ YG+L+ YL  + +E L  +  L  A    +G+EYL  
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL-- 124

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYY 781
           G K   +HRD+ T NIL+  + + K+ DFG +K+ P + E +         + +  PE  
Sbjct: 125 GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (283), Expect = 2e-27
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 605 DITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN 663
           ++  N  +I G+G  G VY     A G EVAIK +     Q  +    E  ++    H N
Sbjct: 19  ELYKNLEKI-GEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYL 720
           +         G  + +V EYM  G+L   +  +    ++     QIA    +  QGLEYL
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMN---EPQIAYVCREVLQGLEYL 132

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
           H      +IHRD+K+ NILL++    KLADFGF+     E       S+VGT  ++ PE 
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPEV 187

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
                   K D++S GI+ +E+  G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (278), Expect = 4e-27
 Identities = 60/191 (31%), Positives = 104/191 (54%), Gaps = 6/191 (3%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           +G G FG V+ GY  +  +VAIK +    +   + F  EAQ++M++ H  L  L G C +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + LV+E+M +G L  YL  + +   S +  L + +D  +G+ YL       +IHRD+
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
              N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ ++ + KSDV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 794 SFGIVLLELIT 804
           SFG+++ E+ +
Sbjct: 186 SFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  110 bits (278), Expect = 8e-27
 Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 30/222 (13%)

Query: 610 FHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRV-HHRNL 664
           F +I+G+G F TV          E AIK+L        +  K  + E ++L R+  H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HG 723
             L     D  N+  V EY   G L QY+      +L  K     A +    LEYLH  G
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS----------------- 766
               IIHRD+K  NILL++ M  K+ DFG +K+    S    +                 
Sbjct: 123 ----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 767 -TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             S VGT  Y+ PE        + SD+++ G ++ +++TG P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  111 bits (278), Expect = 8e-27
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 30/220 (13%)

Query: 612 RILGKGGFGTVYH----GYLADGSE--VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R +G+G FG V+     G L       VA+KML   +S+     F+ EA L+    H N+
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------------FDETKEALSWK 704
             L+G C  G  + L++EYMAYG+L ++L                           LS  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
           ++L IA   A G+ YL    +   +HRD+ T N L+ E M  K+ADFG S+   +     
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            S +    + ++ PE    NR T +SDV+++G+VL E+ +
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (276), Expect = 1e-26
 Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 15/197 (7%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIK-MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG G  G V        G  +A+K +    +    KQ   E  +L + +   +    G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ---IAVDAAQGLEYLHHGCKPPI 728
            + G++ +  EYM  G+L + L    KE            IAV   +GL YLH   K  I
Sbjct: 69  YNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRDVK +NIL+N + Q KL DFG S     +  + ++ + VGT  Y+ PE    N  + 
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 789 KSDVYSFGIVLLELITG 805
           KSD++S G+ L+EL TG
Sbjct: 179 KSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  108 bits (272), Expect = 3e-26
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 14/204 (6%)

Query: 605 DITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN 663
           DIT      LG G +G VY G        VA+K L   + +  ++F  EA ++  + H N
Sbjct: 7   DIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 63

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           L  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL   
Sbjct: 64  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 121

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEY 780
            K   IHRD+   N L+ E    K+ADFG S++   +      T+  G    + +  PE 
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPES 176

Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
            A N+ + KSDV++FG++L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (262), Expect = 5e-25
 Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 10/216 (4%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ G     ++VA+K L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L D    AL   + + +A   A G+ Y+    +   IHRD+
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           ++ANIL+ + +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL+T       G NN  ++ +V    ERG
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQV----ERG 219

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-24
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGS----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G  + +G      VAIK+L   +S +  K+   EA ++  V H ++ 
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL--HHG 723
            L+G C     V L+ + M  G L  Y+    K+ +  +  L   V  A+G+ YL     
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               ++HRD+   N+L+      K+ DFG +K+   + + + +      + ++  E    
Sbjct: 130 ----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
              T KSDV+S+G+ + EL+T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  103 bits (259), Expect = 2e-24
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           LG+G FG V+    H  L +  +  VA+K L  +S    + F+ EA+LL  + H+++   
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL---------FDETKEA----LSWKDRLQIAVDAA 714
            G C +G  + +V+EYM +G+L ++L             ++     L+    L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ + +  K+ DFG S+   +     +    +  + 
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SD++SFG+VL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (257), Expect = 2e-24
 Identities = 60/193 (31%), Positives = 104/193 (53%), Gaps = 14/193 (7%)

Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           I+G+G FG V  G Y   G +VA+K +    +   + F  E  ++ ++HH+NL  L+G  
Sbjct: 13  IIGEGEFGAVLQGEYT--GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
              G + +V E M+ GNL  +L    +  +S    LQ ++D A+G+EYL       ++HR
Sbjct: 69  LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSD 791
           D+   NIL++E   AK++DFG +++     ++         V +  PE     + + KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKHKKFSSKSD 179

Query: 792 VYSFGIVLLELIT 804
           V+S+G++L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  103 bits (257), Expect = 2e-24
 Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 14/221 (6%)

Query: 605 DITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           D+T  F + LG G FG V +G      +VAIKM+    S    +F  EA+++M++ H  L
Sbjct: 5   DLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKL 61

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L G C     + +V EYM+ G L  YL  E  +       L++  D  +G+ YL    
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE--- 117

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYY 781
               IHRD+   N L++++   K++DFG S+ +  + E    TS VG+   V +  PE  
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDE---YTSSVGSKFPVRWSPPEVL 173

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
             ++ + KSDV++FG+++ E+ +        +NN+  V +V
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  102 bits (255), Expect = 6e-24
 Identities = 72/235 (30%), Positives = 108/235 (45%), Gaps = 33/235 (14%)

Query: 612 RILGKGGFGTVYHG----YLADGSE---VAIKML-SASSSQGPKQFRTEAQLLMRVHHRN 663
             LG G FG VY G     L  GS    VA+K L   ++ Q  K+F  EA L+   +H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-----LSWKDRLQIAVDAAQGLE 718
           +  L+G C       ++ E M  G+L  YL D   E      L+ K+ L I +D A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQA-----KLADFGFSK------IFPAESESHIST 767
           YL    +   IHRD+   N L++EK        K+ DFG ++       +  E E  +  
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP- 176

Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
                V ++ PE     + T +SDV+SFG+++ E++T         NN  ++  V
Sbjct: 177 -----VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (254), Expect = 8e-24
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
            LG+G +G+VY   +   G  VAIK++        ++   E  +L +     +    G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPI 728
               ++ +V EY   G++   +   T + L+ +   +IA       +GLEYLH       
Sbjct: 68  FKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEE---EIAAILYQTLKGLEYLH---SNKK 120

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  NILLNE+ QAKLADFG S             +++GT  ++ PE         
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 789 KSDVYSFGIVLLELITGLP 807
           K+D++S GI  +E+  G P
Sbjct: 179 KADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 9e-24
 Identities = 69/203 (33%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G G +G VY    +A G  VAIK++        +  + E  +L    H N+ +  G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIA---VDAAQGLEYLHHGCKPPII 729
               + +V EY   G+L Q ++  T+  LS    LQIA    +  +GL YLH   K   I
Sbjct: 71  RRDKLWIVMEYCGGGSL-QDIYQVTRGPLS---ELQIAYVCRETLKGLAYLHETGK---I 123

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRL- 786
           HRD+K ANILL E    KLADFG S    A+  + I+   S +GT  ++ PE  A  R  
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 787 --TEKSDVYSFGIVLLELITGLP 807
               K D+++ GI  +EL    P
Sbjct: 180 GYDGKCDIWALGITAIELAELQP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 9e-24
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 25/212 (11%)

Query: 612 RILGKGGFGTVYHGYLA--DGS--EVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLA 665
           +ILG+G FG+V  G L+  DGS  +VA+K +     +    ++F +EA  +    H N+ 
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 666 SLVGYCNDGGNVG------LVYEYMAYGNLKQYLFDETKEALSWKDRLQ----IAVDAAQ 715
            L+G C +  ++       ++  +M +G+L  +L       L  K  LQ      VD A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES---ESHISTSIVGT 772
           G+EYL +      IHRD+   N +L E M   +ADFG SK   +     +  I+      
Sbjct: 125 GMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---P 178

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           V ++  E  A    T KSDV++FG+ + E+ T
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (252), Expect = 1e-23
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 219

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  101 bits (252), Expect = 1e-23
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 18/211 (8%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLV 668
           R++G+G FG V+     AD   V IK +     +       + E Q+L  + H N+    
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
               +   + +V EY   G L +Y+       L     L   V   Q L  LHH     I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---QILLALHHVHTKLI 122

Query: 729 IHRDVKTANILLNE-KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+KT NILL++ KM  K+ DFG SKI  ++S+++   ++VGT  Y+ PE        
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCYISPELCEGKPYN 179

Query: 788 EKSDVYSFGIVLLELIT--------GLPAII 810
           +KSD+++ G VL EL +         LPA++
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  101 bits (253), Expect = 2e-23
 Identities = 58/204 (28%), Positives = 106/204 (51%), Gaps = 13/204 (6%)

Query: 610 FHRILGKGGFGTVY----HGYLADGS--EVAIKMLSASSSQGPKQ-FRTEAQLLMRV-HH 661
           F + LG G FG V     +G     +  +VA+KML  ++    ++   +E +++  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL- 720
            N+ +L+G C  GG + ++ EY  YG+L  +L  + +  L+ +D L  +   A+G+ +L 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
              C    IHRD+   N+LL      K+ DFG ++    +S   +  +    V ++ PE 
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             +   T +SDV+S+GI+L E+ +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLAS 666
           +++G G FG V  G L    +    VAIK L A SS   +  F TEA ++ +  H N+  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       V ++ EYM  G+L ++L  E     +    + +    A G++YL      
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG---TVGYLDPEYYAS 783
             +HRD+   NIL+N  +  K++DFG S+    +SE+  +T   G    + +  PE  A 
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTK--GGKIPIRWTAPEAIAY 182

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+SFGIV+ E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  100 bits (250), Expect = 3e-23
 Identities = 66/234 (28%), Positives = 114/234 (48%), Gaps = 24/234 (10%)

Query: 610 FHRILGKGGFGTVYHGYL-ADGSE----VAIKMLS-ASSSQGPKQFRTEAQLLMRVHHRN 663
           F   LG+  FG +Y G+L   G +    VAIK L   ++ Q   +F+ EA L+  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLF------------DE---TKEALSWKDRLQ 708
           +  L+G       V +++EY+  G+L ++L             DE    K +L   D L 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 709 IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
           IA+  A G+EYL        +H+D+   NIL+ E++  K++D G S+   +     +   
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  + ++ PE     + +  SD++SFG+VL E+ +       G++N  ++  V
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  100 bits (250), Expect = 4e-23
 Identities = 86/305 (28%), Positives = 140/305 (45%), Gaps = 50/305 (16%)

Query: 605 DITNNFHRILGKGGFGTVYHGYLA-DGSEV--AIKMLSASSSQGP-KQFRTEAQLLMRV- 659
           DI   F  ++G+G FG V    +  DG ++  AIKML   +S+   + F  E ++L ++ 
Sbjct: 3   DIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--------------TKEALSWKD 705
           HH N+ +L+G C + G + +  EY  YGNL  +L                 T   L+ + 
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
            LQ A D A G++YL    +   IHRD+   N+L+ E + +K+ADFG S+      E ++
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV 173

Query: 766 STSIVGTVGYLDPEYYASNRL-----TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN 820
                 T+G L   + A   L     T KSDV+SFG++L E+++           T    
Sbjct: 174 KK----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--------LGGTPYCG 221

Query: 821 RVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
             C  L     +     R+E   + +   +V E   +C     ++RP  + +  +L + L
Sbjct: 222 MTCAELYEKLPQGY---RMEKPRNCDD--EVYELMRQCWRDRPYERPPFAQISVQLSRML 276

Query: 881 EMETA 885
           E   A
Sbjct: 277 EARKA 281

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 74/304 (24%), Positives = 131/304 (43%), Gaps = 53/304 (17%)

Query: 598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-------VAIKMLSASSSQGPKQ-F 649
           F  S + +IT      LG+G FG V+    A G E       V +K L  +  +  +  F
Sbjct: 2   FPRSNLQEIT-----TLGRGEFGEVFLAK-AKGIEEEGGETLVLVKALQKTKDENLQSEF 55

Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-----DETKEA--LS 702
           R E  +  ++ H+N+  L+G C +     ++ EY   G+LKQ+L      DE  +   LS
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
            K ++ +    A G+++L +      +HRD+   N L++ + + K++    SK     SE
Sbjct: 116 TKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSE 171

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +   + +  + +L PE    +  + KSDV+SFG+++ E+ T       G ++  ++NR 
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR- 230

Query: 823 CPFLERGDVRSIVDPRLEANFDTNSVWKVAETAME--------CVPSISFQRPTMSHVVT 874
              L+ G +                   V E            C       RP+ S +V+
Sbjct: 231 ---LQAGKLE----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271

Query: 875 ELKK 878
            L +
Sbjct: 272 ALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.9 bits (246), Expect = 6e-23
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 12/193 (6%)

Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYC 671
           +LGKG FG V+ G L D + VA+K       Q  K +F +EA++L +  H N+  L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIH 730
                + +V E +  G+   +L  + K+ L  K  ++ A+DAA G+ YL    C    IH
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRLTE 788
           RD+   N L+ E    K++DFG S+    E +   S+S +    + +  PE     R + 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 789 KSDVYSFGIVLLE 801
           +SDV+S+GI+L E
Sbjct: 174 ESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.8 bits (246), Expect = 7e-23
 Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 6/191 (3%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VAIK L    S  P+ F  EA L+ ++ H  L  L      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L       L+    + +A   A+G+ ++    +   IHRD+
Sbjct: 73  E-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL++E +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 794 SFGIVLLELIT 804
           SFGI+L E++T
Sbjct: 188 SFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 30/212 (14%)

Query: 613 ILGKGGFGTVYHGYLADGS-----EVAIKMLS--ASSSQGPKQFRTEAQLLMRVHHRNLA 665
           +L +G FG +++G L D       EV +K +   AS  Q       E+ LL  + H+N+ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNIL 71

Query: 666 SLVGYCNDGGNVGLV-YEYMAYGNLKQYLFD------ETKEALSWKDRLQIAVDAAQGLE 718
            ++  C + G    V Y YM +GNLK +L           +ALS +  + +A+  A G+ 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGT----- 772
           YLH   K  +IH+D+   N +++E++Q K+ D   S+ +FP +         +G      
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC------LGDNENRP 182

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           V ++  E   +   +  SDV+SFG++L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 9e-23
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G           + VAIK ++ ++S   + +F  EA ++   +  ++
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA G+LK YL     EA         + +  +Q+A + A G
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGY 775
           + YL        +HRD+   N ++ E +  K+ DFG ++ I+  +        ++  V +
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE       T KSDV+SFG+VL E+ T
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 99.4 bits (247), Expect = 9e-23
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 612 RILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V+           D   VA+K L  +S    K F  EA+LL  + H ++ 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-----------LSWKDRLQIAVDAA 714
              G C +G  + +V+EYM +G+L ++L     +A           L+    L IA   A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ E +  K+ DFG S+   +     +    +  + 
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SDV+S G+VL E+ T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 99.3 bits (247), Expect = 9e-23
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 34/223 (15%)

Query: 612 RILGKGGFGTVYHGY------LADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNL 664
           + LG+G FG V           A  + VA+KML  ++S    +   +E  LL +V+H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL----------------------FDETKEALS 702
             L G C+  G + L+ EY  YG+L+ +L                       +  + AL+
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAES 761
             D +  A   ++G++YL    +  ++HRD+   N+L+ E  + K++DFG S+ ++  +S
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
               S   +  V ++  E    +  T +SDV+SFG++L E++T
Sbjct: 183 YVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 18/196 (9%)

Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLVG 669
           +G+G FG V+ G L AD + VA+K  S   +  P    +F  EA++L +  H N+  L+G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + +V E +  G+   +L  E    L  K+ +Q+  +AA G+EYL        I
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT----VGYLDPEYYASNR 785
           HRD+   N L+ EK   K++DFG S+    E E  +  S  G     V +  PE     R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 786 LTEKSDVYSFGIVLLE 801
            + +SDV+SFGI+L E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 86/283 (30%), Positives = 129/283 (45%), Gaps = 34/283 (12%)

Query: 612 RILGKGGFGTVYHGYLA--DGS--EVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLA 665
           R+LGKG FG+V    L   DGS  +VA+KML A   SS   ++F  EA  +    H N+ 
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 666 SLVGYCNDGGNVG------LVYEYMAYGNLKQYLF----DETKEALSWKDRLQIAVDAAQ 715
            L+G        G      ++  +M +G+L  +L      E    L  +  ++  +D A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVG 774
           G+EYL        IHRD+   N +LNE M   +ADFG S KI+  +       S +  V 
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVK 180

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
           +L  E  A N  T  SDV++FG+ + E++T       G  N+ I N    +L +G+    
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN---- 232

Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
              RL+   D      V E   +C       RP+  H+  +L+
Sbjct: 233 ---RLKQPPDCLE--DVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 12/192 (6%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
           + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G  
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+   N+L++E   AK++DFG +K    E+ S   T  +  V +  PE     + + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKS 180

Query: 791 DVYSFGIVLLEL 802
           DV+SFGI+L E+
Sbjct: 181 DVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +GKG FG V+     AD    A+K +  S     ++     EA++L ++    +      
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALS----WKDRLQIAVDAAQGLEYLHHGCKP 726
             D G + +V EY   G+L + L  +    L     W+  +QI +    GL +LH     
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH---SK 120

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I+HRD+K+ N+ L+     K+ D G +K+      ++ + +IVGT  YL PE       
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178

Query: 787 TEKSDVYSFGIVLLELITG 805
            EKSDV++ G+VL E  TG
Sbjct: 179 NEKSDVWALGVVLYECCTG 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 97.7 bits (243), Expect = 2e-22
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 27/248 (10%)

Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ---GPKQFRT---EAQLLMRVHHRNLAS 666
           +LGKG +GTVY G    G  +A+K +   +S      K++     E  LL  + H N+  
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
            +G C D   + +  E++  G++   L  F    E +  K   QI      G+ YLH+ C
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI----LDGVAYLHNNC 122

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSK----IFPAESESHISTSIVGTVGYLDPEY 780
              ++HRD+K  N++L      KL DFG ++    +    + S++  S+ GT  ++ PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
              +    KSD++S G  + E+ TG P +         ++R+      G  R ++ PRL 
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLAS-------MDRLAAMFYIGAHRGLM-PRLP 231

Query: 841 ANFDTNSV 848
            +F   ++
Sbjct: 232 DSFSAAAI 239

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.1 bits (242), Expect = 4e-22
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 612 RILGKGGFGTVYHGYL----ADGSE--VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G       D  E  VA+K L  S S Q    F  EA ++ + +H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-----LSWKDRLQIAVDAAQGLEY 719
             L+G   +     ++ E MA G+LK +L +          L+ KD L  A D A+G +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 720 LHHGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           L    +   IHRD+   N LL  K     AK+ADFG ++     S        +  + ++
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLEL 802
            PE +     T K+DV+SFG++L E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.4 bits (242), Expect = 4e-22
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 612 RILGKGGFGTVYHGY------LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V+           D   VA+K L   +    K F+ EA+LL  + H ++ 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD--------------RLQIAV 711
              G C DG  + +V+EYM +G+L ++L     +A+   D               L IA 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 712 DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
             A G+ YL        +HRD+ T N L+   +  K+ DFG S+   +     +    + 
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            + ++ PE     + T +SDV+SFG++L E+ T
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 614 LGKGGFGTVYHGY--LADGSE--VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLV 668
           LG G FG+V  G   +  G E  VA+K L        K+ F  EA ++ ++ H  +  L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C  G  + LV E    G L +YL    +  +   D  ++A   A G+ YL        
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLE-SKH--F 116

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPE--YYASN 784
           +HRD+   N+LL  + QAK++DFG S+   A S+ + +T+  G   + +  PE   Y   
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG-- 173

Query: 785 RLTEKSDVYSFGIVLLELIT 804
           + + KSDV+S+G+ L E  +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 20/206 (9%)

Query: 611 HRILGKGGFGTVYH-GYLADGSEVAIKMLSASS-SQGPKQFR-TEAQLLMRVHHRNLASL 667
            + LGKG +G+VY    L+D    A+K +   S SQ  ++    E ++L  V+H N+ S 
Sbjct: 5   LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLEYLH 721
                DG  + +V EY  +G+L + +    K      E   W+  +Q+     +GL+ LH
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALH 120

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              +  I+HRD+K+ANILL      K+ D G SK+     + +++ + +GT  Y+ PE +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                + KSD++S G +L E+ T  P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP-----KQFRTEAQLLMRVHHRNLA 665
            +LG G FG+VY G  L DG   A+K +S +          KQ   E  LL ++ H N+ 
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
             +G   +  N+ +  E +  G+L + L  +    E +      QI +    GLEYLH  
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLEYLH-- 119

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
                +HRD+K ANIL++     KLADFG +K     S    + S  G+  ++ PE  A 
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQ 175

Query: 784 -NRLTEKSDVYSFGIVLLELITGLP 807
                  +D++S G  +LE+ TG P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS-SSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +G VY       G  VAIK +     S+G PK    E +LL  ++H N+  L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPII 729
               G++ LV+E+M   +L + + D  +  L             QGL + H HG    I+
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHG----IL 120

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           HRD+K  N+L+N +   KLADFG ++ F   S     T  V T  Y  PE        + 
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  EL++  P
Sbjct: 179 PVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG+G FG VY  Y  D G E+A+K       S  + +       E QLL  + H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              G   D   + +  EYM  G++K  L  +    E ++ K   QI     +G+EYLH  
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHSN 123

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA-ESESHISTSIVGTVGYLDPEYYA 782
               I+HRD+K ANIL +     KL DFG SK      S      S+ GT  ++ PE  +
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                 K+DV+S G  ++E++T  P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 68/202 (33%), Positives = 95/202 (47%), Gaps = 22/202 (10%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQF-RTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG VY          VAIK++    ++   +  + E Q L +     +    G  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
             G  + ++ EY   G+    LK    DET  A        I  +   GLEYLH   K  
Sbjct: 69  LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLHEEGK-- 119

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNR 785
            IHRD+K ANILL+E+   KLADFG S     +  S +S   + VGT  ++ PE    + 
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
             EK+D++S GI  +EL  G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     ++VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V E+M  G+L  +L +   + L     + +A   A G+ Y+    +   IHRD+
Sbjct: 73  E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ + +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL+T       G  N  ++ +V    ERG
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQV----ERG 219

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 95.9 bits (238), Expect = 9e-22
 Identities = 82/295 (27%), Positives = 135/295 (45%), Gaps = 52/295 (17%)

Query: 613 ILGKGGFGTVYHGYLA-DGSEV--AIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLASL 667
           ++G+G FG V    +  DG  +  AIK +   +S+   + F  E ++L ++ HH N+ +L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDE--------------TKEALSWKDRLQIAVDA 713
           +G C   G + L  EY  +GNL  +L                 T   LS +  L  A D 
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           A+G++YL    +   IHRD+   NIL+ E   AK+ADFG S+      E ++      T+
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK----TM 170

Query: 774 GYLDPEYYASNRL-----TEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFL 826
           G L   + A   L     T  SDV+S+G++L E+++  G P    G     +  +    L
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEK----L 224

Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
            +G    +  P    N D     +V +   +C     ++RP+ + ++  L + LE
Sbjct: 225 PQG--YRLEKPL---NCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 67/203 (33%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 612 RILGKGGFG-TVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           R+LGKG FG    +    D S V  K   L+  S +  +    E  +L  + H N+ +  
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 669 GYCNDGGNVGLVYEYMAYGNL-------KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
            +  D   + +  EY   G L       K  LF+E  E + W    QI       + Y+H
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE--EMVLWY-LFQIV----SAVSYIH 118

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              K  I+HRD+KT NI L +    KL DFG SKI    SE  ++ ++VGT  Y+ PE  
Sbjct: 119 ---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELC 173

Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
              +   KSD+++ G VL EL+T
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.7 bits (239), Expect = 2e-21
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHHRNLAS 666
           LG+G +  VY       G  VAIK +     +  K        R E +LL  + H N+  
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+       N+ LV+E+M   +L++ +  +    L+  D     +   +GLEYLH     
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIKSYMLMTLRGLEYLH---SN 121

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNR 785
            I+HRD+K  N+L+      KLADFG ++ F   S +   T  V T  Y  PE  + +  
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVVTRWYRAPELLFGARH 179

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
                D++S G +  EL+  +P
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 20/224 (8%)

Query: 613 ILGKGGFGTVYH-GYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
            +GKG FGTV      +DG  +  K +     + +  +Q  +E  +L  + H N+   V 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI---VR 63

Query: 670 YCN---DGGNVGLVYEYMAY---GNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLH 721
           Y +   D  N   +Y  M Y   G+L Q +    + ++ +  +   +I       L   H
Sbjct: 64  YYDRIIDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 722 HGCKPP--IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +   P   ++HRD+K ANI L+     KL DFG +KI     +S  + + VGT  Y+ PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
                   EKSD++S G ++ EL    P      N   + +++ 
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP-FTARNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 6/213 (2%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           F + LG G FG V+ G      +VAIK ++   +   + F  EA+++M++ H  L  L G
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + +V E+M  G L  YL  + +  LS    L +  D  +G+EYL    +   I
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFI 122

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           HRD+   N L++     K++DFG ++ +  + E   S+     V +  PE +  ++ + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 790 SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           SDV+SFG+++ E+ T         +N  +V  +
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 94.6 bits (235), Expect = 3e-21
 Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
           R+LG+G FG V   Y  D      G  VA+K L     Q     ++ E  +L  ++H N+
Sbjct: 10  RVLGEGHFGKVSL-YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 665 ASLVGYCNDGGNVG--LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C++ G  G  L+ EY+  G+L+ YL    K  L+    L  A    +G+ YLH 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH- 124

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPEYY 781
                 IHRD+   N+LL+     K+ DFG +K  P   E + +       V +   E  
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             N+ +  SDV+SFG+ L EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 11/196 (5%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           + LG G FG V+ GY  + ++VA+K L    +   + F  EA L+  + H  L  L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
                + ++ EYMA G+L  +L  +    +     +  +   A+G+ Y+    +   IHR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNRLTE 788
           D++ AN+L++E +  K+ADFG +++     E +  T+  G    + +  PE       T 
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGSFTI 183

Query: 789 KSDVYSFGIVLLELIT 804
           KSDV+SFGI+L E++T
Sbjct: 184 KSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.5 bits (232), Expect = 6e-21
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 14/202 (6%)

Query: 611 HRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLA 665
            +++G G FG V+ G L         VAIK L    ++  +Q F +EA ++ +  H N+ 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L G         ++ EYM  G L +YL D   E  S++  + +    A G++YL     
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLRGIAAGMKYL---SD 125

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG---TVGYLDPEYYA 782
              +HRD+   NIL+N  ++ K++DFG S++   + E   +TS  G    + +  PE  A
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS--GGKIPIRWTAPEAIA 183

Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
             + T  SDV+SFGIV+ E+++
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 6e-21
 Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 25/208 (12%)

Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYC 671
           +G G    VY       +E VAIK +     Q    + R E Q + + +H N+       
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 672 NDGGNVGLVYEYMAYGNL--------KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
             G  + LV  Y++ G+L         +   DE   A   K+ L+       GLEYLH +
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-------GLEYLHSN 121

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
           G     IHRD+K  NILL E    K+ADFG S       +    +  + VGT  ++ PE 
Sbjct: 122 G----QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 781 YASNR-LTEKSDVYSFGIVLLELITGLP 807
                    K+D++SFGI  +EL TG  
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAA 205

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 69/215 (32%), Positives = 95/215 (44%), Gaps = 37/215 (17%)

Query: 614 LGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLAS 666
           + KG +G V+   LA     G   AIK++  +      Q     TE  +L +     +  
Sbjct: 1   ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 667 LVGYCNDG-GNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYL 720
           L  Y   G  N+ LV EY+  G+L   L      DE   A     R+ IA +    LEYL
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-VA-----RIYIA-EIVLALEYL 109

Query: 721 H-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-------IFPAESESHISTSIVGT 772
           H +G    IIHRD+K  NIL++     KL DFG SK       I   + E      IVGT
Sbjct: 110 HSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR-IVGT 164

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             Y+ PE       ++  D +S G +L E + G+P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 93.2 bits (231), Expect = 2e-20
 Identities = 77/306 (25%), Positives = 136/306 (44%), Gaps = 56/306 (18%)

Query: 614 LGKGGFGTVYHGYL--------ADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
               A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +T+ 
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNRV 822
              V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEEL 248

Query: 823 CPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
              L+ G        R++   + TN ++ +       +PS    RPT   +V +L + L 
Sbjct: 249 FKLLKEGH-------RMDKPANCTNELYMMMRDCWHAIPS---HRPTFKQLVEDLDRILT 298

Query: 882 METARE 887
           + T  E
Sbjct: 299 LTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.5 bits (230), Expect = 2e-20
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 25/214 (11%)

Query: 613 ILGKGGFGTVYHGYLAD------GSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNL 664
            LG+G FG V              S VA+KML   ++ +      +E +++  +  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--------------ETKEALSWKDRLQIA 710
            +L+G C   G + +V EY A+GNL+ +L                  +E L+ KD +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   N+L+ E    K+ADFG ++          +T+  
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
             V ++ PE       T +SDV+SFG++L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 48/296 (16%)

Query: 610 FHRILGKGGFGTVYHGYL-ADG--SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNL 664
           F  ++G+G FG V    +  DG   + AIK +   +S+   + F  E ++L ++ HH N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQIA 710
            +L+G C   G + L  EY  +GNL  +L               + T   LS +  L  A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
            D A+G++YL    +   IHRD+   NIL+ E   AK+ADFG S+      E ++     
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK--- 180

Query: 771 GTVGYLDPEYYASNRL-----TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF 825
            T+G L   + A   L     T  SDV+S+G++L E+++           T      C  
Sbjct: 181 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMTCAE 231

Query: 826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
           L     +     RLE   + +   +V +   +C     ++RP+ + ++  L + LE
Sbjct: 232 LYE---KLPQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 93.2 bits (231), Expect = 2e-20
 Identities = 81/299 (27%), Positives = 136/299 (45%), Gaps = 42/299 (14%)

Query: 614 LGKGGFGTVYHGYL--------ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRN 663
           LG+G FG V                  VA+KML   ++ +      +E +++  +  H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           FD  K   E L++KD +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +T+ 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
              V ++ PE       T +SDV+SFG++L E+ T   +   G      V  +   L+ G
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEG 252

Query: 830 DVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
                   R++   + T+ ++ +       VPS   QRPT   +V +L + L + +  E
Sbjct: 253 H-------RMDKPANCTHELYMIMRECWHAVPS---QRPTFKQLVEDLDRVLTVTSTDE 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 70/247 (28%), Positives = 127/247 (51%), Gaps = 34/247 (13%)

Query: 602 EIVDITNNFHRILGKGGFGTVYHGYL---ADGSE---VAIKMLSASSSQGP--KQFRTEA 653
           EI   T  F   LG+  FG VY G+L   A G +   VAIK L    ++GP  ++F+ EA
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59

Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-------------DET-KE 699
            +  R+ H N+  L+G       + +++ Y ++ +L ++L              D+T K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 700 ALSWKDRLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFG-FSKI 756
            L   D + I    A G+E+L  HH     ++H+D+ T N+L+ +K+  K++D G F ++
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREV 174

Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNN 815
           + A+    +  S++  + ++ PE     + +  SD++S+G+VL E+ + GL     GY+N
Sbjct: 175 YAADYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC-GYSN 232

Query: 816 THIVNRV 822
             ++  +
Sbjct: 233 QDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 83/309 (26%), Positives = 143/309 (46%), Gaps = 62/309 (20%)

Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGPKQFRTEAQLLMRV--H 660
           LG+G FG V    +A+            ++VA+KML + +++           +M++   
Sbjct: 26  LGEGCFGQVV---MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL           ++ T+   E LS+KD 
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 248

Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 249 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 298

Query: 879 CLEMETARE 887
            L + + +E
Sbjct: 299 ILALTSNQE 307

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 92.7 bits (230), Expect = 3e-20
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 18/210 (8%)

Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +    VAIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL    +
Sbjct: 73  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLE---E 127

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  A+ + + +      + ++  E      
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187

Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 90.8 bits (225), Expect = 5e-20
 Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 13/200 (6%)

Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ DG      VAIK+L  ++S +  K+   EA ++  V    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V LV + M YG L  Y+  E K+ +  +D L   V  A+G+ YL    +
Sbjct: 73  RLLGICLTS-TVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE---E 127

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA-ESESHISTSIVGTVGYLDPEYYASN 784
             ++HRD+   N+L+      K+ DFG +++    E+E H     V  + ++  E     
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILHR 186

Query: 785 RLTEKSDVYSFGIVLLELIT 804
           R T +SDV+S+G+ + EL+T
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.6 bits (226), Expect = 7e-20
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 610 FHRI--LGKGGFGTVYHGY-LADGSEVAIKML-SASSSQG-PKQFRTEAQLLMRVHHRNL 664
           + ++  LG+G +G VY       G  VA+K +   +  +G P     E  LL  + H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L+   +    + LV+EY    +LK+YL D+    LS      I     +GL Y H   
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE----- 779
              I+HRD+K  NIL+N     KLADFG ++ F         T  V T+ Y  PE     
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 780 -YYASNRLTEKSDVYSFGIVLLELITGLP 807
            +Y     +   D++S G +  E+ITG P
Sbjct: 174 KHY-----STAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.0 bits (226), Expect = 7e-20
 Identities = 90/309 (29%), Positives = 126/309 (40%), Gaps = 57/309 (18%)

Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R +G G FG VY       +E VAIK +S S  Q  ++++    E + L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G         LV EY   G+    L +  K+ L   +   I   A QGL YLH   +  
Sbjct: 81  KGCYLREHTAWLVMEY-CLGSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYAS--- 783
            IHRD+K  NILL E    KLADFG + +  PA        S VGT  ++ PE   +   
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMAPEVILAMDE 188

Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT------HIVNRVCPFLERGD----VRS 833
            +   K DV+S GI  +EL    P +   +N        HI     P L   D     R+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245

Query: 834 IVDPRLEANFDTNSVWKVAE---TAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQ 890
            VD  L+         K+ +   ++ E +      R     V+ +L            IQ
Sbjct: 246 FVDSCLQ---------KIPQDRPSSEELLKHRFVLRERPPTVIIDL------------IQ 284

Query: 891 RTKSQMLSL 899
           RTK  +  L
Sbjct: 285 RTKDAVREL 293

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.9 bits (223), Expect = 9e-20
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 23/209 (11%)

Query: 613 ILGKGGFGTVYHGYLADGSEV-AIKM--LSASSSQGPKQFRT-------EAQLLMRVHHR 662
           ++G G FG+VY G  A   E+ A+K   L + S+    + R+       E  LL  + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYL 720
           N+   +G   D  ++ +  EY+  G++   L  +   +E L      QI     +GL YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST----SIVGTVGYL 776
           H+     IIHRD+K ANIL++ K   K++DFG SK   A S S  +     S+ G+V ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITG 805
            PE       T K+D++S G +++E++TG
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G  G V+       G  VA+K ++    +G  P Q   E + L    H  +  L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEYLHHGCKPP 727
              G    LV EYM   +L + L DE +  L      Q+         G+ Y+H      
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEER-PLP---EAQVKSYMRMLLKGVAYMH---ANG 119

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRL 786
           I+HRD+K AN+L++     K+ADFG +++F  E E  + +  V T  Y  PE  Y + + 
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEE-EPRLYSHQVATRWYRAPELLYGARKY 178

Query: 787 TEKSDVYSFGIVLLELITGLP 807
               D+++ G +  EL+ G P
Sbjct: 179 DPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 24/204 (11%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           R++GKG FG V      D  ++ A+K ++          +    E ++L  ++H  L +L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH- 721
                D  N+ LV + +  G+L+ +L     F E +             +    LEYLH 
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLALEYLHS 118

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
            G    IIHRD+K  NILL+E+    + DF  +     ++   ++TS  GT GY+ PE  
Sbjct: 119 KG----IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVL 171

Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
                +   D +S G+   E + G
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.0 bits (223), Expect = 2e-19
 Identities = 85/298 (28%), Positives = 132/298 (44%), Gaps = 54/298 (18%)

Query: 614 LGKGGFGTVY--HGYLAD------GSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRN 663
           LG+G FG V     Y  D         VA+KML  +++            LM++   H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY A GNL+++L           FD TK   E LS+KD +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +++ 
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNRV 822
              V ++ PE       T +SDV+SFGI++ E+ T       G+P           V  +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----------VEEL 245

Query: 823 CPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
              L  G        R++    +N   ++     EC  ++  QRPT   +V  L K L
Sbjct: 246 FKLLREGH-------RMDK--PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.8 bits (220), Expect = 3e-19
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 612 RILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V    +    D  G +VA+K L   S        + E ++L  ++H N+ 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 666 SLVGYCNDGGNVG--LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              G C + G  G  L+ E++  G+LK+YL    K  ++ K +L+ AV   +G++YL  G
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--G 126

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPEYYA 782
            +   +HRD+   N+L+  + Q K+ DFG +K    + E + +   +   V +  PE   
Sbjct: 127 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
            ++    SDV+SFG+ L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.8 bits (220), Expect = 4e-19
 Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 19/200 (9%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYC 671
           +G+G  GTVY    +A G EVAIK ++    Q  K+      L+MR + H N+ + +   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPI 728
             G  + +V EY+A G+L   +   T+  +   D  QIA    +  Q LE+LH      +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV---TETCM---DEGQIAAVCRECLQALEFLHSN---QV 136

Query: 729 IHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           IHRD+K+ NILL      KL DFGF ++I P +S+    +++VGT  ++ PE        
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYG 193

Query: 788 EKSDVYSFGIVLLELITGLP 807
            K D++S GI+ +E++ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.7 bits (217), Expect = 6e-19
 Identities = 53/199 (26%), Positives = 101/199 (50%), Gaps = 11/199 (5%)

Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKMLSASSSQGPKQFRTEAQLLM-RVHHRNLA 665
           ++LG G FGTV+ G ++ +G      VAIK +   S +   Q  T+  L M  + H  + 
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C  G ++ LV +    G+L  ++  + +++L  +  L   V  A+G+ YL     
Sbjct: 73  RLLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HR++   NILL      ++ADFG + +   + + +  +     + ++  E     R
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 786 LTEKSDVYSFGIVLLELIT 804
            T +SDV+S+G+ + E+++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 88.2 bits (218), Expect = 6e-19
 Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 15/201 (7%)

Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKMLSASSSQGPK---QFRTEAQLLMRVHHRN 663
           ++LG G FGTVY G ++ +G  V    AIK+L+ ++  GPK   +F  EA ++  + H +
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 70

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           L  L+G C     + LV + M +G L  Y+  E K+ +  +  L   V  A+G+ YL   
Sbjct: 71  LVRLLGVCLSP-TIQLVTQLMPHGCLLDYV-HEHKDNIGSQLLLNWCVQIAKGMMYLE-- 126

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            +  ++HRD+   N+L+      K+ DFG +++   + + + +      + ++  E    
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T +SDV+S+G+ + EL+T
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 609 NFHRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHH 661
            F + LG G FG V    L      G   A+K+LS +     KQ      E ++L  + H
Sbjct: 4   EFIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQ- 715
             L +L G   D  N+ LV EY+  G L  +L     F E                AAQ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP----------VARFYAAQV 110

Query: 716 --GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
              LEYLH      I++RD+K  N+LL+     K+ DFGF+K      +    T + GT 
Sbjct: 111 VLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTP 162

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S    +  D ++ GI++ E++ G P
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 15/202 (7%)

Query: 610 FHRILGKGGFGTV-YHGYLADGSEVAIKMLS--ASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           F R++GKG +G V    +  DG +  IK L+   +S +  K    EAQLL ++ H N+  
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-- 61

Query: 667 LVGYCND-GGNVGLVYEYMAY---GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
            V Y     G  GL+Y  M +   G+L   L ++  + L     ++  V  A  L+YLH 
Sbjct: 62  -VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH- 119

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             +  I+HRD+KT N+ L      K+ D G +++   E++  ++++++GT  Y+ PE ++
Sbjct: 120 --EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFS 175

Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
           +     KSDV++ G  + E+ T
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKML-----SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG+G FG VY  Y  D G E+A K +     S  +S+       E QLL  + H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 666 SLVGYCNDGG--NVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLH 721
              G   D     + +  EYM  G++K  L  +    E+++ K   QI     +G+ YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST-SIVGTVGYLDPEY 780
                 I+HRD+K ANIL +     KL DFG SK       S     S+ GT  ++ PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
            +      K+DV+S G  ++E++T  P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVG 669
             LG+G  G+V    L +   + A+K ++   +    KQ   E ++        +    G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 670 YCND--GGNVGLVYEYMAYGNLKQYLFDETKEA---LSWKDRLQIAVDAAQGLEYLHHGC 724
              D    ++G+  EY   G+L   ++ + K+    +  K   +IA    +GL YLH   
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--- 122

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              IIHRD+K +NILL  K Q KL DFG S     E  + ++ +  GT  Y+ PE     
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPERIQGK 178

Query: 785 RLTEKSDVYSFGIVLLEL 802
             +  SDV+S G+ LLE+
Sbjct: 179 PYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 614 LGKGGFGTVYH-GYLADGSEVAIK-MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG G  G+V    ++  G+ +A K +   + S   KQ   E Q++       + S  G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYL---HHGCKP 726
            +  N+ +  E+M  G+L +      K+   +  +   +IAV   +GL YL   H     
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHR---- 124

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I+HRD+K +NIL+N + Q KL DFG S     E  + I+ + VGT  Y+ PE     + 
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 787 TEKSDVYSFGIVLLELITG 805
           T KSDV+S GI ++EL  G
Sbjct: 180 TVKSDVWSLGISIIELALG 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 32/231 (13%)

Query: 609 NFH--RILGKGGFGTVYHGYLA----DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVH 660
            +   + +G+G FG +Y   LA    D     IK +  +    +  +  + E  LL ++ 
Sbjct: 1   RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57

Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQ-------YLFDETKEALSWKDRLQIAVDA 713
           H N+ +      + G + +V EY   G+L +        LF E  + LSW   +QI++  
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW--FVQISL-- 112

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESESHISTSIVGT 772
             GL+++H      I+HRD+K+ NI L++  M AKL DFG ++      E  ++ + VGT
Sbjct: 113 --GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGT 165

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
             YL PE   +     K+D++S G VL EL T L     G N   +V ++C
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKIC 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 67/222 (30%), Positives = 95/222 (42%), Gaps = 21/222 (9%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP--KQFRTEAQLLMRVHHRNLASLVGY 670
           +G G FG VY    L  G  +A+K +    +     K+   E ++L  + H NL    G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEYLH-HGCKP 726
                 V +  EY + G L++ L  E    L   D   I V   Q   GL YLH HG   
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELL--EHGRIL---DEHVIRVYTLQLLEGLAYLHSHG--- 119

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYASN 784
            I+HRD+K ANI L+     KL DFG +      + +      S+ GT  Y+ PE     
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 785 RLTEK---SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
           +       +D++S G V+LE+ TG        N   I+  V 
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.9 bits (212), Expect = 3e-18
 Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 23/202 (11%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V Y +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIVNYLD 84

Query: 673 D---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKP 726
               G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH     
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSN--- 135

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
            +IHRD+K+ NILL      KL DFGF ++I P +S+    +++VGT  ++ PE      
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 192

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
              K D++S GI+ +E+I G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 23/221 (10%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHHRNL 664
           + LG G F + Y    +  G+ +A+K ++   +   +Q       R E +L+ R++H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
             ++G   +  +  L  E+MA G++   L  +   KEA+      Q+     +GL YLH 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE 121

Query: 723 GCKPPIIHRDVKTANILLNEKMQ-AKLADFGFSKIFPAE--SESHISTSIVGTVGYLDPE 779
                IIHRDVK AN+L++   Q  ++ADFG +    A+          ++GT+ ++ PE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN 820
                +     DV+S G V++E+ T  P     +N     N
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP----WNAEKHSN 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 85.9 bits (212), Expect = 3e-18
 Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 23/202 (11%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G+G  GTVY    +A G EVAIK ++    Q PK+     ++L+   ++N  ++V Y +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKN-PNIVNYLD 83

Query: 673 D---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKP 726
               G  + +V EY+A G+L   + +      +  D  QIA    +  Q L++LH     
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHSN--- 134

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
            +IHRD+K+ NILL      KL DFGF ++I P +S+    +++VGT  ++ PE      
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 191

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
              K D++S GI+ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.9 bits (210), Expect = 5e-18
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 10/196 (5%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LGKGGFG V    +   G   A K L        +G +    E ++L +V  R + SL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                 ++ LV   M  G+LK ++++  +        +  A     GLE+LH   +  I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           +RD+K  N+LL++    +++D G +       +        GT GY+ PE          
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174

Query: 790 SDVYSFGIVLLELITG 805
            D ++ G  L E+I G
Sbjct: 175 VDWFALGCTLYEMIAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKML-----SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG+G FG VY  Y AD G E+A+K +     S  +S+       E QLL  + H  + 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 666 SLVGYCNDG--GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              G   D     + +  E+M  G++K  L  ++  AL+     +      +G+ YLH  
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYA 782
               I+HRD+K ANIL +     KL DFG SK       S     S+ GT  ++ PE  +
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                 K+D++S G  ++E++T  P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 22/205 (10%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           ++G+G +G VY G  +  G  VA+K+++  +        + E  LL ++      ++  Y
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 671 CN---DGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                 G  + ++ EY   G+++  +      E   ++  ++ L         L+Y+H  
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-------ALKYIH-- 118

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  +IHRD+K ANIL+      KL DFG + +      S   ++ VGT  ++ PE    
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 784 NRLTE-KSDVYSFGIVLLELITGLP 807
            +  + K+D++S GI + E+ TG P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 2e-17
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 45/226 (19%)

Query: 610 FHRI--LGKGGFGTVYHGY-LADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNL 664
           + +I  +G+G +G VY       G  VA+K +   +  +G P     E +LL ++ H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 665 ASLVGYC--NDGGNVGLVYEYMAY---------------GNLKQYLFDETKEALSWKDRL 707
             L         G++ +V+EYM +                 +K Y+              
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM-------------K 107

Query: 708 QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST 767
           Q+     +GL+YLH      I+HRD+K +NIL+N     KLADFG ++ +  +  S   T
Sbjct: 108 QL----LEGLQYLHS-NG--ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYT 159

Query: 768 SIVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRG 812
           + V T+ Y  PE    + R   + D++S G +L EL  G P I +G
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP-IFQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 20/204 (9%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV-GYC 671
           LG G FG VY   +   G   A K++   S +  + F  E  +L    H N+  L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEYLHHGCKPPI 728
            +   + ++ E+   G L   +  E +  L      QI     Q    L +LH      +
Sbjct: 73  YEN-KLWILIEFCDGGALDS-IMLELERGL---TEPQIRYVCRQMLEALNFLH---SHKV 124

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY-----YAS 783
           IHRD+K  NILL      KLADFG S    +  +     + +GT  ++ PE      +  
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKD 182

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           N    K+D++S GI L+EL    P
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKML-----SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG+G FG VY  Y AD G E+A+K +     S  +S+       E QLL  + H  + 
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 666 SLVGYCND--GGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLH 721
              G   D     + +  EYM  G++K  L  +    E ++ +   QI     QG+ YLH
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLH 123

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEY 780
                 I+HRD+K ANIL +     KL DFG SK       S     S+ GT  ++ PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
            +      K+DV+S    ++E++T  P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLAS 666
           +R+LGKGGFG V    + A G   A K L        +G      E Q+L +V+ R + S
Sbjct: 5   YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L         + LV   M  G+LK +++   +        +  A +   GLE LH   + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QE 121

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I++RD+K  NILL++    +++D G +   P   E       VGTVGY+ PE   + R 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERY 178

Query: 787 TEKSDVYSFGIVLLELITG 805
           T   D ++ G +L E+I G
Sbjct: 179 TFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASL-- 667
            +G+G +G VY     D G  VA+K +   + +   P     E ++L +++HRN+ +L  
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 668 --------VGYCNDGGNVGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
                   + +  D G   LV+EYM     G L+  L   +++         I     Q 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED--------HIKSFMKQL 125

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           LE L++  K   +HRD+K +NILLN K Q KLADFG ++++ +E ES   T+ V T+ Y 
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRPYTNKVITLWYR 184

Query: 777 DPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE      R     DV+S G +L EL T  P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 17/199 (8%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G+G  GTV+    +A G EVAIK ++       +    E  ++  + + N+ + +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPII 729
            G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH      +I
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 730 HRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K+ N+LL      KL DFGF ++I P +S+    +++VGT  ++ PE         
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194

Query: 789 KSDVYSFGIVLLELITGLP 807
           K D++S GI+ +E++ G P
Sbjct: 195 KVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 38/224 (16%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASS-SQGPKQFRT-------------EAQLLMR 658
           LG+G +G V   Y    G  VAIK +     S    + R              E +++  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD--RLQIAVDAAQG 716
           + H N+  LV    +G  + LV + MA  +LK+ +  + +   S      LQI      G
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQIL----NG 131

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK------IFPAESESHIS---- 766
           L  LH   K   +HRD+  ANI +N K   K+ADFG ++           S+        
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 767 --TSIVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
             TS V T+ Y  PE    + +     D++S G +  EL+TG P
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 60/200 (30%), Positives = 86/200 (43%), Gaps = 22/200 (11%)

Query: 616 KGGFGTVYHGYLAD----GSEVAIKMLSASSSQGPKQ---FRTEAQLLM-RVHHRNLASL 667
           KG FG+VY   LA     G   AIK+L  S      Q    + E  ++M +     +A L
Sbjct: 6   KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                    + LV EY+  G+    +  +T   L      Q   +   G+E LH   +  
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLH---QRG 117

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           IIHRD+K  N+L+++    KL DFG S+          +   VGT  YL PE        
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDD 171

Query: 788 EKSDVYSFGIVLLELITGLP 807
           + SD +S G V+ E + G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQGPKQFRT---EAQLLMRVHHRNLASLV 668
           +G+G +G V      A G  VAIK    +   +  K  +T   E ++L ++ H N+ +L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVNLK 66

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
                 G + LV+EY+    L + L + +   L             Q + Y H H     
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELL-EASPGGLPPDAVRSYIWQLLQAIAYCHSHN---- 120

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           IIHRD+K  NIL++E    KL DFGF++   A   S + T  V T  Y  PE    +   
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNY 179

Query: 788 EKS-DVYSFGIVLLELITGLP 807
            K  DV++ G ++ EL+ G P
Sbjct: 180 GKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.1 bits (203), Expect = 5e-17
 Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 17/222 (7%)

Query: 609 NFHRI--LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNL 664
           NF ++  LG+G + TVY G      E VA+K +   + +G P     E  L+  + H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKE-ALSWKDRLQIAVDAAQGLEYLHHG 723
             L    +    + LV+EYM   +LK+Y+       AL             +G+ + H  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEYY 781
               ++HRD+K  N+L+N++ + KLADFG ++ F  P  + S    + V T+ Y  P+  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS----NEVVTLWYRAPDVL 172

Query: 782 ASNRLTEKS-DVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
             +R    S D++S G ++ E+ITG P +  G NN   + ++
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRP-LFPGTNNEDQLLKI 213

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 20/227 (8%)

Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 12  RELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLF--------DETKEALSWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL         +  +   S K  +Q+A + A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           G+ YL+       +HRD+   N ++ E    K+ DFG ++              +  V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 37/216 (17%)

Query: 607 TNNF--HRILGKGGFGTVYHGY-LADGSEVAIK------MLSASSSQGPKQFRTEAQLLM 657
             NF   + +GKG F  VY    L DG  VA+K      M+ A + Q   +   E  LL 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57

Query: 658 RVHHRN----LASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETK----EALSWKDRL 707
           ++ H N    LAS +    +   + +V E    G+L + +  F + K    E   WK  +
Sbjct: 58  QLDHPNVIKYLASFI----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113

Query: 708 QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE-SESHIS 766
           Q+       LE++H      I+HRD+K AN+ +      KL D G  + F ++ + +H  
Sbjct: 114 QLC----SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-- 164

Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
            S+VGT  Y+ PE    N    KSD++S G +L E+
Sbjct: 165 -SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 8e-17
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LG GGFG V      +     A+K +       +   +   +E ++L   +H  +  L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIA--VDAAQGLEYLHH 722
              D   + ++ EY   G L   L     FDE      +  R  IA  V A    EYLH+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE------YTARFYIACVVLA---FEYLHN 111

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                II+RD+K  N+LL+     KL DFGF+K   +  ++    +  GT  Y+ PE   
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPEIIL 165

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
           +       D +S GI+L EL+TG P
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 84.2 bits (208), Expect = 9e-17
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 612 RILGKGGFGTV-YHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVH-------H 661
           R+LG G  GTV     ++DG   A+K+  +   S     + + E   L+          H
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 662 RNLASLVGYCNDGGN------VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
            + A       D  N      + LV +Y   G+L+Q +    K   ++++  +  +   Q
Sbjct: 98  EDFAK-----KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQ 151

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            L  +HH     +IHRD+K+ANILL      KL DFGFSK++ A     +  +  GT  Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     ++K+D++S G++L EL+T
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 1e-16
 Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 33/297 (11%)

Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVG 669
           +G G FG VY    +  +E VA+K +S S  Q  ++++    E + L ++ H N     G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                    LV EY   G+    L +  K+ L   +   I   A QGL YLH       I
Sbjct: 89  CYLKEHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS---NRL 786
           HRD+K  NILL E  Q KLADFG      + S+S  + S VGT  ++ PE   +    + 
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN 846
             K DV+S GI  +EL    P +         +N +          S   P L++N  T+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNDS---PTLQSNEWTD 247

Query: 847 SVWKVAETAMECVPSISFQRPTMSHVVTE--LKKCLEMETAREQIQRTKSQMLSLSS 901
           S     +  ++ +P    +RP  + ++    +++        + IQRTK  +  L +
Sbjct: 248 SFRGFVDYCLQKIPQ---ERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDN 301

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 51/245 (20%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSEVAIKMLSA 640
           +S S    S  + +   + SE+  +       +G G  GTVY   +   G   A+K++  
Sbjct: 55  SSSSSSSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109

Query: 641 SSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL-------KQY 692
           +     + Q   E ++L  V+H N+       +  G + ++ E+M  G+L       +Q+
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169

Query: 693 LFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG 752
           L D  ++ LS             G+ YLH   +  I+HRD+K +N+L+N     K+ADFG
Sbjct: 170 LADVARQILS-------------GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213

Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEY------------YASNRLTEKSDVYSFGIVLL 800
            S+I  A++    ++S VGT+ Y+ PE             YA        D++S G+ +L
Sbjct: 214 VSRIL-AQTMDPCNSS-VGTIAYMSPERINTDLNHGAYDGYA-------GDIWSLGVSIL 264

Query: 801 ELITG 805
           E   G
Sbjct: 265 EFYLG 269

Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 13/182 (7%)

Query: 633 VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQ 691
           VA+K+L   +S   ++ F  E ++L R+   N+A L+G C     + ++ EYM  G+L Q
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 692 YL---------FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE 742
           +L              ++LS+   L +A   A G+ YL        +HRD+ T N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 743 KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
               K+ADFG S+   +     +       + ++  E     + T KSDV++FG+ L E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 803 IT 804
           +T
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 2e-16
 Identities = 70/205 (34%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R +G G FG VY       +EV AIK +S S  Q  ++++    E + L R+ H N    
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G         LV EY   G+    L +  K+ L   +   I   A QGL YLH      
Sbjct: 91  KGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH---SHN 145

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS---N 784
           +IHRD+K  NILL E  Q KLADFG + I         + S VGT  ++ PE   +    
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEG 199

Query: 785 RLTEKSDVYSFGIVLLELITGLPAI 809
           +   K DV+S GI  +EL    P +
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.1 bits (208), Expect = 2e-16
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 23/195 (11%)

Query: 630 GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASLV--GYCNDGGNVGLVYEYM 684
           G EVAIK+L   + +   Q   FR E  L  R++H N+ +L+  G    G  +  V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61

Query: 685 AYGNLKQYLFDETKEALSWKD--RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE 742
               L++ L      AL   +  RL       Q L+ L       I+HRD+K  NI++++
Sbjct: 62  PGRTLREVL--AADGALPAGETGRLM-----LQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 743 ---KMQAKLADFGFSKIFP-----AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYS 794
              +  AK+ DFG   + P       +    +T ++GT  Y  PE      +T  SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 795 FGIVLLELITGLPAI 809
           +G++ LE +TG   +
Sbjct: 175 WGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 9/196 (4%)

Query: 612 RILGKGGFGT---VYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           R++G+G FG    V H   +D      ++    SS   +  R EA LL ++ H N+ +  
Sbjct: 6   RVVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
                 G++ +V EY   G+L Q +  +  +       LQ  V    G++++H   +  +
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRV 121

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+K+ NI L +  + KL DFG +++    S    + + VGT  Y+ PE + +     
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 789 KSDVYSFGIVLLELIT 804
           KSD++S G +L EL T
Sbjct: 180 KSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           +++G G FG V  G L    +    VAIK L A  ++  ++ F +EA ++ +  H N+  
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       V +V EYM  G+L  +L     +  +    + +    A G++YL      
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG---TVGYLDPEYYAS 783
             +HRD+   NIL+N  +  K++DFG S++   + E+  +T   G    + +  PE  A 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTAPEAIAY 183

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+S+GIV+ E+++
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 54/197 (27%), Positives = 80/197 (40%), Gaps = 10/197 (5%)

Query: 614 LGKGGFGTVYHG-YLADGSE---VAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLV 668
           LG G FG V  G +   G +   VA+K L +         F  EA ++  + H NL  L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G       + +V E    G+L   L  +             AV  A G+ YL        
Sbjct: 63  GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRF 118

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLT 787
           IHRD+   NILL    + K+ DFG  +  P   + ++    +     +  PE   +   +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 788 EKSDVYSFGIVLLELIT 804
             SDV+ FG+ L E+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 62/230 (26%), Positives = 109/230 (47%), Gaps = 20/230 (8%)

Query: 609 NFHRILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHH 661
              R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL--------SWKDRLQIAVDA 713
            ++  L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + 
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGT 772
           A G+ YL+       +HRD+   N ++      K+ DFG ++ I+  +        ++  
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-P 184

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           V ++ PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 15/195 (7%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           ILG G  GTVY  Y L     +A+K++    + +  KQ  +E ++L +     +    G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
                 + +  E+M  G+L  Y     +  L      +IAV   +GL YL    K  I+H
Sbjct: 68  FFVENRISICTEFMDGGSLDVY-RKIPEHVLG-----RIAVAVVKGLTYLW-SLK--ILH 118

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RDVK +N+L+N + Q KL DFG S     +  + I+ + VGT  Y+ PE  +  +    S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 791 DVYSFGIVLLELITG 805
           DV+S GI  +EL  G
Sbjct: 175 DVWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 10/199 (5%)

Query: 611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLAS 666
           +R+LGKGGFG V    + A G   A K L        +G      E Q+L +V+ + + +
Sbjct: 5   YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L         + LV   M  G+LK ++++        +  L  A +   GLE LH   + 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RE 121

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             ++RD+K  NILL++    +++D G +   P   E       VGTVGY+ PE   + R 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAPEVLNNQRY 178

Query: 787 TEKSDVYSFGIVLLELITG 805
           T   D +  G ++ E+I G
Sbjct: 179 TLSPDYWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G        VAIK++    ++   +  + E  +L +     +    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
             G  + ++ EY+  G+    L+   FDE + A   K+ L+       GL+YLH   K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-------GLDYLHSEKK-- 122

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E+   KLADFG +      +++ I   + VGT  ++ PE    +  
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 17/234 (7%)

Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           EI   +    + LG G FG V+       ++VA+K +   S    + F  EA ++  + H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L  L         + ++ E+MA G+L  +L  +          +  +   A+G+ ++ 
Sbjct: 61  DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              +   IHRD++ ANIL++  +  K+ADFG +++   ++E          + +  PE  
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI 175

Query: 782 ASNRLTEKSDVYSFGIVLLELIT-------GL--PAIIRGYNNTHIVNRV--CP 824
                T KSDV+SFGI+L+E++T       G+  P +IR     + + R   CP
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 15/224 (6%)

Query: 612 RILGKGGFGTVYHG-YLADGSE---VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG VY G Y++  +E   VA+K     +S   ++ F  EA ++ +  H ++  
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V +V E    G L+ YL    K +L     +  +   +  L YL      
Sbjct: 72  LIGVITEN-PVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+    ES    S   +  + ++ PE     R 
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           T  SDV+ FG+ + E++       +G  N  ++ R    +E G+
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENGE 225

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.9 bits (194), Expect = 7e-16
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 29/221 (13%)

Query: 610 FHRILGKGGFGTVY-------HGYLADGSE--------VAIKMLSASSSQGPKQ-FRTEA 653
               LG+G FG V+         +L +G+         VA+KML A  ++  +  F  E 
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA----------LSW 703
           +++ R+ + N+  L+G C     + ++ EYM  G+L Q+L     E+          +S 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
            + L +AV  A G++YL        +HRD+ T N L+      K+ADFG S+   +    
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            I    V  + ++  E     + T  SDV++FG+ L E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.9 bits (194), Expect = 1e-15
 Identities = 84/300 (28%), Positives = 123/300 (41%), Gaps = 35/300 (11%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R +G G FG VY       SEV AIK +S S  Q  ++++    E + L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G         LV EY   G+    L +  K+ L   +   +   A QGL YLH      
Sbjct: 81  RGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYAS--- 783
           +IHRDVK  NILL+E    KL DFG + I  PA          VGT  ++ PE   +   
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDE 188

Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
            +   K DV+S GI  +EL    P +         +N +          S   P L++  
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIAQNES---PALQSGH 238

Query: 844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE--METAREQIQRTKSQMLSLSS 901
            +       ++ ++ +P     RPT   ++       E       + IQRTK  +  L +
Sbjct: 239 WSEYFRNFVDSCLQKIPQ---DRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 25/274 (9%)

Query: 613 ILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASL 667
           ++G G FG V  G L    +    VAIK L +  + +  + F +EA ++ +  H N+  L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G       V ++ E+M  G L  +L  +     +    + +    A G++YL    +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG---TVGYLDPEYYASN 784
            +HRD+   NIL+N  +  K++DFG S+    ++     TS +G    + +  PE  A  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
           + T  SDV+S+GIV+ E+++         +N  ++N +    E+       D RL    D
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI----EQ-------DYRLPPPMD 235

Query: 845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   + +  ++C       RP    +V+ L K
Sbjct: 236 CPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDK 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 614 LGKGGFGTVYHGYLADG---SEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G FG V  G    G   + V +K L AS++      F  E Q    ++H N+   +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQ-IAVDAAQGLEYLHHGCKP 726
            C +     LV E+   G+LK YL         ++ KD LQ +A + A GL +LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS--IVGTVGYLDPEYYAS- 783
             IH D+   N  L   +  K+ D+G +       E +  T       + +L PE     
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 784 ------NRLTEKSDVYSFGIVLLELIT 804
                    T+KS+++S G+ + EL T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 28/237 (11%)

Query: 612 RILGKGGFGTVYHGYLADGS---EVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLAS 666
           + LG+G FG+V  G L       +VA+K +  +  +    + F +EA  +    H N+  
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 667 LVGYCNDGG-NVG-----LVYEYMAYGNLKQYLF----DETKEALSWKDRLQIAVDAAQG 716
           L+G C     + G     ++  +M +G+L  +L      +  + L  +  ++   D A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAE--SESHISTSIVGTV 773
           +EYL        IHRD+   N +LNE M   +ADFG S KI+  +   +  I+      V
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---PV 178

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
            ++  E  A    T KSDV+SFG+ + E+ T       G  N+ I +    +L +G+
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD----YLRQGN 231

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.7 bits (188), Expect = 3e-15
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)

Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGY 670
           ++G G +G VY G ++  G   AIK++  +  +  ++ + E  +L +  HHRN+A+  G 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 671 C---NDGG---NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
               N  G    + LV E+   G++   + +     L  +    I  +  +GL +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYA 782
           +  +IHRD+K  N+LL E  + KL DFG S    A+ +  +    + +GT  ++ PE  A
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 783 SNRLTE-----KSDVYSFGIVLLELITGLPAI 809
            +   +     KSD++S GI  +E+  G P +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 3e-15
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 38/229 (16%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE-----------------VAIKMLSASSSQGPKQ-FRT 651
           F   LG+G FG V+   + +  +                 VA+K+L   +++  +  F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 652 EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----FDETKE-------- 699
           E ++L R+   N+  L+G C D   + ++ EYM  G+L Q+L     D+ +E        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 700 -----ALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
                A+S+   L +A+  A G++YL        +HRD+ T N L+ E +  K+ADFG S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELI 803
           +   A     I    V  + ++  E     + T  SDV++FG+ L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.8 bits (189), Expect = 5e-15
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 20/206 (9%)

Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLA 665
           ++LG+G FG V+      G +     A+K+L  ++ +   + RT  E  +L  V+H  + 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGC 724
            L       G + L+ +++  G+L   L   +KE +  ++ ++  + + A  L++LH   
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH--- 115

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYA 782
              II+RD+K  NILL+E+   KL DFG SK    ES  H     S  GTV Y+ PE   
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 783 SNRLTEKSDVYSFGIVLLELITG-LP 807
               T+ +D +SFG+++ E++TG LP
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 6e-15
 Identities = 63/241 (26%), Positives = 93/241 (38%), Gaps = 54/241 (22%)

Query: 608 NNFHRI--LGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQ---FRTEAQLLMR 658
           ++F  I  +G+G FG V+   L      G   A+K+L  S      Q    R E  +L  
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDA 713
                +  L     D  ++ LV EYM  G+L   L     F E + A  +   L +A+D+
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFYIAELVLALDS 116

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES---------- 763
              L +         IHRD+K  NIL++     KLADFG  K      +           
Sbjct: 117 VHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 764 -----------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
                              + S VGT  Y+ PE         + D +S G++L E++ G 
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Query: 807 P 807
           P
Sbjct: 228 P 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)

Query: 605 DITNNFHRI-LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR 662
           +   N  R+ LGKG +G VY    L+    +AIK +    S+  +    E  L   + HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEY 719
           N+   +G  ++ G   +  E +  G+L   L   +K      +   I     Q   GL+Y
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSK----IFPAESESHISTSIVGTVG 774
           LH      I+HRD+K  N+L+N      K++DFG SK    I P       + +  GT+ 
Sbjct: 124 LH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC------TETFTGTLQ 174

Query: 775 YLDPE--------YYASNRLTEKSDVYSFGIVLLELITGLPAII 810
           Y+ PE        Y A       +D++S G  ++E+ TG P  I
Sbjct: 175 YMAPEVIDKGPRGYGAP------ADIWSLGCTIVEMATGKPPFI 212

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG VY G      EV AIK++    ++   +  + E  +L +     +    G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
             G  + ++ EY+  G+    LK    +ET  A   ++ L+       GL+YLH   K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILK-------GLDYLHSERK-- 122

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E+   KLADFG +      +++ I   + VGT  ++ PE    +  
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG- 669
           ++G+G +G VY       G  VAIK++     +  ++ + E  +L +  +H N+A+  G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 670 -----YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL---QIAV---DAAQGLE 718
                   +   + LV E    G++     D  K       RL    IA    +  +GL 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVT----DLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYL 776
           YLH   +  +IHRD+K  NILL +  + KL DFG S    A+ +S +    + +GT  ++
Sbjct: 128 YLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS----AQLDSTLGRRNTFIGTPYWM 180

Query: 777 DPEYYASNRLTE-----KSDVYSFGIVLLELITGLP 807
            PE  A +   +     +SDV+S GI  +EL  G P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.7 bits (186), Expect = 9e-15
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 32/223 (14%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------------------VAIKMLSASSSQGPKQ-FR 650
           F   LG+G FG V H   A+G E                  VA+KML   +++  +  F 
Sbjct: 9   FKEKLGEGQFGEV-HLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL---------FDETKEAL 701
            E +++ R+   N+  L+  C     + ++ EYM  G+L Q+L                +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 702 SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
           S+   + +A   A G++YL        +HRD+ T N L+ +    K+ADFG S+   +  
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
              I    V  + ++  E     + T  SDV++FG+ L E++T
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G + TV+ G      + VA+K +     +G P     E  LL  + H N+ +L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+EY+   +LKQYL D     +S  +         +GL Y H      I+HR
Sbjct: 73  HTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEKS 790
           D+K  N+L+NEK + KLADFG ++     ++++ S  +V T+ Y  P+    S   +   
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLGSTEYSTPI 185

Query: 791 DVYSFGIVLLELITGLP 807
           D++  G +L E+ TG P
Sbjct: 186 DMWGVGCILYEMATGRP 202

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 14/162 (8%)

Query: 647 KQFRTEAQLLMRVHHRNLASLVGYCN---DGGNVGLVYEYMAYGNLKQYLFDETKEALSW 703
            Q   E ++L   H  N   +VG+       G + +  E+M  G+L Q L    +   + 
Sbjct: 44  NQIIRELKVL---HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI 100

Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
             ++ IAV   +GL YL    K  I+HRDVK +NIL+N + + KL DFG S     +   
Sbjct: 101 LGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLID 152

Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            ++ S VGT  Y+ PE       T +SD++S G+ L+E+  G
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLAS 666
           +R+LGKGGFG V    + A G   A K L        +G      E ++L +V+ R + S
Sbjct: 5   YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L         + LV   M  G+LK ++++        +  +  A +   GLE L    + 
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I++RD+K  NILL+++   +++D G +   P   E       VGTVGY+ PE   + + 
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIP---EGETVRGRVGTVGYMAPEVINNEKY 178

Query: 787 TEKSDVYSFGIVLLELITG 805
           T   D +  G ++ E+I G
Sbjct: 179 TFSPDWWGLGCLIYEMIQG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 77.4 bits (190), Expect = 1e-14
 Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 21/177 (11%)

Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDR------LQIAVDAAQGLEYLHHGCKPPIIHRD 732
           L+ EY + G+L + +    KE L +++        QI +     L+ +H      ++HRD
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL----ALDEVHSRK---MMHRD 194

Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDV 792
           +K+ANI L      KL DFGFSK +       +++S  GT  YL PE +   R ++K+D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254

Query: 793 YSFGIVLLELITGLPAIIRGYNNTHIVNRV-------CPFLERGDVRSIVDPRLEAN 842
           +S G++L EL+T L    +G +   I+ +V        P      +++++DP L  N
Sbjct: 255 WSLGVILYELLT-LHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310

Length = 478

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G + TVY G    +G  VA+K++S  + +G P     EA LL  + H N+  L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    +  V+EYM + +L QY+         +  RL       +GL Y+H      I+HR
Sbjct: 73  HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG---QHILHR 127

Query: 732 DVKTANILLNEKMQAKLADFGF--SKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L++   + KLADFG   +K  P+++ S    S V T+ Y  P+    +   + 
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYS----SEVVTLWYRPPDVLLGATDYSS 183

Query: 789 KSDVYSFGIVLLELITGLPA 808
             D++  G + +E++ G PA
Sbjct: 184 ALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG 669
            ++G G +G VY G ++  G   AIK++  +  +  ++ + E  +L +  HHRN+A+  G
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYG 80

Query: 670 YCNDGGNVG------LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                   G      LV E+   G++   + +    AL       I  +  +GL +LH  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYY 781
               +IHRD+K  N+LL E  + KL DFG S    A+ +  +    + +GT  ++ PE  
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 782 ASNRLTE-----KSDVYSFGIVLLELITGLPAI 809
           A +   +     +SD++S GI  +E+  G P +
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 27/228 (11%)

Query: 611 HRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASL 667
           +RI G+G +G VY        E VA+K +   + +   P     E  LL+ + H N+  L
Sbjct: 13  NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 668 ----VGYCNDGGNVGLVYEY----MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
               VG   D  ++ LV EY    +A       L D      S      + +   +GL+Y
Sbjct: 72  KEVVVGKHLD--SIFLVMEYCEQDLAS------LLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           LH      IIHRD+K +N+LL +K   K+ADFG ++ +     +   T  V T+ Y  PE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPE 178

Query: 780 -YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL 826
                   T   D+++ G +L EL+   P ++ G +    ++ +   L
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP-LLPGKSEIEQLDLIIQLL 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIK---MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G+G F  VY    L DG  VA+K   +     ++       E  LL +++H N+     
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
              +   + +V E    G+L + +  F + K  +  K   +  V     LE++H      
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRR 126

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           ++HRD+K AN+ +      KL D G  + F   S++  + S+VGT  Y+ PE    N   
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 788 EKSDVYSFGIVLLEL 802
            KSD++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 12/160 (7%)

Query: 648 QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL 707
           Q   E Q+L   +   +    G     G + +  E+M  G+L Q L    KEA    + +
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEI 104

Query: 708 --QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
             ++++   +GL YL    K  I+HRDVK +NIL+N + + KL DFG S     +    +
Sbjct: 105 LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSM 158

Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           + S VGT  Y+ PE       + +SD++S G+ L+EL  G
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 40/217 (18%)

Query: 613 ILGKGGFGTVYHGYLADGSEV-AIKM--LSASSSQGPKQ--------FRTEAQLLMRVHH 661
           ++GKG +G VY        E+ A+K   L A+ +              R+E + L  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDE------TKEALSWKDRLQIA 710
            N+   +G+      + +  EY+  G++   L     F+E      T++ L         
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------- 118

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
               +GL YLH      I+HRD+K  N+L++     K++DFG SK      ++  + S+ 
Sbjct: 119 ----EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 771 GTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITG 805
           G+V ++ PE   S     + K D++S G V+LE+  G
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLAS 666
           +R+LGKGGFG V    + A G   A K L        +G      E Q+L +V+ R + S
Sbjct: 5   YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L         + LV   M  G+LK ++++        +  +  A +   GLE LH   + 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RE 121

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I++RD+K  NILL++    +++D G +   P   E       VGTVGY+ PE   + R 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRVGTVGYMAPEVVKNERY 178

Query: 787 TEKSDVYSFGIVLLELITG 805
           T   D +  G ++ E+I G
Sbjct: 179 TFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           LG+G + TVY G   L D + VA+K +     +G P     E  LL  + H N+ +L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            +   ++ LV+EY+   +LKQYL D+   +++  +         +GL Y H   +  ++H
Sbjct: 73  IHTEKSLTLVFEYLD-KDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLH 127

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEK 789
           RD+K  N+L+NE+ + KLADFG ++     ++++ S  +V T+ Y  P+    S   + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLGSTDYSTQ 185

Query: 790 SDVYSFGIVLLELITGLP 807
            D++  G +  E+ TG P
Sbjct: 186 IDMWGVGCIFYEMSTGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMR-VHHRNLASLVGY 670
           LG+G +G V    ++  G+ +A+K + A+ +SQ  K+   +  + MR V      +  G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLEYLHHGC 724
               G+V +  E M     K Y     K+       +      +IAV   + LEYLH   
Sbjct: 69  LFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              +IHRDVK +N+L+N   Q KL DFG S         ++  S+  T+      Y A  
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVDSVAKTIDAGCKPYMAPE 173

Query: 785 RLTE---------KSDVYSFGIVLLELITG 805
           R+           KSDV+S GI ++EL TG
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 18/206 (8%)

Query: 609 NFHRI--LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
           +  RI  +G G FG V+           A+K+++       KQ      E ++L  V H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
            +  L    +D   + ++ EY+  G L  YL        S    L  A +    LEYLH 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH- 118

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST-SIVGTVGYLDPEYY 781
                I++RD+K  NILL+++   KL DFGF+K      +    T ++ GT  YL PE  
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVI 170

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
            S    +  D ++ GI++ E++ G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 4e-14
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 38/225 (16%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
           R++GKGG G VY  Y       VA+K +    S+ P   K+F  EA++   + H  +  +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 668 VGYCNDGGNVGLVYEYMAY---GNLKQYLFD---------ETKEALSWKDRLQIAVDAAQ 715
              C+DG     VY  M Y     LK  L           E  E  S    L I      
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS------- 768
            +EY+H      ++HRD+K  NILL    +  + D+G +     E E  +          
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 769 ---------IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
                    IVGT  Y+ PE       +E +D+Y+ G++L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIK------MLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +G+G F  VY    L D   VA+K      M+ A + Q   +   E  LL +++H N+  
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
            +    +   + +V E    G+L Q +  F + K  +  +   +  V     +E++H   
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--- 123

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              ++HRD+K AN+ +      KL D G  + F   S++  + S+VGT  Y+ PE    N
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 785 RLTEKSDVYSFGIVLLEL 802
               KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           NF +I G+G  G V      + G +VA+K +     Q  +    E  ++    H N+  +
Sbjct: 23  NFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
                 G  + +V E++  G L   +   T   ++ +    + +   + L +LH  G   
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQG--- 135

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGF----SKIFPAESESHISTSIVGTVGYLDPEYYA 782
            +IHRD+K+ +ILL    + KL+DFGF    SK  P         S+VGT  ++ PE  +
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK------SLVGTPYWMAPEVIS 188

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                 + D++S GI+++E++ G P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           LG+G + TV+ G   L + + VA+K +     +G P     E  LL  + H N+ +L   
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            +   ++ LV+EY+   +LKQY+ D+    +S  +         +GL Y H   +  ++H
Sbjct: 73  VHTDKSLTLVFEYLD-KDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEK 789
           RD+K  N+L+NE+ + KLADFG ++     ++++ S  +V T+ Y  P+    S+  + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLGSSEYSTQ 185

Query: 790 SDVYSFGIVLLELITGLP 807
            D++  G +  E+ +G P
Sbjct: 186 IDMWGVGCIFFEMASGRP 203

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 65/229 (28%), Positives = 94/229 (41%), Gaps = 44/229 (19%)

Query: 598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQ-GPKQFRTEAQL 655
           FT  ++ D+       +G+G FGTV        G+ +A+K + ++  +   K+   +  +
Sbjct: 1   FTAEDLKDLGE-----IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55

Query: 656 LMRVHH-RNLASLVGYCNDGGNVGLVYEYM----------AYGNLKQYLFDETKEALSWK 704
           +MR      +    G     G+  +  E M           Y  LK     E  E L   
Sbjct: 56  VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV-IPE--EILG-- 110

Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
              +IAV   + L YL    K  IIHRDVK +NILL+     KL DFG S          
Sbjct: 111 ---KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--------GQ 157

Query: 765 ISTSIVGTVG-----YLDPEYYASNRLTE---KSDVYSFGIVLLELITG 805
           +  SI  T       Y+ PE    +       +SDV+S GI L E+ TG
Sbjct: 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 22/201 (10%)

Query: 614 LGKGGFG-TVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG  +      DG +  IK ++ S  S +  ++ R E  +L  + H N+      
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 671 CNDGGNVGLVYEYMAYGNL-------KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
             + GN+ +V +Y   G+L       +  LF E  + L W   +QI +     L+++H  
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE-DQILDW--FVQICL----ALKHVH-- 118

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K+ NI L +    KL DFG +++  +  E  ++ + +GT  YL PE   +
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICEN 175

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
                KSD+++ G VL E+ T
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 9e-14
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 40/228 (17%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRT--------EAQLLMRV-HHRN 663
           LG G FG+VY       G  VAIK +        K+F +        E + L ++  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           +  L     +   +  V+EYM  GNL Q + D   +  S      I     QGL ++H H
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPE-- 779
           G      HRD+K  N+L++     K+ADFG ++    E  S    T  V T  Y  PE  
Sbjct: 119 G----FFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEIL 170

Query: 780 ----YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
                Y+S       D+++ G ++ EL T  P +  G +    + ++C
Sbjct: 171 LRSTSYSS-----PVDIWALGCIMAELYTLRP-LFPGSSEIDQLYKIC 212

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.9 bits (179), Expect = 9e-14
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLS----ASSSQGPKQFRTEAQLLMRVHHRN 663
           ++LGKGG+G V+      G++     A+K+L       + +     + E  +L  V H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
           +  L+     GG + L+ EY++ G L  +L    +E +  +D     + + +  LE+LH 
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH- 117

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES--ESHISTSIVGTVGYLDPEY 780
             +  II+RD+K  NILL+ +   KL DFG  K    ES  E  ++ +  GT+ Y+ PE 
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEI 171

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
              +   +  D +S G ++ +++TG P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 612 RILGKGGFGTVY----HGYLADGSEVAIKML-SASSSQGPK---QFRTEAQLLMRVHHRN 663
           R+LG G +G V+     G    G   A+K+L  A+  Q  K     RTE Q+L  V    
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 664 -LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
            L +L         + L+ +Y+  G L  +L+       S + R+ IA +    L++LH 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLH- 122

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             +  II+RD+K  NILL+ +    L DFG SK F AE E   + S  GT+ Y+ PE   
Sbjct: 123 --QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIR 179

Query: 783 SNRLTEKS--DVYSFGIVLLELITGL-PAIIRGYNNT 816
                     D +S G++  EL+TG  P  + G  N+
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G      +V AIK++    ++   +  + E  +L +     +    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 672 NDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                + ++ EY+  G+    L     DET+ A   ++ L+       GL+YLH   K  
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILK-------GLDYLHSEKK-- 122

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E  + KLADFG +      +++ I  +  VGT  ++ PE    +  
Sbjct: 123 -IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVH---HRNLASL 667
           +G G +GTVY       G  VA+K +   +++   P     E  LL R+    H N+  L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 668 VGYC-----NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           +  C     +    V LV+E++   +L+ YL       L  +    +     +GL++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            C   I+HRD+K  NIL+    Q KLADFG ++I+   S     T +V T+ Y  PE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLL 180

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
            +      D++S G +  E+    P
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)

Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 121

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 10/198 (5%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G + TVY G    +G  VA+K++     +G P     EA LL  + H N+  L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+EY+ + +L QY+ D+    L  ++         +GL Y+H   +  I+HR
Sbjct: 73  HTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHR 127

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEKS 790
           D+K  N+L+++  + KLADFG ++       SH  ++ V T+ Y  P+    S   +   
Sbjct: 128 DLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185

Query: 791 DVYSFGIVLLELITGLPA 808
           D++  G + +E+I G+ A
Sbjct: 186 DMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G + TVY G     G  VA+K +     +G P     EA LL  + H N+ +L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+EY+   +LKQY+ D+    LS  +         +GL Y H      ++HR
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHR 127

Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE-YYASNRLTEK 789
           D+K  N+L++E+ + KLADFG ++   A+S  S   ++ V T+ Y  P+    S   +  
Sbjct: 128 DLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTS 184

Query: 790 SDVYSFGIVLLELITGLPA 808
            D++  G +  E+ TG P 
Sbjct: 185 LDMWGVGCIFYEMATGRPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRV---HHRNLAS 666
            +G+G +GTVY    L  G  VA+K +    S+   P     E  LL ++    H N+  
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 667 L----VGYCNDGG-NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           L     G   D    + LV+E++   +L  YL    K  L  +    +     +G+++LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-- 779
                 I+HRD+K  NIL+    Q K+ADFG ++I+    E  + TS+V T+ Y  PE  
Sbjct: 125 SHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMAL-TSVVVTLWYRAPEVL 178

Query: 780 ---YYASNRLTEKSDVYSFGIVLLEL 802
               YA+       D++S G +  EL
Sbjct: 179 LQSSYAT-----PVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 14/200 (7%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           RILG G FG +  G L   S+    VAI  L A  S   ++ F  EA  L +  H N+  
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G    G  + +V EYM+ G L  +L     + L     + +    A G++YL    + 
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG--TVGYLDPEYYASN 784
             +H+ +    +L+N  +  K++  GF ++   +SE+ I T++ G   V +  PE    +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYH 183

Query: 785 RLTEKSDVYSFGIVLLELIT 804
             +  SDV+SFGIV+ E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
            +F  +  +G+GG+G V+     D  E VA+K +  S      + R   TE  +L     
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGL 717
             L  L+    D   + L  EY+  G+ +  L +        A  +   +  AVDA   L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
            Y         IHRD+K  N L++     KL DFG SK          + S+VG+  Y+ 
Sbjct: 121 GY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMA 166

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           PE           D +S G +L E + G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 11/196 (5%)

Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVG 669
           LGKGGFG V    + A G   A K L+    +  K +     E ++L +VH R + SL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLF--DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                 ++ LV   M  G+L+ +++  DE                   GLE+LH   +  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           II+RD+K  N+LL+     +++D G +           +    GT G++ PE        
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175

Query: 788 EKSDVYSFGIVLLELI 803
              D ++ G+ L E+I
Sbjct: 176 FSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 18/224 (8%)

Query: 614 LGKGGFGTVYHGYL---ADGSEVAIKMLSASSSQGP--KQFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  G          VA+K+L   ++      +   EA ++ ++ +  +  ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L ++L  +  + ++ K+  ++    + G++YL    +   
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLE---ETNF 116

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      +G       N V   +E G+
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIESGE 215

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 51/194 (26%), Positives = 99/194 (51%), Gaps = 12/194 (6%)

Query: 614 LGKGGFGTVYHGYLADGS---EVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVG 669
           LG G FG V  G         +VAIK+L   + +  + +   EA+++ ++ +  +  ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C +   + LV E  + G L ++L  + K+ ++  + +++    + G++YL        +
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRLT 787
           HRD+   N+LL  +  AK++DFG SK   A+ +S+      G   + +  PE     + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 788 EKSDVYSFGIVLLE 801
            +SDV+S+GI + E
Sbjct: 177 SRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 18/186 (9%)

Query: 629 DGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLVGY----CNDGGNVGLVY 681
           +  EV I+                  E + L R+   N+  + G+     +D   + L+ 
Sbjct: 42  NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101

Query: 682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
           EY   G L++ L  E  + LS+K +L +A+D  +GL  L+     P  ++++ + + L+ 
Sbjct: 102 EYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVT 157

Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVL 799
           E  + K+   G  KI  +    +++  +     Y   +      +  T K D+YS G+VL
Sbjct: 158 ENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 800 LELITG 805
            E+ TG
Sbjct: 213 WEIFTG 218

Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 39/105 (37%), Positives = 52/105 (49%), Gaps = 13/105 (12%)

Query: 708 QIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
           ++ V   + L YL   HG    +IHRDVK +NILL+     KL DFG S     +S++  
Sbjct: 118 KMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAK- 171

Query: 766 STSIVGTVGYLDPEYYASNRLTEK----SDVYSFGIVLLELITGL 806
            T   G   Y+ PE         K    +DV+S GI L+EL TG 
Sbjct: 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 15/204 (7%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +         +   +    + VA+K   L + S +  K  + E     ++ H N+   V 
Sbjct: 8   KCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH-GCKPPI 728
                  + +V   MAYG+ +  L     E L       I  D    L+Y+H  G     
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF---- 122

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-----ISTSIVGTVGYLDPEYYAS 783
           IHR VK ++ILL+   +  L+   +S       +          S V  + +L PE    
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 784 NRL--TEKSDVYSFGIVLLELITG 805
           N     EKSD+YS GI   EL  G
Sbjct: 183 NLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.6 bits (170), Expect = 2e-12
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 23/220 (10%)

Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSASS----SQGPKQFRTEAQLLMRVHHRN 663
           ++LG G +G V+      G +     A+K+L  ++    ++  +  RTE  +L  V    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLF--DETKEALSWKDRLQIAV-DAAQGLEY 719
               + Y       + L+ +Y++ G +  +L+  D   E     D ++    +    LE+
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALEH 120

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           LH   K  I++RD+K  NILL+ +    L DFG SK F +E +   + S  GT+ Y+ PE
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPE 176

Query: 780 YYASNRLTEKS-DVYSFGIVLLELITGL-PAIIRGYNNTH 817
                    K+ D +S GI++ EL+TG  P  + G  NT 
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ 216

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 18/221 (8%)

Query: 630 GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
           G +VA+K +     Q  +    E  ++   HH N+  +      G  + +V E++  G L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA 749
              +   T   ++ +    + +   + L YLH+     +IHRD+K+ +ILL    + KL+
Sbjct: 107 TDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLS 160

Query: 750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
           DFGF      E       S+VGT  ++ PE  +      + D++S GI+++E+I G P  
Sbjct: 161 DFGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP- 217

Query: 810 IRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK 850
              Y N        P      +R  + PR++ +   +SV +
Sbjct: 218 ---YFNEP------PLQAMRRIRDNLPPRVKDSHKVSSVLR 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 16/182 (8%)

Query: 630 GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
           G +VA+KM+     Q  +    E  ++    H+N+  +      G  + ++ E++  G L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA 749
              +  +T+  L+ +    +     Q L YLH      +IHRD+K+ +ILL    + KL+
Sbjct: 106 TD-IVSQTR--LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLS 159

Query: 750 DFGF----SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           DFGF    SK  P         S+VGT  ++ PE  +      + D++S GI+++E++ G
Sbjct: 160 DFGFCAQISKDVPKRK------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Query: 806 LP 807
            P
Sbjct: 214 EP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)

Query: 609 NFHRI--LGKGGFGTVYHGY-LADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRN 663
           NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           +  L+   +    + LV+E++   +LK+++       +             QGL + H H
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE- 779
                ++HRD+K  N+L+N +   KLADFG ++ F  P  + +H     V T+ Y  PE 
Sbjct: 120 ----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH----EVVTLWYRAPEI 171

Query: 780 -----YYASNRLTEKSDVYSFGIVLLELIT 804
                YY++       D++S G +  E++T
Sbjct: 172 LLGCKYYST-----AVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 14/161 (8%)

Query: 652 EAQLLMRVHHRNLASL----VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL 707
           E  +L+++ H N+ ++    VG   D   + +V EY+ + +LK  L +  K+     +  
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEH-DLKS-LMETMKQPFLQSEVK 109

Query: 708 QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST 767
            + +    G+ +LH      I+HRD+KT+N+LLN +   K+ DFG ++ +   S     T
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYT 164

Query: 768 SIVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
            +V T+ Y  PE    +   +   D++S G +  EL+T  P
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 43/239 (17%)

Query: 604 VDITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRV 659
           V         +G G +G V   +    G +VAIK LS    S+    + +R E +LL  +
Sbjct: 13  VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHM 71

Query: 660 HHRNLASLVG-YC-----NDGGNVGLVYEYMA---YGNLK-QYLFDETKEALSWKDRLQI 709
            H N+  L+  +       D  +V LV   M       +K Q L D+  + L +    QI
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY----QI 127

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
                +GL+Y+H      IIHRD+K +NI +NE  + K+ DFG ++    + E    T  
Sbjct: 128 L----RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDE---MTGY 175

Query: 770 VGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           V T  Y  PE      +Y      +  D++S G ++ EL+TG   +  G ++   + R+
Sbjct: 176 VATRWYRAPEIMLNWMHY-----NQTVDIWSVGCIMAELLTGKT-LFPGSDHIDQLKRI 228

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 74/225 (32%), Positives = 106/225 (47%), Gaps = 30/225 (13%)

Query: 605 DITNNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-H 660
           D T+ +  I  +GKG +G VY      DGS  A+K+L   S    ++   E  +L  + +
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPN 77

Query: 661 HRNLASLVG--YCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---- 711
           H N+    G  Y  D   GG + LV E    G++ + +    K  L    RL  A+    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYI 133

Query: 712 --DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
              A  GL++LH+     IIHRDVK  NILL  +   KL DFG S    + +    +TS 
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTS- 188

Query: 770 VGTVGYLDPEYYASNRLTEKS-----DVYSFGIVLLELITGLPAI 809
           VGT  ++ PE  A  +  + S     DV+S GI  +EL  G P +
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 41/214 (19%)

Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           ++G+G +G V      + G  VAIK    S       K    E ++L ++ H NL +L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 670 YCNDGGNVGLVYEYM---------AYGN------LKQYLFDETKEALSWKDRLQIAVDAA 714
                  + LV+E++          Y N      +++YLF             QI     
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF-------------QIL---- 110

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           +G+E+ H      IIHRD+K  NIL+++    KL DFGF++   A  E +  T  V T  
Sbjct: 111 RGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRW 165

Query: 775 YLDPEYYASN-RLTEKSDVYSFGIVLLELITGLP 807
           Y  PE    + +     D+++ G ++ E++TG P
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + G+  A K++   S +  + +  E ++L   +H  +  L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
             G + ++ E+   G +   +  E    L+     QI V   Q LE L +     IIHRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIML-ELDRGLT---EPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYASNRLTE-- 788
           +K  N+LL      KLADFG S    A++   +    S +GT  ++ PE      + +  
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 789 ---KSDVYSFGIVLLEL 802
              K+D++S GI L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 4e-12
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 8/152 (5%)

Query: 652 EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV 711
           EA LL  V+H ++  +      G    +V  + +  +L  YL   ++  L     L I  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRP-LPIDQALIIEK 164

Query: 712 DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
              +GL YLH      IIHRDVKT NI +N+  Q  + D G ++ FP  + + +   + G
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFL--GLAG 218

Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELI 803
           TV    PE  A ++   K+D++S GIVL E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.3 bits (164), Expect = 5e-12
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 614 LGKGGFGTVYHGYLADG---SEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G FG V  G +  G   ++V +K L  S+S Q   +F  EAQ    + H NL   +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL---QIAVDAAQGLEYLHHGCKP 726
            C +     LV E+   G+LK YL    K  L   D     ++A + A GL +LH   K 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY---AS 783
             IH D+   N LL   +  K+ D+G S     E        +   + ++ PE       
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 784 NRL----TEKSDVYSFGIVLLEL 802
           N L    T++S+V+S G+ + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 23  DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   + L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH---AQ 135

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E       S+VGT  ++ PE  +    
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPY 193

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 23/205 (11%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +G VY G     G  VA+K +   S +   P     E  LL  + H N+  L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRL-QIAVDAAQGLEYLHHGCK 725
                 + L++E+++  +LK+YL      +  +A   K  L QI     QG+ + H    
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYA 782
             ++HRD+K  N+L++ K   KLADFG ++ F  P    +H    +V T+ Y  PE    
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH---EVV-TLWYRAPEVLLG 175

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
           S R +   D++S G +  E+ T  P
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 614 LGKGGFGTVYHGYLADGSEVAI-KMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     +   +A  K++   S +  + +  E  +L    H N+  L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
              N+ ++ E+ A G +   +  E +  L+     QI V   Q LE L++  +  IIHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVML-ELERPLT---EPQIRVVCKQTLEALNYLHENKIIHRD 128

Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRLTE-- 788
           +K  NIL       KLADFG S    A++   I    S +GT  ++ PE        +  
Sbjct: 129 LKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 789 ---KSDVYSFGIVLLEL 802
              K+DV+S GI L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 59/236 (25%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNLASLV-- 668
           LG+G FG VY    +  G  VA+K +L  +   G P     E ++L ++ H N+  L+  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 669 ------GYCNDGGNVGLVYEYMAY------GN---------LKQYLFDETKEALSWKDRL 707
                       G+V +V  YM +       N         +K Y+             L
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM-------------L 122

Query: 708 QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---------- 757
           Q+     +G+ YLH   +  I+HRD+K ANIL++ +   K+ADFG ++ +          
Sbjct: 123 QLL----EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 758 PAESESHISTSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRG 812
                    T++V T  Y  PE     R  T   D++  G V  E+ T  P I++G
Sbjct: 176 GGGGT-RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP-ILQG 229

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASLVG 669
           +G+G +G V+     + G  VAIK    S    P   K    E ++L ++ H NL +L+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPI 728
                  + LV+EY  +  L +   ++    +      +I     Q + + H H C    
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---- 121

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN-RLT 787
           IHRDVK  NIL+ ++ Q KL DFGF++I     + +  T  V T  Y  PE    + +  
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQYG 179

Query: 788 EKSDVYSFGIVLLELITGLP 807
              DV++ G V  EL+TG P
Sbjct: 180 PPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 24/225 (10%)

Query: 609 NFH--RILGKGGFGTVY-----HGYLADGSEVAIKMLSASS----SQGPKQFRTEAQLLM 657
           NF   ++LG G +G V+      G+ + G   A+K+L  ++    ++  +  RTE Q+L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 658 RVHHRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQ 715
            +        + Y       + L+ +Y+  G L  +L    +     +  +QI   +   
Sbjct: 60  HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVL 116

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            LE+LH   K  II+RD+K  NILL+      L DFG SK F  E E   + S  GT+ Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEY 172

Query: 776 LDPEYYASNRLTEKS--DVYSFGIVLLELITGL-PAIIRGYNNTH 817
           + P+             D +S G+++ EL+TG  P  + G  N+ 
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 18/212 (8%)

Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L      +        TE+++L    H  L SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY+  G L    F  ++E +  +DR +    +    L+YLH G   
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I++RD+K  N++L++    K+ DFG  K     +++    +  GT  YL PE    N  
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVG 669
           LG G FG V        G   AIK L        KQ +    E  +LM + H  + +++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ--------GLEYLH 721
              D   V  + E++  G L    F   ++A  + +      D A+          EYLH
Sbjct: 86  SFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPN------DVAKFYHAELVLAFEYLH 135

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 II+RD+K  N+LL+ K   K+ DFGF+K  P       + ++ GT  YL PE  
Sbjct: 136 ---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVI 187

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
            S    +  D ++ G++L E I G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 29/214 (13%)

Query: 615 GKGGFGTVYHGYLADGS---EVAIKMLSASSSQG----PKQFRTEAQLLMRVHHRNLASL 667
           G+G +G VY     +G    E AIK       Q         R E  LL  + H N+ SL
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVSL 67

Query: 668 VGYC--NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLEY 719
           V     +   +V L+++Y  +   +   F    + +S    +      QI      G+ Y
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL----NGVHY 123

Query: 720 LHHGCKPPIIHRDVKTANILL----NEKMQAKLADFGFSKIFPAESESHISTS-IVGTVG 774
           LH      ++HRD+K ANIL+     E+   K+ D G +++F A  +       +V T+ 
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 775 YLDPEYYASNR-LTEKSDVYSFGIVLLELITGLP 807
           Y  PE     R  T+  D+++ G +  EL+T  P
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 603 IVDITNNFH--RILGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLM 657
           + +ITN +   + +G G FG V        G  VAIK  M   S+    K+   E +LL 
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 658 RVHHRNLASLVG-YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDAAQ 715
            + H N+ SL   + +   ++  V E +   +L + L     E    K  +Q       +
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRPLE----KQFIQYFLYQILR 119

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           GL+Y+H      ++HRD+K +NIL+NE    K+ DFG ++I     +    T  V T  Y
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYY 171

Query: 776 LDPEYYAS-NRLTEKSDVYSFGIVLLELITGLP 807
             PE   +  +   + D++S G +  E++ G P
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 32/209 (15%)

Query: 614 LGKGGFGTVYHGYLAD---GSEVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           +G G +GTV      D   G++VAIK L     S    K+   E +LL  + H N+  L+
Sbjct: 23  VGSGAYGTVC--SALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80

Query: 669 GY------CNDGGNVGLVYEYMA--YGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEY 719
                    +   +  LV  +M    G L ++      E LS +DR+Q  V    +GL+Y
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLS-EDRIQFLVYQMLKGLKY 133

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K  N+ +NE  + K+ DFG ++    +SE    T  V T  Y  PE
Sbjct: 134 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE---MTGYVVTRWYRAPE 185

Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITGLP 807
              +    T+  D++S G ++ E++TG P
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV--G 669
           I+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R + SLV  G
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 670 YC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
            C          +    +  + + M  G+L  +L        S K+    A +   GLE+
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEH 112

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT GY+ PE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPE 165

Query: 780 YYASNRLTEKS-DVYSFGIVLLELITG 805
                   + S D +S G +L +L+ G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 11/193 (5%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G G +G VY    +  G   AIK++     +     + E  ++    H N+ +  G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
               + +  E+   G+L Q ++  T   LS      ++ +  QGL YLH   K   +HRD
Sbjct: 77  RRDKLWICMEFCGGGSL-QDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131

Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR---LTEK 789
           +K ANILL +    KLADFG S    A        S +GT  ++ PE  A  R     + 
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 790 SDVYSFGIVLLEL 802
            D+++ GI  +EL
Sbjct: 190 CDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.2 bits (160), Expect = 4e-11
 Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 35/237 (14%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
              + +G G +G V        G +VAIK +S          +  R E +LL  + H N+
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENI 61

Query: 665 ASLV-----GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---- 715
             L+         D  +V +V E M   +L + +          K    +  D  Q    
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME-TDLHKVI----------KSPQPLTDDHIQYFLY 110

Query: 716 ----GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIV 770
               GL+YLH      +IHRD+K +NIL+N     K+ DFG ++ + P E E    T  V
Sbjct: 111 QILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 771 GTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL 826
            T  Y  PE   +S+R T+  D++S G +  EL+T  P +  G +    +N +   L
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP-LFPGRDYIDQLNLIVEVL 223

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 4e-11
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH---ISTSIVGTV 773
           L+Y+H G    +IHRD+K +NILLN   + KLADFG ++      E+    + T  V T 
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 774 GYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
            Y  PE    S R T+  D++S G +L E++ G P
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 5e-11
 Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 5/95 (5%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
           K+ISL+L+   L+G+I   +  L++LE L L +N+ TG IP  L+ LP L+VL L  NK 
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344

Query: 507 SGSVPTSLVARSQNGSLLLSI----GRNPD-LCLS 536
           SG +P +L   +    L LS     G  P+ LC S
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379

Length = 968

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 9/105 (8%)

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
           W   +Q+ +     L YLH   +  I+HRD+   NI+L E  +  + DFG +K    +  
Sbjct: 116 WNIFVQMVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQP 166

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
               TS+VGT+ Y  PE   +    EK+DV++FG +L ++ T  P
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRT---EAQLLMRVHHRNLASLVGY 670
           LGKG +G+VY   L   + V + M          +F     E  +L +     +    G 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL--QIAVDAAQGLEYLHHGCKPPI 728
               G V +  EYM  G+L + L+          + +  +I     +GL++L    +  I
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRDVK  N+L+N   Q KL DFG S        + ++ + +G   Y+ PE   S    +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 789 ------KSDVYSFGIVLLELITG 805
                 +SDV+S G+ +LE+  G
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 8e-11
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 16/202 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLAS-- 666
             +G G +G V        G +VAIK +  +        RT  E ++L    H N+ +  
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 667 --LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L     D  +V +V + M   +L   +   + + L+ +          +GL+Y+H   
Sbjct: 71  DILRPPGADFKDVYVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSAN 127

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPE-YY 781
              +IHRD+K +N+L+NE  + ++ DFG ++   +    H    T  V T  Y  PE   
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 782 ASNRLTEKSDVYSFGIVLLELI 803
           +    T   D++S G +  E++
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 9e-11
 Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 6/158 (3%)

Query: 645 GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWK 704
           G K    E  +L  + HR + +L+        V +V       +L  Y+  +    L  +
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYV--DRSGPLPLE 185

Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
             + I     + L YLH      IIHRDVKT NI L+E   A L DFG +    A  ++ 
Sbjct: 186 QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
                 GT+    PE  A +    K+D++S G+VL E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 29/207 (14%)

Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV--G 669
           I+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R + SLV  G
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 670 YC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
            C          +    +  + + M  G+L  +L        S  +    A +   GLE+
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEH 112

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT GY+ PE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPE 165

Query: 780 YYASNRLTEKS-DVYSFGIVLLELITG 805
                   + S D +S G +L +L+ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 67/232 (28%), Positives = 98/232 (42%), Gaps = 42/232 (18%)

Query: 610 FHRI--LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP---KQFRTEAQLLMRVHHRN 663
           F +I  LGKG  G V+   L    ++ A+K+L           K+  TE ++L  + H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD-RLQIA-VDAAQGLEYLH 721
           L +L         + LV +Y   G L + L  +  + LS +  R   A V  A  LEYLH
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--LEYLH 120

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI------------------------ 756
             G    I++RD+K  NILL+E     L+DF  SK                         
Sbjct: 121 LLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 757 ---FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
                +E  S  S S VGT  Y+ PE  + +      D ++ GI+L E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLL-MRVHHRNLAS 666
           ++LGKG FG V    L    EV AIK+L               TE ++L +   H  L +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           L         +  V EY+  G+L     +   FDE +           A +    L +LH
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-------YAAEVTLALMFLH 113

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
            HG    +I+RD+K  NILL+ +   KLADFG  K          +T+  GT  Y+ PE 
Sbjct: 114 RHG----VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEI 167

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
                     D ++ G+++ E++ G P
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 19/219 (8%)

Query: 614 LGKGGFGTVYHGYLADGSEVA---IKMLSASSSQGPK-----QFRTEAQLLMRVHHRNLA 665
           LGKG FGTVY   + D   VA   +K+L              Q   EAQLL ++ H  + 
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNL--KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                  +     ++ EY    +L  K      T + LS     +  +    G+ Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            +  I+HRD+K  NI L   +  K+ DFG S++     +  ++T+  GT  Y+ PE    
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKH 179

Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
                KSD++S G +L E+     A   G N   +V R+
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRI 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASL- 667
             +G+G +G V        G +VAIK +S    Q   Q RT  E ++L R  H N+  + 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGIL 69

Query: 668 -------VGYCNDGGNVGLVYEYMA---YGNLK-QYLFDETKEALSWKDRLQIAV-DAAQ 715
                      ND   V +V E M    Y  +K Q+L +         D +Q  +    +
Sbjct: 70  DIIRPPSFESFND---VYIVQELMETDLYKLIKTQHLSN---------DHIQYFLYQILR 117

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVG 774
           GL+Y+H      ++HRD+K +N+LLN     K+ DFG ++I   E + +   T  V T  
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 775 YLDPEYYASNRLTEKS-DVYSFGIVLLELITGLP 807
           Y  PE   +++   K+ D++S G +L E+++  P
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 35/205 (17%)

Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSA-SSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +GTV+     +  E VA+K +      +G P     E  LL  + H+N+  L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA----------QGLEYL 720
            +    + LV+EY    +LK+Y            D     +D            +GL + 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYF-----------DSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDP 778
           H      ++HRD+K  N+L+N+  + KLADFG ++ F  P    S      V T+ Y  P
Sbjct: 116 H---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA----EVVTLWYRPP 168

Query: 779 EYYASNRLTEKS-DVYSFGIVLLEL 802
           +     +L   S D++S G +  EL
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           R LG G  G V+    +D    VA+K +  +  Q  K    E +++ R+ H N+  +   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 671 CNDGGN--------------VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
               G+              V +V EYM   +L   L  E         RL       +G
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL--EQGPLSEEHARL-FMYQLLRG 126

Query: 717 LEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESE--SHISTSIVGTV 773
           L+Y+H      ++HRD+K AN+ +N E +  K+ DFG ++I         ++S  +V T 
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TK 182

Query: 774 GYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLP 807
            Y  P    S N  T+  D+++ G +  E++TG P
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 17/196 (8%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G G +G VY    L  G   A+K++           + E  ++    H N+ +  G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPII 729
               + +  EY   G+L Q ++  T   LS    LQIA    +  QGL YLH   K   +
Sbjct: 77  SREKLWICMEYCGGGSL-QDIYHVTG-PLS---ELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR---L 786
           HRD+K ANILL +    KLADFG +    A        S +GT  ++ PE  A  +    
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKNGGY 186

Query: 787 TEKSDVYSFGIVLLEL 802
            +  D+++ GI  +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 610 FHRI--LGKGGFGTVYHG-YLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNL 664
           + ++  +G+G +G VY       G  VA+K   L       P     E  LL  ++H N+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLE 718
             L+   +    + LV+E++   +LK+Y+  ++         L      Q+     QG+ 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLL----QGIA 113

Query: 719 YLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGY 775
           Y H H     ++HRD+K  N+L++ +   KLADFG ++ F  P  + +H    +V T+ Y
Sbjct: 114 YCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWY 165

Query: 776 LDPEYYASNRLTEKS-DVYSFGIVLLELITGLP 807
             PE    +R      D++S G +  E++   P
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 62.8 bits (152), Expect = 5e-10
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 14/170 (8%)

Query: 641 SSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA 700
           + S+   Q   E   L R++H N+  +        N  ++ +   + +L  +++DE   A
Sbjct: 202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDE---A 257

Query: 701 LSWKDR------LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
             WKDR        I       +EY+H      +IHRD+K  NI LN   +  L DFG +
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
             F  E E+      VGTV    PE  A +   E +D++S G++LL++++
Sbjct: 315 MPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMR-VHHRNLAS 666
           +++GKG FG V    + ADG   A+K+L   +    +  K    E  +L++ V H  L  
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L         +  V +Y+  G L  +L  E +     + R   A + A  L YLH     
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARF-YAAEIASALGYLH---SL 115

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            II+RD+K  NILL+ +    L DFG  K     S++  +++  GT  YL PE       
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173

Query: 787 TEKSDVYSFGIVLLELITGLP 807
               D +  G VL E++ GLP
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.2 bits (149), Expect = 7e-10
 Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 31/243 (12%)

Query: 594 DNQQFTYSEIVDITNNFHRILGKGGFGTVY---HGYLADGSEVAIKM-LSASSSQG-PKQ 648
           D  +F + + V       +I G+G FG V+   H        VA+K  L  +  +G P  
Sbjct: 1   DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKK--TKQIVALKKVLMENEKEGFPIT 57

Query: 649 FRTEAQLLMRVHHRNLASLVGYC--------NDGGNVGLVYEYMAY---GNLKQYLFDET 697
              E ++L  + H N+ +L+  C           G+  LV+E+  +   G L       T
Sbjct: 58  ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117

Query: 698 KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF 757
              +  K  +++ ++   GL Y+H      I+HRD+K ANIL+ +    KLADFG ++ F
Sbjct: 118 LSEI--KKVMKMLLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF 169

Query: 758 --PAESESHISTSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYN 814
                S+ +  T+ V T+ Y  PE     R      D++  G ++ E+ T  P I++G  
Sbjct: 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP-IMQGNT 228

Query: 815 NTH 817
             H
Sbjct: 229 EQH 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.6 bits (152), Expect = 7e-10
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 21/151 (13%)

Query: 616 KGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G FG VY G   + S++ A+K++  +   +     Q + E   L       +  L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 672 NDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH-HGCK 725
               NV LV EY+  G++K  L     FDE          ++   + A  L+YLH HG  
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALALDYLHRHG-- 124

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
             IIHRD+K  N+L++ +   KL DFG SK+
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 20/211 (9%)

Query: 614 LGKGGFGTVYHGY-LADGSE-VAIKMLSASSSQGPKQFRT--EAQLLMRVH---HRNLAS 666
           +G+G +G V+    L +G   VA+K +   + +      T  E  +L  +    H N+  
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 667 LVGYC-----NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           L   C     +    + LV+E++   +L  YL    +  +  +    +     +GL++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 ++HRD+K  NIL+    Q KLADFG ++I+   S     TS+V T+ Y  PE  
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVL 181

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRG 812
             +      D++S G +  E+    P + RG
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKP-LFRG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 8e-10
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVG 669
           +GKG FG VY     D   + A+K+LS       K+      E  +L+R        +VG
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 670 Y---CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGCK 725
                    ++ LV +YM+ G L  +L    KE    +DR +  + +    LE+LH   K
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIAELVLALEHLH---K 114

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I++RD+K  NILL+      L DFG SK     +++  + +  GT  YL PE     +
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 786 -LTEKSDVYSFGIVLLELITG 805
             T+  D +S G+++ E+  G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 8e-10
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 11/198 (5%)

Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +GKG FG V      D   + A+K +  +   S         E  +L +V+   +  L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                  + LV  ++  G L  +L  E +  LS + R   A +    LE LH   K  +I
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLH---KFNVI 115

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           +RD+K  NILL+ +    L DFG  K+   + +   + +  GT  YL PE    +  T+ 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKA 173

Query: 790 SDVYSFGIVLLELITGLP 807
            D ++ G++L E++TGLP
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 8e-10
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 30/209 (14%)

Query: 614 LGKGGFGTVYHGYLADGSEVA---IKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G FG V    +   + VA   +K L A+ SS+   +F  +      + H N+   +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR------LQ-IAVDAAQGLEYLHH 722
            C +     LV+EY   G+LK YL  E      W  R      LQ +A + A G+ ++H 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMH- 116

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS--IVGTVGYLDPEY 780
             K   +H D+   N  L   +  K+ D+G         E +I T       + +L PE 
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 781 YAS--NRL-----TEKSDVYSFGIVLLEL 802
                  L     T+ S+V++ G+ L EL
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 46/235 (19%)

Query: 614 LGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH---HRNLASL 667
           LG+G +G V     A   +   VAIK ++   S+     R   +L +  H   H+N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQ-YLFDETKEALSWKDRLQIAVDAAQ----------- 715
                D   V         GN  + YL++E  EA    D  QI                 
Sbjct: 68  Y----DMDIV-------FPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIY 112

Query: 716 ----GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---PAESESHISTS 768
               GL+Y+H      ++HRD+K  N+L+N   + K+ DFG ++ F   P E+   + T 
Sbjct: 113 QILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TE 168

Query: 769 IVGTVGYLDPEYYASNRLTEKS-DVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            V T  Y  PE   S +   K+ DV+S G +L EL+   P + +G +    +N++
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP-VFKGKDYVDQLNQI 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 58/214 (27%), Positives = 85/214 (39%), Gaps = 35/214 (16%)

Query: 609 NFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQF---RTEAQLLM------- 657
               +LG+G FG V    Y   G   AIK L        K     R E + LM       
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIFE 54

Query: 658 ---RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA 714
                 H  L +L        +V  V EY A G+L  ++     +  S    +  A    
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAACVV 111

Query: 715 QGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVG 771
            GL+YLH +     I++RD+K  N+LL+ +   K+ADFG  K    E         +  G
Sbjct: 112 LGLQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCG 163

Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           T  +L PE       T   D +  G+++ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 612 RILGKGGFGTVYHGYLA----DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMR-VHHRN 663
           +++GKG FG V    LA    DG   A+K+L      + +  K    E  +L++ V H  
Sbjct: 1   KVIGKGSFGKVL---LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-- 55

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHH 722
              LVG          +Y  + + N  +  F   +E    + R +  A + A  L YLH 
Sbjct: 56  -PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH- 113

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                I++RD+K  NILL+ +    L DFG  K     ++S  +T+  GT  YL PE   
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIR 169

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                   D +  G VL E++ GLP
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVG-- 669
           +GKG +G V+      +GS+ A+K+L        ++   E  +L  +  H N+    G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 670 YCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ------IAVDAAQGLEYL 720
           Y  D   G  + LV E    G++     D  K  L   +R++      I  +A  GL++L
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
           H       IHRDVK  NILL  +   KL DFG S      S      + VGT  ++ PE 
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEV 195

Query: 781 YASNR-----LTEKSDVYSFGIVLLELITGLPAI 809
            A  +        + DV+S GI  +EL  G P +
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V        G +VAIK LS    S     + +R E  LL  + H N+  L+ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
                   ++  +  LV  YM   +L++ +     E     D++Q  V     GL+Y+H 
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSE-----DKVQYLVYQMLCGLKYIH- 134

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K  N+ +NE  + K+ DFG ++   AE      T  V T  Y  PE   
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVIL 187

Query: 783 S-NRLTEKSDVYSFGIVLLELITG 805
           +     +  D++S G ++ E++TG
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 58/226 (25%)

Query: 611 HRILGKGGFGTVYHGYLA----DGSEVAIKMLSA--SSSQGPKQFRTEAQLLMRV-HHRN 663
           ++ILGK G GT      A     G   AIK +     S +     R E Q L R+  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPN 59

Query: 664 LASL--VGYCNDGGNVGLV--------YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
           +  L  V +    G + LV        YE +     K+ L ++  ++  +    Q+    
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIK--GRKRPLPEKRVKSYMY----QLL--- 110

Query: 714 AQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFG-----FSKIFPAESESHIST 767
            + L+++H +G    I HRD+K  NIL+ + +  KLADFG     +SK  P  +E +IST
Sbjct: 111 -KSLDHMHRNG----IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK--PPYTE-YIST 161

Query: 768 SIVGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLP 807
                  Y  PE      YY       K D+++ G V  E+++  P
Sbjct: 162 R-----WYRAPECLLTDGYY-----GPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 3/124 (2%)

Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
           Y+      +K  L D+  E L+  D L      A+G+E+L        +HRD+   N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL 800
            +    K+ DFG ++    +S      S    V ++ PE    N  T  SDV+S+GI+L 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 801 ELIT 804
           E+ +
Sbjct: 331 EIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 60/203 (29%), Positives = 83/203 (40%), Gaps = 35/203 (17%)

Query: 618 GFGTVYHGYLADGSE--------------VAIKM-LSASSSQGPKQFRTEAQLLMRVHHR 662
           G G   H  L  GSE              V +K    ASS         EA+LL R+ H 
Sbjct: 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVH-------EARLLRRLSHP 220

Query: 663 NLASLVGYCNDGGNVGLVY-EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLE 718
            + +L+     GG   LV  +Y +  +L  YL       L      Q+   A Q    ++
Sbjct: 221 AVLALLDVRVVGGLTCLVLPKYRS--DLYTYL----GARLRPLGLAQVTAVARQLLSAID 274

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           Y+H      IIHRD+KT N+L+N      L DFG +        +     I GTV    P
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 779 EYYASNRLTEKSDVYSFGIVLLE 801
           E  A +  T   D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 18/212 (8%)

Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L +L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY   G L    F  ++E +  ++R +    +    LEYLH     
Sbjct: 61  KYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH---SR 114

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +++RD+K  N++L++    K+ DFG  K     S+     +  GT  YL PE    N  
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 27/57 (47%), Positives = 40/57 (70%)

Query: 458 LTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           L+G I PS+ +L+ L +LDLS+NSL+G IPE + QL  L +L+L  N  +G +P +L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328

Length = 968

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 10/196 (5%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LGKGGFG V    + + G   A K L         G K    E ++L +V+   + +L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                 ++ LV   M  G+LK ++++  +  L  +  +  +     G+ +LH      I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           +RD+K  N+LL+++   +L+D G +       +    T   GT GY+ PE       +  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 790 SDVYSFGIVLLELITG 805
            D ++ G  + E++ G
Sbjct: 175 VDWFAMGCSIYEMVAG 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 24/215 (11%)

Query: 612 RILGKGGFGTVYHGYL----ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNL 664
           ++LGKG FG V    L    A G   A+K+L      +        TE+++L    H  L
Sbjct: 1   KLLGKGTFGKVI---LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  +DR +    +    L YLH  
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+     +  GT  YL PE    
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 169

Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 17/160 (10%)

Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEALSWKD 705
           TEA +L  ++H ++  L G           Y       L +Y  D       K  ++  D
Sbjct: 132 TEAHILRAINHPSIIQLKG--------TFTYNKFTCLILPRYKTDLYCYLAAKRNIAICD 183

Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
            L I     + ++YLH      IIHRD+K  NI +N      L DFG +  FP +  ++ 
Sbjct: 184 ILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANK 239

Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
                GT+    PE  A +      D++S GIVL E+ T 
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 614 LGKGGFGTVYHGY---LADG-----SEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           LG+G F  ++ G    + D      +EV +K+L  S     + F   A ++ ++ H++L 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
              G C  G    +V EY+ +G+L  YL  ++    +SWK  L++A   A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLE--- 117

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI------VGTVGYLDP 778
              + H +V   N+LL  +   K  +  F K+    S+  IS ++      +  + ++ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL----SDPGISITVLPKEILLERIPWVPP 173

Query: 779 EYYASNR-LTEKSDVYSFGIVLLELITG 805
           E   + + L+  +D +SFG  L E+ +G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V    L +  +V A+K+L+        +   FR E  +L+   ++ + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF---DETKEALS--WKDRLQIAVDAAQGLEYLHH 722
                D  N+ LV +Y   G+L   L    D   E ++  +   + IA+D+   L Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                 +HRD+K  NIL++     +LADFG S +   E  +  S+  VGT  Y+ PE   
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 783 S-----NRLTEKSDVYSFGIVLLELITG 805
           +      +   + D +S G+ + E++ G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 15/187 (8%)

Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K+ L+ +D +  +   A+G+E+L        IHRD+   NILL+E    K+ DFG +
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 226

Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +    + +          + ++ PE       T +SDV+SFG++L E+ + L A    Y 
Sbjct: 227 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYP 283

Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT 874
              I    C  L+ G        R+ A   T    ++ +T ++C      QRPT S +V 
Sbjct: 284 GVKIDEEFCRRLKEGT-------RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVE 334

Query: 875 ELKKCLE 881
            L   L+
Sbjct: 335 HLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMR-VHHRNLAS 666
           +++GKG FG V      +DGS  A+K+L   +    +       E  +L++ + H  L  
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCK 725
           L         +  V +Y+  G L    F   +E    + R +  A + A  + YLH    
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLH---S 114

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  NILL+ +    L DFG  K      E+  +++  GT  YL PE      
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEP 172

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
                D +  G VL E++ GLP
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 4e-09
 Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 61/249 (24%)

Query: 608 NNFH--RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHH 661
           ++F   +++G+G FG V      D G   A+K L  S     +Q    R E  +L    +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 662 RNLASLVGYCN--DGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDAA 714
             +  L  Y +  D   + L+ EY+  G++     K+  F E +E   +     +A+D+ 
Sbjct: 61  PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE-EETRFYIAETILAIDSI 117

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF----------------- 757
             L Y         IHRD+K  N+LL+ K   KL+DFG                      
Sbjct: 118 HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168

Query: 758 ---------PAESESHIST----------SIVGTVGYLDPEYYASNRLTEKSDVYSFGIV 798
                    P  S+    T          S VGT  Y+ PE +      ++ D +S G++
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228

Query: 799 LLELITGLP 807
           + E++ G P
Sbjct: 229 MYEMLVGYP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMR-VHHRNLAS 666
           +++GKG FG V    + A+    A+K+L   +    +  K   +E  +L++ V H  L  
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCK 725
           L         +  V +Y+  G L  +L    +E    + R +  A + A  L YLH    
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLH---S 114

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYAS 783
             I++RD+K  NILL+ +    L DFG  K    E+  H  T  +  GT  YL PE    
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
                  D +  G VL E++ GLP
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 58.4 bits (141), Expect = 6e-09
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           R+LGKG FG V    L   G   A+K+L           +   TE ++L    +    + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 668 VGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQGLEYL 720
           +  C      +  V E++  G+L     K   FDE         R +  A +    L +L
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE--------ARARFYAAEITSALMFL 112

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTVGYLDP 778
           H      II+RD+K  N+LL+ +   KLADFG  K  IF        +++  GT  Y+ P
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----NGKTTSTFCGTPDYIAP 165

Query: 779 EYYASNRLTEKSDVYSFGIVLLELITG 805
           E           D ++ G++L E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 15/204 (7%)

Query: 609 NFHRILGKGGFGTVYHGYLADGS--EVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRN 663
           NF R LG G FG V      +     VAIK    S     KQ     +E ++L  ++H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
             +L G   D   + LV E++  G    + F    +          A       EYL   
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ-- 148

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I++RD+K  N+LL++    K+ DFGF+K+   ++ ++   ++ GT  Y+ PE   +
Sbjct: 149 -SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTY---TLCGTPEYIAPEILLN 202

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
               + +D ++ GI + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 9/198 (4%)

Query: 613 ILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVG 669
           ++G+G +G V      +  E VAIK    S      +  T  E ++L  +   N+  L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                G + LV+EY+   N+ + L +        K R  I     Q ++ +H   K  I+
Sbjct: 68  AFRRRGKLYLVFEYVE-KNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIV 122

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           HRD+K  N+L++     KL DFGF++     S ++  T  V T  Y  PE        + 
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGKA 181

Query: 790 SDVYSFGIVLLELITGLP 807
            D++S G +L EL  G P
Sbjct: 182 VDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 38/218 (17%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRN----LA 665
            +G+G +G VY       G  VA+K        +G P     E  LL  +        L 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 666 SLVGYCNDGG--NVGLVYEYMAYGNLKQYLFD---------ETKEALSWKDRLQIAVDAA 714
            +       G  ++ LV+EY+   +LK+++             K   S+  +L       
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQL------L 120

Query: 715 QGLEYLH-HGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIF--PAESESHISTSIV 770
           +G+ + H HG    ++HRD+K  N+L++ +K   K+AD G  + F  P +S +H    IV
Sbjct: 121 KGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV 173

Query: 771 GTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
            T+ Y  PE    S   +   D++S G +  E+    P
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.9 bits (140), Expect = 8e-09
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 50/223 (22%)

Query: 609 NFHRILGKGGFGTVYHGYLAD--GSE--VAIKMLSAS------------------SSQGP 646
           NF  +LGKG FG V    LA+  G++   AIK+L                     +  G 
Sbjct: 3   NFLMVLGKGSFGKVM---LAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 647 KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR 706
             F T+     +   R L  ++ Y N GG+  L+Y     G      F E          
Sbjct: 60  PPFLTQLHSCFQTMDR-LYFVMEYVN-GGD--LMYHIQQVGK-----FKEPHAVF----- 105

Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESH 764
              A + A GL +LH      II+RD+K  N++L+ +   K+ADFG  K  IF  ++   
Sbjct: 106 --YAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--- 157

Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            + +  GT  Y+ PE  A     +  D ++FG++L E++ G P
Sbjct: 158 -TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 17/212 (8%)

Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L         +     TE ++L    H  L +L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY   G L    F  ++E +  +DR +    +    L+YLH   + 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 115

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +++RD+K  N++L++    K+ DFG  K      +     +  GT  YL PE    N  
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173

Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 36/213 (16%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLM---RV-----HHR 662
           ++LGKG FG V    L    E+ A+K+L     +       + +  M   RV      H 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLK----KDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDAAQGL 717
            L  L         +  V EY+  G+L     +   FDE +           A +   GL
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-------YAAEIVLGL 109

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTVG 774
           ++LH  G    II+RD+K  N+LL+ +   K+ADFG  K  I    +    +++  GT  
Sbjct: 110 QFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPD 161

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           Y+ PE  +        D ++ G++L E++ G  
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 66/242 (27%), Positives = 103/242 (42%), Gaps = 33/242 (13%)

Query: 579 NVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGYLADGSEV-AI 635
           N+DN  S+ E + +   +    +E      +F  I  +G+G FG V         +V A+
Sbjct: 20  NIDNFLSRYEKAAEKITKLRMKAE------DFDVIKVIGRGAFGEVQLVRHKSSKQVYAM 73

Query: 636 KMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYC---NDGGNVGLVYEYMAYGNLK 690
           K+LS      +    F  E + +M   H N   +V       D   + +V EYM  G+L 
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMA--HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131

Query: 691 QYLFD---ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK 747
             + +     K A  +   + +A+DA   + +         IHRDVK  N+LL++    K
Sbjct: 132 NLMSNYDIPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLK 182

Query: 748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT----EKSDVYSFGIVLLELI 803
           LADFG      A       T+ VGT  Y+ PE   S         + D +S G+ L E++
Sbjct: 183 LADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Query: 804 TG 805
            G
Sbjct: 242 VG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 57.9 bits (140), Expect = 2e-08
 Identities = 27/80 (33%), Positives = 49/80 (61%), Gaps = 5/80 (6%)

Query: 433 WDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQ 492
           W G+ C+       +++S++L+ + ++GKIS ++  L  ++ ++LSNN L+G IP+ +  
Sbjct: 60  WQGITCN----NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFT 115

Query: 493 LPL-LRVLNLDGNKLSGSVP 511
               LR LNL  N  +GS+P
Sbjct: 116 TSSSLRYLNLSNNNFTGSIP 135

Length = 968

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLL-MRVHHRNLAS 666
           ++LGKG FG V    L   +E  AIK L           +    E ++L +   H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 667 LVGYCNDGGNVGL--VYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
           L  +C       L  V EY+  G+L  ++     FDE +           A +   GL++
Sbjct: 61  L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-------YAAEIICGLQF 111

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           LH   K  II+RD+K  N+LL++    K+ADFG  K      E   ST   GT  Y+ PE
Sbjct: 112 LH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKAST-FCGTPDYIAPE 166

Query: 780 YYASNRLTEKSDVYSFGIVLLELITG 805
                +  E  D +SFG++L E++ G
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 30/208 (14%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLL-MRVHHRNLAS 666
           ++LGKG FG V+   L   ++  AIK L           +    E ++L +   H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH 721
           L        N+  V EY+  G+L  ++     FD  +           A +   GL++LH
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-------YAAEIICGLQFLH 113

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI----STSIVGTVGYLD 777
                 I++RD+K  NILL+     K+ADFG  K      E+ +    + +  GT  Y+ 
Sbjct: 114 ---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIA 164

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITG 805
           PE     +     D +SFG++L E++ G
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 5/92 (5%)

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           +GL+YLH      I+HRD+K  N+L+N     K+ DFG +++   +   H++  +V T  
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169

Query: 775 YLDPE-YYASNRLTEKSDVYSFGIVLLELITG 805
           Y  PE    S   T   D++S G +  EL+  
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 78/324 (24%), Positives = 130/324 (40%), Gaps = 53/324 (16%)

Query: 579 NVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV-AIKM 637
           N+DN  ++ E  ++   +    +E  D+     +++G+G FG V         +V A+K+
Sbjct: 20  NIDNFLNRYEKIVRKIRKLQMKAEDYDVV----KVIGRGAFGEVQLVRHKSSQKVYAMKL 75

Query: 638 LSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
           LS            F  E  ++   +   +  L     D   + +V EYM  G+L   + 
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135

Query: 695 D---ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF 751
           +     K A  +   + +A+DA   +          +IHRDVK  N+LL++    KLADF
Sbjct: 136 NYDVPEKWAKFYTAEVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADF 186

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITG-- 805
           G              T+ VGT  Y+ PE   S         + D +S G+ L E++ G  
Sbjct: 187 GTCMKMDETGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245

Query: 806 ---LPAIIRGYN-----------------NTHIVNRVCPFLERGDV---RSIVDPRLEAN 842
                +++  Y+                 + H  N +C FL   +V   R+ V+   +  
Sbjct: 246 PFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305

Query: 843 FDTNSVW---KVAETAMECVPSIS 863
           F  N  W    + ETA   VP +S
Sbjct: 306 FFKNDQWNWDNIRETAAPVVPELS 329

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 5e-08
 Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 50/237 (21%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V      D   V A+K+L  +     +Q    R E  +L+      +  +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDE---TKEALS-WKDRLQIAVDAAQGLEYLHHG 723
                D  N+ L+ E++  G++   L  +   T+E    +     +A+D+   L +    
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFG----------------FSKIFPAE------- 760
                IHRD+K  N+LL+ K   KL+DFG                 +   P++       
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 761 ----------SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
                     +   ++ S VGT  Y+ PE +      +  D +S G+++ E++ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 8e-08
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)

Query: 693 LFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADF 751
           + +E + AL  +D L  +   A+G+ +L    C    IHRD+   NILL      K+ DF
Sbjct: 203 ILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDF 258

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           G ++    +S   +  +    V ++ PE   +   T +SDV+S+GI+L E+ +
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 29/64 (45%), Positives = 38/64 (59%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L+L    L GKI  SL+NL SLE L L++N L G IP  L Q+  L+ + L  N LSG +
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 511 PTSL 514
           P  +
Sbjct: 229 PYEI 232

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 31/65 (47%), Positives = 39/65 (60%), Gaps = 4/65 (6%)

Query: 451 LNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           LNL++   TG I   S+ NL   E LDLSNN L+G IP  +     L+VL+L GN L G 
Sbjct: 123 LNLSNNNFTGSIPRGSIPNL---ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 510 VPTSL 514
           +P SL
Sbjct: 180 IPNSL 184

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 33/74 (44%), Positives = 42/74 (56%), Gaps = 1/74 (1%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L+L    LTG I  SL NLK+L+ L L  N L+G IP  +  L  L  L+L  N LSG +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300

Query: 511 PTSLVARSQNGSLL 524
           P  LV + QN  +L
Sbjct: 301 P-ELVIQLQNLEIL 313

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 23/197 (11%)

Query: 691 QYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLA 749
           +   +  KE L+ +D +  +   A+G+E+L    C    IHRD+   NILL+E    K+ 
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKIC 215

Query: 750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLP 807
           DFG ++    + +          + ++ PE       T +SDV+SFG++L E+ +    P
Sbjct: 216 DFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Query: 808 AIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQR 866
                Y    I    C  L+ G        R+ A  + T  ++ +        P     R
Sbjct: 276 -----YPGVQIDEEFCRRLKEG-------TRMRAPEYATPEIYSIMLDCWHNNPE---DR 320

Query: 867 PTMSHVVTELKKCLEME 883
           PT S +V  L   L+  
Sbjct: 321 PTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 614 LGKGGFGTVYHGYLADGSE-VAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +G VY       +E +A+K   L       P     E  LL  + H N+  L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEYLHHGCKPP 727
            +    + LV+EY+   +LK+++ D + +    K+   I     Q   G+ Y H      
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHM-DSSPDFA--KNPRLIKTYLYQILRGIAYCH---SHR 122

Query: 728 IIHRDVKTANILLNEKMQA-KLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYAS 783
           ++HRD+K  N+L++ +  A KLADFG ++ F  P  + +H     V T+ Y  PE    S
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH----EVVTLWYRAPEILLGS 178

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
              +   D++S G +  E++   P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 19/148 (12%)

Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANIL 739
           Y   A    ++        ALS+ D +  +   A G+E+L    C    +HRD+   N+L
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVL 271

Query: 740 LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVL 799
           + E    K+ DFG ++    +S      S    + ++ PE   +N  T  SDV+SFGI+L
Sbjct: 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILL 331

Query: 800 LELIT--GLP------------AIIRGY 813
            E+ T  G P            AI RGY
Sbjct: 332 WEIFTLGGTPYPELPMNEQFYNAIKRGY 359

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 5/98 (5%)

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A + + GL +LH   +  II+RD+K  N++L+ +   K+ADFG  K      +   + + 
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTF 161

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            GT  Y+ PE  A     +  D +++G++L E++ G P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V     ++   +VAIK ++ +        RT  E +LL  + H N+ ++   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 671 C--------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLH 721
                    ND   V +VYE M   +L Q +   + + LS  D  Q  +    +GL+Y+H
Sbjct: 73  MPPPHREAFND---VYIVYELMD-TDLHQII--RSSQTLS-DDHCQYFLYQLLRGLKYIH 125

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE- 779
                 ++HRD+K +N+LLN     K+ DFG ++     SE     T  V T  Y  PE 
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTRWYRAPEL 179

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
               +  T   DV+S G +  EL+   P
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 25/222 (11%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +G G  G V   +    G  VA+K LS    + +   + +R E  LL  V+H+N+ SL
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85

Query: 668 VGY------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYL 720
           +          +  +V LV E M   NL Q +  +   E +S+     +      G+++L
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHL 139

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
           H      IIHRD+K +NI++      K+ DFG ++       + + T  V T  Y  PE 
Sbjct: 140 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEV 193

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
                  E  D++S G ++ EL+ G   I +G ++    N+V
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG-SVIFQGTDHIDQWNKV 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 614 LGKGGFGTVYHGYLADGS---EVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL--V 668
           +G+G +G VY     DG    E A+K +  +          E  LL  + H N+ +L  V
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY-----LHHG 723
              +    V L+++Y  +       F    +A   K  +Q+     + L Y     +H+ 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 724 CKPPIIHRDVKTANILL----NEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLD 777
               ++HRD+K ANIL+     E+ + K+AD GF+++F  P +  + +   +V T  Y  
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRA 183

Query: 778 PEYYASNR-LTEKSDVYSFGIVLLELITGLP 807
           PE     R  T+  D+++ G +  EL+T  P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSAS------------------SSQGPKQF 649
           NF  +LGKG FG V         E+ AIK+L                     +  G   F
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
            T+     +   R L  ++ Y N G    L+Y+    G  K+        A+ +      
Sbjct: 63  LTQLHSCFQTMDR-LYFVMEYVNGGD---LMYQIQQVGRFKE------PHAVFY------ 106

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES--ESHIST 767
           A + A GL +LH      II+RD+K  N++L+ +   K+ADFG  K    E+  +   + 
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTK 159

Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           +  GT  Y+ PE  A     +  D ++FG++L E++ G  
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL--VGY 670
           +G+G +G VY     DG +     L      G       E  LL  + H N+ SL  V  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLEYLHHGC 724
            +    V L+++Y  +       F    +A     +L       +      G+ YLH   
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 725 KPPIIHRDVKTANILL----NEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDP 778
              ++HRD+K ANIL+     E+ + K+AD GF+++F  P +  + +   +V T  Y  P
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAP 184

Query: 779 EYYASNR-LTEKSDVYSFGIVLLELITGLP 807
           E     R  T+  D+++ G +  EL+T  P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 32/209 (15%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQ------LLMR-VHHRN 663
           + +G G  G V   Y    G  VAIK LS      P Q  T A+      +LM+ V+H+N
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-----PFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 664 LASLVGY------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQG 716
           +  L+          +  +V LV E M   NL Q +  D   E +S+     +      G
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-----LLYQMLCG 130

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           +++LH      IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y 
Sbjct: 131 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYR 184

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITG 805
            PE        E  D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTV 773
           GL++LH      II+RD+K  N++L+     K+ADFG  K  +F    ++  ST   GT 
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---GDNRAST-FCGTP 160

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            Y+ PE     + T   D +SFG++L E++ G
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 5/117 (4%)

Query: 689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAK 747
            K     E    L   D L+ +   AQG+++L    C    IHRDV   N+LL +   AK
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252

Query: 748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + DFG ++    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 32/207 (15%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L +    QI     +GL+Y
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QIL----RGLKY 135

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 136 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 187

Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V      D   + A+K+L  +     +Q    R E  +L+      +  +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDE----TKEALSWKDRLQIAVDAAQGLEYLHHG 723
                D  N+ L+ E++  G++   L  +     +    +     +A+DA   L +    
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF----------------PAE------- 760
                IHRD+K  N+LL+ K   KL+DFG                     P++       
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 761 ----------SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
                     +   ++ S VGT  Y+ PE +      +  D +S G+++ E++ G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 6e-07
 Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P +  L+L      G + P     K LENLDLS N  +G++P  L  L  L  L L  NK
Sbjct: 452 PSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510

Query: 506 LSGSVPTSLVARSQNGSLLLS 526
           LSG +P  L +  +  SL LS
Sbjct: 511 LSGEIPDELSSCKKLVSLDLS 531

Length = 968

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 64/247 (25%), Positives = 101/247 (40%), Gaps = 40/247 (16%)

Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHR---ILGKGGFGTVYHGYLADGSE-VAIKML 638
           SH+   G    D ++   ++I    N  ++   I+G G FG VY     D SE VAIK +
Sbjct: 41  SHNNNAGE-DEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV 99

Query: 639 SASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC------NDGGNVGL----------VYE 682
                Q P+    E  ++  ++H N+  L  Y        +  N+ L          V++
Sbjct: 100 L----QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155

Query: 683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE 742
           YM +       +     AL        +    + L Y+H      I HRD+K  N+L++ 
Sbjct: 156 YMKH-------YARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDP 205

Query: 743 KMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY-ASNRLTEKSDVYSFGIVLL 800
                KL DFG +K   A   S    S + +  Y  PE    +   T   D++S G ++ 
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIA 262

Query: 801 ELITGLP 807
           E+I G P
Sbjct: 263 EMILGYP 269

Length = 440

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 7/106 (6%)

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTV 773
           + L+Y+H      + HRD+K  NIL N   + K+ DFG +++   ++ + I  T  V T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 774 GYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH 817
            Y  PE   S  ++ T   D++S G +  E++TG P +  G N  H
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKNVVH 215

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 18/105 (17%)

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI-------------FPAESE 762
           LEYLH +G    I+HRD+K  N+L+      KL DFG SKI                ++ 
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             +   + GT  Y+ PE        +  D ++ GI+L E + G  
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 27/209 (12%)

Query: 613 ILGKGGFGTVYH-GYLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLV 668
           ++G+G FG V      A G   A+K++  S   + +    F  E  +L   +   +  L 
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL------FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               D  N+ LV EY   G+L   L      FDE   A  +   L +A+ +   + Y   
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQMGY--- 123

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                 +HRD+K  N+L++     KLADFG +    A      S   VGT  Y+ PE   
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLT 176

Query: 783 SNRLTEKS------DVYSFGIVLLELITG 805
           +     K       D +S G++  E+I G
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYG 205

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 40/128 (31%), Positives = 60/128 (46%), Gaps = 14/128 (10%)

Query: 612 RILGKGGFGTVY----HGYLADGS--EVAIKMLSASSSQGPKQ-FRTEAQLLMRVH-HRN 663
           R LG G FG V     HG     S  +VA+KML +++    KQ   +E +++  +  H N
Sbjct: 43  RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           + +L+G C  GG + ++ EY  YG+L  YL    K        LQ  +D  +    L  G
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYL-HRNKHTF-----LQYYLDKNRDDGSLISG 156

Query: 724 CKPPIIHR 731
              P+  R
Sbjct: 157 GSTPLSQR 164

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 2e-06
 Identities = 26/57 (45%), Positives = 34/57 (59%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
           SL+L++  LT     +   L +L+ LDLS N+LT   PE  S LP LR L+L GN L
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 32/207 (15%)

Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   Y     + VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81

Query: 670 YCNDGGNVGLVYEYMAYGNLK----------QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                 ++    E     NL           Q L DE  + L ++          +GL+Y
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKY 133

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + ++ DFG ++   A+ E    T  V T  Y  PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDE---MTGYVATRWYRAPE 185

Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+ G
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 32/212 (15%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLS-------ASSSQGPKQFRTEAQLLMRVHHRN 663
           +++G+G FG V    + +  +V A+K+L+       A ++     FR E  +L+    R 
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC----FREERDVLVNGDRRW 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDE---TKEALSWKDRLQIAVDAAQGLE 718
           + +L     D  N+ LV +Y   G+L   L  F++      A  +   + +A+D+   L 
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           Y         +HRD+K  N+LL++    +LADFG S +      +  S   VGT  Y+ P
Sbjct: 123 Y---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 779 EYY-----ASNRLTEKSDVYSFGIVLLELITG 805
           E          R   + D +S G+ + E++ G
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 3e-06
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 4/81 (4%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L L S  L G+I  SL   +SL  + L +NS +G +P   ++LPL+  L++  N L G +
Sbjct: 385 LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Query: 511 PTSLVARSQNGSL-LLSIGRN 530
            +    +    SL +LS+ RN
Sbjct: 445 NSR---KWDMPSLQMLSLARN 462

Length = 968

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 3e-06
 Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 12/116 (10%)

Query: 693 LFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLA 749
           LFD  + +  LS  +  +I     + L  LH   K  IIH D+K  N+L +    +  L 
Sbjct: 96  LFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           D+G  KI    S         GT+ Y  PE    +      D ++ G++  EL+TG
Sbjct: 153 DYGLCKIIGTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 3/110 (2%)

Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K  L+ +D +  +   A+G+E+L        IHRD+   NILL+E    K+ DFG +
Sbjct: 165 DLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 221

Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           +    + +     S    + ++ PE       T +SDV+SFG++L E+ +
Sbjct: 222 RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLV 668
           +++G+G FG V         +V A+K+LS      +    F  E + +M   +      +
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 669 GYC-NDGGNVGLVYEYMAYGNLKQYLFD---ETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
            Y   D   + +V EYM  G+L   + +     K A  +   + +A+DA   + +     
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 163

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
               IHRDVK  N+LL++    KLADFG       E      T+ VGT  Y+ PE   S 
Sbjct: 164 ----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQ 218

Query: 785 ----RLTEKSDVYSFGIVLLELITG 805
                   + D +S G+ L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83

Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 84  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 137

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)

Query: 614 LGKGGFGTVYHGYLA----DGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           +G+G F  +   YLA     G+ V +++  L   + +  K  + E  L     H N+ + 
Sbjct: 6   IGRG-FCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
                 G  + ++  +MAYG+    L     E +S      I   A +GL YLH +G   
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY-- 122

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH--------ISTSIVGTVGYLDP 778
             IHR++K ++IL++      L+            +           STS++    +L P
Sbjct: 123 --IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSP 177

Query: 779 EYYASNR--LTEKSDVYSFGIVLLELITG 805
           E    +      KSD+YS GI   EL TG
Sbjct: 178 ELLRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 6e-06
 Identities = 31/69 (44%), Positives = 41/69 (59%)

Query: 458 LTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVAR 517
           L+G+I   +  L SL +LDL  N+LTG IP  L  L  L+ L L  NKLSG +P S+ + 
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283

Query: 518 SQNGSLLLS 526
            +  SL LS
Sbjct: 284 QKLISLDLS 292

Length = 968

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 11/111 (9%)

Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYH------GYLADGSEVAIKMLSASSSQ 644
           D  Q  Y+E  +   +   F + LG G FG V        G   +   VA+KML AS+  
Sbjct: 23  DPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82

Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
             ++   +E ++L  +  H+N+ +L+G C  GG V ++ EY  YG+L  +L
Sbjct: 83  DEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)

Query: 612 RILGKGGFGTVYHGYLADGS------EVAIKMLSASSSQGPKQ-FRTEAQLLMRV-HHRN 663
           RILG G FG V  G     S      +VA+KML  ++    KQ   +E +++  +  H N
Sbjct: 43  RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
           + +L+G C   G + ++ EY  YG+L  YL
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 30/71 (42%), Positives = 38/71 (53%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P++  L L S   +G+I  +L    +L  LDLS N+LTG IPE L     L  L L  N 
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 506 LSGSVPTSLVA 516
           L G +P SL A
Sbjct: 392 LEGEIPKSLGA 402

Length = 968

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 9/102 (8%)

Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR 706
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K +
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 610 FHRILGKGGFGTVYH------GYLADGSEVAIKMLS-ASSSQGPKQFRTEAQLLMRV-HH 661
             + LG+G FG V           A    VA+KML   +++   K   TE ++L+ + HH
Sbjct: 11  LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70

Query: 662 RNLASLVGYCN-DGGNVGLVYEYMAYGNLKQYL 693
            N+ +L+G C   GG + ++ EY  +GNL  YL
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 20/38 (52%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 470 KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            +LE LDLSNN +T  +P  LS LP L  L+L GNK++
Sbjct: 1   TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 62/253 (24%), Positives = 96/253 (37%), Gaps = 60/253 (23%)

Query: 608 NNFH--RILGKGGFGTV-YHGYLADGSEVAIKMLSASSSQGPKQF---RTEAQLLMRVHH 661
            +FH  +++GKG FG V        G   A+K L  S      Q    + E  +L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEY 719
             + SL     D   + L+ E++  G+L   L  +D   E ++   R  +A +    +E 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA-ECVLAIEA 116

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---------------------- 757
           +H   K   IHRD+K  NIL++     KL+DFG S  F                      
Sbjct: 117 VH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 758 -------------PAESESHIST----------SIVGTVGYLDPEYYASNRLTEKSDVYS 794
                           S+  I+T          S VGT  Y+ PE +      ++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 795 FGIVLLELITGLP 807
            G ++ E + G P
Sbjct: 234 LGAIMFECLIGWP 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 11/129 (8%)

Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
           LV EY+  G+L  ++  + +  L  +     A +    L +LH   +  II+RD+K  N+
Sbjct: 73  LVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNV 127

Query: 739 LLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFG 796
           LL+     KL D+G  K  + P ++ S    +  GT  Y+ PE           D ++ G
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDTTS----TFCGTPNYIAPEILRGEEYGFSVDWWALG 183

Query: 797 IVLLELITG 805
           +++ E++ G
Sbjct: 184 VLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 3e-05
 Identities = 26/64 (40%), Positives = 37/64 (57%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L L S  L G+I   L  +KSL+ + L  N+L+G IP  +  L  L  L+L  N L+G +
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Query: 511 PTSL 514
           P+SL
Sbjct: 253 PSSL 256

Length = 968

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 610 FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQGPKQ-FRTEAQLLMRV-HH 661
           F + LG G FG     T Y  + +D +  VA+KML  S+    ++   +E ++L  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
            N+ +L+G C  GG   ++ EY  YG+L  +L
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 3e-05
 Identities = 40/138 (28%), Positives = 62/138 (44%), Gaps = 30/138 (21%)

Query: 715 QGLEYLHHGCKPP----IIHRDVKTANILL-----------------NEKMQAKLADFGF 753
             L Y H+    P    ++HRD+K  NI L                 N +  AK+ DFG 
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 754 SKIFPAESESHISTSIVGTVGYLDPE--YYASNRLTEKSDVYSFGIVLLELITGLPAIIR 811
           SK    ES +H   S VGT  Y  PE   + +    +KSD+++ G ++ EL +G     +
Sbjct: 189 SKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 812 GYNNTHIVNRVCPFLERG 829
             N + +++     L+RG
Sbjct: 246 ANNFSQLISE----LKRG 259

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V    +     + A+K+L+        +   FR E  +L+    + + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF---DETKEALS--WKDRLQIAVDAAQGLEYLHH 722
                D   + LV +Y   G+L   L    D   E ++  +   + +A+ +   L Y   
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYY 781
                 +HRD+K  N+LL+     +LADFG         +  + +S+ VGT  Y+ PE  
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEIL 175

Query: 782 AS-----NRLTEKSDVYSFGIVLLELITG 805
            +      +   + D +S G+ + E++ G
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.2 bits (112), Expect = 4e-05
 Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 1/83 (1%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
           K P +  L++++  L G+I+    ++ SL+ L L+ N   G +P+       L  L+L  
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSR 484

Query: 504 NKLSGSVPTSLVARSQNGSLLLS 526
           N+ SG+VP  L + S+   L LS
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLS 507

Length = 968

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)

Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90

Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDE-TKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  E   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 31/191 (16%)

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEAL--SWKDRLQIAVDAAQGLE 718
           N+  L  Y     +V LV ++   G L  ++  F    E     W   + +A+DA     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG-FSKIFPAESESHISTSIVGTVGYLD 777
            LH   +  I+ RD+   NILL+++   +L  F  +S++  +     +         Y  
Sbjct: 101 -LH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITGL------PAIIRGYNNTHIVNRVCPFLERGDV 831
           PE    +  TE  D +S G +L EL+TG       P+ I    NTH    +  ++   + 
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSE-EA 205

Query: 832 RSIVDPRLEAN 842
           RS++   L+ N
Sbjct: 206 RSLLQQLLQFN 216

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 50/178 (28%)

Query: 673 DGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           D  N+  V +Y+  G++   L      +E L+   R  IA +    +E +H   K   IH
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---KMGFIH 124

Query: 731 RDVKTANILLNEKMQAKLADFGF---------SKIF------------PAESESHIST-- 767
           RD+K  NIL++     KL DFG          SK +            P+E  S I    
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 768 ------------------SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
                             S+VGT  Y+ PE       T+  D +S G++L E++ G P
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 11/129 (8%)

Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
            V EY+  G+L  ++  + +  L  +     + + +  L YLH   +  II+RD+K  N+
Sbjct: 73  FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNV 127

Query: 739 LLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFG 796
           LL+ +   KL D+G  K  + P ++ S    +  GT  Y+ PE           D ++ G
Sbjct: 128 LLDSEGHIKLTDYGMCKEGLRPGDTTS----TFCGTPNYIAPEILRGEDYGFSVDWWALG 183

Query: 797 IVLLELITG 805
           +++ E++ G
Sbjct: 184 VLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 20/179 (11%)

Query: 633 VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQY 692
           V +K+L  S       F   A L+ +V H +LA + G C  G    +V E++ +G L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 693 LFDETKEA-LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA----- 746
           L  E     ++WK  + +A   A  L YL       ++H +V   NILL     A     
Sbjct: 107 LRKEKGRVPVAWK--ITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSP 161

Query: 747 --KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLEL 802
             KL+D G S    +  E       V  + ++ PE     N L+  +D +SFG  LLE+
Sbjct: 162 FIKLSDPGVSFTALSREER------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 19/45 (42%), Positives = 26/45 (57%)

Query: 471 SLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLV 515
           +L++LDLSNN LT         LP L+VL+L GN L+   P +  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFS 45

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 37/116 (31%), Positives = 51/116 (43%), Gaps = 17/116 (14%)

Query: 452 NLTSEGLTGKISPSLSNLKSLENLDLSNNSLT----GSIPEFLSQLPLLRVLNLDGNKLS 507
            +   G+   ++  L    +LE LDL+NN LT     ++ E L+ L  L VLNL  N L 
Sbjct: 176 GIGDAGIR-ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL- 233

Query: 508 GSVPTSLVA---RSQNGSLL-LSIGRNPDLCLSAPCKKEKRNSVMPVVAASVSLLV 559
                + +A    S N SLL LS+  N D+      K         V+A   SLL 
Sbjct: 234 TDAGAAALASALLSPNISLLTLSLSCN-DITDDG-AKDLAE-----VLAEKESLLE 282

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 614 LGKGGFGTVYHGYLADGSE-------------VAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           LG+G    +Y G L    +             V +K+L  S       F   A ++ +V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 661 HRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           H+++  L G C  D  N+ +V E++ +G L  ++  ++ + L+   + ++A   A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENI-MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSY 120

Query: 720 LHHGCKPPIIHRDVKTANILL-NEKMQA------KLADFGFSKIFPAESESHISTSIVGT 772
           L       ++H +V T NILL  E +        KL+D G      +  E       V  
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VER 171

Query: 773 VGYLDPEYYASNR-LTEKSDVYSFGIVLLEL 802
           + ++ PE    ++ L+  +D +SFG  L E+
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESHISTSIVGTVG 774
           L +LH      II+RD+K  N+LL+ +   KL D+G  K  I P ++ S    +  GT  
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS----TFCGTPN 161

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           Y+ PE           D ++ G+++ E++ G
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 24/61 (39%), Positives = 34/61 (55%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L+L++  LTG+I   L +  +L  L L +NSL G IP+ L     LR + L  N  SG +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 511 P 511
           P
Sbjct: 421 P 421

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 20/61 (32%), Positives = 32/61 (52%)

Query: 453 LTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPT 512
           L     +G++    + L  +  LD+SNN+L G I      +P L++L+L  NK  G +P 
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470

Query: 513 S 513
           S
Sbjct: 471 S 471

Length = 968

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 60/250 (24%), Positives = 91/250 (36%), Gaps = 58/250 (23%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQF---RTEAQLLMRVHHRNLASL 667
           + LG G FG V      D  +  A+K L         Q    + E  +L    +  +  L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
                D  N+  V +Y+  G++   L   +   E L+   R  IA +    +E +H   K
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAIESVH---K 119

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFP-------AESESHI------------- 765
              IHRD+K  NIL++     KL DFG    F         +  SHI             
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 766 -------------------------STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL 800
                                    + S+VGT  Y+ PE       T+  D +S G++L 
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 801 ELITGLPAII 810
           E++ G P  +
Sbjct: 240 EMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 28/105 (26%), Positives = 56/105 (53%), Gaps = 11/105 (10%)

Query: 612 RILGKGGFGTVY------HGYLADGSEVAIKMLS--ASSSQGPKQFRTEAQLLMRV-HHR 662
           ++LG G FG V           +  + VA+KML   A++S+  K   +E ++L+ + +H 
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-HKALMSELKILIHIGNHL 71

Query: 663 NLASLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR 706
           N+ +L+G C    G + ++ E+  YGNL  +L  + +    ++++
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 58/253 (22%), Positives = 90/253 (35%), Gaps = 64/253 (25%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQF---RTEAQLLMRVHHRNLASL 667
           + LG G FG V      D  +  A+K L         Q    + E  +L    +  +  L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                D  N+  V +Y+  G++   L     F E   A  +   L  AV++   + +   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL-ARFYIAELTCAVESVHKMGF--- 122

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF------------------------- 757
                 IHRD+K  NIL++     KL DFG    F                         
Sbjct: 123 ------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 758 --------------PAE---SESH---ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGI 797
                         P E   +  H   ++ S+VGT  Y+ PE       T+  D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 798 VLLELITGLPAII 810
           +L E++ G P  +
Sbjct: 237 ILYEMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)

Query: 461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQN 520
            +   L NL +L+NLDLS N L+  +P+ LS L  L  L+L GNK+S  +P  +     +
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL--S 209

Query: 521 GSLLLSIGRNP 531
               L +  N 
Sbjct: 210 ALEELDLSNNS 220

Length = 394

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 14/136 (10%)

Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
           +V  +MAYG+ K  +     + +S      I     + L+Y+HH      +HR VK ++I
Sbjct: 76  VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHI 132

Query: 739 LLNEKMQAKLADFGFSKIFPAESESHISTSI-------VGTVGYLDPEYYASNR--LTEK 789
           L++   +  L+  G        +       +       V  + +L PE    N      K
Sbjct: 133 LISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 190

Query: 790 SDVYSFGIVLLELITG 805
           SD+YS GI   EL  G
Sbjct: 191 SDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	919
PLN03150	623	hypothetical protein; Provisional	100.0
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.98
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.98
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.98
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.88
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.7
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.67
PRK10345	210	hypothetical protein; Provisional	99.65
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.63
smart00090	237	RIO RIO-like kinase.	99.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.58
PLN03150	623	hypothetical protein; Provisional	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.51
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.34
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.32
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.27
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.04
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.01
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.92
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.74
KOG3087	229	consensus Serine/threonine protein kinase [General	98.74
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.68
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.66
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.63
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.58
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.56
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.43
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.41
PRK09902	216	hypothetical protein; Provisional	98.2
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.12
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.08
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.03
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.02
COG4248	637	Uncharacterized protein with protein kinase and he	98.0
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.96
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.96
KOG0617	264	consensus Ras suppressor protein (contains leucine	97.94
PF01636	239	APH: Phosphotransferase enzyme family This family	97.86
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.85
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.83
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.83
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.82
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	97.81
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.77
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.76
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.75
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.74
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.69
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.67
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.66
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.56
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.56
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.56
PRK10593	297	hypothetical protein; Provisional	97.54
KOG0472	565	consensus Leucine-rich repeat protein [Function un	97.52
PLN02876	822	acyl-CoA dehydrogenase	97.52
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	97.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.48
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.44
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	97.41
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.35
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.34
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.32
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.28
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.23
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.19
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.15

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-84  Score=779.24  Aligned_cols=474  Identities=26%  Similarity=0.445  Sum_probs=361.7

Q ss_pred             ccCCCCCcEEeecCCCCCCccccCCCceeeecCccccccCccccccccccccccccccceeeecC--CCCCcceecCCCC
Q 002461           57 KLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVNKNISSKFMSANLQNTYATVRSFP--EGNRNCYSLRPPE  134 (919)
Q Consensus        57 ~~~~~~gf~~idcg~~~~~~~~~~~~~~~~~~D~~~i~~g~~~~~~~~~~~~~~~~~~~tlR~Fp--~g~~nCY~l~~~~  134 (919)
                      +++++.++++||||++.+  ++.+.+|++|++|..|+. |....++..   ....++|.|+|+||  +|+||||+|++ +
T Consensus        18 ~~~~~~~~~~I~CGs~~~--~~~d~~~~~w~~D~~~~~-~~~~~~~~~---~~~~~~~~t~R~F~~~~g~~~cY~~~~-~   90 (623)
T PLN03150         18 LASPEPFTMRISCGARVN--VRTAPTNTLWYKDFAYTG-GIPANATRP---SFIAPPLKTLRYFPLSDGPENCYNINR-V   90 (623)
T ss_pred             cccCCCccEEEeCCCCCC--cccCCCCCEEcCCccccc-CccccccCc---ccccchhhccccCCcccccccceEeee-c
Confidence            344577889999998533  322358999999999864 444333322   23467799999999  58999999964 4


Q ss_pred             CCCceEEEeeeeeecCCCCCCCCCceEEEEcceeeEEEEe--cCCCccEEEEEEEEeccCccceeecccCCCCceeeeee
Q 002461          135 GKAKTYLTRASFMYGDYDDEDKLPEFDLYIGVNRWDSIKF--DNASHVVIKEIIHSALMDEINVCLLNTGKGTPFISALE  212 (919)
Q Consensus       135 ~~~~~ylvR~~f~ygnyd~~~~~p~Fd~~~~~~~w~~v~~--~~~~~~~~~e~i~~~~~~~~~vCl~~~~~~~Pfis~le  212 (919)
                       +++|||||++|+|||||+.+++|.|||++|||+|.+|+.  +.++..+++|+|+.+++++++|||+++++|+||||+||
T Consensus        91 -~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iE  169 (623)
T PLN03150         91 -PKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIE  169 (623)
T ss_pred             -CCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEE
Confidence             789999999999999999999999999999999999985  33455688999999999999999999999999999999


Q ss_pred             eeecccccccccC---c--eeEEEEEeecCCCCce-eeeccCCCC--CcccccCCCC--CCCccccccccccccCCcCCC
Q 002461          213 LRHFHNATYRTQS---G--ALVLYRRLDVGSTTTQ-IIRFKDDHY--DRIWVPYPGF--PGSASINTSFIIDSLVDSQYR  282 (919)
Q Consensus       213 l~~l~~~~Y~~~~---~--~l~~~~r~~~g~~~~~-~~rypdD~~--dR~W~p~~~~--~~~~~~~t~~~~~~~~~~~~~  282 (919)
                      ||||++++|+...   .  +|.++.|.|+|+.+.. .+|||||+|  ||+|.|+.+.  +.|..++|...+....+.+|.
T Consensus       170 v~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~  249 (623)
T PLN03150        170 ILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNF  249 (623)
T ss_pred             EEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCcc
Confidence            9999999997432   1  5899999999986543 489999999  9999997642  457788887766655567788


Q ss_pred             CcHHHHhhccccCCCCCceeecccCCCCCceEEEEEEeccccc-ccCCceeEEEEEECCcccccccc-----cccceeeE
Q 002461          283 LPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELES-RQGNQYREFSIELNGNLWEKSVV-----PEYLQSKT  356 (919)
Q Consensus       283 ~P~~v~qtA~t~~~~~~~l~~~~~~~~~~~~~~v~l~Fae~~~-~~~~~~R~F~i~~n~~~~~~~~~-----p~~~~~~~  356 (919)
                      +|+.|||||.++.++...+.+.|+. ++...|+|+|||||++. ....+.|+|||++||+.....+.     +....+.+
T Consensus       250 ~P~~VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~  328 (623)
T PLN03150        250 YPESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALV  328 (623)
T ss_pred             ChHHHhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceE
Confidence            9999999999987766678888874 57789999999999973 45668999999999987766432     22222222


Q ss_pred             EEeeccCCCCcEEEEEEecCCCCchhHHHHHHHHhhhcCCCCCCChhHHHHHHHHHHhCCCC--CCCCCCCCCCCCCcee
Q 002461          357 ISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLG--KGWQGDPCSPMYYSWD  434 (919)
Q Consensus       357 ~~~~~~~~~~~~~itL~~t~~S~lpP~ina~ei~~~~~~~~~~t~~~d~~al~~~k~~~~~~--~~W~gdpC~~~~~~W~  434 (919)
                      ........++.++|+|.|+.++  ||+|||+|||.+.+. +..|.++|+.||+++|+.++..  .+|+||||+|..+.|.
T Consensus       329 ~~~~v~~~~g~l~isl~p~~~s--~pilNaiEI~~~~~~-~~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~  405 (623)
T PLN03150        329 LNKTVAVSGRTLTIVLQPKKGT--HAIINAIEVFEIITA-ESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWS  405 (623)
T ss_pred             EEeEEeecCCeEEEEEeeCCCC--cceeeeeeeeecccc-ccccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccc
Confidence            2222233458899999998766  799999999999984 5789999999999999999764  3899999999888999


Q ss_pred             EEEcCCCCC-CCCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccc
Q 002461          435 GLNCSYNGY-KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTS  513 (919)
Q Consensus       435 gv~C~~~~~-~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~  513 (919)
                      ||.|+.... ....|+.|+|++|+|+|.+|++|++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..
T Consensus       406 Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~  485 (623)
T PLN03150        406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES  485 (623)
T ss_pred             cceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH
Confidence            999964221 1124566666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             cccccccCccc-----------------------cccCCCCCCCCC---CCcccc
Q 002461          514 LVARSQNGSLL-----------------------LSIGRNPDLCLS---APCKKE  542 (919)
Q Consensus       514 l~~l~~l~~l~-----------------------ls~~~N~~LC~~---~pC~~~  542 (919)
                      ++++++|+.|+                       +++.+|+.+|+.   .+|...
T Consensus       486 l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~  540 (623)
T PLN03150        486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH  540 (623)
T ss_pred             HhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCccc
Confidence            65555555544                       345678889975   457544

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=3.4e-71  Score=619.49  Aligned_cols=325  Identities=43%  Similarity=0.736  Sum_probs=281.5

Q ss_pred             eecCCCCCCc-cccCCCceeeecCccccccCcccccccc--ccccccccccceeeecCCCCCcceecCCCCCCCceEEEe
Q 002461           67 IDCGVPAGFM-YLDEKTQLSYKSDEEFIRTGVNKNISSK--FMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTR  143 (919)
Q Consensus        67 idcg~~~~~~-~~~~~~~~~~~~D~~~i~~g~~~~~~~~--~~~~~~~~~~~tlR~Fp~g~~nCY~l~~~~~~~~~ylvR  143 (919)
                      ||||++.+.+ |+|+.||++|++|++|+++|++++|++.  ...+...++|.|+|+||+|.||||+|++...+|+|||||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yliR   80 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYLIR   80 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEEEE
Confidence            8999987777 9999999999999999999999999432  223566788999999999999999997633367899999


Q ss_pred             eeeeecCCCCCC-----CCCceEEEEcceeeEEEEecCCC-ccEEEE-EEEEeccCccceeecccCCCC-ceeeeeeeee
Q 002461          144 ASFMYGDYDDED-----KLPEFDLYIGVNRWDSIKFDNAS-HVVIKE-IIHSALMDEINVCLLNTGKGT-PFISALELRH  215 (919)
Q Consensus       144 ~~f~ygnyd~~~-----~~p~Fd~~~~~~~w~~v~~~~~~-~~~~~e-~i~~~~~~~~~vCl~~~~~~~-Pfis~lel~~  215 (919)
                      +.|+|||||+++     +||.|||++|+|.|++|+.+++. ..+++| +|+++++++++|||+++++|+ ||||+|||||
T Consensus        81 l~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~~  160 (347)
T PF12819_consen   81 LHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELRP  160 (347)
T ss_pred             EEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEEE
Confidence            999999999984     37889999999999999988722 358899 677776999999999999999 9999999999


Q ss_pred             cccccccc--cCc--eeEEEEEeecCCCCceeeeccCCCCCcccccCCCCCCCcccccccccc-ccCCcCCCCcHHHHhh
Q 002461          216 FHNATYRT--QSG--ALVLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIID-SLVDSQYRLPSAVMKT  290 (919)
Q Consensus       216 l~~~~Y~~--~~~--~l~~~~r~~~g~~~~~~~rypdD~~dR~W~p~~~~~~~~~~~t~~~~~-~~~~~~~~~P~~v~qt  290 (919)
                      |++++|+.  ...  +|.++.|.|+|+.... +|||+|+|||+|+|+...+.|.+++|+.+++ ...+.+|.||.+||||
T Consensus       161 lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~~-iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~T  239 (347)
T PF12819_consen  161 LPDSLYPDTDANSSQALETVYRLNVGGSSSF-IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVYQT  239 (347)
T ss_pred             CCccceeccccCCCceeEEEEeecCCCcccc-cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHHHh
Confidence            99999962  222  6999999999987653 9999999999999986678999999987776 5577899999999999


Q ss_pred             ccccCCCCCceeecccCCCCCceEEEEEEecccccccCCc-eeEEEEEECCcccccccccccceeeEE--Eee---ccCC
Q 002461          291 AVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQ-YREFSIELNGNLWEKSVVPEYLQSKTI--SST---QPAR  364 (919)
Q Consensus       291 A~t~~~~~~~l~~~~~~~~~~~~~~v~l~Fae~~~~~~~~-~R~F~i~~n~~~~~~~~~p~~~~~~~~--~~~---~~~~  364 (919)
                      |+++.+.+..++++|..+++..+|||+|||||++.+..++ .|+|||+|||+.+.++|+|.++....+  +..   ....
T Consensus       240 A~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  319 (347)
T PF12819_consen  240 ARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPD  319 (347)
T ss_pred             hhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecC
Confidence            9999988878999999889999999999999999875444 799999999999888999988777655  322   2445


Q ss_pred             CCcEEEEEEecCCCCchhHHHHHHHHhh
Q 002461          365 GSKLNFSLCKTSNSTLPPILNAIEIYIL  392 (919)
Q Consensus       365 ~~~~~itL~~t~~S~lpP~ina~ei~~~  392 (919)
                      ++.++|+|.+|++|+|||||||+|||.+
T Consensus       320 ~~~~~isL~~t~~S~lppiLNalEIy~v  347 (347)
T PF12819_consen  320 SGFLNISLGPTPDSTLPPILNALEIYKV  347 (347)
T ss_pred             CCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence            5688999999999999999999999864

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-53  Score=476.52  Aligned_cols=287  Identities=50%  Similarity=0.879  Sum_probs=254.1

Q ss_pred             CCcccCHHHHHHHHhhhc--ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEe
Q 002461          594 DNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC  671 (919)
Q Consensus       594 ~~~~~~~~ei~~~t~~~~--~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~  671 (919)
                      ..+.|++.++.++|++|.  ++||+|+||.||+|.+.+|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            467799999999999997  799999999999999999999999988765443156699999999999999999999999


Q ss_pred             ecCC-eEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEec
Q 002461          672 NDGG-NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD  750 (919)
Q Consensus       672 ~~~~-~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~D  750 (919)
                      .+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++|+||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999876543899999999999999999999999888999999999999999999999999


Q ss_pred             cCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCC--Cccchhccccccccc
Q 002461          751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY--NNTHIVNRVCPFLER  828 (919)
Q Consensus       751 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~--~~~~l~~~v~~~~~~  828 (919)
                      ||+|+..+.. ..+......||.+|+|||++..+..++|+|||||||+|+||+||+++.+...  ....+++|++..+..
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999765331 2221111189999999999999999999999999999999999999887543  345589999999999


Q ss_pred             CCcccccccccc-cCCCh-hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          829 GDVRSIVDPRLE-ANFDT-NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       829 ~~~~~ivd~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      +.+.+++|+++. +.+.. +++.++.++|.+|++.+|.+||+|.||+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            999999999997 66664 789999999999999999999999999999966544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.1e-50  Score=509.95  Aligned_cols=419  Identities=26%  Similarity=0.461  Sum_probs=308.7

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcccc
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLL  525 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~l  525 (919)
                      +.++.|+|++|+++|.+|..+++|++|+.|+|++|+|+|.+|..|.+|++|+.|+|++|+++|.+|..+.++.+|+.|++
T Consensus       499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l  578 (968)
T PLN00113        499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI  578 (968)
T ss_pred             hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence            46788899999999999999999999999999999999999999999999999999999999999998888888777765


Q ss_pred             c---------------------cCCCCCCCCC------CCccccC-CcccchhhhHHHH-HHHHHHHHHHhhhhhccccc
Q 002461          526 S---------------------IGRNPDLCLS------APCKKEK-RNSVMPVVAASVS-LLVILIALLVFWTYKRKRAA  576 (919)
Q Consensus       526 s---------------------~~~N~~LC~~------~pC~~~k-~~~vi~vvv~~v~-vlv~ll~ll~~~~~rrk~~~  576 (919)
                      +                     +.+|+.+|+.      ++|.... ......+++++++ +++++++++++++++|++..
T Consensus       579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  658 (968)
T PLN00113        579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL  658 (968)
T ss_pred             cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcc
Confidence            4                     4568889975      3564321 1111111111111 11122222222223332211


Q ss_pred             cccc-CCCCCcCCCC--ccCCCcccCHHHHHHHHhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHH
Q 002461          577 RLNV-DNSHSKKEGS--LKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTE  652 (919)
Q Consensus       577 ~~~~-~~s~~~~~~~--~~~~~~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~E  652 (919)
                      +... .......+..  .......++++++... ....++||+|+||.||+|.. .+|..||||+++....    ...+|
T Consensus       659 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~  733 (968)
T PLN00113        659 ELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSE  733 (968)
T ss_pred             cccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHH
Confidence            1110 0000000000  0011123455555433 23456899999999999997 5789999999864332    22456


Q ss_pred             HHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 002461          653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD  732 (919)
Q Consensus       653 v~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~D  732 (919)
                      ++.+++++||||++++|+|.+.+..++||||+++|+|.++++     .++|.++.+|+.|+|+||+|||+.+.++|+|||
T Consensus       734 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d  808 (968)
T PLN00113        734 IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN  808 (968)
T ss_pred             HHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence            899999999999999999999999999999999999999994     389999999999999999999987788999999


Q ss_pred             cccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccC
Q 002461          733 VKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRG  812 (919)
Q Consensus       733 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~  812 (919)
                      |||+||+++.++.+++. ||.......      .....++..|||||++.+..++.++|||||||++|||+||+.|+...
T Consensus       809 lkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        809 LSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             CCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            99999999999888876 665543211      12236789999999999999999999999999999999999998643


Q ss_pred             CC-ccchhcccccccccCCcccccccccccC--CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          813 YN-NTHIVNRVCPFLERGDVRSIVDPRLEAN--FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       813 ~~-~~~l~~~v~~~~~~~~~~~ivd~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .. .....+|++..........++|+.+...  .+.++...+.+++.+|++.+|++||+|+||+++|+++..
T Consensus       882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            32 3456666665555555667778777543  345667788999999999999999999999999987654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=394.03  Aligned_cols=255  Identities=36%  Similarity=0.533  Sum_probs=212.6

Q ss_pred             hcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--chhhhHHHHHHHhccCcceeeEEeEeecCC-eEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLVGYCNDGG-NVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~-~~~LV~Ey~~~  686 (919)
                      +.+.||+|+||+||+|.+.....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            345699999999999999765559999998654332  458999999999999999999999999887 79999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCC-eeeeccccceEEeCCCC-cEEEeccCcccccCCCCCCc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP-IIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~-iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~  764 (919)
                      |+|.++++......+++..+++++.|||+||+|||+   .+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999987556789999999999999999999994   45 99999999999999997 99999999998653211  2


Q ss_pred             cccccccCccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          765 ISTSIVGTVGYLDPEYYA--SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ..+...||+.|||||++.  ...++.|+|||||||++|||+||+.||..... .+....+.            ....+..
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~------------~~~~Rp~  266 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVV------------VGGLRPP  266 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHH------------hcCCCCC
Confidence            334478999999999999  67999999999999999999999999965433 22222221            1222233


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      .+..+...+..++..||..+|..||++.+++..|+.+...
T Consensus       267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            3444666788999999999999999999999999988753

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=381.91  Aligned_cols=256  Identities=30%  Similarity=0.488  Sum_probs=217.8

Q ss_pred             HhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ...+.+.||+|-||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34566889999999999999998889999999865 34457899999999999999999999999998899999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.++|+...+..+...+.+.++.|||+||+||+   ++++|||||.++||||+++..+||+|||||+.. .++.....
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTAS  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeec
Confidence            99999998877888999999999999999999999   779999999999999999999999999999944 44444445


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....-+..|.|||.+..++++.|+|||||||+||||+| |+.|+. +..+.+.++.+    .+|         .+-.-+.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-~msn~ev~~~l----e~G---------yRlp~P~  427 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-GMSNEEVLELL----ERG---------YRLPRPE  427 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-CCCHHHHHHHH----hcc---------CcCCCCC
Confidence            55556789999999999999999999999999999998 555543 33344433332    222         2223456


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .+...+.+++..||..+|++|||++.+...|+++..
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            677889999999999999999999999888887654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=357.36  Aligned_cols=260  Identities=29%  Similarity=0.434  Sum_probs=212.2

Q ss_pred             cccCHHHHHHHHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeec
Q 002461          596 QQFTYSEIVDITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCND  673 (919)
Q Consensus       596 ~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~  673 (919)
                      ..++.+|+...     +.||+|..|+|||+.++ +++.+|+|++.... ....+++.+|++++++.+||+||.++|.|..
T Consensus        74 ~~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   74 NGISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            34666777543     67999999999999987 57789999995443 3345789999999999999999999999999


Q ss_pred             CC-eEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccC
Q 002461          674 GG-NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG  752 (919)
Q Consensus       674 ~~-~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFG  752 (919)
                      .+ ...++||||++|+|++++...  +.+++...-+|+.++++||.|||+  .++||||||||+|||++..|++||||||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecccc
Confidence            88 599999999999999998543  669999999999999999999996  3689999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCC-ccchhcccccccccCCc
Q 002461          753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN-NTHIVNRVCPFLERGDV  831 (919)
Q Consensus       753 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~-~~~l~~~v~~~~~~~~~  831 (919)
                      .++.+.+.    .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... .....+.+.        
T Consensus       225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~--------  292 (364)
T KOG0581|consen  225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC--------  292 (364)
T ss_pred             ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH--------
Confidence            99876322    55678999999999999999999999999999999999999999875411 111111111        


Q ss_pred             ccccc---cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHHHH
Q 002461          832 RSIVD---PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKCL  880 (919)
Q Consensus       832 ~~ivd---~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~--~Le~~~  880 (919)
                       .+++   |++...   ....++..++..|++.+|.+||++.|+++  .+.+..
T Consensus       293 -~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  293 -AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             -HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence             1122   222221   24557889999999999999999999997  354443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.4e-41  Score=388.68  Aligned_cols=256  Identities=29%  Similarity=0.524  Sum_probs=217.3

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.||+|.||+||+|+..      +.+.||||.++..... ..++|++|++++..++|||||+|+|.|.+++..++|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            45688999999999999953      3456999999987665 6789999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccc------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          682 EYMAYGNLKQYLFDET------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      |||..|+|.++|+...            +.+|+..+.+.||.|||.||+||-   ++.++||||..+|+||.++..|||+
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIs  645 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKIS  645 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEec
Confidence            9999999999997433            223889999999999999999999   6789999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLER  828 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~  828 (919)
                      ||||++.....+..+....-.-..+|||||.+..+++|.++|||||||+|||+++ |+.|+.. ..+++.++.+    +.
T Consensus       646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g-lSn~EVIe~i----~~  720 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG-LSNQEVIECI----RA  720 (774)
T ss_pred             ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc-cchHHHHHHH----Hc
Confidence            9999997655555544444456789999999999999999999999999999997 7788753 3344444433    33


Q ss_pred             CCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          829 GDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       829 ~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      |++         -..++.+..++.+|+..||+.+|++||+++||-.+|+...+
T Consensus       721 g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  721 GQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             CCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            332         23466788899999999999999999999999999987654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-39  Score=366.90  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             HhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ++...+.||+|||+.||+++. ..|+.||+|++.+..   ....+...+|+++.+.|+|||||+++++|++.++.++|.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            445578999999999999997 889999999997642   2334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      +|++++|..+++  .++.+++.++..++.||+.||.|||   +++|+|||||..|++|++++++||+|||||..+..+. 
T Consensus        99 LC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   99 LCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             ecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            999999999984  6678999999999999999999999   6789999999999999999999999999999875433 


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                       ....+.+||+.|+|||++.....+..+||||+|||+|-|+.|++||....- .+..+.++    ..   +       ..
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-kety~~Ik----~~---~-------Y~  236 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KETYNKIK----LN---E-------YS  236 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HHHHHHHH----hc---C-------cc
Confidence             334578999999999999999999999999999999999999999964321 11111111    00   0       01


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ++........+|+.++++.+|.+||++++|+.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            12223345678999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=373.95  Aligned_cols=273  Identities=25%  Similarity=0.422  Sum_probs=226.2

Q ss_pred             cccCHHHHHHHHhhh-----------cceeceeCcEEEEEEEEcC----CCEEEEEEeecCCCC-CchhhhHHHHHHHhc
Q 002461          596 QQFTYSEIVDITNNF-----------HRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV  659 (919)
Q Consensus       596 ~~~~~~ei~~~t~~~-----------~~~LG~G~fG~Vyk~~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l  659 (919)
                      ..++|+|-.++..+|           .++||.|.||.||+|.++-    ...||||.+|....+ ...+|+.|+.+|.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            346666655555544           5789999999999999862    346999999977544 356899999999999


Q ss_pred             cCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEE
Q 002461          660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANIL  739 (919)
Q Consensus       660 ~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NIL  739 (919)
                      .||||++|.|........++|+|||++|+|+.+|+.+..+ +++.+...++.+||.||.||-   ..+++||||.++|||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence            9999999999999999999999999999999999876644 999999999999999999999   789999999999999


Q ss_pred             eCCCCcEEEeccCcccccCCCCCCcc-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccc
Q 002461          740 LNEKMQAKLADFGFSKIFPAESESHI-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTH  817 (919)
Q Consensus       740 ld~~~~vkL~DFGla~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~  817 (919)
                      ++.+..+||+||||++.+.++..... ...-.-..+|.|||.+..++++..+||||||||+||.++ |..|+.+..+   
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---  840 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---  840 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---
Confidence            99999999999999997754432211 112233679999999999999999999999999999886 8888864322   


Q ss_pred             hhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhHHHH
Q 002461          818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAR  886 (919)
Q Consensus       818 l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~~~  886 (919)
                                 +++.+.++...+-..+.++...|.+|++.||+.+-.+||.+.+++..|.+++.-..+-
T Consensus       841 -----------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  841 -----------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             -----------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence                       2223333444444567888999999999999999999999999999999988655443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=347.54  Aligned_cols=193  Identities=31%  Similarity=0.535  Sum_probs=172.9

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .+.||+|+||+||+|+++ ++.+||||.+.+.  .....+....|+.+|+.++|||||.+++++..++..+||||||.+|
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG   94 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence            456999999999999975 5889999999765  3334556788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC------CcEEEeccCcccccCCCC
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK------MQAKLADFGFSKIFPAES  761 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~------~~vkL~DFGla~~~~~~~  761 (919)
                      +|.++|+.  .+.++......++.|+|.||++||   +.+||||||||+||||+..      -.+||+|||+|+.+.   
T Consensus        95 DLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---  166 (429)
T KOG0595|consen   95 DLSDYIRR--RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---  166 (429)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC---
Confidence            99999954  457999999999999999999999   6799999999999999864      468999999999874   


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                      ........+|++-|||||++...+|+.|+|+||.|+++||+++|++||..
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            23345678999999999999999999999999999999999999999974

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-39  Score=346.82  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=202.1

Q ss_pred             HhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCC-------CchhhhHHHHHHHhccCcceeeEEeEeecCCeEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ-------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~-------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~  678 (919)
                      .+-..+.||+|+||.|-+|.- .+|+.||||++++....       .....++|+++|++++|||||++.+++...+..|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            344578999999999999985 57999999999765221       1223469999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC---CcEEEeccCccc
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSK  755 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~---~~vkL~DFGla~  755 (919)
                      +|+||+++|.|.+.+-.  .+.+.......+++|++.|+.|||   +++|+||||||+|||+..+   ..+||+|||+|+
T Consensus       253 mVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999844  455777888999999999999999   7799999999999999765   789999999999


Q ss_pred             ccCCCCCCccccccccCccccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcc
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYASNRL---TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ...   ........+||+.|.|||++.++..   ..+.|+||+|||||-+++|.+||........+.+.+    ..|...
T Consensus       328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~~G~y~  400 (475)
T KOG0615|consen  328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----LKGRYA  400 (475)
T ss_pred             ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----hcCccc
Confidence            763   4456778999999999999986543   347899999999999999999997655444333332    122210


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                        +-|    ..-.+..++.++++.+++..+|++||++.|+++
T Consensus       401 --f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  401 --FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence              000    011233456889999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=334.15  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             hhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEe-EeecCCe-EEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVG-YCNDGGN-VGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g-~~~~~~~-~~LV~E  682 (919)
                      +.+.++||+|.||+|||+. +.+|..||.|.++-..  ....++...|+.+|++|+|||||++++ .+.++.+ ..+|||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            4556889999999999998 5689999999987432  233456889999999999999999998 4555555 889999


Q ss_pred             eccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCC--eeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          683 YMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPP--IIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       683 y~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~--iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      ++..|+|...++.-  .++.++....++++.|+++||.++|... ++  |+||||||.||+|+.+|.|||+||||++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999998643  3567999999999999999999999632 34  9999999999999999999999999999874


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                        .........+||+.||+||.+....|+.|+||||+||++|||..-++||... +-..    .++.+..++...+-|  
T Consensus       180 --s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~----L~~KI~qgd~~~~p~--  250 (375)
T KOG0591|consen  180 --SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLS----LCKKIEQGDYPPLPD--  250 (375)
T ss_pred             --chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHH----HHHHHHcCCCCCCcH--
Confidence              3344566789999999999999999999999999999999999999999632 2222    233344444322222  


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                            .--...+.+|+..|+..+|+.||+...+++.+..
T Consensus       251 ------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  251 ------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                  2223468899999999999999996665555443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=352.91  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=207.7

Q ss_pred             hcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.||+|+||+||+|.+.  ..||||+++.....  ..+.|++|+..+++-+|.||+-+.|||..... .+|+.+|++.
T Consensus       396 l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs  472 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS  472 (678)
T ss_pred             ccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence            4688999999999999985  47999999866443  45789999999999999999999999998877 9999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|+.+||..+ ..+...+.+.||.|||+||.|||   .++|||||||..||+|.+++.|||+||||+..-..-.......
T Consensus       473 SLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~  548 (678)
T KOG0193|consen  473 SLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE  548 (678)
T ss_pred             hhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence            9999998655 56999999999999999999999   7799999999999999999999999999997543222222333


Q ss_pred             ccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          768 SIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ...|...|||||++.   ..+|++.+||||||+|+|||++|..||.  .+..+..-|+   +.+|-+.  .|..   ...
T Consensus       549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifm---VGrG~l~--pd~s---~~~  618 (678)
T KOG0193|consen  549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFM---VGRGYLM--PDLS---KIR  618 (678)
T ss_pred             CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEE---ecccccC--ccch---hhh
Confidence            456888999999985   3579999999999999999999999996  3333333332   2333211  1111   112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ..+...+.+|...||..++++||.+.+|+..|++++.
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            3456678899999999999999999999999988765

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-37  Score=348.33  Aligned_cols=258  Identities=28%  Similarity=0.465  Sum_probs=200.9

Q ss_pred             hhhcceeceeCcEEEEEEEE------cCCCEEEEEEeecCCCC-CchhhhHHHHHHHhc-cCcceeeEEeEeecC-CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDG-GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~-~~~~  678 (919)
                      +.+.++||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|+.++.++ +||||++++++|... ...+
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM   88 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence            45678999999999999974      23567999999754322 235688999999999 899999999998764 4588


Q ss_pred             EEEEeccCCChhhhhhccc------------------------------------------------------------c
Q 002461          679 LVYEYMAYGNLKQYLFDET------------------------------------------------------------K  698 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~------------------------------------------------------------~  698 (919)
                      +||||+++|+|.+++....                                                            .
T Consensus        89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (338)
T cd05102          89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK  168 (338)
T ss_pred             EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence            9999999999999986432                                                            1


Q ss_pred             ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCc
Q 002461          699 EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP  778 (919)
Q Consensus       699 ~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~AP  778 (919)
                      ..+++.+++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            34788899999999999999999   669999999999999999999999999999865332222222234567889999


Q ss_pred             ccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHh
Q 002461          779 EYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAME  857 (919)
Q Consensus       779 E~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~  857 (919)
                      |++.+..++.++|||||||++|||++ |..||............    +..+...         ..+......+.+++.+
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~l~~li~~  312 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----LKDGTRM---------RAPENATPEIYRIMLA  312 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HhcCCCC---------CCCCCCCHHHHHHHHH
Confidence            99998899999999999999999997 99988543222111111    1111100         0112233468899999


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          858 CVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       858 Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      |++.+|++||++.|+++.|++++.
T Consensus       313 cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         313 CWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=373.62  Aligned_cols=258  Identities=33%  Similarity=0.517  Sum_probs=211.9

Q ss_pred             hhhcceeceeCcEEEEEEEEcC--CC----EEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD--GS----EVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~--g~----~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      -.+.+.||+|.||.||+|...+  |.    .||||.+++.. .+...+|.+|..+|++++|||||+++|.|.+....+++
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            3456789999999999999653  33    38999997654 45567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccc-----cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          681 YEYMAYGNLKQYLFDET-----KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~-----~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      +|||++|+|..+|++.+     ...++..+.+.++.|||+|+.||+   ++++|||||..+|+||++...|||+|||+|+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            99999999999998763     456899999999999999999999   6789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccc
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSI  834 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~i  834 (919)
                      .+.............-..+|||||.+..+.++.|+|||||||+|||++| |..||..- ++.++...   +.+.|     
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-~n~~v~~~---~~~gg-----  921 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-SNFEVLLD---VLEGG-----  921 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-chHHHHHH---HHhCC-----
Confidence            6544433333323344679999999999999999999999999999998 66776533 22222221   12222     


Q ss_pred             cccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       835 vd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                         +|  +.+..+..++.+++..||+.+|++||++..+++++..+.+.
T Consensus       922 ---RL--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 ---RL--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ---cc--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence               22  23556777899999999999999999999999998888753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=336.63  Aligned_cols=267  Identities=26%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             hcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHh--ccCcceeeEEeEeecCC----eEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMR--VHHRNLASLVGYCNDGG----NVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~--l~H~NIv~l~g~~~~~~----~~~LV~Ey  683 (919)
                      +.+++|+|+||.||||.+. ++.||||++..   +..+.|++|-+++..  ++|+||++++++-....    +++||+||
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3477999999999999996 59999999964   344678888888775  58999999999876655    89999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhc------CCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG------CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~------~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      .+.|+|.++|..   ..++|....+|+..+++||+|||+.      ++++|+|||||++||||.+|+++.|+|||||..+
T Consensus       290 h~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999999954   5699999999999999999999954      4778999999999999999999999999999988


Q ss_pred             CCCCCCccccccccCccccCcccccCCC-CC-----chhhHHHHHHHHHHHHhCCCCcccCCC-c-c-chhccccccccc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYASNR-LT-----EKSDVYSFGIVLLELITGLPAIIRGYN-N-T-HIVNRVCPFLER  828 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-----~ksDVwSfGvvL~ELltG~~p~~~~~~-~-~-~l~~~v~~~~~~  828 (919)
                      ............+||.+|||||++.+.- +.     .+.||||+|.|||||+++...++.+.. . + -+.+.+.....-
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            6555555555689999999999997642 22     368999999999999998665532111 0 0 011111111111


Q ss_pred             CCccc-ccccccccCC-----ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          829 GDVRS-IVDPRLEANF-----DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       829 ~~~~~-ivd~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      +++.+ ++.++.+..+     ....+..+.+.+..||..||+.|-|+.=|-+++.++....
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            11211 1222222222     1245667899999999999999999999999988776543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=325.41  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=212.0

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhc--cCcceeeEEeEeecC----CeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYCNDG----GNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l--~H~NIv~l~g~~~~~----~~~~LV~E  682 (919)
                      .+.+.||+|.||.||+|.++ |+.||||+|..   .+++.+.+|.++++.+  +|+||+.+++.-..+    .+++||++
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            45689999999999999996 88999999963   3356778888888865  999999999987554    36899999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHh-----cCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH-----GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~-----~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      |.++|||.|+|..   ..++....++++..+|.||+|||.     +.++.|.|||||+.|||+..++...|+|+|||...
T Consensus       290 YHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             cccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            9999999999943   568999999999999999999993     45889999999999999999999999999999877


Q ss_pred             CCCCCC--ccccccccCccccCcccccCCC----C--CchhhHHHHHHHHHHHHhC----------CCCcccCCCccchh
Q 002461          758 PAESES--HISTSIVGTVGYLDPEYYASNR----L--TEKSDVYSFGIVLLELITG----------LPAIIRGYNNTHIV  819 (919)
Q Consensus       758 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~----~--s~ksDVwSfGvvL~ELltG----------~~p~~~~~~~~~l~  819 (919)
                      ......  ......+||.+|||||++...-    +  -..+||||||+|+||+...          +.||..-.+.....
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            544221  2234678999999999986432    1  1358999999999999864          56776555555555


Q ss_pred             cccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       820 ~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      +.+++.+...++...++.+.   .+.+.+..+.+++..||..+|.-|-|+--+.+.|.++.+
T Consensus       447 eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            55666555555544444443   246778889999999999999999999999998887764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.4e-37  Score=329.93  Aligned_cols=250  Identities=34%  Similarity=0.553  Sum_probs=195.5

Q ss_pred             hcceeceeCcEEEEEEEEc-----CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLA-----DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+.||.|.||.||+|.+.     .+..|+||+++..... ..+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999987     3567999999654332 357899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.++|.......+++.++.+|+.|+++||+|||   +.+++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999997765677999999999999999999999   558999999999999999999999999999876322222


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......+...|+|||.+....++.++||||||+++|||++ |+.|+... +..++.+.+.    .+..         ..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~----~~~~---------~~  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLK----QGQR---------LP  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHH----TTEE---------TT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc----cccc---------ce
Confidence            33334557789999999998889999999999999999999 66776433 3333222221    1110         11


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      .+......+.+++.+||+.+|++||+|.++++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1222344688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-36  Score=329.48  Aligned_cols=246  Identities=21%  Similarity=0.336  Sum_probs=198.8

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC---chhhhHHHHHHHhccCcceeeEEeEeec----CCeEEEEEEec
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCND----GGNVGLVYEYM  684 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~---~~~f~~Ev~~L~~l~H~NIv~l~g~~~~----~~~~~LV~Ey~  684 (919)
                      ..||+|++|.||+|.+ +|+.||||+++......   .+.|.+|+.+|++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 68899999997654333   3667899999999999999999999876    35689999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++..  .+.+++...++++.+++.||.|||+.  .+++||||||+|||+++++.+||+|||+++.+....   
T Consensus       105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            99999999954  35689999999999999999999942  367899999999999999999999999998653211   


Q ss_pred             cccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          765 ISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                        ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.... ..++...+..   .+         ....
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~---~~---------~~~~  242 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIIN---KN---------NSLK  242 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHh---cC---------CCCC
Confidence              23467899999999976  689999999999999999999999996432 2222222110   00         0011


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .+......+.+++.+||+.+|++||+++|+++.|+...
T Consensus       243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            12233456889999999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=338.49  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=208.9

Q ss_pred             CCcccCHHHHHHHHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeec
Q 002461          594 DNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND  673 (919)
Q Consensus       594 ~~~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~  673 (919)
                      +.-++.+++|.+.     +-||.|+-|.||.|+++ ++.||||+++...       ..+++.|++|+|+||+.+.|+|..
T Consensus       117 e~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  117 ELWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            3456777777654     55999999999999996 6889999986322       357899999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       674 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ...+|+|||||+.|-|..+|+  .+..++....+.+..+||.||.|||   .+.|||||||+-||||..+-.+||+|||-
T Consensus       184 sPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccc
Confidence            999999999999999999994  4567888899999999999999999   66899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~  833 (919)
                      ++.....   ......+||..|||||++...+.++|+||||||||||||+||.-|+..-    +....++-   -|    
T Consensus       259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV----dssAIIwG---VG----  324 (904)
T KOG4721|consen  259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV----DSSAIIWG---VG----  324 (904)
T ss_pred             hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc----chheeEEe---cc----
Confidence            8865322   3344678999999999999999999999999999999999999998531    11111211   11    


Q ss_pred             ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       834 ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                        ...|.-..+..+...+.-|+.+||+..|.+||++++++..|+-.
T Consensus       325 --sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 --SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             --CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence              12233334566677788899999999999999999999998754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=338.13  Aligned_cols=261  Identities=26%  Similarity=0.326  Sum_probs=212.1

Q ss_pred             HHhhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCC-chhhhHHHHHHHhcc-CcceeeEEeEeecCC-eEEEEE
Q 002461          606 ITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVH-HRNLASLVGYCNDGG-NVGLVY  681 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~-~~~LV~  681 (919)
                      ..|...+.||.|.||.||+|+ ...|..||||+++..-... ...=++|+..|++++ ||||+++.+.+.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            345667899999999999999 4578999999998653332 223467999999998 999999999998877 999999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      |||+. +|++++++. +..++...+..|+.||++||+|+|   ++|+.|||+||+|||+.....+||+||||||...   
T Consensus        90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~---  161 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR---  161 (538)
T ss_pred             Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc---
Confidence            99986 999999776 778999999999999999999999   7799999999999999988899999999999763   


Q ss_pred             CCccccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc---
Q 002461          762 ESHISTSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP---  837 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~---  837 (919)
                      .....+.++.|..|+|||++. .+-|+.+.|||++|||++|+.+-++-| .|.++.+..-.+++.+.......+...   
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-PGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-CCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            233456788999999999864 677999999999999999999976544 566666777777777765443333221   


Q ss_pred             --ccccC-----------CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          838 --RLEAN-----------FDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       838 --~l~~~-----------~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        .+.-.           .-........+++.+|+++||.+|||+++.++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence              11100           111245678899999999999999999999884

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=331.65  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=201.1

Q ss_pred             hhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCC--eEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~--~~~LV~Ey~~  685 (919)
                      ...+.||+|+||+||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|......  .+.+.|||++
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence            345889999999999999754 8999999987654333567899999999999999999999855444  6899999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCcccccCC-CCCC
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSKIFPA-ESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~~~~~-~~~~  763 (919)
                      +|+|.+++..... .++.....+++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+++.... ....
T Consensus       100 ~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen  100 GGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             CCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999999976655 7999999999999999999999   779999999999999999 79999999999987643 1112


Q ss_pred             ccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......||+.|||||++..+ ....++|||||||++.||+||++||..-   ....+++.....+....         .
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~P---------~  243 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSLP---------E  243 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCCC---------C
Confidence            223457899999999999854 3335999999999999999999998642   12222222222222111         2


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+........+++.+|+..+|++|||+.++++..-
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            22333446778999999999999999999998643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=336.58  Aligned_cols=247  Identities=27%  Similarity=0.390  Sum_probs=205.3

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecC---CCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .|.++||+|+|++|++|+. ..++++|||++.+.   .....+....|-++|.+| .||.|++|+..|+++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            4678999999999999995 46899999998754   223345567799999999 899999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.++|++.  +.++......++.+|+.||+|||   +.+||||||||+|||||.||++||.|||-|+.+.+....
T Consensus       156 A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  156 APNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             cCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            9999999999544  66899999999999999999999   779999999999999999999999999999988543221


Q ss_pred             ---------cc--ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcc
Q 002461          764 ---------HI--STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       764 ---------~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                               ..  ....+||..|.+||++..+..+..+|+|+|||+||+|+.|++||.... +..+.+.+.         
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-eyliFqkI~---------  300 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-EYLIFQKIQ---------  300 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-HHHHHHHHH---------
Confidence                     11  145889999999999999999999999999999999999999996443 222222221         


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                           .+.-.++..-.+.+.+|+.+.+..+|.+|++.+++.+.
T Consensus       301 -----~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  301 -----ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                 11223344444678899999999999999999888773

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.4e-36  Score=332.52  Aligned_cols=260  Identities=26%  Similarity=0.408  Sum_probs=199.5

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-----------------CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-----------------GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVG  669 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-----------------g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g  669 (919)
                      +.+.+.||+|+||.||++.+++                 +..||+|.++..... ...+|.+|++++.+++||||+++++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            4457889999999999998543                 336999998754322 2457899999999999999999999


Q ss_pred             EeecCCeEEEEEEeccCCChhhhhhccc-----------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 002461          670 YCNDGGNVGLVYEYMAYGNLKQYLFDET-----------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD  732 (919)
Q Consensus       670 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~-----------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~D  732 (919)
                      ++...+..++||||+++|+|.+++....                 ...++|.+.++++.|++.||+|||   +.+|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~d  163 (304)
T cd05096          87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRD  163 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence            9999999999999999999999885422                 134788999999999999999999   66899999


Q ss_pred             cccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC--CCCcc
Q 002461          733 VKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG--LPAII  810 (919)
Q Consensus       733 LKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG--~~p~~  810 (919)
                      |||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++  ..|+.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            9999999999999999999999865333222223344567899999999888999999999999999999974  45554


Q ss_pred             cCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          811 RGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       811 ~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .. ......+.+......... ..     ....+......+.+++.+|++.+|++||+|.+|.+.|+
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         244 EL-TDEQVIENAGEFFRDQGR-QV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cC-CHHHHHHHHHHHhhhccc-cc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            32 222222222221111100 00     00111233457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-36  Score=342.84  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=201.0

Q ss_pred             hhhcceeceeCcEEEEEEEE------cCCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYL------ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~L  679 (919)
                      ..+.+.||+|+||.||+|+.      .++..||||+++.... ...+.+.+|+.++..+ +||||++++++|...+..++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l  116 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV  116 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence            45678999999999999974      2456899999975432 2345688999999999 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhccc--------------------------------------------------------------
Q 002461          680 VYEYMAYGNLKQYLFDET--------------------------------------------------------------  697 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~--------------------------------------------------------------  697 (919)
                      ||||+++|+|.++++...                                                              
T Consensus       117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (375)
T cd05104         117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID  196 (375)
T ss_pred             eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence            999999999999986422                                                              


Q ss_pred             -----------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          698 -----------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       698 -----------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                                 ...++|..+++++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++...........
T Consensus       197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                       124788999999999999999999   669999999999999999999999999999865433222222


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||..........+.+    ..+.         ....+.
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~----~~~~---------~~~~~~  340 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI----KEGY---------RMLSPE  340 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----HhCc---------cCCCCC
Confidence            23345678999999999999999999999999999998 788875432222222221    1111         000111


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      .....+.+++.+|++.+|++||+|.||++.|++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=325.22  Aligned_cols=238  Identities=24%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.++||+|+||+||.++.+ +++.+|+|++++..   ....+...+|..+|.+++||.||++...|++.+.++||+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            4689999999999999965 58889999998653   2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      ||.|..+|.  +...++...+.-++.+|+.||.|||   +++|+||||||+|||||++|.++|+||||++....  ....
T Consensus       109 GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~~~  181 (357)
T KOG0598|consen  109 GGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DGDA  181 (357)
T ss_pred             CccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CCCc
Confidence            999999994  4456888989999999999999999   78999999999999999999999999999985422  2234


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....+||+.|||||++.+..++..+|.||+|+++|||++|.+||.... .....+.+    ..+++       .  ..+.
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-~~~~~~~I----~~~k~-------~--~~p~  247 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-VKKMYDKI----LKGKL-------P--LPPG  247 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-HHHHHHHH----hcCcC-------C--CCCc
Confidence            456899999999999999999999999999999999999999996432 11111111    11110       0  0111


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCC
Q 002461          846 NSVWKVAETAMECVPSISFQRPT  868 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPs  868 (919)
                      --.....+++...+..+|++|-.
T Consensus       248 ~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  248 YLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             cCCHHHHHHHHHHhccCHHHhcC
Confidence            11234677888999999999963

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=325.37  Aligned_cols=265  Identities=25%  Similarity=0.305  Sum_probs=210.6

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCC-chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      |++.+.||.|..++||+|.. ..+..||||++.-..... .+.+++|+..++.++||||++++..|..+..+|+||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            45678999999999999994 567999999998665443 4789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-c
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-H  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-~  764 (919)
                      +|++.+.++..-...+++..+..|.+++++||.|||   .++.||||||+.||||+++|.|||+|||..-.+...... .
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            999999998777788999999999999999999999   679999999999999999999999999987655433221 1


Q ss_pred             cc-cccccCccccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          765 IS-TSIVGTVGYLDPEYYA--SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       765 ~~-~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      .. ....||+.|||||++.  ...|+.|+||||||+..+||.+|..||..-.....+...+..-.-.-. ....|..-..
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~~~d~~k  263 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGLDKDEDK  263 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccCChHHhh
Confidence            12 5678999999999953  346999999999999999999999999765443333333221110000 0111111111


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKCL  880 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~--~Le~~~  880 (919)
                      .+    ...+.+++..|+..||.+|||++++++  .++.++
T Consensus       264 ~~----~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  264 KF----SKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hh----cHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            11    236889999999999999999999986  455544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=338.92  Aligned_cols=243  Identities=26%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      ++||+|+.|.||.|.- .+++.||||++........+-+.+|+.+|+..+|+|||.+++.+..+++.+.|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            5799999999999984 578899999998776666677899999999999999999999999899999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +.+..   ..+++.++..|+.++++||+|||   .++|+|||||.+|||++.++.+||+|||++..+..+.  ......+
T Consensus       359 DvVt~---~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmV  430 (550)
T KOG0578|consen  359 DVVTK---TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMV  430 (550)
T ss_pred             hhhhc---ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Ccccccc
Confidence            99843   34899999999999999999999   7799999999999999999999999999998774332  2456789


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK  850 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~  850 (919)
                      ||+.|||||+.....|.+|.||||||++++||+.|++||.....    .+.+.-.-.+|.      |.++  ..+.....
T Consensus       431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa~ng~------P~lk--~~~klS~~  498 (550)
T KOG0578|consen  431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNGT------PKLK--NPEKLSPE  498 (550)
T ss_pred             CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHhhcCC------CCcC--CccccCHH
Confidence            99999999999999999999999999999999999999974221    111111111111      1221  22333446


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          851 VAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       851 l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.++..+|+..|+++||+++|+++
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhc
Confidence            888999999999999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-37  Score=345.68  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             cceeceeCcEEEEEEEEcC--C--CE-EEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLAD--G--SE-VAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~--g--~~-VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .++||+|+||.||+|.+..  +  .. ||||..+..   .....++|.+|.+++++++|||||+++|++..+..+++|||
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE  241 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME  241 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence            4889999999999999753  2  23 899998853   23445789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      +|.||+|.++|..... .++..++++++.++|.||+|||   +++++||||.++|+|++.++.+||+||||++.-.   .
T Consensus       242 l~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~  314 (474)
T KOG0194|consen  242 LCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---Q  314 (474)
T ss_pred             ecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc---c
Confidence            9999999999965443 6999999999999999999999   7799999999999999999999999999987431   1


Q ss_pred             Ccccc-ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          763 SHIST-SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       763 ~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      ..... ...-+.+|+|||.+....++.++|||||||++||+++ |..|+.. ....+...++.   .         ...+
T Consensus       315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~---~---------~~~r  381 (474)
T KOG0194|consen  315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIV---K---------NGYR  381 (474)
T ss_pred             eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHH---h---------cCcc
Confidence            11111 2235689999999999999999999999999999998 7777743 33333333331   1         1111


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMET  884 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~  884 (919)
                      -..+......+..+..+|+..+|++||+|.++.+.|+.+.....
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            22233455677888889999999999999999999998876554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=315.24  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=197.8

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      -++|+|+||.|||++.+ +|+.||||++......  ..+-.++|+++|++++|+|+|.+++.|.....++||+||++..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            46899999999999976 5999999999765332  23456889999999999999999999999999999999999854


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+ |. .....++.....+++.|+++|+.|+|   +.+++||||||+|||++.++.+||||||+|+.+...  ....+.
T Consensus        88 L~e-Le-~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTD  160 (396)
T KOG0593|consen   88 LHE-LE-RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTD  160 (396)
T ss_pred             HHH-HH-hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhh
Confidence            444 32 23456888999999999999999999   779999999999999999999999999999988543  233467


Q ss_pred             cccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc------------CC-----
Q 002461          769 IVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER------------GD-----  830 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~------------~~-----  830 (919)
                      ++.|..|+|||.+.+ .+|...+||||.||++.||++|.+-|. +..+.+..-.++..+..            +-     
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P-G~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP-GRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC-CcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            789999999999987 689999999999999999999987654 33333333222222111            11     


Q ss_pred             cccccccc-cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRSIVDPR-LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~ivd~~-l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.+.-++. ++..++. ...-+++++..|+..||.+|++-++++.
T Consensus       240 lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111111 1122221 2235789999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-36  Score=330.85  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             ceeceeCcEEEEEEE-EcCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~~~  686 (919)
                      ++||+|.||.||||+ +.+|+.||+|+++...  .....-..+|+.+|++|+||||++|.+...+.  ..+|||+|||++
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh  202 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH  202 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence            679999999999999 5689999999998654  33345567899999999999999999998776  789999999997


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|.-++.. ..-.++..++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+++...... ..
T Consensus       203 -DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~  276 (560)
T KOG0600|consen  203 -DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PY  276 (560)
T ss_pred             -hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc-cc
Confidence             78777743 2446999999999999999999999   779999999999999999999999999999988544332 35


Q ss_pred             cccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC---cc-------ccc
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---VR-------SIV  835 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~---~~-------~iv  835 (919)
                      +..+-|..|+|||++.+ ..|+...|+||.||||.||++|++.+. +..+.+..+.+.++.....   +.       ..+
T Consensus       277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~  355 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF  355 (560)
T ss_pred             ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-CccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence            66778999999999876 479999999999999999999988764 4444444444443322211   11       111


Q ss_pred             cc------ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          836 DP------RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       836 d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+      .+.+.+ ..-....++|+..+|..+|.+|.|+.++++
T Consensus       356 kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  356 KPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11      111110 111234678899999999999999999986

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.2e-36  Score=340.94  Aligned_cols=258  Identities=29%  Similarity=0.455  Sum_probs=201.3

Q ss_pred             HhhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~  678 (919)
                      .+.+.+.||+|+||.||+|...      ++..||+|+++..... ....+.+|+++++.+ +|+||++++++|...+..+
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            3456789999999999998842      3457999999754322 235688999999999 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccc-------------------------------------------------------------
Q 002461          679 LVYEYMAYGNLKQYLFDET-------------------------------------------------------------  697 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~-------------------------------------------------------------  697 (919)
                      +||||+++|+|.++++...                                                             
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            9999999999999885421                                                             


Q ss_pred             -------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          698 -------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       698 -------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                             ...+++.+.++++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...............
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                   124788899999999999999999   6699999999999999999999999999998653322222222334


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      ++..|||||++.+..++.++|||||||++|||++ |+.||............+    ..+         .....+.....
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~---------~~~~~~~~~~~  342 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRG---------YQMSRPDFAPP  342 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----Hcc---------cCccCCCCCCH
Confidence            5678999999998899999999999999999997 999986432221111111    111         00011111234


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .+.+++.+|++.+|++||++.+|++.|++++
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            6889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1e-35  Score=322.37  Aligned_cols=255  Identities=26%  Similarity=0.370  Sum_probs=201.3

Q ss_pred             HHhhhcceeceeCcEEEEEEEEc----CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~----~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      ....+.+.||+|+||.||+|.+.    .+..||+|+++..... ....|.+|+..+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34566789999999999999863    3568999998765332 235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999998643 346899999999999999999999   668999999999999999999999999987643211


Q ss_pred             CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      . ........++..|+|||.+.+..++.++|||||||++||+++ |+.||.... .....+.+    ..+.         
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-~~~~~~~~----~~~~---------  225 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS-GQDVIKAV----EDGF---------  225 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHH----HCCC---------
Confidence            1 111112345678999999999999999999999999999875 999985332 11222221    1110         


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ....+......+.+++.+||+.+|.+||++.++.+.|+++
T Consensus       226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0011223345688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=319.00  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=204.9

Q ss_pred             HHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ....+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            3455678999999999999998888899999987543 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.......+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~  160 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EA  160 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cc
Confidence            999999996655557899999999999999999999   66899999999999999999999999999987642211 11


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......+..|+|||++.+..++.++||||||++++||++ |+.||.... .......+..    .         .....+
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~----~---------~~~~~~  226 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQVDQ----G---------YRMPCP  226 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHc----C---------CCCCCC
Confidence            111223467999999998899999999999999999999 888875322 2222211111    0         000111


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ......+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            22345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=334.18  Aligned_cols=270  Identities=23%  Similarity=0.376  Sum_probs=224.2

Q ss_pred             HHHHHHHHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCc-hhhhHHHHHHHhccCcceeeEEeEeecCCeEE
Q 002461          600 YSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       600 ~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~-~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~  678 (919)
                      ..|+.+-.-.|.++||+|-||.|..+....+..||||+++....... ++|.+|+++|.+++||||+.++|.|..++.++
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            34444444567899999999999999999889999999987755544 88999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +|+|||++|+|.+++..+..+.+.-...++|+.|||.||+||.   +.+++||||.++|+|+|.++++||+|||+++-+.
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999997776555666778899999999999999   6799999999999999999999999999999765


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCcccCCCccchhcccccccccCCcccccc
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd  836 (919)
                      .....+.....+-+.+|||||.+..++++.++|||+||+.+||+++  ...|+.+.. +.+.++....+...+...... 
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~~~~~~~~l-  766 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFRDQGRQVVL-  766 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcCCCCcceec-
Confidence            5555566666677899999999999999999999999999999875  567775433 344555555554433322111 


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                           .-+.-+...+.++++.||..+-++||+++++...|.+.
T Consensus       767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 12344566889999999999999999999999988653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-35  Score=323.46  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ...+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+.++++++|+|++++.+++.+.+..++|+||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            3457899999999999996 478999999986542   222346788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.......   
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---
Confidence            9999998886555557899999999999999999999   6799999999999999999999999999998653221   


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+.......          ...++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~----------~~~~~  225 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKED----------QEEYS  225 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhcc----------cccCC
Confidence            12345789999999999999999999999999999999999999964332111 01111111110          01112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                      ......+.+++.+|++.+|.+||+     ++++++
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            222346788999999999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-35  Score=303.46  Aligned_cols=258  Identities=24%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .-.++||+|.||.||+|+. ++|+.||||+++.....  ......+|++.|+.++|+||+.+++.|...+...||+|||+
T Consensus         5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~   84 (318)
T KOG0659|consen    5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP   84 (318)
T ss_pred             hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence            3357899999999999995 57999999999865332  23457889999999999999999999999999999999998


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      . +|...++++ ...++..+...++.++++|++|||   .+.|+||||||.|+|++++|.+||+|||+|+.+...+... 
T Consensus        85 t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-  158 (318)
T KOG0659|consen   85 T-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-  158 (318)
T ss_pred             c-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence            5 899988654 456899999999999999999999   6789999999999999999999999999999886544332 


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccc--------
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD--------  836 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd--------  836 (919)
                       +..+-|..|+|||.+.+ ..|+...||||.|||+.||+-|. |+..+..+.+....+...+......+|-+        
T Consensus       159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence             23377899999998876 56999999999999999999986 45556655555555554444322221111        


Q ss_pred             -------cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          837 -------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       837 -------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                             +.+..-++ .+....+++...++..+|.+|++++|++++
T Consensus       237 ~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                   11111122 233456999999999999999999999874

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-35  Score=318.11  Aligned_cols=251  Identities=26%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|+
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             EEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            4568899999999999998888999999986432 235688999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++.......+++.+++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++...... ......
T Consensus        88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~  163 (261)
T cd05072          88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREG  163 (261)
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-eeccCC
Confidence            999997665667899999999999999999999   5689999999999999999999999999998653221 111223


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..++..|+|||++....++.++||||||+++|||++ |+.||.... .......+..    +.     .    .......
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~----~~-----~----~~~~~~~  229 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSALQR----GY-----R----MPRMENC  229 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHHHHc----CC-----C----CCCCCCC
Confidence            346778999999988889999999999999999998 888885322 2222222211    10     0    0011122


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ...+.+++.+|+..+|++||+++++.+.|++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            3468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-35  Score=321.99  Aligned_cols=253  Identities=30%  Similarity=0.545  Sum_probs=202.5

Q ss_pred             hhcceeceeCcEEEEEEEEcCC------CEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLADG------SEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g------~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.||+|+||.||+|.....      ..||+|.++..... ....|.+|++++++++||||+++++++......+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            4568899999999999986432      57999998754322 2356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcccc--------------ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEE
Q 002461          682 EYMAYGNLKQYLFDETK--------------EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK  747 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~--------------~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vk  747 (919)
                      ||+++|+|.+++.....              ..+++.+.+.++.|++.||+|||   ..+++|+||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence            99999999999865321              56889999999999999999999   66899999999999999999999


Q ss_pred             EeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccc
Q 002461          748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFL  826 (919)
Q Consensus       748 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~  826 (919)
                      |+|||+++...............++..|+|||.+....++.++|||||||++|||++ |..||.... ..++.+.+    
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-~~~~~~~i----  239 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-NQEVIEMI----  239 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHH----
Confidence            999999986533322223334457889999999988899999999999999999998 998885322 22222221    


Q ss_pred             ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       827 ~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ..+..         ...+......+.+++.+||+.+|.+||+++||+++|+.
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111         11122344578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=334.33  Aligned_cols=261  Identities=27%  Similarity=0.450  Sum_probs=217.7

Q ss_pred             HHHHHHhhhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          602 EIVDITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       602 ei~~~t~~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      |+.+......++||-|-||.||.|.|+. .-.||||.++... ...++|++|..+|+.++|||+|+|+|+|..+..+|+|
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            3333333457899999999999999875 4569999997543 4468999999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      +|||.+|+|.++|++-.++.++-...+.++.||+.||+||.   ++++|||||..+|+|+.++..+||+||||++++..+
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999999999998888888888889999999999999999   789999999999999999999999999999998544


Q ss_pred             CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ... ......-...|.|||.+....++.|+|||+|||+||||.| |..|+. +.+-.+    +         .+++....
T Consensus       419 TYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-GidlSq----V---------Y~LLEkgy  483 (1157)
T KOG4278|consen  419 TYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQ----V---------YGLLEKGY  483 (1157)
T ss_pred             cee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-CccHHH----H---------HHHHhccc
Confidence            332 1222334678999999999999999999999999999998 666653 222111    1         12223333


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      +-+-++.|..++.+|+.+||+++|.+||++.|+-+.+|.+..
T Consensus       484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            334567788899999999999999999999999999998875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.8e-35  Score=316.94  Aligned_cols=252  Identities=28%  Similarity=0.467  Sum_probs=208.3

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.+.||.|+||.||+|...+++.+|+|+++........++..|+.+++.++|+||+++++++......++||||+++|
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            45568899999999999999889999999998766555678999999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++.......  ....
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~  162 (261)
T cd05148          88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSS  162 (261)
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--cccc
Confidence            9999997766667999999999999999999999   5689999999999999999999999999997653221  1122


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||.+....++.++||||||+++++|++ |+.||.... .......+..             ......+..
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~-------------~~~~~~~~~  228 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITA-------------GYRMPCPAK  228 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHh-------------CCcCCCCCC
Confidence            3446778999999988899999999999999999998 788885322 2222222110             011111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|++.+|.+||+++++++.|+.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            34568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.8e-35  Score=316.96  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=203.3

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ..+.+.||+|+||.||+|... .++.||+|.++.. ....+++.+|+++++.++|+||+++++++..++..+++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            345688999999999999975 5888999998743 23356789999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++.......+++..++.++.|+++||+|||   ..+++||||||+||++++++.+||+|||++........ ...
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~  162 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAH  162 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ecc
Confidence            99999997655567899999999999999999999   66899999999999999999999999999986532211 111


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..|+... +..+..+.+.    .+         .....+.
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~----~~---------~~~~~~~  228 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE----KG---------YRMERPE  228 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH----CC---------CCCCCCC
Confidence            12234668999999998999999999999999999998 88887432 2222111111    10         1111222


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      .....+.+++.+|++.+|++||++.++++.|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            3345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.6e-35  Score=319.46  Aligned_cols=254  Identities=29%  Similarity=0.470  Sum_probs=204.0

Q ss_pred             HhhhcceeceeCcEEEEEEEEcC------CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      ++.+.+.||+|+||.||+|...+      ++.||||.++..... ..+.+.+|++++++++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            45567889999999999998643      478999999765443 34689999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccc------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEE
Q 002461          680 VYEYMAYGNLKQYLFDET------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK  747 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vk  747 (919)
                      ||||+++|+|.+++....            ...+++.+...++.|++.|+.|||   ..+++||||||+||+++.++.+|
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEE
Confidence            999999999999996432            245789999999999999999999   66899999999999999999999


Q ss_pred             EeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccc
Q 002461          748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFL  826 (919)
Q Consensus       748 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~  826 (919)
                      |+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.+.   
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~~~~~~---  238 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECIT---  238 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH---
Confidence            999999876533222222233456788999999999999999999999999999998 9999854322 22222211   


Q ss_pred             ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       827 ~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                       .+...         ..+......+.+++.+||+.+|++||++.||++.|+
T Consensus       239 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 -QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             11111         111223356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.5e-35  Score=334.90  Aligned_cols=257  Identities=28%  Similarity=0.453  Sum_probs=201.8

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV  680 (919)
                      .+.+.||+|+||.||+|+..      .+..||||+++..... ..+.+.+|+++++++. ||||++++++|.+....++|
T Consensus        40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (400)
T cd05105          40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYII  119 (400)
T ss_pred             ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEE
Confidence            45689999999999999853      2346999999754332 2457899999999996 99999999999999999999


Q ss_pred             EEeccCCChhhhhhccc---------------------------------------------------------------
Q 002461          681 YEYMAYGNLKQYLFDET---------------------------------------------------------------  697 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~---------------------------------------------------------------  697 (919)
                      |||+++|+|.++|+...                                                               
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (400)
T cd05105         120 TEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASK  199 (400)
T ss_pred             EEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhh
Confidence            99999999999886431                                                               


Q ss_pred             -------------------------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcE
Q 002461          698 -------------------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA  746 (919)
Q Consensus       698 -------------------------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~v  746 (919)
                                                     ...+++.++++++.|+++||+|||   ..+++|+||||+|||++.++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~  276 (400)
T cd05105         200 YSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIV  276 (400)
T ss_pred             hhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEE
Confidence                                           124788899999999999999999   6689999999999999999999


Q ss_pred             EEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccc
Q 002461          747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPF  825 (919)
Q Consensus       747 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~  825 (919)
                      ||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+............+   
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~---  353 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI---  353 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH---
Confidence            9999999986533222222233456788999999998899999999999999999997 888875432222111111   


Q ss_pred             cccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       826 ~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                       ..+.         ....+......+.+++.+||+.+|++||++.+|+++|+++.+
T Consensus       354 -~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         354 -KSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -hcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             1110         001112234568899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-35  Score=315.62  Aligned_cols=255  Identities=28%  Similarity=0.437  Sum_probs=203.4

Q ss_pred             hhhcceeceeCcEEEEEEEEcC----CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+.+.||+|+||.||+|.+..    ...||||+++..... ....|.+|+.++++++|+||+++++++...+..+++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            3457899999999999999753    357999998754322 34578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++++|.+++.... ..+++.++++++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++.......
T Consensus        86 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          86 YMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             cCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            999999999986533 46899999999999999999999   67899999999999999999999999999987642222


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ........++..|+|||.+.+..++.++||||||++++||++ |..|+.... ..+..+.+.    .+.         ..
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~----~~~---------~~  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVE----DGY---------RL  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHH----cCC---------CC
Confidence            222223345678999999998899999999999999999998 988875322 122222211    110         00


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ..+......+.+++.+|++.+|++||++.+|++.|++++
T Consensus       228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            111223456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-34  Score=311.90  Aligned_cols=248  Identities=28%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.+.||+|+||.||++.+.++..+|+|.++.. ......|.+|++++++++||||+++++++......++||||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC   85 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence            456789999999999999988889999988643 2335678999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.++++... ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++....... .....
T Consensus        86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05114          86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSG  160 (256)
T ss_pred             HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCC
Confidence            999986433 35899999999999999999999   66899999999999999999999999999876532211 11122


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+....+.+    +..  ...       +...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-~~~~~~~i~~----~~~--~~~-------~~~~  226 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-NYEVVEMISR----GFR--LYR-------PKLA  226 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHC----CCC--CCC-------CCCC
Confidence            345678999999988889999999999999999999 888885332 2222222221    110  001       1112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ...+.+++.+|++.+|++||+|.++++.|
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            34688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=327.19  Aligned_cols=245  Identities=25%  Similarity=0.404  Sum_probs=201.0

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecC----CC-CCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS----SS-QGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~----~~-~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|.||+|+.|.+ .+|..||+|++...    .. ...+.+.+|+.+++.++ ||||++++.++......++|
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv   98 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV   98 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence            45578899999999999985 46899999977653    11 23455678999999999 99999999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPA  759 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~  759 (919)
                      |||+.+|+|.+++..  ...+.+.+..+++.|++.|++|||   +++|+||||||+|||++.+ +++||+|||++.... 
T Consensus        99 mEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-  172 (370)
T KOG0583|consen   99 MEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-  172 (370)
T ss_pred             EEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence            999999999999965  567888999999999999999999   7799999999999999999 999999999998763 


Q ss_pred             CCCCccccccccCccccCcccccCCC-CC-chhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNR-LT-EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                       .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ..+...    +..+..      
T Consensus       173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~k----i~~~~~------  240 (370)
T KOG0583|consen  173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRK----IRKGEF------  240 (370)
T ss_pred             -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHH----HhcCCc------
Confidence             2334456789999999999999877 76 689999999999999999999975221 111111    122211      


Q ss_pred             ccccCCChhH-HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          838 RLEANFDTNS-VWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       838 ~l~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          .++... ...+..++.+|+..+|.+|+++.++++
T Consensus       241 ----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                011111 346788999999999999999999983

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.2e-35  Score=324.58  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCC----EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGS----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      +...+.||+|+||.||+|++. +|+    .||+|+++.... ...+++.+|+.+++.++|+||++++|+|... ...+++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            344578999999999999864 343    389999875432 3346788999999999999999999999765 577999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++|+|.+++... ...+++..+++++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        88 e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          88 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             ecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            999999999998643 345889999999999999999999   6799999999999999999999999999998764332


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      .........++..|+|||++.+..++.++|||||||++|||++ |+.|+.... ...+...    ...+.         .
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~~~~~----~~~~~---------~  229 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSI----LEKGE---------R  229 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH----HhCCC---------C
Confidence            2222223345678999999999999999999999999999998 888875321 1111111    11110         0


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      ...+......+.+++.+|+..+|.+||++.++++.|..+....
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            0111223346788999999999999999999999988776433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.4e-35  Score=319.38  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=205.2

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++++++++|+||+++++++......++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34678999999999999843      345689999875554445679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEE
Q 002461          683 YMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL  748 (919)
Q Consensus       683 y~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL  748 (919)
                      |+++++|.+++....              ...+++..+++++.|++.||+|||   ..+++||||||+||+++.++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEE
Confidence            999999999986432              234899999999999999999999   668999999999999999999999


Q ss_pred             eccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccc
Q 002461          749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLE  827 (919)
Q Consensus       749 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~  827 (919)
                      +|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.    ..
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~----~~  239 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIEC----IT  239 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----Hh
Confidence            99999976533222222334456788999999998899999999999999999999 9998854322 112221    11


Q ss_pred             cCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          828 RGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       828 ~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .+....         ........+.+++.+|++.+|++||++.+|+++|+++..
T Consensus       240 ~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         240 QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111         111223468899999999999999999999999998855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-34  Score=316.30  Aligned_cols=266  Identities=26%  Similarity=0.400  Sum_probs=202.9

Q ss_pred             hhcceeceeCcEEEEEEEE-----cCCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV  680 (919)
                      .+.+.||+|+||+||++..     .+++.||+|.++.... .....|.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4568899999999988653     3678899999875432 2346788999999999999999999988653  458899


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+++|+|.+++..   ..+++.++..++.|+++||+|||   +.+++|+||||+|||+++++.+||+|||+++.....
T Consensus        87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999854   35999999999999999999999   668999999999999999999999999999866432


Q ss_pred             CCCc-cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc-cchhcccccccccCCcccccccc
Q 002461          761 SESH-ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       761 ~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      .... ......++..|+|||.+....++.++||||||++++||++|..|+...... .+.............+.+.++..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            2111 122234567799999998888999999999999999999999987543221 11111111111111122222222


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .....+......+.+++.+|++.+|++||+++++++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            222223344567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-34  Score=325.50  Aligned_cols=259  Identities=28%  Similarity=0.474  Sum_probs=201.4

Q ss_pred             HhhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhc-cCcceeeEEeEeec-CCeE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCND-GGNV  677 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~-~~~~  677 (919)
                      .+++.+.||+|+||.||+|...      .++.||+|+++..... ..+.+..|++++.++ +|+||++++++|.. +...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            3556789999999999999742      3578999998754322 234677899999999 89999999998865 4568


Q ss_pred             EEEEEeccCCChhhhhhccc-----------------------------------------------------------c
Q 002461          678 GLVYEYMAYGNLKQYLFDET-----------------------------------------------------------K  698 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~-----------------------------------------------------------~  698 (919)
                      ++++||+++|+|.+++....                                                           .
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999885422                                                           1


Q ss_pred             ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCc
Q 002461          699 EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP  778 (919)
Q Consensus       699 ~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~AP  778 (919)
                      ..++|..+.+++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            36899999999999999999999   669999999999999999999999999999876433222222334567789999


Q ss_pred             ccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHh
Q 002461          779 EYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAME  857 (919)
Q Consensus       779 E~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~  857 (919)
                      |++.+..++.++|||||||+++||++ |..||........+...+    ..+..         ...+......+.+++.+
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~l~~~  311 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL----KEGTR---------MRAPEYATPEIYSIMLD  311 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH----hccCC---------CCCCccCCHHHHHHHHH
Confidence            99999999999999999999999998 998885322211111111    11110         01112233468899999


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          858 CVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       858 Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      |++.+|++||++.|++++|+++++
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-34  Score=317.09  Aligned_cols=253  Identities=28%  Similarity=0.497  Sum_probs=199.9

Q ss_pred             hhcceeceeCcEEEEEEEE-----cCCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.+.||+|+||.||+|..     .++..||+|.++.... +....+.+|++++++++|+||+++++++..+...++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   87 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE   87 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence            4568899999999999984     3567899999875332 223578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccc---------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEE
Q 002461          683 YMAYGNLKQYLFDET---------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK  747 (919)
Q Consensus       683 y~~~GsL~~~L~~~~---------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vk  747 (919)
                      |+++|+|.+++....               ...+++.+.+.++.|++.||+|||   +.+++|+||||+|||+++++.+|
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEE
Confidence            999999999985322               235788999999999999999999   56899999999999999999999


Q ss_pred             EeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccc
Q 002461          748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFL  826 (919)
Q Consensus       748 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~  826 (919)
                      |+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||.... ...+.+.+.   
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~~~~~~---  240 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMVR---  240 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH---
Confidence            999999986533322222334456778999999988889999999999999999998 888875321 112222211   


Q ss_pred             ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       827 ~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                       ....         ...+......+.+++.+|++.+|++||++.++.++|+.
T Consensus       241 -~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 -KRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             1110         01112233468889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-34  Score=317.54  Aligned_cols=256  Identities=27%  Similarity=0.455  Sum_probs=203.2

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus         8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (288)
T cd05093           8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   87 (288)
T ss_pred             eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            45688999999999999852      345689999876544445678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccc-----------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEecc
Q 002461          683 YMAYGNLKQYLFDET-----------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF  751 (919)
Q Consensus       683 y~~~GsL~~~L~~~~-----------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DF  751 (919)
                      |+++++|.+++....           ...+++.+++.++.|++.||+|||   ..+++||||||+|||+++++.+||+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccC
Confidence            999999999986432           235899999999999999999999   668999999999999999999999999


Q ss_pred             CcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCC
Q 002461          752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGD  830 (919)
Q Consensus       752 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~  830 (919)
                      |+++...............++..|+|||.+.+..++.++|||||||+++||++ |..||.... .....+.+    ..+.
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i----~~~~  239 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECI----TQGR  239 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH----HcCC
Confidence            99986533222222223345778999999998899999999999999999998 888875332 12222221    1111


Q ss_pred             cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       831 ~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ...         .+......+.+++.+|++.+|.+||++.+|.+.|+++..
T Consensus       240 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         240 VLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             cCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            110         011223468999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-34  Score=310.03  Aligned_cols=248  Identities=29%  Similarity=0.394  Sum_probs=195.0

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      +.||+|+||.||+|... +++.+|+|.+..... .....+.+|++++++++|+||++++++|......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999975 788999998764332 2345689999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++... ...+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998543 345899999999999999999999   668999999999999999999999999998754321111111112


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV  848 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~  848 (919)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..|+..... ......+.             .......+....
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~~~~~~~-------------~~~~~~~~~~~~  222 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIE-------------QGVRLPCPELCP  222 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HHHHHHHH-------------cCCCCCCcccCC
Confidence            23467999999998899999999999999999998 8877753221 11111110             001111122234


Q ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          849 WKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       849 ~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      ..+.+++.+|++.+|++||++.++.++|+
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            57889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.7e-35  Score=326.20  Aligned_cols=241  Identities=22%  Similarity=0.292  Sum_probs=194.9

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||+|+||.||++... +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999997542   223356788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~  153 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence            99998853  456899999999999999999999   679999999999999999999999999998753211  11233


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.    .+.      .    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~----~~~------~----~~p~~~  218 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL----MEE------I----RFPRTL  218 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-HHHHHHHH----cCC------C----CCCCCC
Confidence            45799999999999999999999999999999999999999864321 11111110    010      0    112222


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ...+.+++.+|++.+|++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            34678899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=326.96  Aligned_cols=242  Identities=28%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.||+|.||.||||+.+ +.+.||+|.+.+..+  ...+.+++|+++++.++||||+.++++|+...+.++|+||+.+
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            4577999999999999965 578899999876533  3346689999999999999999999999999999999999986


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|..+|.  ..+.+++.....|+.++..||.|||   +.+|+|||+||+|||++..+.+|+||||+|+.+.  ....+.
T Consensus        86 -~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vl  157 (808)
T KOG0597|consen   86 -DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSVL  157 (808)
T ss_pred             -hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc--cCceee
Confidence             9999994  4567999999999999999999999   6799999999999999999999999999999764  345567


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      +...||+-|||||+..+..|+..+|+||+||++||+++|++||.... ..++++.+   +.+.        -   ..+..
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~~Lv~~I---~~d~--------v---~~p~~  222 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-ITQLVKSI---LKDP--------V---KPPST  222 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-HHHHHHHH---hcCC--------C---CCccc
Confidence            78899999999999999999999999999999999999999996321 12222221   1111        0   11224


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+.++....+..||.+|-+-.+++.
T Consensus       223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            4456888999999999999999999886

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-34  Score=310.27  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=201.7

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.+.||+|+||.||+|...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~   85 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG   85 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence            456789999999999999988888999999875433 3467999999999999999999999885 45688999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......+++.+++.++.+++.||+|||   +.+++|+||||+||++++++.++|+|||++..+.... .....
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~  161 (260)
T cd05070          86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQ  161 (260)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccccc
Confidence            9999997655566899999999999999999999   5689999999999999999999999999998653221 11122


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||++.+..++.++||||||++++||++ |..||... +..+..+.+..    +         .....+..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~----~---------~~~~~~~~  227 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVER----G---------YRMPCPQD  227 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc----C---------CCCCCCCc
Confidence            2345678999999988889999999999999999999 88887532 22222222111    0         00111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|+..+|++||++.++.+.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            34568899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-34  Score=310.50  Aligned_cols=256  Identities=28%  Similarity=0.437  Sum_probs=205.8

Q ss_pred             HHHHHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          603 IVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       603 i~~~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+..+++.++||+|+||.||+|...+++.||+|.+.... ....++.+|+.++++++|+|++++++++. .+..++++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            3455667789999999999999999899999999987543 33567899999999999999999999874 457899999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-  156 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence            999999999987666667999999999999999999999   6789999999999999999999999999997653221 


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ........++..|+|||++....++.++||||||++++||++ |+.||.... ..+..+.+.    .+.         ..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~----~~~---------~~  222 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-NPEVIQNLE----RGY---------RM  222 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHH----cCC---------CC
Confidence            111223346778999999998889999999999999999999 999885332 222222211    110         00


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      .........+.+++.+|+..+|++||+++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1111223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-34  Score=315.83  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=197.8

Q ss_pred             hhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|+||.||+|...      .+..||+|+++.... ....+|.+|+.+++.++|+||+++++++......++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            445788999999999999853      346799999864322 2235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccc--------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccC
Q 002461          681 YEYMAYGNLKQYLFDET--------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG  752 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~--------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFG  752 (919)
                      |||+++|+|.+++....        ...+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg  164 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCC
Confidence            99999999999986432        124678899999999999999999   5689999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCc
Q 002461          753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDV  831 (919)
Q Consensus       753 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~  831 (919)
                      +++...............++..|+|||++.+..++.++|||||||+++||++ |..||... ......+.+.    .+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~----~~~~  239 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVM----EGGL  239 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH----cCCc
Confidence            9876533222222223345788999999998899999999999999999999 67777432 2222222111    1111


Q ss_pred             ccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       832 ~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .         ..+......+.+++.+|++.+|++||++.|+++.|+
T Consensus       240 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         240 L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            0         112233456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-34  Score=317.80  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=202.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~L  679 (919)
                      ..+.+.||+|+||.||+|...      .+..||||+++.... ...+.+.+|+++++++ +|+||+++++++...+..++
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  116 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV  116 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence            445789999999999999742      345799999875432 2235688999999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ++||+++|+|.++++......+++.+++.++.+++.||+|||   +.+++|+||||+|||++.++.++++|||+++....
T Consensus       117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997555455899999999999999999999   66899999999999999999999999999986543


Q ss_pred             CCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..|+..........+.+    ..+         
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~---------  260 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEG---------  260 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcC---------
Confidence            322112223346778999999998889999999999999999998 888875432222111111    111         


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      .....+......+.+++.+|+..+|++||++.|+++.|+++
T Consensus       261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00011112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-35  Score=323.36  Aligned_cols=239  Identities=23%  Similarity=0.317  Sum_probs=191.6

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||.||+|... +++.||+|+++..   .......+..|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 5789999998753   223345678899999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++..  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  153 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF  153 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence            999854  346899999999999999999999   679999999999999999999999999998854222  1223446


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      .||+.|+|||.+.+..++.++|||||||+++||++|+.||..... ....+.+   . .+..          .++.....
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-~~~~~~~---~-~~~~----------~~~~~~~~  218 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-NEMYRKI---L-QEPL----------RFPDGFDR  218 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-HHHHHHH---H-cCCC----------CCCCcCCH
Confidence            799999999999999999999999999999999999999864221 1111111   1 1100          11122234


Q ss_pred             HHHHHHHhcCCCCCCCCCC---HHHHHH
Q 002461          850 KVAETAMECVPSISFQRPT---MSHVVT  874 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPs---m~eVv~  874 (919)
                      .+.+++.+|++.+|.+||+   +.|++.
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            6788999999999999986   455544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-34  Score=310.14  Aligned_cols=254  Identities=29%  Similarity=0.452  Sum_probs=202.2

Q ss_pred             HhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.++||+|+||.||+|...+...||+|+++... ...+.|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~   84 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   84 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence            356678999999999999998777789999987533 234678999999999999999999998754 567899999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++.......+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.+..... ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~  160 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TAR  160 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccc
Confidence            99999997655556899999999999999999999   66899999999999999999999999999986532221 112


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....++..|+|||+..+..++.++||||||++++||++ |..||..... ....+.+    ..+.         ......
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-~~~~~~~----~~~~---------~~~~~~  226 (262)
T cd05071         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQV----ERGY---------RMPCPP  226 (262)
T ss_pred             cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-HHHHHHH----hcCC---------CCCCcc
Confidence            23446778999999988899999999999999999999 7777753221 1111111    0000         001122


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      +....+.+++.+|++.+|++||++.++++.|++..
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            33456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-34  Score=321.90  Aligned_cols=258  Identities=24%  Similarity=0.330  Sum_probs=198.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ...+.||+|+||.||++... +|..+|+|+++.... ...+.+.+|++++++++|+||+++++++..++..++||||+++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (331)
T cd06649           8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (331)
T ss_pred             eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence            34578999999999999976 678899999875432 2235689999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++......    ..
T Consensus        88 ~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~  159 (331)
T cd06649          88 GSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  159 (331)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence            999999854  3458899999999999999999995  236999999999999999999999999998765321    22


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---C-------------
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---D-------------  830 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~-------------  830 (919)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .++...+......+   .             
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccccccc
Confidence            345689999999999998999999999999999999999999853321 11111100000000   0             


Q ss_pred             --------------cccccccccc---cCC-ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          831 --------------VRSIVDPRLE---ANF-DTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       831 --------------~~~ivd~~l~---~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                    ..+..+....   ... .......+.+++.+||+.+|++||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                          0000000000   000 11123468899999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=324.84  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|++++..++||||+++++++...+..++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            34688999999999999976 58899999997542   223456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++..  ...+++.+...++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++....     
T Consensus        84 ~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          84 PGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            99999999843  346889999999999999999999   66899999999999999999999999999986532     


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+.............++.      
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~------  226 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWKETLQRPVYDDPR------  226 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHHHHHHhccccccCCCCCccc------
Confidence            23345799999999999998999999999999999999999999864321 11111111100000000001110      


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ......+.+++.+|+..+|.+||++.++++.
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1123457789999999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-34  Score=315.60  Aligned_cols=254  Identities=24%  Similarity=0.447  Sum_probs=200.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCCC-chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|+||.||+|...      +++.||+|+++...... ...+.+|+.++..++|+||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455688999999999999864      25679999997543322 35688899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcE
Q 002461          681 YEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA  746 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~v  746 (919)
                      +||+++++|.+++....              ...+++..+++++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            99999999999985321              235888999999999999999999   6689999999999999999999


Q ss_pred             EEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccc
Q 002461          747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPF  825 (919)
Q Consensus       747 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~  825 (919)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+... ...+..+.+.  
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~i~--  240 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVIEMIR--  240 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH--
Confidence            9999999886533322222333456789999999988889999999999999999998 77776432 2222222221  


Q ss_pred             cccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       826 ~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                        .+..         ...+......+.+++..|++.+|.+||++.+|++.|+.
T Consensus       241 --~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 --NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              1111         11223344568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-34  Score=322.77  Aligned_cols=241  Identities=22%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||+|+||.||++... +|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999997542   223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|..++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  153 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence            99988843  346899999999999999999999   6699999999999999999999999999987532211  1223


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+.    .+.      .    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~----~~~------~----~~p~~~  218 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELIL----MEE------I----RFPRTL  218 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHh----cCC------C----CCCCCC
Confidence            4579999999999999999999999999999999999999986432211 111110    000      0    111222


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ...+.+++.+|++.+|++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            34678899999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.6e-34  Score=309.54  Aligned_cols=249  Identities=28%  Similarity=0.447  Sum_probs=199.0

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.+.||+|+||+||+|...++..+|+|.++... ....+|.+|+.++++++||||+++++++......++||||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC   85 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence            4567899999999999998877789999987432 334678999999999999999999999998889999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++.... ..+++.++++++.|++.||+|||   ..+++|+||||+||++++++.+||+|||+++....... .....
T Consensus        86 l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~  160 (256)
T cd05113          86 LLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG  160 (256)
T ss_pred             HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence            999986533 36899999999999999999999   66999999999999999999999999999876532211 11122


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .......+..    +..         ...+...
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~----~~~---------~~~~~~~  226 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQ----GLR---------LYRPHLA  226 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHhc----CCC---------CCCCCCC
Confidence            345678999999988889999999999999999998 888875322 1122222111    100         0011112


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      ...+.+++.+||+.+|.+||++.++++.|+
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            357889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-34  Score=314.42  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             hcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+.||+|+||.||+|...      ....+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++++|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            4578999999999999853      235789998865432 223568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccc----------------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          683 YMAYGNLKQYLFDET----------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       683 y~~~GsL~~~L~~~~----------------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      |+++|+|.+++....                      ...+++.+++.++.|++.||+|||   +.+++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEE
Confidence            999999999875421                      235889999999999999999999   6799999999999999


Q ss_pred             CCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchh
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIV  819 (919)
Q Consensus       741 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~  819 (919)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+... ....+.
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~  239 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-APERLF  239 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence            9999999999999986533222222223345778999999988889999999999999999998 88887432 222222


Q ss_pred             cccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       820 ~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      +.+.    .+         .....+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus       240 ~~~~----~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 NLLK----TG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHh----CC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            2211    11         1111122233468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=310.57  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=198.5

Q ss_pred             hcceeceeCcEEEEEEEEcC----CCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCe------E
Q 002461          610 FHRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGN------V  677 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~----g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~------~  677 (919)
                      +.+.||+|+||.||+|.+..    +..||+|+++.....  ....+.+|++.++.++|+||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            46789999999999999753    367999998754322  23578899999999999999999998866544      7


Q ss_pred             EEEEEeccCCChhhhhhccc----cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          678 GLVYEYMAYGNLKQYLFDET----KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~----~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ++++||+++|+|..++....    ...+++.....++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence            99999999999999885432    346899999999999999999999   56899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ......+++.    .+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~----~~~~-  233 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLR----HGNR-  233 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHH----cCCC-
Confidence            986643322222222345678999999988889999999999999999999 77877432 2222222221    1110 


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                              ...+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    011223345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.8e-34  Score=311.05  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=195.9

Q ss_pred             hcceeceeCcEEEEEEEEcCCC---EEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEE
Q 002461          610 FHRILGKGGFGTVYHGYLADGS---EVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVG  678 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~---~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~  678 (919)
                      +.+.||+|+||.||+|...+..   .+|+|.++...  ....+.+..|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            4578999999999999976433   58999887542  22345788899999999999999999987432      2568


Q ss_pred             EEEEeccCCChhhhhhcc----ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcc
Q 002461          679 LVYEYMAYGNLKQYLFDE----TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS  754 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~----~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla  754 (919)
                      +++||+++|+|.+++...    ....+++.....++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999887432    2345899999999999999999999   568999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccc
Q 002461          755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       755 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~  833 (919)
                      +.+.............++..|+|||+..+..++.++||||||+++|||++ |+.||.. .....+.+.+    ..+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~----~~~~~~-  233 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYL----RQGNRL-  233 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH----HcCCCC-
Confidence            87643222111223346778999999998899999999999999999999 7888743 2222222211    111110 


Q ss_pred             ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       834 ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                              .........+.+++.+|++.+|++||++.++++.|+++
T Consensus       234 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 --------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    01122334688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5e-34  Score=315.25  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=195.0

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+++++.++||||+++++++......++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            345688999999999999976 688999999875433 233467889999999999999999999999999999999996


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                       ++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        87 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  159 (303)
T cd07869          87 -TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHT  159 (303)
T ss_pred             -cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--Ccc
Confidence             6888877543 355888999999999999999999   678999999999999999999999999998754221  122


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Cccc-----ccc
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVRS-----IVD  836 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~~-----ivd  836 (919)
                      .....|++.|+|||.+.+ ..++.++|||||||+++||++|+.||....+..+..+.+...+...   .+..     ..+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            234568999999998865 4578899999999999999999999965433222222211111000   0000     000


Q ss_pred             c---------ccccCCC-hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          837 P---------RLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 ~---------~l~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +         .+....+ ......+.+++.+|++.+|++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0         0000000 001235678999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.4e-34  Score=327.98  Aligned_cols=256  Identities=29%  Similarity=0.453  Sum_probs=200.7

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCCC-chhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV  680 (919)
                      .+.+.||+|+||.||+|.+.      .++.||+|+++...... .+.+.+|++++.++. ||||++++++|...+..++|
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv  119 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII  119 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence            45689999999999999864      34579999997543322 346889999999997 99999999999999999999


Q ss_pred             EEeccCCChhhhhhccc---------------------------------------------------------------
Q 002461          681 YEYMAYGNLKQYLFDET---------------------------------------------------------------  697 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~---------------------------------------------------------------  697 (919)
                      +||+++|+|.++++...                                                               
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            99999999999986432                                                               


Q ss_pred             ---------------------------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          698 ---------------------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       698 ---------------------------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                                                       ...+++...++++.|++.||+|||   ..+++||||||+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCC
Confidence                                             124678888999999999999999   67999999999999999999


Q ss_pred             cEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccc
Q 002461          745 QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVC  823 (919)
Q Consensus       745 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~  823 (919)
                      .+||+|||+++...............++..|+|||.+....++.++|||||||+++||++ |..|+..........+.+ 
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~-  355 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI-  355 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-
Confidence            999999999986532222111223456788999999998889999999999999999998 888875322111111111 


Q ss_pred             cccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          824 PFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       824 ~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                         ..+         .....+......+.+++.+||..+|.+||+++||++.|++++
T Consensus       356 ---~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         356 ---KRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               111         001112223356889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.9e-34  Score=313.86  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=196.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            45678999999999999986 57889999987543  2234568889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      ++.+..+..  ....+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++...... ...
T Consensus        84 ~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (287)
T cd07848          84 KNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NAN  157 (287)
T ss_pred             CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-ccc
Confidence            877765442  2356899999999999999999999   6799999999999999999999999999998653221 112


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc------------cccCCccc
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF------------LERGDVRS  833 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~------------~~~~~~~~  833 (919)
                      .....|+..|+|||++.+..++.++|||||||++|||++|++||........... +...            ........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT-IQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhCCCCHHHHHhhhccchhcc
Confidence            2345689999999999988899999999999999999999999864322111110 0000            00000000


Q ss_pred             ccccccc------cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          834 IVDPRLE------ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 ivd~~l~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+...      ..........+.+++.+|++.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000      0011112345889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-34  Score=316.29  Aligned_cols=255  Identities=29%  Similarity=0.464  Sum_probs=201.1

Q ss_pred             hhcceeceeCcEEEEEEEEcC------CCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLAD------GSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      .+.+.||+|+||.||++...+      ...+|+|.++.... ....++.+|+++++++ +|+||+++++++..++..+++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            456789999999999998642      35799999875422 2235688899999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhcc--------------ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcE
Q 002461          681 YEYMAYGNLKQYLFDE--------------TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA  746 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~--------------~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~v  746 (919)
                      |||+++|+|.+++...              ....+++..+++++.|++.||+|||   ..+++||||||+||++++++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeE
Confidence            9999999999998642              2356899999999999999999999   6689999999999999999999


Q ss_pred             EEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccc
Q 002461          747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPF  825 (919)
Q Consensus       747 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~  825 (919)
                      ||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.... ..+..+.    
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~----  246 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL----  246 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-HHHHHHH----
Confidence            9999999987643222222223345678999999988899999999999999999997 888875322 1111111    


Q ss_pred             cccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       826 ~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ...+.         ....+......+.+++.+|+..+|++||+|.|+++.|++++
T Consensus       247 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11111         11122233456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-34  Score=317.49  Aligned_cols=261  Identities=27%  Similarity=0.452  Sum_probs=204.7

Q ss_pred             HhhhcceeceeCcEEEEEEEEc--------CCCEEEEEEeecCC-CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCe
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA--------DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGN  676 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~  676 (919)
                      .+.+.+.||+|+||.||+|...        ++..||+|.++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   95 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   95 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence            3456789999999999999742        24479999987542 23346788999999999 89999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC
Q 002461          677 VGLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE  742 (919)
Q Consensus       677 ~~LV~Ey~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~  742 (919)
                      .++||||+++|+|.+++....              ...+++.+++.++.|++.||.|||   +.+++||||||+||++++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~  172 (304)
T cd05101          96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTE  172 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcC
Confidence            999999999999999986532              235788999999999999999999   669999999999999999


Q ss_pred             CCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcc
Q 002461          743 KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNR  821 (919)
Q Consensus       743 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~  821 (919)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+... ...+..+.
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~  251 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKL  251 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHH
Confidence            99999999999987643322222233446678999999988889999999999999999998 67776422 11222221


Q ss_pred             cccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhHH
Q 002461          822 VCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMET  884 (919)
Q Consensus       822 v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~  884 (919)
                      +    ..+..         ...+......+.+++.+|++.+|++||+|.|+++.|++++....
T Consensus       252 ~----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         252 L----KEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             H----HcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            1    11110         01122334568889999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-34  Score=313.50  Aligned_cols=265  Identities=27%  Similarity=0.431  Sum_probs=198.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-----CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-----DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-----~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~  681 (919)
                      .+.+.||+|+||.||++...     ++..||+|+++.......+.+.+|++++++++|+||+++++++..  ....++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            45678999999999999853     578899999876554445678999999999999999999998754  34689999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++......
T Consensus        87 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          87 EYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            999999999998543 345899999999999999999999   6689999999999999999999999999998764322


Q ss_pred             CCcc-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc----CCcccccc
Q 002461          762 ESHI-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER----GDVRSIVD  836 (919)
Q Consensus       762 ~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~----~~~~~ivd  836 (919)
                      .... .....++..|+|||++.+..++.++||||||++++||++|..++.....  ...+.+......    ..+.+.+.
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccccccchHHHHHHHh
Confidence            2111 1122344569999999988899999999999999999998766432110  000000000000    00001111


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ..............+.+++.+|++.+|++||||.||++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111223345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=337.30  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=199.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-C-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-D-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.+.||+|+||.||+|... + ++.||+|.+..........++.|+++++.++||||+++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            456789999999999999854 3 56788887754444444567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +|+|.++++..  ....+++.+...++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.+......
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988543  2446889999999999999999999   679999999999999999999999999999876433322


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+    ..+..    +     ..
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-~~~~~~~~----~~~~~----~-----~~  291 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQV----LYGKY----D-----PF  291 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH----HhCCC----C-----CC
Confidence            33445679999999999999999999999999999999999999985321 11111111    01110    0     01


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++..|+..+|++||++.++++
T Consensus       292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1122346889999999999999999999975

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=318.84  Aligned_cols=242  Identities=25%  Similarity=0.352  Sum_probs=195.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+|... +|+.||+|+++....   ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            45688999999999999975 688999999865321   23456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++..  ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          84 PGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            99999999854  346899999999999999999999   679999999999999999999999999999865321    


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                       .....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....+.+    ..+..          .++
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i----~~~~~----------~~~  218 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKI----LAGKL----------EFP  218 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH----HhCCc----------CCC
Confidence             1235689999999999988899999999999999999999999864321 1111111    11110          111


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPT-----MSHVVTE  875 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVv~~  875 (919)
                      ......+.+++.+|++.+|.+||+     ++++++.
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            122345788999999999999995     7777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-34  Score=313.33  Aligned_cols=259  Identities=22%  Similarity=0.356  Sum_probs=193.4

Q ss_pred             hhhcceeceeCcEEEEEEEEc--CCCEEEEEEeecCCCC--CchhhhHHHHHHHhc---cCcceeeEEeEee-----cCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA--DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRV---HHRNLASLVGYCN-----DGG  675 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~--~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l---~H~NIv~l~g~~~-----~~~  675 (919)
                      +.+.+.||+|+||.||+|...  +|+.||+|+++.....  ....+.+|+.+++.+   +||||++++++|.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            345688999999999999863  4678999998754322  234566788777766   6999999999885     345


Q ss_pred             eEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          676 NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       676 ~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      ..++|+||++ ++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6899999997 69999986655566899999999999999999999   6689999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCcc
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVR  832 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~  832 (919)
                      .....   .......|+..|+|||.+....++.++|||||||++|||++|++||....+.. ....+.....   .....
T Consensus       159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhch
Confidence            65322   22334568999999999988889999999999999999999999986543221 1111111100   00000


Q ss_pred             -------ccccccccc---CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 -------SIVDPRLEA---NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 -------~ivd~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                             ..+.+....   .........+.+++.+|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                   000000000   000112345678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=307.75  Aligned_cols=248  Identities=29%  Similarity=0.460  Sum_probs=198.1

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.+.||+|+||.||+|...++..+|+|+++... .....|.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC   85 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence            4568899999999999998877889999986432 234578899999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...... ......
T Consensus        86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~  160 (256)
T cd05059          86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQG  160 (256)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccCC
Confidence            999986433 36899999999999999999999   6689999999999999999999999999987653211 111112


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.    .+         .....+...
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~----~~---------~~~~~~~~~  226 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-NSEVVESVS----AG---------YRLYRPKLA  226 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHH----cC---------CcCCCCCCC
Confidence            234567999999998899999999999999999999 788875322 122222111    11         000111223


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ...+.+++.+|+..+|++||+|.|+++.|
T Consensus       227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            45788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-34  Score=305.53  Aligned_cols=247  Identities=29%  Similarity=0.428  Sum_probs=197.2

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      ++||+|+||.||+|...+++.+|+|+++..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            468999999999999888999999998754332 2346889999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +++... ...+++..++.++.+++.||.|||   ..+++|+||||+||+++.++.+||+|||++....... ........
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ  155 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence            988543 345899999999999999999999   6799999999999999999999999999987542211 11112234


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      ++..|+|||++.+..++.++||||||+++||+++ |..||.... .......+.    .+.         ....+.....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-~~~~~~~~~----~~~---------~~~~~~~~~~  221 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT-NQQAREQVE----KGY---------RMSCPQKCPD  221 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHH----cCC---------CCCCCCCCCH
Confidence            4678999999998899999999999999999998 888885321 111111111    110         0111222345


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+.+++.+|++.+|++||++.|+++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            7889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-34  Score=321.93  Aligned_cols=242  Identities=23%  Similarity=0.304  Sum_probs=194.9

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ++||+|+||.||++... +|+.||+|+++...   ......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999997542   223456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            99988843  346899999999999999999999   679999999999999999999999999998753221  11223


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.    .+.      .    .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~~----~~~------~----~~p~~~  218 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL----MED------I----KFPRTL  218 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHhc----cCC------c----cCCCCC
Confidence            45799999999999988999999999999999999999999864321 11111110    010      0    111222


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRP-----TMSHVVTE  875 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~~  875 (919)
                      ...+.+++.+|+..+|.+||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            34578899999999999997     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-34  Score=312.34  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=203.9

Q ss_pred             HhhhcceeceeCcEEEEEEEEcC-----CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeec-CCeEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD-----GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGL  679 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~-~~~~~L  679 (919)
                      .+.+.+.||+|+||.||+|...+     +..|++|+++.... ...+.+.+|+.++++++|+||+++++++.. ....++
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   86 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV   86 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence            44567899999999999999865     67899999874432 224568899999999999999999998766 567899


Q ss_pred             EEEeccCCChhhhhhcccc------ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          680 VYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~------~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            9999999999999865332      46899999999999999999999   66899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||... +...+..++.    .+.  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~----~~~--  236 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLK----DGY--  236 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHH----cCC--
Confidence            986543322222233456778999999988889999999999999999999 99988542 2222222211    110  


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                             ...........+.+++.+|+..+|++||++.++++.|+++.+
T Consensus       237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 -------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   000111223468899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.9e-34  Score=306.10  Aligned_cols=251  Identities=28%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+++|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            45568899999999999998887789999876433 23467889999999999999999999875 45688999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.++++......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++...... .....
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~  161 (260)
T cd05069          86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQ  161 (260)
T ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccC
Confidence            9999997655556899999999999999999999   6689999999999999999999999999997653221 11122


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||...+..++.++||||||+++|||++ |..|+....+ ....+++..    +.         ....+..
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~----~~---------~~~~~~~  227 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER----GY---------RMPCPQG  227 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc----CC---------CCCCCcc
Confidence            3346778999999988899999999999999999999 8888754322 222222111    10         0011122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|+..+|++||++++|++.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.7e-34  Score=311.03  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=195.0

Q ss_pred             hcceeceeCcEEEEEEEEc-CCC----EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGS----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.||+|+||+||+|... +++    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence            4578999999999999964 444    377777653322 223567778889999999999999998864 457889999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++... ...+++..+..++.|++.||+|||   ..+++|+||||+|||+++++.+||+|||+++........
T Consensus        90 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          90 SPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            9999999999643 346899999999999999999999   568999999999999999999999999999866433322


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....+.    +..+...  ..+     
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~----~~~~~~~--~~~-----  233 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDL----LEKGERL--AQP-----  233 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH----HHCCCcC--CCC-----
Confidence            22334557789999999998899999999999999999998 9888853221 111111    1111110  011     


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                        ......+.+++.+|+..+|++||++.|+++.|+.+..
T Consensus       234 --~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 --QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence              1122356788999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-34  Score=307.53  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=194.7

Q ss_pred             eeceeCcEEEEEEEEc---CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          613 ILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~---~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .||+|+||.||+|.++   +++.+|+|+++.....  ..+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   5788999998754322  2457889999999999999999999885 45678999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc-cc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-IS  766 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~  766 (919)
                      +|.+++..  ...+++..+.+++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999853  346899999999999999999999   6789999999999999999999999999998663322111 11


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+..+.+    ..+.         ....+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~i----~~~~---------~~~~~~  221 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMI----ESGE---------RMECPQ  221 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH----HCCC---------CCCCCC
Confidence            22234678999999988889999999999999999998 898885422 22222221    1111         111122


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      .....+.+++.+|++.+|++||++.+|++.|++.
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            3345688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.9e-34  Score=316.74  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=202.2

Q ss_pred             HhhhcceeceeCcEEEEEEEEc--------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCe
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA--------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGN  676 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~  676 (919)
                      .+.+.+.||+|+||.||++...        ++..+|+|.++.... ....++..|+++++++ +|+||+++++++...+.
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   98 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4556789999999999999852        234699999875422 2345688899999999 79999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC
Q 002461          677 VGLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE  742 (919)
Q Consensus       677 ~~LV~Ey~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~  742 (919)
                      .++|+||+++|+|.+++....              ...+++.++++++.|++.||+|||   +.+++||||||+||+++.
T Consensus        99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcC
Confidence            999999999999999996532              135899999999999999999999   669999999999999999


Q ss_pred             CCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcc
Q 002461          743 KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNR  821 (919)
Q Consensus       743 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~  821 (919)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.. .+..+..+.
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~  254 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKL  254 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHH
Confidence            99999999999876532211111222234568999999988889999999999999999998 7777742 221111111


Q ss_pred             cccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          822 VCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       822 v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                          ...+.         ....+......+.+++.+|+..+|.+||+|.+|++.|++++..
T Consensus       255 ----~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         255 ----LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                11111         0111223345788899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-34  Score=313.51  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=199.9

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.+.||+|+||.||++...      ++..+|+|.++.......+.+.+|+++++.++|+||+++++++......++++|
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            34688999999999999742      356799999876555556789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhcccc-------------ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          683 YMAYGNLKQYLFDETK-------------EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~-------------~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      |+++|+|.+++.....             ..+++..++.++.|++.||+|||   +.+++|+||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEEC
Confidence            9999999999865421             35899999999999999999999   6799999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLER  828 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~  828 (919)
                      |||+++...............++..|+|||++.+..++.++|||||||++|||++ |.+||..... .+..+.+.    .
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~----~  239 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIECIT----Q  239 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHHHH----c
Confidence            9999876532222122223345788999999998899999999999999999998 8888754322 11111110    1


Q ss_pred             CCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          829 GDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       829 ~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      +..         ...+......+.+++.+||+.+|.+||++.||.+.|+
T Consensus       240 ~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 GRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             Ccc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            100         0111122346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-34  Score=309.04  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=200.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCC---EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGS---EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~---~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ...+.||+|+||.||+|... +++   .+|+|.++.... ...+.+..|++++++++|+|++++.+++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            44688999999999999975 333   699999865432 2345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++... ...+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.........
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          88 MENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            9999999998643 356899999999999999999999   668999999999999999999999999998765322211


Q ss_pred             cc-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          764 HI-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       764 ~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      .. ......+..|+|||++....++.++|||||||++|||++ |+.||..... .+....+..    +         ...
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~----~---------~~~  229 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIND----G---------FRL  229 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhc----C---------CCC
Confidence            11 111223567999999988889999999999999999997 9999854321 222222111    1         011


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .........+.+++.+|++.+|++||+|.+|++.|++++
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            111223456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-34  Score=319.24  Aligned_cols=241  Identities=25%  Similarity=0.406  Sum_probs=192.8

Q ss_pred             ceeceeCcEEEEEEEE----cCCCEEEEEEeecCC----CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYL----ADGSEVAIKMLSASS----SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.||+|+||.||++..    .+++.||+|+++...    ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    357889999997532    22235678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+.+.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  154 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G  154 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence            999999998843  345788889999999999999999   668999999999999999999999999998754221  1


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+    ..+.        .  ..
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~----~~~~--------~--~~  219 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKI----LKGK--------L--NL  219 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHH----HcCC--------C--CC
Confidence            2233457999999999999888999999999999999999999998643211 111111    0111        0  11


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      +......+.+++.+|++.+|++||     ++.++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            112234678899999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-34  Score=322.10  Aligned_cols=242  Identities=25%  Similarity=0.365  Sum_probs=195.8

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||+|... +|+.||+|+++...   ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            345689999999999999975 58899999987542   22345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       100 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263        100 VVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---  171 (329)
T ss_pred             CCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence            999999999854  346888999999999999999999   679999999999999999999999999999865322   


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                        .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+    ..+..          .+
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i----~~~~~----------~~  234 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-FRIYEKI----LAGRL----------KF  234 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-HHHHHHH----hcCCc----------CC
Confidence              1235789999999999998999999999999999999999999864221 1111111    11111          01


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                      +......+.+++.+|++.+|.+||+     +.+++.
T Consensus       235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1112235778999999999999997     566664

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=314.84  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=197.4

Q ss_pred             HhhhcceeceeCcEEEEEEEEcC---------------CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD---------------GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGY  670 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~---------------g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~  670 (919)
                      .+.+.+.||+|+||.||++...+               ...||+|+++..... ....|.+|++++++++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            34556889999999999987642               124899998754222 23568899999999999999999999


Q ss_pred             eecCCeEEEEEEeccCCChhhhhhccc----------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          671 CNDGGNVGLVYEYMAYGNLKQYLFDET----------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       671 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~----------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      +......++||||+++++|.+++....          ...+++..+++++.|++.||+|||   +.+++|+||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEE
Confidence            999999999999999999999985432          123688999999999999999999   6689999999999999


Q ss_pred             CCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCcccCCCccch
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHI  818 (919)
Q Consensus       741 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~~~~~~l  818 (919)
                      ++++.+||+|||++................++..|+|||.+....++.++|||||||+++||++  |..||.... ....
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~~~  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DEQV  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hHHH
Confidence            9999999999999976533222222233445778999999988899999999999999999998  455654322 1222


Q ss_pred             hcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       819 ~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+.+.+........      .....+......+.+++.+|++.+|++||+|.+|++.|+
T Consensus       242 ~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            22211111111000      000011122347899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-33  Score=304.94  Aligned_cols=248  Identities=23%  Similarity=0.409  Sum_probs=194.7

Q ss_pred             eeceeCcEEEEEEEEc---CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          613 ILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .||+|+||.||+|.+.   .+..||+|+++..... ..+.|.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   3557999998755332 2356889999999999999999999885 457899999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc-cc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI-ST  767 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~  767 (919)
                      |.+++... ...+++..+++++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++.......... ..
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99998543 356899999999999999999999   56899999999999999999999999999986533222111 11


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||.+....++.++||||||+++||+++ |..||..... ......+    ..+.         ....+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~---------~~~~~~~  222 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMSFI----EQGK---------RLDCPAE  222 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHHHH----HCCC---------CCCCCCC
Confidence            2234578999999988889999999999999999996 9998864322 1111111    1111         1112233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ....+.+++.+||..+|++||++.+|.+.|+..
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            445788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=304.48  Aligned_cols=252  Identities=28%  Similarity=0.455  Sum_probs=203.7

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ..+.+.||+|+||.||+|..++++.+|||.++... ...+++.+|+.++++++|+||+++++++......++||||++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG   86 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence            45578899999999999998888899999987543 34567999999999999999999999999989999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......+++.++..++.+++.||+|||   +.+++|+||||+||++++++.+||+|||+++.+.... .....
T Consensus        87 ~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~  162 (261)
T cd05034          87 SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTARE  162 (261)
T ss_pred             CHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhh
Confidence            9999997665567999999999999999999999   5689999999999999999999999999988653211 11111


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||.+.+..++.++||||||++++||++ |+.||... ......+.+....             ....+..
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~-------------~~~~~~~  228 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGY-------------RMPRPPN  228 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC-------------CCCCCCC
Confidence            2234568999999998889999999999999999998 88888532 2222222221110             0011112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|+..+|++||+++++.+.|+.
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            23468899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-33  Score=316.82  Aligned_cols=198  Identities=28%  Similarity=0.392  Sum_probs=170.5

Q ss_pred             HHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+++.+.||+|+||.||++... ++..+|+|+++.... .....+.+|++++++++|+||++++++|...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34456788999999999999976 578899998875432 2235688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++.....++.+++.||.|||+  ..+++|+||||+|||++.++.+||+|||++......   
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          85 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            999999999854  3458889999999999999999995  247999999999999999999999999998755221   


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             12335689999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-34  Score=324.84  Aligned_cols=252  Identities=26%  Similarity=0.375  Sum_probs=209.1

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ++.+.||+|+-|.|-.|++ .+|+.+|||++.+..   ......+.+|+-+|+-+.|||++++++.+.+..+++||.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            3467899999999999996 479999999997652   223456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|-|.+++.  .++++...+..+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+-   ....
T Consensus        95 ~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk  166 (786)
T KOG0588|consen   95 PGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK  166 (786)
T ss_pred             CCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence            9999999994  4567999999999999999999999   679999999999999999999999999999864   3344


Q ss_pred             cccccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLT-EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ...+.+|++.|.|||++.+.+|. .++||||.||||+.|+||+.||++ .+...+...|    +.|..          +.
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV----~~G~f----------~M  231 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKV----QRGVF----------EM  231 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHH----HcCcc----------cC
Confidence            56678999999999999999885 689999999999999999999973 2333333333    23321          11


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHHHHhhH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTE--LKKCLEME  883 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~--Le~~~~~~  883 (919)
                      +.....+..+|+.+|+..||+.|-|++||.+.  |.......
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            23334467889999999999999999999984  55544433

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5e-34  Score=310.76  Aligned_cols=252  Identities=29%  Similarity=0.449  Sum_probs=196.3

Q ss_pred             hhcceeceeCcEEEEEEEEcC------CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLAD------GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.||+|++|.||+|.+.+      +..||+|.++.... .....|..|+.++++++|+||+++++++.+....++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            345789999999999999753      56789998764432 23356899999999999999999999999989999999


Q ss_pred             EeccCCChhhhhhcccc-----ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC---cEEEeccCc
Q 002461          682 EYMAYGNLKQYLFDETK-----EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---QAKLADFGF  753 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~-----~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~---~vkL~DFGl  753 (919)
                      ||+++++|.+++.....     ..+++.++++++.|++.||+|||   ..+++|+||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            99999999999865431     35899999999999999999999   56899999999999998654   599999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ++................+..|+|||++.+..++.++|||||||+++||++ |..||.... .....+.+.   ...   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~~~---~~~---  238 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEFVT---GGG---  238 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH---cCC---
Confidence            986532221111122234568999999998899999999999999999997 888875322 122211111   000   


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                             ....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus       239 -------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 -------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                   11112223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-34  Score=304.26  Aligned_cols=247  Identities=30%  Similarity=0.468  Sum_probs=201.9

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ..+.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++......++||||++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            355788999999999999875 78999999976544 4578899999999999999999999999899999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++......     .
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~  157 (256)
T cd05039          86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----D  157 (256)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----c
Confidence            9999997655557999999999999999999999   6689999999999999999999999999998652211     1


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ...++..|+|||++....++.++||||||++++|+++ |..||.... ..++.+.+..    +.         ....+..
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~----~~---------~~~~~~~  223 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEK----GY---------RMEAPEG  223 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhc----CC---------CCCCccC
Confidence            2334678999999988899999999999999999997 888875321 1222221111    10         0011122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|+..+|++||++.|++++|+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            34568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-35  Score=293.26  Aligned_cols=245  Identities=28%  Similarity=0.420  Sum_probs=207.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ++.+.||+|.||.||.|+.+ ++-.||+|++-+.   ..+..+++++|+++-..|+||||+++++||.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            45789999999999999965 5678999998654   3345678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +.|.|...|.+.....++......++.|+|.||.|+|   .++|+||||||+|+|++.++..||+|||.+..-+    ..
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~  177 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SN  177 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CC
Confidence            9999999998777788999999999999999999999   7899999999999999999999999999886432    34


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....+||..|.+||...+...+.+.|+|++|++.+|++.|.+||.... ..+..+.+++.       ++.       ++
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~-------~~~-------~p  242 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV-------DLK-------FP  242 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc-------ccc-------CC
Confidence            4567899999999999999999999999999999999999999996443 33333332211       111       22


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ........+++..|+..+|.+|....||+..
T Consensus       243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  243 STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            2233467889999999999999999999864

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=318.26  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=203.8

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      +.||+|.||.||||... .++.||+|++.-... ...++.++|+.+|.+++++||.+++|.+..+..++++||||.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            78999999999999964 688899999975533 3457789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+.|.  ....+......-|+.++..||.|||   ..+.+|||||+.|||+..+|.+||+|||.+..+...  .......
T Consensus        99 ~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~tf  171 (467)
T KOG0201|consen   99 LDLLK--SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKTF  171 (467)
T ss_pred             hhhhc--cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech--hhccccc
Confidence            99984  3344577788889999999999999   668999999999999999999999999999876332  2233678


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      +||+.|||||++....|+.|+||||||++.+||++|.+|+.....    .+.+. .     +.+-.-|.+.+.+    ..
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----mrvlf-l-----Ipk~~PP~L~~~~----S~  237 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----MRVLF-L-----IPKSAPPRLDGDF----SP  237 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----ceEEE-e-----ccCCCCCcccccc----CH
Confidence            999999999999988999999999999999999999999864322    11111 1     1122234444433    33


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHH--HHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVT--ELKKCL  880 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~--~Le~~~  880 (919)
                      .+.+++..|+..+|+.||++.++++  .++...
T Consensus       238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  238 PFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            6889999999999999999999997  455543

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.2e-34  Score=312.63  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=198.0

Q ss_pred             hhcceeceeCcEEEEEEEEcC-CC--EEEEEEeecCC-CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-GS--EVAIKMLSASS-SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|...+ +.  .+++|.++... ....+.|..|++++.++ +||||+++++++...+..++++||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            456889999999999999754 33  47888887432 22345788999999999 799999999999999999999999


Q ss_pred             ccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          684 MAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       684 ~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      +++|+|.++++...              ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999986432              135889999999999999999999   6799999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLER  828 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~  828 (919)
                      |||++......   ........+..|+|||++.+..++.++|||||||+++||++ |..||..... .+..+.+.    .
T Consensus       162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~----~  233 (297)
T cd05089         162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLP----Q  233 (297)
T ss_pred             CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHh----c
Confidence            99998642111   01111223567999999988889999999999999999997 9888853221 11111110    0


Q ss_pred             CCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          829 GDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       829 ~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      +         .....+......+.+++.+|++.+|.+||++.++++.|++++...
T Consensus       234 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         234 G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0         001111223346789999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-33  Score=303.19  Aligned_cols=255  Identities=24%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+|+.. +++.||||.++....   .....+.+|+++++.++||||+++++++...+..++++||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            45678999999999999964 789999998864322   22346888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          685 AYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       685 ~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      ++|+|.+++...  ....++......++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-  160 (267)
T cd08228          85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-  160 (267)
T ss_pred             CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence            999999888532  2345788999999999999999999   6699999999999999999999999999988653221 


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc-cchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                       .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......+    .....     +.   
T Consensus       161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~~-----~~---  227 (267)
T cd08228         161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCDY-----PP---  227 (267)
T ss_pred             -HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCCC-----CC---
Confidence             1122346888999999998888999999999999999999999998543221 1111111    11110     00   


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .........+.+++.+||..+|++||++.+|++.|+++.
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            011122346889999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-34  Score=309.74  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=200.6

Q ss_pred             hhhcceeceeCcEEEEEEEEcC------CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD------GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      ..+.+.||+|+||.||+|...+      +..||+|.+..... .....+.+|+.+++.++|+||+++++++......++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   87 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVV   87 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEE
Confidence            3456889999999999998643      36799999864432 2235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccc--------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccC
Q 002461          681 YEYMAYGNLKQYLFDET--------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG  752 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~--------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFG  752 (919)
                      |||+++|+|.+++....        ...++|..++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg  164 (277)
T cd05032          88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFG  164 (277)
T ss_pred             EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcc
Confidence            99999999999986432        224788999999999999999999   6799999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCc
Q 002461          753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDV  831 (919)
Q Consensus       753 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~  831 (919)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+... +.....+.+.    .+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~----~~~~  239 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SNEEVLKFVI----DGGH  239 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-CHHHHHHHHh----cCCC
Confidence            9986543322222334456789999999988889999999999999999998 88887432 2222222211    1110


Q ss_pred             ccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       832 ~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .         ..+......+.+++.+|++.+|++||++.++++.|+
T Consensus       240 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         240 L---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            0         112223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-33  Score=309.23  Aligned_cols=245  Identities=21%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||+||++... +|+.+|+|++......   ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 6889999998754222   235677899999999999999999999999999999999999999


Q ss_pred             hhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          690 KQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       690 ~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      .+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+....  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            9887532  2456899999999999999999999   6699999999999999999999999999997653221  1223


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...|+..|+|||.+.+..++.++|||||||++|||++|+.||................         .....  .++...
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------~~~~~--~~~~~~  224 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---------LNDSV--TYPDKF  224 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---------cccCC--CCcccC
Confidence            4578999999999999999999999999999999999999986432211111100000         00000  112223


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ...+.+++.+|++.+|++||     +++++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            34678899999999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-34  Score=307.64  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=200.1

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-C---CEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-G---SEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-g---~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .++.+.||+|+||.||+|.+.. +   ..||||+++... ....++|..|+.++++++||||+++.+++..+...++|+|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            4567899999999999999753 3   359999987542 2234679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++|+|.+++... ...+++.+++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          86 FMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             cCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999998643 346899999999999999999999   66999999999999999999999999999876533222


Q ss_pred             Cccccc-cc--cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          763 SHISTS-IV--GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       763 ~~~~~~-~~--Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ...... ..  .+..|+|||++.+..++.++|||||||+++|+++ |..||.... ..+..+++....            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~~i~~~~------------  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQDY------------  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcCC------------
Confidence            111111 11  2457999999998999999999999999999886 998885422 222222221110            


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                       ....+.+....+.+++..|++.+|.+||+|.+|++.|+++
T Consensus       229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             0011122345678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=302.71  Aligned_cols=249  Identities=33%  Similarity=0.504  Sum_probs=202.9

Q ss_pred             ceeceeCcEEEEEEEEcC----CCEEEEEEeecCCCCC-chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|....    +..+++|.++...... .+.+.+|++.++.++|+|++++++++......++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999764    7889999997654433 57889999999999999999999999999999999999999


Q ss_pred             CChhhhhhccc-------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          687 GNLKQYLFDET-------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       687 GsL~~~L~~~~-------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ++|.+++....       ...+++.++..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999996542       367999999999999999999999   67999999999999999999999999999987654


Q ss_pred             CCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ...........++..|+|||.+....++.++||||||++++||++ |..||... ...++.+.+..    +.        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~----~~--------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK----GY--------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc----CC--------
Confidence            332233344567889999999988889999999999999999999 58887543 22222222211    10        


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                       ....+......+.+++.+|+..+|++||++.++++.|+
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             00112222457889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-33  Score=308.00  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=194.6

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||.||++... +|+.+|+|.+.....   ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 589999999864321   1234556799999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            99887666667899999999999999999999   6799999999999999999999999999987653221   12335


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||..........+...... .+.+    .  ..   ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~----~--~~---~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEV----K--FE---HQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-cccc----c--cc---cccCCH
Confidence            689999999999988899999999999999999999999854322111111111000 0000    0  00   011233


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+.+++.+|++.+|++||+++|+++.+.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            5789999999999999999988765443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=306.60  Aligned_cols=249  Identities=28%  Similarity=0.472  Sum_probs=194.2

Q ss_pred             ceeceeCcEEEEEEEEcC-CC--EEEEEEeecCC-CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLAD-GS--EVAIKMLSASS-SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|...+ +.  .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999754 43  46888887432 23345788999999999 899999999999999999999999999


Q ss_pred             CChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccC
Q 002461          687 GNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG  752 (919)
Q Consensus       687 GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFG  752 (919)
                      |+|.+++....              ...+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432              135789999999999999999999   5699999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCc
Q 002461          753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDV  831 (919)
Q Consensus       753 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~  831 (919)
                      ++.....   .........+..|+|||++....++.++||||||++++||++ |..||.... .....+.+.    .+  
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~----~~--  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP----QG--  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHh----CC--
Confidence            9863211   111111233567999999988889999999999999999997 888885322 111111111    00  


Q ss_pred             ccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       832 ~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                             ............+.+++.+|+..+|.+||++.++++.|++++
T Consensus       228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 -------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   000111122346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-33  Score=307.91  Aligned_cols=259  Identities=25%  Similarity=0.335  Sum_probs=194.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            344678999999999999975 688999999875432 234567899999999999999999999999999999999998


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      + +|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        87 ~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~  159 (288)
T cd07871          87 S-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KT  159 (288)
T ss_pred             c-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cc
Confidence            4 898888533 345789999999999999999999   6799999999999999999999999999987542221  12


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc------------CCcc
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER------------GDVR  832 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~------------~~~~  832 (919)
                      .....++..|+|||.+.+ ..++.++||||+||++|||++|++||........ ...+......            ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhh
Confidence            234568899999998865 5689999999999999999999999864322111 1111111000            0001


Q ss_pred             cccccccccCC----ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIVDPRLEANF----DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~ivd~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+......    .........+++.+|+..+|.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111110000    0111235678999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-33  Score=302.84  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|.||+|... +++.|++|.+....  ....+.+.+|++++++++|||++++++++...+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            34678999999999999975 68899999986432  2345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.......+++.++..++.+++.||.|||   ..+++|+||||+||+++.++.++|+|||+++......  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~  157 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF  157 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence            999999997665667999999999999999999999   6699999999999999999999999999988653321  12


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||+..+..++.++|+||||++++||++|+.||.... .......+.    .+...         ....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~----~~~~~---------~~~~  223 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKII----RGVFP---------PVSQ  223 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH----cCCCC---------CCcc
Confidence            234568899999999999889999999999999999999999986432 111111111    11110         1111


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .....+.+++.+|++.+|++||+|.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            223468899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.9e-34  Score=310.78  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             HhhhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+.+.+.||+|+||.||+|...      .+..||+|.++..... ....+.+|+.+++.++|+||+++++++......++
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            3455789999999999999754      2457999988644321 23457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccc--------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEecc
Q 002461          680 VYEYMAYGNLKQYLFDET--------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF  751 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~--------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DF  751 (919)
                      ||||+++|+|.+++....        ...+++..+.+++.|++.||.|||   +++++||||||+|||+++++.+||+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcC
Confidence            999999999999996432        234567788999999999999999   679999999999999999999999999


Q ss_pred             CcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCC
Q 002461          752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGD  830 (919)
Q Consensus       752 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~  830 (919)
                      |+++...............++..|+|||.+.+..++.++|||||||+++||++ |..|+... ...+....+    ..+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-~~~~~~~~~----~~~~  238 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFV----MDGG  238 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH----HcCC
Confidence            99986533222222222345678999999998899999999999999999998 67777432 111211111    1111


Q ss_pred             cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       831 ~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .         ...+......+.+++.+|++.+|++||+|.++++.|++.+
T Consensus       239 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 Y---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             C---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0         0112223357899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-33  Score=303.88  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            44568899999999999996 46889999999765544556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.++++.  ...+++..+..++.|++.||.|||   ..+|+|+||||+||+++.++.+||+|||+++......  ...
T Consensus        91 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~  163 (267)
T cd06646          91 GSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKR  163 (267)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--ccc
Confidence            999998853  346899999999999999999999   6699999999999999999999999999998653221  112


Q ss_pred             cccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          767 TSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ....|+..|+|||.+.   ...++.++|||||||+++||++|+.|+.................        ..+....  
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~--  233 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF--------QPPKLKD--  233 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC--------CCCCCcc--
Confidence            2346888999999874   34578899999999999999999999854322111111110000        0011110  


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      .......+.+++.+|+..+|++||+++++++.|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111234688999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-33  Score=304.83  Aligned_cols=253  Identities=27%  Similarity=0.339  Sum_probs=190.9

Q ss_pred             ceeceeCcEEEEEEEEcC---CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLAD---GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   35699998875433 23357888999999999999999999999999999999999999


Q ss_pred             Chhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          688 NLKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       688 sL~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +|.+++....   ....++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996533   234677888899999999999999   6689999999999999999999999999987543222212


Q ss_pred             cccccccCccccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccc
Q 002461          765 ISTSIVGTVGYLDPEYYASN-------RLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd  836 (919)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||........ ....   . .+....+.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~---~-~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYT---V-REQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHH---h-hcccCCCCC
Confidence            22344578889999998642       35789999999999999996 9999854332211 1110   0 011111222


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      +.+..    .....+.+++..|+ .+|++||+++||++.|+
T Consensus       233 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22211    12234677888998 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-33  Score=318.38  Aligned_cols=259  Identities=28%  Similarity=0.468  Sum_probs=198.7

Q ss_pred             HhhhcceeceeCcEEEEEEEE------cCCCEEEEEEeecCCCC-CchhhhHHHHHHHhc-cCcceeeEEeEeecC-CeE
Q 002461          607 TNNFHRILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDG-GNV  677 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~-~~~  677 (919)
                      .+.+.+.||+|+||.||+|..      .+++.||||+++..... ....+.+|+.++.++ +|+||++++++|... ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            356678999999999999973      35778999999754322 235688899999999 689999999988654 467


Q ss_pred             EEEEEeccCCChhhhhhccc------------------------------------------------------------
Q 002461          678 GLVYEYMAYGNLKQYLFDET------------------------------------------------------------  697 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~------------------------------------------------------------  697 (919)
                      ++++||+++|+|.++++...                                                            
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            89999999999999886421                                                            


Q ss_pred             -----cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccC
Q 002461          698 -----KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT  772 (919)
Q Consensus       698 -----~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  772 (919)
                           ...+++.++.+++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...............++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence                 124788899999999999999999   679999999999999999999999999999865322221222233456


Q ss_pred             ccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHH
Q 002461          773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKV  851 (919)
Q Consensus       773 ~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l  851 (919)
                      ..|+|||.+.+..++.++||||||+++|||++ |..|+............    +..+...         ..+......+
T Consensus       245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~  311 (343)
T cd05103         245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----LKEGTRM---------RAPDYTTPEM  311 (343)
T ss_pred             cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH----HhccCCC---------CCCCCCCHHH
Confidence            78999999988899999999999999999997 88887532211111111    1111100         0011112357


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          852 AETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       852 ~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .+++..|++.+|++||++.||++.|+.+++
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.2e-34  Score=318.29  Aligned_cols=246  Identities=19%  Similarity=0.278  Sum_probs=192.3

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +++.+|+|+++...   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999975 57889999997542   22334577888888877 799999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|..++..  ...+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~  153 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT  153 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence            999988743  356899999999999999999999   6699999999999999999999999999987532211  122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCC----ccchhcccccccccCCcccccccccccC
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN----NTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~----~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.....    ......++.+......          ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence            345789999999999999999999999999999999999999853111    1111111111111111          01


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPT------MSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eVv~  874 (919)
                      .+......+.+++.+|++.+|++||+      +.++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            22233446789999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-34  Score=315.70  Aligned_cols=257  Identities=25%  Similarity=0.467  Sum_probs=213.4

Q ss_pred             hhcceeceeCcEEEEEEEEc---CCC--EEEEEEeecC-CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA---DGS--EVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~---~g~--~VAVK~l~~~-~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ...++||.|-||.||+|...   .|+  .||||..+.. .....+.|+.|.-+|++++||||++++|.|.+. ..++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence            45688999999999999953   233  4889988864 445567899999999999999999999999864 6899999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      .++.|.|.++|..+ +..++......++.||+.||+|||   +.+++||||..+|||+....-+||+||||++.+..+..
T Consensus       471 L~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  471 LAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             cccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            99999999999644 456889999999999999999999   67999999999999999999999999999998855444


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      .+. +...-+..|||||.+.-.+++.++|||-|||.+||+++ |..||..-.+ .+...    .+++|.         +-
T Consensus       547 Yka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-sDVI~----~iEnGe---------Rl  611 (974)
T KOG4257|consen  547 YKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-SDVIG----HIENGE---------RL  611 (974)
T ss_pred             hhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-cceEE----EecCCC---------CC
Confidence            333 34455788999999999999999999999999999985 8899864332 22111    122221         23


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETA  885 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~~  885 (919)
                      ..+..+...+..|+.+||..+|.+||++.++...|.++++++..
T Consensus       612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~  655 (974)
T KOG4257|consen  612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI  655 (974)
T ss_pred             CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence            45677888999999999999999999999999999999987754

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=310.13  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +..+.||+|+||+||++... +++.||+|++.....   .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            44678999999999999964 688999999865322   22345778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++|+|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  156 (285)
T cd05605          83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---
Confidence            9999999886555566999999999999999999999   5689999999999999999999999999988653211   


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+...+..+          ...++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~----------~~~~~  225 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKED----------QEEYS  225 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHHhhhc----------ccccC
Confidence            1223468999999999998889999999999999999999999986432211 111111111111          01112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ......+.+++.+|+..+|++||     ++.++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            22334678899999999999999     6777755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.3e-34  Score=317.32  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=192.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC-----CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV  680 (919)
                      .+.+.||+|+||.||+|... +|+.||||+++...  ......+.+|++++++++||||+++++++...     ...++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            45688999999999999965 68999999987432  22345688999999999999999999987543     358999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+. ++|.+++..  ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          83 FELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            99996 689888843  346899999999999999999999   668999999999999999999999999999864322


Q ss_pred             CC-CccccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---------
Q 002461          761 SE-SHISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---------  828 (919)
Q Consensus       761 ~~-~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---------  828 (919)
                      .. ........|+..|+|||++.+  ..++.++|||||||+++||++|++||..... ....+.+......         
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHh
Confidence            21 112234578999999999865  6789999999999999999999999854321 1111111110000         


Q ss_pred             --CCcccccc---c----ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          829 --GDVRSIVD---P----RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       829 --~~~~~ivd---~----~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        ......++   +    .+...++ .....+.+++.+|++.+|++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              00000000   0    0000000 122357889999999999999999999973

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-33  Score=318.43  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=188.7

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            3478999999999999965 6899999998654322 2356889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+..      ...+.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.+....  ....
T Consensus       158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  226 (353)
T PLN00034        158 SLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCN  226 (353)
T ss_pred             cccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccc
Confidence            986543      2456778899999999999999   6699999999999999999999999999998653221  1123


Q ss_pred             ccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          768 SIVGTVGYLDPEYYAS-----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ...|+..|+|||++..     ...+.++|||||||++|||++|+.||...... +....+... ...         ....
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~-~~~---------~~~~  295 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAI-CMS---------QPPE  295 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHH-hcc---------CCCC
Confidence            4578999999998743     23456899999999999999999998632211 111100000 000         0001


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ........+.+++.+||+.+|++||++.|+++.
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112233468899999999999999999999874

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.4e-33  Score=301.24  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=203.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            345688999999999999986 78999999986432   22346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          684 MAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       684 ~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      +++|+|.+++...  ....+++.+++.++.++++||+|||   ..+++|+||||+||+++.++.++|+|||+++......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999999988542  2455899999999999999999999   6799999999999999999999999999987653221


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      .  ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.....  ...+.. .....+....        
T Consensus       161 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~-~~~~~~~~~~--------  227 (267)
T cd08224         161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLC-KKIEKCDYPP--------  227 (267)
T ss_pred             c--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc--cHHHHH-hhhhcCCCCC--------
Confidence            1  12334688899999999888899999999999999999999999853321  111110 0111111000        


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      .........+.+++.+|+..+|++||++.+|+++|+++
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            00112334688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-33  Score=310.17  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-----------------CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-----------------GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG  669 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g  669 (919)
                      +.+.+.||+|+||.||+|...+                 +..||+|++..... ...+.+.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            3456889999999999998642                 24589999875433 23467889999999999999999999


Q ss_pred             EeecCCeEEEEEEeccCCChhhhhhccc---------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          670 YCNDGGNVGLVYEYMAYGNLKQYLFDET---------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       670 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~---------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      ++..++..++++||+++++|.+++....         ...+++..++.++.|++.||+|||   ..+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceee
Confidence            9999999999999999999999986543         126899999999999999999999   5689999999999999


Q ss_pred             CCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCcccCCCccch
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHI  818 (919)
Q Consensus       741 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~~~~~~l  818 (919)
                      +.++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++  |..|+.... ..+.
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~~~~  242 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQQV  242 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-hHHH
Confidence            9999999999999886543332223334556789999999988889999999999999999998  566664322 2222


Q ss_pred             hcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       819 ~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+.+......+......      ..+......+.+++.+|++.+|.+||++.||++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         243 IENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            22222221111111100      111222357899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.3e-34  Score=320.91  Aligned_cols=243  Identities=24%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             hhhcceeceeCcEEEEEEEEcC--CCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD--GSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~--g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+.+.||+|+||.||+|...+  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4567899999999999998643  3689999986432   2334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       112 y~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        112 FVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            9999999999854  346899999999999999999999   679999999999999999999999999999865321  


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+    ..+..          .
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i----~~~~~----------~  246 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-LLIYQKI----LEGII----------Y  246 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-HHHHHHH----hcCCC----------C
Confidence               2345799999999999988899999999999999999999999964321 1111111    11110          0


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRP-----TMSHVVTE  875 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~~  875 (919)
                      ++......+.+++.+|++.+|.+|+     +++++.+.
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1111223567899999999999995     78887763

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-33  Score=308.20  Aligned_cols=254  Identities=28%  Similarity=0.444  Sum_probs=197.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCC----EEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGS----EVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.++||+|+||+||+|.+. +|+    .||+|+++..... ..+.+.+|+.+++.++|+||+++++++... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~   88 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ   88 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence            44588999999999999853 454    4899998754332 345788999999999999999999999754 5779999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++|+|.++++.. ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.......
T Consensus        89 ~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          89 LMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             cCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            99999999998643 346899999999999999999999   66899999999999999999999999999987643222


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ........++..|+|||...+..++.++|||||||++|||++ |..|+.... ...+..++.    .+..         .
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~----~~~~---------~  230 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLE----KGER---------L  230 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH----CCCc---------C
Confidence            211222345678999999988899999999999999999998 888875322 122222211    1110         0


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ..+......+.+++.+|+..+|++||++.++++.|+++..
T Consensus       231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0111223467889999999999999999999998877654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-33  Score=307.94  Aligned_cols=266  Identities=23%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             hhhcceeceeCcEEEEEEEEc-----CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-----DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGL  679 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~L  679 (919)
                      ..+.+.||+|+||.||+|.+.     +++.+|||+++..... ..+.|.+|+++++.++|+||+++++++..  ....++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            345588999999999999864     3678999999755443 35679999999999999999999999877  567899


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      +|||+++++|.+++.... ..+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        86 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999996433 35999999999999999999999   56899999999999999999999999999987642


Q ss_pred             CCCC-ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCccccc
Q 002461          760 ESES-HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVRSIV  835 (919)
Q Consensus       760 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~~iv  835 (919)
                      .... .......++..|+|||.+.+..++.++||||||++++||++|+.|+.......  ..++.....   ...+.+.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF--LRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh--ccccccccccccHHHHHHHH
Confidence            2221 11222345667999999988899999999999999999999998875432211  110000000   00001111


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ........+......+.+++.+|++.+|++||+|.||+++|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111111223345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-33  Score=314.77  Aligned_cols=238  Identities=24%  Similarity=0.330  Sum_probs=187.8

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57889999997542   22334456677777654 899999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...++..+...++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            999998854  346899999999999999999999   6799999999999999999999999999997542221  223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.    ...          ..++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-~~~~~~~i~----~~~----------~~~~~~  218 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-EDELFDSIL----NDR----------PHFPRW  218 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH----cCC----------CCCCCC
Confidence            45579999999999998899999999999999999999999986322 111111111    000          011122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSH  871 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~e  871 (919)
                      ....+.+++.+|++.+|.+||++.+
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChH
Confidence            2335778999999999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-34  Score=319.64  Aligned_cols=243  Identities=22%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||+|+||.||++... +|+.||+|+++...   ......+..|+++++.++|+||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68899999997542   223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|..++..  ...+++.++..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            99988843  3468999999999999999999994  2589999999999999999999999999987532211  1223


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.    .+.      .    .++...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~----~~~------~----~~p~~~  219 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELIL----MEE------I----RFPRTL  219 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHh----cCC------C----CCCCCC
Confidence            45699999999999999999999999999999999999999854321 11111110    000      0    111122


Q ss_pred             HHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRP-----TMSHVVTE  875 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~~  875 (919)
                      ...+.+++.+|++.+|++|+     ++.++++.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            34578899999999999996     89998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-33  Score=317.09  Aligned_cols=249  Identities=25%  Similarity=0.359  Sum_probs=193.3

Q ss_pred             hhcceeceeCcEEEEEEEE----cCCCEEEEEEeecCC----CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL----ADGSEVAIKMLSASS----SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+.+.||+|+||.||+++.    .+++.||+|+++...    ....+.+..|++++..+ +|+||+++++++...+..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            4568899999999999885    357899999987432    22235678899999999 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ||||+++|+|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        83 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          83 ILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            9999999999999853  456899999999999999999999   66899999999999999999999999999986532


Q ss_pred             CCCCccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||......... ..+...+..      .++.
T Consensus       158 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~------~~~~  229 (332)
T cd05614         158 EEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK------CDPP  229 (332)
T ss_pred             cCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc------CCCC
Confidence            221 222345799999999998765 4788999999999999999999998532211111 111100000      0111


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                          .+......+.+++.+|++.+|++||     +++++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                1122234578899999999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.8e-33  Score=302.42  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||+|.. .+++.+|||.+......   ...++.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            34567899999999999995 47899999988654322   235788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          684 MAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       684 ~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      +++++|.+++...  ....+++.....++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            9999999988532  2456899999999999999999999   6799999999999999999999999999987653221


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc-cchhcccccccccCCcccccccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                        .......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ......+    ...     ..+.+ 
T Consensus       161 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~-----~~~~~-  228 (267)
T cd08229         161 --TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQC-----DYPPL-  228 (267)
T ss_pred             --cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh----hcC-----CCCCC-
Confidence              1123456889999999998888999999999999999999999998532211 1111111    100     01111 


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                        ........+.+++.+|+..+|++||+|.+|++.++++
T Consensus       229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              0112334688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-33  Score=302.47  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=192.5

Q ss_pred             ceeceeCcEEEEEEEEc----CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEee-cCCeEEEEEEecc
Q 002461          612 RILGKGGFGTVYHGYLA----DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCN-DGGNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~----~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~-~~~~~~LV~Ey~~  685 (919)
                      +.||+|+||.||+|...    ++..+|+|++.... ....+.+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    23579999885432 223467888999999999999999999875 4556889999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc-
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~-  764 (919)
                      +|+|.+++... ...+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++......... 
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999998643 334678888999999999999999   5689999999999999999999999999997553221111 


Q ss_pred             -cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          765 -ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       765 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                       ......++..|+|||.+.+..++.++||||||+++|||++|..|.....+..+....+.    .+..       .  ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----~~~~-------~--~~  223 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QGRR-------L--LQ  223 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----cCCC-------C--CC
Confidence             11233467789999999888999999999999999999996544333322222222211    1100       0  00


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      +......+.+++..|+..+|++||++.+|++.|+++.
T Consensus       224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            1112346889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-33  Score=303.60  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=198.9

Q ss_pred             ceeceeCcEEEEEEEEcC--CC--EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLAD--GS--EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~--g~--~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|++|.||+|.+.+  ++  .||+|.++.... ...+.+..|+.++++++|+||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999743  33  699999976655 445678999999999999999999999988 889999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-cc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-HI  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-~~  765 (919)
                      |+|.+++.......+++.....++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999996654356899999999999999999999   679999999999999999999999999999876432221 11


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....++..|+|||++.+..++.++||||||++++||++ |+.|+.... ..+..+.+..   ...       .+  ..+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~---~~~-------~~--~~~  223 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQILKKIDK---EGE-------RL--ERP  223 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHh---cCC-------cC--CCC
Confidence            223457789999999998899999999999999999999 999985322 1112221111   000       00  011


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      ......+.+++.+|++.+|++||++.++++.|.
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-33  Score=308.16  Aligned_cols=267  Identities=25%  Similarity=0.408  Sum_probs=200.2

Q ss_pred             HhhhcceeceeCcEEEEEEEE-----cCCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVG  678 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~  678 (919)
                      ++...+.||+|+||.||.+..     .++..||+|.++... ......+.+|++++++++|+|++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            345567899999999999984     357789999987543 22346789999999999999999999998775  5688


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +||||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.+.
T Consensus        85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999998543 335899999999999999999999   6699999999999999999999999999998664


Q ss_pred             CCCCC-ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc---c
Q 002461          759 AESES-HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS---I  834 (919)
Q Consensus       759 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~---i  834 (919)
                      ..... .......++..|+|||++.+..++.++||||||++++||++++.|.......  ..........+.....   .
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL--FLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch--hhhhcccccccccHHHHHHH
Confidence            32221 1222345677899999998888999999999999999999987664322110  0000000000000000   0


Q ss_pred             cccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       835 vd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      +...............+.+++.+|++.+|++||++.++++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000111222345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=300.48  Aligned_cols=248  Identities=29%  Similarity=0.434  Sum_probs=197.2

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      ++||+|+||.||++...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998765433 3467899999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +++... ...+++..++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++...............
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            998543 345889999999999999999999   5689999999999999999999999999987553211111111223


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      ++..|+|||.+.+..++.++|+||||++++||++ |..|+..... ....+.+.    .+         .....+.....
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~~~~~----~~---------~~~~~~~~~~~  222 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIE----SG---------YRMPAPQLCPE  222 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHHHHHh----cC---------CCCCCCccCCH
Confidence            4567999999988899999999999999999999 7777743221 11111111    00         00011222344


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .+.+++.+|+..+|++||++.|+++.|+
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            7889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-33  Score=305.48  Aligned_cols=249  Identities=30%  Similarity=0.462  Sum_probs=196.6

Q ss_pred             ceeceeCcEEEEEEEEcC-------CCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYLAD-------GSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-------g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998643       2579999886543 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccc-----cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-----cEEEeccCc
Q 002461          684 MAYGNLKQYLFDET-----KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-----QAKLADFGF  753 (919)
Q Consensus       684 ~~~GsL~~~L~~~~-----~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-----~vkL~DFGl  753 (919)
                      +++|+|.+++....     ...+++.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532     234789999999999999999999   56899999999999999877     899999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+....+.    .+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-~~~~~~~~~----~~~--  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVT----AGG--  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHh----cCC--
Confidence            976533222222223356788999999999999999999999999999998 998885322 122222111    110  


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                             ....+......+.+++.+|+..+|.+||++.+|.+.|+
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   00111223456789999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=332.46  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             HhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCC--------
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG--------  675 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~--------  675 (919)
                      .+.+.+.||+|+||+||+|.. .+|+.||||++.....  .....+.+|+..+..++|+|++++.+.+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            345678999999999999985 4789999999875432  23456788999999999999999887764332        


Q ss_pred             eEEEEEEeccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          676 NVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       676 ~~~LV~Ey~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            3679999999999999986432  356889999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~  833 (919)
                      ++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+    ..+..  
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-~~~~~~~~----~~~~~--  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKT----LAGRY--  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHH----hcCCC--
Confidence            987643322333445679999999999999999999999999999999999999985321 11111111    01110  


Q ss_pred             ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       834 ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        +     ..+......+.+++.+|++.+|.+||++.++++.
T Consensus       263 --~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 --D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence              0     1122233468899999999999999999999863

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=331.30  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=209.5

Q ss_pred             hhcceeceeCcEEEEEEEEcCC-CEEEEEEeecCCCCCchhhhHHHHHHHhcc-CcceeeEEeEe-ec------CCeEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLADG-SEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYC-ND------GGNVGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g-~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~-~~------~~~~~L  679 (919)
                      .+.+.|.+|||+.||.|....+ .++|+|++-..+....+...+|+++|++|+ |+|||.+++.. ..      .-+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            4568899999999999998766 999999987777777888999999999997 99999999932 11      246889


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      .||||++|.|-+++.......|+..++++|+.++++|+++||.. +++|||||||-+||||+.++..||||||.|.....
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999999766666799999999999999999999965 88999999999999999999999999999864322


Q ss_pred             CCCC--cc-----ccccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC
Q 002461          760 ESES--HI-----STSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG  829 (919)
Q Consensus       760 ~~~~--~~-----~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~  829 (919)
                      ....  .+     .-...-|+.|+|||++.   +..+++|+|||+|||+||-|+....||..+..               
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------------  263 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------------  263 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------------
Confidence            1111  00     01234689999999874   67899999999999999999999999964321               


Q ss_pred             CcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhHH
Q 002461          830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMET  884 (919)
Q Consensus       830 ~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~  884 (919)
                        ..|++....-.........+..||..||+.+|.+||++-+|++.+-+++..+.
T Consensus       264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence              12223232222223456689999999999999999999999999998876543

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.4e-33  Score=301.44  Aligned_cols=246  Identities=29%  Similarity=0.455  Sum_probs=197.1

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEee-cCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN-DGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~-~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||++... |..+|+|.++..  ...+.|.+|+.++++++|+|++++++++. ..+..++++||+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            345688999999999999875 788999998643  23467899999999999999999999764 55678999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++.......+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.....     .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~  156 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q  156 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc-----C
Confidence            99999997655556899999999999999999999   668999999999999999999999999998754221     1


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....++..|+|||++.+..++.++||||||+++|||++ |+.|+... +..+....+.    .+.         ......
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~----~~~---------~~~~~~  222 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVE----KGY---------KMDAPD  222 (256)
T ss_pred             CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHh----cCC---------CCCCCC
Confidence            22345678999999998889999999999999999997 88887432 1112222211    111         011112


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      .....+.+++.+|++.+|++||++.++++.|++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-33  Score=303.31  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             HHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ....+.+.||+|+||.||++...++..+|+|.++... ...+.|.+|++++++++|+|++++.+++.. ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            3456678999999999999998888889999886432 234678899999999999999999999887 77899999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++.......+++.+++.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++...... ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~  159 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTA  159 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC-Cccc
Confidence            999999997655567899999999999999999999   568999999999999999999999999999765322 1112


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....++..|+|||++....++.++|+|||||+++|+++ |+.||... +..+..+++.    .+...         ...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~----~~~~~---------~~~  225 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALE----RGYRM---------PRP  225 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHh----CCCCC---------CCc
Confidence            223345678999999998889999999999999999999 88887532 2222222211    11100         011


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=321.21  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||+|... +|+.||||+++...   ......+.+|++++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            45688999999999999975 68999999997542   233457889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC---
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES---  761 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~---  761 (919)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......   
T Consensus        84 ~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          84 PGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            999999999544  56899999999999999999999   6799999999999999999999999999998653322   


Q ss_pred             ------------------------CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccc
Q 002461          762 ------------------------ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH  817 (919)
Q Consensus       762 ------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~  817 (919)
                                              .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~-  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE-  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH-
Confidence                                    0112234569999999999999999999999999999999999999986443211 


Q ss_pred             hhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 002461          818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT-MSHVVTE  875 (919)
Q Consensus       818 l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-m~eVv~~  875 (919)
                      ....+......          +.-.........+.+++..|+. +|.+||+ +.++++.
T Consensus       238 ~~~~i~~~~~~----------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         238 TYNKIINWKES----------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHhccCCc----------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11111110000          0000001123467788999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-33  Score=301.17  Aligned_cols=248  Identities=27%  Similarity=0.445  Sum_probs=195.7

Q ss_pred             ceeceeCcEEEEEEEEcC----CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++||+|+||.||+|....    +..+|+|.++..... ..+++.+|+++++.+.|+|++++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    268999998755432 3467899999999999999999999876 4568999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc-
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI-  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~-  765 (919)
                      |+|.+++...  ..+++..++.++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999999643  36899999999999999999999   56899999999999999999999999999986633222111 


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ..+....+.+    +..         ...+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~~----~~~---------~~~~  220 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLES----GER---------LPRP  220 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHc----CCc---------CCCC
Confidence            112224568999999998899999999999999999998 899885432 2223332221    110         0111


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ......+.+++.+|+..+|++||++.++++.|++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            22334688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-33  Score=316.72  Aligned_cols=246  Identities=18%  Similarity=0.267  Sum_probs=193.3

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++||+|+||.||++... +++.||+|+++...   ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 68899999997542   22235578899999988 799999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT  153 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence            999988843  356999999999999999999999   679999999999999999999999999998743211  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc----cchhcccccccccCCcccccccccccC
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN----THIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~----~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......    ....++..+.+..+.        .  .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--C
Confidence            3467999999999999999999999999999999999999999532111    111111111111111        0  1


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCC------HHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPT------MSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPs------m~eVv~  874 (919)
                      .+......+.+++.+|++.+|.+||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12222346788999999999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-33  Score=311.55  Aligned_cols=257  Identities=29%  Similarity=0.458  Sum_probs=199.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc--------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA--------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNV  677 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~  677 (919)
                      ..+.+.||+|+||.||++...        ....+|+|+++.... .....+..|+++++++ +|+||+++++++...+..
T Consensus        14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   93 (314)
T cd05099          14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL   93 (314)
T ss_pred             eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence            345789999999999999742        245699999875432 2345688899999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC
Q 002461          678 GLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK  743 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~  743 (919)
                      ++++||+++|+|.+++....              ...+++.+.++++.|++.||.|||   +.+++||||||+|||++++
T Consensus        94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~  170 (314)
T cd05099          94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTED  170 (314)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCC
Confidence            99999999999999986532              245899999999999999999999   6699999999999999999


Q ss_pred             CcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccc
Q 002461          744 MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRV  822 (919)
Q Consensus       744 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v  822 (919)
                      +.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.. .+.....+.+
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~  249 (314)
T cd05099         171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLL  249 (314)
T ss_pred             CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence            9999999999986532222111222234567999999988889999999999999999999 7877742 2222222221


Q ss_pred             ccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          823 CPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       823 ~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                          ..+...         ..+......+.+++.+|+..+|++||++.++++.|+++..
T Consensus       250 ----~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         250 ----REGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                111100         1122233467889999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-33  Score=315.45  Aligned_cols=241  Identities=23%  Similarity=0.316  Sum_probs=192.0

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 57899999997542   22334577888888866 799999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|...+..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT  153 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence            999988853  346899999999999999999999   668999999999999999999999999998754221  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.    .+..          .++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-~~~~~~~i~----~~~~----------~~p~~  218 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-EDDLFESIL----HDDV----------LYPVW  218 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-HHHHHHHHH----cCCC----------CCCCC
Confidence            34568999999999998899999999999999999999999996432 222222111    1110          01111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC-------CHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRP-------TMSHVVT  874 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RP-------sm~eVv~  874 (919)
                      ....+.+++..|+..+|++||       ++.++++
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            224578899999999999999       7777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-33  Score=310.85  Aligned_cols=255  Identities=29%  Similarity=0.484  Sum_probs=197.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCC--EEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGS--EVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~--~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|... ++.  .+|+|.++.... ...+.+.+|++++.++ +|+||+++++++..++..++|+||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            45688999999999999975 454  357777764322 2345788899999999 899999999999999999999999


Q ss_pred             ccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          684 MAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       684 ~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      +++|+|.++++...              ...+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeC
Confidence            99999999986432              235789999999999999999999   6799999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhccccccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLER  828 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~  828 (919)
                      |||+++....   ........++..|+|||++.+..++.++|||||||+++||+| |..||.... ..+..+.+.    .
T Consensus       167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~~----~  238 (303)
T cd05088         167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLP----Q  238 (303)
T ss_pred             ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC-hHHHHHHHh----c
Confidence            9999863211   111112234678999999988889999999999999999998 998885322 111111111    0


Q ss_pred             CCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          829 GDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       829 ~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      +         .....+......+.+++.+|++.+|++||++.++++.|+++++..
T Consensus       239 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         239 G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0         000111122346789999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-34  Score=304.09  Aligned_cols=247  Identities=24%  Similarity=0.421  Sum_probs=207.1

Q ss_pred             HHHhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          605 DITNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       605 ~~t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +..+++.+.||+|.||.|-+|.- ..|++||||.+++..-   ++.-.+++|+++|..|+||||+.++.+|.+.+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45567778999999999999984 6899999999976543   3344678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||..+|.|++++  ..++.|+..+...++.||..|+.|+|   +.+++|||||.+|||||.++++||+||||+-.+.  
T Consensus       132 MEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~--  204 (668)
T KOG0611|consen  132 MEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--  204 (668)
T ss_pred             EEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence            9999999999999  45677999999999999999999999   7799999999999999999999999999998773  


Q ss_pred             CCCccccccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLT-EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                       .....+..+|++-|.+||.+.+.+|. +..|-||+||+||-|+.|.-||+ +.+...+++.+    ..|...+-     
T Consensus       205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-G~Dhk~lvrQI----s~GaYrEP-----  273 (668)
T KOG0611|consen  205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-GRDHKRLVRQI----SRGAYREP-----  273 (668)
T ss_pred             -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-CchHHHHHHHh----hcccccCC-----
Confidence             23456778999999999999998875 68999999999999999999985 33433333332    23322111     


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                            +......-|+.+++..+|++|.|+.+|...
T Consensus       274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 ------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                  112234568889999999999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.1e-34  Score=314.61  Aligned_cols=238  Identities=24%  Similarity=0.327  Sum_probs=193.3

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ...||+|+||.||.|+-+ +|..+|+|++++...   ...+..+.|-.+|....++.||+|+..|++.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            368999999999999965 689999999987643   3346678899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC------
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE------  760 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~------  760 (919)
                      |++..+|  .....|+......++.+++.|++-||   +.++|||||||+|+|||..|++||+||||+.-+...      
T Consensus       226 GD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~  300 (550)
T KOG0605|consen  226 GDMMTLL--MRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY  300 (550)
T ss_pred             ccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence            9999999  45567999999999999999999999   789999999999999999999999999998532110      


Q ss_pred             ----------------CCC------c-----------------cccccccCccccCcccccCCCCCchhhHHHHHHHHHH
Q 002461          761 ----------------SES------H-----------------ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLE  801 (919)
Q Consensus       761 ----------------~~~------~-----------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~E  801 (919)
                                      ...      .                 .....+||+.|||||++.+..|+..+|.||+|||+||
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE  380 (550)
T KOG0605|consen  301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE  380 (550)
T ss_pred             cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence                            000      0                 0113579999999999999999999999999999999


Q ss_pred             HHhCCCCcccCCCc---cchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCC
Q 002461          802 LITGLPAIIRGYNN---THIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT  868 (919)
Q Consensus       802 LltG~~p~~~~~~~---~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs  868 (919)
                      |+.|.+||......   ..++.|...+...              .......+..+||.+|+. +|++|-.
T Consensus       381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  381 MLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999754432   2344443222111              111222467788999998 9999986

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-33  Score=309.43  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=197.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-----------------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-----------------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG  669 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g  669 (919)
                      +.+.+.||+|+||.||++...                 ++..+|+|+++.... ....+|.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            355688999999999998532                 234689999875432 23467899999999999999999999


Q ss_pred             EeecCCeEEEEEEeccCCChhhhhhcccc---------ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          670 YCNDGGNVGLVYEYMAYGNLKQYLFDETK---------EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       670 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~---------~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      ++...+..++||||+++|+|.+++.....         ..+++.+...++.|++.||+|||   +.+++|+||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence            99999999999999999999999865331         24778899999999999999999   6689999999999999


Q ss_pred             CCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCcccCCCccch
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHI  818 (919)
Q Consensus       741 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt--G~~p~~~~~~~~~l  818 (919)
                      +.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..|+..... .+.
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~~~  242 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-EQV  242 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence            9999999999999986533222222223345678999999888889999999999999999998  6677743221 222


Q ss_pred             hcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       819 ~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .....+........ ...     ..+..+...+.+++.+|++.+|.+||+|.+|++.|+
T Consensus       243 ~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         243 IENTGEFFRDQGRQ-VYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHhhcccc-ccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22111111111000 000     011223357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-33  Score=314.60  Aligned_cols=236  Identities=23%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999987532   23345677888888876 699999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~  153 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT  153 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence            999998854  346899999999999999999999   679999999999999999999999999998753211  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+.    .+..          ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~----~~~~----------~~~~~  218 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----NDEV----------VYPTW  218 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHHh----cCCC----------CCCCC
Confidence            34579999999999998899999999999999999999999986332 122222111    1110          01111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCH
Q 002461          847 SVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      ....+.+++.+|++.+|.+||++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            23357889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-33  Score=299.37  Aligned_cols=238  Identities=25%  Similarity=0.389  Sum_probs=188.4

Q ss_pred             ceeceeCcEEEEEEEEcCCC-----------EEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          612 RILGKGGFGTVYHGYLADGS-----------EVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~-----------~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999986433           4788877654433 6789999999999999999999999988 778999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-------cEEEeccCc
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-------QAKLADFGF  753 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-------~vkL~DFGl  753 (919)
                      +||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999986543 26899999999999999999999   67999999999999999887       799999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhC-CCCcccCCCccchhcccccccccCC
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASN--RLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGD  830 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~l~~~v~~~~~~~~  830 (919)
                      +.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+.... ......+.    ....
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~----~~~~  223 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFY----QDQH  223 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHH----hcCC
Confidence            886532      1233567789999998876  789999999999999999995 56654321 11111110    0000


Q ss_pred             cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       831 ~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                                 ..+......+.+++.+|+..+|.+||++.+|++.|+
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 -----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                       001111157889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-33  Score=301.88  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=186.6

Q ss_pred             eeceeCcEEEEEEEEcCC---CEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          613 ILGKGGFGTVYHGYLADG---SEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .||+|+||.||+|...++   ..+|+|.+..... .....|.+|++.++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            589999999999986443   4678887754332 223568899999999999999999999999999999999999999


Q ss_pred             hhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          689 LKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       689 L~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      |.+++....   ....++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999986543   233567888999999999999999   66899999999999999999999999999875432221111


Q ss_pred             ccccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccc
Q 002461          766 STSIVGTVGYLDPEYYAS-------NRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||....+.. .....   ...+. ..+.++
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~---~~~~~-~~~~~~  233 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQV---VREQD-IKLPKP  233 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHH---hhccC-ccCCCC
Confidence            223346778999998643       356789999999999999999 677775332211 11111   11111 111222


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      .+.    ......+.+++..|+ .+|++||++++|++.|
T Consensus       234 ~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 QLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            221    122335667888888 4999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-33  Score=321.49  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=191.0

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.||+|+||+||+|... +++.||+|+++...   ....+.+..|++++++++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            4578999999999999864 67899999997542   2234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC---
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE---  762 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~---  762 (919)
                      +|+|.+++..  ...+++.....++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        85 gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          85 GGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999854  346888999999999999999999   67999999999999999999999999999764311000   


Q ss_pred             ------------------------------------------CccccccccCccccCcccccCCCCCchhhHHHHHHHHH
Q 002461          763 ------------------------------------------SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL  800 (919)
Q Consensus       763 ------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~  800 (919)
                                                                ........||..|+|||.+.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                      00112357999999999999888999999999999999


Q ss_pred             HHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHh--cCCCCCCCCCCHHHHHHH
Q 002461          801 ELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAME--CVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       801 ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPsm~eVv~~  875 (919)
                      ||++|+.||.......... .+...  ....      ....  .......+.+++.+  |+..++..||++.++++.
T Consensus       240 elltG~~Pf~~~~~~~~~~-~i~~~--~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQL-KVINW--ENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHH-HHHcc--cccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999996543221111 11100  0000      0000  00112245556655  667777789999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-33  Score=313.38  Aligned_cols=262  Identities=28%  Similarity=0.452  Sum_probs=203.2

Q ss_pred             HHHhhhcceeceeCcEEEEEEEEc--------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEeecC
Q 002461          605 DITNNFHRILGKGGFGTVYHGYLA--------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDG  674 (919)
Q Consensus       605 ~~t~~~~~~LG~G~fG~Vyk~~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~  674 (919)
                      ...+.+.+.||+|+||.||++...        .+..||+|.++.... ...+++.+|+++++++ +|+||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            345567789999999999999742        123689998875432 2346788999999999 799999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhccc--------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          675 GNVGLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       675 ~~~~LV~Ey~~~GsL~~~L~~~~--------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      +..++++||+++|+|.+++....              ...++|.+++.++.|++.||+|||   ..+++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            99999999999999999986432              235889999999999999999999   6799999999999999


Q ss_pred             CCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchh
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIV  819 (919)
Q Consensus       741 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~  819 (919)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||... +.....
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence            9999999999999986532221111222334568999999998899999999999999999998 77777432 211111


Q ss_pred             cccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       820 ~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      ..+    ..+..         ...+......+.+++.+|++.+|.+||+|.|+++.|+++....
T Consensus       247 ~~~----~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         247 KLL----KEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHH----HcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            111    11110         0111223346889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-33  Score=303.40  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             hhhcceeceeCcEEEEEEEEc-C---CCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-D---GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~---g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +++.+.||+|+||.||+|... +   +..+|+|.++.... ...+.|..|+.++++++||||+++++++..++..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            345789999999999999864 2   33699999865432 224578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+|||++.++.++|+|||+++.+.....
T Consensus        86 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          86 YMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999999996443 45899999999999999999999   67899999999999999999999999999987643221


Q ss_pred             Ccc-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          763 SHI-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       763 ~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      ... .....++..|+|||++.+..++.++||||||++++|+++ |..||.... ..+....+.+..   .          
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~---~----------  227 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEGY---R----------  227 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCCC---c----------
Confidence            111 112233568999999998899999999999999999886 999885432 122222221110   0          


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                      ..........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            011112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-33  Score=313.30  Aligned_cols=237  Identities=22%  Similarity=0.321  Sum_probs=187.1

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHH---HhccCcceeeEEeEeecCCeEEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLL---MRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L---~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+.||+|+||.||+|... +|+.||||+++...   ....+.+..|++++   +.++||||+++++++...+..++|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            4578999999999999865 68899999997542   22234566666655   46679999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++|+|...++.   ..+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--  154 (324)
T cd05589          83 YAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--  154 (324)
T ss_pred             CCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--
Confidence            9999999988743   46999999999999999999999   679999999999999999999999999998753221  


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+    ..+.      .    .
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i----~~~~------~----~  219 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSI----VNDE------V----R  219 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHH----HhCC------C----C
Confidence            1223346799999999999998999999999999999999999999853321 1111111    0110      0    1


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      ++......+.+++.+|+..+|.+||++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence            111223457889999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-33  Score=312.80  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=192.7

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||+||+|... +++.||||+++...   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 57889999997542   23345677888898888 699999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|..++..  ...+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT  153 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence            999988853  346899999999999999999999   679999999999999999999999999998743211  1122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.    ....          .++..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~i~----~~~~----------~~~~~  218 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQSIL----EDEV----------RYPRW  218 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHHHH----cCCC----------CCCCc
Confidence            34568999999999999999999999999999999999999985332 111111111    1100          11112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTM-----SHVVT  874 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm-----~eVv~  874 (919)
                      ....+.+++.+|+..+|.+||++     .++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            23467899999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4e-34  Score=318.50  Aligned_cols=238  Identities=24%  Similarity=0.330  Sum_probs=190.9

Q ss_pred             ceeceeCcEEEEEEEE----cCCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          612 RILGKGGFGTVYHGYL----ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l----~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.||+|+||.||++..    .+|+.+|+|+++....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3688999999975422  223457789999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~  154 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK  154 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence            9999999843  356899999999999999999999   678999999999999999999999999998764322  112


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.    ....          ..+.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~----~~~~----------~~p~  219 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMIL----KAKL----------GMPQ  219 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHH----cCCC----------CCCC
Confidence            2345789999999999988899999999999999999999999863321 11111111    0100          1111


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSH  871 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~e  871 (919)
                      .....+.+++.+|++.+|++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            22345778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=290.17  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=208.2

Q ss_pred             HhhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecC-----CeEEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGLV  680 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV  680 (919)
                      ++.+.+.||+|||+-||.++ +.++..+|+|++.....++.+..++|++..++++|||++++++++..+     ...+|+
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            45667899999999999998 567889999999877767778899999999999999999999987543     358999


Q ss_pred             EEeccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          681 YEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      ++|...|+|.+.+....  +..++..+.+.|+.++++||++||.. .++++||||||.|||+.+.+.+++.|||.++...
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~  180 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP  180 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence            99999999999986543  44699999999999999999999965 5579999999999999999999999999987653


Q ss_pred             CCCCC----c---cccccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc
Q 002461          759 AESES----H---ISTSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER  828 (919)
Q Consensus       759 ~~~~~----~---~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~  828 (919)
                      -.-..    .   .......|..|+|||.+.   +...++++|||||||+||+|+.|..||.........+..+.   ..
T Consensus       181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv---~n  257 (302)
T KOG2345|consen  181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV---QN  257 (302)
T ss_pred             eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee---ec
Confidence            21111    0   112345789999999985   44678999999999999999999999976544333222221   11


Q ss_pred             CCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          829 GDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       829 ~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      +        .+.-.-+..-.+.+.+++.+|++.+|.+||++.+++..+..+.
T Consensus       258 ~--------q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  258 A--------QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             c--------ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1        1111111123457899999999999999999999999887654

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-33  Score=307.63  Aligned_cols=252  Identities=30%  Similarity=0.515  Sum_probs=198.1

Q ss_pred             hhcceeceeCcEEEEEEEEc------CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.||+|+||.||+|...      ++..||+|+++.... ...++|.+|+.++++++|+||+++++++..+...++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            44678999999999999864      467899999875432 22456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhccc--------------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC
Q 002461          682 EYMAYGNLKQYLFDET--------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN  741 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~--------------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld  741 (919)
                      ||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   ..+++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEec
Confidence            9999999999986432                    124788899999999999999999   56899999999999999


Q ss_pred             CCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhc
Q 002461          742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVN  820 (919)
Q Consensus       742 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~  820 (919)
                      +++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||... ...+...
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~~~~~~  243 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEEVIY  243 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence            999999999999876533222222223345678999999988899999999999999999997 77777422 1112211


Q ss_pred             ccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          821 RVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       821 ~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .    ...+...         ..+......+.+++.+|++.+|++||++.|+++.|+
T Consensus       244 ~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         244 Y----VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H----HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1    1111111         011223356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-33  Score=311.16  Aligned_cols=240  Identities=23%  Similarity=0.332  Sum_probs=189.8

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +++.||||+++...   ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57889999997542   22334566777888764 899999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence            999999853  346899999999999999999999   669999999999999999999999999998753211  1122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.    .+.      +.    ++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~i~----~~~------~~----~~~~  218 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQSIR----MDN------PC----YPRW  218 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH----hCC------CC----CCcc
Confidence            34578999999999998899999999999999999999999986432 122222111    110      11    1111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMS-HVV  873 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~-eVv  873 (919)
                      ....+.+++.+|++.+|++||++. ++.
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            223577899999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-33  Score=311.86  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=190.2

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +|+.||+|+++...   ......+..|..++... +|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 68899999997542   22334566788887754 899999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA  153 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence            999998854  356889999999999999999999   67999999999999999999999999999874311  11223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+.    .+      .+.    ++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-~~~~~~~~~----~~------~~~----~~~~  218 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFESIR----VD------TPH----YPRW  218 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHH----hC------CCC----CCCC
Confidence            45679999999999999999999999999999999999999986332 122222111    00      011    1111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMS-HVV  873 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~-eVv  873 (919)
                      ....+.+++.+|++.+|++||++. ++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            234577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-34  Score=305.33  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=197.3

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCC-----eEEEEEEec
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG-----NVGLVYEYM  684 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~-----~~~LV~Ey~  684 (919)
                      .+++|.|+||.||+|.+. +++.||||+.-....    .-..|+++|+++.|||||+++-++....     ...||||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            478999999999999975 568999999754332    2346999999999999999998885432     345899999


Q ss_pred             cCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCCCC
Q 002461          685 AYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAES  761 (919)
Q Consensus       685 ~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~~~  761 (919)
                      +. +|.+.++..  .+..++.....-+..|+.+||+|||   ..+|+||||||+|+|+|.+ |.+||||||.|+.+....
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            96 999988643  2566888888999999999999999   6799999999999999976 899999999999874332


Q ss_pred             CCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC---cc-----
Q 002461          762 ESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---VR-----  832 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~---~~-----  832 (919)
                      .   ...+..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|. +.+..+....+.+.+....   +.     
T Consensus       181 p---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp-G~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  181 P---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP-GDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             C---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC-CCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            2   245678999999999875 579999999999999999999987664 4444444444443333211   11     


Q ss_pred             --ccccccccc-----CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHHHHh
Q 002461          833 --SIVDPRLEA-----NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKCLE  881 (919)
Q Consensus       833 --~ivd~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~--~Le~~~~  881 (919)
                        +.-.+.+..     -+........++++.+++..+|.+|.++.|+++  .+.+++.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence              111111111     123344557889999999999999999999986  3555543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.7e-33  Score=301.18  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=187.8

Q ss_pred             ceeceeCcEEEEEEEEcCCC---EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLADGS---EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~---~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||+|+||.||+|...++.   .+++|.++.... ...+.|.+|+.+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            35999999999999865443   456666654332 33567999999999999999999999999999999999999999


Q ss_pred             Chhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          688 NLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       688 sL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|.+++....  ...+.+.....++.|+++||+|||   +.+++|+||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999996542  234667778899999999999999   56899999999999999999999999999864322211122


Q ss_pred             ccccccCccccCcccccC-------CCCCchhhHHHHHHHHHHHHhC-CCCcccCCCccchhcccccccccCCccccccc
Q 002461          766 STSIVGTVGYLDPEYYAS-------NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+.... .......   ... +....+.++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~---~~~-~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNH---VIK-DQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH---HHh-hcccccCCC
Confidence            234567889999998753       2457899999999999999975 55664322 2111111   111 112233344


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      .+...++    ..+.+++..|+ .+|++||++++|++.|
T Consensus       233 ~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         233 QLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            4433222    35677888899 5799999999999877

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-33  Score=320.51  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=191.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||++... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|++. 
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            445688999999999999964 68899999753      2356789999999999999999999999999999999985 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus       167 ~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~  240 (391)
T PHA03212        167 TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKY  240 (391)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccccc
Confidence            688888743  346899999999999999999999   669999999999999999999999999999754221 11223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc------cchhccccccccc----------CC
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN------THIVNRVCPFLER----------GD  830 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~------~~l~~~v~~~~~~----------~~  830 (919)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+......      ......+......          ..
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            3457999999999999989999999999999999999999887543210      0011111000000          00


Q ss_pred             ccccc---------ccccccCC--ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRSIV---------DPRLEANF--DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~iv---------d~~l~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +....         .+......  .......+.+++.+|++.+|.+|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000         00000000  0012346788999999999999999999986

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-33  Score=312.21  Aligned_cols=239  Identities=23%  Similarity=0.313  Sum_probs=189.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCc-ceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHR-NLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~-NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45688999999999999975 57789999997542   23345678899999999765 588899999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        83 ~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~  155 (324)
T cd05587          83 VNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G  155 (324)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence            999999998843  346889999999999999999999   679999999999999999999999999998743211  1


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..    ..          ..+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i~~----~~----------~~~  220 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-EDELFQSIME----HN----------VSY  220 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHc----CC----------CCC
Confidence            12234579999999999999999999999999999999999999986332 1222221111    10          011


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      +......+.+++.+|+..+|.+|++.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            12223467889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.8e-33  Score=305.95  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||||++++
T Consensus        23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~  102 (296)
T cd06654          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (296)
T ss_pred             eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence            3457899999999999985 468899999998665555677899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++..   ..+++.++..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++.......  ....
T Consensus       103 ~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~  174 (296)
T cd06654         103 SLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS  174 (296)
T ss_pred             CHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccC
Confidence            99999843   35889999999999999999999   6689999999999999999999999999987653221  1123


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...|+..|+|||.+.+..++.++|||||||+++||++|+.||.............    ..+.      +.+  ..+...
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~--~~~~~~  242 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----TNGT------PEL--QNPEKL  242 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----cCCC------CCC--CCcccc
Confidence            3468899999999998889999999999999999999999986433211111111    0000      000  011122


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+.+++.+|+..+|++||++.++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            345788999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.1e-33  Score=300.23  Aligned_cols=239  Identities=25%  Similarity=0.386  Sum_probs=187.1

Q ss_pred             ceeceeCcEEEEEEEEcC-------------CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEE
Q 002461          612 RILGKGGFGTVYHGYLAD-------------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-------------g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~  678 (919)
                      +.||+|+||.||+|++..             ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998542             2258999887655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCc-------EEEecc
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ-------AKLADF  751 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~-------vkL~DF  751 (919)
                      +||||+++|+|..++... ...+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999887543 345899999999999999999999   679999999999999987654       899999


Q ss_pred             CcccccCCCCCCccccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCcccCCCccchhcccccccccC
Q 002461          752 GFSKIFPAESESHISTSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELI-TGLPAIIRGYNNTHIVNRVCPFLERG  829 (919)
Q Consensus       752 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELl-tG~~p~~~~~~~~~l~~~v~~~~~~~  829 (919)
                      |++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..... .+..    .... +
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~----~~~~-~  224 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKE----RFYE-G  224 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHH----HHHh-c
Confidence            998754211      2345788999999886 466899999999999999998 57777642211 1100    0000 0


Q ss_pred             CcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       830 ~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      .. .         ........+.+++.+||+.+|.+||++.++++.|
T Consensus       225 ~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             Cc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00 0         0111234678999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.5e-33  Score=304.33  Aligned_cols=244  Identities=25%  Similarity=0.328  Sum_probs=193.5

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ..+.||+|+||+||+|... +++.+|+|.+.....   .....+.+|++++++++|+|++++.+++..++..+++|||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            3578999999999999974 688999999865422   223457889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......   .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~  157 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S  157 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence            999999886555557999999999999999999999   6789999999999999999999999999987543211   1


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||++.+..++.++|+||||++++||++|..||....+.... +.+......+.          ..+..
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~~~~~~~----------~~~~~  226 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDRRVLETE----------EVYSA  226 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhhccc----------cccCc
Confidence            23456899999999999889999999999999999999999998643221111 11111111110          01111


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMS  870 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~  870 (919)
                      .....+.+++..|++.+|++||++.
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         227 KFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             cCCHHHHHHHHHHccCCHhHcCCCc
Confidence            2233578899999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.1e-33  Score=316.36  Aligned_cols=198  Identities=24%  Similarity=0.448  Sum_probs=170.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||++... +++.||+|+++...   ......+..|+.++.+++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            34678999999999999865 58899999997532   222356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC--
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE--  762 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~--  762 (919)
                      ++|+|.+++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        84 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          84 PGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999854  356899999999999999999999   67999999999999999999999999999875422110  


Q ss_pred             -------------------------------CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          763 -------------------------------SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       763 -------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                                                     ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                           0011235799999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-33  Score=304.24  Aligned_cols=238  Identities=27%  Similarity=0.369  Sum_probs=185.3

Q ss_pred             eeceeCcEEEEEEEEcC-------------------------CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeE
Q 002461          613 ILGKGGFGTVYHGYLAD-------------------------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL  667 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l  667 (919)
                      .||+|+||.||+|.+..                         ...||+|++..........|.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998521                         13488998865544444678889999999999999999


Q ss_pred             EeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC---
Q 002461          668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---  744 (919)
Q Consensus       668 ~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~---  744 (919)
                      +++|......++||||+++|+|..++... ...+++..++.++.|+++||+|||   ..+|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999988543 346899999999999999999999   67999999999999997643   


Q ss_pred             ----cEEEeccCcccccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCcccCCCccch
Q 002461          745 ----QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELI-TGLPAIIRGYNNTHI  818 (919)
Q Consensus       745 ----~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELl-tG~~p~~~~~~~~~l  818 (919)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+..... ...
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK  230 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence                4899999987643211      12357788999998865 56899999999999999995 78888753321 111


Q ss_pred             hcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       819 ~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ....    ...       ..    .+......+.+++.+|++.+|++||+|.+|++.|
T Consensus       231 ~~~~----~~~-------~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ERFY----EKK-------HR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHH----Hhc-------cC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1110    000       00    1111123578899999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.8e-33  Score=296.59  Aligned_cols=248  Identities=29%  Similarity=0.526  Sum_probs=198.3

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.+.||+|+||.||+|...++..+|+|.++... .....|.+|++++++++|+|++++++++......++|+||+++++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC   85 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence            4568899999999999998878899999986432 234678999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++... ...+++..+..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++...... ......
T Consensus        86 L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~  160 (256)
T cd05112          86 LSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG  160 (256)
T ss_pred             HHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence            99998543 345889999999999999999999   5689999999999999999999999999987653221 111122


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ....+.+.    .+.  ....+.       ..
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~----~~~--~~~~~~-------~~  226 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETIN----AGF--RLYKPR-------LA  226 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHh----CCC--CCCCCC-------CC
Confidence            335678999999998889999999999999999998 8888853221 12222111    110  001111       12


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ...+.+++.+|++.+|++||++.+++++|
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            34688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.9e-33  Score=300.79  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=199.7

Q ss_pred             hhhcceeceeCcEEEEEEEEcCC----CEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLADG----SEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g----~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ..+.+.||+|+||.||+|...+.    ..||||...... ....+.+.+|+.++++++|+||+++++++.. ...++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            44578999999999999986432    468999886543 2334678999999999999999999999875 45789999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++|+|.+++... ...+++.+++.++.+++.||+|||   ..+++|+||||+||+++.++.+||+|||+++...... 
T Consensus        87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  161 (270)
T cd05056          87 LAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-  161 (270)
T ss_pred             cCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc-
Confidence            99999999999543 345899999999999999999999   6689999999999999999999999999998653321 


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ........++..|+|||.+....++.++||||||++++|+++ |..||..... .+...++.    .+.-       +  
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~----~~~~-------~--  227 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIE----NGER-------L--  227 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH----cCCc-------C--
Confidence            111222334568999999988889999999999999999986 9999854332 22222211    1110       0  


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      ..+......+.+++.+|+..+|++||++.++++.|++++..
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            01122334688899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-33  Score=304.53  Aligned_cols=241  Identities=23%  Similarity=0.392  Sum_probs=189.0

Q ss_pred             ceeceeCcEEEEEEEEcC--------CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.||+|+||.||+|....        ...+|+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998642        234888888655444456789999999999999999999999998999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCc--------EEEeccCccc
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ--------AKLADFGFSK  755 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~--------vkL~DFGla~  755 (919)
                      +++|+|.++++... ..+++..+++++.|++.||+|||   +.+|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999986543 36899999999999999999999   679999999999999987765        6999999886


Q ss_pred             ccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccc
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI  834 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~i  834 (919)
                      ....      .....++..|+|||++.+ ..++.++||||||+++|||++|..++....+........    ..      
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~----~~------  220 (258)
T cd05078         157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY----ED------  220 (258)
T ss_pred             ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH----Hc------
Confidence            5422      123457889999999876 457899999999999999999954433222211111100    00      


Q ss_pred             cccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       835 vd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                           ....+......+.+++.+|++.+|++||+++++++.|+
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 01112222346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-33  Score=302.23  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-CC----EEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-GS----EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-g~----~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      ..+.+.||+|+||.||+|...+ |.    .+|+|+++.... ....++.+|+.++++++|+||++++++|.. ...++|+
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   87 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT   87 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence            3556889999999999999643 33    589998865533 234578899999999999999999999987 7889999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++|+|.+++... ...+++...+.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......
T Consensus        88 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          88 QLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             ecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            999999999998653 335899999999999999999999   5799999999999999999999999999998764322


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      .........++..|+|||.+....++.++|+||||++++|+++ |+.|+.... ..++.+.+.    .+..         
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~----~~~~---------  229 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDLLE----KGER---------  229 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHh----CCCC---------
Confidence            2222222234578999999988889999999999999999998 999885322 222222211    1110         


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ...+......+.+++.+|+..+|.+||++.++++.|+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            01111223467889999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=296.42  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=197.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-----CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-----GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ...+.||+|++|.||+|... +++.+|+|.+......     ..+.+.+|++++++++||||+++++++......++|+|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            34688999999999999864 6899999998644221     23468889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+++++|.+++..  ...+++.....++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++.......
T Consensus        85 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          85 YMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             ECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            9999999998853  345889999999999999999999   66999999999999999999999999999876532211


Q ss_pred             Ccc-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHI-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...   ..         ....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~---~~---------~~~~  226 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIA---TQ---------PTNP  226 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHh---cc---------CCCC
Confidence            111 123457889999999999889999999999999999999999986432211111 110   00         0011


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ..+......+.+++.+|+..+|.+||++.++++.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            1222233467889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=319.05  Aligned_cols=249  Identities=21%  Similarity=0.343  Sum_probs=193.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||+|... +|+.||||+++...   ......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34588999999999999975 68899999997532   223456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-  763 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-  763 (919)
                      ++|+|.+++..  ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          84 PGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999854  346899999999999999999999   668999999999999999999999999998754211100 


Q ss_pred             -----------------------------------ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002461          764 -----------------------------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPA  808 (919)
Q Consensus       764 -----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p  808 (919)
                                                         .......||+.|+|||++....++.++|||||||+++||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                               001124699999999999988999999999999999999999999


Q ss_pred             cccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCC---HHHHHH
Q 002461          809 IIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT---MSHVVT  874 (919)
Q Consensus       809 ~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eVv~  874 (919)
                      |..... ......+....  ..        +...........+.+++.+|+. +|.+|++   +.++++
T Consensus       239 f~~~~~-~~~~~~i~~~~--~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNP-QETYRKIINWK--ET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCH-HHHHHHHHcCC--Cc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            964321 11111111100  00        0000000112356678888886 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=321.27  Aligned_cols=264  Identities=25%  Similarity=0.329  Sum_probs=207.4

Q ss_pred             HHHHHHHHhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-C-----cceeeEEeEee
Q 002461          600 YSEIVDITNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-H-----RNLASLVGYCN  672 (919)
Q Consensus       600 ~~ei~~~t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H-----~NIv~l~g~~~  672 (919)
                      ..|...-++.+.+.||+|.||.|-||.. .+++.||||+++.... -..+-..|+.+|..|+ |     -|+|++++||.
T Consensus       180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            3444444666789999999999999995 4689999999985432 2355677999999997 4     37999999999


Q ss_pred             cCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC--CcEEEec
Q 002461          673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK--MQAKLAD  750 (919)
Q Consensus       673 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~--~~vkL~D  750 (919)
                      ..++.|||+|.+.. ||+++|+.+....++......|+.||+.||.+||   +.+|||+||||+||||.+.  ..+||+|
T Consensus       259 fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  259 FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEe
Confidence            99999999998864 9999999988889999999999999999999999   7799999999999999754  4799999


Q ss_pred             cCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC
Q 002461          751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD  830 (919)
Q Consensus       751 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~  830 (919)
                      ||.+.....     ....+.-+..|+|||++.+.+|+.+.||||||||+.||++|. |+..+.+..+....+.+.+....
T Consensus       335 FGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e~lG~Pp  408 (586)
T KOG0667|consen  335 FGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIEVLGLPP  408 (586)
T ss_pred             cccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHHHhCCCC
Confidence            999986422     222567788999999999999999999999999999999994 55566665555555443322100


Q ss_pred             ---------ccccccc-----------------------------cc-----------ccCCChhHHHHHHHHHHhcCCC
Q 002461          831 ---------VRSIVDP-----------------------------RL-----------EANFDTNSVWKVAETAMECVPS  861 (919)
Q Consensus       831 ---------~~~ivd~-----------------------------~l-----------~~~~~~~~~~~l~~l~~~Cl~~  861 (919)
                               ....++.                             ..           ........-..+.+++.+|+..
T Consensus       409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~  488 (586)
T KOG0667|consen  409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW  488 (586)
T ss_pred             HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence                     0000110                             00           0011123445689999999999


Q ss_pred             CCCCCCCHHHHHH
Q 002461          862 ISFQRPTMSHVVT  874 (919)
Q Consensus       862 ~P~~RPsm~eVv~  874 (919)
                      ||.+|+|..++++
T Consensus       489 dP~~R~tp~qal~  501 (586)
T KOG0667|consen  489 DPAERITPAQALN  501 (586)
T ss_pred             CchhcCCHHHHhc
Confidence            9999999999987

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-32  Score=297.71  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            345678999999999999864 6889999998766544456688899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++..  ...+++.+.+.++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||++......  ....
T Consensus        91 ~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~  163 (267)
T cd06645          91 GSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKR  163 (267)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccc
Confidence            999998843  346899999999999999999999   568999999999999999999999999998765321  1122


Q ss_pred             cccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          767 TSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ....|+..|+|||++.   ...++.++|||||||++|||++|..|+..............     ...   ..+..... 
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-----~~~---~~~~~~~~-  234 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----SNF---QPPKLKDK-  234 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----cCC---CCCccccc-
Confidence            3456899999999874   45688899999999999999999999854332111111100     000   00111100 


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       ......+.+++.+|+..+|++||+++++++
T Consensus       235 -~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         235 -MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence             011235788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.5e-33  Score=299.64  Aligned_cols=246  Identities=23%  Similarity=0.371  Sum_probs=193.5

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ...||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            357999999999999965 5778999998766555567889999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccC--ChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCcccccCCCCCCccc
Q 002461          690 KQYLFDETKEAL--SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       690 ~~~L~~~~~~~l--s~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      .+++.... ..+  ++..+..++.|++.||+|||   ..+|+||||||+||+++. ++.++|+|||++.......  ...
T Consensus        93 ~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~  166 (268)
T cd06624          93 SALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCT  166 (268)
T ss_pred             HHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Ccc
Confidence            99986532 234  78888999999999999999   669999999999999986 6799999999987653221  122


Q ss_pred             cccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          767 TSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ....|+..|+|||++....  ++.++||||||+++|||++|+.|+....... ...+......           .....+
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-~~~~~~~~~~-----------~~~~~~  234 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMFKVGMFK-----------IHPEIP  234 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-hhHhhhhhhc-----------cCCCCC
Confidence            2345889999999986543  7889999999999999999999985432111 1111100000           001112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            223346788999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=291.32  Aligned_cols=201  Identities=29%  Similarity=0.459  Sum_probs=177.2

Q ss_pred             cCHHHHHHHHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCC---chhhhHHHHHHHhccCcceeeEEeEeec
Q 002461          598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCND  673 (919)
Q Consensus       598 ~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~~L~~l~H~NIv~l~g~~~~  673 (919)
                      +.+++.     ++.+.||.|+||+|..++.+ +|..+|+|++++..--.   .+...+|..+|+.+.||.++++.+.|.+
T Consensus        41 ~~l~df-----e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDF-----ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhh-----hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            555554     33578999999999999976 57889999998654322   3446789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       674 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      .+..+|||||+++|.|.++|+.  .++++.....-+|.+|+.||+|||   +..|++|||||+|||||.+|.+||.|||+
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccc
Confidence            9999999999999999999954  456999999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY  813 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~  813 (919)
                      |+....     .....+||+.|+|||.+..+.+...+|.|||||++|||+.|.+||....
T Consensus       191 AK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  191 AKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             eEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            997632     2457899999999999999999999999999999999999999997543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-32  Score=297.24  Aligned_cols=247  Identities=27%  Similarity=0.434  Sum_probs=193.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecC------CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDG------GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~------~~~~LV  680 (919)
                      ...+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+|++++++++...      ...+++
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            44578999999999999975 57889999987543 3446788899999998 799999999998653      468899


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            99999999999987655567899999999999999999999   568999999999999999999999999998765321


Q ss_pred             CCCccccccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                        ........|+..|+|||++.     ...++.++|||||||++|||++|+.|+........... .   . ....    
T Consensus       165 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-~---~-~~~~----  233 (272)
T cd06637         165 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-I---P-RNPA----  233 (272)
T ss_pred             --cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-H---h-cCCC----
Confidence              11233456899999999985     34578899999999999999999999854322111100 0   0 0000    


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       +.+   ........+.+++.+|+..+|.+||++.++++
T Consensus       234 -~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         234 -PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             011   01112346789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1e-33  Score=316.66  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=195.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||++... +|+.||+|+++....   ...+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            45688999999999999965 688999999975422   23456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++... ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus        84 ~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~  158 (330)
T cd05601          84 PGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MV  158 (330)
T ss_pred             CCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-ce
Confidence            999999998543 346899999999999999999999   6799999999999999999999999999998663222 12


Q ss_pred             cccccccCccccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYA------SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........ ...+.   .........   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~---~~~~~~~~~---  231 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIM---NFQRFLKFP---  231 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHH---cCCCccCCC---
Confidence            233457899999999986      45678899999999999999999999864332111 11111   101000000   


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          ........+.+++..|+. +|.+||++.++++
T Consensus       232 ----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         232 ----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                011123457788889997 9999999999886

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2e-33  Score=313.64  Aligned_cols=237  Identities=27%  Similarity=0.361  Sum_probs=186.8

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHH-HHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQ-LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~-~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||+||+|... +|+.||+|++....   ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999997532   122234455544 56789999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++.....++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT  153 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence            999998853  456889999999999999999999   669999999999999999999999999998753221  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.    .+..      .+.    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~----~~~~------~~~----~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNIL----NKPL------RLK----PN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHH----cCCC------CCC----CC
Confidence            34579999999999999999999999999999999999999986422 111111111    1100      111    11


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMS  870 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~  870 (919)
                      ....+.+++.+|++.+|.+||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            234678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.2e-33  Score=310.32  Aligned_cols=239  Identities=23%  Similarity=0.299  Sum_probs=189.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|... +++.||+|+++....   ...+.+..|..++..+ +|++|+++.+++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            34678999999999999975 577899999975422   2234566788888777 588999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  .
T Consensus        83 ~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~  155 (323)
T cd05616          83 VNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--G  155 (323)
T ss_pred             CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--C
Confidence            999999998843  346899999999999999999999   669999999999999999999999999998753211  1


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+..    ..          ..+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~----~~----------~~~  220 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIME----HN----------VAY  220 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-HHHHHHHHHh----CC----------CCC
Confidence            12334579999999999999999999999999999999999999986432 2222222111    11          011


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      +......+.+++.+|++.+|.+|++.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            22233467889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1e-32  Score=308.37  Aligned_cols=262  Identities=18%  Similarity=0.261  Sum_probs=193.7

Q ss_pred             hcceecee--CcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          610 FHRILGKG--GFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       610 ~~~~LG~G--~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +.++||+|  +||+||++... +|+.||+|+++.....  ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34689999  78999999864 7899999998754322  2345778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-  763 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-  763 (919)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999996554556899999999999999999999   668999999999999999999999999865433211110 


Q ss_pred             ----ccccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc----ccc-----
Q 002461          764 ----HISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF----LER-----  828 (919)
Q Consensus       764 ----~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~----~~~-----  828 (919)
                          .......++..|+|||++.+  ..++.++|||||||+++||++|+.||................    ...     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                01122356778999999875  458899999999999999999999986432211111111000    000     


Q ss_pred             ----------C---Cccccc-----c----cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          829 ----------G---DVRSIV-----D----PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       829 ----------~---~~~~iv-----d----~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                                +   ......     .    ..............+.+++.+|++.+|++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                      0   000000     0    00000011122346889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7e-33  Score=297.42  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=199.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|+||.||++... +++.+|+|.++... ....+.+..|+.+++.++|+|++++++.+..++..++++||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            35688999999999999965 68899999986432 23346788899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++.......++....+.++.|++.||.|||   +.+++|+||||+||++++++.++++|||++.......  ...
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~  157 (255)
T cd08219          83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYA  157 (255)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--ccc
Confidence            99999886655566899999999999999999999   6799999999999999999999999999987653221  122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++||||||+++++|++|+.||..... ......+    ..+....         .+..
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~----~~~~~~~---------~~~~  223 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKV----CQGSYKP---------LPSH  223 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHH----hcCCCCC---------CCcc
Confidence            345688999999999988899999999999999999999999864221 1111111    1111110         1111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....+.+++.+||+.+|++||++.+++.+
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            22357889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=316.64  Aligned_cols=236  Identities=23%  Similarity=0.339  Sum_probs=196.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.++||+|.||+|+++.++ +++.+|||++++..   ..+.+..+.|..++... +||.+++++++|+..++.++||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45689999999999999986 57789999998763   33456677888888877 599999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +.||++..+.   ....++.....-++..++.||.|||   .++||+||||.+|||||.+|.+||+|||+++.-..  ..
T Consensus       451 ~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g  522 (694)
T KOG0694|consen  451 VAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QG  522 (694)
T ss_pred             cCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC--CC
Confidence            9999955444   3456999999999999999999999   67999999999999999999999999999986422  23


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc--
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA--  841 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~--  841 (919)
                      ....+.+||+.|||||++.+..|+..+|.|||||+||||+.|+.||.... +.++                +|..+..  
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-Eee~----------------FdsI~~d~~  585 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-EEEV----------------FDSIVNDEV  585 (694)
T ss_pred             CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-HHHH----------------HHHHhcCCC
Confidence            35678899999999999999999999999999999999999999996322 2222                2222211  


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      .++.....+.+.|+.+.+..+|++|-.+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            2345555677889999999999999987

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.3e-33  Score=303.06  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ..+.||+|+||.||++... +++.+|+|.+......   ....+..|+.++++++|+|++++++.+...+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            4578999999999999965 6889999998654322   23457789999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.......+++.+++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||++.......   .
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~  157 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T  157 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence            999999986555556999999999999999999999   6799999999999999999999999999987543221   1


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... +........          ....+..
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~----------~~~~~~~  226 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE----------VQEEYSE  226 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh----------hhhhcCc
Confidence            12346899999999999989999999999999999999999999643221100 000000000          0011112


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                      .....+.+++..|++.+|++||+     +.|+++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            22345788999999999999999     778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-33  Score=322.84  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=188.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecC--------CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--------GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--------~~~~  678 (919)
                      +.+.++||+|+||.||+|... +++.||||++...    .....+|+.+++.++|+||+++++++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            345688999999999999974 6889999988532    23345799999999999999998876432        2466


Q ss_pred             EEEEeccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCccc
Q 002461          679 LVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSK  755 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~  755 (919)
                      +||||+++ +|.+++...  ....+++.....++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            89999985 777766432  3456899999999999999999999   67899999999999999664 79999999998


Q ss_pred             ccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC----
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD----  830 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~----  830 (919)
                      .+....   ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||........+.+ +.+.+....    
T Consensus       220 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-i~~~~~~p~~~~~  295 (440)
T PTZ00036        220 NLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR-IIQVLGTPTEDQL  295 (440)
T ss_pred             hccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCHHHH
Confidence            653221   1234578999999998765 4689999999999999999999999864332222111 111111000    


Q ss_pred             -----------cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 -----------VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 -----------~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                                 ...+....+...++......+.+++.+|+..+|.+||++.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                       00111111112222233456889999999999999999999986

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-32  Score=298.83  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=197.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++......++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            344577999999999999865 578899999874432 234578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++..   ..+++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++..+....  ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999998843   45899999999999999999999   6699999999999999999999999999987653221  11


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||++.+..++.++||||||++++||++|+.|+....... ....    ...+.     .+.    ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~----~~~~~-----~~~----~~~  223 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLFL----IPKNS-----PPT----LEG  223 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHhh----hhcCC-----CCC----CCc
Confidence            223467889999999998889999999999999999999999975322111 1111    00110     111    122


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .....+.+++.+|++.+|++||+|.++++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            234568899999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.9e-33  Score=316.64  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||++... +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY  124 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence            345688999999999999975 6889999999743   222335578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..   ..++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       125 ~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~  197 (370)
T cd05596         125 MPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-M  197 (370)
T ss_pred             CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence            999999998853   34788889999999999999999   6799999999999999999999999999998653221 1


Q ss_pred             ccccccccCccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...... .....+.   ....       .+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~---~~~~-------~~  266 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIM---DHKN-------SL  266 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHH---cCCC-------cC
Confidence            122345799999999998653    4788999999999999999999998643221 1111111   0000       00


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQ--RPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVv~~  875 (919)
                      .-.........+.+++..|+..+|.+  ||++.|+++.
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00001112346778999999988987  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-32  Score=299.75  Aligned_cols=258  Identities=25%  Similarity=0.375  Sum_probs=191.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhc---cCcceeeEEeEeec-----CCeE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRV---HHRNLASLVGYCND-----GGNV  677 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l---~H~NIv~l~g~~~~-----~~~~  677 (919)
                      .+.+.||+|+||+||+|... +|+.||+|.++.....  ....+.+|+++++.+   +||||+++++++..     ....
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            45678999999999999975 6889999998754322  234566777777766   69999999998754     3458


Q ss_pred             EEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          678 GLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      ++++||++ ++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            99999998 48988886655566899999999999999999999   668999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCcc--
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVR--  832 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~--  832 (919)
                      ....   ......|+..|+|||++.+..++.++|||||||+++||++|++||........+ ..+.....   ...+.  
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHHHHHhCCCChhhCccc
Confidence            3221   123456889999999999889999999999999999999999988543221111 11111000   00000  


Q ss_pred             -----cccccccc---cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 -----SIVDPRLE---ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 -----~ivd~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                           ..+.+...   .....+....+.+++.+|++.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00000000   0001122345789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-33  Score=314.53  Aligned_cols=243  Identities=26%  Similarity=0.335  Sum_probs=189.3

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHH-HHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQ-LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~-~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||+||+|... +|+.+|+|++....   ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999964 68999999997542   222344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|..++..  ...+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  153 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT  153 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence            999988843  456899999999999999999999   679999999999999999999999999998753211  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.    .+.+      .+    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~~~----~~~~------~~----~~~  218 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNIL----HKPL------VL----RPG  218 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-HHHHHHHH----cCCc------cC----CCC
Confidence            345799999999999999999999999999999999999999864321 11111111    1110      01    111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ....+.+++.+|+..+|.+||++.+.++.+
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            234577899999999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-32  Score=320.39  Aligned_cols=256  Identities=23%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+||+++++++..++..++|||++. +
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~  244 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S  244 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence            34678999999999999976 47889999642      2346789999999999999999999999999999999995 7


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++... ...++|.+++.|+.|+++||+|||   ..+|+||||||+|||++.++.+||+|||+++............
T Consensus       245 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        245 DLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            888887543 346999999999999999999999   6689999999999999999999999999998664332222233


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc-------cchhcccccccc-cCCccccccccc
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN-------THIVNRVCPFLE-RGDVRSIVDPRL  839 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-------~~l~~~v~~~~~-~~~~~~ivd~~l  839 (919)
                      ...||..|+|||++.+..++.++|||||||++|||++|..++......       .++.+.+..... ..........++
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            467999999999999999999999999999999999988765432211       111111110000 000000000000


Q ss_pred             ------------ccCCCh-------hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          840 ------------EANFDT-------NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       840 ------------~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                  ......       .....+.+++.+|++.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                        000000       011257789999999999999999999874

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-32  Score=294.77  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=198.8

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||+|...+ ++.+++|.++....  .+++.+|++++++++|+||+++++++......++++||+++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            3456789999999999999865 78999999875433  67899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++... ...+++.....++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.......  ...
T Consensus        83 ~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~  156 (256)
T cd06612          83 GSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKR  156 (256)
T ss_pred             CcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--ccc
Confidence            9999998542 456899999999999999999999   5689999999999999999999999999988653322  122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||++.+..++.++||||||++++||++|+.|+..............     .     ..+.+.  .+..
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-----~-----~~~~~~--~~~~  224 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-----K-----PPPTLS--DPEK  224 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-----C-----CCCCCC--chhh
Confidence            334578899999999988999999999999999999999999864322111111000     0     000010  1111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+.+++.+|++.+|++||++.||++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2246788999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.8e-32  Score=295.93  Aligned_cols=248  Identities=25%  Similarity=0.417  Sum_probs=196.3

Q ss_pred             hcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC------CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+.||+|+||+||+|...+|+.+|+|.++.....      ....+.+|++++++++|+||+++++++.+....++++||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            45789999999999999888999999998744221      124588899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC--
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES--  761 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~--  761 (919)
                      +++++|.+++...  ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++.......  
T Consensus        84 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          84 VPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999998543  45889999999999999999999   5689999999999999999999999999987542111  


Q ss_pred             --CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          762 --ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       762 --~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                        .........|+..|+|||++.+..++.++||||||++++||++|+.||..............   ..+.     .+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-----~~~~  230 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRGL-----MPRL  230 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---ccCC-----CCCC
Confidence              11112345688999999999988899999999999999999999999864322111111000   0000     0111


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          +......+.+++.+|++.+|.+||++.++++
T Consensus       231 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         231 ----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                1222346788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-32  Score=300.36  Aligned_cols=248  Identities=27%  Similarity=0.387  Sum_probs=193.3

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            3467899999999999986 4688999999865422 2345688999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|..+.      .+++.....++.|++.||.|||   +.+++|+||||+|||++.++.++|+|||++......    ..
T Consensus        84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~  150 (279)
T cd06619          84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IA  150 (279)
T ss_pred             CChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cc
Confidence            9997543      3678888999999999999999   679999999999999999999999999998765322    12


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++||||||+++|||++|+.||.............      +....+.++.........
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL------QLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH------HHHHHHhccCCCCCCCCc
Confidence            34578999999999998899999999999999999999999986432211110000      000000000000000111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....+.+++.+|++.+|++||+++|+++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            22357889999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-33  Score=309.80  Aligned_cols=242  Identities=19%  Similarity=0.271  Sum_probs=189.9

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||+||+|... +++.||+|+++....   ...+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 578899999985422   2235578899999888 699999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|..++..  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            999988843  346999999999999999999999   669999999999999999999999999998753211  1122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc--chhcccccccccCCcccccccccccCCC
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT--HIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+..  ...+++.+......        .  ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~--~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I--RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C--CCC
Confidence            34679999999999999999999999999999999999999995322111  11111111111110        0  112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMS  870 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~  870 (919)
                      ......+.+++.+|++.+|++||++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            22234577899999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-33  Score=297.95  Aligned_cols=249  Identities=30%  Similarity=0.476  Sum_probs=197.1

Q ss_pred             hhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCch--hhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPK--QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~--~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ++.+.||+|+||+||++.... ++.+|+|++.........  ....|+.++++++|+||+++++++......++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            456899999999999999865 568999999865433222  23459999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.  ....+++.++..++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+...  ......
T Consensus        82 ~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   82 GGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             ccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence            999999996  4566899999999999999999999   569999999999999999999999999998754  112223


Q ss_pred             ccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC-
Q 002461          766 STSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF-  843 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~-  843 (919)
                      .....++..|+|||.+. +..++.++||||+|+++++|++|..|+..... .+......+.         ....+.... 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-~~~~~~~~~~---------~~~~~~~~~~  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-DDQLEIIEKI---------LKRPLPSSSQ  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-HHHHHHHHHH---------HHTHHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-hhhhhhhhhc---------cccccccccc
Confidence            44567899999999998 88899999999999999999999999864410 1111111000         000000000 


Q ss_pred             -ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 -DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 -~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       .......+.+++..|++.+|++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0111267999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-32  Score=294.66  Aligned_cols=249  Identities=31%  Similarity=0.504  Sum_probs=199.1

Q ss_pred             hcceeceeCcEEEEEEEEcC-----CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLAD-----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.||.|+||.||++...+     +..||+|+++..... ..+.+..|++.++.++|+||+++++++...+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999999764     478999999755433 456899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99999999996544434899999999999999999999   669999999999999999999999999999866433111


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                       ......++..|+|||.+.+..++.++||||+|++++||++ |.+|+.. .+.....+.+..    +..         ..
T Consensus       160 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~----~~~---------~~  224 (258)
T smart00219      160 -KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKK----GYR---------LP  224 (258)
T ss_pred             -ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhc----CCC---------CC
Confidence             1112337789999999988889999999999999999998 6777643 222222222211    110         01


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ........+.+++.+|+..+|++||++.++++.|
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1112344688899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.3e-33  Score=306.11  Aligned_cols=253  Identities=26%  Similarity=0.450  Sum_probs=195.7

Q ss_pred             cceeceeCcEEEEEEEEc-CCC----EEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          611 HRILGKGGFGTVYHGYLA-DGS----EVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.||+|+||.||+|... +|.    .+|+|.+...... ...++.+|+.+++.++|+||++++++|... ...+++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            468999999999999864 444    4788887644322 234688999999999999999999998754 467999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++... ...+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++.+.......
T Consensus        91 ~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          91 PHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            999999998543 345889999999999999999999   6689999999999999999999999999998764332222


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ..+..+.+    ..+..       +  ..
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~----~~~~~-------~--~~  232 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLL----EKGER-------L--PQ  232 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH----HCCCC-------C--CC
Confidence            2223445778999999998899999999999999999997 888875321 11122211    11110       0  01


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      .......+.+++..|+..+|++||+|.++++.|+++...
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            112234678899999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-32  Score=301.91  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=202.6

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            34467899999999999996 57999999999766555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++..   ..+++.++..++.|++.||.|||   +.+++|+||||+|||++.++.++|+|||++.......  ...
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~  172 (297)
T cd06656         101 GSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  172 (297)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCc
Confidence            999999843   45889999999999999999999   6689999999999999999999999999987653221  112


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||.+.+..++.++|||||||++++|++|+.||...........    ....+. .     .+  ..+..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~~-~-----~~--~~~~~  240 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGT-P-----EL--QNPER  240 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCCC-C-----CC--CCccc
Confidence            345688899999999988899999999999999999999999854322111111    000010 0     00  01112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHH--HHHHHHh
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVT--ELKKCLE  881 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~--~Le~~~~  881 (919)
                      ....+.+++.+|+..+|++||++.++++  .++.++.
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            2345778999999999999999999998  4554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-33  Score=302.48  Aligned_cols=252  Identities=27%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +++.+.||+|+||+||++... +|+.||+|++..... ...+.+.+|+++++.++|+||+++++++......++||||++
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD   86 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence            455688999999999999965 688999998865432 335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++..  .+.+++.....++.+++.||.|||+  .++++|+||||+||++++++.++|+|||++......    .
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~  158 (284)
T cd06620          87 CGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I  158 (284)
T ss_pred             CCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence            9999998854  3468999999999999999999995  247999999999999999999999999998754221    1


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccc-------hhcccccccccCCcccccccc
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH-------IVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~-------l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      .....|+..|+|||++.+..++.++|||||||+++||++|+.||.......+       +.+.+.......      .+.
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  232 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR  232 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence            2235689999999999888899999999999999999999999864332111       111111110000      011


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      +.   ..+....+.+++.+|++.+|++||++.|++++.
T Consensus       233 ~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            10   111334688999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=322.04  Aligned_cols=254  Identities=27%  Similarity=0.458  Sum_probs=209.4

Q ss_pred             cceeceeCcEEEEEEEE-cCCC----EEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          611 HRILGKGGFGTVYHGYL-ADGS----EVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l-~~g~----~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .++||+|+||+||||.+ .+|+    +||+|++.... .+..+++.+|+-+|.+++|||+++++|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            47899999999999995 3443    58999987553 345688999999999999999999999998776 88999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +.|+|.++++.+ +..+.-...+.|..|||+||.|||   +++++||||..+|||+.+-..+||.|||+++.+..+....
T Consensus       780 P~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  780 PLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             ccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            999999999764 566888999999999999999999   7799999999999999999999999999999886665554


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ......-.+.|||-|.+....++.++|||||||.+||++| |..|++..     ..+.+.++++.|.       +|  .-
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi-----~~~eI~dlle~ge-------RL--sq  921 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI-----PAEEIPDLLEKGE-------RL--SQ  921 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC-----CHHHhhHHHhccc-------cC--CC
Confidence            4445556788999999999999999999999999999998 77777532     1222333333221       12  22


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhhH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      +.-+...+..++.+||..++..||+++++...+.+.....
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            4455667888999999999999999999999988876443

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-33  Score=316.26  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=193.9

Q ss_pred             hcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCC-----eEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG-----NVGLVY  681 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~-----~~~LV~  681 (919)
                      ..+.||+|+||.||++.. .+|+.||||++....  ....+.+.+|+++++.++|+||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            457899999999999996 478999999986432  223457889999999999999999999998766     789999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+. ++|.+.+..  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus        84 e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          84 ELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9997 578887743  456899999999999999999999   6689999999999999999999999999998653221


Q ss_pred             CCccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccc------
Q 002461          762 ESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI------  834 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~i------  834 (919)
                       ........++..|+|||.+.+. .++.++|||||||+++||++|+.||..... .+..+.+.+........++      
T Consensus       158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         158 -SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-IQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             -cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCCCCHHHHHHhhHH
Confidence             1222344678999999998764 478999999999999999999999864322 1112211111111100000      


Q ss_pred             ----c-----c-ccccc--CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          835 ----V-----D-PRLEA--NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       835 ----v-----d-~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                          +     . +....  .........+.+++.+|++.+|.+||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                0     0 00000  0111223467899999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-32  Score=332.68  Aligned_cols=259  Identities=27%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+|... +|+.||+|+++.....   ..++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            44688999999999999965 5889999999754322   2356889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccc---------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          685 AYGNLKQYLFDET---------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       685 ~~GsL~~~L~~~~---------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      ++|+|.+++....         ...+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            9999999885321         234677888999999999999999   6689999999999999999999999999998


Q ss_pred             ccCCCCC----------------CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchh
Q 002461          756 IFPAESE----------------SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV  819 (919)
Q Consensus       756 ~~~~~~~----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~  819 (919)
                      .......                ........||+.|||||++.+..++.++|||||||+++||+||+.||...... ...
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-ki~  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-KIS  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-hhh
Confidence            6521110                01112356999999999999999999999999999999999999998542211 110


Q ss_pred             cccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHHHHhh
Q 002461          820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRP-TMSHVVTELKKCLEM  882 (919)
Q Consensus       820 ~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-sm~eVv~~Le~~~~~  882 (919)
                      ..       ..   +.++.-.. ...+....+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus       241 ~~-------~~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        241 YR-------DV---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh-------hh---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00       00   00110000 0012234578899999999999995 677888888877653

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-34  Score=320.63  Aligned_cols=245  Identities=28%  Similarity=0.509  Sum_probs=202.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC----CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCe--EEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS----SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGN--VGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~----~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~--~~LV~  681 (919)
                      .|.++||+|+|-+||||... +|.+||--.++..    .....++|..|+++|+.|+|+||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34578999999999999964 5778875444321    23334789999999999999999999999977654  88999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCcccccCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~~~~~~  760 (919)
                      |.|..|+|..++++.  +.++.....+|+.||++||.|||++ .++|||||||..||+|+. -|.|||+|+|||..+...
T Consensus       123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999999554  4578889999999999999999987 789999999999999985 489999999999987432


Q ss_pred             CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      .    .....||+.|||||+.. ..|.+.+||||||+.++||+|+..|+....+..++...|.+=+....+..+-||   
T Consensus       200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP---  271 (632)
T KOG0584|consen  200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP---  271 (632)
T ss_pred             c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH---
Confidence            2    23478999999999988 789999999999999999999999998887777776666544444434444443   


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                               .+.++|.+|+.. ..+||++.|+++
T Consensus       272 ---------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 ---------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---------HHHHHHHHHhcC-chhccCHHHHhh
Confidence                     467899999999 999999999987

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-32  Score=299.59  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            34577999999999999976 47788999886554444567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|..++... ...+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++......  .....
T Consensus        88 ~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          88 AVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            999887542 346899999999999999999999   669999999999999999999999999998754221  11223


Q ss_pred             ccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          768 SIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      ...++..|+|||++.     +..++.++|||||||++|||++|++||..............     ........      
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~------  230 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-----SEPPTLAQ------  230 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh-----cCCCCCCC------
Confidence            456889999999974     34577899999999999999999999854322111111110     00000000      


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       +......+.+++.+|++.+|.+||++.++++.
T Consensus       231 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 -PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11122467889999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-32  Score=296.21  Aligned_cols=245  Identities=28%  Similarity=0.462  Sum_probs=195.5

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++|+|++++++++... ..+++|||++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            35578999999999999975 67889999986432  346789999999999999999999998654 479999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....     ..
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~  155 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VD  155 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CC
Confidence            9999997655566899999999999999999999   679999999999999999999999999998754211     11


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....+..|+|||.+.+..++.++||||||++++||++ |+.||..... ....+.+    ..+.         .......
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~---------~~~~~~~  221 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KEVKECV----EKGY---------RMEPPEG  221 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHH----hCCC---------CCCCCCc
Confidence            2234568999999988899999999999999999997 8888753221 1111111    1111         0011122


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ....+.+++.+|++.+|++||+++++++.|++
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            33567899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-32  Score=294.82  Aligned_cols=246  Identities=28%  Similarity=0.419  Sum_probs=195.9

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCc---------hhhhHHHHHHHhccCcceeeEEeEeecCCeEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP---------KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~---------~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      +.+.||+|++|.||+|... +++.+|+|.+........         +.+.+|++++++++|+||+++++++...+..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            4578999999999999864 578999998875433221         457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |+||+++++|.+++..  ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          84 FLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            9999999999999954  356889999999999999999999   56899999999999999999999999999986642


Q ss_pred             CCCC----ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccc
Q 002461          760 ESES----HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       760 ~~~~----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                      ....    .......|+..|+|||.+.+..++.++||||||++++||++|+.||......... ..+.         ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~---------~~~  228 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIG---------ENA  228 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHh---------ccC
Confidence            2111    1112345888999999999888999999999999999999999998643221111 1100         001


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.    .+......+.+++.+|++.+|.+||++.++++
T Consensus       229 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 SPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111    12223346788999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-33  Score=311.73  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=189.1

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHH-HHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEA-QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev-~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 57789999987532   12223344444 456788999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+.......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~  153 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT  153 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence            999998854  345788888899999999999999   679999999999999999999999999998754221  1123


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.    ....          .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~----~~~~----------~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----NKPL----------QLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-HHHHHHHHH----hCCc----------CCCCC
Confidence            34579999999999999999999999999999999999999986322 111111111    0100          01112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      ....+.+++.+|++.+|.+||++.+.+..+.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            2345788999999999999999876554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9e-33  Score=308.56  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=189.8

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ++.+.||+|+||+||+|... +|+.||+|+++...   ....+.+..|..++..+. |++|+++.+++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            45689999999999999965 68899999997542   223356778888988885 56788899999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--  155 (323)
T cd05615          83 VNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--  155 (323)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--
Confidence            999999998843  356899999999999999999999   6699999999999999999999999999987542211  


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+..    ...          .+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i~~----~~~----------~~  220 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-EDELFQSIME----HNV----------SY  220 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh----CCC----------CC
Confidence            12234568999999999998899999999999999999999999986432 1222222111    100          11


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      +......+.+++.+|++.+|.+|++.
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            12223467889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-32  Score=294.98  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=199.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||++... +|+.||+|.+....  ....+++.+|+.++++++|+||+++++++...+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            44688999999999999864 68899999987542  2234578999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.......+++.+.++++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  157 (256)
T cd08218          83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL  157 (256)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence            999999986655556899999999999999999999   5689999999999999999999999999997653221  11


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....|+..|+|||++.+...+.++|||||||+++||++|+.|+..........+..     .+..         ...+.
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-----~~~~---------~~~~~  223 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-----RGSY---------PPVSS  223 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-----cCCC---------CCCcc
Confidence            223458889999999998889999999999999999999999986432211111111     1110         01122


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .....+.+++.+|++.+|++||+|.+|++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            23446889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.4e-32  Score=293.10  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=197.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeec-CCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~-~~~~~LV~Ey  683 (919)
                      +.+.+.||+|++|.||++... +++.+|+|++.....  ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            345688999999999999965 578899999875432  234568889999999999999999998764 4467899999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++.......+++.++..++.+++.|+++||   +.+++|+||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--  156 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--  156 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence            99999999997655567899999999999999999999   6689999999999999999999999999998653221  


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......++..|+|||.+.+..++.++||||||++++||++|+.||....... ...   . +..+...         ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~---~-~~~~~~~---------~~  222 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVY---R-IIEGKLP---------PM  222 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHH---H-HHhcCCC---------CC
Confidence            22334568899999999999999999999999999999999999885322111 111   1 1111110         11


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1223346889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.9e-33  Score=314.92  Aligned_cols=250  Identities=21%  Similarity=0.282  Sum_probs=191.5

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||++... +++.+|+|+++..   .....+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY  124 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence            345678999999999999975 5788999998643   222345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..   ..++......++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus       125 ~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~  197 (370)
T cd05621         125 MPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M  197 (370)
T ss_pred             CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence            999999999843   34788899999999999999999   6799999999999999999999999999998653221 1


Q ss_pred             ccccccccCccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....... ....+.   ....       .+
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~---~~~~-------~~  266 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIM---DHKN-------SL  266 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHH---hCCc-------cc
Confidence            122356799999999998654    37889999999999999999999996432211 111111   0000       00


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCC--CCCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISF--QRPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPsm~eVv~~  875 (919)
                      .-.........+.+++..|+...+.  .||++.|+++.
T Consensus       267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0000111233566778888875554  38899999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.9e-32  Score=301.89  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=198.5

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .+.+.||.|++|.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+|++++++++......++|+||++++
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            3457899999999999985 578999999997665555677889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++..   ..+++.++..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++........  ...
T Consensus       102 ~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~  173 (296)
T cd06655         102 SLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS  173 (296)
T ss_pred             cHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence            99998843   35899999999999999999999   67999999999999999999999999999876532211  123


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .   . ...     +.+.  .+...
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-~---~-~~~-----~~~~--~~~~~  241 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-A---T-NGT-----PELQ--NPEKL  241 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-H---h-cCC-----cccC--CcccC
Confidence            346889999999999888999999999999999999999998643321111110 0   0 000     0000  11122


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+.+++.+|+..+|.+||++.++++
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            335778999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.1e-32  Score=296.15  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=196.6

Q ss_pred             hhcceeceeCcEEEEEEEEcC--CCEEEEEEeecCCC----------CCchhhhHHHHHHHh-ccCcceeeEEeEeecCC
Q 002461          609 NFHRILGKGGFGTVYHGYLAD--GSEVAIKMLSASSS----------QGPKQFRTEAQLLMR-VHHRNLASLVGYCNDGG  675 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~--g~~VAVK~l~~~~~----------~~~~~f~~Ev~~L~~-l~H~NIv~l~g~~~~~~  675 (919)
                      .+.+.||+|+||.||+|....  ++.+|+|.+.....          ....++..|+.++.+ ++|+||+++++++...+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            345789999999999999865  67899998864321          112346678887765 79999999999999999


Q ss_pred             eEEEEEEeccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          676 NVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       676 ~~~LV~Ey~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ..+++|||+++++|.+++...  ....+++..+++++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccc
Confidence            999999999999999987532  24568999999999999999999994  25799999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~  833 (919)
                      +.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+    ..+... 
T Consensus       161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-~~~~~----~~~~~~-  231 (269)
T cd08528         161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-LATKI----VEAVYE-  231 (269)
T ss_pred             eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-HHHHH----hhccCC-
Confidence            98653322   2344568899999999998889999999999999999999999985432111 11111    111100 


Q ss_pred             ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       834 ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                         +.    ........+.+++.+|++.+|++||++.||.++++
T Consensus       232 ---~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         232 ---PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               00    01112346888999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-33  Score=317.21  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=190.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||++... +|+.||||++....   ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            34688999999999999864 68899999986532   223456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-  763 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-  763 (919)
                      ++|+|.+++..  ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        84 ~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          84 PGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999999853  356888999999999999999999   679999999999999999999999999998643210000 


Q ss_pred             --------------------------------------------ccccccccCccccCcccccCCCCCchhhHHHHHHHH
Q 002461          764 --------------------------------------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVL  799 (919)
Q Consensus       764 --------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL  799 (919)
                                                                  .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                        000124699999999999988999999999999999


Q ss_pred             HHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCC---CCHHHHHHH
Q 002461          800 LELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQR---PTMSHVVTE  875 (919)
Q Consensus       800 ~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Psm~eVv~~  875 (919)
                      |||++|+.||..... .+....+......-.        +..  .......+.+++.+|+. +|.+|   +++.|+++.
T Consensus       239 ~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~--------~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         239 FECLIGWPPFCSENS-HETYRKIINWRETLY--------FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhcCCCCCCCCCH-HHHHHHHHccCCccC--------CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999864322 111111111000000        000  00112356788888987 66654   699998874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5e-33  Score=310.10  Aligned_cols=237  Identities=24%  Similarity=0.345  Sum_probs=186.3

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHH-HHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQ-LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~-~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999987532   122334555544 67889999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|..++..  ...++..+...++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            999988843  356888899999999999999999   668999999999999999999999999998753211  1223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+.    .+.        +  ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~----~~~--------~--~~~~~  218 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNIL----HKP--------L--QLPGG  218 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHh----cCC--------C--CCCCC
Confidence            34578999999999998899999999999999999999999986432 111111111    010        0  11222


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMS  870 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~  870 (919)
                      ....+.+++.+|++.+|.+||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            334678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-32  Score=293.01  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=200.0

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||.|+||.||.+.. .+++.+++|.+....  ....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            4568899999999999885 468899999986542  3334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++.......+++.++..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++........  .
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~  157 (256)
T cd08221          83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M  157 (256)
T ss_pred             CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence            999999997655567899999999999999999999   56899999999999999999999999999986533221  2


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....++..|+|||.+.+...+.++||||||++++||++|..||...... .....+    ..+....         ...
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~----~~~~~~~---------~~~  223 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-NLVVKI----VQGNYTP---------VVS  223 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHH----HcCCCCC---------Ccc
Confidence            33456899999999998888899999999999999999999988532211 111111    1111110         011


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .....+.+++.+|++.+|.+||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            223467889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.2e-32  Score=302.50  Aligned_cols=195  Identities=26%  Similarity=0.387  Sum_probs=158.9

Q ss_pred             cceeceeCcEEEEEEEEc---CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEEEecc
Q 002461          611 HRILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~Ey~~  685 (919)
                      .++||+|+||+||+|...   +++.+|+|.++...  ....+.+|++++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999965   46789999986432  23567889999999999999999998854  456889999986


Q ss_pred             CCChhhhhhccc-------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe----CCCCcEEEeccCcc
Q 002461          686 YGNLKQYLFDET-------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL----NEKMQAKLADFGFS  754 (919)
Q Consensus       686 ~GsL~~~L~~~~-------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl----d~~~~vkL~DFGla  754 (919)
                       ++|.+++....       ...+++.....++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             48887764321       235888999999999999999999   6689999999999999    45678999999999


Q ss_pred             cccCCCCC-CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          755 KIFPAESE-SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       755 ~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                      +....... ........||+.|+|||++.+ ..++.++||||+||+++||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            87632211 112234578999999999876 4588999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.1e-33  Score=317.71  Aligned_cols=198  Identities=25%  Similarity=0.383  Sum_probs=167.8

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ..+.||+|+||+||+|... +++.||+|++.....   .....+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            4578999999999999964 678899999875421   223568889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC----
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES----  761 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~----  761 (919)
                      +|+|.+++...  ..++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+....    
T Consensus        85 gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          85 GGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            99999998543  45888889999999999999999   6689999999999999999999999999975331000    


Q ss_pred             -----------------------------------------CCccccccccCccccCcccccCCCCCchhhHHHHHHHHH
Q 002461          762 -----------------------------------------ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL  800 (919)
Q Consensus       762 -----------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~  800 (919)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                     000112346999999999999999999999999999999


Q ss_pred             HHHhCCCCcccC
Q 002461          801 ELITGLPAIIRG  812 (919)
Q Consensus       801 ELltG~~p~~~~  812 (919)
                      ||++|++||...
T Consensus       240 elltG~~Pf~~~  251 (382)
T cd05625         240 EMLVGQPPFLAQ  251 (382)
T ss_pred             HHHhCCCCCCCC
Confidence            999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-32  Score=296.81  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=193.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|.||+|+.. +++.||+|+++....  ...+.+.+|+.+++.++|+|++++++++..+...++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            34578999999999999975 688999999865432  234578899999999999999999999999999999999997


Q ss_pred             CCChhhhhhccc-cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~-~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                       ++|.+++.... ...+++.++..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++.......  .
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--R  156 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--c
Confidence             68888875433 356899999999999999999999   6799999999999999999999999999987553221  1


Q ss_pred             cccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc--ccCC---------cc
Q 002461          765 ISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL--ERGD---------VR  832 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~--~~~~---------~~  832 (919)
                      ......++..|+|||.+.+ ..++.++||||||++++||++|++||.................  .+..         ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2233457889999998765 4578999999999999999999999864322111111000000  0000         00


Q ss_pred             ----cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 ----SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ----~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          .+....+.. ........+.+++.+|+..+|.+||++.+|++
T Consensus       237 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         237 NTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000000000 00112345678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.3e-32  Score=297.90  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||+|... +++.+++|++........+.+.+|+++++.++|+|++++++++..++..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            345678999999999999975 4889999999766555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|..++... ...+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++......  ....
T Consensus        94 ~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~  167 (292)
T cd06644          94 GAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRR  167 (292)
T ss_pred             CcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cccc
Confidence            9998887543 346899999999999999999999   679999999999999999999999999998754221  1112


Q ss_pred             cccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          767 TSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ....++..|+|||++.     ...++.++|||||||++|||++|..|+..........+.    .. ...     +.+  
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~-~~~-----~~~--  235 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI----AK-SEP-----PTL--  235 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH----hc-CCC-----ccC--
Confidence            3446788999999984     345678999999999999999999998532211111111    00 000     000  


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..+......+.+++.+|+..+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            001122335788999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.1e-32  Score=301.88  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=196.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++.+.||+|+||.||++... ++..+|+|.++.... ....++.+|++++++++||||+++++++..++..++|+||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            34678999999999999965 578899998865422 2235688899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++...  ..+++..+..++.|+++||+|||+  ..+++|+||||+|||++.++.+||+|||++......    ..
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~  155 (308)
T cd06615          84 GSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  155 (308)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence            9999999543  568899999999999999999995  248999999999999999999999999998754221    12


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC----------------
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD----------------  830 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~----------------  830 (919)
                      ....|+..|+|||.+.+..++.++||||||++++||++|+.|+..... ...............                
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            345788999999999888899999999999999999999999853321 111111110000000                


Q ss_pred             ----cccccccccc---cCCC-hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          831 ----VRSIVDPRLE---ANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       831 ----~~~ivd~~l~---~~~~-~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                          ..+..+....   ...+ ......+.+++.+|+..+|++||++.+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000000000   0000 0122357899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-32  Score=289.64  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=198.1

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCC--chhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~Ey~~~  686 (919)
                      +.|++|.||.||+|+.+ +++.||+|+++......  .-.-.+|+.+|.+++|||||.+-.....  -+..++|||||++
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            67999999999999965 67889999998654322  2345789999999999999999887754  4679999999987


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|.+++.. .++++...+..-++.|+++|++|||   ..-|+|||||++|+|+...|.+||+|||||+.+...  ....
T Consensus       162 -DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~  234 (419)
T KOG0663|consen  162 -DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPY  234 (419)
T ss_pred             -hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC--cccC
Confidence             89988854 3578999999999999999999999   568999999999999999999999999999987433  2334


Q ss_pred             cccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC---cccc--------
Q 002461          767 TSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---VRSI--------  834 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~---~~~i--------  834 (919)
                      +..+-|..|+|||++.+. .|+...|+||+|||+.||+++++.|. +....+.+..+.+.+....   +..+        
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-GKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-CCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            567789999999998764 58999999999999999999987664 4444444555544443211   1111        


Q ss_pred             ------cccccccCCChh-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          835 ------VDPRLEANFDTN-SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       835 ------vd~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                            .-..++..|... -.+.-.++....+..||.+|-|++|.++
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                  111222223222 1234567888899999999999999987

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.8e-33  Score=317.23  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=190.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+++.. +++.||||++....   ......+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            34678999999999999964 58899999986432   223456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC---
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES---  761 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~---  761 (919)
                      ++|+|.+++..  ...++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+....   
T Consensus        84 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          84 PGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999999854  345888888999999999999999   6799999999999999999999999999975321000   


Q ss_pred             --------------------------------------CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHH
Q 002461          762 --------------------------------------ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELI  803 (919)
Q Consensus       762 --------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELl  803 (919)
                                                            .........||+.|||||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                  000112357999999999999999999999999999999999


Q ss_pred             hCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCC---CHHHHHHH
Q 002461          804 TGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRP---TMSHVVTE  875 (919)
Q Consensus       804 tG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---sm~eVv~~  875 (919)
                      +|+.||....... ....+.....          .+...........+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       239 ~G~~Pf~~~~~~~-~~~~i~~~~~----------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAE-TQLKVINWET----------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHH-HHHHHhccCc----------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999996433211 1111110000          0000000111234556666665 4899999   88888864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-32  Score=314.78  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=197.2

Q ss_pred             HHHHHhhhcceeceeCcEEEEEEEEc---CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEE
Q 002461          603 IVDITNNFHRILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       603 i~~~t~~~~~~LG~G~fG~Vyk~~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      +....+.+.+.||+|+||.||++...   .+..||+|.+...     +...+|++++++++|+||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            33445667789999999999999753   3567999987532     345689999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      +||++. ++|.+++  .....+++.+++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus       164 v~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        164 VMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            999986 6888888  33467999999999999999999999   66899999999999999999999999999986643


Q ss_pred             CCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc--chhcccccccccCCcc-----
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT--HIVNRVCPFLERGDVR-----  832 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~l~~~v~~~~~~~~~~-----  832 (919)
                      ...........||..|+|||++.+..++.++|||||||++|||++|+.||.......  +....+.+.+......     
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            333333345679999999999999999999999999999999999999986433211  1111111100000000     


Q ss_pred             --cc------cccccccCCC-------hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          833 --SI------VDPRLEANFD-------TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       833 --~i------vd~~l~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        .+      .....+..+.       ......+.+++.+|+..+|++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              00      0000000000       0112356788999999999999999999874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=295.39  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=197.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+|++++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            44578999999999999975 68899999987543 23346788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++...   .+++.....++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++......  ...
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~  155 (274)
T cd06609          84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR  155 (274)
T ss_pred             CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence            9999998543   7899999999999999999999   6689999999999999999999999999998764321  122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ......    ...+.     .+.+...   .
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~~~~~~----~~~~~-----~~~~~~~---~  222 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-MRVLFL----IPKNN-----PPSLEGN---K  222 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-HHHHHH----hhhcC-----CCCCccc---c
Confidence            345688899999999988899999999999999999999999853321 111111    11111     1111111   0


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+.+++.+|+..+|++||+++++++
T Consensus       223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         223 FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2235788999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-32  Score=294.34  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=198.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ...+.||.|+||.||+|... +++.||+|+++... ....+.+.+|+.++++++|+||+++++++.+....++||||+++
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence            34577999999999999975 58899999987543 23346788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..   ..+++.+...++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        87 ~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06640          87 GSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence            999998853   45889999999999999999999   6699999999999999999999999999997653221  122


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||++.+..++.++||||||++++||++|+.|+....... ....    ...+         ........
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~----~~~~---------~~~~~~~~  224 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLFL----IPKN---------NPPTLTGE  224 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hhhh----hhcC---------CCCCCchh
Confidence            33467889999999988889999999999999999999999985432111 1110    0000         01112233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....+.+++.+|++.+|++||++.++++.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         225 FSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            45678899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-32  Score=302.02  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=193.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ...+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++..++..++||||+++
T Consensus         9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   88 (309)
T cd07872           9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence            44678999999999999975 578899999875432 2345678899999999999999999999999999999999985


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        89 -~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  161 (309)
T cd07872          89 -DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTY  161 (309)
T ss_pred             -CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--ccc
Confidence             888877543 345889999999999999999999   6699999999999999999999999999987542221  112


Q ss_pred             cccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Cccccc------c
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVRSIV------D  836 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~~iv------d  836 (919)
                      ....++..|+|||.+.+ ..++.++|||||||+++||++|++||...... +....+...+...   .+..+.      +
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            23467899999998764 56889999999999999999999998643221 1111111111000   000000      0


Q ss_pred             ---ccccc----CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          837 ---PRLEA----NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 ---~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         +....    .........+.+++.+|++.+|.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence               00000    000112235678999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-32  Score=291.10  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .+.+.||.|+||.||+|... +++.+++|.+........+.+.+|++++++++|+||+++++++......+++|||++++
T Consensus         6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            45678999999999999975 57889999998765556678999999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++... ...++..++..++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++.......  ....
T Consensus        86 ~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~  159 (262)
T cd06613          86 SLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK  159 (262)
T ss_pred             cHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence            999988543 356899999999999999999999   6689999999999999999999999999987653211  1223


Q ss_pred             ccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          768 SIVGTVGYLDPEYYASN---RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ...++..|+|||.+...   .++.++||||||++++||++|+.|+.............     ....   ..+.+.  ..
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-----~~~~---~~~~~~--~~  229 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-----KSNF---PPPKLK--DK  229 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hccC---CCcccc--ch
Confidence            45688899999998776   88999999999999999999999986433211111110     0000   000110  11


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|.+||++++|+.
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            122346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-33  Score=296.23  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=201.3

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeec--CCCCCchhhhHHHHHHHhccCcceeeEEeEeec-----CCeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND-----GGNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~--~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~-----~~~~~LV~E  682 (919)
                      .+.||+|+||.|+.+... +|+.||||++..  ...-..++-.+|+.+|+.++|+||+.+.+.+..     -...++|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            367999999999999964 789999999873  233445778899999999999999999998754     457999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      +|+ .+|...++.  .+.++......++.|+++||+|+|   +.+|+||||||+|+|++.+...||+|||+|+.......
T Consensus       107 lMe-tDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  107 LME-TDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             HHh-hHHHHHHHc--CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            995 589888843  445999999999999999999999   67999999999999999999999999999998754433


Q ss_pred             CccccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCc---cccccc-
Q 002461          763 SHISTSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDV---RSIVDP-  837 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~---~~ivd~-  837 (919)
                      ....+.++.|..|.|||.+. ...|+...||||.||++.||++|++-| .+.+..+..+.+...+.....   ..+-.+ 
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            44457788999999999875 567999999999999999999998766 455545555544444333211   111100 


Q ss_pred             --------------ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          838 --------------RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       838 --------------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                    .+...++ ......++|..+++..||.+|+|++|.++.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                          0011111 223356889999999999999999999874

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-32  Score=292.21  Aligned_cols=244  Identities=27%  Similarity=0.390  Sum_probs=196.3

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-----CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-----QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+.||+|++|.||+|... +++.|++|.+.....     +..+.+.+|+++++.++|+|++++++++......++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4578999999999999976 789999999875432     2345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++...  ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          84 VPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            9999999998543  45889999999999999999999   5689999999999999999999999999987653222  


Q ss_pred             ccccccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                       ......|+..|+|||.+.... ++.++|+||||+++++|++|+.||.............    .....         ..
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~---------~~  222 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG----RSKEL---------PP  222 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----hcccC---------CC
Confidence             223456889999999987766 8999999999999999999999986543211111110    00000         01


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11122346788999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.9e-32  Score=299.44  Aligned_cols=195  Identities=26%  Similarity=0.392  Sum_probs=158.5

Q ss_pred             ceeceeCcEEEEEEEEc---CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEee--cCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN--DGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~--~~~~~~LV~Ey~~~  686 (919)
                      .+||+|+||.||+|...   ++..||+|.++...  ....+.+|++++++++||||+++++++.  .....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999975   35689999986432  2346788999999999999999999884  35678999999875


Q ss_pred             CChhhhhhcc-------ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe----CCCCcEEEeccCccc
Q 002461          687 GNLKQYLFDE-------TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL----NEKMQAKLADFGFSK  755 (919)
Q Consensus       687 GsL~~~L~~~-------~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl----d~~~~vkL~DFGla~  755 (919)
                       +|.+++...       ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777776422       1235888999999999999999999   6689999999999999    566789999999998


Q ss_pred             ccCCCCCC-ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccC
Q 002461          756 IFPAESES-HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRG  812 (919)
Q Consensus       756 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~  812 (919)
                      ........ .......||..|+|||.+.+ ..++.++|||||||++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            66332211 12234568999999999876 45889999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-33  Score=312.34  Aligned_cols=245  Identities=24%  Similarity=0.409  Sum_probs=201.4

Q ss_pred             ceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      -+||+|.||+||-|+..+ ...+|||-+.....+..+.+.+|+.+-++++|+|||+++|.|.+.+..-+.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            379999999999999655 4569999998887777788999999999999999999999999999999999999999999


Q ss_pred             hhhhccccccC--ChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC-CCCcEEEeccCcccccCCCCCCcccc
Q 002461          691 QYLFDETKEAL--SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       691 ~~L~~~~~~~l--s~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      ++|+..- +++  +....-.+.+||++||.|||   ...|+|||||-.|||++ -.|.+||+|||-++.+..  -+....
T Consensus       661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9996543 334  66777888999999999999   56899999999999997 568999999999987632  334456


Q ss_pred             ccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          768 SIVGTVGYLDPEYYASN--RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ..-||..|||||++..+  .|...+|||||||.+.||.||++||..-...+...-.+ .++           +.-.+.++
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-Gmy-----------KvHP~iPe  802 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMY-----------KVHPPIPE  802 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cce-----------ecCCCCcH
Confidence            67899999999999765  48889999999999999999999997543322111111 000           01123355


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +...+...++++|+.++|.+||+++++++
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            66677889999999999999999999987

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=300.37  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=195.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--------------CchhhhHHHHHHHhccCcceeeEEeEeec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--------------GPKQFRTEAQLLMRVHHRNLASLVGYCND  673 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--------------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~  673 (919)
                      .+.+.||+|.||.|-+|... +++.||||++.+....              ..+..++|+.+|++++|+|||+|+++..+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            34577999999999999954 6899999999643111              12467899999999999999999999865


Q ss_pred             --CCeEEEEEEeccCCChhhhhhcccccc-CChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEec
Q 002461          674 --GGNVGLVYEYMAYGNLKQYLFDETKEA-LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD  750 (919)
Q Consensus       674 --~~~~~LV~Ey~~~GsL~~~L~~~~~~~-ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~D  750 (919)
                        .+..|||+|||..|.+...-   .... ++..+..+++.++..||+|||   .++||||||||+|+||+++|++||+|
T Consensus       180 P~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             cccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeec
Confidence              56899999999998876543   3334 899999999999999999999   67999999999999999999999999


Q ss_pred             cCcccccCCCC---CCccccccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc
Q 002461          751 FGFSKIFPAES---ESHISTSIVGTVGYLDPEYYASNR----LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC  823 (919)
Q Consensus       751 FGla~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~  823 (919)
                      ||.+.......   ........+||+.|||||...++.    .+.+.||||+||.||-|+-|+.||..... ..+.+   
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-~~l~~---  329 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-LELFD---  329 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-HHHHH---
Confidence            99987663221   111223468999999999987643    34678999999999999999999974332 11111   


Q ss_pred             cccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          824 PFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       824 ~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                               +++...|.-....+..+.+.+|++++|..||++|-+..+|....-
T Consensus       330 ---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  330 ---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                     122223322222345667889999999999999999999987653

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.7e-32  Score=294.58  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=195.5

Q ss_pred             hcceeceeCcEEEEEEEEc----CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCC------eE
Q 002461          610 FHRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG------NV  677 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~----~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~------~~  677 (919)
                      +.+.||+|+||.||+|.+.    +++.||||+++....  ...+++.+|+++++.++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999864    367899999875422  23456889999999999999999999885432      24


Q ss_pred             EEEEEeccCCChhhhhhccc----cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          678 GLVYEYMAYGNLKQYLFDET----KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~----~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ++++||+++|+|.+++....    ...+++...++++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence            78899999999998874322    235788999999999999999999   56899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCcc
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ++...............++..|++||.+....++.++||||||+++|||++ |++|+... +......++...   ... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~---~~~-  234 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKG---NRL-  234 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC-CHHHHHHHHHcC---CcC-
Confidence            986533222222223345678999999988889999999999999999999 77877532 222222222110   000 


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                               ..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus       235 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         235 ---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     01112335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-32  Score=291.02  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=198.6

Q ss_pred             cceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcc-eeeEEeEeecCC------eEEEE
Q 002461          611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRN-LASLVGYCNDGG------NVGLV  680 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~N-Iv~l~g~~~~~~------~~~LV  680 (919)
                      .++||+|+||+||+|+. .+|+.||+|+++-...  .......+|+.+|+.++|+| |+.+.+++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            36699999999999995 4789999999986544  23455688999999999999 999999998877      78899


Q ss_pred             EEeccCCChhhhhhcccc--ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          681 YEYMAYGNLKQYLFDETK--EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~--~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +||++. +|..++.....  ..++......++.|+++||+|||   +++|+||||||+|||++++|.+||+|||+|+.+.
T Consensus        96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            999975 89998865443  46777889999999999999999   6799999999999999999999999999999653


Q ss_pred             CCCCCccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Ccccc
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVRSI  834 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~~i  834 (919)
                      -..  ...+..++|..|.|||++.+. .|+...||||+||++.||+++++-|. +..+.+....+.+.+...   .+..+
T Consensus       172 ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp-G~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  172 IPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP-GDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             CCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC-CCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            222  224556789999999998876 79999999999999999999876664 333344444444443322   12111


Q ss_pred             cc-cccccCCC------------hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          835 VD-PRLEANFD------------TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       835 vd-~~l~~~~~------------~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .. +.....+.            ........+++.+|++.+|.+|.+++.++++
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            10 01100110            0011357889999999999999999999885

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-33  Score=310.30  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=208.0

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCe-EEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGN-VGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~-~~LV~Ey  683 (919)
                      +...+.+|+|+||.++..+++ +++.+++|.+.....  ...+...+|+.++++++|||||.+.+.+.+++. .++||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            345688999999999999875 577899999875432  223467889999999999999999999999888 9999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      ++||+|.+.|...+...++......++.|++.|+.|||   +..|+|||||+.||+++.+..|||+|||+|+.+..+.  
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--  160 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--  160 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence            99999999998877778999999999999999999999   5689999999999999999999999999999885443  


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|... +-..++..+.+-.             ....
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~ki~~~~-------------~~Pl  226 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILKINRGL-------------YSPL  226 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHHHhhcc-------------CCCC
Confidence            3456789999999999999999999999999999999999999988532 2233333322110             1112


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +......+..++..|++.+|..||++.+++.+
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            33334568889999999999999999999986

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-32  Score=295.42  Aligned_cols=259  Identities=24%  Similarity=0.317  Sum_probs=195.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ++.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|++++++++|+|++++++++......++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            44578999999999999976 588999999865432  233567899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      ++.|..++..  ...+++.+++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++........  .
T Consensus        84 ~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07847          84 HTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D  156 (286)
T ss_pred             ccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence            9888877633  345899999999999999999999   57899999999999999999999999999987643221  1


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccc---cccc-------ccCCc-cc
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV---CPFL-------ERGDV-RS  833 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v---~~~~-------~~~~~-~~  833 (919)
                      .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....+........   ....       ..... ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            223457889999999865 557899999999999999999999986433211111100   0000       00000 00


Q ss_pred             ccccccccCCC-----hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          834 IVDPRLEANFD-----TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 ivd~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+......+     ......+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00011000000     011346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.7e-32  Score=294.36  Aligned_cols=250  Identities=24%  Similarity=0.421  Sum_probs=196.6

Q ss_pred             cceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          611 HRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.||+|+||.||+|+..      +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY   89 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence            467999999999999964      3457999988654333 346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhcccc-------ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          684 MAYGNLKQYLFDETK-------EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~-------~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      +++|+|.+++.....       ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++++|||++..
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            999999999965441       26899999999999999999999   56899999999999999999999999999875


Q ss_pred             cCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccc
Q 002461          757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       757 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                      ..... ........++..|+|||.+.+...+.++||||||++++||++ |..||....+ .......    ..+...   
T Consensus       167 ~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~----~~~~~~---  237 (275)
T cd05046         167 VYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRL----QAGKLE---  237 (275)
T ss_pred             cCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHH----HcCCcC---
Confidence            42211 112223356778999999988888999999999999999998 7777743222 2222211    111111   


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                           ..........+.+++.+|++.+|.+||++.|+++.|.
T Consensus       238 -----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 0111123346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.1e-32  Score=292.96  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=194.1

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--C--------chhhhHHHHHHHhccCcceeeEEeEeecCCeEEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--G--------PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~--------~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+.||+|+||.||+|... +|+.+|+|.++.....  .        .+.+..|+.+++.++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            578999999999999864 6889999988643211  1        1357789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |+||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus        86 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             EEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            99999999999998544  56899999999999999999999   56899999999999999999999999999976532


Q ss_pred             CCCCccccccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      ...........|+..|+|||.+....  ++.++||||||++++|+++|..|+..........+    ... ......+.+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~  235 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK----LGN-KRSAPPIPP  235 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH----hhc-cccCCcCCc
Confidence            22222233456889999999987654  78999999999999999999999853222111111    100 000111111


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..    ..+....+.+++.+|+..+|++||++.+|++
T Consensus       236 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         236 DV----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11    1122346888999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.8e-32  Score=289.21  Aligned_cols=246  Identities=26%  Similarity=0.385  Sum_probs=197.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||++... +++.+|+|.+....  ....+.+.+|+++++.++|+|++++++.+..++..++|+||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            45678999999999999864 68889999987542  2234678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +++|.+++.......+++..+.+++.++++||+|||   ..+++|+||||+||+++++ +.+||+|||++.......   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (256)
T cd08220          83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---  156 (256)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence            999999997655566899999999999999999999   6699999999999999855 468999999998653221   


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......++..|+|||.+.+...+.++||||||+++++|++|+.|+..... ......+.   . +...         ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~---~-~~~~---------~~~  222 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIM---S-GTFA---------PIS  222 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHH---h-cCCC---------CCC
Confidence            12235688899999999988899999999999999999999999854321 11111111   0 0000         111


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|++||++.|+++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            122346789999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=4.5e-32  Score=295.95  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=194.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|... +|+.+|+|.++....  .....+.+|++++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            44578999999999999975 688999999875422  223567889999999999999999999999999999999997


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                       ++|.+++... ...+++...+.++.|+++||.|||   ..+++|+||||+||+++.++.+||+|||+++......  ..
T Consensus        83 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~  155 (284)
T cd07839          83 -QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RC  155 (284)
T ss_pred             -CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CC
Confidence             5788877543 345899999999999999999999   6689999999999999999999999999998653221  11


Q ss_pred             ccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC------cccccccc
Q 002461          766 STSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD------VRSIVDPR  838 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~------~~~ivd~~  838 (919)
                      .....++..|+|||.+.+. .++.++|||||||+++||++|..|+..+.+.....+.+........      +....+..
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            2234578899999998664 4789999999999999999999887654443222222111110000      00000000


Q ss_pred             ccc---------CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          839 LEA---------NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~---------~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...         .........+.+++.+|++.+|.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000         001112346778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=9.3e-32  Score=289.73  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=200.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+......++|+|++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            45688999999999999964 67889999987543 23456789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcccc-ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC--
Q 002461          687 GNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--  763 (919)
Q Consensus       687 GsL~~~L~~~~~-~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~--  763 (919)
                      ++|.+++..... ..+++.....++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++..+......  
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            999999965433 56899999999999999999999   678999999999999999999999999998866433222  


Q ss_pred             ccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......|+..|+|||++... ..+.++|||||||+++||++|+.||..........+...    ..      .+.+...
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~----~~------~~~~~~~  230 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ----ND------PPSLETG  230 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc----CC------CCCcCCc
Confidence            122345688999999998776 789999999999999999999999864332221111111    10      0111110


Q ss_pred             C-ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 F-DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      . .......+.+++.+|+..+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0 0122356789999999999999999999976

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=9.1e-32  Score=294.77  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=193.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT   87 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC
Confidence            34578999999999999975 6889999998754322 235577899999999999999999999999999999999984


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|.+++.... ..+++.....++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||+++......  ...
T Consensus        88 -~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~  160 (291)
T cd07844          88 -DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTY  160 (291)
T ss_pred             -CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--ccc
Confidence             9999885433 36899999999999999999999   6689999999999999999999999999987542111  111


Q ss_pred             cccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---CCcccc--------
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---GDVRSI--------  834 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---~~~~~i--------  834 (919)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+....+...+..   .....+        
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            22346788999998865 458899999999999999999999985433211111111111110   000000        


Q ss_pred             ------cccccccCC-ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          835 ------VDPRLEANF-DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       835 ------vd~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                            ....+.... .......+.+++.+|++.+|++||++.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  000010000 0111246788999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=7.6e-32  Score=294.44  Aligned_cols=248  Identities=26%  Similarity=0.356  Sum_probs=191.2

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEee-----cCCeEEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCN-----DGGNVGLVYE  682 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~-----~~~~~~LV~E  682 (919)
                      +.+.||+|+||.||++... +++.+|+|+++... .....+.+|+.+++++ +|+||+++++++.     .++..++|||
T Consensus        22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e  100 (286)
T cd06638          22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE  100 (286)
T ss_pred             eeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence            3578999999999999874 57889999886432 2235688899999999 6999999999874     3457899999


Q ss_pred             eccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          683 YMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       683 y~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |+++++|.+++...  ....+++..+..++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  177 (286)
T cd06638         101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  177 (286)
T ss_pred             ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence            99999999987532  2356889999999999999999999   668999999999999999999999999998765322


Q ss_pred             CCCccccccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYAS-----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                      .  .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+............    . ........
T Consensus       178 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~  250 (286)
T cd06638         178 R--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI----P-RNPPPTLH  250 (286)
T ss_pred             C--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc----c-ccCCCccc
Confidence            1  12234468999999998753     45788999999999999999999998643221111111    0 00001111


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ++.       .....+.+++.+|++.+|++||++.|+++.
T Consensus       251 ~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         251 QPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            111       112358889999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=310.33  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             hcceeceeCcEEEEEEEEc--CCC--EEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          610 FHRILGKGGFGTVYHGYLA--DGS--EVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~--~g~--~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ..|+||+|.||.|++|.|.  +|+  .||||.++..... ...+|++|+.+|.+|+|+|+++|+|...+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3478999999999999986  355  4899999866544 56789999999999999999999999987 6788999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +.|+|.+.|++..+..|-......++.|||.||.||.   .+++|||||..+|+||-..-.+||+||||.+.+.......
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999998866677888888999999999999999   6799999999999999999899999999999886444333


Q ss_pred             c-ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          765 I-STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       765 ~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      . .....-.+.|.|||.+...+++.++|||+|||.+|||+|+ ..||. +....++++.             +|..-+-.
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~-G~~g~qIL~~-------------iD~~erLp  335 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV-GCRGIQILKN-------------IDAGERLP  335 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC-CCCHHHHHHh-------------ccccccCC
Confidence            2 2334456789999999999999999999999999999984 55653 2223333222             33222223


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      -+..+.+.+++++..||..+|++||++.++.+.+
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3567788999999999999999999999998654

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.98  E-value=8.2e-32  Score=297.16  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=193.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++...+..++|+||++ 
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-   87 (301)
T cd07873           9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   87 (301)
T ss_pred             EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence            44578999999999999875 578999999875432 234567889999999999999999999999999999999997 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++... ...+++.....++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++.......  ...
T Consensus        88 ~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~  161 (301)
T cd07873          88 KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY  161 (301)
T ss_pred             cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccc
Confidence            5898888543 345889999999999999999999   6799999999999999999999999999987542211  112


Q ss_pred             cccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCcccccc------
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVRSIVD------  836 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~~ivd------  836 (919)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++|++||..... .+....+.....   ...+..+++      
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            23457889999998765 4578899999999999999999999864321 111111111100   000111100      


Q ss_pred             ---cccccC----CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          837 ---PRLEAN----FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 ---~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         +.....    ........+.+++.+|+..+|.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               110000    01112335788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=3e-32  Score=310.33  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=191.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.+.+.||+|+||.||++... +++.+|+|+++...   ....+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (371)
T cd05622          45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY  124 (371)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            445688999999999999976 57889999986432   22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..   ..++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       125 ~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~  197 (371)
T cd05622         125 MPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M  197 (371)
T ss_pred             CCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence            999999998853   34788889999999999999999   6799999999999999999999999999998663221 1


Q ss_pred             ccccccccCccccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .......||+.|+|||++...    .++.++|||||||++|||++|+.||...... .....+.   .......+.+   
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~---~~~~~~~~~~---  270 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIM---NHKNSLTFPD---  270 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHH---cCCCcccCCC---
Confidence            223356799999999998653    3788999999999999999999999643211 1111111   1100000000   


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQ--RPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVv~~  875 (919)
                          .......+.+++..|+...+.+  ||++.|+.+.
T Consensus       271 ----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         271 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                1122345678888999744433  7888888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=2.4e-32  Score=298.18  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+++++.++|+||+++++++..+...++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            44688999999999999986 5889999998654322  34568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.++...  ...+++.+++.++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        84 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~  156 (286)
T cd07846          84 HTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV  156 (286)
T ss_pred             ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence            9998887643  345899999999999999999999   5689999999999999999999999999988653322  22


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc----cccc-------cCCc-c
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC----PFLE-------RGDV-R  832 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~----~~~~-------~~~~-~  832 (919)
                      .....++..|+|||++.+ ..++.++||||||++++||++|++|+..... .+....+.    .+..       ...+ .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            234567899999999875 4578899999999999999999988753221 11110000    0000       0000 0


Q ss_pred             cccccccccC-----CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIVDPRLEAN-----FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~ivd~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+.....     ........+.+++.+|+..+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000000     01122356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=6e-32  Score=294.51  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||.|+||.||+|... +++.+|+|.++.......+.|..|++++++++|+|++++++++......++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            445678999999999999975 6889999998765544556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++... ...+++.+...++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......  ....
T Consensus        87 ~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~  160 (280)
T cd06611          87 GALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKR  160 (280)
T ss_pred             CcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cccc
Confidence            9999988543 346899999999999999999999   668999999999999999999999999988754221  1122


Q ss_pred             cccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          767 TSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ....++..|+|||.+.     ...++.++||||||+++|||++|+.||............     ..+..     +.+. 
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~-----~~~~-  229 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-----LKSEP-----PTLD-  229 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-----hcCCC-----CCcC-
Confidence            3456889999999874     345678999999999999999999998643211111111     11110     0110 


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       .+......+.+++..|+..+|.+||++.++++.
T Consensus       230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 -QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             011122357789999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=4.4e-32  Score=292.43  Aligned_cols=249  Identities=28%  Similarity=0.402  Sum_probs=198.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|++|.||++... +++.+|+|.+..... ...+++.+|++++++++|+||+++++.+......++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            34578999999999999976 688999999876532 3446788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCC-CCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK-PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~-~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      ++|.+++.... ..++.....+++.|++.||+|||   + .+++|+||||+||++++++.++|+|||.+.......    
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----  155 (265)
T cd06605          84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----  155 (265)
T ss_pred             CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence            99999985433 56889999999999999999999   5 799999999999999999999999999987552211    


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCc-cchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~-~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ....+.+........      +.+.   .
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~  226 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------PRLP---S  226 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------CCCC---h
Confidence            11256888999999999889999999999999999999999998654211 111111111111000      0110   0


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|++||++.+++.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            012345789999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=8.2e-32  Score=291.39  Aligned_cols=246  Identities=27%  Similarity=0.400  Sum_probs=188.6

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-----CCchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-----QGPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVY  681 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~  681 (919)
                      ..+.||+|+||.||+|... ++..||+|+++....     ...+.+.+|+.++++++|+||+++++++..  ....++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            4578999999999999874 588999999864322     122458889999999999999999998865  35678999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++++|.+++..  ...+++...+.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        86 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          86 EYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            99999999999854  345889999999999999999999   6689999999999999999999999999987653211


Q ss_pred             C-CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          762 E-SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      . ........++..|+|||++.+..++.++|||||||++|||++|+.||..........    ......     ..+.+ 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~-----~~~~~-  230 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQP-----TNPQL-  230 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCC-----CCCCC-
Confidence            1 111123458899999999998889999999999999999999999986432211111    111000     01111 


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         +......+..++ .|+..+|++||+|+||++
T Consensus       231 ---~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         231 ---PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               111222344455 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=6e-32  Score=302.93  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=189.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||++... +++.||+|+++..   .....+.+.+|+.++..++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            45688999999999999975 5889999999742   2223456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..+.... ..
T Consensus        84 ~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  158 (331)
T cd05597          84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TV  158 (331)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Cc
Confidence            999999998532 346889999999999999999999   6799999999999999999999999999987653221 11


Q ss_pred             cccccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYAS-----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ......||+.|+|||++..     ..++.++|||||||++|||++|+.||..... .+....+   ........+ .+. 
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i---~~~~~~~~~-~~~-  232 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKI---MNHKEHFQF-PPD-  232 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHH---HcCCCcccC-CCc-
Confidence            2233468999999999863     4578899999999999999999999863221 1111111   111100000 000 


Q ss_pred             ccCCChhHHHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECV--PSISFQRPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl--~~~P~~RPsm~eVv~~  875 (919)
                          .......+.+++.+|+  ..++..||++.++++.
T Consensus       233 ----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         233 ----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                0112234556666655  4444558899998874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=6e-32  Score=298.16  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      ..||+|+||.||++... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999999864 68899999997655555667889999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +++..   ..+++.++..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++.......  .......
T Consensus       107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  178 (297)
T cd06659         107 DIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLV  178 (297)
T ss_pred             HHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccccee
Confidence            87743   45899999999999999999999   6689999999999999999999999999987553221  1123456


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK  850 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~  850 (919)
                      |+..|+|||++.+..++.++||||||++++||++|+.||...... .....+.    ....     +...  ........
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~~~~-----~~~~--~~~~~~~~  246 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLR----DSPP-----PKLK--NAHKISPV  246 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh----ccCC-----CCcc--ccCCCCHH
Confidence            889999999999888999999999999999999999998643221 1111111    0000     0000  00112235


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          851 VAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       851 l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +.+++.+|++.+|++||++.++++.
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhC
Confidence            7889999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.98  E-value=1.1e-31  Score=292.77  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++|+||+++++++..+...++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            45678999999999999974 68999999987654  223467899999999999999999999999999999999999 


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++.... ..+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++........ ..
T Consensus        82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (286)
T cd07832          82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL  156 (286)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence            999999986433 56999999999999999999999   66899999999999999999999999999986643221 12


Q ss_pred             ccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC------------Ccc
Q 002461          766 STSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG------------DVR  832 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~------------~~~  832 (919)
                      .....|+..|+|||.+.+. .++.++||||+|++++||++|.+++.... ......++.......            ...
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            2345688999999998654 46899999999999999999977664322 211111111111100            000


Q ss_pred             ccccc-----ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          833 SIVDP-----RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       833 ~ivd~-----~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .+..+     .+.. ...+....+.+++.+|+..+|.+||+++++++.
T Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         236 KITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000     0000 011223678899999999999999999999763

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.98  E-value=2.4e-32  Score=309.77  Aligned_cols=197  Identities=25%  Similarity=0.451  Sum_probs=169.4

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.||+|+||.||++... +++.||+|+++...   ......+..|+.++..++|+||+++++.+.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4578999999999999975 58899999997432   2334567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC---
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE---  762 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~---  762 (919)
                      +|+|.+++..  ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        85 gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          85 GGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             CccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            9999999853  356899999999999999999999   67999999999999999999999999999875421110   


Q ss_pred             ------------------------------CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          763 ------------------------------SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       763 ------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                                                    ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                          0011235799999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=8.7e-32  Score=304.93  Aligned_cols=256  Identities=24%  Similarity=0.267  Sum_probs=190.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCC------eEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG------NVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~------~~~  678 (919)
                      +...+.||+|+||.||++... +|+.||||+++...  ......+.+|+.+++.++||||+++++++....      ..+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            345688999999999999864 58899999986542  233456888999999999999999999886443      579


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +||||+++ +|.+.++    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         103 LVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             EEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99999975 5666553    24788899999999999999999   6699999999999999999999999999997542


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---------  829 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---------  829 (919)
                      .   ........||..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.+.....         
T Consensus       175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         175 T---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             c---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHHHHH
Confidence            2   12233457899999999999999999999999999999999999998643211 1111111000000         


Q ss_pred             ----------------Ccccccccccc---cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          830 ----------------DVRSIVDPRLE---ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       830 ----------------~~~~ivd~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                      ...+.......   ..........+.+++.+|+..+|++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            00000000000   00011123457899999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=6.3e-32  Score=306.08  Aligned_cols=190  Identities=28%  Similarity=0.383  Sum_probs=161.5

Q ss_pred             HhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.+.||+|+||.||+|... +++.||+|+...      .....|+.++++++|+||+++++++......++|+|++.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            3455789999999999999975 467899997432      234579999999999999999999999999999999995


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                       ++|.+++.. ....+++.+++.|+.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....   ..
T Consensus       141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~  212 (357)
T PHA03209        141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA  212 (357)
T ss_pred             -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence             688888854 3456899999999999999999999   668999999999999999999999999998753211   12


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcc
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAII  810 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~  810 (919)
                      .....||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            234568999999999999999999999999999999998766553

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=7.7e-32  Score=294.23  Aligned_cols=260  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +++.+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            345688999999999999976 57899999987542  233467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +++.+..++.  ....+++.+...++.+++.||+|||   ..+++|+||+|+||++++++.+||+|||++........ .
T Consensus        83 ~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~  156 (288)
T cd07833          83 ERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S  156 (288)
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence            9877766553  2345899999999999999999999   56899999999999999999999999999987643322 1


Q ss_pred             cccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc------------ccC--
Q 002461          765 ISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL------------ERG--  829 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~------------~~~--  829 (919)
                      ......++..|+|||++.+. .++.++||||||+++|||++|++|+....... .........            ...  
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCccc
Confidence            22345678899999999887 88999999999999999999999885332111 110000000            000  


Q ss_pred             ---Ccccccccc-cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          830 ---DVRSIVDPR-LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       830 ---~~~~ivd~~-l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ......++. ....++......+.+++.+|+..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               001111110 011122223567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.98  E-value=9e-32  Score=288.93  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~Ey  683 (919)
                      ++.+.||.|+||.||++... +++.+|+|.++....  ...+++..|++++++++|+|++++++++..  +...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            34578999999999999864 678899999875432  224568889999999999999999998754  4567899999


Q ss_pred             ccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcC--CCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          684 MAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGC--KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       684 ~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~--~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      +++++|.+++....  ...+++...+.++.+++.||+|||..+  +.+++|+||||+||++++++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            99999999986432  457899999999999999999999543  56899999999999999999999999999987633


Q ss_pred             CCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ...  ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.... .....+.+    ..+..        
T Consensus       163 ~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~----~~~~~--------  227 (265)
T cd08217         163 DSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKI----KEGKF--------  227 (265)
T ss_pred             Ccc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHH----hcCCC--------
Confidence            221  1234568999999999998889999999999999999999999986432 22222211    11111        


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       ...+......+.+++.+|++.+|++||++.+|++.
T Consensus       228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             11222334578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=1.9e-31  Score=287.15  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=198.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ...+.||+|+||.||+|... +++.+++|.++.....  ..+.+..|+++++.++|+||+++++.+...+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            34578999999999999965 6889999999765443  45678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++..  ...+++..+..++.++++||.|||   +.+++|+||+|+||++++++.+||+|||++...........
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          83 GGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            9999999854  345889999999999999999999   66899999999999999999999999999887643222111


Q ss_pred             --ccccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          766 --STSIVGTVGYLDPEYYASNR---LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       766 --~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                        .....++..|+|||++....   .+.++||||||++++|+++|+.||....+.......+..    +.     .+.+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~-----~~~~~  228 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GH-----KPPIP  228 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CC-----CCCCC
Confidence              12356788999999998766   889999999999999999999998643322211111110    10     01110


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .  .......+.+++.+|++.+|++||++.+++.
T Consensus       229 ~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 D--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             c--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0  0111345778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=2.7e-31  Score=289.33  Aligned_cols=246  Identities=25%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++.+++|+||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            445678999999999999864 688999999864432 234568899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++..   ..+++.....++.+++.|+.|||   ..+++|+||||+||+++.++.++|+|||++.......  ..
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999998843   45899999999999999999999   6799999999999999999999999999987653221  12


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....++..|+|||.+.+..++.++|||||||+++||++|..|+..... ......+    ..+..     +.    ...
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~----~~~~~-----~~----~~~  223 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFLI----PKNNP-----PT----LEG  223 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHHH----hcCCC-----CC----CCc
Confidence            2334678899999999888899999999999999999999999853221 1111111    11100     11    112


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .....+.+++.+|++.+|.+||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            233467889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=8.8e-32  Score=294.14  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=195.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +++.+.||+|+||.||++... +|+.||+|.++... ......+.+|++++++++|+||+++++++...+..++|+||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345688999999999999976 78999999987542 2223578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccc-cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~-~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +++|.+++.... ...+++..+..++.+++.||.|||+  +.+++|+||||+||+++.++.+||+|||++..+...    
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  156 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----  156 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence            999999885432 3468999999999999999999995  248999999999999999999999999998755221    


Q ss_pred             cccccccCccccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYASNR------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      ......++..|+|||.+.+..      ++.++|||||||++|||++|+.||....... ....+.         .+.+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~---------~~~~~~  226 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLS---------AIVDGD  226 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHH---------HHhhcC
Confidence            223346788999999985543      4789999999999999999999985432111 111100         000100


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       ....+......+.+++.+|+..+|++||++.+++.
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 -PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             00112223446788999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=1.9e-31  Score=286.92  Aligned_cols=247  Identities=27%  Similarity=0.427  Sum_probs=202.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++......++|+||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            34688999999999999987 489999999876544 3456799999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCC-CCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK-PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~-~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      ++|.+++...  ..+++..++.++.|+++||+|||   . .+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--  156 (264)
T cd06623          84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--  156 (264)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence            9999999543  56899999999999999999999   5 79999999999999999999999999998866332221  


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCC--CccchhcccccccccCCcccccccccccCC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY--NNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~--~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....  ...+..+++.    ....     +    ..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~----~~  223 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----P----SL  223 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----C----CC
Confidence            224567889999999998899999999999999999999999986543  1122222211    1110     0    11


Q ss_pred             Chh-HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          844 DTN-SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       844 ~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +.. ....+.+++.+|+..+|++||++.++++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111 33578899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=6.1e-32  Score=305.63  Aligned_cols=257  Identities=23%  Similarity=0.253  Sum_probs=190.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~  678 (919)
                      +...+.||+|+||.||++... .++.||||+++....  ...+.+.+|+.+++.++|+||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            344678999999999999864 588999999875422  2345678899999999999999999987543      3579


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +||||+++ +|.+.+.    ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        99 lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          99 LVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             EEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            99999975 6666663    24888999999999999999999   6799999999999999999999999999998542


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc---------------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC---------------  823 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~---------------  823 (919)
                      .   ........||..|+|||++.+..++.++|||||||+++||++|+.||............+.               
T Consensus       171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         171 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             C---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            2   1223345789999999999988999999999999999999999999854321111000000               


Q ss_pred             ---ccccc-CCc-----ccccccccc---cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          824 ---PFLER-GDV-----RSIVDPRLE---ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       824 ---~~~~~-~~~-----~~ivd~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                         ..... ...     .......+.   ..........+.+++.+|+..+|++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00000 000     000000000   00111223467899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.98  E-value=4e-32  Score=298.78  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=195.6

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      ..||+|+||.||++... ++..||||++........+.+.+|+..++.++|+|++++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            56999999999999864 68899999987655555567889999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +++..   ..+++.+...++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.......  .......
T Consensus       108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~  179 (292)
T cd06658         108 DIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV  179 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence            98743   35899999999999999999999   5689999999999999999999999999987553221  1123356


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK  850 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~  850 (919)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||....... ....+.         ..+.+.+...  ......
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~---------~~~~~~~~~~--~~~~~~  247 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIR---------DNLPPRVKDS--HKVSSV  247 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---------hcCCCccccc--cccCHH
Confidence            8899999999988889999999999999999999999986432211 111110         0111111110  111235


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          851 VAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       851 l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +.+++.+|+..+|.+||+++++++.
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhC
Confidence            7788999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.98  E-value=1e-31  Score=293.18  Aligned_cols=258  Identities=20%  Similarity=0.275  Sum_probs=194.2

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ..+.||.|++|.||+|+.. +|+.||||+++....  .....+.+|++++++++||||+++++++.+.+..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            4578999999999999875 688999999875432  233578899999999999999999999999999999999996 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++.......+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||++.......  ...
T Consensus        83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~  157 (284)
T cd07860          83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY  157 (284)
T ss_pred             cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--ccc
Confidence            68999887655667899999999999999999999   6689999999999999999999999999987653221  112


Q ss_pred             cccccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---------------CC
Q 002461          767 TSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---------------GD  830 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---------------~~  830 (919)
                      ....++..|+|||.+.+.. ++.++||||||++++||+||+.||....+.....+.....-..               ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2345688999999886644 6889999999999999999999986433222111111100000               00


Q ss_pred             cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+....+... .......+.+++.+|++.+|.+||+++++++
T Consensus       238 ~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000000000000 0011235678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=8.8e-32  Score=305.44  Aligned_cols=256  Identities=24%  Similarity=0.270  Sum_probs=191.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~  678 (919)
                      +.+.+.||+|+||.||++... .++.||||+++...  ....+.+.+|+.+++.++|+||+++++++...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            345688999999999999964 58889999987542  22345678899999999999999999987543      3579


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +||||+++ +|.+.+.    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       106 lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         106 IVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            99999975 6777663    24788999999999999999999   6799999999999999999999999999998642


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---------  829 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---------  829 (919)
                      .   ........||..|+|||++.+..++.++|||||||++|||++|+.||...... +....+.......         
T Consensus       178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         178 T---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             C---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHhhh
Confidence            2   12223457899999999999999999999999999999999999998543221 1111111100000         


Q ss_pred             -----------C-----ccccccccc---ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          830 -----------D-----VRSIVDPRL---EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       830 -----------~-----~~~ivd~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                 .     ...+.....   ...........+.+++.+|++.+|.+|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                       0     000000000   000111123467899999999999999999999884

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=1.2e-31  Score=294.08  Aligned_cols=256  Identities=27%  Similarity=0.371  Sum_probs=195.2

Q ss_pred             HHHHHHHhhh--cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecC--
Q 002461          601 SEIVDITNNF--HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDG--  674 (919)
Q Consensus       601 ~ei~~~t~~~--~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~--  674 (919)
                      .++.+++.++  .+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|+|++++++++...  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            3444444444  578999999999999974 68899999986432 2245678899999999 899999999998643  


Q ss_pred             ---CeEEEEEEeccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          675 ---GNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       675 ---~~~~LV~Ey~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                         +..++|+||+++|+|.++++..  ....+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEe
Confidence               3689999999999999988532  2456899999999999999999999   6699999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR-----LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP  824 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~  824 (919)
                      |||++........  ......|+..|+|||.+....     ++.++|||||||++|||++|+.|+........+.+..  
T Consensus       171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~--  246 (291)
T cd06639         171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP--  246 (291)
T ss_pred             ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh--
Confidence            9999886532211  122346889999999976433     6889999999999999999999986432222221111  


Q ss_pred             ccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          825 FLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       825 ~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         .+....+.+       ..+....+.+++.+|++.+|++||++.|+++
T Consensus       247 ---~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         247 ---RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               111111111       1122235889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-31  Score=301.62  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=205.4

Q ss_pred             HhhhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCC---chhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQG---PKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~---~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.+.||+|.||.||+++.+. |+.+|+|++++.....   .....+|+.+|+++. |||||.+.+.+......++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            45566899999999999999875 9999999998764433   357899999999998 999999999999999999999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC----CcEEEeccCccccc
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK----MQAKLADFGFSKIF  757 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~----~~vkL~DFGla~~~  757 (919)
                      |++.+|.|.+.+...   .++......++.|++.++.|||   ..+|+||||||+|+|+...    +.+|++|||++...
T Consensus       116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999655   3999999999999999999999   6799999999999999643    47999999999977


Q ss_pred             CCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      ..   .......+||+.|+|||++....++..+||||+||++|.|++|.+||....+......     +..+..      
T Consensus       190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i~~~~~------  255 (382)
T KOG0032|consen  190 KP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----ILRGDF------  255 (382)
T ss_pred             cC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----HHcCCC------
Confidence            43   3456678999999999999999999999999999999999999999975443222221     111111      


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....+.-......+.+++..++..+|..|+++.++++.
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11111111223457789999999999999999999984

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=297.31  Aligned_cols=252  Identities=25%  Similarity=0.305  Sum_probs=197.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +..+.||+|++|.||+|... +++.+|+|.+......   ..+.+..|+++++.++|+||+++++.+......++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            34578999999999999976 4899999999765332   3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-  763 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-  763 (919)
                      .+++|.+++.......+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9999999987555567999999999999999999999   678999999999999999999999999998754221100 


Q ss_pred             --------------------------ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccc
Q 002461          764 --------------------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH  817 (919)
Q Consensus       764 --------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~  817 (919)
                                                .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                      011234688899999999988899999999999999999999999864322211


Q ss_pred             hhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       818 l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      +.+.             .+....-.........+.+++.+|+..+|++||++...++.+
T Consensus       241 ~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         241 FSNI-------------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             HHHH-------------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            1111             111110001111345788999999999999999944444333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=291.87  Aligned_cols=258  Identities=21%  Similarity=0.289  Sum_probs=194.6

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ..+.||.|++|.||+|... +|+.||+|++.....  .....+.+|++.+++++|+|++++++++...+..+++|||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            4578999999999999965 799999999875432  223568889999999999999999999999999999999995 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++.......+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||+++.......  ..
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~  156 (283)
T cd07835          82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY  156 (283)
T ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence            68999886554457899999999999999999999   56899999999999999999999999999876532211  11


Q ss_pred             cccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC--------C-------
Q 002461          767 TSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG--------D-------  830 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~--------~-------  830 (919)
                      ....++..|+|||++.+. .++.++||||||+++|||++|++||....+.....+.........        .       
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            233568899999987654 578999999999999999999999864332111111110000000        0       


Q ss_pred             cccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .......... .........+.+++.+|++.+|.+||+++|+++
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000 011122246789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=1.6e-31  Score=293.91  Aligned_cols=259  Identities=24%  Similarity=0.305  Sum_probs=194.8

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-----CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-----GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.+.||+|++|.||+|... +|+.||||.++.....     ....+..|++++++++|+||+++++++...+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34578999999999999965 6899999999765432     23456789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |+ +|+|.+++.... ..+++..++.++.|+++||.|||   ..+++|+||||+||+++.++.++|+|||+++.......
T Consensus        83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            99 899999985433 36999999999999999999999   66899999999999999999999999999986633221


Q ss_pred             CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---------Ccc
Q 002461          763 SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---------DVR  832 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---------~~~  832 (919)
                        ......++..|+|||.+.+ ..++.++|||||||+++||++|.++|.... ..+....+.......         ...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         158 --KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             --cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhhccccc
Confidence              1223356788999998854 467899999999999999999977664322 211111111110000         000


Q ss_pred             cccccccccC-----CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          833 SIVDPRLEAN-----FDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       833 ~ivd~~l~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ..........     ........+.+++.+|++.+|++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000     011224568899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=4.6e-31  Score=281.67  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEEec
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYEYM  684 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~  684 (919)
                      ..+.||+|++|.||+|... +++.|++|+++....  ...+.+.+|++.+++++|+||+++++.+...  ...++++||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            3578999999999999986 688999999875543  3456789999999999999999999999888  8899999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++++|.+++...  ..+++.++..++.++++||+|||   +.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        84 ~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          84 SGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999998543  37999999999999999999999   5689999999999999999999999999998764332211


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......++..|+|||.+.+...+.++||||||+++++|++|..|+....+......   .......         ....+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~---------~~~~~  226 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY---KIGSSGE---------PPEIP  226 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---hccccCC---------CcCCC
Confidence            13345688999999999888899999999999999999999999865432111111   1111011         11112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|++||++.++++
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            222457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.2e-32  Score=302.30  Aligned_cols=252  Identities=19%  Similarity=0.278  Sum_probs=190.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||+||+++.. +++.||+|+++...   ......+.+|..++..++|+||+++.+++...+..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            45688999999999999975 57889999986531   223345788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        84 ~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  158 (331)
T cd05624          84 VGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TV  158 (331)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-ce
Confidence            999999999643 346889999999999999999999   6799999999999999999999999999998653222 11


Q ss_pred             cccccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYAS-----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ......|++.|+|||++.+     ..++.++|||||||++|||++|+.||..... ......+...  .... . +.+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~--~~~~-~-~p~~~  233 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNH--EERF-Q-FPSHI  233 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-HHHHHHHHcC--CCcc-c-CCCcc
Confidence            2234569999999999875     4678899999999999999999999864321 1111111100  0000 0 00000


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQ--RPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPsm~eVv~~  875 (919)
                           ......+.+++.+|+...+.+  |++++++.+.
T Consensus       234 -----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         234 -----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 112345777888888755443  4678877753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-32  Score=305.09  Aligned_cols=240  Identities=24%  Similarity=0.303  Sum_probs=183.9

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhc---cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRV---HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l---~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ||+|+||+||+|+.. +|+.||||++.....   .....+..|..++...   +||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 588999999864321   1223455566777665   699999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..  ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~  153 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTT  153 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCc
Confidence            999998853  456899999999999999999999   668999999999999999999999999998753221  1223


Q ss_pred             cccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          767 TSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....||..|+|||.+.+. .++.++|||||||++|||++|+.||..... ....+.    +..+..      .+..   .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~----i~~~~~------~~~~---~  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRN----IAFGKV------RFPK---N  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHH----HHcCCC------CCCC---c
Confidence            345799999999998754 478999999999999999999999854221 111111    111110      0000   0


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPT----MSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPs----m~eVv~  874 (919)
                      .....+.+++.+|++.+|.+||+    +.++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11235678999999999999995    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=1.4e-31  Score=295.88  Aligned_cols=253  Identities=21%  Similarity=0.293  Sum_probs=196.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||++... .++.||+|.+.....   ...+.+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            34578999999999999975 578899999875532   22356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC----
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE----  760 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~----  760 (919)
                      ++++|.+++..  ...+++.....++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus        84 ~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          84 EGGDCATLLKN--IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            99999999954  346899999999999999999999   568999999999999999999999999998642100    


Q ss_pred             ---------CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCc
Q 002461          761 ---------SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDV  831 (919)
Q Consensus       761 ---------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~  831 (919)
                               ..........++..|+|||.+....++.++|+||||+++|||++|..||.... ...+....    ..+. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~----~~~~-  232 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQV----ISDD-  232 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH----Hhcc-
Confidence                     00011122457889999999988889999999999999999999999985322 11111111    0010 


Q ss_pred             ccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       832 ~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                        ...+....    .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus       233 --~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 --IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              00111100    123357899999999999999998777776665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=1.2e-31  Score=300.64  Aligned_cols=252  Identities=20%  Similarity=0.291  Sum_probs=189.6

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.++||+|+||.||++... +++.+|+|++.+.   .......+.+|+.++..++|+||+++.+++.+.+..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            45688999999999999976 4778999998642   1222345888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....... ..
T Consensus        84 ~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~  158 (332)
T cd05623          84 VGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TV  158 (332)
T ss_pred             CCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cc
Confidence            999999999642 346899999999999999999999   6799999999999999999999999999987553221 12


Q ss_pred             cccccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||..... ......+.   ....... + +. 
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~---~~~~~~~-~-p~-  231 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIM---NHKERFQ-F-PA-  231 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHh---CCCcccc-C-CC-
Confidence            223457999999999986     34678899999999999999999999864321 11111111   1100000 0 00 


Q ss_pred             ccCCChhHHHHHHHHHHhcCCC--CCCCCCCHHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPS--ISFQRPTMSHVVTE  875 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPsm~eVv~~  875 (919)
                         ........+.+++.+|+..  ++..|+++.|+++.
T Consensus       232 ---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         232 ---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence               0011223566677776654  34447899998875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=2e-31  Score=293.22  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=198.2

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  100 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG  100 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence            34567899999999999985 46889999998755444556789999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++..   ..+++.++..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||++........  ..
T Consensus       101 ~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~  172 (293)
T cd06647         101 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR  172 (293)
T ss_pred             CcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence            999999853   35789999999999999999999   66899999999999999999999999998875533221  22


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||.+....++.++||||||+++||+++|+.||...........    ....+.      +..  .....
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~~~------~~~--~~~~~  240 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNGT------PEL--QNPEK  240 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcCCC------CCC--CCccc
Confidence            334688899999999888899999999999999999999999864322111111    100110      000  01111


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....+.+++.+|+..+|++||++.+++.+
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            23357889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.5e-31  Score=313.86  Aligned_cols=255  Identities=21%  Similarity=0.285  Sum_probs=186.1

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCc------ceeeEEeEeecC-CeEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR------NLASLVGYCNDG-GNVGL  679 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~------NIv~l~g~~~~~-~~~~L  679 (919)
                      +.+.+.||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++|.      +++++++++... .+.++
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i  209 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI  209 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence            345678999999999999965 57889999996432 2234566788888877654      588899988754 57889


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC---------------
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---------------  744 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~---------------  744 (919)
                      |||++ +++|.+++..  ...+++.++..|+.|++.||+|||+  +.+|+||||||+|||++.++               
T Consensus       210 v~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        210 VMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            99987 6788888854  3568999999999999999999994  24899999999999998765               


Q ss_pred             -cEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc
Q 002461          745 -QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC  823 (919)
Q Consensus       745 -~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~  823 (919)
                       .+||+|||++....     .......||..|+|||++.+..++.++|||||||++|||++|+.||....+. +....+.
T Consensus       285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~  358 (467)
T PTZ00284        285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EHLHLME  358 (467)
T ss_pred             ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence             49999999876321     2234567999999999999999999999999999999999999999643321 1111111


Q ss_pred             ccccc---------------------CCcccccccccc----c-C--CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          824 PFLER---------------------GDVRSIVDPRLE----A-N--FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       824 ~~~~~---------------------~~~~~ivd~~l~----~-~--~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.+..                     +.+....++...    . .  ........+.+++..||..||++||++.|+++
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            10000                     000000111000    0 0  00011245779999999999999999999987

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.6e-31  Score=286.55  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=197.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|+++++.++|+|++++++.+......++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            34678999999999999975 58899999986542  2334578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~  764 (919)
                      +++|.+++.......+++..++.++.|+++||+|||   ..+++|+||||+||++++++ .+||+|||.+.......  .
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~  157 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--E  157 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--c
Confidence            999999997655556899999999999999999999   56899999999999999875 56999999988653222  1


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......|+..|+|||++.+..++.++||||||++++||++|+.|+......    +.+.... .+....         ..
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~~---------~~  223 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLKIC-QGYFAP---------IS  223 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHh-cccCCC---------CC
Confidence            222346889999999998888999999999999999999999998532211    1111111 111110         11


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|++||++.|+++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            112246888999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.5e-31  Score=289.98  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=192.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeec------CCeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCND------GGNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~------~~~~~LV  680 (919)
                      .+.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+|++++++++..      ....+++
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            44578999999999999974 67889999986543 2345678899999998 69999999999853      4578999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++......
T Consensus        98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636          98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            99999999999987655566888889999999999999999   668999999999999999999999999998754221


Q ss_pred             CCCccccccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                      .  .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||...........    ... .     .
T Consensus       175 ~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~-~-----~  242 (282)
T cd06636         175 V--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPR-N-----P  242 (282)
T ss_pred             c--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----Hhh-C-----C
Confidence            1  1123456889999999875     34578899999999999999999999864322111110    000 0     0


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.+.   .......+.+++.+|++.+|.+||++.|+++
T Consensus       243 ~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         243 PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            01110   1112346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.5e-31  Score=289.23  Aligned_cols=249  Identities=26%  Similarity=0.321  Sum_probs=195.2

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~~  685 (919)
                      ..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++...  ...++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3578999999999999975 578899999875433 2346789999999999999999999988653  46899999999


Q ss_pred             CCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|.+++...  ....+++.....++.|+++||+|||   ..+++|+||+|+||++++++.++|+|||++.......  
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  159 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--  159 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence            99999887532  2456889999999999999999999   6689999999999999999999999999987543211  


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCC----ccchhcccccccccCCccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN----NTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~----~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ..+...++..    ...     +.+
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~-----~~~  228 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPN-----PEL  228 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCc-----hhh
Confidence              1234578899999999988999999999999999999999999865421    1111222111    000     111


Q ss_pred             ccCCC--hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFD--TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .....  ..-...+.+++.+|+..+|.+||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11000  112346889999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=4.4e-31  Score=280.60  Aligned_cols=246  Identities=28%  Similarity=0.443  Sum_probs=199.7

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      ..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            4578999999999999986 688999999976655456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++.... ..+++..+..++.+++.||+|||   ..+++|+||+|+||++++++.++|+|||.+........   ...
T Consensus        84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~  156 (253)
T cd05122          84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT  156 (253)
T ss_pred             HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence            999985432 56899999999999999999999   67999999999999999999999999999886643221   234


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV  848 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~  848 (919)
                      ..++..|+|||.+.+...+.++||||||+++++|++|+.|+........... ..    ........+       .....
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~----~~~~~~~~~-------~~~~~  224 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IA----TNGPPGLRN-------PEKWS  224 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HH----hcCCCCcCc-------ccccC
Confidence            5688999999999888899999999999999999999999864321111111 00    011111111       01113


Q ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          849 WKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       849 ~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..+.+++.+|+..+|++||++.++++
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            46889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.4e-31  Score=286.32  Aligned_cols=245  Identities=25%  Similarity=0.423  Sum_probs=195.1

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCC-CCCchhhhHHHHHHHhcc---CcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVH---HRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~---H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ...+.||+|+||.||+|.. .+++.+|+|.++... .....++.+|++++++++   |+|++++++++..+...++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            3457899999999999996 468899999987543 233467889999999997   99999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++..   ..+++...+.++.+++.||.|||   ..+++|+||+|+||++++++.++|+|||++..+....  
T Consensus        84 ~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06917          84 AEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--  155 (277)
T ss_pred             CCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence            999999998843   36899999999999999999999   6699999999999999999999999999998764332  


Q ss_pred             ccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          764 HISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... .....    ...     ..+.+...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~----~~~-----~~~~~~~~  225 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-AMMLI----PKS-----KPPRLEDN  225 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-hhhcc----ccC-----CCCCCCcc
Confidence            122344688999999988654 46889999999999999999999985332111 11110    010     01111111


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         .....+.+++.+|+..+|++||++.++++
T Consensus       226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 ---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               12346888999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.5e-31  Score=287.10  Aligned_cols=250  Identities=22%  Similarity=0.395  Sum_probs=195.6

Q ss_pred             hcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCC------CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ..+.||+|++|.||+|.. .+++.+|+|+++.....      ..+.+..|++.+++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            457899999999999985 57889999998743321      23568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCcccccCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAES  761 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~~~  761 (919)
                      |+++++|.+++..  ...+++.....++.|++.||+|||   +.+++|+||||+||+++.++ .+||+|||++..+....
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          84 WMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             ccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            9999999999854  346889999999999999999999   66999999999999998775 59999999987664321


Q ss_pred             C--CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          762 E--SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       762 ~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .  ........++..|+|||.+.+..++.++||||+|+++++|++|..|+....... ....+.+....         ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~  228 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIASA---------TT  228 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhcc---------CC
Confidence            1  111223468899999999988889999999999999999999999985332111 11111100000         00


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+......+.+++.+|+..+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11122233356888999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=287.34  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=194.4

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCC------eEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGG------NVGL  679 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~------~~~L  679 (919)
                      +.+.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....      ..++
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            345688999999999999975 578899999875433 346789999999999 6999999999996544      4899


Q ss_pred             EEEeccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          680 VYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      ||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            999999999999886533  467899999999999999999999   678999999999999999999999999998765


Q ss_pred             CCCCCCccccccccCccccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYAS-----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~  832 (919)
                      ...  ........|+..|+|||++..     ..++.++||||||++++||++|+.||..........+..     .+.. 
T Consensus       164 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~-  235 (275)
T cd06608         164 DST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-----RNPP-  235 (275)
T ss_pred             ccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-----ccCC-
Confidence            322  122234568899999998753     346789999999999999999999986432211111110     0100 


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          +.+.  ........+.+++.+|+..+|++||++.++++
T Consensus       236 ----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 ----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                0111  11112346889999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=3.7e-31  Score=290.47  Aligned_cols=259  Identities=21%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYE  682 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~E  682 (919)
                      +.+.+.||+|+||.||+|... +++.+|+|.++.....  ....+.+|++++++++||||+++++++...  ...++|+|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344678999999999999976 5889999999754322  234567899999999999999999998777  88999999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      |++ ++|.+++... ...+++.+.+.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++....... 
T Consensus        87 ~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          87 YVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             hcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence            997 4898887543 236899999999999999999999   5689999999999999999999999999988664321 


Q ss_pred             CccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc---------------
Q 002461          763 SHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---------------  826 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~---------------  826 (919)
                       .......++..|+|||.+.+. .++.++|+||||++++||++|.+||........ ...+....               
T Consensus       161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccc
Confidence             112334578899999998654 468999999999999999999998864322111 11100000               


Q ss_pred             --ccCCcccccccccccCCChh-HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          827 --ERGDVRSIVDPRLEANFDTN-SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       827 --~~~~~~~ivd~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                        ............+...++.. ....+.+++.+|++.+|++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              00001111111122222222 2456788999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=305.30  Aligned_cols=237  Identities=32%  Similarity=0.438  Sum_probs=194.1

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCC---chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +-||+|+||.||.|.. .+.+.||||++.-...+.   ..++.+|+..|++++|||++.+-|++..+...+||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            4589999999999995 467889999997654443   4578899999999999999999999999999999999996 5


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +-.+++. ..++++...++..|+.+.++||+|||   +++.||||||..||||++.|.|||+|||.|....+      ..
T Consensus       111 SAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An  180 (948)
T KOG0577|consen  111 SASDLLE-VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN  180 (948)
T ss_pred             cHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence            7777763 33567899999999999999999999   67899999999999999999999999999886633      34


Q ss_pred             ccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc---chhcccccccccCCccccccccccc
Q 002461          768 SIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT---HIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~---~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ..+||+.|||||++.   .+.|+-|+||||+|+...||...++|++....-.   ++.+.-             .|.|. 
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-------------sPtLq-  246 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------SPTLQ-  246 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------CCCCC-
Confidence            578999999999864   5789999999999999999999999986432211   111111             11221 


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        ..+=...+++++..|++.-|.+|||..++++.
T Consensus       247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             --CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence              11223467899999999999999999998863

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=289.37  Aligned_cols=258  Identities=24%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEEec
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYEYM  684 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~Ey~  684 (919)
                      +.+.||+|++|.||+|... +|+.+|+|+++...  ......+.+|++++++++|+|++++++++...  +..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4578999999999999976 58899999998653  23345688899999999999999999999887  8899999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++ +|.+++... ...+++.+++.++.|+++||+|||   ..+++|+||||+||++++++.+||+|||++........ .
T Consensus        83 ~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~  156 (287)
T cd07840          83 DH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A  156 (287)
T ss_pred             cc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence            85 888887543 246899999999999999999999   56899999999999999999999999999986643321 1


Q ss_pred             cccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCcc--------
Q 002461          765 ISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVR--------  832 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~--------  832 (919)
                      ......++..|+|||.+.+ ..++.++||||||++++||++|+.|+..... ......+.+...   .....        
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccchhh
Confidence            1233456788999998764 4578999999999999999999999854322 111111111000   00000        


Q ss_pred             ------cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 ------SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ------~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                            ......+...+...+...+.+++.+|+..+|.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  001111111111112457889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=5.2e-31  Score=288.95  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=191.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+++++.++|+||+++.+++..+...++|+||+. 
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence            34678999999999999864 6889999998754332 23467889999999999999999999999999999999996 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++... ...+.+.++..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++......  ...
T Consensus        87 ~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~  160 (291)
T cd07870          87 TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTY  160 (291)
T ss_pred             CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCC
Confidence            6787776433 345788889999999999999999   5689999999999999999999999999987542211  112


Q ss_pred             cccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---C------Cc----c
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---G------DV----R  832 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---~------~~----~  832 (919)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+..+....+......   .      ..    .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            23457889999999875 357889999999999999999999986433211111111100000   0      00    0


Q ss_pred             ccc----ccccccCC-ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIV----DPRLEANF-DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~iv----d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.    .+.+.... .......+.+++.+|+..+|.+|||+.|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000    00000000 0011346778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=293.88  Aligned_cols=262  Identities=21%  Similarity=0.301  Sum_probs=192.7

Q ss_pred             hhcceeceeCcEEEEEEEEcC---CCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLAD---GSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~---g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV  680 (919)
                      .+.+.||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++...  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            446789999999999999754   7899999998643   33346678899999999999999999999887  789999


Q ss_pred             EEeccCCChhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC----CCcEEEeccCc
Q 002461          681 YEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE----KMQAKLADFGF  753 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~----~~~vkL~DFGl  753 (919)
                      |||+++ +|.+++....   ...++......++.|++.||+|||   +.+++||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999975 6776664322   236888999999999999999999   668999999999999999    89999999999


Q ss_pred             ccccCCCCC-CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc--------chhcccc
Q 002461          754 SKIFPAESE-SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT--------HIVNRVC  823 (919)
Q Consensus       754 a~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--------~l~~~v~  823 (919)
                      ++....... ........++..|+|||.+.+ ..++.++||||||++++||++|++||.......        ...+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            986533222 112234567889999998766 457899999999999999999999986432211        0000000


Q ss_pred             cccccC------------CcccccccccccCCC---------h--hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          824 PFLERG------------DVRSIVDPRLEANFD---------T--NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       824 ~~~~~~------------~~~~ivd~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..+...            ......+......++         .  .....+.+++.+|++.+|++||++.|+++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000            000000000000111         0  22346889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.3e-31  Score=291.19  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=191.8

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .+.||+|+||.||++... +++.+|+|.+..... .....+.+|+.++.++. |+||+++++++..+...++++||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            467999999999999965 588999999875432 23456889999999996 99999999999999999999999864 


Q ss_pred             Chhhh---hhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          688 NLKQY---LFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       688 sL~~~---L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +|.++   +.......+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++......   
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---  162 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---  162 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---
Confidence            55443   333334678999999999999999999995  3489999999999999999999999999997653221   


Q ss_pred             cccccccCccccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          765 ISTSIVGTVGYLDPEYYASN---RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||.....   ..+.+.+... +.     .+.+..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~-~~-----~~~~~~  233 (288)
T cd06616         163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVK-GD-----PPILSN  233 (288)
T ss_pred             ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcC-CC-----CCcCCC
Confidence            11233678899999998766   688999999999999999999999864321   1111111111 11     111111


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .........+.+++.+|++.+|++||++.+|++.
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112234468899999999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=4.3e-31  Score=285.42  Aligned_cols=246  Identities=25%  Similarity=0.346  Sum_probs=189.1

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-----CchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEE
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-----GPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVY  681 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~  681 (919)
                      ..+.||+|+||.||+|... +|..||+|.+......     ..+.+.+|++++++++|+||+++++++.+.  ...++++
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            4678999999999999975 5889999988643211     124678899999999999999999988663  4678999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++++|.+++...  ..+++...++++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++......
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          86 EHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            999999999998533  45788999999999999999999   5689999999999999999999999999987653211


Q ss_pred             C-CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          762 E-SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      . ........|+..|+|||.+.+..++.++||||||+++|||++|+.||..........+.    ....         ..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~---------~~  227 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI----ATQP---------TN  227 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH----hcCC---------CC
Confidence            1 11122345889999999998888999999999999999999999998532211111110    0000         01


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+......+..++.+|+. +|++||+++||++
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11122233456778888885 8999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=3.4e-31  Score=289.71  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=197.9

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      +.+.||+|++|.||+|... +++.+++|+++.... ..+.+.+|++.++.++|+|++++++++......++++||+++++
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~  101 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS  101 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence            3467999999999999987 688999999976544 45678899999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++.... ..+++..+..++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~  175 (286)
T cd06614         102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNS  175 (286)
T ss_pred             HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhcc
Confidence            999996543 37999999999999999999999   6799999999999999999999999999887553221  12233


Q ss_pred             cccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHH
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV  848 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~  848 (919)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+.............     ........+       .....
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~-------~~~~~  243 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT-----TKGIPPLKN-------PEKWS  243 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcCCCCCcc-------hhhCC
Confidence            457889999999988889999999999999999999999985322211111110     011100000       11123


Q ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          849 WKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       849 ~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..+.+++.+|++.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhh
Confidence            46788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.4e-31  Score=326.27  Aligned_cols=251  Identities=21%  Similarity=0.329  Sum_probs=193.2

Q ss_pred             HhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeec--CCeEEEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVY  681 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--~~~~~LV~  681 (919)
                      .+.+.+.||+|+||+||++... .+..+|+|.+.....  .....|..|+.++++++||||+++++++..  ....+|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            3456789999999999999975 567899999875422  234568899999999999999999998854  45689999


Q ss_pred             EeccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcC----CCCeeeeccccceEEeCC-------------
Q 002461          682 EYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGC----KPPIIHRDVKTANILLNE-------------  742 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~----~~~iiH~DLKp~NILld~-------------  742 (919)
                      ||+++|+|.++|....  ...+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.             
T Consensus        94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~  173 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN  173 (1021)
T ss_pred             eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence            9999999999986432  356999999999999999999999532    146999999999999964             


Q ss_pred             ----CCcEEEeccCcccccCCCCCCccccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc
Q 002461          743 ----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT  816 (919)
Q Consensus       743 ----~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~  816 (919)
                          ...+||+|||++..+...   .......||+.|+|||++.+  ..++.++|||||||+||||++|+.||.......
T Consensus       174 n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~  250 (1021)
T PTZ00266        174 NLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS  250 (1021)
T ss_pred             ccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence                235899999999865322   12234579999999999854  458899999999999999999999996443322


Q ss_pred             chhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          817 HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       817 ~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+...+    ..+.       .+.   .......+.+++..||..+|.+||++.++++
T Consensus       251 qli~~l----k~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        251 QLISEL----KRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHH----hcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            222111    1110       000   0111246788999999999999999999984

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=3.4e-31  Score=285.50  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.5

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||.|++|.||+++.. +++.+|+|++.....   ...+.+.+|+++++.++|+||+++++++.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 488999999875432   2346789999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++...  ..+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||+++......   .....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            9999543  45899999999999999999999   6799999999999999999999999999998663322   22334


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCC-ccchhcccccccccCCcccccccccccCCChhHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN-NTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV  848 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~-~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~  848 (919)
                      .++..|+|||.+....++.++|+||||+++|||++|..|+..... .......+            .+......++....
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~  220 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI------------LKGNGKLEFPNYID  220 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH------------hccCCCCCCCcccC
Confidence            688899999999888899999999999999999999999865432 11111111            11011112222224


Q ss_pred             HHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 002461          849 WKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       849 ~~l~~l~~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                      ..+.+++.+|++.+|++||+     ++|+++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            57899999999999999999     555544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=4.3e-31  Score=295.37  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=193.4

Q ss_pred             ceecee--CcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKG--GFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G--~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|  +||+||++... +|+.||+|++......  ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999974 7899999998754322  235688899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc--
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH--  764 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~--  764 (919)
                      ++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987655556899999999999999999999   6689999999999999999999999998654332111110  


Q ss_pred             ---cccccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc-------------
Q 002461          765 ---ISTSIVGTVGYLDPEYYASN--RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL-------------  826 (919)
Q Consensus       765 ---~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~-------------  826 (919)
                         ......++..|+|||++.+.  .++.++|||||||+++||++|+.||..........+......             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112346679999998763  478999999999999999999999865432222211111000             


Q ss_pred             -------------------ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          827 -------------------ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       827 -------------------~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                                         ..+....+.+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                               000000111111222222334567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=6.5e-31  Score=287.97  Aligned_cols=244  Identities=22%  Similarity=0.347  Sum_probs=196.5

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      .+.||+|++|.||++... +++.+++|+++.......+.+.+|+.+++.++|+|++++++++...+..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            368999999999999964 6889999998755444556788999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++..   ..+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.......  ......
T Consensus       104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~  175 (285)
T cd06648         104 TDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSL  175 (285)
T ss_pred             HHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccc
Confidence            999854   45899999999999999999999   6689999999999999999999999999887553221  122335


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      .|+..|+|||.+.+..++.++||||||++++||++|+.||..... ....+.+.    .+.     .+.+..  ......
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-~~~~~~~~----~~~-----~~~~~~--~~~~~~  243 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-LQAMKRIR----DNL-----PPKLKN--LHKVSP  243 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHH----hcC-----CCCCcc--cccCCH
Confidence            688999999999888899999999999999999999999854221 11111111    110     011110  111234


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.+++.+|+..+|++||++.++++
T Consensus       244 ~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         244 RLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHcc
Confidence            6889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=6.1e-31  Score=286.52  Aligned_cols=241  Identities=22%  Similarity=0.294  Sum_probs=189.7

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||+||++... +|+.+|+|.+....   ......+..|+++++.++|||++++++++...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 68899999986532   22344677899999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++.......+++.++..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99997655557999999999999999999999   668999999999999999999999999998765321   112334


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      .++..|+|||.+.+..++.++||||||+++++|++|+.||.......... .+.......          ....+.....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTLEM----------AVEYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-HHHhccccc----------cccCCccCCH
Confidence            67889999999988889999999999999999999999985432211100 000000000          0011122234


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSH  871 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~e  871 (919)
                      .+.+++.+|++.+|.+||+..+
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCc
Confidence            6788999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=4.1e-31  Score=287.98  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=188.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHH-HHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQL-LMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~-L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|... +|+.||+|+++.... ....++..|+.. ++.++|+|++++++++..++..+++|||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            34578999999999999975 689999999875432 233455566665 566789999999999999999999999997


Q ss_pred             CCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                       |+|.+++...  ....+++..++.++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++.....   
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  157 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---  157 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc---
Confidence             6888877542  235689999999999999999999942  38999999999999999999999999998865321   


Q ss_pred             ccccccccCccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYAS----NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+............   .....      .+.+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------~~~~  228 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ---VVEEP------SPQL  228 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH---HHhcC------CCCC
Confidence            11223468889999998864    44688999999999999999999998543221111111   11100      0111


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .   .......+.+++.+|+..+|++||++.++++
T Consensus       229 ~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 P---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   0111245788999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-33  Score=286.18  Aligned_cols=245  Identities=23%  Similarity=0.375  Sum_probs=202.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ++.++||+|+||.||||.++ .|+.+|||.+...  .+.+++.+|+.++++++.+++|+++|.+-....+++|||||..|
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            34578999999999999975 6999999998643  45678999999999999999999999998999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      ++.+.++- ++++++..+...++...++||+|||   ...-+|||||..||||+.+|.+||+|||.|..+..  ......
T Consensus       114 SiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  114 SISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             cHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            99999854 4678999999999999999999999   55679999999999999999999999999976522  122345


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC--Ch
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF--DT  845 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~--~~  845 (919)
                      ...||+.|||||++..-.|..++||||+|+...||..|++|+..    .|..+.+...          ...-...|  ++
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD----IHPMRAIFMI----------PT~PPPTF~KPE  253 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD----IHPMRAIFMI----------PTKPPPTFKKPE  253 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc----ccccceeEec----------cCCCCCCCCChH
Confidence            67899999999999999999999999999999999999999853    2222222111          11111122  22


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +=...+-+++..|+-.+|++|-|+.++.+.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            223468899999999999999999998873

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4e-31  Score=285.23  Aligned_cols=248  Identities=27%  Similarity=0.315  Sum_probs=204.1

Q ss_pred             cceeceeCcEEEEEEEEcC-CCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          611 HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.||+|.-|+||.+.+.+ +...|+|++.+..   .....+.+.|.+||+.+.||.++.|++.++.+...||+||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            4789999999999999875 5789999997653   33345678899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC-------
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA-------  759 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~-------  759 (919)
                      |+|...++.+..+.++...+.-++.+++-||+|||   ..|||.|||||+||||.++|.+.|+||.|+.....       
T Consensus       162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence            99999999888899999999999999999999999   78999999999999999999999999998753210       


Q ss_pred             ----------------------C---C-C---------------------CccccccccCccccCcccccCCCCCchhhH
Q 002461          760 ----------------------E---S-E---------------------SHISTSIVGTVGYLDPEYYASNRLTEKSDV  792 (919)
Q Consensus       760 ----------------------~---~-~---------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDV  792 (919)
                                            .   . .                     ...+...+||-.|+|||++.+...+.++|.
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW  318 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW  318 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence                                  0   0 0                     011234679999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCC----
Q 002461          793 YSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT----  868 (919)
Q Consensus       793 wSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs----  868 (919)
                      |+|||++|||+.|..||-...+...+..-+             -..+.-....+....+.+||.+.+..||.+|-.    
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG  385 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETLRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG  385 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhHHHHh-------------cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence            999999999999999996544333333322             222221112244557889999999999999998    


Q ss_pred             HHHHHH
Q 002461          869 MSHVVT  874 (919)
Q Consensus       869 m~eVv~  874 (919)
                      +.||.+
T Consensus       386 A~eIK~  391 (459)
T KOG0610|consen  386 AAEIKR  391 (459)
T ss_pred             hHHhhc
Confidence            777766

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.7e-31  Score=289.53  Aligned_cols=241  Identities=27%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||++... +++.+|+|+++...   ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            45688999999999999975 58899999987542   223456888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++++|.+++...  ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||+++.....    
T Consensus        84 ~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          84 PGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            999999998543  56899999999999999999999   679999999999999999999999999998865322    


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                       .....++..|+|||.+.+...+.++||||||+++++|++|+.||..... ....+.+    ..+..          ..+
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~----~~~~~----------~~~  218 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKI----LEGKV----------RFP  218 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH----hcCCc----------cCC
Confidence             2344688999999999888889999999999999999999999854321 1111111    11110          111


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ......+.+++.+|+..+|.+||     +++|+++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            12234678899999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=2.4e-31  Score=285.58  Aligned_cols=246  Identities=25%  Similarity=0.340  Sum_probs=194.1

Q ss_pred             eceeCcEEEEEEEEcC-CCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||.||++.... |+.+++|++.....   ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 89999999875433   3346788899999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC------C
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE------S  763 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~------~  763 (919)
                      .+++...  ..+++..+..++.|+++||+|||   ..+++|+||+|+||++++++.++|+|||++........      .
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9998543  36899999999999999999999   66899999999999999999999999999875432211      1


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......++..|+|||.......+.++||||||++++||++|+.||...... ...+.+.    .+...        ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~----~~~~~--------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQNIL----NGKIE--------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh----cCCcC--------CCc
Confidence            1223456788999999998888999999999999999999999998643321 1111111    01100        000


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      .......+.+++.+|++.+|++||++.++.+.|+
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            0001346789999999999999999966665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=300.13  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=188.5

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~  678 (919)
                      +...+.||+|+||.||+|.. .+++.||||+++....  ...+.+.+|++++++++|+||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            34457899999999999986 4678999999875322  2335677899999999999999999887532      4578


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +++|++ +++|.+++.   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          97 LVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            999987 678988774   245899999999999999999999   6699999999999999999999999999998653


Q ss_pred             CCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC-------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD-------  830 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~-------  830 (919)
                      ..     .....|+..|+|||++.+ ..++.++|||||||+++||++|+.||...... +....+........       
T Consensus       170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhc
Confidence            21     234568999999999876 56889999999999999999999998532211 11111111000000       


Q ss_pred             ----ccc-------ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          831 ----VRS-------IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       831 ----~~~-------ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                          ...       .....+...+ ......+.+++.+|+..+|.+||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                000       0000000000 0112246789999999999999999999973

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.6e-30  Score=287.87  Aligned_cols=244  Identities=30%  Similarity=0.400  Sum_probs=191.5

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +...+.||+|+||.||+|+.. +|+.||+|.+......   ..+++.+|+++++.++|||++++.++|...+..++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445678999999999999975 6889999998654332   234688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      ++ |+|.+.+... ...+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++......   
T Consensus        97 ~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          97 CL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            97 5777766432 346899999999999999999999   568999999999999999999999999998754221   


Q ss_pred             ccccccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                         ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+........ ...+   .. ...     +.+.
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~---~~-~~~-----~~~~  235 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHI---AQ-NDS-----PTLS  235 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHH---hc-CCC-----CCCC
Confidence               2346788999999874   45688899999999999999999999853321111 0000   00 000     0010


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                         .......+.+++.+||+.+|++||+|.+++..
T Consensus       236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               11123468899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.9e-32  Score=299.33  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=203.1

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecC--CCCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEec
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +...+.||+||.+.||++.-.+.+.+|+|++...  +.+....|.+|+..|.+++ |.+|+++++|-..++.+++||||=
T Consensus       363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G  442 (677)
T KOG0596|consen  363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG  442 (677)
T ss_pred             hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence            3445789999999999999888889999887533  4445677999999999995 999999999999999999999975


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      + -+|..+|.........| .+..+..|++.++.++|   ..+|||.||||.|+|+-. |.+||+|||+|..+..+..+-
T Consensus       443 d-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  443 D-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             c-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccce
Confidence            4 59999997666655556 78889999999999999   669999999999999975 579999999999887777777


Q ss_pred             cccccccCccccCcccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc
Q 002461          765 ISTSIVGTVGYLDPEYYASN-----------RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~  833 (919)
                      .....+||+.||+||.+...           +++.++||||+|||||+|+.|++||..-.+.   ..         .+..
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---~a---------Kl~a  584 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---IA---------KLHA  584 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---HH---------HHHh
Confidence            77788999999999987532           3567899999999999999999999632211   11         2344


Q ss_pred             ccccccccCCCh-hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          834 IVDPRLEANFDT-NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 ivd~~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.||.-.-+|+. ...+.+++++..|+..||++||+..|+++
T Consensus       585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            555544333422 22234999999999999999999999998

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=9.2e-31  Score=290.20  Aligned_cols=260  Identities=21%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+.+|.|+++.||++.. +++.||||+++..  .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34556666666666655 6899999998754  23345679999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-----
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-----  763 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-----  763 (919)
                      |.+++.......+++.....++.|+++||+|||   +.+|+|+||||+||+++.++.+||+|||.+.........     
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            999997655566889999999999999999999   668999999999999999999999999988755322111     


Q ss_pred             ccccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccc----ccccCC-------
Q 002461          764 HISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP----FLERGD-------  830 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~----~~~~~~-------  830 (919)
                      .......++..|+|||++..  ..++.++|||||||+++||++|+.||..........+....    .+....       
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence            11233457788999999875  35788999999999999999999999754332222221110    000000       


Q ss_pred             ccc----ccccccc----cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRS----IVDPRLE----ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~----ivd~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...    ..++...    ..........+.+++.+||..+|++||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000    0011000    0111122346788999999999999999999998

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=3.4e-31  Score=284.81  Aligned_cols=245  Identities=23%  Similarity=0.314  Sum_probs=197.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ++.+.||.|+||.||+|... +++.+|+|++.....   ...+.+.+|++++++++||||+++++++......++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45688999999999999976 588999999975432   33567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      .+++|.+++...  ..+++.+...++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++.......   
T Consensus        83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            999999998543  57899999999999999999999   5689999999999999999999999999988653322   


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      ......|+..|+|||.+.+..++.++|+||||+++++|++|..|+......  ...+.......          .....+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~~~  222 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET----------ADVLYP  222 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc----------ccccCc
Confidence            223456888999999998888999999999999999999999998644321  11111111110          001112


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTM--SHVV  873 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm--~eVv  873 (919)
                      ......+.+++.+|++.+|.+||++  +|+.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            2223578899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=283.91  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=191.7

Q ss_pred             hcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCC--CchhhhHHHHHHHhc---cCcceeeEEeEeecCCe-----EE
Q 002461          610 FHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQ--GPKQFRTEAQLLMRV---HHRNLASLVGYCNDGGN-----VG  678 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l---~H~NIv~l~g~~~~~~~-----~~  678 (919)
                      +.+.||+|+||.||+|+... ++.+|+|+++.....  ....+.+|+.+++++   +|+|++++++++...+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            45789999999999999864 899999999754322  234566788777766   59999999999987766     99


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      ++|||+. ++|.+++.......+++..++.++.|+++||.|||   +.+++|+||+|+||+++.++.+||+|||++..+.
T Consensus        83 l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          83 LVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             EEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999997 48988886544456999999999999999999999   5689999999999999999999999999998653


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc-CCc------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER-GDV------  831 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~-~~~------  831 (919)
                      ...   ......++..|+|||.+.+..++.++||||||++++||++|++|+....... ....+.+.... +..      
T Consensus       159 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCc
Confidence            221   1123357889999999998899999999999999999999988875332211 11111110000 000      


Q ss_pred             ---ccccccccccC---CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          832 ---RSIVDPRLEAN---FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 ---~~ivd~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ...........   ...+....+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               00000000000   01122356788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.1e-30  Score=278.91  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=200.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||++... +++.+++|++.....  ...+.+.+|+++++.++|+|++++.+.+......++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34578999999999999975 588999999876533  345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|.+++....  ...+++.++..++.++++||+|||   +.+++|+||+|+||++++++.++|+|||++.......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            999999986543  467999999999999999999999   5699999999999999999999999999998653322  


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      .......|+..|+|||......++.++||||+|+++++|++|+.|+..... ..+....    .....         ...
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~----~~~~~---------~~~  223 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKI----LKGQY---------PPI  223 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHH----hcCCC---------CCC
Confidence            223345688899999999888899999999999999999999999854321 1111110    01110         011


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++.+|+..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1123346888999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=1.9e-30  Score=288.74  Aligned_cols=246  Identities=30%  Similarity=0.374  Sum_probs=193.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +...+.||+|+||.||+|... ++..+|+|++......   ..+.+.+|++++++++|+|++++++++..+...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            344578999999999999964 6889999998754322   234688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      ++ |+|.+.+... ...+++.++..++.+++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            97 5787776432 456899999999999999999999   56899999999999999999999999999875422    


Q ss_pred             ccccccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                        .....|+..|+|||++.   ...++.++|||||||+++||++|+.|+..............    .+.         .
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~---------~  242 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NES---------P  242 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----ccC---------C
Confidence              12346888999999974   45688999999999999999999999864321111111110    000         0


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                      ..........+.+++.+|++.+|.+||++.++++.+.
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            0001122345788999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=1.7e-30  Score=283.35  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=194.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.+.||.|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34678999999999999975 6889999998765433 345678899999999999999999999999999999999985


Q ss_pred             CChhhhhhccc-cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          687 GNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       687 GsL~~~L~~~~-~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                       +|.+++.... ...+++.++..++.|++.||+|||   ..+++|+||||+||++++++.++|+|||+++......  ..
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~  156 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NT  156 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cc
Confidence             8888875433 346899999999999999999999   5689999999999999999999999999997553221  11


Q ss_pred             ccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc---cCCcccccc-cccc
Q 002461          766 STSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVRSIVD-PRLE  840 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~---~~~~~~ivd-~~l~  840 (919)
                      .....++..|++||.+.+. .++.++||||||+++|||++|+.||....... ....+.....   ...+..+.+ +.+.
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            2234578899999988654 56889999999999999999999986433211 1111110000   000000000 0000


Q ss_pred             cC-----------CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 AN-----------FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~-----------~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..           ........+.+++.+|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00           01112345789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=7.5e-32  Score=275.56  Aligned_cols=245  Identities=27%  Similarity=0.434  Sum_probs=193.6

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC----CCc----hhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS----QGP----KQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~----~~~----~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      .++||+|..++|-++.++ +|++.|+|++.....    +..    +.-++|+.+|+++ .||+|+++.++++.....++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            578999999999988865 688999999864322    112    2345699999998 599999999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      +|.|+.|.|.++|.  ..-.++.....+|+.|+..|++|||   ..+|+||||||+|||+|++.++||+|||++..+.+.
T Consensus       102 Fdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen  102 FDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999994  4556899999999999999999999   779999999999999999999999999999977432


Q ss_pred             CCCccccccccCccccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI  834 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~i  834 (919)
                         ......+||++|+|||.+..      ..|+...|+|+.||++|.|+.|.+||.--....     +.+.+-+|.. +.
T Consensus       177 ---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----MLR~ImeGky-qF  247 (411)
T KOG0599|consen  177 ---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----MLRMIMEGKY-QF  247 (411)
T ss_pred             ---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----HHHHHHhccc-cc
Confidence               33457899999999998753      357889999999999999999999985211100     0011111211 00


Q ss_pred             cccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       835 vd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      -.|..     .+......+|+.+|++.+|.+|-|++|+++
T Consensus       248 ~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  248 RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            00111     112235778999999999999999999987

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=316.79  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=204.8

Q ss_pred             hhcceeceeCcEEEEEEEEc----C----CCEEEEEEeecCCCC-CchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA----D----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~----~----g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~  678 (919)
                      .+.+.||+|.||.|++|...    .    ...||||+++..... ..+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45569999999999999853    1    346999999865443 457799999999999 6999999999999999999


Q ss_pred             EEEEeccCCChhhhhhccc------------c--ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          679 LVYEYMAYGNLKQYLFDET------------K--EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~------------~--~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                      +|.||+..|+|.++|+..+            .  ..++..+.+.++.|||.||+||+   +.+++||||..+|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999997654            0  23888999999999999999999   67899999999999999999


Q ss_pred             cEEEeccCcccccCCCCCCccccccc--cCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcc
Q 002461          745 QAKLADFGFSKIFPAESESHISTSIV--GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNR  821 (919)
Q Consensus       745 ~vkL~DFGla~~~~~~~~~~~~~~~~--Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~  821 (919)
                      .+||+|||+|+.......... ..-.  -...|||||.+....++.|+|||||||+||||+| |..|+..-....++.+ 
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-  533 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-  533 (609)
T ss_pred             EEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-
Confidence            999999999996543333221 1112  3566999999999999999999999999999998 5666643111223322 


Q ss_pred             cccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          822 VCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       822 v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                         ++++|.         +-+.+..+..++.+++..||+.+|++||++.++++.++..+.
T Consensus       534 ---~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  534 ---FLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ---HHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence               333332         112344456678899999999999999999999999998543

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.2e-30  Score=286.51  Aligned_cols=258  Identities=20%  Similarity=0.264  Sum_probs=191.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|.||+|... +|+.||+|++.....  ...+.+.+|++++++++|+||+++++++......++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            34578999999999999975 688999999865432  233568899999999999999999999999999999999996


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~  764 (919)
                       ++|.+++.......+++.....++.|++.||+|||   ..+++|+||+|+||+++. ++.+||+|||++......  ..
T Consensus        85 -~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~  158 (294)
T PLN00009         85 -LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VR  158 (294)
T ss_pred             -ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--cc
Confidence             58888775444444678888899999999999999   568999999999999985 567999999999765322  11


Q ss_pred             cccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Cc------ccc
Q 002461          765 ISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DV------RSI  834 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~------~~i  834 (919)
                      ......++..|+|||++.+ ..++.++||||||+++|+|+||++||..........+ +.......   .+      ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhccccccchhh
Confidence            1233457889999998865 4578999999999999999999999854322111111 00000000   00      000


Q ss_pred             -------cccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          835 -------VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       835 -------vd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                             ....+. .........+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        238 KSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000000 001122345788999999999999999999987

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=1.4e-30  Score=284.44  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=184.6

Q ss_pred             eeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHh---ccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          613 ILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMR---VHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~---l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +||+|+||.||++... +++.+|+|.+......   ....+.+|..+++.   .+|+|++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999974 5889999998654321   12334455544443   379999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++..  ...+++.....++.|++.||+|||   ..+++|+||||+|||+++++.++|+|||++......    .
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            9999998853  346999999999999999999999   668999999999999999999999999998754221    1


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....|+..|+|||.+.+ ..++.++|||||||+++||++|..||........  ..+.....      .....    .+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~------~~~~~----~~  219 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL------TVNVE----LP  219 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhh------cCCcC----Cc
Confidence            223468999999999864 5688999999999999999999999864322110  00000000      00111    12


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRP-----TMSHVVTE  875 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~~  875 (919)
                      ......+.+++.+|+..+|++||     +++|+++.
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            22334678899999999999999     58888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.3e-30  Score=283.78  Aligned_cols=256  Identities=23%  Similarity=0.275  Sum_probs=189.9

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhcc-CcceeeEEeEeecC--CeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVH-HRNLASLVGYCNDG--GNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~--~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|... +++.+|+|+++.... ........|+..+.++. |+|++++++++.+.  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            34578999999999999964 688999999875422 22334557888898885 99999999999887  889999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      ++ |+|.+.+... ...+++.++..++.|++.||+|||   ..+++||||||+||+++. +.+||+|||+++....... 
T Consensus        82 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          82 MD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             CC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            97 5888887543 346899999999999999999999   568999999999999999 9999999999986532211 


Q ss_pred             ccccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc-----------CCc
Q 002461          764 HISTSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER-----------GDV  831 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~-----------~~~  831 (919)
                        .....++..|+|||++. +..++.++|||||||+++||++|.+||.... ..+.+.+.......           ...
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence              12345788999999764 4567889999999999999999999885432 11222221111100           000


Q ss_pred             cccccccccc----CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          832 RSIVDPRLEA----NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 ~~ivd~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .....+...+    .........+.+++.+|++.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    001123467899999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=288.31  Aligned_cols=246  Identities=21%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             HhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .|++.+.||+|.|..|-.|++ -.|..||||++.+....  ....+.+|++.|+-++|||||+++++......++||.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            345668899999999999985 48999999999765333  345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC-CCCcEEEeccCcccccCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld-~~~~vkL~DFGla~~~~~~~~  762 (919)
                      -++|+|.++|-++. +.+.+....+++.||+.|+.|+|   +..++||||||+||.+- .-|-+||.|||++-.+.+.  
T Consensus        99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            99999999996544 56899999999999999999999   67899999999998875 5689999999998776433  


Q ss_pred             CccccccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLT-EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                       ...+..+|+..|-|||.+.+..|+ +..||||+|||||.|++|++||....+..             .+..++|-+.  
T Consensus       173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------TLTmImDCKY--  236 (864)
T KOG4717|consen  173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------TLTMIMDCKY--  236 (864)
T ss_pred             -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------hhhhhhcccc--
Confidence             234567999999999999999887 56799999999999999999997655432             2333444332  


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..+.....+..+|+..|+..+|++|.+.+||+.
T Consensus       237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            224444567889999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.1e-30  Score=287.59  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=194.4

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      .+||+|+||.||++... +|+.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999874 68899999986554445567889999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      +++..   ..+++.....++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus       106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTH---TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            98743   35899999999999999999999   5689999999999999999999999999987553221  1123456


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK  850 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~  850 (919)
                      |+..|+|||.+.+..++.++|+||||++++||++|..||..... ......+...         ..+.+..  .......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~~~~~~~~~---------~~~~~~~--~~~~~~~  245 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDN---------LPPKLKN--LHKVSPS  245 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhh---------CCcccCC--cccCCHH
Confidence            88999999999888899999999999999999999999853221 1111111100         0011100  0112235


Q ss_pred             HHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          851 VAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       851 l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.+++.+|+..+|.+||++.++++
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc
Confidence            778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=277.08  Aligned_cols=245  Identities=28%  Similarity=0.432  Sum_probs=198.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|+|++++++++..+...++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            34678999999999999865 578999999976543  234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++...  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........  .
T Consensus        83 ~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  155 (254)
T cd06627          83 NGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--D  155 (254)
T ss_pred             CCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--c
Confidence            99999998543  56899999999999999999999   66999999999999999999999999999987643222  1


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .....++..|+|||...+...+.++||||+|+++++|++|+.|+.............    . ..         ....+.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~----~-~~---------~~~~~~  221 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----Q-DD---------HPPLPE  221 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----c-cC---------CCCCCC
Confidence            234568889999999988888999999999999999999999986432211111100    0 00         001112


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .....+.+++.+|+..+|++||++.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            22346789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.5e-30  Score=290.24  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=192.2

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCchhhhHHHHHHHhc-cCcceeeEEeEeecC--CeEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDG--GNVGLVY  681 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~--~~~~LV~  681 (919)
                      +.+.+.||+|+||.||+|... +|+.+|+|++...  .......+..|+.+++++ +|+||++++++|...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            445688999999999999975 5788999988543  222345677899999999 999999999998653  4689999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||++ ++|.+++...   .++|..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          89 EYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             cccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            9997 5998888442   6889999999999999999999   6699999999999999999999999999998664332


Q ss_pred             CC---ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---------
Q 002461          762 ES---HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---------  828 (919)
Q Consensus       762 ~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---------  828 (919)
                      ..   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +....+......         
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHH
Confidence            21   22334568999999998754 55788999999999999999999998533221 111111100000         


Q ss_pred             --CCcccccc-------cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          829 --GDVRSIVD-------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       829 --~~~~~ivd-------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                        .....+++       ..+.. ........+.+++.+|++.+|++||++.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              00000000       00000 011123468899999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=283.56  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=193.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC-CchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|+||+|+.. +++.|+||++...... ......+|+..+++++ |+|++++++++...+..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            34678999999999999986 4788999998754322 2234567999999999 999999999999999999999999 


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++.......+++.+++.++.|++.+|.|||   ..+++|+||+|+||++++++.++|+|||++.......   .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~  154 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---P  154 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---C
Confidence            789999886655557899999999999999999999   5689999999999999999999999999998653221   1


Q ss_pred             ccccccCccccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc-------------CCc
Q 002461          766 STSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER-------------GDV  831 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~-------------~~~  831 (919)
                      .....++..|+|||.+. ...++.++|+||||++++||++|++||....... ....+...+..             ..+
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            22346788999999875 4557899999999999999999998885332211 11111000000             000


Q ss_pred             ----ccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          832 ----RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 ----~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          .......+..... .....+.+++.+|++.+|++||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                0000001110011 11356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=279.63  Aligned_cols=243  Identities=23%  Similarity=0.290  Sum_probs=185.9

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHH-HhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLL-MRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L-~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.||+|+||.||+|... +|+.||+|+++.....   ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874 6889999998654321   122344454444 445899999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++..  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            999999853  346889999999999999999999   56899999999999999999999999999875422      2


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                      ....++..|+|||.+.+..++.++||||||++++||++|..||...... .....+    ..+...      ........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~------~~~~~~~~  219 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVFDNI----LSRRIN------WPEEVKEF  219 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHH----HhcccC------CCCccccc
Confidence            2346788999999998888899999999999999999999998543221 111111    011100      00001112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       847 ~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      ....+.+++.+|+..+|++||++.++.+.|
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            234688999999999999999876664433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=4.4e-30  Score=282.76  Aligned_cols=259  Identities=27%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCC---------
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG---------  675 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~---------  675 (919)
                      +.+.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++|||++++++++.+..         
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            345688999999999999986 588999999975432  22356778999999999999999999987654         


Q ss_pred             -eEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcc
Q 002461          676 -NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS  754 (919)
Q Consensus       676 -~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla  754 (919)
                       ..++|+||+++ ++...+... ...+++.++..++.|++.||+|||   ..+|+|+||||+||++++++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence             78999999986 677766433 346899999999999999999999   568999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---C
Q 002461          755 KIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---D  830 (919)
Q Consensus       755 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~  830 (919)
                      ........ .......++..|+|||.+.+ ..++.++|||||||+++||++|++||........ .+.+.+.....   .
T Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (302)
T cd07864         164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ-LELISRLCGSPCPAV  241 (302)
T ss_pred             ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhh
Confidence            86643221 11222346788999998764 4578899999999999999999999864332111 11111110000   0


Q ss_pred             cccc--------cc------cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          831 VRSI--------VD------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 ~~~i--------vd------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...+        .+      ......+. .....+.+++..|++.+|.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000        00      00000111 12346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.4e-30  Score=292.54  Aligned_cols=256  Identities=23%  Similarity=0.273  Sum_probs=191.4

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVG  678 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~  678 (919)
                      +...+.||+|+||.||+|... +|+.||+|.+....  ....+.+.+|+.++++++|+||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            344578999999999999964 68899999986432  22335677899999999999999999987543      3579


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +|+||+. ++|.+.+..    .++......++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++...
T Consensus        98 lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          98 LVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            9999996 588887743    2888999999999999999999   6699999999999999999999999999998653


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc----------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER----------  828 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~----------  828 (919)
                      ..   .......++..|+|||.+.+..++.++|||||||++++|++|+.||..... ......+...+..          
T Consensus       170 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         170 TS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             CC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHHHHHHhh
Confidence            22   112334678899999999999999999999999999999999999853321 1111111000000          


Q ss_pred             ---------------CCcccccccccc----cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          829 ---------------GDVRSIVDPRLE----ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       829 ---------------~~~~~ivd~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                     ....+++...+.    ..........+.+++.+|++.+|++||++.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                           000011111110    00011234567899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3.4e-30  Score=284.32  Aligned_cols=259  Identities=22%  Similarity=0.319  Sum_probs=188.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCC--------e
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGG--------N  676 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~--------~  676 (919)
                      +...+.||+|+||.||+|... +++.||||.+......  ....+.+|++++++++||||++++++|....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            445678999999999999975 6889999998654322  2345678999999999999999999986543        4


Q ss_pred             EEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          677 VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       677 ~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      .++||||+.+ +|.+.+... ...+++.+...++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          94 FYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             EEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            5999999974 788777432 346899999999999999999999   56899999999999999999999999999986


Q ss_pred             cCCCCCC--ccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCcc--chhcccccccccCCc
Q 002461          757 FPAESES--HISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNT--HIVNRVCPFLERGDV  831 (919)
Q Consensus       757 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~l~~~v~~~~~~~~~  831 (919)
                      +......  .......++..|+|||.+.+. .++.++||||||++++||++|++|+.......  .....+......+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            6332211  112234578899999988654 46889999999999999999998885432111  011111100000000


Q ss_pred             cc------------------ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          832 RS------------------IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 ~~------------------ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..                  .+...+..   ......+.+++.+|+..+|.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00                  00000000   011235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=282.28  Aligned_cols=257  Identities=24%  Similarity=0.318  Sum_probs=196.0

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ..+.||+|++|.||+|... +|+.+++|.++.....  ....+..|++++++++|+||+++++++..+...++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            3578999999999999975 6888999998755332  346788899999999999999999999999999999999975


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                       +|.+++.... ..+++.++..++.+++.||+|||   ..+++|+||||+||+++.++.+||+|||.+.......  ...
T Consensus        83 -~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~  155 (283)
T cd05118          83 -DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY  155 (283)
T ss_pred             -CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence             8888875433 56899999999999999999999   6689999999999999999999999999998664332  122


Q ss_pred             cccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Ccccccc------
Q 002461          767 TSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVRSIVD------  836 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~~ivd------  836 (919)
                      ....++..|+|||.+.+. ..+.++||||||+++++|++|+.||...... +....+...+...   ....+.+      
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            234578899999998776 7899999999999999999999888543321 1111111111000   0000000      


Q ss_pred             ---cccc----cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          837 ---PRLE----ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 ---~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         +...    ..........+.+++.+|++.+|.+||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence               0000    0011123457889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2.9e-30  Score=283.29  Aligned_cols=259  Identities=20%  Similarity=0.268  Sum_probs=190.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhcc-CcceeeEEeEeecCCe-----EEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGN-----VGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~-----~~L  679 (919)
                      ...+.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.+++.++ |+||+++++++.....     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            34578999999999999975 688999999865432  23456888999999995 6999999999877655     899


Q ss_pred             EEEeccCCChhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCccc
Q 002461          680 VYEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSK  755 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~  755 (919)
                      ||||+++ +|.+++....   ...+++...+.++.|+++||.|||   ..+++||||||+||+++. ++.+||+|||+++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 8888875433   246899999999999999999999   669999999999999998 8899999999988


Q ss_pred             ccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC---c
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---V  831 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~---~  831 (919)
                      .+.....  ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||....+...... +...+....   .
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  236 (295)
T cd07837         160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVW  236 (295)
T ss_pred             ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCCCChhhC
Confidence            6532211  1122356788999998765 4578999999999999999999998864322111111 000000000   0


Q ss_pred             ccccc-------cccc----cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          832 RSIVD-------PRLE----ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 ~~ivd-------~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+       +...    ..........+.+++.+|+..+|.+||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000       0000    0001123346789999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=3.1e-30  Score=282.74  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=191.2

Q ss_pred             hhcceeceeCcEEEEEEEE----cCCCEEEEEEeecCCC----CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL----ADGSEVAIKMLSASSS----QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+.+.||+|+||.||++..    .+|+.||+|+++....    ...+.+.+|+++++++ +|+||+++.+++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3457899999999999986    3688999999975422    2235678899999999 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |+||+++++|.+++..  ...+++.....++.|+++||.|||   +.+++||||+|+|||+++++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          83 ILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            9999999999999854  346888999999999999999999   67999999999999999999999999999986532


Q ss_pred             CCCCccccccccCccccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASN--RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      .. ........|+..|+|||.+...  .++.++||||||+++++|++|..|+..........+.........        
T Consensus       158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------  228 (290)
T cd05613         158 DE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------  228 (290)
T ss_pred             cc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--------
Confidence            21 1122235688999999998753  467899999999999999999999853221111111111110000        


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                         ..++......+.+++.+|++.+|++||     ++.++..
T Consensus       229 ---~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ---PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               011222334678899999999999997     5566654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.7e-30  Score=284.54  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=194.9

Q ss_pred             hhcceeceeCcEEEEEEEE----cCCCEEEEEEeecCC----CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL----ADGSEVAIKMLSASS----SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+.+.||+|++|.||+++.    .+++.||||.++...    ....+.+.+|++++.++ +|+||+++.+.+......++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            3457899999999999985    357889999987532    12335688899999999 59999999999999999999


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ||||+++|+|.+++..  ...+++.....++.|+++||.|||   ..+++|+||||+||+++.++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          83 ILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            9999999999999853  346889999999999999999999   67899999999999999999999999999886533


Q ss_pred             CCCCccccccccCccccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      .. ........|+..|+|||.+.+..  .+.++||||||++++||++|..|+..........+....... .      .+
T Consensus       158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~------~~  229 (288)
T cd05583         158 EE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-S------KP  229 (288)
T ss_pred             cc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-c------CC
Confidence            22 11223346889999999987665  788999999999999999999998532111111111000000 0      00


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                          ..+......+.+++.+|++.+|++|||+.++.+.|+-
T Consensus       230 ----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         230 ----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                1111122357789999999999999999988776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=6e-30  Score=279.26  Aligned_cols=241  Identities=22%  Similarity=0.295  Sum_probs=185.0

Q ss_pred             eeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHH---HHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          613 ILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQL---LMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~---L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +||+|+||.||+|... +++.||+|.+......   ....+..|..+   ++...|+||+++.+++...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 5889999998754322   12234445444   344579999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++..  ...+++.++..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++..+...    .
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~  151 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence            9999998843  356999999999999999999999   568999999999999999999999999998755321    1


Q ss_pred             ccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          766 STSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....|+..|+|||.+.++ .++.++||||||++++||++|+.||.........  .......      ..+..    .+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~------~~~~~----~~  219 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTL------TMAVE----LP  219 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhh------ccCCC----CC
Confidence            2234689999999998754 6889999999999999999999998643221110  0000000      00111    11


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      ......+.+++.+|+..+|.+||     ++.++++
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            12234688899999999999999     8989875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3e-30  Score=283.93  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=190.0

Q ss_pred             hhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCC-CCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSS-QGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|+||.||+|...+ ++.||||.++.... .....+..|+.++.+.. |+||+++++++......+++|||+.
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            456899999999999999875 88999999975432 23345667777777775 9999999999999999999999985


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                       ++|.+++.. ....+++..+..++.|+++||+|||+  ..+++||||+|+||++++++.+||+|||++..+.....   
T Consensus        98 -~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---  170 (296)
T cd06618          98 -TCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---  170 (296)
T ss_pred             -cCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---
Confidence             467666543 23478999999999999999999994  24899999999999999999999999999876532211   


Q ss_pred             ccccccCccccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          766 STSIVGTVGYLDPEYYASNR----LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......+....+.   ... ..     .+. 
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~-----~~~-  240 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---QEE-PP-----SLP-  240 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh---cCC-CC-----CCC-
Confidence            12335788999999987554    78899999999999999999999854322211111111   110 00     000 


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       ........+.+++.+|+..+|.+||++.++++.
T Consensus       241 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 -PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             001123468899999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2e-30  Score=277.63  Aligned_cols=245  Identities=26%  Similarity=0.411  Sum_probs=198.0

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||+|++|.||++... +++.+|+|.+.....  .....+.+|++++++++|+||+++.+++......++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            34678999999999999864 678999999875432  234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++|.+++....  ...+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||+++.....   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            999999985532  356899999999999999999999   679999999999999999999999999999876432   


Q ss_pred             ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                       ......++..|+|||.+.+..++.++|+||||++++||++|+.|+..... ..+...+    ..+...         ..
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~----~~~~~~---------~~  221 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKV----QRGKYP---------PI  221 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH----hcCCCC---------CC
Confidence             22234678899999999988899999999999999999999999853321 1111111    111111         11


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++.+|+..+|++||++.++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1233456889999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.2e-30  Score=285.24  Aligned_cols=256  Identities=16%  Similarity=0.191  Sum_probs=179.0

Q ss_pred             HhhhcceeceeCcEEEEEEEEcCC----CEEEEEEeecCCCCCch-----------hhhHHHHHHHhccCcceeeEEeEe
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADG----SEVAIKMLSASSSQGPK-----------QFRTEAQLLMRVHHRNLASLVGYC  671 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~g----~~VAVK~l~~~~~~~~~-----------~f~~Ev~~L~~l~H~NIv~l~g~~  671 (919)
                      .+.+.++||+|+||.||+|...++    ..+|+|+..........           ....+...+..+.|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            455678999999999999997643    45666654322211100           112233445567899999999976


Q ss_pred             ecCC----eEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEE
Q 002461          672 NDGG----NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK  747 (919)
Q Consensus       672 ~~~~----~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vk  747 (919)
                      ....    ..++++|++. .++.+.+..  ....++..+..++.|++.||+|||   +.+++||||||+|||++.++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            5443    3456777654 356555532  223578888999999999999999   66999999999999999999999


Q ss_pred             EeccCcccccCCCCCC-----ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccc
Q 002461          748 LADFGFSKIFPAESES-----HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV  822 (919)
Q Consensus       748 L~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v  822 (919)
                      |+|||+++.+......     .......||+.|+|||+..+..++.++|||||||+++||++|+.||.............
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999999876322111     11223469999999999999999999999999999999999999996442222211111


Q ss_pred             c-cccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          823 C-PFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       823 ~-~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      . .+     +..+..+.+.   .......+.+++..|+..+|++||++.++.+.|
T Consensus       247 ~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0 00     0111111111   112235688999999999999999999999876

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=5.7e-30  Score=283.55  Aligned_cols=257  Identities=24%  Similarity=0.300  Sum_probs=190.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV~Ey  683 (919)
                      ++.+.||+|+||.||+|... +|+.||+|+++.....  ....+.+|+.++++++|+|++++++++...  +..++|+||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            34578999999999999975 5899999998754322  233567899999999999999999998654  568999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +.+ +|.+++... ...+++.++..++.|+++||+|||   ..+++||||||+||++++++.+||+|||++........ 
T Consensus        90 ~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~-  163 (309)
T cd07845          90 CEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-  163 (309)
T ss_pred             CCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence            974 888887543 356899999999999999999999   56899999999999999999999999999986643221 


Q ss_pred             ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCC---ccc------
Q 002461          764 HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---VRS------  833 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~---~~~------  833 (919)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|++||..... ......+........   ...      
T Consensus       164 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         164 -PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             -CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhhcccc
Confidence             1223345788999999865 4578999999999999999999999864322 111111111110000   000      


Q ss_pred             --cc--c-c---ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          834 --IV--D-P---RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 --iv--d-~---~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                        .+  . .   .+...+ ......+.+++.+|++.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              00  0 0   000000 011345678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=274.06  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             hhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +.+.+.||+|.|+.||+..+ .+|+.+|+|++...  .....+++.+|+.+.+.++||||+++.+...+....++|+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            34557899999999999885 46889999987532  3345678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC---CCcEEEeccCcccccCCCC
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE---KMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~---~~~vkL~DFGla~~~~~~~  761 (919)
                      .+++|..-+-  .+...++...-..+.||+.+|.|+|   ..+|+|||+||+|+||..   .--+||+|||+|..+.   
T Consensus        93 ~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---  164 (355)
T KOG0033|consen   93 TGGELFEDIV--AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---  164 (355)
T ss_pred             cchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence            9999977662  3366788888899999999999999   669999999999999963   3458999999999774   


Q ss_pred             CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~  841 (919)
                      ........+||++|||||++...+++..+|||+.||+|+-|+.|.+||... +...+.+.+.    .+..  -+++... 
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~----~g~y--d~~~~~w-  236 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIK----AGAY--DYPSPEW-  236 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHh----cccc--CCCCccc-
Confidence            344556778999999999999999999999999999999999999999642 2223333321    1110  0111111 


Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ....+...+|+.+|+..+|.+|-|+.|.+.
T Consensus       237 ---~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  237 ---DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               112235678899999999999999999875

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=5.2e-30  Score=287.27  Aligned_cols=257  Identities=25%  Similarity=0.308  Sum_probs=192.1

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCC--------------chhhhHHHHHHHhccCcceeeEEeEeecC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQG--------------PKQFRTEAQLLMRVHHRNLASLVGYCNDG  674 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~  674 (919)
                      +.+.||+|+||.||+|... +++.||||+++......              ...+.+|+++++.++|+||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            3467999999999999965 68899999986543221              12467899999999999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcc
Q 002461          675 GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS  754 (919)
Q Consensus       675 ~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla  754 (919)
                      +..++||||+. |+|.+++..  ...+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccce
Confidence            99999999997 689988843  345899999999999999999999   678999999999999999999999999999


Q ss_pred             cccCCCC------------CCccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcc
Q 002461          755 KIFPAES------------ESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNR  821 (919)
Q Consensus       755 ~~~~~~~------------~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~  821 (919)
                      +......            .........++..|+|||.+.+. .++.++||||||++++||++|++||....+ .+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-~~~~~~  245 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-IDQLGR  245 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence            7653111            01111233467889999998764 468999999999999999999998864332 222222


Q ss_pred             cccccccCC---ccc------------ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          822 VCPFLERGD---VRS------------IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       822 v~~~~~~~~---~~~------------ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +........   +..            ...+..... .......+.+++..|++.+|++||++.|++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            111111100   000            000111110 1112346789999999999999999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.2e-30  Score=275.47  Aligned_cols=247  Identities=27%  Similarity=0.370  Sum_probs=191.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-----CCCchhhhHHHHHHHhccCcceeeEEeEeecC--CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-----SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--~~~~LV  680 (919)
                      .+.+.||+|+||.||+|... +++.||+|.+....     .+..+.+.+|++++++++|+||+++++++...  ...+++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            45689999999999999964 68899999875321     12235688899999999999999999998654  468899


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      +||+++++|.+++..  ...+++....+++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        85 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          85 VEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            999999999999853  345889999999999999999999   668999999999999999999999999999865321


Q ss_pred             CC-CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          761 SE-SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       761 ~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      .. ........++..|+|||++.+..++.++|||||||+++||++|+.||..........+    ....+         .
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~---------~  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK----IATQP---------T  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH----HHcCC---------C
Confidence            11 1112235688999999999888899999999999999999999999864321111111    11000         0


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+......+.+++.+|+. +|..||+..+++.
T Consensus       227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            111223334568889999999 4799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=290.00  Aligned_cols=259  Identities=24%  Similarity=0.345  Sum_probs=190.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecC-----CeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV~  681 (919)
                      .+.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.++++++|+||+++++++...     ...++++
T Consensus         8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   87 (336)
T cd07849           8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ   87 (336)
T ss_pred             EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence            44688999999999999864 68999999986432 22345678899999999999999999887543     3589999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+++ +|.+.+.   ...+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        88 e~~~~-~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          88 ELMET-DLYKLIK---TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             hhccc-CHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            99974 7877763   346899999999999999999999   6689999999999999999999999999987653221


Q ss_pred             C-CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Ccccccc
Q 002461          762 E-SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVRSIVD  836 (919)
Q Consensus       762 ~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~~ivd  836 (919)
                      . ........|+..|+|||.+.+ ..++.++|||||||+++||++|+.||.... .......+...+...   .+..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD-YLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1 111233568899999998654 568899999999999999999999985322 111111111111110   0011111


Q ss_pred             cccc---------cC-----CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          837 PRLE---------AN-----FDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       837 ~~l~---------~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      ....         ..     ........+.+++.+|++.+|++||++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000         00     001123457899999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.1e-30  Score=304.82  Aligned_cols=265  Identities=21%  Similarity=0.280  Sum_probs=182.2

Q ss_pred             HHhhhcceeceeCcEEEEEEEEcC--CCEEEEEEe--------------ec---CCCCCchhhhHHHHHHHhccCcceee
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLAD--GSEVAIKML--------------SA---SSSQGPKQFRTEAQLLMRVHHRNLAS  666 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~~--g~~VAVK~l--------------~~---~~~~~~~~f~~Ev~~L~~l~H~NIv~  666 (919)
                      ..+.+.+.||+|+||+||++.++.  +...++|.+              .+   ........+.+|++++++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            345567899999999999987542  222222211              00   11112345789999999999999999


Q ss_pred             EEeEeecCCeEEEEEEeccCCChhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC
Q 002461          667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK  743 (919)
Q Consensus       667 l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~  743 (919)
                      +++++...+..++|+|++. ++|.+++....   .......+...++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence            9999999999999999985 57777764332   122345567789999999999999   6799999999999999999


Q ss_pred             CcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCc-ccCCC--ccchhc
Q 002461          744 MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI-IRGYN--NTHIVN  820 (919)
Q Consensus       744 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~-~~~~~--~~~l~~  820 (919)
                      +.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..++ .....  ...+.+
T Consensus       304 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            999999999998763321 22233467999999999999999999999999999999999987543 32211  111111


Q ss_pred             cccccc-ccCCc-------ccccccc-ccc---CC-----ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          821 RVCPFL-ERGDV-------RSIVDPR-LEA---NF-----DTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       821 ~v~~~~-~~~~~-------~~ivd~~-l~~---~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .+.... .....       .+.++.. +..   ..     .......+.+++.+|++.||.+||++.|+++.
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            110000 00000       0000000 000   00     00012245677889999999999999999873

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.5e-30  Score=280.64  Aligned_cols=246  Identities=28%  Similarity=0.423  Sum_probs=196.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+.+.||+|+||.||+|... +|+.||+|++....   ....+.+..|++++++++ |+||+++++++...+..++||||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            45678999999999999975 78999999987532   223456888999999998 99999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++++|.+++..  ...+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          84 APNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            999999999854  346999999999999999999999   568999999999999999999999999998865432211


Q ss_pred             ------------------ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc
Q 002461          764 ------------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF  825 (919)
Q Consensus       764 ------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~  825 (919)
                                        .......++..|+|||.+.....+.++||||||++++++++|+.|+....... ..+.+.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~--  235 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKIL--  235 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH--
Confidence                              11223457889999999988889999999999999999999999986433111 111110  


Q ss_pred             cccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 002461          826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTM----SHVVT  874 (919)
Q Consensus       826 ~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm----~eVv~  874 (919)
                        .          .....+......+.+++.+|++.+|.+||++    +++++
T Consensus       236 --~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 --K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              0          0111122223468899999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-30  Score=278.66  Aligned_cols=256  Identities=26%  Similarity=0.334  Sum_probs=194.5

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +.+.||+|++|.||+|+.. +++.+|+|+++...  ....+.+..|++++++++|+|++++++++......++|+||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            3467999999999999976 48999999998653  2334677889999999999999999999999999999999998 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      ++|.+++.... ..+++..+..++.++++||+|||   ..+++|+||+|+||++++++.+||+|||+++.......  ..
T Consensus        82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  155 (282)
T cd07829          82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TY  155 (282)
T ss_pred             cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--cc
Confidence            58999986432 46999999999999999999999   56899999999999999999999999999886533221  12


Q ss_pred             cccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc----------------cC
Q 002461          767 TSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE----------------RG  829 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~----------------~~  829 (919)
                      ....++..|+|||.+.+. .++.++||||||++++||++|++||..... ......+.+...                ..
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            233467789999998766 789999999999999999999888854321 111111111000                00


Q ss_pred             CcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       830 ~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .............++ .....+.+++..|+..+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000011 11346899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=8.9e-30  Score=282.23  Aligned_cols=245  Identities=29%  Similarity=0.394  Sum_probs=190.9

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +...+.||+|+||.||+|... +++.+|+|.+.....   ...+++.+|+++++.++|+|++++.+++......++|+||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            444578999999999999965 578899999864322   2234678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +. |+|.+.+... ...+++.++..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++......   
T Consensus        97 ~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          97 CL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             cC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            97 6887776433 345899999999999999999999   568999999999999999999999999998765321   


Q ss_pred             ccccccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          764 HISTSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       764 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                         ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+.............     .+..     +...
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~-----~~~~  235 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNES-----PALQ  235 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hcCC-----CCcC
Confidence               2345788999999974   3567889999999999999999999975432111111110     0100     0000


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                         .......+.+++.+|+..+|++||++.++++..
T Consensus       236 ---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence               112234578899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=284.00  Aligned_cols=238  Identities=26%  Similarity=0.367  Sum_probs=193.2

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .++||+||||.||-+..+ +|+.+|.|++.+.   ..+.....++|-.+|.+++.+.||.+--.+...+..+||+..|.+
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            579999999999998865 6889999988543   234445678899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.-+|.......++....+-++.+|+.||++||   ..+|+.|||||+|||||+.|+++|+|+|||..+...   ...
T Consensus       270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~  343 (591)
T KOG0986|consen  270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPI  343 (591)
T ss_pred             CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC---Ccc
Confidence            99999998777788999999999999999999999   679999999999999999999999999999977432   223


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc---ccCC
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL---EANF  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l---~~~~  843 (919)
                      ...+||.+|||||++++..|+...|.||+||++|||+.|+.||..-....   .       .    +-+|.+.   ..++
T Consensus       344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k-------~----eEvdrr~~~~~~ey  409 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---K-------R----EEVDRRTLEDPEEY  409 (591)
T ss_pred             ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---h-------H----HHHHHHHhcchhhc
Confidence            34589999999999999999999999999999999999999996432211   0       0    0111111   1122


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCC
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPT  868 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPs  868 (919)
                      ++.-.+....|....+..+|++|..
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhcc
Confidence            3333345566777788888888764

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=293.46  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=195.7

Q ss_pred             ceeceeCcEEEEEEEEcCCC-EEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~-~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      --||.|+||.||||.-++.. ..|.|++...+....++|.-|+++|..+.||+||++++.+..++.++++.|||.||-++
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD  117 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD  117 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence            45899999999999976544 35678887777777889999999999999999999999999999999999999999999


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      ..+.. -...|+..++.-++++++.||.|||   +.+|||||||..|||++-+|.++|+|||.+-..  ...........
T Consensus       118 aimlE-L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRDsFI  191 (1187)
T KOG0579|consen  118 AIMLE-LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRDSFI  191 (1187)
T ss_pred             HHHHH-hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc--hhHHhhhcccc
Confidence            88754 3567999999999999999999999   679999999999999999999999999987532  11223345678


Q ss_pred             cCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          771 GTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       771 Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ||+.|||||+..     ..+|+.++||||||+.|.||..+.+|...-....-++..     .......+..|.       
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-----aKSePPTLlqPS-------  259 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-----AKSEPPTLLQPS-------  259 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-----hhcCCCcccCcc-------
Confidence            999999999875     457899999999999999999999987543221111111     111111122221       


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .=...+.++...|+..+|..||++.++++
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11235778999999999999999999886

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1e-29  Score=280.60  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=188.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecC--------CeE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDG--------GNV  677 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--------~~~  677 (919)
                      .+.+.||+|+||.||+|... +++.+|+|++......  ....+.+|+++++.++|+||+++++++...        ...
T Consensus        11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   90 (311)
T cd07866          11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV   90 (311)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence            44678999999999999965 6889999998654322  234678899999999999999999987543        346


Q ss_pred             EEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          678 GLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      ++|+||+.. +|...+... ...+++.++..++.|+++||+|||   ..+++|+||||+||++++++.+||+|||+++..
T Consensus        91 ~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          91 YMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            999999875 677766432 346999999999999999999999   668999999999999999999999999999865


Q ss_pred             CCCCCC---------ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc
Q 002461          758 PAESES---------HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE  827 (919)
Q Consensus       758 ~~~~~~---------~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~  827 (919)
                      ......         .......++..|+|||.+.+ ..++.++||||||++++||++|++||...... ...+.+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~  244 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLIFKLCG  244 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            322211         11123457888999998765 45889999999999999999999988533221 11111110000


Q ss_pred             c---C------Cccc--------ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          828 R---G------DVRS--------IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       828 ~---~------~~~~--------ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .   .      .+..        ...+.+...+. .....+.+++.+|++.+|.+||++.|++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-KLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcc-cCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0   0      0000        01111111111 11246789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.9e-30  Score=288.10  Aligned_cols=261  Identities=23%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecC-----CeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV  680 (919)
                      ...+.||+|+||+||+|... +++.||||.++..  .......+.+|+.+++.++|+||+++++++...     ...++|
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv   87 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV   87 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence            34578999999999999964 6889999998753  222345677899999999999999999987643     358999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      +||+. ++|.+++..  ...+++.....++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          88 YELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            99996 689888843  356899999999999999999999   668999999999999999999999999999865322


Q ss_pred             CCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccc-----------cccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP-----------FLER  828 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~-----------~~~~  828 (919)
                      .  .......++..|+|||.+.. ..++.++|||||||++++|++|++||.... .......+..           ....
T Consensus       162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhcCc
Confidence            1  22234567889999998764 468899999999999999999999985321 1110100000           0000


Q ss_pred             CCccccc-------ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHHH
Q 002461          829 GDVRSIV-------DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE--LKKC  879 (919)
Q Consensus       829 ~~~~~iv-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~--Le~~  879 (919)
                      +.....+       ++.+... .......+.+++.+|++.+|++||+++++++.  ++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0000000       0111100 11233567899999999999999999999985  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=2.4e-29  Score=279.60  Aligned_cols=241  Identities=29%  Similarity=0.400  Sum_probs=188.9

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCC---chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+.||+|+||.||+|+.. +|+.|++|++.......   .+.+.+|+++++.++|+|++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            367999999999999964 68899999987543322   2467889999999999999999999999999999999996 


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++... ...+++.+++.++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++.....      .
T Consensus       105 ~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~  174 (313)
T cd06633         105 GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------A  174 (313)
T ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------C
Confidence            5787777432 456899999999999999999999   56899999999999999999999999998864321      1


Q ss_pred             cccccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          767 TSIVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ....|+..|+|||++.   ...++.++||||||+++|||++|..|+........ .....   . ........       
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~---~-~~~~~~~~-------  242 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA---Q-NDSPTLQS-------  242 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH---h-cCCCCCCc-------
Confidence            2346888999999974   45688899999999999999999999864322111 11110   0 00111111       


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       ......+.+++.+|++.+|.+||++.+++..
T Consensus       243 -~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 -NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1112357889999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=6.3e-30  Score=286.73  Aligned_cols=260  Identities=20%  Similarity=0.287  Sum_probs=192.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeec----CCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCND----GGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~----~~~~~LV~  681 (919)
                      .+.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.++++++|+||+++.+++..    ....++|+
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~   87 (334)
T cd07855           8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM   87 (334)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence            34578999999999999965 689999999875422  234567889999999999999999988753    35689999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+. |+|.+++..  ...+++.....++.|++.||+|||   ..+++||||||+||++++++.+||+|||++.......
T Consensus        88 e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          88 DLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             ehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            9996 689888843  345899999999999999999999   5689999999999999999999999999997653322


Q ss_pred             CC--ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc-----------cc
Q 002461          762 ES--HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF-----------LE  827 (919)
Q Consensus       762 ~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~-----------~~  827 (919)
                      ..  .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...... .....+...           ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHhhhhhc
Confidence            11  11234578899999998765 46889999999999999999999998543211 111110000           00


Q ss_pred             cCCcccccccc-cccCC-----ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          828 RGDVRSIVDPR-LEANF-----DTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       828 ~~~~~~ivd~~-l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .+.+.+..+.. .....     .......+.+++.+|++.+|.+||++.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00111100000 00000     11224568899999999999999999998873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=4.3e-29  Score=271.01  Aligned_cols=233  Identities=22%  Similarity=0.266  Sum_probs=180.5

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccCCChhh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQ  691 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~  691 (919)
                      ||+|+||.||++... ++..+|+|.++......     .|+.....+ +|+|++++++++...+..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999964 67889999986542211     123222222 79999999999999999999999999999999


Q ss_pred             hhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCcccccCCCCCCccccccc
Q 002461          692 YLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       692 ~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      ++...  ..+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||+++.....      ....
T Consensus        99 ~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~  167 (267)
T PHA03390         99 LLKKE--GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYD  167 (267)
T ss_pred             HHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCC
Confidence            98543  37999999999999999999999   66899999999999999988 9999999998765321      2246


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc-chhcccccccccCCcccccccccccCCChhHHH
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT-HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~-~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      ++..|+|||++.+..++.++||||||++++||++|+.||....+.. ....+....  ..        ..  ........
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--------~~--~~~~~~~~  235 (267)
T PHA03390        168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QK--------KL--PFIKNVSK  235 (267)
T ss_pred             CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cc--------cC--CcccccCH
Confidence            8899999999998889999999999999999999999986332211 111111100  00        00  01112334


Q ss_pred             HHHHHHHhcCCCCCCCCCC-HHHHHH
Q 002461          850 KVAETAMECVPSISFQRPT-MSHVVT  874 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPs-m~eVv~  874 (919)
                      .+.+++.+|++.+|.+||+ ++++++
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhc
Confidence            6788999999999999995 688864

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.8e-30  Score=284.55  Aligned_cols=264  Identities=24%  Similarity=0.329  Sum_probs=198.4

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCC-----eEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG-----NVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~-----~~~LV  680 (919)
                      .+.+.||+|++|.||+|... +++.+|+|++....  ....+.+.+|+++++.++|+||+++.+++....     ..+++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            45688999999999999975 48899999987643  334567899999999999999999999987765     78999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||++ ++|.+++..  ...+++..+..++.+++.||+|||   ..+++|+||||+|||++.++.++|+|||++......
T Consensus        83 ~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          83 TELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             ecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            99998 488888853  337999999999999999999999   668999999999999999999999999999876432


Q ss_pred             CCC-ccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc----------
Q 002461          761 SES-HISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER----------  828 (919)
Q Consensus       761 ~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~----------  828 (919)
                      ... .......++..|+|||.+.+. .++.++||||||+++++|++|++||..... ....+.+......          
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhcc
Confidence            210 112345678899999999887 789999999999999999999999854321 1111111110000          


Q ss_pred             -CCccccccc---cc---ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHHH
Q 002461          829 -GDVRSIVDP---RL---EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE--LKKC  879 (919)
Q Consensus       829 -~~~~~ivd~---~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~--Le~~  879 (919)
                       ......+..   .-   ...........+.+++.+|++.+|.+||++.++++.  +++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence             000000000   00   000011123467899999999999999999999873  5443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=7.3e-30  Score=274.84  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=191.0

Q ss_pred             hhhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCC-----CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASS-----SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~-----~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      +.+.+.||+|+||.||++.... +..+++|+++...     .....++..|+.++++++||||+++++++.+....++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3456889999999999998653 4556666665322     122345677999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          682 EYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ||+++++|.+++...  ....+++.+++.++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            999999999988642  3456999999999999999999999   679999999999999986 4699999999876533


Q ss_pred             CCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l  839 (919)
                      ..  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.....    ........ .+.     .+. 
T Consensus       158 ~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~~-~~~-----~~~-  224 (260)
T cd08222         158 SC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRIV-EGP-----TPS-  224 (260)
T ss_pred             Cc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHH-cCC-----CCC-
Confidence            22  122344678899999999888889999999999999999999998853211    11111110 111     011 


Q ss_pred             ccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         .+......+.+++.+|+..+|++||++.|+++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 ---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               12233346888999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=268.86  Aligned_cols=266  Identities=20%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             CHHHHHHHHhhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCe
Q 002461          599 TYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGN  676 (919)
Q Consensus       599 ~~~ei~~~t~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~  676 (919)
                      ++.|+.+.|.   +.||+|+++.|--++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++++++|.++..
T Consensus        74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            3566666664   789999999998877 6789999999998887677788899999999995 9999999999999999


Q ss_pred             EEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC---cEEEeccCc
Q 002461          677 VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---QAKLADFGF  753 (919)
Q Consensus       677 ~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~---~vkL~DFGl  753 (919)
                      .|||||-|.+|+|.++|+  .+..++..+..++.++|+.||.+||   .++|.||||||+|||-....   -+|||||.|
T Consensus       151 FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            999999999999999995  4566999999999999999999999   78999999999999996543   489999998


Q ss_pred             ccccCCCC-----CCccccccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc
Q 002461          754 SKIFPAES-----ESHISTSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC  823 (919)
Q Consensus       754 a~~~~~~~-----~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~  823 (919)
                      ..-.....     ........+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||..--.  .--.|-+
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg--~dCGWdr  303 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG--ADCGWDR  303 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC--CcCCccC
Confidence            76432111     111223567999999999863     34678899999999999999999999953211  0011111


Q ss_pred             cccccCCccccccccccc--CCChhHHH----HHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          824 PFLERGDVRSIVDPRLEA--NFDTNSVW----KVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       824 ~~~~~~~~~~ivd~~l~~--~~~~~~~~----~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      -...+.--..++...-.+  +|+++++.    ...+++...+..++.+|-++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            000000001112211122  34554443    2356667777789999999988887

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-29  Score=269.24  Aligned_cols=236  Identities=28%  Similarity=0.343  Sum_probs=191.5

Q ss_pred             eceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      ||+|+||.||++... +++.+|+|+++.....   ....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 5889999998765332   345788999999999999999999999999999999999999999


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI  769 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~  769 (919)
                      .+++...  ..+++.....++.|+++||.|||   ..+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            9998543  46899999999999999999999   5789999999999999999999999999988653321  123345


Q ss_pred             ccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       770 ~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      .++..|+|||...+...+.++|+||||++++||++|+.||..... ....+.+..    +.          ...+.....
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~----~~----------~~~~~~~~~  218 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK----DP----------LRFPEFLSP  218 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc----CC----------CCCCCCCCH
Confidence            688899999999888889999999999999999999999854322 122222111    00          011122234


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSH  871 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~e  871 (919)
                      .+.+++.+|+..+|++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            6788999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-30  Score=293.01  Aligned_cols=198  Identities=33%  Similarity=0.484  Sum_probs=169.3

Q ss_pred             cceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~LV~E  682 (919)
                      .+.||+|+||.||+|+. ..|+.||||.++.... ...+....|+++|++++|+|||++++.-...      ....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            46899999999999994 5799999999986543 3346678899999999999999999876543      36789999


Q ss_pred             eccCCChhhhhhccc-cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC--CCC--cEEEeccCccccc
Q 002461          683 YMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN--EKM--QAKLADFGFSKIF  757 (919)
Q Consensus       683 y~~~GsL~~~L~~~~-~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld--~~~--~vkL~DFGla~~~  757 (919)
                      ||.+|+|...|.+.. ...|+..+.+.+..+++.||.|||   ..+|+||||||.||++-  ++|  .-||+|||.|+.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999996544 457999999999999999999999   56999999999999984  333  4799999999977


Q ss_pred             CCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCC
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYN  814 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~  814 (919)
                      ..+   ......+||..|.+||++.. +.|+..+|.|||||++|+++||..||..-..
T Consensus       175 ~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  175 DDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             CCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            432   35677899999999999994 8899999999999999999999999975443

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.1e-29  Score=283.62  Aligned_cols=256  Identities=24%  Similarity=0.328  Sum_probs=188.6

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVGLVY  681 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~LV~  681 (919)
                      .+.||+|+||.||+|... +|+.||||+++...  ......+.+|+.+++.++|+||+++++++...      ...++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            578999999999999964 68999999987532  22235678899999999999999999988654      3568999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      ||+.. +|.+++    ...+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++..... 
T Consensus       100 e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-  170 (342)
T cd07879         100 PYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-  170 (342)
T ss_pred             ccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence            99864 666654    235899999999999999999999   668999999999999999999999999998754221 


Q ss_pred             CCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc-----------ccC
Q 002461          762 ESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL-----------ERG  829 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~-----------~~~  829 (919)
                          .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+....           ...
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhccc
Confidence                123467889999999866 4688999999999999999999999864321111 11110000           000


Q ss_pred             Cccccc-------ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHHHHh
Q 002461          830 DVRSIV-------DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE--LKKCLE  881 (919)
Q Consensus       830 ~~~~iv-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~--Le~~~~  881 (919)
                      .....+       ...+...++ .....+.+++.+|++.+|++||++.++++.  +++...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000       000000000 122357899999999999999999999963  666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=3.5e-29  Score=280.26  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=188.2

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeec-CCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~-~~~~~LV~Ey~~  685 (919)
                      +.+.||+|+||.||+|... +++.||+|++....  ....+.+..|++++++++||||+++.+++.. ....++++||+ 
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            3588999999999999855 78999999886432  2234678889999999999999999998865 56789999998 


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +++|.+++..   ..+++.....++.|+++||+|||   ..+++|+||+|+||++++++.+||+|||++......     
T Consensus        93 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----  161 (328)
T cd07856          93 GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----  161 (328)
T ss_pred             ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----
Confidence            4688888742   35788888999999999999999   678999999999999999999999999998754221     


Q ss_pred             ccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchh-----------cccccccccCCccc
Q 002461          766 STSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV-----------NRVCPFLERGDVRS  833 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~-----------~~v~~~~~~~~~~~  833 (919)
                      .....++..|+|||.+.+ ..++.++||||||++++||++|+.||..........           ++...........-
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            123457889999998765 568999999999999999999999885332111000           00000000000000


Q ss_pred             ccccccccCCC-----hhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          834 IVDPRLEANFD-----TNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       834 ivd~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +..-......+     ......+.+++.+|++.+|++||++.+++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000011     1123568899999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-30  Score=280.69  Aligned_cols=244  Identities=24%  Similarity=0.386  Sum_probs=198.2

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      .++||.|-||+||-|+++ +|+.||||++.+.  ......++++|+.+|++++||.||.+-.-|+..+..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            589999999999999975 7999999999754  33345779999999999999999999999999999999999885 6


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC---CcEEEeccCcccccCCCCCCc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~---~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +..+.|.....+.++...-..++.||+.||.|||   -++|+|+||||+||||.+.   -++||||||+|+++..   ..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence            7777776777788999888899999999999999   6799999999999999743   4799999999998743   33


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....+||+.|+|||++..+.|...-|+||.||++|--++|..||.++.+..+..+.+.-.+-...+.++          
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~ei----------  791 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEI----------  791 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhc----------
Confidence            4567899999999999999999999999999999999999999998877755555544322222222211          


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ....++++...++..-.+|-+...-+.
T Consensus       792 ---s~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  792 ---SPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---CHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               123456666677776677777665543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=271.04  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=204.6

Q ss_pred             cceeceeCcEEEEEEEEc------CCCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecC-CeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDG-GNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-~~~~LV~E  682 (919)
                      .-.+-+|.||.||+|.+.      +.+.|.||.++...++ ....+..|...+..+.|||+.++.+.+.+. ...+.+|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            346889999999999764      3456788888765443 345688899999999999999999998664 56788999


Q ss_pred             eccCCChhhhhh-----cc-ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          683 YMAYGNLKQYLF-----DE-TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       683 y~~~GsL~~~L~-----~~-~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      ++.-|+|..+|.     +. ..+.++-.+.+.++.|++.||+|||   +++++|.||..+|+++|+..++||+|=.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999997     21 2456788899999999999999999   78999999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccccccCCccccc
Q 002461          757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       757 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~~~~~~~~~iv  835 (919)
                      +.+.+..........+..||+||.+....|+..+|||||||+||||+| |+.|+.+-.. .+....    +..|      
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-fEm~~y----lkdG------  514 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-FEMEHY----LKDG------  514 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-HHHHHH----Hhcc------
Confidence            777666666667778899999999999999999999999999999997 7788753221 111111    1111      


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                       .++..  +.++..++..++.-||...|++||+.++++.-|.+.
T Consensus       515 -yRlaQ--P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  515 -YRLAQ--PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -ceecC--CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence             12222  345677899999999999999999999999988765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=5.4e-29  Score=278.92  Aligned_cols=258  Identities=24%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             hhcceeceeCcEEEEEEEEc-C--CCEEEEEEeecCCC--CCchhhhHHHHHHHhc-cCcceeeEEeEeec----CCeEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-D--GSEVAIKMLSASSS--QGPKQFRTEAQLLMRV-HHRNLASLVGYCND----GGNVG  678 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~--g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~----~~~~~  678 (919)
                      .+.+.||+|+||.||++... .  +..||+|++.....  ...+.+.+|+++++++ +|+||+++++++..    ....+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999975 3  67899999864322  2245678899999999 59999999987543    24577


Q ss_pred             EEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      +++||+. ++|.+++..  ...+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++.+.
T Consensus        83 ~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          83 LYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            8888886 689888843  456899999999999999999999   6689999999999999999999999999998653


Q ss_pred             CCCCC--ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccC---Ccc
Q 002461          759 AESES--HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---DVR  832 (919)
Q Consensus       759 ~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~---~~~  832 (919)
                      .....  .......|+..|+|||.+.+ ..++.++|||||||++++|++|++||..... .+....+.......   .+.
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence            22111  11233568999999998765 4688999999999999999999998854321 11111111100000   000


Q ss_pred             cccc---------------cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          833 SIVD---------------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ~ivd---------------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.+               ..+.. ........+.+++.+|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000               00000 01112346889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.4e-29  Score=285.74  Aligned_cols=240  Identities=25%  Similarity=0.405  Sum_probs=196.8

Q ss_pred             hcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          610 FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      +...||+|.|+.|..|++. .|.+||+|.+.+..-.  ....+.+|+++|..++|||||+++.+...+..+++||||+.+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            4578999999999999965 6899999999765433  234588899999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |.+.+++...  ..+.......++.|+.+|++|||   .+.|+|||||++||||+.++++||+|||++..+.   .....
T Consensus       140 ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~l  211 (596)
T KOG0586|consen  140 GELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLML  211 (596)
T ss_pred             chhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---ccccc
Confidence            9999999554  34566888899999999999999   7789999999999999999999999999998874   34456


Q ss_pred             cccccCccccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC--
Q 002461          767 TSIVGTVGYLDPEYYASNRL-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF--  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~--  843 (919)
                      ...+|++.|.|||++.+.++ .+++|+||+|+++|-|+.|..||+... -..+.                ++.+.+.+  
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr----------------~rvl~gk~rI  274 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELR----------------PRVLRGKYRI  274 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-ccccc----------------chheeeeecc
Confidence            77899999999999998775 478999999999999999999996321 11111                11111111  


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.-......+++.+.+-.+|.+|++++++.+
T Consensus       275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1111224567888899999999999999976

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=259.78  Aligned_cols=246  Identities=25%  Similarity=0.385  Sum_probs=190.5

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecC-CCCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSAS-SSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~-~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      ..||.|..|.|+++.+. .|..+|||.+... +.+..++++..+.++.+-+ +|.||+.+|||......++.||.|.. .
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C  176 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C  176 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence            56999999999999976 5889999998765 3344566777777776665 89999999999999999999998853 4


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      +..+| ....+++++.-.=++...+.+||.||.+  +++|+|||+||+|||+|+.|++|+||||++..+..   +...+.
T Consensus       177 ~ekLl-krik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtr  250 (391)
T KOG0983|consen  177 AEKLL-KRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTR  250 (391)
T ss_pred             HHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---cccccc
Confidence            44444 3345668877777899999999999996  67999999999999999999999999999987632   233445


Q ss_pred             cccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          769 IVGTVGYLDPEYYAS---NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      .+|.+.|||||.+.-   .+|+.++||||||+.++||.||+.||.....+-+....+.   .+.      -|.|.+..  
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl---n~e------PP~L~~~~--  319 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL---NEE------PPLLPGHM--  319 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH---hcC------CCCCCccc--
Confidence            689999999999863   4688999999999999999999999965433322222221   111      12332211  


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .-...+.++...|+..|+.+||...++++.
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            123467889999999999999999998873

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=3.4e-29  Score=281.91  Aligned_cols=260  Identities=22%  Similarity=0.298  Sum_probs=188.7

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecC------------
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------------  674 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------------  674 (919)
                      +.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++|+||+++++++...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            344678999999999999964 6889999999776666667788999999999999999999776543            


Q ss_pred             --CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC-CCCcEEEecc
Q 002461          675 --GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADF  751 (919)
Q Consensus       675 --~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld-~~~~vkL~DF  751 (919)
                        ...++|+||++ ++|.+++..   ..+++.....++.|++.||.|||   ..+++||||||+||+++ +++.+|++||
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCc
Confidence              35789999997 588887742   35889999999999999999999   56899999999999998 4567899999


Q ss_pred             CcccccCCCCCC-ccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc--cc
Q 002461          752 GFSKIFPAESES-HISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF--LE  827 (919)
Q Consensus       752 Gla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~--~~  827 (919)
                      |+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||................  ..
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999765321111 11123357889999998654 567889999999999999999999996433211111100000  00


Q ss_pred             cCCcccc---cccccc-----c-----CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          828 RGDVRSI---VDPRLE-----A-----NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       828 ~~~~~~i---vd~~l~-----~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .......   ....+.     .     .........+.+++.+|+..+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000000   000000     0     000112245788999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=312.01  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=193.9

Q ss_pred             cceeceeCcEEEEEEE-EcCCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          611 HRILGKGGFGTVYHGY-LADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ...||.|.||.||-|. .++|.-.|+|-++....  ...+...+|+.++..++|||+|+++|.-.+++..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4579999999999998 56788899998875433  33466788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC--Ccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE--SHI  765 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~--~~~  765 (919)
                      +|.+.+...  ...++.....+..|++.|++|||   +++||||||||.||+|+.+|.+|++|||.|..+.+...  ...
T Consensus      1320 sLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1320 SLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             cHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999998433  33555566677899999999999   67999999999999999999999999999987754421  222


Q ss_pred             ccccccCccccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          766 STSIVGTVGYLDPEYYASNR---LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .....||+.|||||++.+.+   ...+.||||+|||++||+||+.||..-.++-.+.-.|    ..|..         ..
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V----~~gh~---------Pq 1461 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV----AAGHK---------PQ 1461 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH----hccCC---------CC
Confidence            45678999999999997543   4567899999999999999999997654332222111    12221         12


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .++.....-.+++..|+..||++|.++.|+++
T Consensus      1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            23333345567899999999999988876654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.5e-28  Score=259.10  Aligned_cols=238  Identities=28%  Similarity=0.378  Sum_probs=193.0

Q ss_pred             CcEEEEEEEEc-CCCEEEEEEeecCCCCC-chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhc
Q 002461          618 GFGTVYHGYLA-DGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD  695 (919)
Q Consensus       618 ~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~  695 (919)
                      +||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997665544 67899999999999999999999999999999999999999999999854


Q ss_pred             cccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccc
Q 002461          696 ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY  775 (919)
Q Consensus       696 ~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y  775 (919)
                      ..  .+++..+..++.++++++.|||   +.+++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            32  3899999999999999999999   5699999999999999999999999999998764322   23345678899


Q ss_pred             cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHH
Q 002461          776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETA  855 (919)
Q Consensus       776 ~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~  855 (919)
                      ++||.+....++.++||||||+++++|++|..|+....+.....+...    .+....    .   .........+.+++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~----~---~~~~~~~~~~~~~i  221 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF----P---PPEWKISPEAKDLI  221 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC----c---cccccCCHHHHHHH
Confidence            999999888899999999999999999999999865333222222211    111000    0   00000234688999


Q ss_pred             HhcCCCCCCCCCCHHHHHH
Q 002461          856 MECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       856 ~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+|+..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.5e-29  Score=281.03  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=189.3

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCe------EEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGN------VGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~------~~L  679 (919)
                      .+.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++|+|++++.+++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            34578999999999999975 57889999986532  2233567789999999999999999988765544      899


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |+||+ +++|.+++..   ..+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        98 v~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          98 VTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            99998 5699988853   46899999999999999999999   66899999999999999999999999999986532


Q ss_pred             CCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc----------
Q 002461          760 ESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER----------  828 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~----------  828 (919)
                      .     .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+.+....          
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhcc
Confidence            2     233467889999998765 46789999999999999999999998543221 111111111000          


Q ss_pred             -CCcccccc-------cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          829 -GDVRSIVD-------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       829 -~~~~~ivd-------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       ......+.       +.+...+ ......+.+++.+|++.+|++||++.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             00000000       0000000 112356889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.8e-29  Score=279.15  Aligned_cols=253  Identities=25%  Similarity=0.311  Sum_probs=187.7

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--CCchhhhHHHHHHHhccCcceeeEEeEeecCC------eEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG------NVGL  679 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~------~~~L  679 (919)
                      ...+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|++++++++|+||+++++++....      ..++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07880          18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL   97 (343)
T ss_pred             EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence            34578999999999999854 688999999864322  22346788999999999999999999886543      4689


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |+||+ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        98 v~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          98 VMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            99998 6789888742   46899999999999999999999   67899999999999999999999999999886522


Q ss_pred             CCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc----------ccccc
Q 002461          760 ESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC----------PFLER  828 (919)
Q Consensus       760 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~----------~~~~~  828 (919)
                      .     .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||..............          ..+..
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            1     123457889999999875 4588999999999999999999999864322111110000          00000


Q ss_pred             CCccc-------ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          829 GDVRS-------IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       829 ~~~~~-------ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .....       .-...+. .........+.+++.+|++.+|++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000       0000000 001122335789999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=8.8e-29  Score=278.97  Aligned_cols=260  Identities=23%  Similarity=0.308  Sum_probs=189.4

Q ss_pred             HHHHHHhhh--cceeceeCcEEEEEEEE-cCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecC--
Q 002461          602 EIVDITNNF--HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG--  674 (919)
Q Consensus       602 ei~~~t~~~--~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~--  674 (919)
                      ++..++.++  .+.||+|+||.||+|.. .+|+.||+|+++...  ....+.+.+|++++++++|+||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            344444444  56899999999999985 468899999987532  22245678899999999999999999987543  


Q ss_pred             ----CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEec
Q 002461          675 ----GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD  750 (919)
Q Consensus       675 ----~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~D  750 (919)
                          ...+++++++ +++|.+++..   ..+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence                3467888876 6799887743   35899999999999999999999   66899999999999999999999999


Q ss_pred             cCcccccCCCCCCccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc---
Q 002461          751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---  826 (919)
Q Consensus       751 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~---  826 (919)
                      ||+++....     ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ ...+....   
T Consensus       164 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~  237 (345)
T cd07877         164 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTP  237 (345)
T ss_pred             ccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence            999875421     1233467889999998765 5688899999999999999999999853222111 11110000   


Q ss_pred             --------ccCCcc-------cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          827 --------ERGDVR-------SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       827 --------~~~~~~-------~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                              ......       ........ .........+.+++.+|++.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                    000000       00000000 0000123457899999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=2.5e-29  Score=299.62  Aligned_cols=246  Identities=28%  Similarity=0.405  Sum_probs=182.1

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCC-CCCchhhhHHHHHHHhccCcceeeEEeEeecC---------------
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASS-SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG---------------  674 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~---------------  674 (919)
                      +.||+||||.|||++-+ ||+.+|||++.-.. ........+|+++|.+|+|||||+++..+.+.               
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            57999999999999965 89999999987553 22335578899999999999999987432100               


Q ss_pred             --------------------------------------------------------------------------------
Q 002461          675 --------------------------------------------------------------------------------  674 (919)
Q Consensus       675 --------------------------------------------------------------------------------  674 (919)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ------------------------CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeee
Q 002461          675 ------------------------GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH  730 (919)
Q Consensus       675 ------------------------~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH  730 (919)
                                              ...|+=||||+.-.|.++++.+.... .....++++.+|+.||+|+|   .+++||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH---~~giIH  720 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH---DQGIIH  720 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH---hCceee
Confidence                                    01345577777766666664433211 35667899999999999999   678999


Q ss_pred             eccccceEEeCCCCcEEEeccCcccccC----------------CCCCCccccccccCccccCcccccCC---CCCchhh
Q 002461          731 RDVKTANILLNEKMQAKLADFGFSKIFP----------------AESESHISTSIVGTVGYLDPEYYASN---RLTEKSD  791 (919)
Q Consensus       731 ~DLKp~NILld~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksD  791 (919)
                      |||||.||+||++..|||+|||+|....                ........+..+||.-|+|||++.+.   +|+.|+|
T Consensus       721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD  800 (1351)
T KOG1035|consen  721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID  800 (1351)
T ss_pred             ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence            9999999999999999999999998621                00111234567899999999998754   5999999


Q ss_pred             HHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHH
Q 002461          792 VYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSH  871 (919)
Q Consensus       792 VwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~e  871 (919)
                      +||+|||++||+.   ||....+.......    ++.+.+..-      ..+.......=..++.++++.+|.+|||+.|
T Consensus       801 mYSLGIVlFEM~y---PF~TsMERa~iL~~----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  801 MYSLGIVLFEMLY---PFGTSMERASILTN----LRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             hHHHHHHHHHHhc---cCCchHHHHHHHHh----cccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            9999999999986   56544443333332    233433322      2233344445678999999999999999999


Q ss_pred             HHH
Q 002461          872 VVT  874 (919)
Q Consensus       872 Vv~  874 (919)
                      ++.
T Consensus       868 LL~  870 (1351)
T KOG1035|consen  868 LLN  870 (1351)
T ss_pred             Hhh
Confidence            986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.7e-28  Score=261.40  Aligned_cols=222  Identities=19%  Similarity=0.149  Sum_probs=175.5

Q ss_pred             eCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhc
Q 002461          617 GGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD  695 (919)
Q Consensus       617 G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~  695 (919)
                      |.+|.||++... +++.+|+|+++...     .+..|...+....|||++++++++......++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999964 68899999987543     234455556666799999999999999999999999999999999854


Q ss_pred             cccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccc
Q 002461          696 ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY  775 (919)
Q Consensus       696 ~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y  775 (919)
                        ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.++++|||++......     .....++..|
T Consensus        79 --~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 --FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             --hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence              345899999999999999999999   679999999999999999999999999987654221     1223456789


Q ss_pred             cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHH
Q 002461          776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETA  855 (919)
Q Consensus       776 ~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~  855 (919)
                      +|||...+..++.++||||+|++++||++|+.|+.......   ..            .....    .+......+.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~~------------~~~~~----~~~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---NT------------HTTLN----IPEWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---cc------------ccccC----CcccCCHHHHHHH
Confidence            99999988889999999999999999999998764221100   00            00000    1111224578899


Q ss_pred             HhcCCCCCCCCCCHHHH
Q 002461          856 MECVPSISFQRPTMSHV  872 (919)
Q Consensus       856 ~~Cl~~~P~~RPsm~eV  872 (919)
                      .+|++.+|++||++.+.
T Consensus       210 ~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         210 QQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHccCCHHHhcCCCcc
Confidence            99999999999997444

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=3.1e-28  Score=296.69  Aligned_cols=142  Identities=29%  Similarity=0.406  Sum_probs=126.1

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.||+|+||.||+|... +++.||||+++.....   ....+..|+.++..++|+||+++++++......++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            34688999999999999976 6889999999754322   2356888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      .+++|.+++..  ...+++...+.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999854  345888999999999999999999   5689999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=264.18  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             cccCHHHHHHHHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC-CCchhhhHHHHHHHhc-cCcceeeEEeEee
Q 002461          596 QQFTYSEIVDITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRV-HHRNLASLVGYCN  672 (919)
Q Consensus       596 ~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~  672 (919)
                      ..|+.+++.+.     ..||.|.||+|+|-.++ .|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+-
T Consensus        59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            34555555443     45999999999999875 699999999986544 4456788888866555 7999999999999


Q ss_pred             cCCeEEEEEEeccCCChhh---hhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          673 DGGNVGLVYEYMAYGNLKQ---YLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       673 ~~~~~~LV~Ey~~~GsL~~---~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      .++..++.||.|+- +|+.   ++.......+++.-.-.|..-+..||.||..  ...|||||+||+|||+|..|.+|||
T Consensus       134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeee
Confidence            99999999999963 5544   3334445668887778888889999999986  4689999999999999999999999


Q ss_pred             ccCcccccCCCCCCccccccccCccccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccc
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE  827 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~  827 (919)
                      |||++..+.   .+...+.-+|...|||||.+..  ..|+.++||||||+.|+|+.||..|+....+   +.+.+++...
T Consensus       211 DFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~  284 (361)
T KOG1006|consen  211 DFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVI  284 (361)
T ss_pred             cccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHc
Confidence            999987652   2233455679999999999863  3488999999999999999999999864332   2333333322


Q ss_pred             cCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          828 RGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       828 ~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                       |+...+..+    ....+-...+...+..|+..+-.+||...++.++
T Consensus       285 -gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  285 -GDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -CCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             221111111    1112234568889999999999999999998763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=3.7e-29  Score=260.19  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=193.3

Q ss_pred             hhcceeceeCcEEEEEEEEcC-----CCEEEEEEeecCCCC--CchhhhHHHHHHHhccCcceeeEEeEeec-CCeEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-----GSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGLV  680 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-----g~~VAVK~l~~~~~~--~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~-~~~~~LV  680 (919)
                      +....||+|.||.||||.-.+     .+.+|+|+++.....  ......+|+.+++.++|+|++.+...+.. +...+|+
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            345679999999999997432     336999999865332  23456789999999999999999998876 7889999


Q ss_pred             EEeccCCChhhhhhccc---cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC----CcEEEeccCc
Q 002461          681 YEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK----MQAKLADFGF  753 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~---~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~----~~vkL~DFGl  753 (919)
                      +||.+. +|.+.|+.++   ...++.....+|+.||+.|+.|||++   =|+||||||.|||+..+    |.|||+|+|+
T Consensus       107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999987 8888886443   45688889999999999999999955   59999999999999877    8999999999


Q ss_pred             ccccCCCCCCc-cccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCC--------ccchhcccc
Q 002461          754 SKIFPAESESH-ISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYN--------NTHIVNRVC  823 (919)
Q Consensus       754 a~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~--------~~~l~~~v~  823 (919)
                      ++.+...-..- .....+-|..|+|||++.+. .||.+.|||+.||++.||+|-++.|.....        ..+.+..+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            99875432221 23345679999999998765 589999999999999999998776643221        122333333


Q ss_pred             cccccCCcccccc----cc-------cc-cCCChh-----------HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          824 PFLERGDVRSIVD----PR-------LE-ANFDTN-----------SVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       824 ~~~~~~~~~~ivd----~~-------l~-~~~~~~-----------~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      +++.......+-|    |.       .+ ..++..           .....++|..+++..||.+|-|+++.++.
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            3333221111111    00       00 001110           01125788899999999999999998873

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-29  Score=258.07  Aligned_cols=241  Identities=23%  Similarity=0.326  Sum_probs=194.6

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeec----CCeEEEEEEecc
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCND----GGNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~----~~~~~LV~Ey~~  685 (919)
                      ++||-|-.|.|-.+.++ +|+.+|+|++...     ...++|+++--.. .|+|||.+++.+.+    ...+.+|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            78999999999998875 6888999998643     3446788875555 69999999998754    456789999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC---CCCcEEEeccCcccccCCCCC
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld---~~~~vkL~DFGla~~~~~~~~  762 (919)
                      ||.|.+.+.++..+.+++.+.-.|+.||+.|+.|||   ..+|.||||||+|+|..   .+-.+||+|||+|+.-   ..
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t---~~  216 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET---QE  216 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccccccc---CC
Confidence            999999998888888999999999999999999999   78999999999999997   4557999999999853   22


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||..... ..+.--++..+..|.          -.
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gq----------y~  285 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQ----------YE  285 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccC----------cc
Confidence            3345567889999999999999999999999999999999999999975332 222222333333332          13


Q ss_pred             CChhHH----HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          843 FDTNSV----WKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~----~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      |+.+++    +...+++...+..+|.+|-|+.++..
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            444443    34567888999999999999999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=276.58  Aligned_cols=235  Identities=24%  Similarity=0.345  Sum_probs=189.8

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      .+...+|.|+|+.|-++.+ .+++..+||++....    .+-.+|+.++... +|+||+++.+.+.+..+.++|||.+.+
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            4556799999999988885 468899999997652    2345577666655 799999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe-CCCCcEEEeccCcccccCCCCCCcc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL-NEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl-d~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +-|.+.+....  ... .++..|+.+++.|+.|||   .++++||||||+|||+ ++.++++|+|||.++.....     
T Consensus       401 ~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----  469 (612)
T KOG0603|consen  401 GELLRRIRSKP--EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----  469 (612)
T ss_pred             cHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence            98888775432  223 778889999999999999   6799999999999999 58899999999999876433     


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                      ....+-|..|.|||++....+++.+|+||||++||+|++|+.|+.....+.++...    +..+.            +..
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~----i~~~~------------~s~  533 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR----IQMPK------------FSE  533 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh----hcCCc------------ccc
Confidence            23346688999999999999999999999999999999999999765544222222    22222            223


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .......+|+.+|++.+|.+||+|.++..
T Consensus       534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  534 CVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            33345678999999999999999999976

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=257.52  Aligned_cols=237  Identities=25%  Similarity=0.316  Sum_probs=190.2

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      +|-++||+|.||.|-.++-+ .|+.+|+|++++..-   .....-..|-++|+..+||.+..+--.|+..+++|+||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            45688999999999999854 689999999986532   22334567899999999999999988899999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      .+|.|.-+|  +....++.....-+...|..||.|||   +.+|+.||||.+|.|||.+|.+||.||||++.-  -....
T Consensus       251 nGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~  323 (516)
T KOG0690|consen  251 NGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGD  323 (516)
T ss_pred             cCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--ccccc
Confidence            999999888  34567888888889999999999999   679999999999999999999999999999853  22334


Q ss_pred             cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCC
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~  844 (919)
                      .....+||+.|+|||++....|....|.|.+|||+|||++|+.||..... ..+.+.+    -.++        +  .|+
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLI----l~ed--------~--kFP  388 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELI----LMED--------L--KFP  388 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHH----Hhhh--------c--cCC
Confidence            45678999999999999999999999999999999999999999974332 2111111    1111        1  122


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCC
Q 002461          845 TNSVWKVAETAMECVPSISFQRP  867 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RP  867 (919)
                      ..-..+...|....+..+|.+|.
T Consensus       389 r~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  389 RTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCHHHHHHHHHHhhcChHhhc
Confidence            22223455667778889999996

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.8e-28  Score=278.40  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=200.9

Q ss_pred             hhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEee-----cCCeEEEEE
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCN-----DGGNVGLVY  681 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~-----~~~~~~LV~  681 (919)
                      .|.+.||+|.+|.||+++. ++|+.+|||++.... ...++...|.++|+.. .|||++.++|++.     .++.++|||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            4568999999999999995 578899999986543 3456778899999988 6999999999984     357899999


Q ss_pred             EeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCC
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~  761 (919)
                      |||.+|+..|+++.-....+.|.....|+..++.|+.+||   ...++|||+|-.|||++.++.||++|||++..+.  .
T Consensus       101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld--s  175 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--S  175 (953)
T ss_pred             eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee--c
Confidence            9999999999998777888999999999999999999999   5689999999999999999999999999987652  2


Q ss_pred             CCccccccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccc
Q 002461          762 ESHISTSIVGTVGYLDPEYYASN-----RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       762 ~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd  836 (919)
                      .........||+.|||||++...     .|+..+|+||+|++..||.-|.+|+...    |..+.+....+..      -
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm----HPmraLF~IpRNP------P  245 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM----HPMRALFLIPRNP------P  245 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc----chhhhhccCCCCC------C
Confidence            23345567899999999998643     4677899999999999999999998643    2223222222221      1


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      |.|..  +..=..++.+++..|+..+-++||++.++++
T Consensus       246 PkLkr--p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 PKLKR--PKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccccc--hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            22221  2233457889999999999999999999987

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=9.5e-28  Score=232.15  Aligned_cols=256  Identities=22%  Similarity=0.327  Sum_probs=195.2

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      ++||+|.||+||||+. +.++.||+|.++-.  +........+|+-+|+.++|+|||++++....+....+|+|||.. +
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence            6799999999999995 45778999998744  333346678999999999999999999999999999999999975 7


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |..+. +..++.++......++.|+++||.++|   ++++.||||||+|.|++.+|+.|++|||+++.+.-.-  .-.+.
T Consensus        87 lkkyf-dslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--rcysa  160 (292)
T KOG0662|consen   87 LKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSA  160 (292)
T ss_pred             HHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eeeec
Confidence            77665 344667899999999999999999999   6799999999999999999999999999999763221  12234


Q ss_pred             cccCccccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccccc---CCcc---ccccccccc
Q 002461          769 IVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---GDVR---SIVDPRLEA  841 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~~~~-~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~---~~~~---~ivd~~l~~  841 (919)
                      .+-|..|.+|.++.+.+ |+...|+||-||++.|+.....|...+.+-.+....+...+..   +.+.   .+-|-....
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            56789999999987654 7889999999999999998777777777765555555544432   2222   222322222


Q ss_pred             CCChh-HHH--------HHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          842 NFDTN-SVW--------KVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~-~~~--------~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      -++.. ...        .=.++....+.-+|.+|.++++.++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            22211 111        1245566666678899998887765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-28  Score=260.13  Aligned_cols=241  Identities=23%  Similarity=0.297  Sum_probs=189.3

Q ss_pred             HHhhhcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCC---CCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEE
Q 002461          606 ITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSS---QGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       606 ~t~~~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      ...+|..+||+|+||.|..|..+. .+.+|||++++...   .+.+--+.|-++|... +-|.++++..+++..+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            335788999999999999998764 45699999986522   2223345577777665 567889999999999999999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~  760 (919)
                      |||+.+|+|--+++  .-+.+....++-+|..||-||-+||   +++|+.||||..|||||.+|.+||+|||+++.-.  
T Consensus       429 MEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--  501 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--  501 (683)
T ss_pred             EEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc--
Confidence            99999999988884  3455788889999999999999999   7899999999999999999999999999998432  


Q ss_pred             CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       761 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                      .........+||+.|+|||.+...+|...+|.|||||+||||+.|++||+. .++.++.+.+.+.            .  
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh------------n--  566 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH------------N--  566 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc------------c--
Confidence            223345578999999999999999999999999999999999999999963 3333333322211            1  


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCC
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPT  868 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs  868 (919)
                      -.++.....+...+....+...|.+|..
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCccccC
Confidence            1233344445667777888888888853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=261.84  Aligned_cols=268  Identities=25%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             CcccCHHHHHHHHhhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCC---C----CchhhhHHHHHHHhccCcceee
Q 002461          595 NQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSS---Q----GPKQFRTEAQLLMRVHHRNLAS  666 (919)
Q Consensus       595 ~~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~---~----~~~~f~~Ev~~L~~l~H~NIv~  666 (919)
                      +.+|.-.-.....+-+.++||+|||+.||||. +...+.||||+-.....   +    -.+...+|..+-+.|.||.||+
T Consensus       452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            34444444445555566889999999999999 45677899998542211   1    1234567999999999999999


Q ss_pred             EEeEeec-CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC---
Q 002461          667 LVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE---  742 (919)
Q Consensus       667 l~g~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~---  742 (919)
                      +++|+.- .+.+|-|.|||++.+|+-+|+.  ...++..+...|+.||+.||.||.+. +++|||-||||.||||.+   
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence            9999964 5678999999999999999943  45689999999999999999999865 899999999999999964   


Q ss_pred             CCcEEEeccCcccccCCCCCCcc-----ccccccCccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Q 002461          743 KMQAKLADFGFSKIFPAESESHI-----STSIVGTVGYLDPEYYAS----NRLTEKSDVYSFGIVLLELITGLPAIIRGY  813 (919)
Q Consensus       743 ~~~vkL~DFGla~~~~~~~~~~~-----~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~  813 (919)
                      -|.+||.||||++++..+...+.     ....+||..|++||.+.-    .+++.|+||||.||++|+++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            47899999999999866554432     345689999999998753    368899999999999999999999997655


Q ss_pred             CccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          814 NNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       814 ~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...++++.-.- +....+.      +  ............++.+|++..-++|-...++..
T Consensus       689 sQQdILqeNTI-lkAtEVq------F--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  689 SQQDILQENTI-LKATEVQ------F--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hHHHHHhhhch-hcceecc------C--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            55555544211 1110000      0  001112234567889999999999988777654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=6.6e-27  Score=272.61  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=172.0

Q ss_pred             hhcceeceeCcEEEEEEEE-----------------cCCCEEEEEEeecCCCCCch--------------hhhHHHHHHH
Q 002461          609 NFHRILGKGGFGTVYHGYL-----------------ADGSEVAIKMLSASSSQGPK--------------QFRTEAQLLM  657 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l-----------------~~g~~VAVK~l~~~~~~~~~--------------~f~~Ev~~L~  657 (919)
                      .+.++||+|+||.||+|.+                 .+++.||||+++.......+              .+..|+..+.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            3468999999999999974                 24567999998754322222              3344677777


Q ss_pred             hccCcce-----eeEEeEeec--------CCeEEEEEEeccCCChhhhhhccc----------------------cccCC
Q 002461          658 RVHHRNL-----ASLVGYCND--------GGNVGLVYEYMAYGNLKQYLFDET----------------------KEALS  702 (919)
Q Consensus       658 ~l~H~NI-----v~l~g~~~~--------~~~~~LV~Ey~~~GsL~~~L~~~~----------------------~~~ls  702 (919)
                      +++|.++     +++++||..        ++..+|||||+++|+|.++++...                      ...++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            7877654     677887753        356899999999999999986421                      12346


Q ss_pred             hHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCccccc
Q 002461          703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA  782 (919)
Q Consensus       703 ~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~  782 (919)
                      |..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++.+..... .......+++.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhc
Confidence            7888999999999999999   56899999999999999999999999999976532211 1111233578999999875


Q ss_pred             CCCC----------------------CchhhHHHHHHHHHHHHhCCC-CcccCCC-c-------cchhcccccccccCCc
Q 002461          783 SNRL----------------------TEKSDVYSFGIVLLELITGLP-AIIRGYN-N-------THIVNRVCPFLERGDV  831 (919)
Q Consensus       783 ~~~~----------------------s~ksDVwSfGvvL~ELltG~~-p~~~~~~-~-------~~l~~~v~~~~~~~~~  831 (919)
                      ....                      ..+.||||+||+++||++|.. |+..... .       .+...|.  ...... 
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~-  460 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQK-  460 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccC-
Confidence            4321                      134699999999999999875 5432110 0       1111111  011111 


Q ss_pred             ccccccccccCCChhHHHHHHHHHHhcCCCCC---CCCCCHHHHHH
Q 002461          832 RSIVDPRLEANFDTNSVWKVAETAMECVPSIS---FQRPTMSHVVT  874 (919)
Q Consensus       832 ~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPsm~eVv~  874 (919)
                         .+-.    ..........+++.+++..+|   .+|+|++|+++
T Consensus       461 ---~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 ---YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ---CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence               0000    011122356677888887655   68999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=3.9e-27  Score=280.72  Aligned_cols=254  Identities=21%  Similarity=0.254  Sum_probs=161.9

Q ss_pred             hhcceeceeCcEEEEEEEEcC-----CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeE------eecCCeE
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-----GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY------CNDGGNV  677 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~-----g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~------~~~~~~~  677 (919)
                      .+.+.||+|+||.||+|.+.+     +..||||+++....  .+.+..|  .++...+.++..++..      +......
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence            346899999999999999754     68899998764321  1111111  1122222222222211      2456789


Q ss_pred             EEEEEeccCCChhhhhhccccc------------------cCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEE
Q 002461          678 GLVYEYMAYGNLKQYLFDETKE------------------ALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANIL  739 (919)
Q Consensus       678 ~LV~Ey~~~GsL~~~L~~~~~~------------------~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NIL  739 (919)
                      ++|+||+++++|.+++......                  ......+..++.|++.||+|||   +++|+||||||+|||
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NIL  287 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNII  287 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEE
Confidence            9999999999999988643210                  0112345679999999999999   669999999999999


Q ss_pred             eCC-CCcEEEeccCcccccCCCCCCccccccccCccccCcccccCC----------------------CCCchhhHHHHH
Q 002461          740 LNE-KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN----------------------RLTEKSDVYSFG  796 (919)
Q Consensus       740 ld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksDVwSfG  796 (919)
                      +++ ++.+||+|||+++.+... .........+++.|||||.+...                      .+..++||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            986 579999999999865322 22334456789999999965322                      234567999999


Q ss_pred             HHHHHHHhCCCCcccCCCccchhcccccccccC----Ccccccccc----cccCCC--hhHHHHHHHHHHhcCCCCCCCC
Q 002461          797 IVLLELITGLPAIIRGYNNTHIVNRVCPFLERG----DVRSIVDPR----LEANFD--TNSVWKVAETAMECVPSISFQR  866 (919)
Q Consensus       797 vvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~----~~~~ivd~~----l~~~~~--~~~~~~l~~l~~~Cl~~~P~~R  866 (919)
                      |++|||+++..+....     .......+...+    .+...+.+.    +...+.  ........+++.+|++.+|.+|
T Consensus       367 viL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        367 LIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999999976553211     000000000000    000111111    000000  0011234579999999999999


Q ss_pred             CCHHHHHHH
Q 002461          867 PTMSHVVTE  875 (919)
Q Consensus       867 Psm~eVv~~  875 (919)
                      ||+.++++.
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999983

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-28  Score=260.66  Aligned_cols=268  Identities=20%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             ccCHHHHHHHHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-C-cc----eeeEEe
Q 002461          597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-H-RN----LASLVG  669 (919)
Q Consensus       597 ~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H-~N----Iv~l~g  669 (919)
                      .+...|.....+.+...+|+|.||.|-++... .+..||||+++.-... .+.-+-|+++|+++. + |+    +|.+.+
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            35556666666777889999999999999854 4688999999754332 234567999999994 2 23    788899


Q ss_pred             EeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-------
Q 002461          670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-------  742 (919)
Q Consensus       670 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-------  742 (919)
                      +|.-.++.|+|+|.+ +-|+.++|..+.-.+++..+...|+.|+++++++||   +.+++|.||||+|||+.+       
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEe
Confidence            999999999999987 449999998888888999999999999999999999   679999999999999931       


Q ss_pred             -------------CCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCc
Q 002461          743 -------------KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI  809 (919)
Q Consensus       743 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~  809 (919)
                                   +..+||+|||-|+.-...     .+..+.|..|+|||++.+..++.++||||+||||.|+.||..-|
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                         346899999999864221     24567899999999999999999999999999999999998877


Q ss_pred             ccCCCccchh--cccc--------------cccccCCc-----------cccccc-cc---ccCCChhHHHHHHHHHHhc
Q 002461          810 IRGYNNTHIV--NRVC--------------PFLERGDV-----------RSIVDP-RL---EANFDTNSVWKVAETAMEC  858 (919)
Q Consensus       810 ~~~~~~~~l~--~~v~--------------~~~~~~~~-----------~~ivd~-~l---~~~~~~~~~~~l~~l~~~C  858 (919)
                      ..-.+..++.  +.+.              +....+.+           ..+.++ +.   .-.....+...+.+|+..+
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            5433333221  1111              00011110           001110 00   0012345667899999999


Q ss_pred             CCCCCCCCCCHHHHHH
Q 002461          859 VPSISFQRPTMSHVVT  874 (919)
Q Consensus       859 l~~~P~~RPsm~eVv~  874 (919)
                      +..||.+|+|+.|++.
T Consensus       390 L~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  390 LEFDPARRITLREALS  405 (415)
T ss_pred             HccCccccccHHHHhc
Confidence            9999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=283.52  Aligned_cols=197  Identities=25%  Similarity=0.348  Sum_probs=173.5

Q ss_pred             hhcceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.++||+|+||.|..++++ .++.+|.|++++.   .......|.+|-.+|..-+.+-|+.+.-.|++..+.|+|||||
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~  157 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM  157 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence            34688999999999999985 5788999999863   3445567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~  764 (919)
                      +||+|-.++....  .++...+..++..|.-||.-||   +.|+|||||||.|||||..|++||+|||-+-.+.. +..-
T Consensus       158 pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~V  231 (1317)
T KOG0612|consen  158 PGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGTV  231 (1317)
T ss_pred             cCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC-CCcE
Confidence            9999999995433  6888999999999999999999   78999999999999999999999999998877743 3344


Q ss_pred             cccccccCccccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          765 ISTSIVGTVGYLDPEYYA----S-NRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       765 ~~~~~~Gt~~Y~APE~l~----~-~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                      .....+|||.|++||++.    + +.|...+|.||+||++|||+.|..||+.
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            456778999999999985    2 6789999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=274.20  Aligned_cols=241  Identities=28%  Similarity=0.374  Sum_probs=184.6

Q ss_pred             cceeceeCcEE-EEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          611 HRILGKGGFGT-VYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       611 ~~~LG~G~fG~-Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      .+++|.|+.|+ ||+|.. +|++||||++-..   ...-.++|+..|+.- +|||||++++.-.++...++..|.|.. +
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            46799999876 599998 4789999998532   233457899999988 699999999999999999999999975 9


Q ss_pred             hhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC---C--CcEEEeccCcccccCCCC
Q 002461          689 LKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE---K--MQAKLADFGFSKIFPAES  761 (919)
Q Consensus       689 L~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~---~--~~vkL~DFGla~~~~~~~  761 (919)
                      |.+++...  ......-...+.+..|++.||++||   +.+|+||||||+||||+.   +  .+++|+|||+++.+....
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999653  1111222456788999999999999   679999999999999975   2  579999999999885433


Q ss_pred             CC-ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCcccCCCc-cchhcccccccccCCcccccccc
Q 002461          762 ES-HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNN-THIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       762 ~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~-~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      .. .......||-||+|||++...+-+..+||||+|||+|+.++| ..||...... ..++.-...+      .     .
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L------~-----~  734 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL------V-----H  734 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce------e-----e
Confidence            22 234567899999999999998888999999999999999987 7888644321 1111111000      0     0


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +..  ..++  ...+|+.+++..+|..||++.+|+.
T Consensus       735 L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111  0111  6778999999999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.1e-25  Score=230.59  Aligned_cols=210  Identities=36%  Similarity=0.593  Sum_probs=182.2

Q ss_pred             eceeCcEEEEEEEEcC-CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChhh
Q 002461          614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQ  691 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~  691 (919)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999998755432 34678999999999999999999999999999999999999999999


Q ss_pred             hhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-CCcEEEeccCcccccCCCCCCccccccc
Q 002461          692 YLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-KMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       692 ~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      ++.... ..+++..+..++.++++++.+||   ..+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            985432 46899999999999999999999   569999999999999999 89999999999986633221  123355


Q ss_pred             cCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHH
Q 002461          771 GTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW  849 (919)
Q Consensus       771 Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~  849 (919)
                      +...|++||..... ..+.+.|+|++|+++++|                                              .
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~  188 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P  188 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence            78899999999877 788999999999999999                                              3


Q ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          850 KVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       850 ~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .+.+++..|++.+|++||++.++++.
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            57889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.8e-28  Score=245.39  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=188.2

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeec--------CCeEEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCND--------GGNVGL  679 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~--------~~~~~L  679 (919)
                      ..+||+|.||.||+|+.+ .|+.||+|++-..  ...-...-.+|+.+|+.++|+|++.+++.|..        ....+|
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl  101 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL  101 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence            357999999999999975 4777898875432  22234556789999999999999999998843        235899


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      ||++|+. +|.-.|. .....++..++.+++.++..||.|+|   ...|+|||+|+.|+||+.++.+||+|||+++.+..
T Consensus       102 Vf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  102 VFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             eHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            9999986 7777773 33467899999999999999999999   66899999999999999999999999999987643


Q ss_pred             CCC--CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc---cccCCccc
Q 002461          760 ESE--SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF---LERGDVRS  833 (919)
Q Consensus       760 ~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~---~~~~~~~~  833 (919)
                      ...  ....+..+-|..|++||.+.+ ..++++.|||.-|||+.||+||.+.+.... +.+....+..+   +..+.+.+
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-eqqql~~Is~LcGs~tkevWP~  255 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-EQQQLHLISQLCGSITKEVWPN  255 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-HHHHHHHHHHHhccCCcccCCC
Confidence            222  222345567999999999876 568999999999999999999987665333 22222222211   11111111


Q ss_pred             ccc----------cccccCCC--hhHH------HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          834 IVD----------PRLEANFD--TNSV------WKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 ivd----------~~l~~~~~--~~~~------~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +..          |--++.+.  .+..      ...++++...+..||.+|+++.+++.
T Consensus       256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            111          10011110  0111      14678888999999999999988875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-27  Score=230.67  Aligned_cols=197  Identities=29%  Similarity=0.383  Sum_probs=161.2

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecC-CCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~-~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      +.||+|++|.|=+-++ .+|+.+|+|.+... ..+..++.+.|+.+..+. .+|.+|+++|....+...++.||.|+- +
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence            5699999999988876 58999999999765 334456677777765544 699999999999999999999999974 7


Q ss_pred             hhhhhhcc--ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          689 LKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       689 L~~~L~~~--~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+.+-.+.  ....+++.-.=+|+..+.+||.|||+  +..++|||+||+|||++.+|++|+||||++..+.+   +-..
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiAk  205 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIAK  205 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhHH
Confidence            76654322  24567888888999999999999997  56899999999999999999999999999886632   1222


Q ss_pred             cccccCccccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCcccCCC
Q 002461          767 TSIVGTVGYLDPEYYAS----NRLTEKSDVYSFGIVLLELITGLPAIIRGYN  814 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~  814 (919)
                      +...|...|||||.+..    ..|+.|+||||||+.+.||.+++.|+.....
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            33578899999998753    4688999999999999999999999976554

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=6.1e-26  Score=253.46  Aligned_cols=276  Identities=22%  Similarity=0.345  Sum_probs=199.2

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.||-|+||.|.++.- ++...+|.|.+++.+.   ........|-.||..-..+-||+|+-.|.+++.+|+||||+++|
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            4699999999999984 4456689998876533   22345678999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC--------C
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP--------A  759 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~--------~  759 (919)
                      ++-++|..  .+.+.+.....++.++..|+++.|   +.++|||||||.|||||.+|.+||.||||+.-+.        .
T Consensus       715 DmMSLLIr--mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  715 DMMSLLIR--MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            99998843  355777778888899999999999   8899999999999999999999999999986331        0


Q ss_pred             CCCC--------------------------------ccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 002461          760 ESES--------------------------------HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP  807 (919)
Q Consensus       760 ~~~~--------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~  807 (919)
                      ++..                                ......+||..|+|||++....++..+|.||.||||+||+.|++
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence            0000                                01124679999999999999999999999999999999999999


Q ss_pred             CcccCCCcc---chhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCC---HHHHHH--HHHHH
Q 002461          808 AIIRGYNNT---HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT---MSHVVT--ELKKC  879 (919)
Q Consensus       808 p~~~~~~~~---~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---m~eVv~--~Le~~  879 (919)
                      ||.......   .+..|          ...++--..++...++...+.+   .|..  ++.|..   ..+|..  .++. 
T Consensus       870 pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li~k---Lc~s--ad~RLGkng~d~vKaHpfFkg-  933 (1034)
T KOG0608|consen  870 PFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLIQK---LCCS--ADSRLGKNGADQVKAHPFFKG-  933 (1034)
T ss_pred             CccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHHHH---HhcC--hhhhhcccchhhhhcCccccc-
Confidence            997654322   22233          2333333344455555444333   4553  334432   222322  1111 


Q ss_pred             HhhHHHHHHHHHhhhhcccCCcccccchhhhh
Q 002461          880 LEMETAREQIQRTKSQMLSLSSSVDISAVEVE  911 (919)
Q Consensus       880 ~~~~~~~~~~~~~~~~~~s~~~~~~~s~~~~~  911 (919)
                        ++-+. -.++....+..+.-..|+|..|-.
T Consensus       934 --IDfss-lRkq~ApYIP~ItHptDTSNFdpv  962 (1034)
T KOG0608|consen  934 --IDFSS-LRKQRAPYIPRITHPTDTSNFDPV  962 (1034)
T ss_pred             --cchHh-hhhccCCcCccccCCCccccCCcC
Confidence              12222 223444466777777777777543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=4.6e-26  Score=228.27  Aligned_cols=253  Identities=20%  Similarity=0.358  Sum_probs=198.7

Q ss_pred             hhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-CcceeeEEeEeecC--CeEEEEEEe
Q 002461          608 NNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDG--GNVGLVYEY  683 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~--~~~~LV~Ey  683 (919)
                      +++.+++|+|.++.||.|. ..+.+.++||+++..   ..+.+.+|+.+|+.++ ||||+++++...+.  ....||+||
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            3456889999999999998 467888999999743   3467889999999997 99999999998654  567899999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~~~~  762 (919)
                      +.+.+...+-     +.++.......+.+++.||.|+|   ++||.|||+||.|+++|.. -..+|+|+|||.++.+..+
T Consensus       117 v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  117 VNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             hccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            9987766543     45777888999999999999999   7899999999999999954 5799999999998754433


Q ss_pred             CccccccccCccccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccc-------c
Q 002461          763 SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS-------I  834 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~-------i  834 (919)
                      ..   ..+.+..|.-||++.. ..++-.-|+|||||++.+|+..+.||..+.++.+..-.+.+.+....+..       .
T Consensus       189 Yn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  189 YN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             ee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            22   3355677889999865 45777889999999999999999999999888777666666655433221       1


Q ss_pred             ccccccc---CCChh-------------HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          835 VDPRLEA---NFDTN-------------SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       835 vd~~l~~---~~~~~-------------~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +||++..   .....             ...+.++++.+.+..|-.+|||++|...
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            3333322   11100             1245778889999999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-26  Score=254.51  Aligned_cols=236  Identities=24%  Similarity=0.334  Sum_probs=190.2

Q ss_pred             ceeceeCcEEEEEEEEcCCCE-EEEEEeecCCC---CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~-VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      ..||-|+||.|=.+...+... +|+|++++..-   ...+....|-.+|...+.|.||+++-.+.+....|++||-|-+|
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            469999999999988765443 88898876532   33455778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      .|...|++  ++.++......++..+.+|++|||   .++||.|||||+|.|||.+|-+||.|||+|+.+..   ....-
T Consensus       506 ElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KTw  577 (732)
T KOG0614|consen  506 ELWTILRD--RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKTW  577 (732)
T ss_pred             hhhhhhhh--cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc---CCcee
Confidence            99999954  566888888999999999999999   78999999999999999999999999999997743   23345


Q ss_pred             ccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhH
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~  847 (919)
                      ..+||+.|.|||.+..+..+..+|.||+|++++||++|.+||..... -.....+    -.|     +|   .-.++...
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~I----LkG-----id---~i~~Pr~I  644 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLI----LKG-----ID---KIEFPRRI  644 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHH----Hhh-----hh---hhhccccc
Confidence            68999999999999999999999999999999999999999964322 1111111    011     01   11223333


Q ss_pred             HHHHHHHHHhcCCCCCCCCCC
Q 002461          848 VWKVAETAMECVPSISFQRPT  868 (919)
Q Consensus       848 ~~~l~~l~~~Cl~~~P~~RPs  868 (919)
                      .....+++.+.+..+|.+|..
T Consensus       645 ~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  645 TKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             chhHHHHHHHHHhcCcHhhhc
Confidence            445677888888899999876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=1.2e-24  Score=227.56  Aligned_cols=197  Identities=32%  Similarity=0.501  Sum_probs=170.2

Q ss_pred             hcceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCC-CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          610 FHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45789999999999999875 889999999866544 5678899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcccc
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++..... .+++.....++.+++.++.+||   ..+++|+|++|+||+++.++.++|+|||.+........ ....
T Consensus        83 ~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~  157 (225)
T smart00221       83 DLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK  157 (225)
T ss_pred             CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence            99999854332 2889999999999999999999   56999999999999999999999999999987643321 1223


Q ss_pred             ccccCccccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 002461          768 SIVGTVGYLDPEYY-ASNRLTEKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       768 ~~~Gt~~Y~APE~l-~~~~~s~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                      ...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            44678889999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=226.61  Aligned_cols=240  Identities=19%  Similarity=0.296  Sum_probs=186.3

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCC---CCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEecc
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .++||+|+|.+|-.+.+. +.+.+|+|++++..   .++..-.+.|-.+..+- +||.+|.+..+|+.+...++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            478999999999999975 56779999998653   23334456677777666 79999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|+|--++.  ....++...+..+...|..||.|||   ..+|+.||||..|+|+|.+|.+||.|+|+++.-..  ....
T Consensus       335 ggdlmfhmq--rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~--~gd~  407 (593)
T KOG0695|consen  335 GGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDT  407 (593)
T ss_pred             Ccceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC--CCcc
Confidence            999977663  4456899999999999999999999   77999999999999999999999999999985322  2334


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCccc-CCCc--cchhcccccccccCCcccccccccccC
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR-GYNN--THIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~-~~~~--~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                      .+..+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+- +.++  ..-.++..+.+-+.+        ++  
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--------ir--  477 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--------IR--  477 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--------cc--
Confidence            5678999999999999999999999999999999999999999963 2221  111222222221111        11  


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCC
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRP  867 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RP  867 (919)
                      .+.....+...+....+..+|.+|.
T Consensus       478 iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhc
Confidence            1112222445667778888998875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-24  Score=234.68  Aligned_cols=139  Identities=27%  Similarity=0.420  Sum_probs=114.9

Q ss_pred             cCHHHHHH-HHhhhcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-----C---cceeeE
Q 002461          598 FTYSEIVD-ITNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-----H---RNLASL  667 (919)
Q Consensus       598 ~~~~ei~~-~t~~~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-----H---~NIv~l  667 (919)
                      ....|... ..|-..++||-|.|++||++.. .+.+.||+|+.+... .-.+.-..|+++|++++     |   ..||+|
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            34455555 6666789999999999999995 456789999987332 22345678999999984     3   359999


Q ss_pred             EeEee----cCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEe
Q 002461          668 VGYCN----DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       668 ~g~~~----~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      +++|.    .+.+.|||+|++ +-+|..+|....-+.++.....+|+.||+.||.|||..|  +|||.||||+|||+
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            99985    456899999998 458999998888888999999999999999999999876  89999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.3e-26  Score=232.51  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=188.3

Q ss_pred             cceeceeCcEEEEEEEE-cCCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecC-----CeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV~E  682 (919)
                      .+.||-|+||.||..+. ++|+.||.|++..-  +-...+.+.+|+++|..++|.|++..++...-.     .+.++++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            47799999999999985 47999999998642  122346788999999999999999888765433     35677888


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      .|. .+|...+  ...+.++-....-+.+||++||+|||   +.+|.||||||.|.|++.+...||||||+++....+..
T Consensus       138 LmQ-SDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  138 LMQ-SDLHKII--VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHH-hhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            886 4777777  45678998999999999999999999   67999999999999999999999999999997644433


Q ss_pred             CccccccccCccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcc---------
Q 002461          763 SHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR---------  832 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~---------  832 (919)
                      .+ .+..+-|..|+|||.+++. .|+...||||.||++.||+..+--|.... ..+..+.+.+++.....+         
T Consensus       212 ~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  212 LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-PIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-hHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            33 3345668899999999875 68999999999999999998776654322 222333333333221111         


Q ss_pred             --cccc-----c---ccccCC-ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          833 --SIVD-----P---RLEANF-DTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       833 --~ivd-----~---~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                        -++.     |   .+..-. ....-...+.+.+.++..+|+.|.+..+.+..+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence              0111     1   111000 111122345677788899999999998887743

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=241.05  Aligned_cols=191  Identities=26%  Similarity=0.379  Sum_probs=162.4

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC--------CCchhhhHHHHHHHhcc---CcceeeEEeEeecCCeEE
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--------QGPKQFRTEAQLLMRVH---HRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ev~~L~~l~---H~NIv~l~g~~~~~~~~~  678 (919)
                      .+.+|.|+||.|+.|.++ +..+|+||++.+..-        ...-..-.|+++|..++   |+||++++++|++.+.++
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            367999999999999986 456799999875421        11223567999999997   999999999999999999


Q ss_pred             EEEEec-cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          679 LVYEYM-AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       679 LV~Ey~-~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      |+||-. ++-+|.++|  ..+..+++.+...|++|++.|+++||   .++|+|||||-+|+.++.+|-+||+|||.+...
T Consensus       646 l~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             EEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            999964 567888988  44567999999999999999999999   779999999999999999999999999988754


Q ss_pred             CCCCCCccccccccCccccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCcc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYASNRLT-EKSDVYSFGIVLLELITGLPAII  810 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSfGvvL~ELltG~~p~~  810 (919)
                      .    +.......||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       721 k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 K----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             c----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            2    2233457899999999999998875 45799999999999998888875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-24  Score=243.51  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=197.2

Q ss_pred             hcceeceeCcEEEEEEEE-cCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCC
Q 002461          610 FHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      ..+.+|.|.+|.|||++. ..++..|||+++-.......-.++|+-+++..+|+||+.++|.+......++.||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            347899999999999995 4788999999998877777888999999999999999999999999999999999999999


Q ss_pred             hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccc
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+.-+  ...+++..+....++...+||+|||   +++-+|||||-.|||+++.+.+|++|||.+-.+..  .-.....
T Consensus        99 lQdiy~--~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Krks  171 (829)
T KOG0576|consen   99 LQDIYH--VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKS  171 (829)
T ss_pred             ccceee--ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhhhhhc
Confidence            999763  4567899999999999999999999   66889999999999999999999999998765421  1223456


Q ss_pred             cccCccccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccc-cccccCCC
Q 002461          769 IVGTVGYLDPEYYA---SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD-PRLEANFD  844 (919)
Q Consensus       769 ~~Gt~~Y~APE~l~---~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd-~~l~~~~~  844 (919)
                      ..||+.|||||+..   .+.|.+++|||+.|+...|+-.-++|...-..    .+... ++.    ...++ +.++.+. 
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~-LmT----kS~~qpp~lkDk~-  241 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALF-LMT----KSGFQPPTLKDKT-  241 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHH-Hhh----ccCCCCCcccCCc-
Confidence            78999999999863   56689999999999999999888887653221    11110 000    01111 2222211 


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                       .=...+-+++..|+-.+|++||+++.+++
T Consensus       242 -kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  242 -KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             11235778999999999999999988776

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=220.78  Aligned_cols=249  Identities=26%  Similarity=0.306  Sum_probs=184.4

Q ss_pred             ceeceeCcEEEEEEEE-cCCCEEEEEEeecC--CCCCchhhhHHHHHHHhccCcceeeEEeEeecC------CeEEEEEE
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDG------GNVGLVYE  682 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~------~~~~LV~E  682 (919)
                      ..+|.|.- .|..+.. -.++.||+|++...  .....++..+|..++..++|+|+++++.++.-.      .+.++|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            34666666 4444442 25788999987543  334456778899999999999999999988533      46899999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCC
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~  762 (919)
                      +|. ++|...++    ..++-.....|..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.-   ..
T Consensus       102 ~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e---~~  170 (369)
T KOG0665|consen  102 LMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE---DT  170 (369)
T ss_pred             hhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc---Cc
Confidence            997 58988885    23667788899999999999999   679999999999999999999999999999853   22


Q ss_pred             CccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccc--cccccCC----------
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC--PFLERGD----------  830 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~--~~~~~~~----------  830 (919)
                      ....+.++.|..|.|||++.+..+.+++||||.||++.||++|+--|. +.+  ++.+|.+  +.++..+          
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~-g~d--~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP-GKD--HIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec-Cch--HHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            245677889999999999998889999999999999999999987664 322  3333322  1111100          


Q ss_pred             ---------------ccccc-cccccc--CCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          831 ---------------VRSIV-DPRLEA--NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       831 ---------------~~~iv-d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                                     ..+.+ |.....  +.+.-......+++.+++-.+|++|-+++++++.
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                           00111 111111  0111223456789999999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=7.3e-24  Score=233.08  Aligned_cols=269  Identities=24%  Similarity=0.259  Sum_probs=202.9

Q ss_pred             cccCHHHHHHHHhhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhcc------CcceeeEE
Q 002461          596 QQFTYSEIVDITNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH------HRNLASLV  668 (919)
Q Consensus       596 ~~~~~~ei~~~t~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~------H~NIv~l~  668 (919)
                      ..+.+.|+++..|.+.-..|+|-|++|.+|... -|++||||++..... ..+.=+.|+++|++|+      .-|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            346778888888888888999999999999964 478999999975432 2345578999999995      34789999


Q ss_pred             eEeecCCeEEEEEEeccCCChhhhhhccc-cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcE
Q 002461          669 GYCNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQA  746 (919)
Q Consensus       669 g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~-~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~v  746 (919)
                      -.|...+++|||||-+. .+|.++|+.-. .-.|.......++.|+.-||..|.   +.+|+|.||||.|||+++. ..+
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence            99999999999999875 59999996544 456888999999999999999999   5699999999999999965 568


Q ss_pred             EEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccc--
Q 002461          747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP--  824 (919)
Q Consensus       747 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~--  824 (919)
                      ||||||.|......    ..+.+.-+..|.|||.+.+..|+...|+||.||.||||.||+-.|....+ .+++.....  
T Consensus       577 KLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN-N~MLrl~me~K  651 (752)
T KOG0670|consen  577 KLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN-NQMLRLFMELK  651 (752)
T ss_pred             eeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc-HHHHHHHHHhc
Confidence            99999998765322    12334556789999999999999999999999999999999876643333 222222111  


Q ss_pred             ------ccccCCc---------------------------cccccc------cccc--CCChhH---HHHHHHHHHhcCC
Q 002461          825 ------FLERGDV---------------------------RSIVDP------RLEA--NFDTNS---VWKVAETAMECVP  860 (919)
Q Consensus       825 ------~~~~~~~---------------------------~~ivd~------~l~~--~~~~~~---~~~l~~l~~~Cl~  860 (919)
                            +++.|..                           ...+.|      .|.+  .++.+.   ...+.+|...|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence                  1111110                           111112      1111  123333   3456788999999


Q ss_pred             CCCCCCCCHHHHHH
Q 002461          861 SISFQRPTMSHVVT  874 (919)
Q Consensus       861 ~~P~~RPsm~eVv~  874 (919)
                      .+|++|-+..+.++
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.88  E-value=2.6e-23  Score=259.12  Aligned_cols=196  Identities=18%  Similarity=0.200  Sum_probs=138.1

Q ss_pred             hccC-cceeeEEeEe-------ecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCee
Q 002461          658 RVHH-RNLASLVGYC-------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII  729 (919)
Q Consensus       658 ~l~H-~NIv~l~g~~-------~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~ii  729 (919)
                      .++| .||.+++++|       ......++++|++ .++|.++|... ...+++.+++.++.||++||+|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4556 5888888887       2234567888987 56999999643 355999999999999999999999   67999


Q ss_pred             eeccccceEEeCCC-------------------CcEEEeccCcccccCCCCC--------------CccccccccCcccc
Q 002461          730 HRDVKTANILLNEK-------------------MQAKLADFGFSKIFPAESE--------------SHISTSIVGTVGYL  776 (919)
Q Consensus       730 H~DLKp~NILld~~-------------------~~vkL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~Y~  776 (919)
                      ||||||+||||+..                   +.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4456666666653210000              00011245788999


Q ss_pred             CcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHH
Q 002461          777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAM  856 (919)
Q Consensus       777 APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~  856 (919)
                      |||++.+..++.++|||||||+||||++|.+|+.....   ....+.    .    ....+..     .........++.
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~----~----~~~~~~~-----~~~~~~~~~~~~  246 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLR----H----RVLPPQI-----LLNWPKEASFCL  246 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHH----H----hhcChhh-----hhcCHHHHHHHH
Confidence            99999999999999999999999999999887642111   000000    0    0011111     111234567888


Q ss_pred             hcCCCCCCCCCCHHHHHH
Q 002461          857 ECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       857 ~Cl~~~P~~RPsm~eVv~  874 (919)
                      +|++.+|.+||+|.|+++
T Consensus       247 ~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HhCCCChhhCcChHHHhh
Confidence            999999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=9.4e-23  Score=209.30  Aligned_cols=249  Identities=16%  Similarity=0.243  Sum_probs=182.6

Q ss_pred             hhhcceeceeCcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeE-eecCCeEEEEEEec
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGY-CNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~-~~~~~~~~LV~Ey~  684 (919)
                      +++.+.||+|.||.+-.+.++ ..+.+++|-+.... ...++|.+|...--.| .|.||+.-++. |+..+.+++++||+
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a  104 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA  104 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence            456789999999999999987 46679999886432 2357888888766666 58999987664 67778899999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC--CCCcEEEeccCcccccCCCCC
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN--EKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld--~~~~vkL~DFGla~~~~~~~~  762 (919)
                      +.|+|.+-+..   ..+.+....+++.|++.|+.|||   +++++|||||.+|||+-  +..++||||||+.+...    
T Consensus       105 P~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g----  174 (378)
T KOG1345|consen  105 PRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG----  174 (378)
T ss_pred             ccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC----
Confidence            99999988743   45788889999999999999999   77999999999999993  34589999999987542    


Q ss_pred             CccccccccCccccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCcccCC-CccchhcccccccccCCcccccc
Q 002461          763 SHISTSIVGTVGYLDPEYYASN-----RLTEKSDVYSFGIVLLELITGLPAIIRGY-NNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       763 ~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSfGvvL~ELltG~~p~~~~~-~~~~l~~~v~~~~~~~~~~~ivd  836 (919)
                       .......-+..|-+||.....     ...+.+|+|.||++++.++||..|+.... ......+|....  .+....  -
T Consensus       175 -~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~rk~~~--~  249 (378)
T KOG1345|consen  175 -TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KRKNPA--L  249 (378)
T ss_pred             -ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cccCcc--C
Confidence             112233446678899986532     35677899999999999999999997533 244455554321  111111  1


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~L  876 (919)
                      |+.-..+.    .++.++-.+-+..++++|-...++.++-
T Consensus       250 P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  250 PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11111222    2456677788899999996666665543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=2.8e-22  Score=203.17  Aligned_cols=168  Identities=21%  Similarity=0.216  Sum_probs=124.9

Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++... ...+++.++..++.|+++||+|||+.   +      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence            6899998543 45699999999999999999999953   3      999999999999999  9998865321      


Q ss_pred             cccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChh
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~  846 (919)
                       ...|++.|||||++.+..++.++|||||||++|||++|+.||............+.......      ++... .....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~~  134 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRDR-SNLES  134 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------Ccccc-ccHHH
Confidence             12588999999999999999999999999999999999999864332222111111111000      00000 00111


Q ss_pred             HH--HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          847 SV--WKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       847 ~~--~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ..  ..+.+++.+|+..+|.+||++.|+++.+....
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            11  25889999999999999999999999886553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.6e-23  Score=210.41  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=192.8

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCC--CCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccC
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~  686 (919)
                      ++..+|.+...|..|+|+++ |..+++|+++...  ....++|.+|.-.|+.+.||||++++|.|....+..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            44567888999999999996 5567778876442  23457899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccc
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~  766 (919)
                      |+|+..|++...-..+-.+.++++.++|+|++|||+- .+-|..--|.+..+++|++.+++|+= +-+++      +...
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQE  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee------eeec
Confidence            9999999998888889999999999999999999965 44455567899999999999988751 11111      0111


Q ss_pred             cccccCccccCcccccCCCCC---chhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCC
Q 002461          767 TSIVGTVGYLDPEYYASNRLT---EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       767 ~~~~Gt~~Y~APE~l~~~~~s---~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~  843 (919)
                      ....-.+.||+||.++.++-+   ..+|+|||++++|||.|...||.+-..-.-           |  .++.-+.++-..
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------g--mkialeglrv~i  410 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------G--MKIALEGLRVHI  410 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------h--hhhhhccccccC
Confidence            223456889999999876543   578999999999999999999964322110           0  011111223333


Q ss_pred             ChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       844 ~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      +......+.+++.-|+.+||.+||.+..|+-.||+.+
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            4444557888999999999999999999999998753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.87  E-value=2.1e-22  Score=218.98  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=191.3

Q ss_pred             cceeceeCcEEEEEEEEc----CCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEecc
Q 002461          611 HRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~----~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .++||.|.|++||++++.    ....||+|.+...+  ......+|++.|..+ -+.||+++.+++...+..++|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            578999999999999964    35679999986543  346788999999999 49999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCCC----
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAE----  760 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~~----  760 (919)
                      +-...++...     ++..+...++..+..||+++|   ..+|+||||||+|+|.+.. +.-.|.|||||......    
T Consensus       119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            9888888743     678899999999999999999   6799999999999999854 56799999999721100    


Q ss_pred             --------------------------------------CCCccccccccCccccCccccc-CCCCCchhhHHHHHHHHHH
Q 002461          761 --------------------------------------SESHISTSIVGTVGYLDPEYYA-SNRLTEKSDVYSFGIVLLE  801 (919)
Q Consensus       761 --------------------------------------~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSfGvvL~E  801 (919)
                                                            .........+||+||.|||++. ....+.++||||-|||++-
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                                                  0000112457999999999976 4567899999999999999


Q ss_pred             HHhCCCCcccCCCccchhcccccccc----------cCC--------cccc---------cc-ccccc---------CCC
Q 002461          802 LITGLPAIIRGYNNTHIVNRVCPFLE----------RGD--------VRSI---------VD-PRLEA---------NFD  844 (919)
Q Consensus       802 LltG~~p~~~~~~~~~l~~~v~~~~~----------~~~--------~~~i---------vd-~~l~~---------~~~  844 (919)
                      +++++.||....++.+....+.....          .|.        +..+         ++ +.+..         ...
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            99999999877764433332221110          011        0000         10 00000         001


Q ss_pred             hhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +.-...++++..+|+..+|.+|-+++|.++
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            111226789999999999999999999987

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.2e-20  Score=211.53  Aligned_cols=162  Identities=20%  Similarity=0.207  Sum_probs=124.5

Q ss_pred             hhhcceeceeCcEEEEEEEEc--CCCEEEEEEeecCCC-----CCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEE
Q 002461          608 NNFHRILGKGGFGTVYHGYLA--DGSEVAIKMLSASSS-----QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~--~g~~VAVK~l~~~~~-----~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|+||+||+|.+.  +++.||||++.....     ...+.|.+|+++|++++|+|+++.+..   .+..++|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            445689999999999999875  577889998753311     123568999999999999999853322   2457999


Q ss_pred             EEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeecc-ccceEEeCCCCcEEEeccCcccccCC
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV-KTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       681 ~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DL-Kp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      |||+++++|....   ..      ....++.++++||.|||   ..+|+|||| ||+|||++.++.+||+|||+++.+..
T Consensus        97 mE~~~G~~L~~~~---~~------~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         97 RGWTEGVPLHLAR---PH------GDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEccCCCCHHHhC---cc------chHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            9999999996321   10      12467889999999999   679999999 99999999999999999999997754


Q ss_pred             CCCCcc------ccccccCccccCcccccCC
Q 002461          760 ESESHI------STSIVGTVGYLDPEYYASN  784 (919)
Q Consensus       760 ~~~~~~------~~~~~Gt~~Y~APE~l~~~  784 (919)
                      ......      .....+++.|+|||++...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            322111      1356688899999998644

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=4.9e-19  Score=192.33  Aligned_cols=256  Identities=30%  Similarity=0.450  Sum_probs=194.5

Q ss_pred             hcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC---CchhhhHHHHHHHhccCc-ceeeEEeEeecCCeEEEEEEecc
Q 002461          610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHR-NLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       610 ~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~---~~~~f~~Ev~~L~~l~H~-NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ..+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++++.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            4578999999999999987  88999998765443   256799999999999988 79999999977777899999999


Q ss_pred             CCChhhhhhcccc-ccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCcccccCCCCCC
Q 002461          686 YGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~~~-~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~~~~~  763 (919)
                      ++++.+++..... ..+.......++.+++.++.|+|   ..+++|||+||+||+++... .++++|||+++.+......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999976643221 26888999999999999999999   56799999999999999988 7999999999865433222


Q ss_pred             c----cccccccCccccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCcccCCC---ccchhcccccccccCCccc
Q 002461          764 H----ISTSIVGTVGYLDPEYYAS---NRLTEKSDVYSFGIVLLELITGLPAIIRGYN---NTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       764 ~----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~---~~~l~~~v~~~~~~~~~~~  833 (919)
                      .    ......|+..|+|||.+.+   .......|+||+|++++++++|..|+.....   .....+.+......     
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence            1    3456789999999999987   5788999999999999999999999654332   11222211111100     


Q ss_pred             ccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       834 ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .................+.+++..|+..+|..|.++.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000000001223467788999999999999999988765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=4.5e-19  Score=198.16  Aligned_cols=261  Identities=20%  Similarity=0.228  Sum_probs=192.4

Q ss_pred             HhhhcceeceeCcEEEEEEEEcCC--CEEEEEEeecCCCCCchhhhHHHHHHHhccC----cceeeEEeEe-ecCCeEEE
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADG--SEVAIKMLSASSSQGPKQFRTEAQLLMRVHH----RNLASLVGYC-NDGGNVGL  679 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~l~~g--~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H----~NIv~l~g~~-~~~~~~~L  679 (919)
                      .+.+.+.||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            345578999999999999997654  4788888776544433478889999999973    5788888888 47778899


Q ss_pred             EEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-----CcEEEeccCcc
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-----MQAKLADFGFS  754 (919)
Q Consensus       680 V~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-----~~vkL~DFGla  754 (919)
                      ||+.+ +.+|.++......+.++..+.++|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99966 679999775555578999999999999999999999   6799999999999999854     46999999999


Q ss_pred             c--ccCCCCCC---cc---ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhccccccc
Q 002461          755 K--IFPAESES---HI---STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL  826 (919)
Q Consensus       755 ~--~~~~~~~~---~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~  826 (919)
                      +  .+......   ..   .....||.+|.++....+...+.+.|+||++.++.|++.|..|+........ ...+.+..
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            9  43222211   11   1234599999999999999999999999999999999999988843322111 11111000


Q ss_pred             ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       827 ~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .    ......     ........+.++...+-..+..++|....+...|+++..
T Consensus       254 ~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  254 R----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0    000000     111223345556666666889999999999998776654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=2e-18  Score=178.00  Aligned_cols=139  Identities=20%  Similarity=0.206  Sum_probs=107.8

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC--C-------chhh-----------------hHHHHHHHhccCccee
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ--G-------PKQF-----------------RTEAQLLMRVHHRNLA  665 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ev~~L~~l~H~NIv  665 (919)
                      ..||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            679999999999999889999999999754221  1       1122                 2499999999887764


Q ss_pred             eEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCc
Q 002461          666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ  745 (919)
Q Consensus       666 ~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~  745 (919)
                      ....+..  ...++||||++++++...+.  ....++..+...++.|++.+|.+|||  ..+|+||||||+|||+++ +.
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~~-~~  155 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYHD-GK  155 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEEC-Cc
Confidence            3333222  22389999999887765432  23468899999999999999999943  458999999999999984 78


Q ss_pred             EEEeccCccccc
Q 002461          746 AKLADFGFSKIF  757 (919)
Q Consensus       746 vkL~DFGla~~~  757 (919)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=1.3e-18  Score=198.69  Aligned_cols=219  Identities=23%  Similarity=0.362  Sum_probs=164.3

Q ss_pred             HHhccCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeecccc
Q 002461          656 LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKT  735 (919)
Q Consensus       656 L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp  735 (919)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++++++.||+|||+.  +--.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence            4578999999999999999999999999999999999965 456699999999999999999999953  2239999999


Q ss_pred             ceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCC-------CCCchhhHHHHHHHHHHHHhCCCC
Q 002461          736 ANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN-------RLTEKSDVYSFGIVLLELITGLPA  808 (919)
Q Consensus       736 ~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSfGvvL~ELltG~~p  808 (919)
                      +|+++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998866321111111222245679999998653       146789999999999999999999


Q ss_pred             cccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHh
Q 002461          809 IIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       809 ~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      |.......+..+.+.. +.. .-...+.|.+....  +....+..++..||.++|.+||++..|-..++.+..
T Consensus       158 ~~~~~~~~~~~eii~~-~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILR-VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHH-HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9865443332222222 111 11122233332111  333368899999999999999999999888776654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=1.6e-18  Score=181.67  Aligned_cols=174  Identities=13%  Similarity=0.130  Sum_probs=131.8

Q ss_pred             HHHHHHhhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchh---------hhHHHHHHHhccCcceeeEEeEee
Q 002461          602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQ---------FRTEAQLLMRVHHRNLASLVGYCN  672 (919)
Q Consensus       602 ei~~~t~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ev~~L~~l~H~NIv~l~g~~~  672 (919)
                      ++.+-.+...++||.|+||.||.... ++..+|||+++.......+.         +.+|++.+.+++|++|..+..++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            44444555578999999999999766 57789999997654333322         678999999999999999888754


Q ss_pred             cC--------CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          673 DG--------GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       673 ~~--------~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                      ..        +..+|+|||++|.+|.++..      ++.    ....+++.+|..||   ..+++|||+||+||+++.++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence            32        35889999999999988641      221    34568999999999   67999999999999999988


Q ss_pred             cEEEeccCcccccCCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 002461          745 QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT  804 (919)
Q Consensus       745 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELlt  804 (919)
                       ++|+|||..+....+...              ..+.....+..++|+|+||+.+..+..
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence             999999987654211110              113344456679999999998876653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=5.3e-19  Score=210.73  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=181.9

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecC--CCCCc----hhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS--SSQGP----KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~--~~~~~----~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      .+++|.|.+|.|+..... ..+..+.|.....  .....    ..+..|+.+-..++|+|++..+..+.+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            478999999988777643 2333444433210  11111    1255577777788999998888777766666666999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~  763 (919)
                      +++ +|..++...  ..++..++-.++.|+..|++|||   ..+|.|||+|++|++++.++.+||+|||.+..+....+.
T Consensus       403 ~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             ccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            999 999988432  46888899999999999999999   779999999999999999999999999999876544444


Q ss_pred             --ccccccccCccccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccc
Q 002461          764 --HISTSIVGTVGYLDPEYYASNRLTEK-SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       764 --~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~  840 (919)
                        .......|+..|+|||.+....|.+. .||||.|+++..|++|+.||-......+......   ..++ ..+..+.  
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---~~~~-~~~~~~~--  550 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---YSDQ-RNIFEGP--  550 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---cccc-cccccCh--
Confidence              66778899999999999999998875 6999999999999999999865433221100000   0000 0000000  


Q ss_pred             cCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ...-.........++-++++.+|.+|-+|++|++
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0001122335577888999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=6.7e-19  Score=208.81  Aligned_cols=249  Identities=20%  Similarity=0.219  Sum_probs=181.0

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCC-CCCchhhhHHHHH--HHhccCcceeeEEeEeecCCeEEEEEEecc
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASS-SQGPKQFRTEAQL--LMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~-~~~~~~f~~Ev~~--L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+.+.||.+.|=+|.+|++++|. |+||++-+.. .-..+.|.++++-  ...++|||.+++...-......+||-+|..
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk  104 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK  104 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence            44678999999999999998888 8999986654 3344555554444  444589999998877666677788888886


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC-CCCCCc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP-AESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~-~~~~~~  764 (919)
                      + +|+|.|  ..+.-+...+..-|+.|++.||..+|   +.+|+|||||.+|||++.-.-+.|+||.--+... +++...
T Consensus       105 h-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  105 H-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             h-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            5 999998  56677888999999999999999999   7899999999999999999999999998665321 121111


Q ss_pred             c----ccccccCccccCcccccCC-----------CCCchhhHHHHHHHHHHHHh-CCCCcccCCCccchhcccccc--c
Q 002461          765 I----STSIVGTVGYLDPEYYASN-----------RLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPF--L  826 (919)
Q Consensus       765 ~----~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSfGvvL~ELlt-G~~p~~~~~~~~~l~~~v~~~--~  826 (919)
                      .    ......-.+|+|||.+...           ..+++-||||.||++.||++ |+++|.-    .++..+...-  .
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccC
Confidence            1    1122334579999987431           26678899999999999987 5776642    2222221100  0


Q ss_pred             ccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       827 ~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      .+.-+.++-|+            .+.++++.|++.+|++|-++++.++.-.+..
T Consensus       255 ~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  255 PEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             HHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            00001111121            4678999999999999999999999855554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=1.8e-17  Score=171.09  Aligned_cols=140  Identities=17%  Similarity=0.178  Sum_probs=109.4

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--------------------------chhhhHHHHHHHhccCcce
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--------------------------PKQFRTEAQLLMRVHHRNL  664 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ev~~L~~l~H~NI  664 (919)
                      ...||+|++|+||+|...+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36799999999999998889999999997653210                          0113568899999999987


Q ss_pred             eeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       665 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                      .....+...  ..+|||||++++++.....  ....++..+..+++.+++.++.+||+  ..+|+||||||+|||++ ++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence            544433322  2489999999886544321  12357788899999999999999994  16999999999999999 78


Q ss_pred             cEEEeccCccccc
Q 002461          745 QAKLADFGFSKIF  757 (919)
Q Consensus       745 ~vkL~DFGla~~~  757 (919)
                      .++|+|||+++..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            9999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=4.1e-17  Score=172.40  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=188.2

Q ss_pred             HhhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEec
Q 002461          607 TNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       607 t~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .+.+.++||+|.||..+.|+ +-+++.||||.-...+  ..-++..|....+.|. .++|...+-+-.++.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            34567899999999999998 5689999999864332  3456788888888884 788888887778888889999987


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-----CCcEEEeccCcccccCC
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-----KMQAKLADFGFSKIFPA  759 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-----~~~vkL~DFGla~~~~~  759 (919)
                       +-+|.++. +-....++..+...+|.|+..-++|+|   .+.+|.|||||+|+||..     ...+.++|||+|+.+..
T Consensus       107 -GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 -GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             -CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence             45887754 556777999999999999999999999   678999999999999963     34689999999998743


Q ss_pred             -CCCCcc----ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCC--CccchhcccccccccCCcc
Q 002461          760 -ESESHI----STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY--NNTHIVNRVCPFLERGDVR  832 (919)
Q Consensus       760 -~~~~~~----~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~--~~~~l~~~v~~~~~~~~~~  832 (919)
                       ....++    .....||.+||+-....+...+.+.|+-|+|-|+++.+.|..||..-.  +..+-.+.+-+.-+.-.+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence             223332    346779999999999899999999999999999999999999996432  2233333332221111111


Q ss_pred             cccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          833 SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       833 ~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      +     |...++. +...-++.+   -..+=.+-|...-+...+..++
T Consensus       262 ~-----Lc~g~P~-efa~Yl~yv---R~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  262 V-----LCEGFPE-EFATYLRYV---RRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             H-----HHhcCHH-HHHHHHHHH---HhcCcccCCCHHHHHHHHHHHH
Confidence            1     1122332 222223322   2334456688777766666654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.70  E-value=4e-17  Score=165.69  Aligned_cols=257  Identities=21%  Similarity=0.283  Sum_probs=188.5

Q ss_pred             hhhcceeceeCcEEEEEEE-EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccC-cceeeEEeEeecCCeEEEEEEecc
Q 002461          608 NNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH-RNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H-~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      +.+.++||.|+||.+|.|. ..+|.+||||+-+...  ...++.-|..+.+.++| ..|..+..|..++..-.+|||.+ 
T Consensus        17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             eEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            4567899999999999998 5789999999965432  23467789999999975 56778888888899999999987 


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC---CcEEEeccCcccccCCC-C
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAE-S  761 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~---~~vkL~DFGla~~~~~~-~  761 (919)
                      +-+|.++. .-....++..+.+-++-|++.-++|+|   .++++||||||+|+|..-+   ..+.++||||++.+... .
T Consensus        94 GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   94 GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            56888765 334556899999999999999999999   6789999999999999743   46899999999877422 2


Q ss_pred             CCc----cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCcc--chhcccccccccCCccccc
Q 002461          762 ESH----ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT--HIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       762 ~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~--~l~~~v~~~~~~~~~~~iv  835 (919)
                      ..+    ......||.+|.+-....+...+.+.|+-|+|.+|.++..|..||..-....  +-.+.+    .+..+.-.+
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK~s~~i  245 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKKMSTPI  245 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhhcCCCH
Confidence            222    2346779999998888777788899999999999999999999996433211  111111    111111111


Q ss_pred             ccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHH
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       836 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                       ..|-..++    .++.-.+.-|-...=++-|...-+-+.+.-+.
T Consensus       246 -e~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  246 -EVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             -HHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence             11222233    24555566677777788888877776665443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.2e-16  Score=162.50  Aligned_cols=184  Identities=18%  Similarity=0.097  Sum_probs=137.0

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC----chhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEecc
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG----PKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~----~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ...|++|+||+||.+.- .+..++.+.++....-.    ...|.+|+++|+++. |+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46899999999997765 67788877776443211    125789999999995 5789999886    45699999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeecc-ccceEEeCCCCcEEEeccCcccccCCCCCC-
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV-KTANILLNEKMQAKLADFGFSKIFPAESES-  763 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DL-Kp~NILld~~~~vkL~DFGla~~~~~~~~~-  763 (919)
                      +.+|.+.+..         ....++.+++++|.++|   ..+|+|||| ||+|||++.++.++|+|||++......... 
T Consensus        82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         82 GAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             CccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            9888754311         12457789999999999   679999999 799999999999999999999865432210 


Q ss_pred             ---c---c----ccccccCccccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCccc
Q 002461          764 ---H---I----STSIVGTVGYLDPEYYASN-RLT-EKSDVYSFGIVLLELITGLPAIIR  811 (919)
Q Consensus       764 ---~---~----~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSfGvvL~ELltG~~p~~~  811 (919)
                         .   .    ......++.|++|+...-. ..+ ...+.++-|..+|.++|+..+...
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence               0   0    1122357777777754321 223 567999999999999999887643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=4.7e-16  Score=189.05  Aligned_cols=247  Identities=20%  Similarity=0.221  Sum_probs=178.7

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc---CcceeeEEeEeecCCeEEEEEEec
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH---HRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~---H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      ..+.+.||+|+||+||+|...+|+.||+|+=+....   -+|.-=.+++.+|+   -+-|.++...+.-.+.-+||+||.
T Consensus       700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            345678999999999999999999999999765433   33443445555555   122333444445567789999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeC-------CCCcEEEeccCccccc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-------EKMQAKLADFGFSKIF  757 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld-------~~~~vkL~DFGla~~~  757 (919)
                      +.|+|.+++.  ..+.++|...+.++.|+++.+++||   ..+||||||||+|+||.       +..-++|+|||.+-.+
T Consensus       777 ~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  777 PYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             ccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999994  6778999999999999999999999   67999999999999994       2346899999988654


Q ss_pred             CCCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCccccccc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~  837 (919)
                      ..-..........+|-.+-.+|+..+..++-.+|.|.++-+++-|+.|+..-                ...|. ...++.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~g~-~~~~~~  914 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKNGS-SWMVKT  914 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcCCc-ceeccc
Confidence            3222223445667889999999999999999999999999999999996521                00111 111222


Q ss_pred             ccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHHHhh
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      .+..-...+.+.++..+++-   .+-..=|...++...|++.+.-
T Consensus       915 ~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  915 NFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             cchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHHH
Confidence            22222233344455554444   5556668888888888887653

>PRK10345 hypothetical protein; Provisional

Probab=99.65  E-value=8.8e-16  Score=160.30  Aligned_cols=134  Identities=16%  Similarity=0.214  Sum_probs=104.3

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhc-----cCcceeeEEeEeecCC---e-EEEEE
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-----HHRNLASLVGYCNDGG---N-VGLVY  681 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-----~H~NIv~l~g~~~~~~---~-~~LV~  681 (919)
                      .+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            36899999999996 3234444 79988765455567899999999999     5799999999998763   3 33789


Q ss_pred             Ee--ccCCChhhhhhccccccCChHhHHHHHHHHHHHH-HHHHhcCCCCeeeeccccceEEeCC----CCcEEEeccCcc
Q 002461          682 EY--MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL-EYLHHGCKPPIIHRDVKTANILLNE----KMQAKLADFGFS  754 (919)
Q Consensus       682 Ey--~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL-~yLH~~~~~~iiH~DLKp~NILld~----~~~vkL~DFGla  754 (919)
                      ||  +++|+|.+++...   .++..  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+||+.+
T Consensus        85 e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             cCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            99  5689999999542   35544  45677888777 9999   678999999999999973    347999995433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.65  E-value=1.2e-15  Score=164.88  Aligned_cols=228  Identities=20%  Similarity=0.237  Sum_probs=143.3

Q ss_pred             cceeceeCcEEEEEEEEc-CCCEEEEEEeecCCC---CCchhhhHHHHHHHhccC----------cceeeEEeEe-----
Q 002461          611 HRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS---QGPKQFRTEAQLLMRVHH----------RNLASLVGYC-----  671 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~~L~~l~H----------~NIv~l~g~~-----  671 (919)
                      .+.||.|+++.||.+++. +|+++|||++.....   ...+++++|.-....+.+          -.++..++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999986 489999999864432   223456666655544322          1222211111     


Q ss_pred             ----ecC---C-----eEEEEEEeccCCChhhhhhc---cc--cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccc
Q 002461          672 ----NDG---G-----NVGLVYEYMAYGNLKQYLFD---ET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVK  734 (919)
Q Consensus       672 ----~~~---~-----~~~LV~Ey~~~GsL~~~L~~---~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLK  734 (919)
                          ...   .     +.+++|+-+. ++|.+++..   ..  ...+....++.+..|+.+.+++||   ..+++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence                111   1     3467787774 688877532   11  223556677888899999999999   6699999999


Q ss_pred             cceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccC--------CCCCchhhHHHHHHHHHHHHhCC
Q 002461          735 TANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--------NRLTEKSDVYSFGIVLLELITGL  806 (919)
Q Consensus       735 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSfGvvL~ELltG~  806 (919)
                      |+|++++.+|.++|+||+.......    .... ...+..|.+||....        -.++.+.|.|++|+++|.|++|.
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999987765421    1111 344578999997643        25788999999999999999999


Q ss_pred             CCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCC
Q 002461          807 PAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQR  866 (919)
Q Consensus       807 ~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R  866 (919)
                      .||........ .++                .+ .... +..+.+..|+...++.+|.+|
T Consensus       248 lPf~~~~~~~~-~~~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEAD-PEW----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGST-SGG----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCcccc-ccc----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99864321110 000                11 1122 456678899999999999887

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.5e-15  Score=158.75  Aligned_cols=134  Identities=24%  Similarity=0.382  Sum_probs=112.5

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--------chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--------PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      +.||+|++|.||+|.. +|..+++|+........        ...+.+|++++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67789999875432211        13577899999999999988777777777788999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      +++++|.+++...     .+ .+..++.+++.+|.+||   ..+++|+|++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432     22 78899999999999999   67899999999999999 78899999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.63  E-value=5.4e-17  Score=185.26  Aligned_cols=225  Identities=26%  Similarity=0.299  Sum_probs=173.3

Q ss_pred             eeceeCcEEEEEEE----EcCCCEEEEEEeecCCCCC--chhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEecc
Q 002461          613 ILGKGGFGTVYHGY----LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~----l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      .+|+|.||.|+.+.    .+.|..+|.|++++.....  ......|..++..++ ||.++++.-.++.+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998765    3457778999887653221  124566888999997 9999999999999999999999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCcc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~  765 (919)
                      +|.|...+.  ....+...........++-+++++|   +.+++|||+|++||+++.+|.+++.|||+.+..-....   
T Consensus        81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            999988773  3344666666777788899999999   77999999999999999999999999999986533222   


Q ss_pred             ccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCCh
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~  845 (919)
                         .+||..|||||...  ......|.||||++++||+||..||..     +....+   +           +.+-..+.
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~I---l-----------~~~~~~p~  208 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRI---L-----------KAELEMPR  208 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHH---h-----------hhccCCch
Confidence               28999999999988  567789999999999999999999864     111111   1           11112344


Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCH
Q 002461          846 NSVWKVAETAMECVPSISFQRPTM  869 (919)
Q Consensus       846 ~~~~~l~~l~~~Cl~~~P~~RPsm  869 (919)
                      +.......+.......+|.+|--.
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhcc
Confidence            444456667777778888887655

>smart00090 RIO RIO-like kinase

Probab=99.62  E-value=3.1e-15  Score=159.60  Aligned_cols=139  Identities=18%  Similarity=0.212  Sum_probs=107.8

Q ss_pred             hhcceeceeCcEEEEEEE--EcCCCEEEEEEeecCCCCC------------------------chhhhHHHHHHHhccCc
Q 002461          609 NFHRILGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG------------------------PKQFRTEAQLLMRVHHR  662 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~--l~~g~~VAVK~l~~~~~~~------------------------~~~f~~Ev~~L~~l~H~  662 (919)
                      .+.+.||+|++|.||+|.  ..+|+.||+|+++......                        ...+..|++.+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            456889999999999998  5689999999987542110                        01246799999999763


Q ss_pred             c--eeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCC-eeeeccccceEE
Q 002461          663 N--LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP-IIHRDVKTANIL  739 (919)
Q Consensus       663 N--Iv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~-iiH~DLKp~NIL  739 (919)
                      .  +.+++++    ...++||||+++++|......  ...+...+...++.|++.++.+||   ..+ ++||||||+||+
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIl  181 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNIL  181 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEE
Confidence            3  3445543    235899999999888765422  233555667899999999999999   567 999999999999


Q ss_pred             eCCCCcEEEeccCccccc
Q 002461          740 LNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       740 ld~~~~vkL~DFGla~~~  757 (919)
                      ++ +++++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 789999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.61  E-value=3.5e-15  Score=154.62  Aligned_cols=130  Identities=28%  Similarity=0.400  Sum_probs=105.8

Q ss_pred             eeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--------chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEec
Q 002461          613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--------PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~  684 (919)
                      .||+|+||.||+|.+ +|..+++|+........        ..++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999995 57889999865432111        245678999999999987665555555666779999999


Q ss_pred             cCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      ++++|.+.+.....         .++.+++++|.+||   ..+++|+|++|+||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988743211         88999999999999   67999999999999999 78999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=6.5e-15  Score=152.87  Aligned_cols=135  Identities=19%  Similarity=0.215  Sum_probs=107.1

Q ss_pred             hhhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC----------------------CchhhhHHHHHHHhccCcc--
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ----------------------GPKQFRTEAQLLMRVHHRN--  663 (919)
Q Consensus       608 ~~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ev~~L~~l~H~N--  663 (919)
                      +.+.+.||+|+||.||++...+|+.||||+++.....                      ....+..|..++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4456889999999999999988999999987643210                      0112567888999998874  


Q ss_pred             eeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC
Q 002461          664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK  743 (919)
Q Consensus       664 Iv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~  743 (919)
                      +...++.    ...++||||+++++|......        .....++.+++.++.++|   ..+++|+||||+||+++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence            4444442    345899999999998765421        345678899999999999   5799999999999999999


Q ss_pred             CcEEEeccCccccc
Q 002461          744 MQAKLADFGFSKIF  757 (919)
Q Consensus       744 ~~vkL~DFGla~~~  757 (919)
                      +.++|+|||++...
T Consensus       162 ~~~~liDfg~~~~~  175 (198)
T cd05144         162 EKIYIIDWPQMVST  175 (198)
T ss_pred             CcEEEEECCccccC
Confidence            99999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.58  E-value=8.4e-15  Score=174.86  Aligned_cols=131  Identities=25%  Similarity=0.367  Sum_probs=107.8

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEE-eecCCCC-------CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKM-LSASSSQ-------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~-l~~~~~~-------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      .+.||+|+||+||+|.+.+.. +++|+ +......       ..+.+.+|+++++.++|++++....++......++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            578999999999999876544 44443 3221111       12457889999999999999988888877778899999


Q ss_pred             eccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       683 y~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      |+++++|.+++.          .+..++.+++++|.+||   +.+++||||||+|||+ +++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999873          45789999999999999   6799999999999999 577899999999874

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=2.8e-13  Score=163.85  Aligned_cols=73  Identities=53%  Similarity=0.795  Sum_probs=69.3

Q ss_pred             CCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccc
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVAR  517 (919)
Q Consensus       445 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l  517 (919)
                      .++|+.|+|++|+|+|.+|+.+++|++|+.|||++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+..+
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~  513 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR  513 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence            3579999999999999999999999999999999999999999999999999999999999999999988653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=1.1e-13  Score=134.80  Aligned_cols=133  Identities=19%  Similarity=0.218  Sum_probs=113.8

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccC--cceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH--RNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H--~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      +.||+|.++.||++...+ ..+++|..+....  ...+..|+..++.++|  .++++++++....+..++++||++++.+
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            679999999999999855 7899999865433  4678999999999987  4899999988888889999999998777


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      ..+         +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543         5567788999999999999964446799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=8.2e-14  Score=142.78  Aligned_cols=137  Identities=18%  Similarity=0.248  Sum_probs=98.1

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--chhh----------------------hHHHHHHHhccCcc--e
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--PKQF----------------------RTEAQLLMRVHHRN--L  664 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--~~~f----------------------~~Ev~~L~~l~H~N--I  664 (919)
                      .+.||+|+||+||+|...+|+.||||+++......  ...+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            36799999999999998889999999987542211  1111                      34555666665443  3


Q ss_pred             eeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       665 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                      .+.+++    ...++||||++++.+.........  .. .+...++.+++.++.++|.  ..+++|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence            444443    245899999998654322111100  11 5678899999999999993  17899999999999999 88


Q ss_pred             cEEEeccCccccc
Q 002461          745 QAKLADFGFSKIF  757 (919)
Q Consensus       745 ~vkL~DFGla~~~  757 (919)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=9.3e-14  Score=150.00  Aligned_cols=197  Identities=18%  Similarity=0.231  Sum_probs=135.5

Q ss_pred             cCcceeeEEeEeec---------------------------CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHH
Q 002461          660 HHRNLASLVGYCND---------------------------GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD  712 (919)
Q Consensus       660 ~H~NIv~l~g~~~~---------------------------~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~  712 (919)
                      +|||||++.++|.+                           ....++||...+. +|.+++..+   ..+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999887632                           2357788887764 888888443   3556677788899


Q ss_pred             HHHHHHHHHhcCCCCeeeeccccceEEeC--CCC--cEEEeccCcccccCCCC----CCccccccccCccccCcccccCC
Q 002461          713 AAQGLEYLHHGCKPPIIHRDVKTANILLN--EKM--QAKLADFGFSKIFPAES----ESHISTSIVGTVGYLDPEYYASN  784 (919)
Q Consensus       713 ia~gL~yLH~~~~~~iiH~DLKp~NILld--~~~--~vkL~DFGla~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~  784 (919)
                      +++|+.|||   +++|.|||+|++|||+.  +|.  ...|+|||++---....    ...-.-...|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   78999999999999983  444  46789999875321100    00111234578889999997643


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhc
Q 002461          785 R------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMEC  858 (919)
Q Consensus       785 ~------~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~C  858 (919)
                      +      --.|+|.|+.|-+.||+++...||....+  ...+- + .+++.++.         ..+......+.+++...
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~-r-~Yqe~qLP---------alp~~vpp~~rqlV~~l  493 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT-R-TYQESQLP---------ALPSRVPPVARQLVFDL  493 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech-h-hhhhhhCC---------CCcccCChHHHHHHHHH
Confidence            2      23589999999999999999999975211  11110 0 02222221         12334445678899999


Q ss_pred             CCCCCCCCCCHHHHHHHH
Q 002461          859 VPSISFQRPTMSHVVTEL  876 (919)
Q Consensus       859 l~~~P~~RPsm~eVv~~L  876 (919)
                      ++.+|.+||+..=....|
T Consensus       494 L~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hcCCccccCCccHHHhHH
Confidence            999999999865554444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.48  E-value=9.9e-15  Score=164.04  Aligned_cols=174  Identities=25%  Similarity=0.376  Sum_probs=128.9

Q ss_pred             eEEEEEEeccCCChhhhhhcc-ccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcc
Q 002461          676 NVGLVYEYMAYGNLKQYLFDE-TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS  754 (919)
Q Consensus       676 ~~~LV~Ey~~~GsL~~~L~~~-~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla  754 (919)
                      ..++.|++|...+|.+||... .....+|...+.++.|++.|++|      ++.+|+|+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578899999999999999633 35668899999999999999999      37899999999999999999999999998


Q ss_pred             cccCCCC----CCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCcccCCCccchhcccccccccC
Q 002461          755 KIFPAES----ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERG  829 (919)
Q Consensus       755 ~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~~~~~l~~~v~~~~~~~  829 (919)
                      .......    .....+...||..||+||.+.+..|+.|+||||||++|+||+.- ..++..    .....    -++.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~----d~r~g  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLT----DIRDG  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhh----hhhcC
Confidence            8664332    12234567899999999999999999999999999999999982 222211    00000    01112


Q ss_pred             CcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 002461          830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHV  872 (919)
Q Consensus       830 ~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV  872 (919)
                      .    ++|....+++.     =..+.++.+...|.+||+..++
T Consensus       476 ~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  476 I----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             C----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence            2    22222222222     2457789999999999944443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.42  E-value=1.3e-12  Score=139.81  Aligned_cols=135  Identities=19%  Similarity=0.218  Sum_probs=104.7

Q ss_pred             cceec-eeCcEEEEEEEEcCCCEEEEEEeecCC-------------CCCchhhhHHHHHHHhccCcce--eeEEeEeecC
Q 002461          611 HRILG-KGGFGTVYHGYLADGSEVAIKMLSASS-------------SQGPKQFRTEAQLLMRVHHRNL--ASLVGYCNDG  674 (919)
Q Consensus       611 ~~~LG-~G~fG~Vyk~~l~~g~~VAVK~l~~~~-------------~~~~~~f~~Ev~~L~~l~H~NI--v~l~g~~~~~  674 (919)
                      ..+|| .||.|+||++... +..++||.+....             ......+.+|++++.+++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            36798 8999999999885 7789999875321             1123457889999999998885  6777765432


Q ss_pred             C----eEEEEEEeccC-CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEe
Q 002461          675 G----NVGLVYEYMAY-GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       675 ~----~~~LV~Ey~~~-GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~  749 (919)
                      .    ..++|+|++++ .+|.+++..   ..++.    ..+.+++.+|.+||   ..+|+|+||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE---APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc---CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 689888743   23443    23678999999999   6799999999999999998899999


Q ss_pred             ccCcccc
Q 002461          750 DFGFSKI  756 (919)
Q Consensus       750 DFGla~~  756 (919)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.34  E-value=3.5e-12  Score=147.95  Aligned_cols=139  Identities=21%  Similarity=0.226  Sum_probs=99.6

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC----------------------------------------chhhhH
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG----------------------------------------PKQFRT  651 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~~  651 (919)
                      +.||.|++|+||+|++.+|+.||||+.+......                                        +-+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999999999999999986432110                                        012455


Q ss_pred             HHHHHHhcc----CcceeeEEeEe-ecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHH-HHHHHHhcCC
Q 002461          652 EAQLLMRVH----HRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ-GLEYLHHGCK  725 (919)
Q Consensus       652 Ev~~L~~l~----H~NIv~l~g~~-~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~-gL~yLH~~~~  725 (919)
                      |.+.+.+++    |.+-+.+-..+ ...+..+|||||+++++|.+....... ..   .+.+++..++. .+..+|   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence            666666553    22223322222 234567999999999999987643211 12   35567777766 467788   5


Q ss_pred             CCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       726 ~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      .+++|+|+||.||+++++++++++|||++..+
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            69999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=2.5e-13  Score=162.45  Aligned_cols=253  Identities=20%  Similarity=0.239  Sum_probs=184.4

Q ss_pred             hhcceeceeCcEEEEEEEEcCC--CEEEEEEeecCC--CCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEe
Q 002461          609 NFHRILGKGGFGTVYHGYLADG--SEVAIKMLSASS--SQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g--~~VAVK~l~~~~--~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ++.+.||+|.|+.|-.......  ..+|+|.+....  .........|..+-..+. |+|++++++.....+..+++.+|
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            3446699999999987775433  346666665443  222334455777766776 99999999999999999999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC-cEEEeccCcccccCC-CC
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPA-ES  761 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkL~DFGla~~~~~-~~  761 (919)
                      ..++++.+.+........+....-.+..|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|..+.. .+
T Consensus       103 s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g  180 (601)
T KOG0590|consen  103 SDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG  180 (601)
T ss_pred             ccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence            999999988832222245667788899999999999994  34799999999999999999 999999999998765 44


Q ss_pred             CCcccccccc-CccccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCcccCCC-ccchhcccccccccCCcccccccc
Q 002461          762 ESHISTSIVG-TVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYN-NTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       762 ~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSfGvvL~ELltG~~p~~~~~~-~~~l~~~v~~~~~~~~~~~ivd~~  838 (919)
                      .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+..... ......|....   +..    ...
T Consensus       181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~----~~~  253 (601)
T KOG0590|consen  181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF----TQL  253 (601)
T ss_pred             cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc----ccC
Confidence            4555566778 9999999998874 456778999999999999999999865443 22223332211   000    000


Q ss_pred             cccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                          .-........++..+++..+|..|.+.+++..
T Consensus       254 ----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  254 ----PWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ----ccccCChhhhhcccccccCCchhccccccccc
Confidence                00111224556777888899999999888754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.32  E-value=7.9e-13  Score=158.09  Aligned_cols=208  Identities=23%  Similarity=0.333  Sum_probs=132.5

Q ss_pred             cceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCCh
Q 002461          611 HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL  689 (919)
                      .+.|..|++|.||...++. .+.+|.|+=+..            .+++     ||..+.+      ..+.|      |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~------------lilR-----nilt~a~------npfvv------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN------------LILR-----NILTFAG------NPFVV------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccc------------hhhh-----ccccccC------Cccee------chh
Confidence            4789999999999998764 456777442211            1111     1222111      11222      333


Q ss_pred             hhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCC---------
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE---------  760 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~---------  760 (919)
                      ...++..  +.++.        +++.+++|||   ..+|+|||+||+|.+|+.-|.+|+.|||+.+.-...         
T Consensus       139 ~tllk~~--g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  139 ATLLKNI--GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhhcccC--CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            3333221  22222        2278899999   779999999999999999999999999998743110         


Q ss_pred             ----CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccc
Q 002461          761 ----SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       761 ----~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd  836 (919)
                          .........+||+.|+|||++....|...+|.|++|+++||.+-|+.||+.... .++...+.   ...  .++. 
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~vi---sd~--i~wp-  278 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVI---SDD--IEWP-  278 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhh---hhh--cccc-
Confidence                011112346899999999999999999999999999999999999999974422 11111111   000  0000 


Q ss_pred             cccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHV  872 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eV  872 (919)
                           +.++....+..+++.+.++.+|.+|--....
T Consensus       279 -----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga  309 (1205)
T KOG0606|consen  279 -----EEDEALPPEAQDLIEQLLRQNPLCRLGTGGA  309 (1205)
T ss_pred             -----ccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence                 1122223456778888889999888644433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.27  E-value=1.2e-11  Score=158.35  Aligned_cols=122  Identities=27%  Similarity=0.518  Sum_probs=88.0

Q ss_pred             CCChhHHHHHHHHHHhCCC----CCCCC-CCCCCCCCCceeEEEcCCCCCCCCcEEEEEeecCCCccccCccccCCCCCC
Q 002461          399 PTDQDDVNAIMDIKLSYDL----GKGWQ-GDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLE  473 (919)
Q Consensus       399 ~t~~~d~~al~~~k~~~~~----~~~W~-gdpC~~~~~~W~gv~C~~~~~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~  473 (919)
                      -.+++|..||++||+++..    ..+|+ ++.||    .|+||+|+..    .+|+.|+|++|+++|.+|+.|..|++|+
T Consensus        25 ~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~----~~v~~L~L~~~~i~~~~~~~~~~l~~L~   96 (968)
T PLN00113         25 MLHAEELELLLSFKSSINDPLKYLSNWNSSADVC----LWQGITCNNS----SRVVSIDLSGKNISGKISSAIFRLPYIQ   96 (968)
T ss_pred             CCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC----cCcceecCCC----CcEEEEEecCCCccccCChHHhCCCCCC
Confidence            3577999999999999853    35795 45565    8999999752    4788888888888888888888888888


Q ss_pred             EEECcCCccccCCCccCC-CCCCceEEEcCCCCC----------------------CCCCccccccccccCccccccC
Q 002461          474 NLDLSNNSLTGSIPEFLS-QLPLLRVLNLDGNKL----------------------SGSVPTSLVARSQNGSLLLSIG  528 (919)
Q Consensus       474 ~L~Ls~N~l~g~iP~~l~-~l~~L~~L~Ls~N~l----------------------~g~iP~~l~~l~~l~~l~ls~~  528 (919)
                      .|+|++|+++|.+|..+. ++++|++|+|++|++                      +|.+|..++++++|+.|+++.+
T Consensus        97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n  174 (968)
T PLN00113         97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN  174 (968)
T ss_pred             EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccC
Confidence            888888888777776654 555555555555555                      4555666666777777666544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1e-11  Score=131.85  Aligned_cols=206  Identities=21%  Similarity=0.321  Sum_probs=140.9

Q ss_pred             HHHHHHhccCcceeeEEeEeecC-----CeEEEEEEeccCCChhhhhhccc--cccCChHhHHHHHHHHHHHHHHHHhcC
Q 002461          652 EAQLLMRVHHRNLASLVGYCNDG-----GNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGC  724 (919)
Q Consensus       652 Ev~~L~~l~H~NIv~l~g~~~~~-----~~~~LV~Ey~~~GsL~~~L~~~~--~~~ls~~~~l~Ia~~ia~gL~yLH~~~  724 (919)
                      -...|-++-|.|||++..|+.+.     .+..++.|||..|+|.++|++..  ...+......+++.||..||.|||.. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            34456667899999999988543     45789999999999999997654  34577777889999999999999964 


Q ss_pred             CCCeeeeccccceEEeCCCCcEEEeccCcccccC--CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHH
Q 002461          725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP--AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL  802 (919)
Q Consensus       725 ~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~--~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~EL  802 (919)
                      .++|+|+++..+-|++..++-+|+.----.....  ............+-++|.+||+=...+.+..+|||+||...+||
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            8999999999999999999888874211110000  00011111223467899999998777888899999999999999


Q ss_pred             HhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 002461          803 ITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE  875 (919)
Q Consensus       803 ltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~  875 (919)
                      .-+.---..+.......+.+...     +...-++.-            ...+..|++..|..||+|.+++..
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~-----i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANV-----IIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhh-----eeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence            88754222111111111111000     000011111            236678999999999999998753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.13  E-value=2.4e-10  Score=114.87  Aligned_cols=129  Identities=16%  Similarity=0.092  Sum_probs=95.9

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCccee-eEEeEeecCCeEEEEEEeccCCChh
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA-SLVGYCNDGGNVGLVYEYMAYGNLK  690 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv-~l~g~~~~~~~~~LV~Ey~~~GsL~  690 (919)
                      +.|+.|.++.||++... ++.+++|+...... ....+..|++.++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56889999999999875 77899998754322 234568899999999766654 444443  23458999999998776


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcC--CCCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC--KPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~--~~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      +..          .....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            430          112345678999999999532  12369999999999999 5689999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.07  E-value=1.4e-09  Score=126.20  Aligned_cols=232  Identities=18%  Similarity=0.188  Sum_probs=154.6

Q ss_pred             EcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhH
Q 002461          627 LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR  706 (919)
Q Consensus       627 l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~  706 (919)
                      ..++.+|.|+..+...........+-++.|+.+|||||++++.....++..+||+|.+.  .|..++...     .-...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence            45788999999887666444557778899999999999999999999999999999874  566666432     24455


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccccCccccCcccccCCCC
Q 002461          707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL  786 (919)
Q Consensus       707 l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~  786 (919)
                      .-.+.||+.||.|||+.  .+++|++|.-..|++++.|+.||++|.++.....-..  ......--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            56789999999999974  4899999999999999999999999998764422111  111112223456666544322 


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCCCccchhc-ccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCC
Q 002461          787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN-RVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQ  865 (919)
Q Consensus       787 s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~-~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~  865 (919)
                       -..|.|-||++++|++.|..+-........... ...         +..-+++.. -..... ...+.+..|....+--
T Consensus       182 -~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~---------~~~~k~~~~-~~~~r~-n~~~~~~~~~~~~gff  249 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALI---------ELYCKKLGA-TELKRP-NKLRFILECRLLGGFF  249 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHH---------HHHHHHhcc-cccccc-chhhHHHHHHhccccc
Confidence             346999999999999999322110000000000 000         000000000 000001 1566777888888888


Q ss_pred             CCCHHHHHHHHHHHHhh
Q 002461          866 RPTMSHVVTELKKCLEM  882 (919)
Q Consensus       866 RPsm~eVv~~Le~~~~~  882 (919)
                      |=..-+++..|+++.-.
T Consensus       250 ~n~fvd~~~fLeel~lk  266 (690)
T KOG1243|consen  250 RNDFVDTLLFLEELRLK  266 (690)
T ss_pred             cchHHHHHHHHHhcccC
Confidence            88888888888887643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=2.6e-10  Score=131.14  Aligned_cols=253  Identities=22%  Similarity=0.203  Sum_probs=178.9

Q ss_pred             HHHHHHhhhcceece--eCcEEEEEEEE---cCCCEEEEEEeecCCC--CCchhhhHHHHHHHhc-cCcceeeEEeEeec
Q 002461          602 EIVDITNNFHRILGK--GGFGTVYHGYL---ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRV-HHRNLASLVGYCND  673 (919)
Q Consensus       602 ei~~~t~~~~~~LG~--G~fG~Vyk~~l---~~g~~VAVK~l~~~~~--~~~~~f~~Ev~~L~~l-~H~NIv~l~g~~~~  673 (919)
                      +..+.+..+.+.+|.  |.+|.||++..   .++..+|+|+-+....  .....=.+|+....++ .|+|.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            444445566788999  99999999987   3677899998543322  3333445566666666 49999998888888


Q ss_pred             CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHH----HHHHHHhcCCCCeeeeccccceEEeCCC-CcEEE
Q 002461          674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ----GLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKL  748 (919)
Q Consensus       674 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~----gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL  748 (919)
                      ++..++-+|++. .+|.++.+... ..+.......+..+..+    ||.++|   ...++|-|+||.||++..+ ...++
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             CCcceeeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence            899999999886 67777764322 22555666777777777    999999   6789999999999999999 88999


Q ss_pred             eccCcccccCCCCCCc---cccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccc
Q 002461          749 ADFGFSKIFPAESESH---ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF  825 (919)
Q Consensus       749 ~DFGla~~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~  825 (919)
                      .|||+...+.......   ......|...|++||...+ .++...|+|++|.+.++-.++......+.+..    |.  .
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----W~--~  337 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS----WS--Q  337 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC----cc--c
Confidence            9999998775443221   2233468889999998764 57889999999999999999876554332211    10  0


Q ss_pred             cccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 002461          826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       826 ~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+.+.        +..++.......+...+..+++.+|-.|++.+.+..
T Consensus       338 ~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11110        111222222234555888899999999998887765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.04  E-value=4.3e-10  Score=132.34  Aligned_cols=141  Identities=16%  Similarity=0.132  Sum_probs=92.0

Q ss_pred             ceeceeCcEEEEEEEEcC-CCEEEEEEeecCCCC--------------------------C--------------chhhh
Q 002461          612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQ--------------------------G--------------PKQFR  650 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-g~~VAVK~l~~~~~~--------------------------~--------------~~~f~  650 (919)
                      +.||.|++|+||+|++.+ |++||||+++.....                          .              +-+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            479999999999999987 999999999743110                          0              01245


Q ss_pred             HHHHHHHhcc----CcceeeEEeEee-cCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHH-HHHHHhcC
Q 002461          651 TEAQLLMRVH----HRNLASLVGYCN-DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG-LEYLHHGC  724 (919)
Q Consensus       651 ~Ev~~L~~l~----H~NIv~l~g~~~-~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~g-L~yLH~~~  724 (919)
                      .|+..+.+++    +.+.+.+-..+. -....+|||||++|+.+.+.-.-. ....+   +..++...++. +..++   
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d---~~~la~~~v~~~~~Qif---  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTD---MKLLAERGVEVFFTQVF---  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCC---HHHHHHHHHHHHHHHHH---
Confidence            5555555553    333333333332 245678999999999998742111 11121   22233222221 22223   


Q ss_pred             CCCeeeeccccceEEeCCCC----cEEEeccCcccccCC
Q 002461          725 KPPIIHRDVKTANILLNEKM----QAKLADFGFSKIFPA  759 (919)
Q Consensus       725 ~~~iiH~DLKp~NILld~~~----~vkL~DFGla~~~~~  759 (919)
                      ..+++|+|+||.||+++.++    +++++|||++..+..
T Consensus       278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            45899999999999999888    999999999987643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.01  E-value=3.2e-09  Score=111.32  Aligned_cols=141  Identities=20%  Similarity=0.288  Sum_probs=110.9

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCC-CCchhhhHHHHHHHhccCc--ceeeEEeEeecC---CeEEEEEEecc
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHR--NLASLVGYCNDG---GNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~H~--NIv~l~g~~~~~---~~~~LV~Ey~~  685 (919)
                      +.|+.|..+.||++...+|+.+++|+...... .....+..|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999999764332 2356788999999999764  456777777654   35689999999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG------------------------------------------  723 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~------------------------------------------  723 (919)
                      +.++.+.+..   ..++..++..++.+++++|..||+.                                          
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876521   3467778888888999999988842                                          


Q ss_pred             -----------CCCCeeeeccccceEEeCC--CCcEEEeccCccc
Q 002461          724 -----------CKPPIIHRDVKTANILLNE--KMQAKLADFGFSK  755 (919)
Q Consensus       724 -----------~~~~iiH~DLKp~NILld~--~~~vkL~DFGla~  755 (919)
                                 ....++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                       0245799999999999998  6678999999776

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.92  E-value=1.3e-08  Score=104.87  Aligned_cols=136  Identities=18%  Similarity=0.175  Sum_probs=97.1

Q ss_pred             ceeceeCcEEEEEEEEcC-------CCEEEEEEeecCCC----------CC------------chhhh----HHHHHHHh
Q 002461          612 RILGKGGFGTVYHGYLAD-------GSEVAIKMLSASSS----------QG------------PKQFR----TEAQLLMR  658 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~-------g~~VAVK~l~~~~~----------~~------------~~~f~----~Ev~~L~~  658 (919)
                      .+||.|.-+.||.|.-.+       +..+|||+.+....          +.            .+.+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       47899998753210          00            11233    79999999


Q ss_pred             ccC--cceeeEEeEeecCCeEEEEEEeccCCChhh-hhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeecccc
Q 002461          659 VHH--RNLASLVGYCNDGGNVGLVYEYMAYGNLKQ-YLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKT  735 (919)
Q Consensus       659 l~H--~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~-~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp  735 (919)
                      +..  -++..++++    ...+|||||+.+..+.. .+.+   ..++..+...+..+++.+|..|+|  +.+++|+||++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCCCH
Confidence            864  356666654    45689999998654422 2211   124445667788999999999932  56999999999


Q ss_pred             ceEEeCCCCcEEEeccCccccc
Q 002461          736 ANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       736 ~NILld~~~~vkL~DFGla~~~  757 (919)
                      .|||+++ +.+.|+|||.+...
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 67999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=7.8e-08  Score=96.28  Aligned_cols=131  Identities=24%  Similarity=0.331  Sum_probs=100.4

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC--------chhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG--------PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+++|+-+.+|.+.+. |..+++|.-....-..        ...-.+|+.++.+++--.|.-.+=|..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 3446666543221111        12456799999999877766666667778888999999


Q ss_pred             ccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      +++-.|.+.+...         +..++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432         3567778888889999   67999999999999999875 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.74  E-value=7.4e-08  Score=95.91  Aligned_cols=141  Identities=23%  Similarity=0.313  Sum_probs=104.9

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEE-eecCCCC-------CchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEe
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKM-LSASSSQ-------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~-l~~~~~~-------~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey  683 (919)
                      ..+-+|+-+.|+++... |+...||. +.+.-..       ..++..+|++.|.+++--.|.-..-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            67889999999999985 66666664 3322111       124567899999999866666555566666677899999


Q ss_pred             ccC-CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC---cEEEeccCcccc
Q 002461          684 MAY-GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---QAKLADFGFSKI  756 (919)
Q Consensus       684 ~~~-GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~---~vkL~DFGla~~  756 (919)
                      +++ .++.+++...............++..|-+.+.-||   ...++|+||..+||+|..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 47888886554443444444788899999999999   66899999999999997554   468999999763

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.70  E-value=3.7e-07  Score=103.19  Aligned_cols=168  Identities=18%  Similarity=0.253  Sum_probs=129.7

Q ss_pred             CcEEEEEEEEc-CCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcceeeEEeEee----cCCeEEEEEEeccC-CChhh
Q 002461          618 GFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN----DGGNVGLVYEYMAY-GNLKQ  691 (919)
Q Consensus       618 ~fG~Vyk~~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~----~~~~~~LV~Ey~~~-GsL~~  691 (919)
                      ...+.||+... +|..+++|+++....+.......-++.++++.|.|+|++...+.    .+..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34577899864 89999999996655555545566789999999999999998876    34578999999885 67777


Q ss_pred             hhhccc-------------cccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccC
Q 002461          692 YLFDET-------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       692 ~L~~~~-------------~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~  758 (919)
                      .-+...             +...++...+.++.|+..||.++|   +.|+.-+-|.+++||++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            654322             234567889999999999999999   5588889999999999999999999988876653


Q ss_pred             CCCCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP  807 (919)
Q Consensus       759 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~  807 (919)
                      .+..                |-+.   --++-|.=.||.+++.|.||..
T Consensus       445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            2220                1111   1246799999999999999954

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.68  E-value=1.1e-08  Score=117.93  Aligned_cols=239  Identities=19%  Similarity=0.188  Sum_probs=167.1

Q ss_pred             cceeceeCcEEEEEEEEc--CCCEEEEEEeecCCCCCchh--hhHHHHHHHhc-cCcceeeEEeEeecCCeEEEEEEecc
Q 002461          611 HRILGKGGFGTVYHGYLA--DGSEVAIKMLSASSSQGPKQ--FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~--~g~~VAVK~l~~~~~~~~~~--f~~Ev~~L~~l-~H~NIv~l~g~~~~~~~~~LV~Ey~~  685 (919)
                      ...||.|.|+.|++...+  ++..+++|.+.........+  -..|+-+...+ .|.+++.....+..-.+.++--||++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            467999999999988744  67789999887553332222  23455555555 58888887777766667778899999


Q ss_pred             CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC-CcEEEeccCcccccCCCCCCc
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkL~DFGla~~~~~~~~~~  764 (919)
                      ++++...+  .....++...++++..|++.++.++|   ++.++|+|+||+||++..+ +.-++.|||++..+.-.    
T Consensus       350 ~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----  420 (524)
T KOG0601|consen  350 GGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----  420 (524)
T ss_pred             Ccchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccccee----
Confidence            99887766  44566888889999999999999999   7899999999999999876 78899999998643111    


Q ss_pred             cccccccCcccc--CcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccC
Q 002461          765 ISTSIVGTVGYL--DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       765 ~~~~~~Gt~~Y~--APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~  842 (919)
                       .......-++.  +++......+..+.|++|||.-+.|.++|..--..+      ++|..  +..+...     .+   
T Consensus       421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------~~~~~--i~~~~~p-----~~---  483 (524)
T KOG0601|consen  421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------VQSLT--IRSGDTP-----NL---  483 (524)
T ss_pred             -cccccccccccccchhhccccccccccccccccccccccccCcccCccc------cccee--eeccccc-----CC---
Confidence             01112223333  566666677889999999999999999986432111      11110  1111111     11   


Q ss_pred             CChhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK  877 (919)
Q Consensus       843 ~~~~~~~~l~~l~~~Cl~~~P~~RPsm~eVv~~Le  877 (919)
                       +... ..+..++......++..||.+.+.....+
T Consensus       484 -~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  484 -PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -CchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence             1111 45667788888999999999888776544

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.66  E-value=3e-09  Score=103.76  Aligned_cols=83  Identities=34%  Similarity=0.498  Sum_probs=78.7

Q ss_pred             CCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCccc
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       445 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~  524 (919)
                      ...++.|.||+|.|+ .+|+.|++|.+|+.|+|+||+++ .+|.+++.|++|+.|+++-|+|. .+|..++.++.|+.|+
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            457899999999999 99999999999999999999999 89999999999999999999998 8999999999999999


Q ss_pred             cccCCC
Q 002461          525 LSIGRN  530 (919)
Q Consensus       525 ls~~~N  530 (919)
                      |.|++-
T Consensus       109 ltynnl  114 (264)
T KOG0617|consen  109 LTYNNL  114 (264)
T ss_pred             cccccc
Confidence            999853

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.63  E-value=2.5e-08  Score=83.00  Aligned_cols=61  Identities=49%  Similarity=0.662  Sum_probs=55.2

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCC
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL  506 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l  506 (919)
                      |+|+.|+|++|+|+..-+..|.++++|+.|+|++|+|+..-|..|.+|++|++|+|++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999955557899999999999999999977778899999999999999986

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.58  E-value=6.8e-07  Score=97.09  Aligned_cols=141  Identities=16%  Similarity=0.118  Sum_probs=101.0

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCC-----------CCchhhhHHHHHHHhccCcce--eeEEeEeec-----
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSS-----------QGPKQFRTEAQLLMRVHHRNL--ASLVGYCND-----  673 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~-----------~~~~~f~~Ev~~L~~l~H~NI--v~l~g~~~~-----  673 (919)
                      +.+-.-....|.+..+ +|+.+.||.......           .....+.+|...+.++...+|  +.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777766 577899997643221           111247789999999865544  345556543     


Q ss_pred             CCeEEEEEEeccCC-ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC-------CCc
Q 002461          674 GGNVGLVYEYMAYG-NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-------KMQ  745 (919)
Q Consensus       674 ~~~~~LV~Ey~~~G-sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~-------~~~  745 (919)
                      ...-+||+|++++- +|.+++........+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999975 7888874322334556677899999999999999   679999999999999975       468


Q ss_pred             EEEeccCcccc
Q 002461          746 AKLADFGFSKI  756 (919)
Q Consensus       746 vkL~DFGla~~  756 (919)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=5.6e-07  Score=92.43  Aligned_cols=126  Identities=25%  Similarity=0.325  Sum_probs=82.7

Q ss_pred             EEEEEEEcCCCEEEEEEeecCCCC---------------------C-----chhhhHHHHHHHhccCc--ceeeEEeEee
Q 002461          621 TVYHGYLADGSEVAIKMLSASSSQ---------------------G-----PKQFRTEAQLLMRVHHR--NLASLVGYCN  672 (919)
Q Consensus       621 ~Vyk~~l~~g~~VAVK~l~~~~~~---------------------~-----~~~f~~Ev~~L~~l~H~--NIv~l~g~~~  672 (919)
                      .||.|...+|..+|||+.+.....                     .     .....+|.+.|.++...  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999999999999987532100                     0     01246799999999766  455666542 


Q ss_pred             cCCeEEEEEEecc--CCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEec
Q 002461          673 DGGNVGLVYEYMA--YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD  750 (919)
Q Consensus       673 ~~~~~~LV~Ey~~--~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~D  750 (919)
                         ..+|||||++  +..+..+. ..   .++......++.+++..+..+++  ..+++|+||.+.|||++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEEe
Confidence               3479999998  54554432 21   12245667788888886666533  5699999999999999988 899999


Q ss_pred             cCccccc
Q 002461          751 FGFSKIF  757 (919)
Q Consensus       751 FGla~~~  757 (919)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=3.6e-07  Score=107.18  Aligned_cols=141  Identities=19%  Similarity=0.220  Sum_probs=94.7

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC--------------------------Cc--------------hhhhH
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ--------------------------GP--------------KQFRT  651 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~--------------------------~~--------------~~f~~  651 (919)
                      +.|+.++-|+||+|++.+|+.||||+.+..-..                          ..              -++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            579999999999999999999999997532110                          00              02445


Q ss_pred             HHHHHHhcc-----CcceeeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHH-HHHHHhcCC
Q 002461          652 EAQLLMRVH-----HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG-LEYLHHGCK  725 (919)
Q Consensus       652 Ev~~L~~l~-----H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~g-L~yLH~~~~  725 (919)
                      |...+.+++     .+++.-.-=|..-.+...|+|||++|-.+.+...-.. ..++   +..++..++++ +..+-   .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~---~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL---R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---h
Confidence            555555552     2333222222333567899999999999988753222 3344   33444444433 22222   3


Q ss_pred             CCeeeeccccceEEeCCCCcEEEeccCcccccCC
Q 002461          726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       726 ~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~  759 (919)
                      .+++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            4899999999999999999999999999887643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.43  E-value=1.1e-06  Score=93.16  Aligned_cols=133  Identities=19%  Similarity=0.226  Sum_probs=95.9

Q ss_pred             hhcceeceeCcEEEEEEEEcCCCEEEEEEeecCCCC----------------------CchhhhHHHHHHHhccCc--ce
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ----------------------GPKQFRTEAQLLMRVHHR--NL  664 (919)
Q Consensus       609 ~~~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ev~~L~~l~H~--NI  664 (919)
                      .+.+.||-|.-+.||.|..++|.++|||.-+.....                      .....++|.++|+++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            456889999999999999999999999975321100                      012346789999998755  66


Q ss_pred             eeEEeEeecCCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCC
Q 002461          665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM  744 (919)
Q Consensus       665 v~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~  744 (919)
                      .+.+++    +..++|||++++-.|...-       ++....-.++..|++-+.-+-   ..+++|+|+.+-||+++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            666654    4568999999986665432       123334445555555555554   35899999999999999999


Q ss_pred             cEEEeccCccc
Q 002461          745 QAKLADFGFSK  755 (919)
Q Consensus       745 ~vkL~DFGla~  755 (919)
                      .+.++||--+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999996554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.41  E-value=1.4e-07  Score=114.15  Aligned_cols=242  Identities=20%  Similarity=0.258  Sum_probs=154.4

Q ss_pred             ceeceeCcEEEEEEEEc-CCCEEEEEEeecC---CCCCchhhhHHHHHHHhccCcceeeEEeEeecCCeEEEEEEeccCC
Q 002461          612 RILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG  687 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~~L~~l~H~NIv~l~g~~~~~~~~~LV~Ey~~~G  687 (919)
                      +-+-+|.++.++.+.-. .|...++|+....   .....+..+.+-.++-..+||-++...--+.......|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            35667888888766532 2322333333221   1122233333444444445666665554455667889999999999


Q ss_pred             ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCC------C-
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA------E-  760 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~------~-  760 (919)
                      +|...|+...  ..+..........+.++++|||   ...+.|+|++|.|+|...++..++.|||.......      . 
T Consensus       890 ~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s  964 (1205)
T KOG0606|consen  890 DLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS  964 (1205)
T ss_pred             CchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence            9999886543  3444445555666788999999   45689999999999999999999999984432110      0 


Q ss_pred             ----------------------CCCccccccccCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCcccCCCccch
Q 002461          761 ----------------------SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHI  818 (919)
Q Consensus       761 ----------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l  818 (919)
                                            ..........||+.|.+||...+......+|.|++|++++|.++|.+||......+ .
T Consensus       965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-~ 1043 (1205)
T KOG0606|consen  965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-I 1043 (1205)
T ss_pred             cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh-h
Confidence                                  00011234568999999999999999999999999999999999999986543222 1


Q ss_pred             hcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCCCCCCCHH
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMS  870 (919)
Q Consensus       819 ~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPsm~  870 (919)
                      .+.    +..+.+. +.      ..+.+.......++..-+..+|.+|-.|.
T Consensus      1044 f~n----i~~~~~~-~p------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 FEN----ILNRDIP-WP------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhc----cccCCCC-CC------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            111    1111110 00      11122223445566667777777777665

>PRK09902 hypothetical protein; Provisional

Probab=98.20  E-value=2e-05  Score=81.75  Aligned_cols=137  Identities=15%  Similarity=0.137  Sum_probs=102.8

Q ss_pred             eceeCcEEEEEEEEcCCCEEEEEEeecCC------CCCchhhhHHHHHHHhccCcc--eeeEEeEee-c----CCeEEEE
Q 002461          614 LGKGGFGTVYHGYLADGSEVAIKMLSASS------SQGPKQFRTEAQLLMRVHHRN--LASLVGYCN-D----GGNVGLV  680 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~------~~~~~~f~~Ev~~L~~l~H~N--Iv~l~g~~~-~----~~~~~LV  680 (919)
                      -|+||.+.|++-.++ |+.+-+|.-....      +.....|.+|...|.++...+  +.+.+ ++. .    .-.-.||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            367899999998775 4468888754211      234567999999999996443  44444 332 1    2246799


Q ss_pred             EEeccC-CChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCc--EEEeccCccc
Q 002461          681 YEYMAY-GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ--AKLADFGFSK  755 (919)
Q Consensus       681 ~Ey~~~-GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~--vkL~DFGla~  755 (919)
                      +|-+++ -+|.+++......+.+..++..+..++++.++-||   ..++.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997763 58888885544455677888999999999999999   679999999999999986666  9999998665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.18  E-value=1.1e-05  Score=84.37  Aligned_cols=107  Identities=21%  Similarity=0.207  Sum_probs=83.5

Q ss_pred             chhhhHHHHHHHhccCcc--eeeEEeEeecC----CeEEEEEEeccC-CChhhhhhccccccCChHhHHHHHHHHHHHHH
Q 002461          646 PKQFRTEAQLLMRVHHRN--LASLVGYCNDG----GNVGLVYEYMAY-GNLKQYLFDETKEALSWKDRLQIAVDAAQGLE  718 (919)
Q Consensus       646 ~~~f~~Ev~~L~~l~H~N--Iv~l~g~~~~~----~~~~LV~Ey~~~-GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~  718 (919)
                      .....+|...+..++...  ..+.+++....    ...+||+|++++ -+|.+++.....  .+...+..++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            345778888888886444  45666666542    245899999987 478888854222  566678899999999999


Q ss_pred             HHHhcCCCCeeeeccccceEEeCCCC---cEEEeccCccccc
Q 002461          719 YLHHGCKPPIIHRDVKTANILLNEKM---QAKLADFGFSKIF  757 (919)
Q Consensus       719 yLH~~~~~~iiH~DLKp~NILld~~~---~vkL~DFGla~~~  757 (919)
                      -||   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   67999999999999999886   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.1e-05  Score=94.50  Aligned_cols=157  Identities=20%  Similarity=0.245  Sum_probs=102.8

Q ss_pred             CCcccCHHHHHHHHh------------hh-cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCC---------------
Q 002461          594 DNQQFTYSEIVDITN------------NF-HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQG---------------  645 (919)
Q Consensus       594 ~~~~~~~~ei~~~t~------------~~-~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~---------------  645 (919)
                      ..++++++|+.+.-.            .| .+.||.-+.|+||+|++++|+.||||+-+..-...               
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l  215 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVL  215 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHH
Confidence            446677776654433            23 26799999999999999999999999865321110               


Q ss_pred             ----------------------chhhhHHHHHHHhc----cCcc------eeeEEeEeecCCeEEEEEEeccCCChhhhh
Q 002461          646 ----------------------PKQFRTEAQLLMRV----HHRN------LASLVGYCNDGGNVGLVYEYMAYGNLKQYL  693 (919)
Q Consensus       646 ----------------------~~~f~~Ev~~L~~l----~H~N------Iv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L  693 (919)
                                            +-+|..|.+-..++    +|-+      |.+++.  .-.....|+||||+|..+.+.-
T Consensus       216 ~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~  293 (538)
T KOG1235|consen  216 QKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLD  293 (538)
T ss_pred             HHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHH
Confidence                                  11355565544444    3555      223322  2345789999999999888764


Q ss_pred             hccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCC----CCcEEEeccCcccccC
Q 002461          694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE----KMQAKLADFGFSKIFP  758 (919)
Q Consensus       694 ~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~----~~~vkL~DFGla~~~~  758 (919)
                      .- ....++......-+.++..-+-+     ..|++|+|-+|.||++..    ++++.+.|||+...+.
T Consensus       294 ~i-~~~gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  294 AI-DKRGISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HH-HHcCCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22 23446655444444433322333     348999999999999984    6789999999987653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.12  E-value=1e-06  Score=103.19  Aligned_cols=152  Identities=22%  Similarity=0.357  Sum_probs=102.5

Q ss_pred             HHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCC-------ccccccccCccccCcccccC
Q 002461          711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-------HISTSIVGTVGYLDPEYYAS  783 (919)
Q Consensus       711 ~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~  783 (919)
                      .+++.||.|+|.  ..++||++|.|++|.++..+..||+.|+.+....+....       ...........|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999996  568999999999999999999999999987654332111       11111224567999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccCCCccchhcccccccccCCcccccccccccCCChhHHHHHHHHHHhcCCCCC
Q 002461          784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSIS  863 (919)
Q Consensus       784 ~~~s~ksDVwSfGvvL~ELltG~~p~~~~~~~~~l~~~v~~~~~~~~~~~ivd~~l~~~~~~~~~~~l~~l~~~Cl~~~P  863 (919)
                      ...+.++|+||+||+++-+..|..+..................         +-. ...+..+...++.+=+.+.+..++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------~~~-~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------NAG-AFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------ccc-cccccccCcHHHHHHHHHHhcCCc
Confidence            8889999999999999999955554433332211111111110         000 011223445567777788999999


Q ss_pred             CCCCCHHHHHH
Q 002461          864 FQRPTMSHVVT  874 (919)
Q Consensus       864 ~~RPsm~eVv~  874 (919)
                      .-||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998777654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.08  E-value=1.8e-06  Score=71.71  Aligned_cols=59  Identities=39%  Similarity=0.466  Sum_probs=51.4

Q ss_pred             CCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCccccccC
Q 002461          470 KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIG  528 (919)
Q Consensus       470 ~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~ls~~  528 (919)
                      ++|+.|+|++|+|+..-+..|..+++|++|+|++|+|+...|..|..+++|+.|+++.+
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            57899999999999544468899999999999999999777789999999998887654

...

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.03  E-value=5.5e-05  Score=80.35  Aligned_cols=138  Identities=17%  Similarity=0.296  Sum_probs=85.2

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcce--eeEEeEeecCCeEEEEEEeccCCC-
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL--ASLVGYCNDGGNVGLVYEYMAYGN-  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NI--v~l~g~~~~~~~~~LV~Ey~~~Gs-  688 (919)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.+  .+.++++...+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            56899999999984   25567788875422  33456889999999875444  677888777777889999999863 


Q ss_pred             hhhhh---------------------hccccccCChHhHHH-HHH----------HHHH-HHHHHHh-cCCCCeeeeccc
Q 002461          689 LKQYL---------------------FDETKEALSWKDRLQ-IAV----------DAAQ-GLEYLHH-GCKPPIIHRDVK  734 (919)
Q Consensus       689 L~~~L---------------------~~~~~~~ls~~~~l~-Ia~----------~ia~-gL~yLH~-~~~~~iiH~DLK  734 (919)
                      +...+                     |.-.........+.. +..          .+.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            22111                     110000111111000 000          0011 1122221 113457899999


Q ss_pred             cceEEeCCCCcEEEeccCccc
Q 002461          735 TANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       735 p~NILld~~~~vkL~DFGla~  755 (919)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.02  E-value=2e-06  Score=94.27  Aligned_cols=84  Identities=29%  Similarity=0.387  Sum_probs=71.5

Q ss_pred             CCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccc----------------------cCCCcc-CCCCCCceEEEc
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT----------------------GSIPEF-LSQLPLLRVLNL  501 (919)
Q Consensus       445 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~----------------------g~iP~~-l~~l~~L~~L~L  501 (919)
                      .++++.|+|++|-|. .+|.+++.+..|++||||+|+|.                      |.+|.+ +.+|.+|+.|||
T Consensus       434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL  512 (565)
T KOG0472|consen  434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL  512 (565)
T ss_pred             hhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence            358899999999888 99999999999999999999886                      344444 888999999999


Q ss_pred             CCCCCCCCCccccccccccCccccccCCCCC
Q 002461          502 DGNKLSGSVPTSLVARSQNGSLLLSIGRNPD  532 (919)
Q Consensus       502 s~N~l~g~iP~~l~~l~~l~~l~ls~~~N~~  532 (919)
                      .+|.|. .||+.++++.+++.|.++  |||.
T Consensus       513 ~nNdlq-~IPp~LgnmtnL~hLeL~--gNpf  540 (565)
T KOG0472|consen  513 QNNDLQ-QIPPILGNMTNLRHLELD--GNPF  540 (565)
T ss_pred             CCCchh-hCChhhccccceeEEEec--CCcc
Confidence            999998 899999999999977654  6653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.00  E-value=5.9e-05  Score=83.76  Aligned_cols=255  Identities=17%  Similarity=0.205  Sum_probs=147.8

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhc-cCcceeeEEeE------eecC-CeEEEEEE
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGY------CNDG-GNVGLVYE  682 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l-~H~NIv~l~g~------~~~~-~~~~LV~E  682 (919)
                      .+.||+|+-+.+|-.-  .-...+.|+..........+   .+..|.+. .||-+-.-+.+      -.++ ....+.|.
T Consensus        16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            5679999999998432  11223456655443322222   23333333 45533221111      1112 22566776


Q ss_pred             eccCC-Chhhhhhc----cccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCccccc
Q 002461          683 YMAYG-NLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF  757 (919)
Q Consensus       683 y~~~G-sL~~~L~~----~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~  757 (919)
                      .+++. ....+...    .......|.-.++.+..+|.+.+-||   ..+.+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence            66543 22222211    12345789999999999999999999   568888999999999999999999875433322


Q ss_pred             CCCCCCccccccccCccccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCcccCC---Cccchhc-ccccccc
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITG-LPAIIRGY---NNTHIVN-RVCPFLE  827 (919)
Q Consensus       758 ~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSfGvvL~ELltG-~~p~~~~~---~~~~l~~-~v~~~~~  827 (919)
                         .........+|...|.+||...     +..-+...|.|.+||++++++.| +.||..-.   +.....+ .+.    
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia----  240 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA----  240 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh----
Confidence               1122233457889999999764     34556789999999999999877 78875211   1111111 110    


Q ss_pred             cCCcccccccc--ccc---CCChh-HHHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHHH
Q 002461          828 RGDVRSIVDPR--LEA---NFDTN-SVWKVAETAMECVPSI--SFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       828 ~~~~~~ivd~~--l~~---~~~~~-~~~~l~~l~~~Cl~~~--P~~RPsm~eVv~~Le~~~  880 (919)
                      .|.....-|.+  +..   ..+-+ -...+..+-.+|+...  +.-||+++..+..|.++.
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            01100000000  000   00111 1123556667787643  568999999998887654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.96  E-value=2.1e-06  Score=94.11  Aligned_cols=88  Identities=26%  Similarity=0.428  Sum_probs=73.6

Q ss_pred             EEcCCCC------CCCCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEc-CCCCCCC
Q 002461          436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL-DGNKLSG  508 (919)
Q Consensus       436 v~C~~~~------~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~L-s~N~l~g  508 (919)
                      |+|+..|      ..|+..+.|+|..|+|+-.-|.+|+.|.+|+.||||+|+|+-.-|+.|.+|++|..|-| ++|+|+ 
T Consensus        51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-  129 (498)
T KOG4237|consen   51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-  129 (498)
T ss_pred             EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence            8898764      57899999999999999555568999999999999999999888999999999887765 559999 


Q ss_pred             CCc-cccccccccCccc
Q 002461          509 SVP-TSLVARSQNGSLL  524 (919)
Q Consensus       509 ~iP-~~l~~l~~l~~l~  524 (919)
                      .+| ..|.+|..++.|.
T Consensus       130 ~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             hhhhhHhhhHHHHHHHh
Confidence            666 4567777766544

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.96  E-value=5.4e-06  Score=64.09  Aligned_cols=37  Identities=57%  Similarity=0.792  Sum_probs=28.0

Q ss_pred             CCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCC
Q 002461          470 KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS  507 (919)
Q Consensus       470 ~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~  507 (919)
                      ++|++|+|++|+|+ .||..|++|++|+.|+|++|+|+
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            46788888888888 67777888888888888888877

...

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=97.94  E-value=1.3e-06  Score=85.59  Aligned_cols=78  Identities=28%  Similarity=0.440  Sum_probs=63.3

Q ss_pred             cEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCC-CCccccccccccCcccc
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG-SVPTSLVARSQNGSLLL  525 (919)
Q Consensus       447 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g-~iP~~l~~l~~l~~l~l  525 (919)
                      .++.|+|++|+|. .+|.+++.|++|+.|+++-|+|. .+|..|+.++.|+.|||.+|+|+- .+|..+.-+..|+.|.|
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl  134 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL  134 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence            4677888888888 88888888888888888888888 788888888888888888888864 46888877777666554


Q ss_pred             c
Q 002461          526 S  526 (919)
Q Consensus       526 s  526 (919)
                      +
T Consensus       135 ~  135 (264)
T KOG0617|consen  135 G  135 (264)
T ss_pred             c
Confidence            3

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.86  E-value=0.0001  Score=77.54  Aligned_cols=141  Identities=20%  Similarity=0.233  Sum_probs=84.5

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcc--eeeEEeEee---cCCeEEEEEEeccC
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN--LASLVGYCN---DGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~N--Iv~l~g~~~---~~~~~~LV~Ey~~~  686 (919)
                      +.|+.|..+.||+....+ ..+++|.....  ........|..+++.+....  +.+++.++.   .....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            568999999999999887 69999997533  33467788999999886443  456666443   23457899999999


Q ss_pred             CChhh----------------hh---hccc--cccCChHh---------HHHH------------HHHHHH-HHHHHHh-
Q 002461          687 GNLKQ----------------YL---FDET--KEALSWKD---------RLQI------------AVDAAQ-GLEYLHH-  722 (919)
Q Consensus       687 GsL~~----------------~L---~~~~--~~~ls~~~---------~l~I------------a~~ia~-gL~yLH~-  722 (919)
                      ..+..                .+   +...  .....+..         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11   0110  00111100         0000            111222 2333332 


Q ss_pred             ---cCCCCeeeeccccceEEeC-CCCcEEEeccCccc
Q 002461          723 ---GCKPPIIHRDVKTANILLN-EKMQAKLADFGFSK  755 (919)
Q Consensus       723 ---~~~~~iiH~DLKp~NILld-~~~~vkL~DFGla~  755 (919)
                         .....++|+|+.|+|||++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               2356799999999999999 66666899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.85  E-value=1.3e-05  Score=91.53  Aligned_cols=87  Identities=30%  Similarity=0.343  Sum_probs=78.4

Q ss_pred             CCCCCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccC
Q 002461          442 GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNG  521 (919)
Q Consensus       442 ~~~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~  521 (919)
                      |..|+.++.|||++|.|+-.-+..|-+|++|+.++|.+|.|+ .||.......+|+.|+|.+|.++..-.++|..++.|+
T Consensus        74 g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alr  152 (873)
T KOG4194|consen   74 GFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALR  152 (873)
T ss_pred             CcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhh
Confidence            457888999999999999888888999999999999999999 9999877788899999999999966678899999999


Q ss_pred             ccccccCC
Q 002461          522 SLLLSIGR  529 (919)
Q Consensus       522 ~l~ls~~~  529 (919)
                      .|+||-+.
T Consensus       153 slDLSrN~  160 (873)
T KOG4194|consen  153 SLDLSRNL  160 (873)
T ss_pred             hhhhhhch
Confidence            99988654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.83  E-value=1e-05  Score=82.07  Aligned_cols=81  Identities=38%  Similarity=0.498  Sum_probs=29.5

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccC-CCCCCceEEEcCCCCCCCCCc-cccccccccCcc
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL-SQLPLLRVLNLDGNKLSGSVP-TSLVARSQNGSL  523 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l-~~l~~L~~L~Ls~N~l~g~iP-~~l~~l~~l~~l  523 (919)
                      .+++.|+|++|+|+ .|+ .+..|++|+.|+|++|+|+ .+++.+ ..+++|+.|+|++|++...-- ..+..+++|+.|
T Consensus        42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            46778888888877 443 4677788888888888887 565444 357788888888888763211 233444444433


Q ss_pred             ccccCCCC
Q 002461          524 LLSIGRNP  531 (919)
Q Consensus       524 ~ls~~~N~  531 (919)
                        +..+||
T Consensus       119 --~L~~NP  124 (175)
T PF14580_consen  119 --SLEGNP  124 (175)
T ss_dssp             --E-TT-G
T ss_pred             --eccCCc
Confidence              445565

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.83  E-value=4.5e-06  Score=95.51  Aligned_cols=77  Identities=29%  Similarity=0.382  Sum_probs=46.1

Q ss_pred             cEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCcc-CCCCCCceEEEcCCCCCCCCCccccccccccCcccc
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLL  525 (919)
Q Consensus       447 ~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~l  525 (919)
                      .++.||||+|+|. ..|..+.+-.++-.|+||+|++. +||.. +.+|..|-+||||+|+|. .+|+.+..|..|+.|.|
T Consensus       104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L  180 (1255)
T KOG0444|consen  104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL  180 (1255)
T ss_pred             cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence            3566666666666 66666666666666666666666 55654 345666666666666665 55555555555555444


Q ss_pred             c
Q 002461          526 S  526 (919)
Q Consensus       526 s  526 (919)
                      |
T Consensus       181 s  181 (1255)
T KOG0444|consen  181 S  181 (1255)
T ss_pred             C
Confidence            3

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.82  E-value=1e-05  Score=82.06  Aligned_cols=81  Identities=37%  Similarity=0.539  Sum_probs=27.9

Q ss_pred             CCCcEEEEEeecCCCccccCcccc-CCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccc-cccccC
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLS-NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLV-ARSQNG  521 (919)
Q Consensus       444 ~~~~l~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~-~l~~l~  521 (919)
                      .+.+++.|+|.+|+|+ .|. .++ .|++|+.||||+|.|+ .|+. +..|++|+.|+|++|+++ .+++.+. .+++|+
T Consensus        17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred             cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence            4557899999999998 553 576 6899999999999999 6664 888999999999999999 5665553 688899


Q ss_pred             ccccccCC
Q 002461          522 SLLLSIGR  529 (919)
Q Consensus       522 ~l~ls~~~  529 (919)
                      .|.++.+.
T Consensus        92 ~L~L~~N~   99 (175)
T PF14580_consen   92 ELYLSNNK   99 (175)
T ss_dssp             EEE-TTS-
T ss_pred             EEECcCCc
Confidence            88876443

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=97.81  E-value=9.1e-05  Score=75.37  Aligned_cols=138  Identities=18%  Similarity=0.316  Sum_probs=72.7

Q ss_pred             EEeecCCCCCCccccCCCceeeecCccccccCcc-----------ccccccccccccccccceeeecCCCCCcceecCCC
Q 002461           65 ISIDCGVPAGFMYLDEKTQLSYKSDEEFIRTGVN-----------KNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPP  133 (919)
Q Consensus        65 ~~idcg~~~~~~~~~~~~~~~~~~D~~~i~~g~~-----------~~~~~~~~~~~~~~~~~tlR~Fp~g~~nCY~l~~~  133 (919)
                      +.|+||+   ..+ ++..|+.|.+|..|..++..           ...........-.+-++|-|+=|.  ..-|.+|. 
T Consensus         3 ~~IN~Gg---~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--~f~Y~ip~-   75 (174)
T PF11721_consen    3 LRINAGG---PAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--SFSYDIPV-   75 (174)
T ss_dssp             EEEEETS---SSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--SEEEEEE--
T ss_pred             EEEECCC---Ccc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--ceEEEEec-
Confidence            4799997   344 45789999999999755441           111112112222344778898333  57899963 


Q ss_pred             CCCCceEEEeeee---eecCCCCCCCCC---ceEEEEccee-eEEEEecC---CCc-cEEEEE-EEEeccCccceeecc-
Q 002461          134 EGKAKTYLTRASF---MYGDYDDEDKLP---EFDLYIGVNR-WDSIKFDN---ASH-VVIKEI-IHSALMDEINVCLLN-  200 (919)
Q Consensus       134 ~~~~~~ylvR~~f---~ygnyd~~~~~p---~Fd~~~~~~~-w~~v~~~~---~~~-~~~~e~-i~~~~~~~~~vCl~~-  200 (919)
                      . +.+.|-||.-|   +++. ++....|   +||+.++|+. ...+++-.   ... ....+. -+.+.+..+.++|.. 
T Consensus        76 ~-~~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~  153 (174)
T PF11721_consen   76 V-PNGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWA  153 (174)
T ss_dssp             --S-EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE
T ss_pred             C-CCcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEec
Confidence            3 77889999999   4444 3333344   7999999954 33333211   111 223333 123477789999985 


Q ss_pred             ----------cCCCCceeeee
Q 002461          201 ----------TGKGTPFISAL  211 (919)
Q Consensus       201 ----------~~~~~Pfis~l  211 (919)
                                ...|.|.||+|
T Consensus       154 ~~~~~~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  154 GKGTLCIPFIGSYGNPLISAI  174 (174)
T ss_dssp             --SEEEEEEESSSSSSSEEEE
T ss_pred             CCCcEEeeccccCCCcEEeeC
Confidence                      44667888886

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.77  E-value=0.00024  Score=76.16  Aligned_cols=137  Identities=17%  Similarity=0.137  Sum_probs=84.4

Q ss_pred             ceeCc-EEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhcc-CcceeeEEeEeecCCeEEEEEEeccCCChhhh
Q 002461          615 GKGGF-GTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQY  692 (919)
Q Consensus       615 G~G~f-G~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~-H~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~  692 (919)
                      -.|.+ ..||+.... +..+.||+.....   .....+|+++++.+. +--+.+++++....+..++|||++++.+|...
T Consensus         7 ~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           7 TEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            33444 788999765 4678888875432   345778999998884 44456778877766678999999998877643


Q ss_pred             hh-------------------ccccc--cCC--hHhHHHHHH--------------------HHHHHHHHHHh----cCC
Q 002461          693 LF-------------------DETKE--ALS--WKDRLQIAV--------------------DAAQGLEYLHH----GCK  725 (919)
Q Consensus       693 L~-------------------~~~~~--~ls--~~~~l~Ia~--------------------~ia~gL~yLH~----~~~  725 (919)
                      ..                   .....  .+.  ...++....                    .+...+..|-.    ...
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            21                   00000  000  001110000                    01111222211    113


Q ss_pred             CCeeeeccccceEEeCCCCcEEEeccCccc
Q 002461          726 PPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       726 ~~iiH~DLKp~NILld~~~~vkL~DFGla~  755 (919)
                      ..++|+|+.|.|||++++..+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            558999999999999998778999998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.76  E-value=0.0001  Score=75.92  Aligned_cols=103  Identities=26%  Similarity=0.300  Sum_probs=82.1

Q ss_pred             hHHHHHHHhccC-cceeeEEeEeecCCeEEEEEEeccCCChhhhhhc-cccccCChHhHHHHHHHHHHHHHHHHhcCCCC
Q 002461          650 RTEAQLLMRVHH-RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP  727 (919)
Q Consensus       650 ~~Ev~~L~~l~H-~NIv~l~g~~~~~~~~~LV~Ey~~~GsL~~~L~~-~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~  727 (919)
                      ..|.-+++.+++ +++++++|+|..    ++|.||...+++...-.. ..--.-+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 699999999943    789999987766421000 01123689999999999999999999876667


Q ss_pred             eeeeccccceEEeCCCCcEEEeccCcccc
Q 002461          728 IIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       728 iiH~DLKp~NILld~~~~vkL~DFGla~~  756 (919)
                      +.-.|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.75  E-value=7.4e-06  Score=98.20  Aligned_cols=77  Identities=34%  Similarity=0.453  Sum_probs=46.9

Q ss_pred             CcEEEEEeecCCCccccCc-cccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCccc
Q 002461          446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~  524 (919)
                      .+++.|+|++|+|. ++|. .+.+|..|+.|+||+|+|+ .||+.+..++.|++|...+|+|. ..| ++.++++|+.++
T Consensus       383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD  458 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD  458 (1081)
T ss_pred             cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence            46777777777776 5554 4677777777777777777 66655555555555555555554 444 444444444444


Q ss_pred             cc
Q 002461          525 LS  526 (919)
Q Consensus       525 ls  526 (919)
                      +|
T Consensus       459 lS  460 (1081)
T KOG0618|consen  459 LS  460 (1081)
T ss_pred             cc
Confidence            43

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.74  E-value=0.00027  Score=74.56  Aligned_cols=135  Identities=21%  Similarity=0.252  Sum_probs=91.1

Q ss_pred             eeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCc---------hh---------------hhHHHHHHHhcc--Ccceee
Q 002461          613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGP---------KQ---------------FRTEAQLLMRVH--HRNLAS  666 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~---------~~---------------f~~Ev~~L~~l~--H~NIv~  666 (919)
                      .|+.|.-+.||+|.-.++..+|||+.+.......         ..               ..+|+..|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            5778888999999988899999999864322110         11               234666666663  333444


Q ss_pred             EEeEeecCCeEEEEEEeccCCC-hhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCc
Q 002461          667 LVGYCNDGGNVGLVYEYMAYGN-LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ  745 (919)
Q Consensus       667 l~g~~~~~~~~~LV~Ey~~~Gs-L~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~  745 (919)
                      .+++.    +-.|||||+.... -.-.|.+   -.+...+...+..++++.+.-|-.  ..+++|+||..-|||+. ++.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence            45443    3479999986531 1111211   112333566777888888888874  35899999999999999 779


Q ss_pred             EEEeccCccccc
Q 002461          746 AKLADFGFSKIF  757 (919)
Q Consensus       746 vkL~DFGla~~~  757 (919)
                      +.|+|+|-|...
T Consensus       205 p~iID~~QaV~~  216 (268)
T COG1718         205 PYIIDVSQAVTI  216 (268)
T ss_pred             EEEEECcccccc
Confidence            999999987644

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.73  E-value=9e-06  Score=93.14  Aligned_cols=84  Identities=32%  Similarity=0.368  Sum_probs=73.3

Q ss_pred             CCCcEEEEEeecCCCcc-ccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccc-cccccC
Q 002461          444 KPPKIISLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLV-ARSQNG  521 (919)
Q Consensus       444 ~~~~l~~L~L~~n~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~-~l~~l~  521 (919)
                      ..|+++++.+.+|+|.. .||+.|-.|..|+.||||+|+|. ..|..+..-+++-.|+||+|++. +||.++. +|..|-
T Consensus        76 ~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLL  153 (1255)
T KOG0444|consen   76 DLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLL  153 (1255)
T ss_pred             cchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHh
Confidence            34678889999999874 59999999999999999999999 89999999999999999999998 8998764 787777


Q ss_pred             ccccccCC
Q 002461          522 SLLLSIGR  529 (919)
Q Consensus       522 ~l~ls~~~  529 (919)
                      .|+||.+.
T Consensus       154 fLDLS~Nr  161 (1255)
T KOG0444|consen  154 FLDLSNNR  161 (1255)
T ss_pred             hhccccch
Confidence            77777654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.69  E-value=8.8e-06  Score=94.38  Aligned_cols=180  Identities=20%  Similarity=0.201  Sum_probs=130.9

Q ss_pred             eeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcc-eeeEEeEeecCCeEEEEEEeccCC-Chh
Q 002461          613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN-LASLVGYCNDGGNVGLVYEYMAYG-NLK  690 (919)
Q Consensus       613 ~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~N-Iv~l~g~~~~~~~~~LV~Ey~~~G-sL~  690 (919)
                      -+++|++++++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..+...+++++++..+ +..
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            36889999999988544455556665432     34566899999999999 777777777788889999999876 222


Q ss_pred             hhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCcccccCCCCCCccccccc
Q 002461          691 QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV  770 (919)
Q Consensus       691 ~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~~  770 (919)
                      .-. ......+...+...+...-++++++||+.   .=+|+|    ||+..+ ...|..||+....+....   ......
T Consensus       324 ~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~  391 (829)
T KOG0576|consen  324 LEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI  391 (829)
T ss_pred             ccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence            111 11122233444555666778899999942   347888    887776 578999999887663322   345667


Q ss_pred             cCccccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCc
Q 002461          771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI  809 (919)
Q Consensus       771 Gt~~Y~APE~l~~~~~s~ksDVwSfGvvL~ELltG~~p~  809 (919)
                      ++..++|||+.....+..+.|+|+.|+-..++.-|.+|-
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            999999999999999999999999998777887776654

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.67  E-value=2.4e-05  Score=60.50  Aligned_cols=40  Identities=40%  Similarity=0.682  Sum_probs=34.4

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCC
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIP  487 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP  487 (919)
                      ++++.|+|++|+|+ .||+.|++|++|+.|+|++|+|+ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            46889999999999 78989999999999999999999 444

...

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.66  E-value=0.00021  Score=74.61  Aligned_cols=130  Identities=15%  Similarity=0.133  Sum_probs=81.4

Q ss_pred             cceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhh---------hHHHHHHHhccCc---ceeeEEeEee-----c
Q 002461          611 HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQF---------RTEAQLLMRVHHR---NLASLVGYCN-----D  673 (919)
Q Consensus       611 ~~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f---------~~Ev~~L~~l~H~---NIv~l~g~~~-----~  673 (919)
                      .+++-......|.+-.. +|+.+.+|..+.......+.|         .+++..+.+++..   ....++....     -
T Consensus        36 ~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~  114 (229)
T PF06176_consen   36 IKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY  114 (229)
T ss_pred             EEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence            34455555455555444 568888998765443322222         2344444444322   2223222222     2


Q ss_pred             CCeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCCCcEEEeccCc
Q 002461          674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       674 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~~~vkL~DFGl  753 (919)
                      ....+|+|||++|..|.+...      ++.    .++..+++++.-||   +.|+.|+|.+|+|+++++++ ++++||+.
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcc
Confidence            345679999999988876531      221    35566778899999   67999999999999999665 99999986


Q ss_pred             cc
Q 002461          754 SK  755 (919)
Q Consensus       754 a~  755 (919)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.56  E-value=0.00037  Score=86.02  Aligned_cols=36  Identities=8%  Similarity=0.105  Sum_probs=26.4

Q ss_pred             CCCCCCChhHHHHHHHHHHhCCCC-------CCCCC--CCCCCCC
Q 002461          395 TLQEPTDQDDVNAIMDIKLSYDLG-------KGWQG--DPCSPMY  430 (919)
Q Consensus       395 ~~~~~t~~~d~~al~~~k~~~~~~-------~~W~g--dpC~~~~  430 (919)
                      ++..+|.+.++..+.++.+.+..+       .+|+|  |.|--..
T Consensus        55 ~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~   99 (754)
T PRK15370         55 HPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSE   99 (754)
T ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCC
Confidence            455789999999999999987532       34976  6785433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.56  E-value=2.4e-05  Score=89.46  Aligned_cols=84  Identities=31%  Similarity=0.245  Sum_probs=71.4

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcccc
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLL  525 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~l  525 (919)
                      ..++.|+|..|+|+..-...+-+|++|+.||||+|.++..-++.+.-.++|+.|+|++|+|+-.-|.+|..|.+|+.|.|
T Consensus       269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL  348 (873)
T KOG4194|consen  269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL  348 (873)
T ss_pred             cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence            36888999999999777778889999999999999999888888888999999999999999666778888888888877


Q ss_pred             ccCC
Q 002461          526 SIGR  529 (919)
Q Consensus       526 s~~~  529 (919)
                      +.+.
T Consensus       349 s~Ns  352 (873)
T KOG4194|consen  349 SHNS  352 (873)
T ss_pred             cccc
Confidence            6554

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.56  E-value=2e-05  Score=86.56  Aligned_cols=90  Identities=23%  Similarity=0.280  Sum_probs=80.1

Q ss_pred             CCCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcc
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l  523 (919)
                      ..++++.|+|++|.|++.-+.+|..+..|+.|.|..|+|.-.--..|.+|..|+.|+|.+|+|+-.-|..|..+..|+.|
T Consensus       272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l  351 (498)
T KOG4237|consen  272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL  351 (498)
T ss_pred             hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence            56899999999999999999999999999999999999996666678899999999999999998889999888888865


Q ss_pred             ccccCCCCCCCC
Q 002461          524 LLSIGRNPDLCL  535 (919)
Q Consensus       524 ~ls~~~N~~LC~  535 (919)
                      .  .-+||..|.
T Consensus       352 ~--l~~Np~~Cn  361 (498)
T KOG4237|consen  352 N--LLSNPFNCN  361 (498)
T ss_pred             e--hccCcccCc
Confidence            5  457888775

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.0012  Score=73.24  Aligned_cols=75  Identities=15%  Similarity=0.155  Sum_probs=56.8

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccC---cceeeEEeEeec---CCeEEEEEEecc
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH---RNLASLVGYCND---GGNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H---~NIv~l~g~~~~---~~~~~LV~Ey~~  685 (919)
                      +.||.|..+.||+....+++ +++|..+.  ......|..|.+.|+.+..   -.+.+++++|..   .+..+||||+++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            57999999999998876664 66777542  1123578999999999853   357788888754   366899999999


Q ss_pred             CCCh
Q 002461          686 YGNL  689 (919)
Q Consensus       686 ~GsL  689 (919)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=97.52  E-value=1.2e-05  Score=88.39  Aligned_cols=66  Identities=30%  Similarity=0.405  Sum_probs=37.3

Q ss_pred             EEEEeecCCCccccCcccc-CCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccc
Q 002461          449 ISLNLTSEGLTGKISPSLS-NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVAR  517 (919)
Q Consensus       449 ~~L~L~~n~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l  517 (919)
                      .+|++..|+|. .+|.+.. +|.+|..|||..|+|. +.|+++.-|++|..||||+|.++ .+|.+++++
T Consensus       231 ~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl  297 (565)
T KOG0472|consen  231 KELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL  297 (565)
T ss_pred             HHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence            34444555554 4555444 5566666666666665 55666666666666666666665 455555555

>PLN02876 acyl-CoA dehydrogenase

Probab=97.52  E-value=0.00093  Score=84.34  Aligned_cols=78  Identities=17%  Similarity=0.299  Sum_probs=57.4

Q ss_pred             ceeceeCcEEEEEEEEcCC---CEEEEEEeecCCC-CCchhhhHHHHHHHhcc-Ccce--eeEEeEeecC---CeEEEEE
Q 002461          612 RILGKGGFGTVYHGYLADG---SEVAIKMLSASSS-QGPKQFRTEAQLLMRVH-HRNL--ASLVGYCNDG---GNVGLVY  681 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ev~~L~~l~-H~NI--v~l~g~~~~~---~~~~LV~  681 (919)
                      +.++.|.+..+|+....++   ..+++|+...... .....+.+|+++++.+. |.++  .+++++|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5688999999999887654   3677777543321 23356889999999995 6665  7888888664   4678999


Q ss_pred             EeccCCCh
Q 002461          682 EYMAYGNL  689 (919)
Q Consensus       682 Ey~~~GsL  689 (919)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99997654

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=97.51  E-value=9.2e-05  Score=75.33  Aligned_cols=107  Identities=20%  Similarity=0.249  Sum_probs=58.6

Q ss_pred             EEEeecCCCCceeeeccCCCCCcccccCCCC--CCCcccccc----ccccccCCcCCCCcHHHHhhccccCCCCCceeec
Q 002461          231 YRRLDVGSTTTQIIRFKDDHYDRIWVPYPGF--PGSASINTS----FIIDSLVDSQYRLPSAVMKTAVKPMNVNDSLDFD  304 (919)
Q Consensus       231 ~~r~~~g~~~~~~~rypdD~~dR~W~p~~~~--~~~~~~~t~----~~~~~~~~~~~~~P~~v~qtA~t~~~~~~~l~~~  304 (919)
                      +.|.|.|+..     | +|..++.|+++...  ..|.-..+.    ..........+..+..++||+=...   ..+.|.
T Consensus         2 ~~~IN~Gg~~-----~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~   72 (174)
T PF11721_consen    2 VLRINAGGPA-----Y-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYD   72 (174)
T ss_dssp             EEEEEETSSS-----E-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEE
T ss_pred             EEEEECCCCc-----c-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEE
Confidence            5689999864     4 89999999997633  333111110    0011223344566789999996632   246665


Q ss_pred             ccCCCCCceEEEEEEeccccccc-----CCceeEEEEEECCccccccc
Q 002461          305 FEIGDPTLQFYVYMHFAELESRQ-----GNQYREFSIELNGNLWEKSV  347 (919)
Q Consensus       305 ~~~~~~~~~~~v~l~Fae~~~~~-----~~~~R~F~i~~n~~~~~~~~  347 (919)
                      .+. .++-.|-|-|||||+.--.     ....|+|||++||+...+.+
T Consensus        73 ip~-~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~  119 (174)
T PF11721_consen   73 IPV-VPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNF  119 (174)
T ss_dssp             EE---S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE
T ss_pred             Eec-CCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEecc
Confidence            542 4567799999999996322     14689999999998766533

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.48  E-value=0.0011  Score=68.91  Aligned_cols=131  Identities=23%  Similarity=0.383  Sum_probs=92.1

Q ss_pred             ceeceeCcEEEEEEEEcCCCEEEEEEeecCC----------------CCCchhhhHHHHHHHhcc------CcceeeEEe
Q 002461          612 RILGKGGFGTVYHGYLADGSEVAIKMLSASS----------------SQGPKQFRTEAQLLMRVH------HRNLASLVG  669 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~----------------~~~~~~f~~Ev~~L~~l~------H~NIv~l~g  669 (919)
                      ..||+|+.-.||.  +++.....||+.....                ....+++.+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5799999999984  5566778899987554                223467778888777776      788999999


Q ss_pred             EeecCCeEEEEEEeccC--C----ChhhhhhccccccCChHhHHHHHHHHHHHHHHHHhcCCCCeeeeccccceEEeCCC
Q 002461          670 YCNDGGNVGLVYEYMAY--G----NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK  743 (919)
Q Consensus       670 ~~~~~~~~~LV~Ey~~~--G----sL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~~~~~~iiH~DLKp~NILld~~  743 (919)
                      +........+|+|.+.+  |    +|.+++..   +.++. +..+.+.++   ..||-   ...|+.+|++|+||++...
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEec
Confidence            99999999999998743  3    56666632   23444 344444444   44554   4469999999999999633


Q ss_pred             --C--cEEEec-cCcc
Q 002461          744 --M--QAKLAD-FGFS  754 (919)
Q Consensus       744 --~--~vkL~D-FGla  754 (919)
                        +  .+.|+| ||-.
T Consensus       155 ~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCCceEEEEEeCCCCc
Confidence              2  466676 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.44  E-value=2e-05  Score=74.96  Aligned_cols=76  Identities=26%  Similarity=0.418  Sum_probs=64.5

Q ss_pred             CcEEEEEeecCCCccccCccccCC-CCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCccc
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNL-KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l-~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~  524 (919)
                      .+++.++|++|.|. .+|+.|... +.++.|+|++|.|+ .+|.++..++.|+.||++.|.|. ..|.-+..|.++..|+
T Consensus        53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            47888999999998 788887655 58999999999999 89999999999999999999998 6777777777665544

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=97.41  E-value=9.7e-05  Score=56.83  Aligned_cols=33  Identities=36%  Similarity=0.880  Sum_probs=24.2

Q ss_pred             hhHHHHHHHHHHhCCC-----CCCCCC----CCCCCCCCceeEEEcC
Q 002461          402 QDDVNAIMDIKLSYDL-----GKGWQG----DPCSPMYYSWDGLNCS  439 (919)
Q Consensus       402 ~~d~~al~~~k~~~~~-----~~~W~g----dpC~~~~~~W~gv~C~  439 (919)
                      ++|++||++||+++..     +.+|+.    +||     +|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-----~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-----SWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-----CSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-----eeccEEeC
Confidence            6799999999999863     479963    556     89999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.35  E-value=4.7e-05  Score=91.55  Aligned_cols=79  Identities=30%  Similarity=0.431  Sum_probs=51.7

Q ss_pred             EEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcccccc
Q 002461          448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSI  527 (919)
Q Consensus       448 l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~ls~  527 (919)
                      ++.|||++|+++ ..|..+..+.+|+.|+++.|.+. .+|.+.+++.+|++|+|.+|++. ..|.++..+.+|+.|++|+
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence            666666666665 66666666666666666666666 56666666666666666666665 6666666666666666665


Q ss_pred             CC
Q 002461          528 GR  529 (919)
Q Consensus       528 ~~  529 (919)
                      +.
T Consensus       124 N~  125 (1081)
T KOG0618|consen  124 NH  125 (1081)
T ss_pred             hc
Confidence            53

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.34  E-value=0.0012  Score=70.54  Aligned_cols=73  Identities=19%  Similarity=0.277  Sum_probs=46.0

Q ss_pred             ceeceeCcE-EEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCc---ceeeEEeEeecC---CeEEEEEEec
Q 002461          612 RILGKGGFG-TVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR---NLASLVGYCNDG---GNVGLVYEYM  684 (919)
Q Consensus       612 ~~LG~G~fG-~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~---NIv~l~g~~~~~---~~~~LV~Ey~  684 (919)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+..|.+.+..+...   .+.++++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766666 58875    34577776543  12345788899999888632   344445443332   2358899999


Q ss_pred             cCCChh
Q 002461          685 AYGNLK  690 (919)
Q Consensus       685 ~~GsL~  690 (919)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.32  E-value=0.0023  Score=68.01  Aligned_cols=74  Identities=14%  Similarity=0.170  Sum_probs=49.3

Q ss_pred             ceeceeCcEEEEEEEEcC--CCEEEEEEeecCCCCCchhhhHHHHHHHhccCcce-eeEEeEeecCCeEEEEEEeccCCC
Q 002461          612 RILGKGGFGTVYHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL-ASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       612 ~~LG~G~fG~Vyk~~l~~--g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NI-v~l~g~~~~~~~~~LV~Ey~~~Gs  688 (919)
                      +.|..|-...+|+....+  ++.+++|+...... ..-....|+.++..+...++ +++++.+.    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457788888999998764  67899997654322 12233478889998864444 34444332    248999999877


Q ss_pred             hh
Q 002461          689 LK  690 (919)
Q Consensus       689 L~  690 (919)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.28  E-value=9.3e-05  Score=90.90  Aligned_cols=71  Identities=28%  Similarity=0.345  Sum_probs=40.5

Q ss_pred             CcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcccc
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLL  525 (919)
Q Consensus       446 ~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l~l  525 (919)
                      ..|+.|+|++|+|+ .+|..   .++|+.|+|++|+|+ .||..   ..+|+.|+|++|+|+ .+|.++.++.+|..|+|
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL  452 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  452 (788)
T ss_pred             cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence            34566666666666 35543   245666666666666 35543   234556666666665 56666666666555444

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.23  E-value=0.0016  Score=70.40  Aligned_cols=136  Identities=16%  Similarity=0.126  Sum_probs=79.1

Q ss_pred             eceeCcEEEEEEEEcCCCEEEEEEeecCCCCCchhhhHHHHHHHhccCcce-eeEEeEeecCCeEEEEEEeccCCChhhh
Q 002461          614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL-ASLVGYCNDGGNVGLVYEYMAYGNLKQY  692 (919)
Q Consensus       614 LG~G~fG~Vyk~~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~~L~~l~H~NI-v~l~g~~~~~~~~~LV~Ey~~~GsL~~~  692 (919)
                      +..|-...+|+.. .+++.+++|..........-...+|.++++.+....+ .++++.+.    -++|+||+++..+...
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            5567888999887 4567788887544322221245789999999865444 34444432    3689999998766421


Q ss_pred             -----------------hhccc--cccCChHhHH-HHHH---------HHHHHHHHHHhc-----CCCCeeeeccccceE
Q 002461          693 -----------------LFDET--KEALSWKDRL-QIAV---------DAAQGLEYLHHG-----CKPPIIHRDVKTANI  738 (919)
Q Consensus       693 -----------------L~~~~--~~~ls~~~~l-~Ia~---------~ia~gL~yLH~~-----~~~~iiH~DLKp~NI  738 (919)
                                       ||...  ...++...++ ....         .+.+.+..+...     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111  1112211111 1110         111112222111     134589999999999


Q ss_pred             EeCCCCcEEEeccCccc
Q 002461          739 LLNEKMQAKLADFGFSK  755 (919)
Q Consensus       739 Lld~~~~vkL~DFGla~  755 (919)
                      ++++++ +.|+||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999877 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.19  E-value=0.00025  Score=87.20  Aligned_cols=69  Identities=29%  Similarity=0.374  Sum_probs=49.1

Q ss_pred             CCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCcccccccc
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARS  518 (919)
Q Consensus       445 ~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~  518 (919)
                      +.+++.|+|++|+|+ .||..+   .+|+.|+|++|+|+ .||..+.+|++|+.|+|++|+|+|.+|.++.++.
T Consensus       401 ~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~  469 (788)
T PRK15387        401 PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  469 (788)
T ss_pred             ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence            346777788888777 466533   45667777888777 6777777777788888888888777777665443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.18  E-value=9.1e-05  Score=78.68  Aligned_cols=78  Identities=28%  Similarity=0.317  Sum_probs=46.8

Q ss_pred             CCCcEEEEEeecCCCccccCccccCCCCCCEEECcCCccccCCCccCCCCCCceEEEcCCCCCCCCCccccccccccCcc
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~l~~L~L~~n~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~l~~l  523 (919)
                      ..|.|+.|+||+|+|. .+- ++..|.+|+.||||+|.|+ .+-..--.|.+.+.|.|+.|.+..  -..++.+.+|..|
T Consensus       305 L~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnL  379 (490)
T KOG1259|consen  305 LAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNL  379 (490)
T ss_pred             hccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheec
Confidence            4566777777777766 332 2666677777777777776 455555556667777777776641  1234445555555


Q ss_pred             ccc
Q 002461          524 LLS  526 (919)
Q Consensus       524 ~ls  526 (919)
                      +++
T Consensus       380 Dl~  382 (490)
T KOG1259|consen  380 DLS  382 (490)
T ss_pred             ccc
Confidence            554

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.15  E-value=0.0038  Score=64.54  Aligned_cols=123  Identities=25%  Similarity=0.325  Sum_probs=86.8

Q ss_pred             hhhcceeceeCc-EEEEEEEEcCCCEEEEEEeecC---CC------------------CCchhhhHHHHHHHhcc---Cc
Q 002461          608 NNFHRILGKGGF-GTVYHGYLADGSEVAIKMLSAS---SS------------------QGPKQFRTEAQLLMRVH---HR  662 (919)
Q Consensus       608 ~~~~~~LG~G~f-G~Vyk~~l~~g~~VAVK~l~~~---~~------------------~~~~~f~~Ev~~L~~l~---H~  662 (919)
                      .+|-+.||.|.- |.|||+.+. |+.+|+|+++.-   ..                  .-...|..|.+...+++   +.
T Consensus        39 I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e  117 (207)
T PF13095_consen   39 IEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE  117 (207)
T ss_pred             EeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence            356688999999 999999994 779999994321   00                  01235788999988885   33


Q ss_pred             ce--eeEEeEeecC------------------CeEEEEEEeccCCChhhhhhccccccCChHhHHHHHHHHHHHHHHHHh
Q 002461          663 NL--ASLVGYCNDG------------------GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH  722 (919)
Q Consensus       663 NI--v~l~g~~~~~------------------~~~~LV~Ey~~~GsL~~~L~~~~~~~ls~~~~l~Ia~~ia~gL~yLH~  722 (919)
                      ++  |+.+||..-.                  ..+.+|.||++...               ....+-+.++.+-|..+| 
T Consensus       118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~~-  181 (207)
T PF13095_consen  118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKILH-  181 (207)
T ss_pred             CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHHH-
Confidence            55  8889987221                  12467778766432               112334556677788889 


Q ss_pred             cCCCCeeeeccccceEEeCCCCcEEEeccCcc
Q 002461          723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFS  754 (919)
Q Consensus       723 ~~~~~iiH~DLKp~NILld~~~~vkL~DFGla  754 (919)
                        +.+|+-+|+++.|..     .-||+|||.+
T Consensus       182 --k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 --KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             --HCCeeeccCcccccc-----CCEEEecccC
Confidence              779999999999986     4599999853

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	919
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-52
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-29
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-25
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-24
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-23
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-23
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-23
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-23
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-23
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-23
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-23
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-23
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-23
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-23
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-23
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-23
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-23
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-23
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-23
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-23
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-23
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-23
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-23
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-23
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-23
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-23
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-23
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-23
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-23
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-23
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-23
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-23
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-21
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-20
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-19
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-19
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-19
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-19
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-18
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-18
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-18
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-18
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-18
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-18
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-18
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-18
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-18
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-17
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-17
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-14
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-07
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  207 bits (526), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 112/291 (38%), Positives = 177/291 (60%), Gaps = 10/291 (3%)
Query: 596 QQFTYSEIVDITNNF--HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTE 652
           ++F+  E+   ++NF    ILG+GGFG VY G LADG+ VA+K L     QG + QF+TE
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIA 710
            +++    HRNL  L G+C       LVY YMA G++   L +  E++  L W  R +IA
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
           + +A+GL YLH  C P IIHRDVK ANILL+E+ +A + DFG +K+   + + H+  ++ 
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DXHVXXAVR 204
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI----IRGYNNTHIVNRVCPFL 826
           GT+G++ PEY ++ + +EK+DV+ +G++LLELITG  A     +   ++  +++ V   L
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
           +   + ++VD  L+ N+    V ++ + A+ C  S   +RP MS VV  L+
Sbjct: 265 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  205 bits (521), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 111/291 (38%), Positives = 176/291 (60%), Gaps = 10/291 (3%)
Query: 596 QQFTYSEIVDITNNF--HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTE 652
           ++F+  E+   ++NF    ILG+GGFG VY G LADG  VA+K L    +QG + QF+TE
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIA 710
            +++    HRNL  L G+C       LVY YMA G++   L +  E++  L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
           + +A+GL YLH  C P IIHRDVK ANILL+E+ +A + DFG +K+   + + H+  ++ 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DXHVXXAVR 196
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI----IRGYNNTHIVNRVCPFL 826
           G +G++ PEY ++ + +EK+DV+ +G++LLELITG  A     +   ++  +++ V   L
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
           +   + ++VD  L+ N+    V ++ + A+ C  S   +RP MS VV  L+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  204 bits (519), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 178/291 (61%), Gaps = 11/291 (3%)
Query: 602 EIVDITNNF-HRIL-GKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           ++ + TNNF H+ L G G FG VY G L DG++VA+K  +  SSQG ++F TE + L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF--DETKEALSWKDRLQIAVDAAQGL 717
            H +L SL+G+C++   + L+Y+YM  GNLK++L+  D    ++SW+ RL+I + AA+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
            YLH      IIHRDVK+ NILL+E    K+ DFG SK      ++H+   + GT+GY+D
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVRSI 834
           PEY+   RLTEKSDVYSFG+VL E++    AI++      +VN     +E    G +  I
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETA 885
           VDP L       S+ K  +TA++C+   S  RP+M  V+ +L+  L ++ +
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  204 bits (518), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 120/291 (41%), Positives = 178/291 (61%), Gaps = 11/291 (3%)
Query: 602 EIVDITNNF-HRIL-GKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           ++ + TNNF H+ L G G FG VY G L DG++VA+K  +  SSQG ++F TE + L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF--DETKEALSWKDRLQIAVDAAQGL 717
            H +L SL+G+C++   + L+Y+YM  GNLK++L+  D    ++SW+ RL+I + AA+GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
            YLH      IIHRDVK+ NILL+E    K+ DFG SK      ++H+   + GT+GY+D
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGDVRSI 834
           PEY+   RLTEKSDVYSFG+VL E++    AI++      +VN     +E    G +  I
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETA 885
           VDP L       S+ K  +TA++C+   S  RP+M  V+ +L+  L ++ +
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 92/226 (40%), Positives = 139/226 (61%), Gaps = 20/226 (8%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
           F++ E+ ++TNNF           +G+GGFG VY GY+ + + VA+K L+A    ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSW 703
            +QF  E +++ +  H NL  L+G+ +DG ++ LVY YM  G+L   L   D T   LSW
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSW 132
Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
             R +IA  AA G+ +LH       IHRD+K+ANILL+E   AK++DFG ++     +++
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
            + + IVGT  Y+ PE      +T KSD+YSFG+VLLE+ITGLPA+
Sbjct: 190 VMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/226 (40%), Positives = 138/226 (61%), Gaps = 20/226 (8%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
           F++ E+ ++TNNF           +G+GGFG VY GY+ + + VA+K L+A    ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSW 703
            +QF  E +++ +  H NL  L+G+ +DG ++ LVY YM  G+L   L   D T   LSW
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSW 132
Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
             R +IA  AA G+ +LH       IHRD+K+ANILL+E   AK++DFG ++     +++
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
            +   IVGT  Y+ PE      +T KSD+YSFG+VLLE+ITGLPA+
Sbjct: 190 VMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (405), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/226 (40%), Positives = 137/226 (60%), Gaps = 20/226 (8%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
           F++ E+ ++TNNF           +G+GGFG VY GY+ + + VA+K L+A    ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSW 703
            +QF  E +++ +  H NL  L+G+ +DG ++ LVY YM  G+L   L   D T   LSW
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSW 126
Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
             R +IA  AA G+ +LH       IHRD+K+ANILL+E   AK++DFG ++     ++ 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
            +   IVGT  Y+ PE      +T KSD+YSFG+VLLE+ITGLPA+
Sbjct: 184 VMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 91/226 (40%), Positives = 133/226 (58%), Gaps = 20/226 (8%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
           F++ E+ ++TNNF            G+GGFG VY GY+ + + VA+K L+A    ++ + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSW 703
            +QF  E ++  +  H NL  L+G+ +DG ++ LVY Y   G+L   L   D T   LSW
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-PLSW 123
Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
             R +IA  AA G+ +LH       IHRD+K+ANILL+E   AK++DFG ++     ++ 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
              + IVGT  Y  PE      +T KSD+YSFG+VLLE+ITGLPA+
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 225

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  128 bits (322), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 16/269 (5%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK 647
           +G++  D+    + ++     N    +G G FGTV+      GS+VA+K+L        +
Sbjct: 24  QGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER 77
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE-TKEALSWK 704
             +F  E  ++ R+ H N+   +G      N+ +V EY++ G+L + L     +E L  +
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
            RL +A D A+G+ YLH+   PPI+HRD+K+ N+L+++K   K+ DFG S++    S   
Sbjct: 138 RRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFL 194
Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP 824
            S    GT  ++ PE        EKSDVYSFG++L EL T L       N   +V  V  
Sbjct: 195 XSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGF 253
Query: 825 FLERGDVRSIVDPRLEANFD---TNSVWK 850
             +R ++   ++P++ A  +   TN  WK
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWK 282

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 140/269 (52%), Gaps = 16/269 (5%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK 647
           +G++  D+    + ++     N    +G G FGTV+      GS+VA+K+L        +
Sbjct: 24  QGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER 77
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE-TKEALSWK 704
             +F  E  ++ R+ H N+   +G      N+ +V EY++ G+L + L     +E L  +
Sbjct: 78  VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 137
Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
            RL +A D A+G+ YLH+   PPI+HR++K+ N+L+++K   K+ DFG S++  +   S 
Sbjct: 138 RRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS- 195
Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP 824
            S S  GT  ++ PE        EKSDVYSFG++L EL T L       N   +V  V  
Sbjct: 196 -SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGF 253
Query: 825 FLERGDVRSIVDPRLEANFD---TNSVWK 850
             +R ++   ++P++ A  +   TN  WK
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWK 282

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  114 bits (285), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 148/293 (50%), Gaps = 30/293 (10%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-DETKEALSWKDRLQIAVDAAQGLE 718
            H N+   +GY      + +V ++    +L  +L   ETK  +  K  + IA   A+G++
Sbjct: 66  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMD 122
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K+ NI L+E    K+ DFG + +    S SH    + G++ ++ P
Sbjct: 123 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179
Query: 779 EYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
           E      SN  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG     
Sbjct: 180 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGS---- 230
Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
           + P L +   +N   ++     EC+     +RP+   ++ E++     E ARE
Sbjct: 231 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE-----ELARE 277

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 146/293 (49%), Gaps = 30/293 (10%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-DETKEALSWKDRLQIAVDAAQGLE 718
            H N+   +GY      + +V ++    +L  +L   ETK     K  + IA   A+G++
Sbjct: 78  RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMD 134
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K+ NI L+E    K+ DFG +      S SH    + G++ ++ P
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 779 EYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
           E      SN  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG     
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGS---- 242
Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
           + P L +   +N   ++     EC+     +RP+   ++ E++     E ARE
Sbjct: 243 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE-----ELARE 289

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/293 (31%), Positives = 146/293 (49%), Gaps = 30/293 (10%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-DETKEALSWKDRLQIAVDAAQGLE 718
            H N+   +GY      + +V ++    +L  +L   ETK     K  + IA   A+G++
Sbjct: 78  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMD 134
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K+ NI L+E    K+ DFG +      S SH    + G++ ++ P
Sbjct: 135 YLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 779 EYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
           E      SN  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG     
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGS---- 242
Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETARE 887
           + P L +   +N   ++     EC+     +RP+   ++ E++     E ARE
Sbjct: 243 LSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE-----ELARE 289

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H  L  L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV+E+M +G L  YL   T+  L + +  L + +D  +G+ YL   C   
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    S     F  EA+++M++ H  L  L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV+E+M +G L  YL   T+  L + +  L + +D  +G+ YL   C   
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 143
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F R LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ E++ YG+L++YL  + KE +     LQ      +G+EYL  
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 134 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  109 bits (273), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H  L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV+E+M +G L  YL   T+  L + +  L + +D  +G+ YL   C   
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 123
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  109 bits (273), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H  L  L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV+E+M +G L  YL   T+  L + +  L + +D  +G+ YL   C   
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 126
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 143/299 (47%), Gaps = 40/299 (13%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
           +F  S +  + +N   + + +GKGGFG V+ G L  D S VAIK L    S+G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD 705
            ++F+ E  ++  ++H N+  L G  ++     +V E++  G+L   L D+    + W  
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSV 123
Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL-----NEKMQAKLADFGFSKIFPAE 760
           +L++ +D A G+EY+ +   PPI+HRD+++ NI L     N  + AK+ADFG S     +
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----Q 177
Query: 761 SESHISTSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGL-PAIIRGYNNTH 817
              H  + ++G   ++ PE   +     TEK+D YSF ++L  ++TG  P     Y    
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
            +N +     R  +     PRL           V E      P    +RP  S++V EL
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPK---KRPHFSYIVKEL 284

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/224 (33%), Positives = 113/224 (50%), Gaps = 17/224 (7%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSS 643
           GS   D  QF    +      F + LGKG FG+V    +  L D  G  VA+K L  S+ 
Sbjct: 1   GSEDRDPTQFEERHL-----KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 55
Query: 644 QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEAL 701
           +  + F  E ++L  + H N+    G C   G  N+ L+ EY+ YG+L+ YL  + KE +
Sbjct: 56  EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERI 114
Query: 702 SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
                LQ      +G+EYL  G K   IHRD+ T NIL+  + + K+ DFG +K+ P + 
Sbjct: 115 DHIKLLQYTSQICKGMEYL--GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 762 E-SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           E   +       + +  PE    ++ +  SDV+SFG+VL EL T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 130 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 135 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 131 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 136 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 129 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 137
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 138 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 131 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 162 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 137 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 144/301 (47%), Gaps = 40/301 (13%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
           +F  S +  + +N   + + +GKGGFG V+ G L  D S VAIK L    S+G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD 705
            ++F+ E  ++  ++H N+  L G  ++     +V E++  G+L   L D+    + W  
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSV 123
Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL-----NEKMQAKLADFGFSKIFPAE 760
           +L++ +D A G+EY+ +   PPI+HRD+++ NI L     N  + AK+ADFG S     +
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----Q 177
Query: 761 SESHISTSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGL-PAIIRGYNNTH 817
              H  + ++G   ++ PE   +     TEK+D YSF ++L  ++TG  P     Y    
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            +N +     R  +     PRL           V E      P    +RP  S++V EL 
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPK---KRPHFSYIVKELS 285
Query: 878 K 878
           +
Sbjct: 286 E 286

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 113/215 (52%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H  L  L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV E+M +G L  YL   T+  L + +  L + +D  +G+ YL   C   
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 124
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 149 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 148
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 149 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 208 TESKFSVASDVWSFGVVLYELFT 230

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  107 bits (268), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 115/208 (55%), Gaps = 13/208 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 147
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 781 YASNRLTEKSDVYSFGIVLLELIT-GLP 807
             + + T KSDV+SFG++L EL+T G P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  107 bits (268), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 168
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 167
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 115/208 (55%), Gaps = 13/208 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 781 YASNRLTEKSDVYSFGIVLLELIT-GLP 807
             + + T KSDV+SFG++L EL+T G P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 115/208 (55%), Gaps = 13/208 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 781 YASNRLTEKSDVYSFGIVLLELIT-GLP 807
             + + T KSDV+SFG++L EL+T G P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 141
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 154
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 131 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 146
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 147
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 113/204 (55%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 208
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E +S H  T     V ++  E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ ++  E  S H  T     V ++  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ G     ++VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM  G+L  +L D    AL   + + +A   A G+ Y+    +   IHRD+
Sbjct: 76  E-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           ++ANIL+   +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 132 RSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL+T       G NN  ++ +V    ERG
Sbjct: 191 SFGILLTELVTKGRVPYPGMNNREVLEQV----ERG 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           + SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESES-HISTSIVGTVGYLDPEY 780
                 +HRD+   N +L+EK   K+ADFG ++ +   E +S H  T     V ++  E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
             + + T KSDV+SFG++L EL+T
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 143/301 (47%), Gaps = 40/301 (13%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
           +F  S +  + +N   + + +GKGGFG V+ G L  D S VAIK L    S+G       
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD 705
            ++F+ E  ++  ++H N+  L G  ++     +V E++  G+L   L D+    + W  
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSV 123
Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL-----NEKMQAKLADFGFSKIFPAE 760
           +L++ +D A G+EY+ +   PPI+HRD+++ NI L     N  + AK+ADF  S     +
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----Q 177
Query: 761 SESHISTSIVGTVGYLDPEYYASNR--LTEKSDVYSFGIVLLELITGL-PAIIRGYNNTH 817
              H  + ++G   ++ PE   +     TEK+D YSF ++L  ++TG  P     Y    
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 818 IVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            +N +     R  +     PRL           V E      P    +RP  S++V EL 
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLR---------NVIELCWSGDPK---KRPHFSYIVKELS 285
Query: 878 K 878
           +
Sbjct: 286 E 286

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL  + KE +     LQ      +G+EYL  
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPEYY 781
           G K   IHR++ T NIL+  + + K+ DFG +K+ P + E + +       + +  PE  
Sbjct: 132 GTKR-YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 89  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 144
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 145 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 252
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 253 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 145
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 253
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 254 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 67  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 122
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 230
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 231 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 75  E-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 131 RAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 190 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 221

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 62  RHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 117
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 225
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 8/215 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H  L  L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL-SWKDRLQIAVDAAQGLEYLHHGCKPP 727
           G C +   + LV+E+M +G L  YL   T+  L + +  L + +D  +G+ YL    +  
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAS 123
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+   N L+ E    K++DFG ++ F  + +   ST     V +  PE ++ +R +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            KSDV+SFG+++ E+ +         +N+ +V  +
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 64  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 119
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 120 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 227
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 228 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 67  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 122
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 230
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 231 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 62  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 117
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ 
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 225
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V    +  L D  G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
               G C   G  N+ L+ EY+ YG+L+ YL     E +     LQ      +G+EYL  
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL-- 133
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYY 781
           G K   IHRD+ T NIL+  + + K+ DFG +K+ P + E   +       + +  PE  
Sbjct: 134 GTKR-YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
             ++ +  SDV+SFG+VL EL T
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 24/210 (11%)
Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASS----SQGPKQFRTEAQLLMRVHHRNLA 665
              I+G GGFG VY  +   G EVA+K          SQ  +  R EA+L   + H N+ 
Sbjct: 11  LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
           +L G C    N+ LV E+   G L + L   + + +     +  AV  A+G+ YLH    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 726 PPIIHRDVKTANILLNEKMQ--------AKLADFGFSKIFPAESESHIST--SIVGTVGY 775
            PIIHRD+K++NIL+ +K++         K+ DFG ++      E H +T  S  G   +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAW 180
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           + PE   ++  ++ SDV+S+G++L EL+TG
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 137/277 (49%), Gaps = 37/277 (13%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQF---RTEAQLLMRVHHRNLASLVGY 670
           +G G FGTVY G      +VA+K+L       P+QF   R E  +L +  H N+   +GY
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                N+ +V ++    +L ++L   ETK  +     + IA   AQG++YLH      II
Sbjct: 101 MTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLH---AKNII 154
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA---SNRL 786
           HRD+K+ NI L+E +  K+ DFG + +    S S       G+V ++ PE      +N  
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT 845
           + +SDVYS+GIVL EL+TG LP        +HI NR        D    +  R  A+ D 
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPY-------SHINNR--------DQIIFMVGRGYASPDL 259
Query: 846 NSVWKVAETAM-----ECVPSISFQRPTMSHVVTELK 877
           + ++K    AM     +CV  +  +RP    +++ ++
Sbjct: 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 78  E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 134 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 193 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 224

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (258), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 397

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 140/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 145
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG +      S SH    + G++ ++ 
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 253
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 254 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 397

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 334 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 480

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 140/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 82  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 137
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG +      S SH    + G++ ++ 
Sbjct: 138 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 245
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 246 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 251 E-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 397

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/284 (30%), Positives = 140/284 (49%), Gaps = 27/284 (9%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
           EI D      + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-FDETK-EALSWKDRLQIAVDAAQGL 717
            H N+   +GY      + +V ++    +L  +L   ETK E +   D   IA   AQG+
Sbjct: 62  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGM 117
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +YLH      IIHRD+K+ NI L+E +  K+ DFG +      S SH    + G++ ++ 
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 778 PEYYA---SNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRS 833
           PE       N  + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG    
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRG---- 225
Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
            + P L +   +N    +     EC+     +RP    ++  ++
Sbjct: 226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G FG VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 9   ERTDITMK-HK-LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-HISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++ + H        + +  PE
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 76  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 132 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 191 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 222

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 74  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 130 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 189 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 220

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM  G+L  +L  ET + L     + ++   A G+ Y+    +   +HRD+
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 228

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM  G+L  +L  ET + L     + ++   A G+ Y+    +   +HRD+
Sbjct: 82  E-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 228

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 34/261 (13%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYL---ADGSE---VAIKMLSAS 641
           E  L + ++Q    EI      F   LG+  FG VY G+L   A G +   VAIK L   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-D 66
Query: 642 SSQGP--KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF----- 694
            ++GP  ++FR EA L  R+ H N+  L+G       + +++ Y ++G+L ++L      
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 695 --------DET-KEALSWKDRLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEK 743
                   D T K AL   D + +    A G+EYL  HH     ++H+D+ T N+L+ +K
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDK 181
Query: 744 MQAKLADFG-FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
           +  K++D G F +++ A+    +  S++  + ++ PE     + +  SD++S+G+VL E+
Sbjct: 182 LNVKISDLGLFREVYAADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240
Query: 803 IT-GLPAIIRGYNNTHIVNRV 822
            + GL     GY+N  +V  +
Sbjct: 241 FSYGLQPYC-GYSNQDVVEMI 260

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 142/290 (48%), Gaps = 39/290 (13%)
Query: 606 ITNNFHRILGKGGFGTVYHGYLADGS----EVAIKMLS-ASSSQGPKQFRTEAQLLMRVH 660
           +  +  R++GKG FG VYHG   D +    + AIK LS  +  Q  + F  E  L+  ++
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 661 HRNLASLVG-YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           H N+ +L+G      G   ++  YM +G+L Q++    +   + KD +   +  A+G+EY
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEY 139
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK------IFPAESESHISTSIVGTV 773
           L    +   +HRD+   N +L+E    K+ADFG ++       +  +   H    +  T 
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAI--IRGYNNTHIVNRVCPFLERGD 830
                E   + R T KSDV+SFG++L EL+T G P    I  ++ TH       FL +G 
Sbjct: 197 L----ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-------FLAQG- 244
Query: 831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
            R +  P     +  +S+++V +   E  P++   RPT   +V E+++ +
Sbjct: 245 -RRLPQP----EYCPDSLYQVMQQCWEADPAV---RPTFRVLVGEVEQIV 286

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 9   ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 252 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+ E +  K+ADFG  ++   ++E          + +  PE     R T KSDV+
Sbjct: 308 RAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 367 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 398

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 16  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 9   ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L    ++
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EYM+ G+L  +L  E  + L     + +A   A G+ Y+    +   +HRD+
Sbjct: 85  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
             ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T KSDV+
Sbjct: 141 AAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L EL T       G  N  ++++V    ERG
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQV----ERG 231

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 12  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-HISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++ + H        + +  PE
Sbjct: 129 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 183
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 16  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 187
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 16  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 16  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 612 RILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V+           D   VA+K L  +S    K F  EA+LL  + H ++ 
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-----------LSWKDRLQIAVDAA 714
              G C +G  + +V+EYM +G+L ++L     +A           L+    L IA   A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ E +  K+ DFG S+   +     +    +  + 
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SDV+S G+VL E+ T
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 11  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 15  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 71
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 186
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 24  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 80
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 141 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 195
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 16  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 13  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 184
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 13  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 184
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 30  ERTDITMK-HK-LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 86
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       +V EYM YGNL  YL +  +E ++    L +A   +  +EYL
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL 146
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHRD+   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 147 E---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 201
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N  + KSDV++FG++L E+ T
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 123/238 (51%), Gaps = 32/238 (13%)
Query: 610 FHRILGKGGFGTVYHGYL---ADGSE---VAIKMLSASSSQGP--KQFRTEAQLLMRVHH 661
           F   LG+  FG VY G+L   A G +   VAIK L    ++GP  ++FR EA L  R+ H
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQH 71
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-------------DET-KEALSWKDRL 707
            N+  L+G       + +++ Y ++G+L ++L              D T K AL   D +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 708 QIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFG-FSKIFPAESESH 764
            +    A G+EYL  HH     ++H+D+ T N+L+ +K+  K++D G F +++ A+    
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           +  S++  + ++ PE     + +  SD++S+G+VL E+ +       GY+N  +V  +
Sbjct: 187 LGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 243

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 8/204 (3%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 12  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
               K   IHRD+   N L+ E    K+ADFG S++   ++ +  + +    + +  PE 
Sbjct: 129 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPES 184
Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
            A N+ + KSDV++FG++L E+ T
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 89  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 144
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 145 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 204 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 235

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT   H+ LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 13  ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLD 777
               K   IHRD+   N L+ E    K+ADFG S++   ++     T+  G    + +  
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIKWTA 182
Query: 778 PEYYASNRLTEKSDVYSFGIVLLELIT 804
           PE  A N+ + KSDV++FG++L E+ T
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 107/244 (43%), Gaps = 34/244 (13%)
Query: 612 RILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V+           D   VA+K L   +    K F+ EA+LL  + H ++ 
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLF--------------DETKEALSWKDRLQIAV 711
              G C DG  + +V+EYM +G+L ++L                + K  L     L IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 712 DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
             A G+ YL        +HRD+ T N L+   +  K+ DFG S+   +     +    + 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN----------- 820
            + ++ PE     + T +SDV+SFG++L E+ T         +NT ++            
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 257
Query: 821 RVCP 824
           RVCP
Sbjct: 258 RVCP 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 88  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 143
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 144 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 234

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 86  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 141
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 232

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           +HRD+   N L+N++   K++DFG S+    + E    TS VG+   V +  PE    ++
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE----TSSVGSKFPVRWSPPEVLMYSK 197
Query: 786 LTEKSDVYSFGIVLLEL 802
            + KSD+++FG+++ E+
Sbjct: 198 FSSKSDIWAFGVLMWEI 214

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           LG+G FG V+    H  L +  +  VA+K L  +S    + F+ EA+LL  + H+++   
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-------------LSWKDRLQIAVDAA 714
            G C +G  + +V+EYM +G+L ++L     +A             L     L +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ + +  K+ DFG S+   +     +    +  + 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SDV+SFG+VL E+ T
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           LG+G FG V+    H  L +  +  VA+K L  +S    + F+ EA+LL  + H+++   
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-------------LSWKDRLQIAVDAA 714
            G C +G  + +V+EYM +G+L ++L     +A             L     L +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ + +  K+ DFG S+   +     +    +  + 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SDV+SFG+VL E+ T
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 82  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 137
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 138 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 197 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT      LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 218 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 274
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHR++   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 389
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 226

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 81  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 136
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 137 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           LG+G FG V+    H  L +  +  VA+K L  +S    + F+ EA+LL  + H+++   
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA-------------LSWKDRLQIAVDAA 714
            G C +G  + +V+EYM +G+L ++L     +A             L     L +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL        +HRD+ T N L+ + +  K+ DFG S+   +     +    +  + 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++ PE     + T +SDV+SFG+VL E+ T
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 85  EP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 140
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 200 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 231

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 86  EP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 141
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 232

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 90  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 145
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 205 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 236

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 226

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 75  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 130
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 131 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 190 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N L+N++   K++DFG S+ +   E  S + +     V +  PE    ++ +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFS 179
Query: 788 EKSDVYSFGIVLLEL 802
            KSD+++FG+++ E+
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 10/205 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E  DIT      LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + 
Sbjct: 257 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 313
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           H NL  L+G C       ++ E+M YGNL  YL +  ++ ++    L +A   +  +EYL
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSIVGTVGYLDPE 779
               K   IHR++   N L+ E    K+ADFG S++   ++  +H        + +  PE
Sbjct: 374 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 428
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             A N+ + KSDV++FG++L E+ T
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N L+N++   K++DFG S+ +   E  S + +     V +  PE    ++ +
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFS 183
Query: 788 EKSDVYSFGIVLLEL 802
            KSD+++FG+++ E+
Sbjct: 184 SKSDIWAFGVLMWEI 198

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 610 FHRILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHH 661
           + R +G+G FG V+    A G       + VA+KML   +S   +  F+ EA L+    +
Sbjct: 51  YVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------------------- 700
            N+  L+G C  G  + L++EYMAYG+L ++L   +                        
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 701 -LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFP 758
            LS  ++L IA   A G+ YL        +HRD+ T N L+ E M  K+ADFG S+ I+ 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           A+         +  + ++ PE    NR T +SDV+++G+VL E+ +
Sbjct: 227 ADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N L+N++   K++DFG S+ +   E  S + +     V +  PE    ++ +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFS 184
Query: 788 EKSDVYSFGIVLLEL 802
            KSD+++FG+++ E+
Sbjct: 185 SKSDIWAFGVLMWEI 199

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N L+N++   K++DFG S+ +   E  S + +     V +  PE    ++ +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFS 199
Query: 788 EKSDVYSFGIVLLELIT 804
            KSD+++FG+++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N L+N++   K++DFG S+ +   E  S + +     V +  PE    ++ +
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFS 190
Query: 788 EKSDVYSFGIVLLEL 802
            KSD+++FG+++ E+
Sbjct: 191 SKSDIWAFGVLMWEI 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL        
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+   N L+N++   K++DFG S+ +  + E   S      V +  PE    ++ + 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 789 KSDVYSFGIVLLEL 802
           KSD+++FG+++ E+
Sbjct: 186 KSDIWAFGVLMWEI 199

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHR++
Sbjct: 76  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNL 131
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 132 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 191 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 222

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 10/216 (4%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G  G V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L      
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + ANIL+++ +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 794 SFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
           SFGI+L E++T       G  N  ++      LERG
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L D  +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANIL++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 145/311 (46%), Gaps = 62/311 (19%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 36  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDET---KEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL           F+ +   +E LS KD 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 258
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 259 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 308
Query: 879 CLEMETAREQI 889
            + + + +E +
Sbjct: 309 IVALTSNQEXL 319

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 126/271 (46%), Gaps = 29/271 (10%)
Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G FG V+ G L AD + VA+K    +     K +F  EA++L +  H N+  L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
                + +V E +  G+   +L  E    L  K  LQ+  DAA G+EYL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG----TVGYLDPEYYASNRLT 787
           D+   N L+ EK   K++DFG S+    E    +  +  G     V +  PE     R +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTN 846
            +SDV+SFGI+L E  +   +     +N         F+E+G        RL       +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVEKGG-------RLPCPELCPD 342
Query: 847 SVWKVAETAMECVPSISFQRPTMSHVVTELK 877
           +V+++ E      P    QRP+ S +  EL+
Sbjct: 343 AVFRLMEQCWAYEPG---QRPSFSTIYQELQ 370

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L D  +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANI+++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L D  +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANI+++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY  + ++VA+K L    +   + F  EA L+  + H  L  L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ EYMA G+L  +L  +    +     +  +   A+G+ Y+    +   IHRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + AN+L++E +  K+ADFG +++   ++E          + +  PE       T KSDV+
Sbjct: 137 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 794 SFGIVLLELIT 804
           SFGI+L E++T
Sbjct: 196 SFGILLYEIVT 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 36/293 (12%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           N  + LG+G FG V           A    VA+KML   ++    +   +E ++L+ + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ----------I 709
           H N+ +L+G C   GG + ++ E+  +GNL  YL  +  E + +KD  +           
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           +   A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +       
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
              + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEG 263
Query: 830 DVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                   R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 264 T-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 126/271 (46%), Gaps = 29/271 (10%)
Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G FG V+ G L AD + VA+K    +     K +F  EA++L +  H N+  L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
                + +V E +  G+   +L  E    L  K  LQ+  DAA G+EYL   C    IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG----TVGYLDPEYYASNRLT 787
           D+   N L+ EK   K++DFG S+    E    +  +  G     V +  PE     R +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTN 846
            +SDV+SFGI+L E  +   +     +N         F+E+G        RL       +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVEKGG-------RLPCPELCPD 342
Query: 847 SVWKVAETAMECVPSISFQRPTMSHVVTELK 877
           +V+++ E      P    QRP+ S +  EL+
Sbjct: 343 AVFRLMEQCWAYEPG---QRPSFSTIYQELQ 370

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 31  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------- 693
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L         
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 694 ---FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD 750
              F      LS +D L  +   AQG+ +L        IHRDV   N+LL     AK+ D
Sbjct: 151 DPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           FG ++    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
           G+++S  +Q+   +         R LGKG FG VY   LA   +    +A+K+L  +  +
Sbjct: 1   GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDE 696
                 Q R E ++   + H N+  L GY +D   V L+ EY   G + + L     FDE
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 112
Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            + A           + A  L Y H      +IHRD+K  N+LL    + K+ADFG+S  
Sbjct: 113 QRTA-------TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            P+       T++ GT+ YL PE        EK D++S G++  E + G P
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 18  RPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANALSY 127
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G+P
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
           G+++S  +Q+   +         R LGKG FG VY   LA   +    +A+K+L  +  +
Sbjct: 1   GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDE 696
                 Q R E ++   + H N+  L GY +D   V L+ EY   G + + L     FDE
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE 112
Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            + A           + A  L Y H      +IHRD+K  N+LL    + K+ADFG+S  
Sbjct: 113 QRTA-------TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            P+       T++ GT+ YL PE        EK D++S G++  E + G P
Sbjct: 163 APSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 12/192 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
           + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+   N+L++E   AK++DFG +K    E+ S   T  +  V +  PE     + + KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKS 367
Query: 791 DVYSFGIVLLEL 802
           DV+SFGI+L E+
Sbjct: 368 DVWSFGILLWEI 379

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 12/192 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
           + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G  
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+   N+L++E   AK++DFG +K    E+ S   T  +  V +  PE     + + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKS 180
Query: 791 DVYSFGIVLLEL 802
           DV+SFGI+L E+
Sbjct: 181 DVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 12/192 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
           + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+   N+L++E   AK++DFG +K    E+ S   T  +  V +  PE     + + KS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKS 195
Query: 791 DVYSFGIVLLEL 802
           DV+SFGI+L E+
Sbjct: 196 DVWSFGILLWEI 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 94
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 147
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + S VGT  Y+ P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 247

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 144/311 (46%), Gaps = 43/311 (13%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFH-------RILGKGGFGTVYHGYLADGS-----EVAI 635
           +G++ SD  Q     ++  T   H       +++G G FG VY G L   S      VAI
Sbjct: 23  QGAMGSDPNQ----AVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78
Query: 636 KMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
           K L A  ++  +  F  EA ++ +  H N+  L G  +    + ++ EYM  G L ++L 
Sbjct: 79  KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           ++  E  S    + +    A G++YL +      +HRD+   NIL+N  +  K++DFG S
Sbjct: 139 EKDGE-FSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 755 KIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY 813
           ++   + E+  +TS     + +  PE  +  + T  SDV+SFGIV+ E++T        Y
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT--------Y 246
Query: 814 NNTHIVNRVCPFLERGD---VRSIVDP-RLEANFDTNSVWKVAETAMECVPSISFQRPTM 869
                     P+ E  +   +++I D  RL    D  S   + +  M+C      +RP  
Sbjct: 247 GER-------PYWELSNHEVMKAINDGFRLPTPMDCPSA--IYQLMMQCWQQERARRPKF 297
Query: 870 SHVVTELKKCL 880
           + +V+ L K +
Sbjct: 298 ADIVSILDKLI 308

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 23  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 82
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-------- 694
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L         
Sbjct: 83  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD 142
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
            E    L  +D L  +   AQG+ +L        IHRDV   N+LL     AK+ DFG +
Sbjct: 143 KEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 199
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           +    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 200 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 71
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 124
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 125 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 224

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 25  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 247
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 248 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 297
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 298 IVALTSNQE 306

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-------YTAEIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + S VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E       ++ SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 246

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 31  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-------- 694
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L         
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD 150
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
            E    L  +D L  +   AQG+ +L        IHRDV   N+LL     AK+ DFG +
Sbjct: 151 KEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 207
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           +    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 208 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 90
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 143
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + S VGT  Y+ P
Sbjct: 144 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 243

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 36  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 258
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 259 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 308
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 309 IVALTSNQE 317

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 29  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 251
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 252 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 301
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 302 IVALTSNQE 310

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 21  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 243
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 244 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 293
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 294 IVALTSNQE 302

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 31  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 88  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P    S   T++ GT+ YL PE
Sbjct: 141 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 193
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 194 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 39/296 (13%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           N  + LG+G FG V           A    VA+KML   ++    +   +E ++L+ + H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK-------DRLQI--- 709
           H N+ +L+G C   GG + ++ E+  +GNL  YL  +  E + +K       D L +   
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 710 ---AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
              +   A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +    
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL 826
                 + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRL 264
Query: 827 ERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
           + G        R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 265 KEGT-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 40  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 149
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P    S   T++ GT+ YL PE
Sbjct: 150 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 202
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 28  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 250
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 251 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 300
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 301 IVALTSNQE 309

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 77  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 299
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 300 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 349
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 350 IVALTSNQE 358

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 141/309 (45%), Gaps = 62/309 (20%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 36  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 258
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 259 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 308
Query: 879 CLEMETARE 887
            + + + +E
Sbjct: 309 IVALTSNQE 317

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 142/311 (45%), Gaps = 62/311 (19%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           LG+G FG V    LA+            ++VA+KML + +++       +E +++  +  
Sbjct: 36  LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
           H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIV 819
           T+    V ++ PE       T +SDV+SFG++L E+ T       G+P           V
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V 258
Query: 820 NRVCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
             +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L +
Sbjct: 259 EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDR 308
Query: 879 CLEMETAREQI 889
            + + + +E +
Sbjct: 309 IVALTSNQEYL 319

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 19  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 128
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 181
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 70
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 123
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 124 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 68
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 121
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 122 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 612 RILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V    +    D  G +VA+K L   S        + E ++L  ++H N+ 
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 666 SLVGYCN-DGGN-VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              G C  DGGN + L+ E++  G+LK+YL  + K  ++ K +L+ AV   +G++YL  G
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 143
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPEYYA 782
            +   +HRD+   N+L+  + Q K+ DFG +K    + E   +       V +  PE   
Sbjct: 144 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
            ++    SDV+SFG+ L EL+T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 69
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 122
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 123 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 28/236 (11%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 31  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE------ 696
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L  +      
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLE 150
Query: 697 --------TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL 748
                    +E LS +D L  +   AQG+ +L        IHRDV   N+LL     AK+
Sbjct: 151 YSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 207
Query: 749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            DFG ++    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 208 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 13  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 70  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 122
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 175
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 176 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 144
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + + VGT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 244

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 132/290 (45%), Gaps = 38/290 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR------------LQIAVD 712
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K              +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
            A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +          
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR 832
           + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G   
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT-- 268
Query: 833 SIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 269 -----RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 612 RILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLA 665
           R LG+G FG V    +    D  G +VA+K L   S        + E ++L  ++H N+ 
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 666 SLVGYCN-DGGN-VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              G C  DGGN + L+ E++  G+LK+YL  + K  ++ K +L+ AV   +G++YL  G
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--G 131
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPEYYA 782
            +   +HRD+   N+L+  + Q K+ DFG +K    + E   +       V +  PE   
Sbjct: 132 SRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
            ++    SDV+SFG+ L EL+T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 15  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 124
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPE 177
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 26/234 (11%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 31  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------- 693
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L         
Sbjct: 91  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150
Query: 694 ---FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD 750
              F       S +D L  +   AQG+ +L        IHRDV   N+LL     AK+ D
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           FG ++    +S   +  +    V ++ PE       T +SDV+S+GI+L E+ +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 209 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 313
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 314 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 363
Query: 881 EMETARE 887
            + T  E
Sbjct: 364 TLTTNEE 370

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 18  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 127
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 19  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 76  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 128
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 129 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPE 181
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 150 TYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 254
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 255 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 304
Query: 881 EMETARE 887
            + T +E
Sbjct: 305 TLTTNQE 311

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 11  RPLGKGKFGNVY---LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 68  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 120
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPE 173
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 174 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 48/296 (16%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
           F  ++G+G FG V    +  DG   + AIK M   +S    + F  E ++L ++ HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQIA 710
            +L+G C   G + L  EY  +GNL  +L               + T   LS +  L  A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
            D A+G++YL    +   IHRD+   NIL+ E   AK+ADFG S+      E ++     
Sbjct: 139 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK--- 188
Query: 771 GTVGYLDPEYYASNRL-----TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF 825
            T+G L   + A   L     T  SDV+S+G++L E+++           T      C  
Sbjct: 189 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMTCAE 239
Query: 826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
           L     +     RLE   + +   +V +   +C     ++RP+ + ++  L + LE
Sbjct: 240 LYEKLPQGY---RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 18  RPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 75  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANALSY 127
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+        ++ GT+ YL PE
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPE 180
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G+P
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 48/296 (16%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
           F  ++G+G FG V    +  DG   + AIK M   +S    + F  E ++L ++ HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQIA 710
            +L+G C   G + L  EY  +GNL  +L               + T   LS +  L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
            D A+G++YL    +   IHRD+   NIL+ E   AK+ADFG S+      E ++     
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK--- 198
Query: 771 GTVGYLDPEYYASNRL-----TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF 825
            T+G L   + A   L     T  SDV+S+G++L E+++           T      C  
Sbjct: 199 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMTCAE 249
Query: 826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
           L     +     RLE   + +   +V +   +C     ++RP+ + ++  L + LE
Sbjct: 250 LYEKLPQGY---RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V+ GY  + ++VA+K L    +   + F  EA L+  + H  L  L      
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + ++ E+MA G+L  +L  +    +     +  +   A+G+ Y+    +   IHRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
           + AN+L++E +  K+ADFG +++   ++E          + +  PE       T KS+V+
Sbjct: 136 RAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 794 SFGIVLLELIT 804
           SFGI+L E++T
Sbjct: 195 SFGILLYEIVT 205

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 15  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 124
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T++ GT+ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPE 177
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 144
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 244

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 102/192 (53%), Gaps = 12/192 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
           + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G  
Sbjct: 18  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 131
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+   N+L++E   AK++DFG +K    E+ S   T  +  V +  PE       + KS
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREAAFSTKS 186
Query: 791 DVYSFGIVLLEL 802
           DV+SFGI+L E+
Sbjct: 187 DVWSFGILLWEI 198

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 75
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 128
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 186 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 144
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 244

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 98
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 151
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 251

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F +I G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V
Sbjct: 25  FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
            Y +    G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS 134
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYY 781
                +IHRD+K+ NILL      KL DFGF ++I P +S+    +++VGT  ++ PE  
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 188
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 246

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 246

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 137/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           +  L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 94
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 147
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 205 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    ++ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQGPK---QFRTEAQLLMRVHHRN 663
           ++LG G FGTVY G      E     VAIK+L+ ++  GPK   +F  EA ++  + H +
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 78
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           L  L+G C     + LV + M +G L +Y+  E K+ +  +  L   V  A+G+ YL   
Sbjct: 79  LVRLLGVCL-SPTIQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE-- 134
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            +  ++HRD+   N+L+      K+ DFG +++   + + + +      + ++  E    
Sbjct: 135 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T +SDV+S+G+ + EL+T
Sbjct: 194 RKFTHQSDVWSYGVTIWELMT 214

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 152 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 256
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 257 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 306
Query: 881 EMETARE 887
            + T  E
Sbjct: 307 TLTTNEE 313

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+       T + GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L    +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANI+++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQGPK---QFRTEAQLLMRVHHRN 663
           ++LG G FGTVY G      E     VAIK+L+ ++  GPK   +F  EA ++  + H +
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 101
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           L  L+G C     + LV + M +G L +Y+  E K+ +  +  L   V  A+G+ YL   
Sbjct: 102 LVRLLGVCLSP-TIQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               ++HRD+   N+L+      K+ DFG +++   + + + +      + ++  E    
Sbjct: 160 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T +SDV+S+G+ + EL+T
Sbjct: 217 RKFTHQSDVWSYGVTIWELMT 237

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 96
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 149
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 150 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 207 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 249

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 90
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 143
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 144 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 201 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 243

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++ EY + GNL++YL           +D  +   E +++KD +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 155 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 259
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 260 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 309
Query: 881 EMETARE 887
            + T  E
Sbjct: 310 TLTTNEE 316

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 609 NFHRILGKGGFGT-VYHGYLADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F T V    LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET              +    LE
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-------YTAEIVSALE 144
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           E        + SD+++ G ++ +L+ GLP   R  N   I  ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKI 244

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 16  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 125
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+A+FG+S   P+       T++ GT+ YL PE
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPE 178
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 259
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+    +++
Sbjct: 260 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 259
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+    +++
Sbjct: 260 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 268
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 269 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
           R LGKG FG VY     +   + A+K+L  +  +      Q R E ++   + H N+  L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
            GY +D   V L+ EY   G + + L     FDE + A           + A  L Y H 
Sbjct: 74  YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSYCH- 125
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                +IHRD+K  N+LL    + K+ADFG+S   P+   +    ++ GT+ YL PE   
Sbjct: 126 --SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGTLDYLPPEMIE 179
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                EK D++S G++  E + G P
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F +I G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V
Sbjct: 25  FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
            Y +    G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS 134
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYY 781
                +IHRD+K+ NILL      KL DFGF ++I P +S+    + +VGT  ++ PE  
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVV 188
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 15  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 124
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+        ++ GT+ YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPE 177
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+   +    ++ GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 24/200 (12%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           ++G+G FG V         +VAIK + + S +  K F  E + L RV+H N+  L G C 
Sbjct: 16  VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 673 DGGNVGLVYEYMAYGNLKQYL-------FDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
           +   V LV EY   G+L   L       +     A+SW       +  +QG+ YLH    
Sbjct: 73  N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQP 124
Query: 726 PPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
             +IHRD+K  N+LL       K+ DFG +     + ++H++ +  G+  ++ PE +  +
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNN-KGSAAWMAPEVFEGS 179
Query: 785 RLTEKSDVYSFGIVLLELIT 804
             +EK DV+S+GI+L E+IT
Sbjct: 180 NYSEKCDVFSWGIILWEVIT 199

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F +I G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V
Sbjct: 26  FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIV 81
Query: 669 GYCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
            Y +    G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS 135
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYY 781
                +IHRD+K+ NILL      KL DFGF ++I P +S+    + +VGT  ++ PE  
Sbjct: 136 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVV 189
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRG 812
           E        + SD+++ G ++ +L+ GLP    G
Sbjct: 204 ELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRN 663
            F +ILG+G F TV     LA   E AIK+L        ++ P   R E  ++ R+ H  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-ERDVMSRLDHPF 93
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLE 718
              L     D   +     Y   G L +Y+     FDET        R   A +    LE
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALE 146
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      IIHRD+K  NILLNE M  ++ DFG +K+   ES+   +   VGT  Y+ P
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRG 812
           E        + SD+++ G ++ +L+ GLP    G
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+   +    ++ GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA----ALCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L    +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 136
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANI+++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+A+FG+S   P+       T++ GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
           G+++S  +Q+   +         R LGKG FG VY   LA   +    +A+K+L  +  +
Sbjct: 1   GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDE 696
                 Q R E ++   + H N+  L GY +D   V L+ EY   G + + L     FDE
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE 112
Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            + A           + A  L Y H      +IHRD+K  N+LL    + K+ADFG+S  
Sbjct: 113 QRTA-------TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH 162
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            P+         + GT+ YL PE        EK D++S G++  E + G P
Sbjct: 163 APSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F +I G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V
Sbjct: 25  FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
            Y +    G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS 134
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYY 781
                +IHRD+K+ NILL      KL DFGF ++I P +S+    + +VGT  ++ PE  
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVV 188
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 36/293 (12%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
           N  + LG+G FG V           A    VA+KML   ++    +   +E ++L+ + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----------LQI 709
           H N+ +L+G C   GG + ++ E+  +GNL  YL  +  E + +KD           +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           +   A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +       
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
              + ++ PE       T +SDV+SFG++L E+ + L A    Y    I       L+ G
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFXRRLKEG 263
Query: 830 DVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                   R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 264 T-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 42/293 (14%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL---------FDETKEALSWKDRLQI------ 709
           +L+G C   GG + ++ E+  +GNL  YL         + E  E L +KD L +      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL-YKDFLTLEHLICY 155
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           +   A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +       
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
              + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEG 269
Query: 830 DVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                   R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 270 T-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 24/200 (12%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           ++G+G FG V         +VAIK + + S +  K F  E + L RV+H N+  L G C 
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 673 DGGNVGLVYEYMAYGNLKQYL-------FDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
           +   V LV EY   G+L   L       +     A+SW       +  +QG+ YLH    
Sbjct: 72  N--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQP 123
Query: 726 PPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
             +IHRD+K  N+LL       K+ DFG +     + ++H++ +  G+  ++ PE +  +
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNN-KGSAAWMAPEVFEGS 178
Query: 785 RLTEKSDVYSFGIVLLELIT 804
             +EK DV+S+GI+L E+IT
Sbjct: 179 NYSEKCDVFSWGIILWEVIT 198

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 268
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 269 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 40  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 97  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 149
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+         + GT+ YL PE
Sbjct: 150 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCGTLDYLPPE 202
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 203 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 230

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 16  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 73  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 125
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+         + GT+ YL PE
Sbjct: 126 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLDYLPPE 178
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 137/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++  Y + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 48/296 (16%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
           F  ++G+G FG V    +  DG   + AIK M   +S    + F  E ++L ++ HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQIA 710
            +L+G C   G + L  EY  +GNL  +L               + T   LS +  L  A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
            D A+G++YL    +   IHR++   NIL+ E   AK+ADFG S+      E ++     
Sbjct: 146 ADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVKK--- 195
Query: 771 GTVGYLDPEYYASNRL-----TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF 825
            T+G L   + A   L     T  SDV+S+G++L E+++           T      C  
Sbjct: 196 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMTCAE 246
Query: 826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
           L     +     RLE   + +   +V +   +C     ++RP+ + ++  L + LE
Sbjct: 247 LYEKLPQGY---RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 268
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 269 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 259
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+    +++
Sbjct: 260 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 259
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+    +++
Sbjct: 260 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDR 308

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 82  RLLGICLTS-TVQLIMQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F +I G+G  GTVY    +A G EVAI+ ++    Q PK+     ++L+   ++N  ++V
Sbjct: 26  FEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKN-PNIV 81
Query: 669 GYCND---GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
            Y +    G  + +V EY+A G+L   + +      +  D  QIA    +  Q LE+LH 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS 135
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYY 781
                +IHR++K+ NILL      KL DFGF ++I P +S+    +++VGT  ++ PE  
Sbjct: 136 N---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVV 189
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 190 TRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
           LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH N+ 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWK--------DRLQI------A 710
           +L+G C   GG + ++ E+  +GNL  YL  +  E + +K        D L +      +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
              A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +        
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + ++ PE       T +SDV+SFG++L E+ + L A    Y    I    C  L+ G 
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYPGVKIDEEFCRRLKEGT 305
Query: 831 VRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                  R+ A ++ T  ++   +T ++C      QRPT S +V  L   L+
Sbjct: 306 -------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+         + GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 82  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 137
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 138 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 226

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 17  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 74  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 126
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+         + GT+ YL PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----DLCGTLDYLPPE 179
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  +  +      Q R E ++   + H N+
Sbjct: 14  RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L GY +D   V L+ EY   G + + L     FDE + A           + A  L Y
Sbjct: 71  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSY 123
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      +IHRD+K  N+LL    + K+ADFG+S   P+         + GT+ YL PE
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLDYLPPE 176
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++S G++  E + G P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 91  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 146
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 147 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 206 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 85  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAI-----KMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V I     ++  A+S +  K+   EA ++  V + ++ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 115 RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 170
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 171 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 230 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 259

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 25/267 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
           LG G FG V  G      +VA+KM+    S    +F  EAQ +M++ H  L    G C+ 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 674 GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDV 733
              + +V EY++ G L  YL    K  L     L++  D  +G+ +L        IHRD+
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 734 KTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNRLTEKS 790
              N L++  +  K++DFG ++      + ++S+  VGT   V +  PE +   + + KS
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS--VGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 791 DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWK 850
           DV++FGI++ E+ +        Y N+ +V +V           +  P L ++        
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGHRLYRPHLASD-------T 233
Query: 851 VAETAMECVPSISFQRPTMSHVVTELK 877
           + +    C   +  +RPT   +++ ++
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 137/307 (44%), Gaps = 58/307 (18%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
           LG+G FG V              +   VA+KML   +++       +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----------FDETK---EALSWKDRLQI 709
           + +L+G C   G + ++  Y + GNL++YL           +D  +   E +++KD +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
               A+G+EYL    C    IHRD+   N+L+ E    K+ADFG ++          +T+
Sbjct: 163 TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-------GLPAIIRGYNNTHIVNR 821
               V ++ PE       T +SDV+SFG+++ E+ T       G+P           V  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VEE 267
Query: 822 VCPFLERGDVRSIVDPRLEANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
           +   L+ G        R++   + TN ++ +       VPS   QRPT   +V +L + L
Sbjct: 268 LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAVPS---QRPTFKQLVEDLDRIL 317
Query: 881 EMETARE 887
            + T  E
Sbjct: 318 TLTTNEE 324

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 84  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 75  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 130
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 131 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 78  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGMNYLEDR-- 133
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 134 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 193 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 222

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ DG  V    AIK+L  ++S +  K+   EA ++  V    ++
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V LV + M YG L  ++  E +  L  +D L   +  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLVTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLED--- 137
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA-ESESHISTSIVGTVGYLDPEYYASN 784
             ++HRD+   N+L+      K+ DFG +++    E+E H     V  + ++  E     
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILRR 196
Query: 785 RLTEKSDVYSFGIVLLELIT-------GLPA 808
           R T +SDV+S+G+ + EL+T       G+PA
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 84  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 84  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 106 RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 161
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 162 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 221 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 250

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 84  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 139
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 140 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 87  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 142
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 143 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 202 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 231

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 122/232 (52%), Gaps = 29/232 (12%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
           +H  KEG  K+D  QF   E++       ++LG+G FG V+      GS+     A+K+L
Sbjct: 11  THHVKEGHEKADPSQF---ELL-------KVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
             ++ +   + RT  E  +L+ V+H  +  L       G + L+ +++  G+L   L   
Sbjct: 61  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--- 117
Query: 697 TKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           +KE +  ++ ++  + + A  L++LH      II+RD+K  NILL+E+   KL DFG SK
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 756 IFPAESESH--ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
               ES  H   + S  GTV Y+ PE       T+ +D +SFG+++ E++TG
Sbjct: 175 ----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 88  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G +G VY    + G  VA+K   L A     P     E  LL  +HH N+ SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+E+M   +LK+ L DE K  L      QI +   Q L  + H  +  I+HR
Sbjct: 89  HSERCLTLVFEFME-KDLKKVL-DENKTGLQ---DSQIKIYLYQLLRGVAHCHQHRILHR 143
Query: 732 DVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L+N     KLADFG ++ F  P  S +H     V T+ Y  P+    S + + 
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH----EVVTLWYRAPDVLMGSKKYST 199
Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  E+ITG P
Sbjct: 200 SVDIWSIGCIFAEMITGKP 218

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 610 FHRILGKGGFGTVY----HGYLADGS--EVAIKMLSASSSQGPKQ-FRTEAQLLMRV-HH 661
           F ++LG G FG V     +G    G   +VA+KML   +    ++   +E +++ ++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF---------------------DETKEA 700
            N+ +L+G C   G + L++EY  YG+L  YL                      +E    
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 701 LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE 760
           L+++D L  A   A+G+E+L        +HRD+   N+L+      K+ DFG ++   ++
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           S   +  +    V ++ PE       T KSDV+S+GI+L E+ +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
           D  Q  Y+E  +   N   F + LG G FG V        G E     VA+KML +++  
Sbjct: 16  DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 75
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF-------- 694
             K+   +E +++  +  H N+ +L+G C  GG V ++ EY  YG+L  +L         
Sbjct: 76  DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLG 135
Query: 695 -------------DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
                         E    L  +D L  +   AQG+ +L        IHRDV   N+LL 
Sbjct: 136 PSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 192
Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLE 801
               AK+ DFG ++    +S   +  +    V ++ PE       T +SDV+S+GI+L E
Sbjct: 193 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 252
Query: 802 LIT 804
           + +
Sbjct: 253 IFS 255

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 85  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 140
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 141 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G +G VY    + G  VA+K   L A     P     E  LL  +HH N+ SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+E+M   +LK+ L DE K  L      QI +   Q L  + H  +  I+HR
Sbjct: 89  HSERCLTLVFEFME-KDLKKVL-DENKTGLQ---DSQIKIYLYQLLRGVAHCHQHRILHR 143
Query: 732 DVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L+N     KLADFG ++ F  P  S +H     V T+ Y  P+    S + + 
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH----EVVTLWYRAPDVLMGSKKYST 199
Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  E+ITG P
Sbjct: 200 SVDIWSIGCIFAEMITGKP 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 119/232 (51%), Gaps = 29/232 (12%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
           +H  KEG  K+D  QF             ++LG+G FG V+      GS+     A+K+L
Sbjct: 11  THHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
             ++ +   + RT  E  +L+ V+H  +  L       G + L+ +++  G+L   L   
Sbjct: 61  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--- 117
Query: 697 TKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           +KE +  ++ ++  + + A  L++LH      II+RD+K  NILL+E+   KL DFG SK
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174
Query: 756 IFPAESESH--ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
               ES  H   + S  GTV Y+ PE       T+ +D +SFG+++ E++TG
Sbjct: 175 ----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           ILG GG   V+    L    +VA+K+L A  ++ P    +FR EAQ    ++H  + ++ 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 669 GYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
                    G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H   
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQN- 152
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYAS 783
              IIHRDVK ANI+++     K+ DFG ++       S   T+ ++GT  YL PE    
Sbjct: 153 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + +  +SDVYS G VL E++TG P
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 119/232 (51%), Gaps = 29/232 (12%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
           +H  KEG  K+D  QF             ++LG+G FG V+      GS+     A+K+L
Sbjct: 12  THHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 61
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
             ++ +   + RT  E  +L+ V+H  +  L       G + L+ +++  G+L   L   
Sbjct: 62  KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--- 118
Query: 697 TKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           +KE +  ++ ++  + + A  L++LH      II+RD+K  NILL+E+   KL DFG SK
Sbjct: 119 SKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 175
Query: 756 IFPAESESH--ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
               ES  H   + S  GTV Y+ PE       T+ +D +SFG+++ E++TG
Sbjct: 176 ----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 83  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 138
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 139 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 88  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 31/285 (10%)
Query: 612 RILGKGGFGTVYHGYLA--DGS--EVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           +ILG+G FG+V  G L   DG+  +VA+K   L  SS +  ++F +EA  +    H N+ 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 666 SLVGYCNDGGNVGL-----VYEYMAYGNLKQYLFDETKEA----LSWKDRLQIAVDAAQG 716
            L+G C +  + G+     +  +M YG+L  YL     E     +  +  L+  VD A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           +EYL +      +HRD+   N +L + M   +ADFG SK   +             V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
             E  A    T KSDV++FG+ + E+ T       G  N  + +    +L  G       
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD----YLLHGH------ 266
Query: 837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
            RL+   D     ++ E    C  +    RPT S +  +L+K LE
Sbjct: 267 -RLKQPEDCLD--ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           LGKG FG+V    +  L D  G+ VA+K L  S     + F+ E Q+L  +H   +    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           G     G  ++ LV EY+  G L+ +L    +  L     L  +    +G+EYL  G + 
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 134
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYYASNR 785
             +HRD+   NIL+  +   K+ADFG +K+ P + + ++        + +  PE  + N 
Sbjct: 135 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 786 LTEKSDVYSFGIVLLELIT 804
            + +SDV+SFG+VL EL T
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           LGKG FG+V    +  L D  G+ VA+K L  S     + F+ E Q+L  +H   +    
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           G     G  ++ LV EY+  G L+ +L    +  L     L  +    +G+EYL  G + 
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 135
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYYASNR 785
             +HRD+   NIL+  +   K+ADFG +K+ P + + ++        + +  PE  + N 
Sbjct: 136 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 786 LTEKSDVYSFGIVLLELIT 804
            + +SDV+SFG+VL EL T
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 117/260 (45%), Gaps = 31/260 (11%)
Query: 578 LNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLA--DGS--EV 633
           L + +   +K   +    QQFT            R+LGKG FG+V    L   DGS  +V
Sbjct: 5   LGISDELKEKLEDVLIPEQQFTLG----------RMLGKGEFGSVREAQLKQEDGSFVKV 54
Query: 634 AIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG------LVYEYMA 685
           A+KML A   +S   ++F  EA  +    H ++A LVG        G      ++  +M 
Sbjct: 55  AVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114
Query: 686 YGNLKQYLF----DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
           +G+L  +L      E    L  +  ++  VD A G+EYL        IHRD+   N +L 
Sbjct: 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLA 171
Query: 742 EKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL 800
           E M   +ADFG S KI+  +       S +  V +L  E  A N  T  SDV++FG+ + 
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKL-PVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 801 ELITGLPAIIRGYNNTHIVN 820
           E++T       G  N  I N
Sbjct: 231 EIMTRGQTPYAGIENAEIYN 250

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           LGKG FG+V    +  L D  G+ VA+K L  S     + F+ E Q+L  +H   +    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           G     G  ++ LV EY+  G L+ +L    +  L     L  +    +G+EYL  G + 
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 147
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             +HRD+   NIL+  +   K+ADFG +K+ P + + ++      + + +  PE  + N 
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 786 LTEKSDVYSFGIVLLELIT 804
            + +SDV+SFG+VL EL T
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASLV 668
           +LGKG F  VY    +  G EVAIKM+   +   +   ++ + E ++  ++ H ++  L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
            Y  D   V LV E    G + +YL +  K   S  +          G+ YLH HG    
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSHG---- 132
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           I+HRD+  +N+LL   M  K+ADFG +       E H   ++ GT  Y+ PE    +   
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSAHG 190
Query: 788 EKSDVYSFGIVLLELITGLP 807
            +SDV+S G +   L+ G P
Sbjct: 191 LESDVWSLGCMFYTLLIGRP 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 46/229 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
           + LG+G FG     T +H     GY    + VA+KML  ++S  P + R   +E  +L +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK-------------------- 698
           V+H ++  L G C+  G + L+ EY  YG+L+ +L +  K                    
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 699 --EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK- 755
              AL+  D +  A   +QG++YL    +  ++HRD+   NIL+ E  + K++DFG S+ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++  +S    S   +  V ++  E    +  T +SDV+SFG++L E++T
Sbjct: 200 VYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 46/229 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
           + LG+G FG     T +H     GY    + VA+KML  ++S  P + R   +E  +L +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK-------------------- 698
           V+H ++  L G C+  G + L+ EY  YG+L+ +L +  K                    
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 699 --EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK- 755
              AL+  D +  A   +QG++YL    +  ++HRD+   NIL+ E  + K++DFG S+ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++  +S    S   +  V ++  E    +  T +SDV+SFG++L E++T
Sbjct: 200 VYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 25/233 (10%)
Query: 613 ILGKGGFG-TVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +LGKG FG  +   +   G  + +K L     +  + F  E +++  + H N+   +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
                +  + EY+  G L+  +         W  R+  A D A G+ YLH      IIHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 732 DVKTANILLNEKMQAKLADFGFSKIFPAES------------ESHISTSIVGTVGYLDPE 779
           D+ + N L+ E     +ADFG +++   E             +     ++VG   ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 780 YYASNRLTEKSDVYSFGIVLLELITG-------LPAIIR-GYNNTHIVNRVCP 824
                   EK DV+SFGIVL E+I         LP  +  G N    ++R CP
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 108/236 (45%), Gaps = 35/236 (14%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  S  +      Q R E ++   + H N+
Sbjct: 20  RPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             +  Y +D   + L+ E+   G L + L     FDE + A           + A  L Y
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-------TFMEELADALHY 129
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H   +  +IHRD+K  N+L+  K + K+ADFG+S      + S     + GT+ YL PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPE 182
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIR-GYNNTH--IVN---RVCPFLERG 829
                   EK D++  G++  E + G+P      +  TH  IVN   +  PFL  G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 238

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++L  G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 88  RLLGICLTS-TVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 232

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++L  G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 108/236 (45%), Gaps = 35/236 (14%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    +A+K+L  S  +      Q R E ++   + H N+
Sbjct: 21  RPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             +  Y +D   + L+ E+   G L + L     FDE + A           + A  L Y
Sbjct: 78  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-------TFMEELADALHY 130
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H   +  +IHRD+K  N+L+  K + K+ADFG+S      + S     + GT+ YL PE
Sbjct: 131 CH---ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPE 183
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIR-GYNNTH--IVN---RVCPFLERG 829
                   EK D++  G++  E + G+P      +  TH  IVN   +  PFL  G
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 239

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           + YL+       +HRD+   N ++      K+ DFG ++              +  V ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSEV----AIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++L  G FGTVY G ++ +G +V    AIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+  E K+ +  +  L   V  A+G+ YL     
Sbjct: 88  RLLGICLTS-TVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 143
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 144 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 786 LTEKSDVYSFGIVLLELIT-------GLPA 808
            T +SDV+S+G+ + EL+T       G+PA
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPYDGIPA 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           + YL+       +HRD+   N ++      K+ DFG ++              +  V ++
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 39/270 (14%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
            R+LGKG FG V      D   G E A+K++S          +    E QLL ++ H N+
Sbjct: 37  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHH 722
             L  +  D G   LV E    G L    FDE  +++  S  D  +I      G+ Y+H 
Sbjct: 95  MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH- 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             K  I+HRD+K  N+LL  K +    ++ DFG S  F A   S      +GT  Y+ PE
Sbjct: 150 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPE 204
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                   EK DV+S G++L  L++G P    G N   I+ +V    E+G          
Sbjct: 205 VLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV----EKG---------- 248
Query: 840 EANFDTNSVWKVAETAMECVPSISFQRPTM 869
           +  F+     KV+E+A + +  +    P+M
Sbjct: 249 KYTFELPQWKKVSESAKDLIRKMLTYVPSM 278

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 39/270 (14%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
            R+LGKG FG V      D   G E A+K++S          +    E QLL ++ H N+
Sbjct: 31  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHH 722
             L  +  D G   LV E    G L    FDE  +++  S  D  +I      G+ Y+H 
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH- 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             K  I+HRD+K  N+LL  K +    ++ DFG S  F A   S      +GT  Y+ PE
Sbjct: 144 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPE 198
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                   EK DV+S G++L  L++G P    G N   I+ +V    E+G          
Sbjct: 199 VLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV----EKG---------- 242
Query: 840 EANFDTNSVWKVAETAMECVPSISFQRPTM 869
           +  F+     KV+E+A + +  +    P+M
Sbjct: 243 KYTFELPQWKKVSESAKDLIRKMLTYVPSM 272

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
           R LG+G FG V   Y  D      G  VA+K L A +  GP+    ++ E  +L  ++H 
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHE 93
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           ++    G C D G  ++ LV EY+  G+L+ YL    + ++     L  A    +G+ YL
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE 779
           H       IHRD+   N+LL+     K+ DFG +K  P   E + +       V +  PE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
                +    SDV+SFG+ L EL+T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 46/229 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
           + LG+G FG     T +H     GY    + VA+KML  ++S  P + R   +E  +L +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK-------------------- 698
           V+H ++  L G C+  G + L+ EY  YG+L+ +L +  K                    
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 699 --EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK- 755
              AL+  D +  A   +QG++YL    +  ++HRD+   NIL+ E  + K++DFG S+ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           ++  +S    S   +  V ++  E    +  T +SDV+SFG++L E++T
Sbjct: 200 VYEEDSYVKRSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           + YL+       +HRD+   N ++      K+ DFG ++              +  V ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 119/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 39/270 (14%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
            R+LGKG FG V      D   G E A+K++S          +    E QLL ++ H N+
Sbjct: 54  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHH 722
             L  +  D G   LV E    G L    FDE  +++  S  D  +I      G+ Y+H 
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH- 166
Query: 723 GCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             K  I+HRD+K  N+LL  K +    ++ DFG S  F A   S      +GT  Y+ PE
Sbjct: 167 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPE 221
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                   EK DV+S G++L  L++G P    G N   I+ +V    E+G          
Sbjct: 222 VLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV----EKG---------- 265
Query: 840 EANFDTNSVWKVAETAMECVPSISFQRPTM 869
           +  F+     KV+E+A + +  +    P+M
Sbjct: 266 KYTFELPQWKKVSESAKDLIRKMLTYVPSM 295

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 16  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           G+ YL+       +HRD+   N ++ E    K+ DFG ++              +  V +
Sbjct: 135 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 191
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 192 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
           +++ +D TN +  +++G G FG V  G L   S+    VAIK L    ++  ++ F  EA
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G       V +V EYM  G+L  +L     +  +    + +    
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGI 127
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT- 772
           A G++YL        +HRD+   NIL+N  +  K++DFG S++   + E+  +T      
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + +  PE  A  + T  SDV+S+GIVL E+++
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 39/270 (14%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
            R+LGKG FG V      D   G E A+K++S          +    E QLL ++ H N+
Sbjct: 55  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHH 722
             L  +  D G   LV E    G L    FDE  +++  S  D  +I      G+ Y+H 
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMH- 167
Query: 723 GCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             K  I+HRD+K  N+LL  K +    ++ DFG S  F A   S      +GT  Y+ PE
Sbjct: 168 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIAPE 222
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                   EK DV+S G++L  L++G P    G N   I+ +V    E+G          
Sbjct: 223 VLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV----EKG---------- 266
Query: 840 EANFDTNSVWKVAETAMECVPSISFQRPTM 869
           +  F+     KV+E+A + +  +    P+M
Sbjct: 267 KYTFELPQWKKVSESAKDLIRKMLTYVPSM 296

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
           +++ +D TN +  +++G G FG V  G L   S+    VAIK L    ++  ++ F  EA
Sbjct: 26  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G       V +V EYM  G+L  +L     +  +    + +    
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGI 144
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT- 772
           A G++YL        +HRD+   NIL+N  +  K++DFG S++   + E+  +T      
Sbjct: 145 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + +  PE  A  + T  SDV+S+GIVL E+++
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           LGKG FG+V    +  L D  G+ VA+K L  S     + F+ E Q+L  +H   +    
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           G     G   + LV EY+  G L+ +L    +  L     L  +    +G+EYL  G + 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL--GSRR 131
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYYASNR 785
             +HRD+   NIL+  +   K+ADFG +K+ P + +  +        + +  PE  + N 
Sbjct: 132 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 786 LTEKSDVYSFGIVLLELIT 804
            + +SDV+SFG+VL EL T
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 25  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           G+ YL+       +HRD+   N ++ E    K+ DFG ++              +  V +
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++     TY          ++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ +++H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++     TY          ++ +D TN +  +++G G FG V  G
Sbjct: 4   RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 62
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 63  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 122
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 123 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 178
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 179 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 238
Query: 800 LELIT 804
            E+++
Sbjct: 239 WEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++     TY          ++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 119/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 119/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           + YL+       +HRD+   N ++      K+ DFG ++     +        +  V ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ +++H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 170 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
            R+LGKG FG V      D   G E A+K++S          +    E QLL ++ H N+
Sbjct: 31  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLHH 722
             L  +  D G   LV E    G L    FDE  +++  S  D  +I      G+ Y H 
Sbjct: 89  XKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYXH- 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
             K  I+HRD+K  N+LL  K +    ++ DFG S  F A   S      +GT  Y+ PE
Sbjct: 144 --KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKXKDKIGTAYYIAPE 198
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
                   EK DV+S G++L  L++G P    G N   I+ +V
Sbjct: 199 VLHGT-YDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV 239

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
           R LGKG FG VY   LA   +    VA+K+L  S  +      Q R E ++   +HH N+
Sbjct: 29  RPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEY 719
             L  Y  D   + L+ EY   G L + L     FDE + A        I  + A  L Y
Sbjct: 86  LRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA-------TIMEELADALMY 138
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H G K  +IHRD+K  N+LL  K + K+ADFG+S   P+        ++ GT+ YL PE
Sbjct: 139 CH-GKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----TMCGTLDYLPPE 191
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   EK D++  G++  EL+ G P
Sbjct: 192 MIEGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 117/223 (52%), Gaps = 18/223 (8%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSE----VAIKMLSASSS 643
           G++K   + F  +E+  +     ++LG G FGTV+ G ++ +G      V IK++   S 
Sbjct: 1   GAMKVLARIFKETELRKL-----KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG 55
Query: 644 QGPKQFRTEAQLLM-RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
           +   Q  T+  L +  + H ++  L+G C  G ++ LV +Y+  G+L  ++  + + AL 
Sbjct: 56  RQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALG 113
Query: 703 WKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
            +  L   V  A+G+ YL  HG    ++HR++   N+LL    Q ++ADFG + + P + 
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHG----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           +  + +     + ++  E     + T +SDV+S+G+ + EL+T
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 172 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 606 ITNNFHRI---LGKGGFGTVYHGYLADGS----EVAIKML---SASSSQGPKQFRTEAQL 655
           I N  ++I   LG GG  TVY   LA+ +    +VAIK +        +  K+F  E   
Sbjct: 8   IINERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 656 LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
             ++ H+N+ S++    +     LV EY+    L +Y+  E+   LS    +       Q
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFT---NQ 119
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            L+ + H     I+HRD+K  NIL++     K+ DFG +K     S +  +  ++GTV Y
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQY 178
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             PE        E +D+YS GIVL E++ G P
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGY 775
           + YL+       +HRD+   N ++      K+ DFG ++ I+  +        ++  V +
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 198
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 162 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 147 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 170 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 119/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG +++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 13/200 (6%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKMLSASSSQGPKQFRTEAQLLM-RVHHRNLA 665
           ++LG G FGTV+ G ++ +G      V IK++   S +   Q  T+  L +  + H ++ 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGC 724
            L+G C  G ++ LV +Y+  G+L  ++  + + AL  +  L   V  A+G+ YL  HG 
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 153
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              ++HR++   N+LL    Q ++ADFG + + P + +  + +     + ++  E     
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 785 RLTEKSDVYSFGIVLLELIT 804
           + T +SDV+S+G+ + EL+T
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 719 YLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
           R LG+G FG V   Y  D      G  VA+K L A    GP+    ++ E  +L  ++H 
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHE 76
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           ++    G C D G  ++ LV EY+  G+L+ YL    + ++     L  A    +G+ YL
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE 779
           H       IHR++   N+LL+     K+ DFG +K  P   E + +       V +  PE
Sbjct: 134 H---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
                +    SDV+SFG+ L EL+T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGY 775
           + YL+       +HRD+   N ++      K+ DFG ++ I+  +        ++  V +
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 197
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 19/275 (6%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           EI   +    + LG G FG V+       ++VA+K +    S   + F  EA ++  + H
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQH 69
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L  L         + ++ E+MA G+L  +L  +          +  +   A+G+ ++ 
Sbjct: 70  DKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                  IHRD++ ANIL++  +  K+ADFG +++   ++E          + +  PE  
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI 184
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
                T KSDV+SFGI+L+E++T       G +N  ++      LERG       PR E 
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LERG----YRMPRPE- 235
Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
               N   ++    M C  +   +RPT  ++ + L
Sbjct: 236 ----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
           R LG+G FG V   Y  D      G  VA+K L A    GP+    ++ E  +L  ++H 
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHE 76
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           ++    G C D G  ++ LV EY+  G+L+ YL    + ++     L  A    +G+ YL
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYL 133
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE 779
           H       IHR++   N+LL+     K+ DFG +K  P   E + +       V +  PE
Sbjct: 134 H---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
                +    SDV+SFG+ L EL+T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            EYM  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG  ++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 31  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 205
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 22  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 141 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 196
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 244

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 24  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 198
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 24  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 198
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 18  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 192
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 19/275 (6%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           EI   +    + LG G FG V+       ++VA+K +   S    + F  EA ++  + H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 242
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L  L         + ++ E+MA G+L  +L  +          +  +   A+G+ ++ 
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                  IHRD++ ANIL++  +  K+ADFG +++   ++E          + +  PE  
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI 357
Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
                T KSDV+SFGI+L+E++T       G +N  ++      LERG       PR E 
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LERG----YRMPRPE- 408
Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
               N   ++    M C  +   +RPT  ++ + L
Sbjct: 409 ----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++     S        +  V +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 25  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 199
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLAS 666
               ++G G    V   Y A   E VAIK ++    Q    +   E Q + + HH N+ S
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 667 ------------LVGYCNDGGNV-GLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
                       LV     GG+V  ++   +A G  K  + DE+  A   ++ L+     
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE----- 132
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE---SHISTSIV 770
             GLEYLH   +   IHRDVK  NILL E    ++ADFG S       +   + +  + V
Sbjct: 133 --GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 771 GTVGYLDPEYYASNRLTE-KSDVYSFGIVLLELITG 805
           GT  ++ PE     R  + K+D++SFGI  +EL TG
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 130/290 (44%), Gaps = 26/290 (8%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEA 653
           +++ +DI+     +++G G FG V  G+L    +    VAIK L S  + +  + F +EA
Sbjct: 26  FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA 85
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G       V ++ E+M  G+L  +L  +     +    + +    
Sbjct: 86  SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGI 144
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG-- 771
           A G++YL        +HRD+   NIL+N  +  K++DFG S+    ++     TS +G  
Sbjct: 145 AAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 772 -TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             + +  PE     + T  SDV+S+GIV+ E+++          N  ++N +    E+  
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI----EQ-- 255
Query: 831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
                D RL    D  S   + +  ++C       RP    +V  L K +
Sbjct: 256 -----DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 298

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 21  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL---------SWKDRLQIAVDAA 714
           +  L+G  + G    ++ E M  G+LK YL    + A+         S    +Q+A + A
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTV 773
            G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PV 194
Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 195 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 243

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 31  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL---------SWKDRLQIAVDAA 714
           +  L+G  + G    ++ E M  G+LK YL    + A+         S    +Q+A + A
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTV 773
            G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PV 204
Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++              +  V +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
           R LG G FG VY G ++    D S  +VA+K L    S Q    F  EA ++ + +H+N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK------EALSWKDRLQIAVDAAQGLE 718
              +G         ++ E MA G+LK +L  ET+       +L+  D L +A D A G +
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 719 YLHHGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           YL        IHRD+   N LL        AK+ DFG ++              +  V +
Sbjct: 173 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + PE +     T K+D +SFG++L E+ +
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 53  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N ++ E    K+ DFG ++ I+  +        ++  V 
Sbjct: 172 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 227
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 275

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLAS 666
               ++G G    V   Y A   E VAIK ++    Q    +   E Q + + HH N+ S
Sbjct: 13  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 72
Query: 667 ------------LVGYCNDGGNV-GLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
                       LV     GG+V  ++   +A G  K  + DE+  A   ++ L+     
Sbjct: 73  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE----- 127
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE---SHISTSIV 770
             GLEYLH   +   IHRDVK  NILL E    ++ADFG S       +   + +  + V
Sbjct: 128 --GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 771 GTVGYLDPEYYASNRLTE-KSDVYSFGIVLLELITG 805
           GT  ++ PE     R  + K+D++SFGI  +EL TG
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 118/245 (48%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKS--DNQQFT--------YSEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++  D   F         +++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            E M  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
           +++ +D TN +  +++G G FG V  G L   S+    VAIK L    ++  ++ F  EA
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G       V +V E M  G+L  +L     +  +    + +    
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGI 127
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT- 772
           A G++YL        +HRD+   NIL+N  +  K++DFG S++   + E+  +T      
Sbjct: 128 ASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + +  PE  A  + T  SDV+S+GIVL E+++
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 597 QFTYSEIVDITNNF---HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQF 649
           Q+ + E   +T N    +R+LGKGGFG V    + A G   A K L     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
             E Q+L +V+ R + SL         + LV   M  G+LK +++   +        +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A +   GLE LH   +  I++RD+K  NILL++    +++D G +   P   E       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           VGTVGY+ PE   + R T   D ++ G +L E+I G
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGY 775
           + YL+       +HR++   N ++      K+ DFG ++ I+  +        ++  V +
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 198
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
           R LG+G FG VY G   D       + VA+K ++ S+S   + +F  EA ++      ++
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--------LSWKDRLQIAVDAAQG 716
             L+G  + G    +V E MA+G+LK YL     EA         + ++ +Q+A + A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGY 775
           + YL+       +HR++   N ++      K+ DFG ++ I+  +        ++  V +
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 199
Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           + PE       T  SD++SFG+VL E+ +      +G +N  ++  V
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 22/245 (8%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
           RL+  N H K  G L++     TY          ++ +D TN +  +++G G FG V  G
Sbjct: 6   RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
            L   S+    VAIK L    ++  ++ F  EA ++ +  H N+  L G       V +V
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL 740
            E M  G+L  +L     +  +    + +    A G++YL        +HRD+   NIL+
Sbjct: 125 TEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILI 180
Query: 741 NEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNRLTEKSDVYSFGIVL 799
           N  +  K++DFG S++   + E+  +T      + +  PE  A  + T  SDV+S+GIVL
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 800 LELIT 804
            E+++
Sbjct: 241 WEVMS 245

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHR 662
           R LG+G FG V   Y  D      G  VA+K L      GP+    ++ E ++L  ++H 
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHE 71
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           ++    G C D G  +V LV EY+  G+L+ YL    +  +     L  A    +G+ YL
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYL 128
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE 779
           H       IHR +   N+LL+     K+ DFG +K  P   E + +       V +  PE
Sbjct: 129 H---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 780 YYASNRLTEKSDVYSFGIVLLELI----------TGLPAIIRGYNNTHIVNRVCPFLERG 829
                +    SDV+SFG+ L EL+          T    +I        V R+   LERG
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG 245
Query: 830 D 830
           +
Sbjct: 246 E 246

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 597 QFTYSEIVDITNNF---HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQF 649
           Q+ + E   +T N    +R+LGKGGFG V    + A G   A K L     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
             E Q+L +V+ R + SL         + LV   M  G+LK +++   +        +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A +   GLE LH   +  I++RD+K  NILL++    +++D G +   P   E       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           VGTVGY+ PE   + R T   D ++ G +L E+I G
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 31/241 (12%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHR 662
           R LG+G FG V   Y  D      G  VA+K L      GP+    ++ E ++L  ++H 
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHE 70
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           ++    G C D G  +V LV EY+  G+L+ YL    +  +     L  A    +G+ YL
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYL 127
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH-ISTSIVGTVGYLDPE 779
           H       IHR +   N+LL+     K+ DFG +K  P   E + +       V +  PE
Sbjct: 128 H---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 780 YYASNRLTEKSDVYSFGIVLLELI----------TGLPAIIRGYNNTHIVNRVCPFLERG 829
                +    SDV+SFG+ L EL+          T    +I        V R+   LERG
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG 244
Query: 830 D 830
           +
Sbjct: 245 E 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG G + TVY G     G  VA+K +   S +G P     E  L+  + H N+  L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 672 NDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +    + LV+E+M   +LK+Y+       T   L             QGL + H      
Sbjct: 73  HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           I+HRD+K  N+L+N++ Q KL DFG ++ F     +   +S V T+ Y  P+    +R  
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSRTY 186
Query: 788 EKS-DVYSFGIVLLELITGLP 807
             S D++S G +L E+ITG P
Sbjct: 187 STSIDIWSCGCILAEMITGKP 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 35/278 (12%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           EI   +    + LG G FG V+       ++VA+K +   S    + F  EA ++  + H
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 236
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L  L         + ++ E+MA G+L  +L  +          +  +   A+G+ ++ 
Sbjct: 237 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI---FPAESESHISTSIVGTVGYLDP 778
                  IHRD++ ANIL++  +  K+ADFG +++   FP              + +  P
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFP--------------IKWTAP 338
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
           E       T KSDV+SFGI+L+E++T       G +N  ++      LERG       PR
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LERG----YRMPR 390
Query: 839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL 876
            E     N   ++    M C  +   +RPT  ++ + L
Sbjct: 391 PE-----NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 22/228 (9%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           R LG+G FG VY G +A G       + VAIK ++ ++S   + +F  EA ++   +  +
Sbjct: 18  RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-----ETKEAL---SWKDRLQIAVDAAQ 715
           +  L+G  + G    ++ E M  G+LK YL       E    L   S    +Q+A + A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVG 774
           G+ YL+       +HRD+   N  + E    K+ DFG ++ I+  +        ++  V 
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR 192
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG GGFG V      D G +VAIK      S +  +++  E Q++ +++H N+ S     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 672 NDGGNVG------LVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           +    +       L  EY   G+L++YL   E    L       +  D +  L YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 141
Query: 725 KPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              IIHRD+K  NI+L    +++  K+ D G++K      +  + T  VGT+ YL PE  
Sbjct: 142 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 196
Query: 782 ASNRLTEKSDVYSFGIVLLELITG----LP--------AIIRGYNNTHIV 819
              + T   D +SFG +  E ITG    LP          +R  +N HIV
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 246

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYL-ADGSE---VAIKMLSAS-SSQGPKQFRTEA 653
           +++ +D++      ++G G FG V  G L A G +   VAIK L    + +  ++F +EA
Sbjct: 9   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G   +   V ++ E+M  G L  +L     +  +    + +    
Sbjct: 69  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGI 127
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG-- 771
           A G+ YL    +   +HRD+   NIL+N  +  K++DFG S+     S     TS +G  
Sbjct: 128 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 772 -TVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
             + +  PE  A  + T  SD +S+GIV+ E+++
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG GGFG V      D G +VAIK      S +  +++  E Q++ +++H N+ S     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 672 NDGGNVG------LVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           +    +       L  EY   G+L++YL   E    L       +  D +  L YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140
Query: 725 KPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              IIHRD+K  NI+L    +++  K+ D G++K      +  + T  VGT+ YL PE  
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 195
Query: 782 ASNRLTEKSDVYSFGIVLLELITG----LP--------AIIRGYNNTHIV 819
              + T   D +SFG +  E ITG    LP          +R  +N HIV
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYL-ADGSE---VAIKMLSAS-SSQGPKQFRTEA 653
           +++ +D++      ++G G FG V  G L A G +   VAIK L    + +  ++F +EA
Sbjct: 7   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEA 66
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
            ++ +  H N+  L G   +   V ++ E+M  G L  +L     +  +    + +    
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGI 125
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG-- 771
           A G+ YL    +   +HRD+   NIL+N  +  K++DFG S+     S     TS +G  
Sbjct: 126 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 772 -TVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
             + +  PE  A  + T  SD +S+GIV+ E+++
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
              R++G G FG V  G L    +    VAIK L    ++  ++ F  EA ++ +  H N
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L G    G  V +V E+M  G L  +L     +  +    + +    A G+ YL   
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL--- 161
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-HISTSIVGTVGYLDPEYYA 782
                +HRD+   NIL+N  +  K++DFG S++   + E+ + +T     V +  PE   
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
             + T  SDV+S+GIV+ E+++
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMS 243

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
             R++G G FG V  G L    +    VAIK L    ++  ++ F  EA ++ +  H N+
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 85
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L G       V +V EYM  G+L  +L  +     +    + +    + G++YL    
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLRGISAGMKYLSDMG 144
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYAS 783
               +HRD+   NIL+N  +  K++DFG S++   + E+  +T      + +  PE  A 
Sbjct: 145 ---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+S+GIV+ E+++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSAS----SSQGPKQFRTEAQLLMRVHHRN 663
           R+LGKGG+G V+      G+      A+K+L  +    +++     + E  +L  V H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
           +  L+     GG + L+ EY++ G L   L    +E +  +D     + + +  L +LH 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH- 138
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             +  II+RD+K  NI+LN +   KL DFG  K   +  +  ++ +  GT+ Y+ PE   
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +      D +S G ++ +++TG P    G N    ++++
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKI 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQ-GPKQF-------RTEAQLLMRVH-HR 662
           ++G+G    V    + A G E A+K++  ++ +  P+Q        R E  +L +V  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           ++ +L+        + LV++ M  G L  YL +  K ALS K+   I     + + +LH 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA 218
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEYY 781
                I+HRD+K  NILL++ MQ +L+DFGFS  + P E        + GT GYL PE  
Sbjct: 219 NN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEIL 271
Query: 782 ASNR------LTEKSDVYSFGIVLLELITGLP 807
             +         ++ D+++ G++L  L+ G P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP--KQFRTEAQLLMRVHHRNLASLVG 669
           +LGKG FG V          E A+K+++ +S++         E +LL ++ H N+  L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
              D  +  +V E    G L    FDE   ++  S  D  +I      G+ Y+H   K  
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHN 141
Query: 728 IIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
           I+HRD+K  NILL  K +    K+ DFG S  F   ++       +GT  Y+ PE     
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLRGT 198
Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
              EK DV+S G++L  L++G P    G N   I+ RV
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRV 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNL 664
             +++G G FG V  G L    +    VAIK L A  + +  + F +EA ++ +  H N+
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L G       V ++ EYM  G+L  +L  +     +    + +      G++YL    
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSDMS 151
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYAS 783
               +HRD+   NIL+N  +  K++DFG S++   + E+  +T      + +  PE  A 
Sbjct: 152 A---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+S+GIV+ E+++
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS 229

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP--KQFRTEAQLLMRVHHRNLASLVG 669
           +LGKG FG V          E A+K+++ +S++         E +LL ++ H N+  L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
              D  +  +V E    G L    FDE   ++  S  D  +I      G+ Y+H   K  
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHN 141
Query: 728 IIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
           I+HRD+K  NILL  K +    K+ DFG S  F   ++       +GT  Y+ PE     
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT 198
Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
              EK DV+S G++L  L++G P    G N   I+ RV
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP--KQFRTEAQLLMRVHHRNLASLVG 669
           +LGKG FG V          E A+K+++ +S++         E +LL ++ H N+  L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
              D  +  +V E    G L    FDE   ++  S  D  +I      G+ Y+H   K  
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHN 141
Query: 728 IIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
           I+HRD+K  NILL  K +    K+ DFG S  F   ++       +GT  Y+ PE     
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT 198
Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
              EK DV+S G++L  L++G P    G N   I+ RV
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRV 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSAS----SSQGPKQFRTEAQLLMRVHHRN 663
           R+LGKGG+G V+      G+      A+K+L  +    +++     + E  +L  V H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
           +  L+     GG + L+ EY++ G L   L    +E +  +D     + + +  L +LH 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH- 138
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             +  II+RD+K  NI+LN +   KL DFG  K   +  +  ++    GT+ Y+ PE   
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +      D +S G ++ +++TG P    G N    ++++
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKI 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGY 670
           ++G G +G VY G ++  G   AIK++  +  +  ++ + E  +L +  HHRN+A+  G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 671 C---NDGG---NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
               N  G    + LV E+   G++   + +     L  +    I  +  +GL +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYA 782
           +  +IHRD+K  N+LL E  + KL DFG S    A+ +  +    + +GT  ++ PE  A
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 783 SNRLTE-----KSDVYSFGIVLLELITGLPAI 809
            +   +     KSD++S GI  +E+  G P +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 116/230 (50%), Gaps = 25/230 (10%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLA----DGSEVAIKML 638
           +H  K GS K+D   F   E++       ++LG+G FG V+          G   A+K+L
Sbjct: 15  THHVKAGSEKADPSHF---ELL-------KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVL 64
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
             ++ +   + RT  E  +L  V+H  +  L       G + L+ +++  G+L   L   
Sbjct: 65  KKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--- 121
Query: 697 TKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           +KE +  ++ ++  + + A GL++LH      II+RD+K  NILL+E+   KL DFG SK
Sbjct: 122 SKEVMFTEEDVKFYLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 178
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
              A      + S  GTV Y+ PE       +  +D +S+G+++ E++TG
Sbjct: 179 --EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNL 664
             +++G G FG V  G L    +    VAIK L A  + +  + F +EA ++ +  H N+
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L G       V ++ EYM  G+L  +L  +     +    + +      G++YL    
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSD-- 134
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYAS 783
               +HRD+   NIL+N  +  K++DFG S++   + E+  +T      + +  PE  A 
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+S+GIV+ E+++
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +  +G FG V+   L +   VA+K+      Q   Q   E   L  + H N+   +G   
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 673 DGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH------ 722
            G +V     L+  +   G+L  +L       +SW +   IA   A+GL YLH       
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 723 -GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
            G KP I HRD+K+ N+LL   + A +ADFG +  F A   +  +   VGT  Y+ PE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 782 ASNRLTEKS-----DVYSFGIVLLELIT 804
                 ++      D+Y+ G+VL EL +
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 26/289 (8%)
Query: 601 SEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQ 654
           S+ +DI+     +++G G FG V  G+L    +    VAIK L S  + +  + F +EA 
Sbjct: 1   SKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 60
Query: 655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA 714
           ++ +  H N+  L G       V ++ E+M  G+L  +L  +     +    + +    A
Sbjct: 61  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIA 119
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG--- 771
            G++YL        +HR +   NIL+N  +  K++DFG S+    ++     TS +G   
Sbjct: 120 AGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176
Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDV 831
            + +  PE     + T  SDV+S+GIV+ E+++          N  ++N +    E+   
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI----EQ--- 229
Query: 832 RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL 880
               D RL    D  S   + +  ++C       RP    +V  L K +
Sbjct: 230 ----DYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 272

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 16/237 (6%)
Query: 573 KRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYH-GYLAD 629
           K+   L +D    K+  +  +  Q+    E+ D  ++F +I  LG G  G V+   +   
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKV--GELKD--DDFEKISELGAGNGGVVFKVSHKPS 57
Query: 630 GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN 688
           G  +A K++        + Q   E Q+L   +   +    G     G + +  E+M  G+
Sbjct: 58  GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL 748
           L Q L    +       ++ IAV   +GL YL    K  I+HRDVK +NIL+N + + KL
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 173
Query: 749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            DFG S     +    ++ S VGT  Y+ PE       + +SD++S G+ L+E+  G
Sbjct: 174 CDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNL 664
             +++G G FG V  G L    +    VAIK L A  + +  + F +EA ++ +  H N+
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L G       V ++ EYM  G+L  +L  +     +    + +      G++YL    
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSD-- 128
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYAS 783
               +HRD+   NIL+N  +  K++DFG S++   + E+  +T      + +  PE  A 
Sbjct: 129 -MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + T  SDV+S+GIV+ E+++
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G      +V AIK++    +    +  + E  +L +     +    G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
             G  + ++ EY+  G+    L+   FDE + A   K+ L+       GL+YLH   K  
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-------GLDYLHSEKK-- 141
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E+   KLADFG +      +++ I   + VGT  ++ PE    +  
Sbjct: 142 -IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 198 DSKADIWSLGITAIELAKGEP 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 19/231 (8%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFH--------RILGKGGFGTVYHGYLADGSEV-AIKMLS 639
           G L SD +     EI D+  +          R LGKGGF   Y     D  EV A K++ 
Sbjct: 1   GPLGSDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP 60
Query: 640 ASSSQGPKQ---FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
            S    P Q     TE  +   + + ++    G+  D   V +V E     +L +    +
Sbjct: 61  KSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHK 118
Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            ++A++  +         QG++YLH+     +IHRD+K  N+ LN+ M  K+ DFG +  
Sbjct: 119 RRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATK 175
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
              + E      + GT  Y+ PE       + + D++S G +L  L+ G P
Sbjct: 176 IEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP 224

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYH-GYLADGSEV 633
           RL    +  +K G LK D+              F +I  LG G  G V+   +   G  +
Sbjct: 51  RLEAFLTQKQKVGELKDDD--------------FEKISELGAGNGGVVFKVSHKPSGLVM 96
Query: 634 AIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQY 692
           A K++        + Q   E Q+L   +   +    G     G + +  E+M  G+L Q 
Sbjct: 97  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 156
Query: 693 LFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFG 752
           L    +       ++ IAV   +GL YL    K  I+HRDVK +NIL+N + + KL DFG
Sbjct: 157 LKKAGRIPEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 212
Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            S     +    ++ S VGT  Y+ PE       + +SD++S G+ L+E+  G
Sbjct: 213 VS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR-TEAQLLMRVHHRNL----ASLV 668
           +GKG +G V+ G L  G  VA+K+ S+   Q    FR TE    + + H N+    AS +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQS--WFRETEIYNTVLLRHDNILGFIASDM 72
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-----HG 723
              N    + L+  Y  +G+L  +L  +T E       L++AV AA GL +LH       
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI---STSIVGTVGYLDPEY 780
            KP I HRD K+ N+L+   +Q  +AD G + +  ++   ++   +   VGT  Y+ PE 
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 781 YASNRLTE------KSDVYSFGIVLLEL 802
                 T+       +D+++FG+VL E+
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 596 QQFTYSEIVDITNNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRT 651
           Q+    E+ D  ++F RI  LG G  G V    +   G  +A K++        + Q   
Sbjct: 6   QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 652 EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL--QI 709
           E Q+L   +   +    G     G + +  E+M  G+L Q L    KEA    + +  ++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKV 119
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           ++   +GL YL    K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S 
Sbjct: 120 SIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 173
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           VGT  Y+ PE       + +SD++S G+ L+EL  G
Sbjct: 174 VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 123
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVG 199

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 83
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +     ++ GT  Y+ PE  +    + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 197 EVDVWSIGCIMYTLLVGKP 215

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 87
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +     ++ GT  Y+ PE  +    + 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 201 EVDVWSIGCIMYTLLVGKP 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 573 KRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYH-GYLAD 629
           ++  RL    +  +K G LK D+              F +I  LG G  G V+   +   
Sbjct: 4   QQRKRLEAFLTQKQKVGELKDDD--------------FEKISELGAGNGGVVFKVSHKPS 49
Query: 630 GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN 688
           G  +A K++        + Q   E Q+L   +   +    G     G + +  E+M  G+
Sbjct: 50  GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 109
Query: 689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL 748
           L Q L    +       ++ IAV   +GL YL    K  I+HRDVK +NIL+N + + KL
Sbjct: 110 LDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 165
Query: 749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPA 808
            DFG S     +    ++ S VGT  Y+ PE       + +SD++S G+ L+E+  G   
Sbjct: 166 CDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221
Query: 809 IIRGYNNT-------HIVNRVCPFLERG 829
           I  G  +        +IVN   P L  G
Sbjct: 222 IGSGSGSMAIFELLDYIVNEPPPKLPSG 249

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 83
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +     ++ GT  Y+ PE  +    + 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 197 EVDVWSIGCIMYTLLVGKP 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 19/228 (8%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
            +RILG+G FG VY G    +  +   VA+K      +   K+ F +EA ++  + H ++
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH-G 723
             L+G   +     ++ E   YG L  YL +  K +L     +  ++   + + YL    
Sbjct: 72  VKLIGIIEEEPT-WIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESIN 129
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYA 782
           C    +HRD+   NIL+      KL DFG S+    E E +   S+    + ++ PE   
Sbjct: 130 C----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPESIN 183
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             R T  SDV+ F + + E+++          N  ++      LE+GD
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGD 227

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           R LGKGGF   Y     D  EV A K++  S    P Q     TE  +   + + ++   
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G+  D   V +V E     +L +    + ++A++  +         QG++YLH+     
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+K  N+ LN+ M  K+ DFG +     + E     ++ GT  Y+ PE       +
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPNYIAPEVLCKKGHS 220
Query: 788 EKSDVYSFGIVLLELITGLP 807
            + D++S G +L  L+ G P
Sbjct: 221 FEVDIWSLGCILYTLLVGKP 240

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 19/228 (8%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
            +RILG+G FG VY G    +  +   VA+K      +   K+ F +EA ++  + H ++
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH-G 723
             L+G   +     ++ E   YG L  YL +  K +L     +  ++   + + YL    
Sbjct: 88  VKLIGIIEEEPT-WIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESIN 145
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYA 782
           C    +HRD+   NIL+      KL DFG S+    E E +   S+    + ++ PE   
Sbjct: 146 C----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPESIN 199
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             R T  SDV+ F + + E+++          N  ++      LE+GD
Sbjct: 200 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGD 243

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVG 199

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 106/244 (43%), Gaps = 27/244 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R +G G FG VY       SEV AIK +S S  Q  ++++    E + L ++ H N    
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
            G         LV EY   G+    L +  K+ L   +   +   A QGL YLH H    
Sbjct: 81  RGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--- 783
            +IHRDVK  NILL+E    KL DFG + I         +   VGT  ++ PE   +   
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDE 188
Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT---HIVNRVCPFLERGD----VRSIVD 836
            +   K DV+S GI  +EL    P +      +   HI     P L+ G      R+ VD
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 837 PRLE 840
             L+
Sbjct: 249 SCLQ 252

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/244 (31%), Positives = 106/244 (43%), Gaps = 27/244 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R +G G FG VY       SEV AIK +S S  Q  ++++    E + L ++ H N    
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
            G         LV EY   G+    L +  K+ L   +   +   A QGL YLH H    
Sbjct: 120 RGCYLREHTAWLVMEY-CLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS--- 783
            +IHRDVK  NILL+E    KL DFG + I         +   VGT  ++ PE   +   
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDE 227
Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT---HIVNRVCPFLERGD----VRSIVD 836
            +   K DV+S GI  +EL    P +      +   HI     P L+ G      R+ VD
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287
Query: 837 PRLE 840
             L+
Sbjct: 288 SCLQ 291

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVG 199

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 19/228 (8%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
            +RILG+G FG VY G    +  +   VA+K      +   K+ F +EA ++  + H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH-G 723
             L+G   +     ++ E   YG L  YL +  K +L     +  ++   + + YL    
Sbjct: 76  VKLIGIIEEEPT-WIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYA 782
           C    +HRD+   NIL+      KL DFG S+    E E +   S+    + ++ PE   
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSPESIN 187
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
             R T  SDV+ F + + E+++          N  ++      LE+GD
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG----VLEKGD 231

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 614 LGKGGFG-TVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG  +      DG +  IK ++ S  SS+  ++ R E  +L  + H N+      
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 671 CNDGGNVGLVYEYMAYGNL-------KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
             + G++ +V +Y   G+L       K  LF E  + L W  ++ +A         L H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-QILDWFVQICLA---------LKHV 141
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K+ NI L +    +L DFG +++  +  E  ++ + +GT  YL PE   +
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICEN 199
Query: 784 NRLTEKSDVYSFGIVLLELIT 804
                KSD+++ G VL EL T
Sbjct: 200 KPYNNKSDIWALGCVLYELCT 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     +    ++ S VGT  Y+ PE    
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVG 199

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA+K++  +   SS   K FR E +++  ++H N+  L
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 71
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                    + LV EY + G +  YL      A  W    +      Q +  + +  +  
Sbjct: 72  FEVIETEKTLYLVMEYASGGEVFDYLV-----AHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           I+HRD+K  N+LL+  M  K+ADFGFS  F   ++     +  G+  Y  PE +   +  
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYD 183
Query: 788 -EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
             + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           R LGKGGF   Y     D  EV A K++  S    P Q     TE  +   + + ++   
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G+  D   V +V E     +L +    + ++A++  +         QG++YLH+     
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+K  N+ LN+ M  K+ DFG +     + E      + GT  Y+ PE       +
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHS 220
Query: 788 EKSDVYSFGIVLLELITGLP 807
            + D++S G +L  L+ G P
Sbjct: 221 FEVDIWSLGCILYTLLVGKP 240

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           R LGKGGF   Y     D  EV A K++  S    P Q     TE  +   + + ++   
Sbjct: 48  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G+  D   V +V E     +L +    + ++A++  +         QG++YLH+     
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+K  N+ LN+ M  K+ DFG +     + E      + GT  Y+ PE       +
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHS 220
Query: 788 EKSDVYSFGIVLLELITGLP 807
            + D++S G +L  L+ G P
Sbjct: 221 FEVDIWSLGCILYTLLVGKP 240

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIK---MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G+G F  VY    L DG  VA+K   +     ++       E  LL +++H N+     
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
              +   + +V E    G+L + +  F + K  +  +   +  V     LE++H      
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---R 156
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           ++HRD+K AN+ +      KL D G  + F   S++  + S+VGT  Y+ PE    N   
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD----------------V 831
            KSD++S G +L E+          Y +   +  +C  +E+ D                V
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 832 RSIVDPRLEANFDTNSVWKVAETAMECVPS 861
              ++P  E   D   V+ VA+    C  S
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 105
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +      + GT  Y+ PE  +    + 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 219 EVDVWSIGCIMYTLLVGKP 237

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 107
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +      + GT  Y+ PE  +    + 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 221 EVDVWSIGCIMYTLLVGKP 239

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVH----HRNLASLV 668
           LGKGGF   +    AD  EV A K++  S    P Q R +  + + +H    H+++    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVGFH 81
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G+  D   V +V E     +L +    + ++AL+  +          G +YLH      +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           IHRD+K  N+ LNE ++ K+ DFG +     E +      + GT  Y+ PE  +    + 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 789 KSDVYSFGIVLLELITGLP 807
           + DV+S G ++  L+ G P
Sbjct: 195 EVDVWSIGCIMYTLLVGKP 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 27/235 (11%)
Query: 585 SKKEGSLKSDNQQFTYSEIVDITNNFHRI-LGKGGFGTVYHGY-LADGSEVAIKMLSASS 642
           S +EG  +SD  ++ Y    +   N  R+ LGKG +G VY G  L++   +AIK +    
Sbjct: 4   STEEGDCESDLLEYDY----EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 643 SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
           S+  +    E  L   + H+N+   +G  ++ G + +  E +  G+L   L  +      
Sbjct: 60  SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK------ 113
Query: 703 W---KDRLQI----AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFS 754
           W   KD  Q          +GL+YLH      I+HRD+K  N+L+N      K++DFG S
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS 170
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYY--ASNRLTEKSDVYSFGIVLLELITGLP 807
           K     +    + +  GT+ Y+ PE          + +D++S G  ++E+ TG P
Sbjct: 171 KRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA+K++  +   SS   K FR E +++  ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+  M  K+ADFGFS  F   +  +   +  G+  Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF---TFGNKLDTFCGSPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG     T Y    +D +  VA+KML  S+  
Sbjct: 24  DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 83
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
             ++   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L  +    + 
Sbjct: 84  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 143
Query: 703 WKDRLQI----------------AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQ 745
            K    I                +   A+G+ +L    C    IHRD+   NILL     
Sbjct: 144 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 199
Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +
Sbjct: 200 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           +F  +LG G F  V    LA+       VAIK ++  + +G +     E  +L ++ H N
Sbjct: 21  DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLH 721
           + +L      GG++ L+ + ++ G L    FD   E    + +D  ++       ++YLH
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 722 HGCKPPIIHRDVKTANIL---LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
                 I+HRD+K  N+L   L+E  +  ++DFG SK+   E    + ++  GT GY+ P
Sbjct: 134 ---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  A    ++  D +S G++   L+ G P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA+K++  +   SS   K FR E +++  ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+  M  K+ADFGFS  F   +  +   +  G+  Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF---TFGNKLDTFCGSPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           +F  +LG G F  V    LA+       VAIK ++  + +G +     E  +L ++ H N
Sbjct: 21  DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLH 721
           + +L      GG++ L+ + ++ G L    FD   E    + +D  ++       ++YLH
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 722 HGCKPPIIHRDVKTANIL---LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
                 I+HRD+K  N+L   L+E  +  ++DFG SK+   E    + ++  GT GY+ P
Sbjct: 134 ---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  A    ++  D +S G++   L+ G P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           ++F +I  LG G  G V+   +   G  +A K++        + Q   E Q+L   +   
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +    G     G + +  E+M  G+L Q L    +       ++ IAV   +GL YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLRE- 125
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            K  I+HRDVK +NIL+N + + KL DFG S     E    ++   VGT  Y+ PE    
Sbjct: 126 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
              + +SD++S G+ L+E+  G
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVG 202

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG     T Y    +D +  VA+KML  S+  
Sbjct: 26  DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 85
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
             ++   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L  +    + 
Sbjct: 86  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 145
Query: 703 WKDRLQI----------------AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQ 745
            K    I                +   A+G+ +L    C    IHRD+   NILL     
Sbjct: 146 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 201
Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +
Sbjct: 202 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 12/198 (6%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           LG+G + TVY G   L D   VA+K +     +G P     E  LL  + H N+ +L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            +   ++ LV+EY+   +LKQYL D+    ++  +         +GL Y H   +  ++H
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLH 123
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEK 789
           RD+K  N+L+NE+ + KLADFG ++     ++++ +   V T+ Y  P+    S   + +
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVTLWYRPPDILLGSTDYSTQ 181
Query: 790 SDVYSFGIVLLELITGLP 807
            D++  G +  E+ TG P
Sbjct: 182 IDMWGVGCIFYEMATGRP 199

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           +F  +LG G F  V    LA+       VAIK ++  + +G +     E  +L ++ H N
Sbjct: 21  DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLH 721
           + +L      GG++ L+ + ++ G L    FD   E    + +D  ++       ++YLH
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 722 HGCKPPIIHRDVKTANIL---LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
                 I+HRD+K  N+L   L+E  +  ++DFG SK+   E    + ++  GT GY+ P
Sbjct: 134 ---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  A    ++  D +S G++   L+ G P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 110/261 (42%), Gaps = 42/261 (16%)
Query: 614 LGKGGFGTVYHGYLADGS------EVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA-- 665
           +G+G F TVY G   + +      E+  + L+ S  Q   +F+ EA+ L  + H N+   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVRF 90
Query: 666 --SLVGYCNDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEY 719
             S          + LV E    G LK YL      + K   SW  ++       +GL++
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQF 144
Query: 720 LHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           LH    PPIIHRD+K  NI +       K+ D G + +      +  + +++GT  +  P
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAP 199
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
           E Y   +  E  DVY+FG   LE  T         N   I  RV          S V P 
Sbjct: 200 EXY-EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVT---------SGVKP- 248
Query: 839 LEANFDTNSVWKVAETAMECV 859
             A+FD  ++ +V E    C+
Sbjct: 249 --ASFDKVAIPEVKEIIEGCI 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG     T Y    +D +  VA+KML  S+  
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
             ++   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L  +    + 
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 703 WKDRLQI----------------AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQ 745
            K    I                +   A+G+ +L    C    IHRD+   NILL     
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 183
Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG     T Y    +D +  VA+KML  S+  
Sbjct: 31  DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
             ++   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L  +    + 
Sbjct: 91  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 703 WKDRLQI----------------AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQ 745
            K    I                +   A+G+ +L    C    IHRD+   NILL     
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 206
Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +
Sbjct: 207 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
           +F  +LG G F  V    LA+       VAIK ++  + +G +     E  +L ++ H N
Sbjct: 21  DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLH 721
           + +L      GG++ L+ + ++ G L    FD   E    + +D  ++       ++YLH
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 722 HGCKPPIIHRDVKTANIL---LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
                 I+HRD+K  N+L   L+E  +  ++DFG SK+   E    + ++  GT GY+ P
Sbjct: 134 ---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  A    ++  D +S G++   L+ G P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG     T Y    +D +  VA+KML  S+  
Sbjct: 31  DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
             ++   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L  +    + 
Sbjct: 91  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 703 WKDRLQI----------------AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQ 745
            K    I                +   A+G+ +L    C    IHRD+   NILL     
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRI 206
Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +
Sbjct: 207 TKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMR--VHHRNLASLVGY 670
           I  +G FG V+   L +   VA+K+      Q    +++E ++     + H NL   +  
Sbjct: 22  IKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFIAA 77
Query: 671 CNDGGNV----GLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH---- 722
              G N+     L+  +   G+L  YL       ++W +   +A   ++GL YLH     
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 723 ----GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
               G KP I HRD K+ N+LL   + A LADFG +  F        +   VGT  Y+ P
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 779 EYYASNRLTEKS-----DVYSFGIVLLELIT 804
           E        ++      D+Y+ G+VL EL++
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA+K++  +   SS   K FR E +++  ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+  M  K+ADFGFS  F   +  +   +  G   Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF---TFGNKLDAFCGAPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 606 ITNNFHRI--LGKGGFGTVYHGYLAD---GSEVAIKMLSASS---SQGPKQFRTEAQLLM 657
           +++ + R+  LG G +G V      D   G+E AIK++  SS   +        E  +L 
Sbjct: 19  LSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQ 715
           ++ H N+  L  +  D  N  LV E    G L    FDE   ++  S  D   I      
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLS 132
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGT 772
           G  YLH   K  I+HRD+K  N+LL  K +    K+ DFG S  F    +       +GT
Sbjct: 133 GTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGT 186
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
             Y+ PE     +  EK DV+S G++L  L+ G P    G  +  I+ RV
Sbjct: 187 AYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP-FGGQTDQEILKRV 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 14/220 (6%)
Query: 593 SDNQQFTYSEIVDITNNFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGP-KQFR 650
           S  +   +   +D    F R LG G FG V+     + G E  IK ++   SQ P +Q  
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK--EALSWKDRLQ 708
            E ++L  + H N+  +     D  N+ +V E    G L + +       +ALS     +
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 709 IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE---KMQAKLADFGFSKIFPAESESHI 765
           +       L Y H      ++H+D+K  NIL  +       K+ DFG +++F  +S+ H 
Sbjct: 129 LMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEH- 182
Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           ST+  GT  Y+ PE +  + +T K D++S G+V+  L+TG
Sbjct: 183 STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 606 ITNNFHRI--LGKGGFGTVYHGYLAD---GSEVAIKMLSASS---SQGPKQFRTEAQLLM 657
           +++ + R+  LG G +G V      D   G+E AIK++  SS   +        E  +L 
Sbjct: 2   LSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQ 715
           ++ H N+  L  +  D  N  LV E    G L    FDE   ++  S  D   I      
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLS 115
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGT 772
           G  YLH   K  I+HRD+K  N+LL  K +    K+ DFG S  F    +       +GT
Sbjct: 116 GTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGT 169
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
             Y+ PE     +  EK DV+S G++L  L+ G P    G  +  I+ RV
Sbjct: 170 AYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPP-FGGQTDQEILKRV 217

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 115/251 (45%), Gaps = 34/251 (13%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKML---SAS 641
           +G L++    F  S+   ++  + R+  LG G +G V          E AIK++   S S
Sbjct: 17  QGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS 76
Query: 642 SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL 701
           +S   K    E  +L  + H N+  L  +  D  N  LV E    G L    FDE    +
Sbjct: 77  TSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM 131
Query: 702 SWKDRLQIAVDAA-------QGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADF 751
            + +     VDAA        G+ YLH   K  I+HRD+K  N+LL  K +    K+ DF
Sbjct: 132 KFNE-----VDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIR 811
           G S +F  E++  +   + GT  Y+ PE     +  EK DV+S G++L  L+ G P    
Sbjct: 184 GLSAVF--ENQKKMKERL-GTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPP-FG 238
Query: 812 GYNNTHIVNRV 822
           G  +  I+ +V
Sbjct: 239 GQTDQEILRKV 249

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 110/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA++++  +   SS   K FR E +++  ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+  M  K+ADFGFS  F   +  +   +  G+  Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF---TFGNKLDTFCGSPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
           +  +I+G G  G V +G L    +    VAIK L A  ++  ++ F +EA ++ +  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L G    G    +V EYM  G+L  +L     +  +    + +      G+ YL   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL--- 167
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYA 782
                +HRD+   N+L++  +  K++DFG S++   + ++  +T+     + +  PE  A
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
               +  SDV+SFG+V+ E++ 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
           +  +I+G G  G V +G L    +    VAIK L A  ++  ++ F +EA ++ +  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L G    G    +V EYM  G+L  +L     +  +    + +      G+ YL   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL--- 167
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYYA 782
                +HRD+   N+L++  +  K++DFG S++   + + ++ +T     + +  PE  A
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
               +  SDV+SFG+V+ E++ 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLAD---GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++       VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+     +    S   +  + ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRF 189
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 125
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 186 PVDVWSCGIVLTAMLAG 202

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 107/249 (42%), Gaps = 30/249 (12%)
Query: 612 RILGKGGFGTVYHGYLADG-SEVAIKMLSASS-------------SQGPKQFRTEAQLLM 657
           R LG G +G V      +G SE AIK++  S               +  ++   E  LL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL 717
            + H N+  L     D     LV E+   G L + + +  K      D   I      G+
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGI 159
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            YLH   K  I+HRD+K  NILL  K   +  K+ DFG S  F   S+ +     +GT  
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAY 213
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCP---FLERGDV 831
           Y+ PE     +  EK DV+S G+++  L+ G P    G N+  I+ +V     + +  D 
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 832 RSIVDPRLE 840
           ++I D   E
Sbjct: 272 KNISDEAKE 280

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 13/231 (5%)
Query: 578 LNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSEVAIK 636
           + + N   ++   L  D+      E+ D+       LG+G +G+VY   +   G  VAIK
Sbjct: 5   VQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK----LGEGSYGSVYKAIHKETGQIVAIK 60
Query: 637 MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
            +   S    ++   E  ++ +    ++    G      ++ +V EY   G++   +   
Sbjct: 61  QVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            K  L+  +   I     +GLEYLH   K   IHRD+K  NILLN +  AKLADFG +  
Sbjct: 119 NK-TLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
                       ++GT  ++ PE          +D++S GI  +E+  G P
Sbjct: 175 LTDXMAKR--NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA++++  +   SS   K FR E +++  ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+  M  K+ADFGFS  F   +  +      G+  Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEF---TFGNKLDEFCGSPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVAIK++  +    +   K FR E +++  ++H N+  L
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL 76
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + L+ EY + G +  YL      + KEA S   + +  V A Q   Y H  
Sbjct: 77  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCH-- 128
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            +  I+HRD+K  N+LL+  M  K+ADFGFS  F    +     +  G+  Y  PE +  
Sbjct: 129 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYAAPELFQG 184
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 229

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLAD---GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++       VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG 669
           + LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +  +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG-- 125
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL- 786
           I HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE        
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 787 TEKSDVYSFGIVLLELITG 805
            E  DV+S GIVL  ++ G
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 127
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 108/231 (46%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVAIK++  +    +   K FR E +++  ++H N+  L
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL 79
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + L+ EY + G +  YL      + KEA S   + +  V A Q   Y H  
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCH-- 131
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            +  I+HRD+K  N+LL+  M  K+ADFGFS  F    +     +  G   Y  PE +  
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQG 187
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVG 669
           + LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +  +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG-- 124
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL- 786
           I HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE        
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 787 TEKSDVYSFGIVLLELITG 805
            E  DV+S GIVL  ++ G
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G +G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLAD---GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++       VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 76  LIGVITEN-PVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGS---EVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++  +    VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGS---EVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++  +    VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 127
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 25/303 (8%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +G V+     D G  VAIK    S       K    E ++L ++ H NL +L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPII 729
                 + LV+EY  +  L +   D  +  +       I     Q + + H H C    I
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC----I 124
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN-RLTE 788
           HRDVK  NIL+ +    KL DFGF+++    S+ +     V T  Y  PE    + +   
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVGDTQYGP 182
Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
             DV++ G V  EL++G+P     +     V+++  +L R  +  ++ PR +  F TN  
Sbjct: 183 PVDVWAIGCVFAELLSGVPL----WPGKSDVDQL--YLIRKTLGDLI-PRHQQVFSTNQY 235
Query: 849 WK-VAETAMECVPSISFQRPTMSH-VVTELKKCLEMETAREQIQRTKSQMLSLSSSVDIS 906
           +  V     E +  +  + P +S+  +  LK CL M+      + T  Q+L      +I 
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTE---RLTCEQLLHHPYFENIR 292
Query: 907 AVE 909
            +E
Sbjct: 293 EIE 295

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 109/240 (45%), Gaps = 14/240 (5%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGS---EVAIKMLSASSS 643
           +G++ S  + +   EI        R +G+G FG V+ G Y++  +    VAIK     +S
Sbjct: 23  QGAMGSSTRDY---EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 79
Query: 644 QGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
              ++ F  EA  + +  H ++  L+G   +   V ++ E    G L+ +L    K +L 
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLD 137
Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
               +  A   +  L YL        +HRD+   N+L++     KL DFG S+ +  +S 
Sbjct: 138 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDST 193
Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            + ++     + ++ PE     R T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 194 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGS---EVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++  +    VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 78  LIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 132
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGS---EVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++  +    VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 81  LIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 135
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 124/282 (43%), Gaps = 24/282 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGS---EVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++  +    VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 79  LIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE---SK 133
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN 846
           T  SDV+ FG+ + E++       +G  N  ++ R+    E G+ R  + P        N
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPP--------N 239
Query: 847 SVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
               +     +C      +RP  + +  +L   LE E A+++
Sbjct: 240 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQE 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 29/233 (12%)
Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLA 665
             + +GKG F  V    ++  G EVA+K++  +    +   K FR E +++  ++H N+ 
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFD----ETKEALSWKDRLQIAVDAAQGLEYLH 721
            L         + LV EY + G +  YL      + KEA   + + +  V A Q   Y H
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVSAVQ---YCH 131
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 I+HRD+K  N+LL+  M  K+ADFGFS  F   ++     +  G+  Y  PE +
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK---LDTFCGSPPYAAPELF 185
Query: 782 ASNRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
              +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 232

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLVG 669
           LG G FG V  G +   G +VA+K+L+    +      + R E Q L    H ++  L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
             +   ++ +V EY++ G L  Y+    +  L  K+  ++      G++Y H      ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE- 788
           HRD+K  N+LL+  M AK+ADFG S +    S+        G+  Y  PE   S RL   
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRXSCGSPNYAAPE-VISGRLYAG 194
Query: 789 -KSDVYSFGIVLLELITG 805
            + D++S G++L  L+ G
Sbjct: 195 PEVDIWSSGVILYALLCG 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 591 LKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQ 648
           L ++N  F   +  ++     +I GKG FG V+ G      +V AIK++    +    + 
Sbjct: 13  LGTENLYFQSMDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED 71
Query: 649 FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWK 704
            + E  +L +     +    G       + ++ EY+  G+    L     DET+ A   +
Sbjct: 72  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR 131
Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
           + L+       GL+YLH   K   IHRD+K AN+LL+E  + KLADFG +      +++ 
Sbjct: 132 EILK-------GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQ 178
Query: 765 IS-TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           I   + VGT  ++ PE    +    K+D++S GI  +EL  G P
Sbjct: 179 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG VY G      EV AIK++    +    +  + E  +L +     +    G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                + ++ EY+  G+    LK    +ET  A        I  +  +GL+YLH   K  
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-------TILREILKGLDYLHSERK-- 137
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E+   KLADFG +      +++ I  +  VGT  ++ PE    +  
Sbjct: 138 -IHRDIKAANVLLSEQGDVKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 194 DFKADIWSLGITAIELAKGEP 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 612 RILGKGGFGTVY-----HGYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRN 663
           R LG G FG V+     H    +G   A+K+L        KQ      E  +L  V H  
Sbjct: 12  RTLGTGSFGRVHLIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ--IAVDAAQGLEYLH 721
           +  + G   D   + ++ +Y+  G L    F   +++  + + +    A +    LEYLH
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 II+RD+K  NILL++    K+ DFGF+K  P      ++  + GT  Y+ PE  
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVV 175
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
           ++    +  D +SFGI++ E++ G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLAD---GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++       VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G      +V AIK++    +    +  + E  +L +     +    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                + ++ EY+  G+    L     DET+ A        I  +  +GL+YLH   K  
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------TILREILKGLDYLHSEKK-- 125
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E  + KLADFG +      +++ I   + VGT  ++ PE    +  
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 612 RILGKGGFGTVYHG-YLAD---GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G Y++       VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+G   +   V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLE---SK 510
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
             +HRD+   N+L++     KL DFG S+ +  +S  + ++     + ++ PE     R 
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           T  SDV+ FG+ + E++       +G  N  ++ R+
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+G  G V         E VA+K++    +   P+  + E  +   ++H N+    G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            +G    L  EY + G L    FD  E    +   D  +       G+ YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-GIG--IT 126
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-TE 788
           HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 789 KSDVYSFGIVLLELITG 805
             DV+S GIVL  ++ G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 613 ILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           ILG G FG V+     A G ++A K++     +  ++ + E  ++ ++ H NL  L    
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
               ++ LV EY+  G L   + DE+   L+  D +       +G+ ++H      I+H 
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMY---ILHL 211
Query: 732 DVKTANILL--NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           D+K  NIL    +  Q K+ DFG ++ +    +  ++    GT  +L PE    + ++  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYDFVSFP 268
Query: 790 SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
           +D++S G++   L++GL   + G N+   +N +
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNI 300

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +LGKG +G VY G  L++   +AIK +    S+  +    E  L   + H+N+   +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYL------FDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
           ++ G + +  E +  G+L   L        + ++ + +  + QI     +GL+YLH    
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QI----LEGLKYLHDN-- 127
Query: 726 PPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY--A 782
             I+HRD+K  N+L+N      K++DFG SK     +    + +  GT+ Y+ PE     
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKG 184
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                + +D++S G  ++E+ TG P
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKP 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G      +V AIK++    +    +  + E  +L +     +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 672 NDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                + ++ EY+  G+    L     DET+ A   ++ L+       GL+YLH   K  
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILK-------GLDYLHSEKK-- 140
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E  + KLADFG +      +++ I     VGT  ++ PE    +  
Sbjct: 141 -IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 197 DSKADIWSLGITAIELARGEP 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           ++G GGFG V+   +  DG    IK +  ++ +  +    E + L ++ H N+    G C
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNG-C 72
Query: 672 NDGGN-----------------VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA 714
            DG +                 + +  E+   G L+Q++     E L     L++     
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           +G++Y+H      +I+RD+K +NI L +  Q K+ DFG       + +   S    GT+ 
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK---GTLR 186
Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELI 803
           Y+ PE  +S    ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 628 ADGSEVAIKMLS-ASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGL--VYEY 683
           +DG  +  K L   S ++  KQ   +E  LL  + H N+        D  N  L  V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 684 MAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLHHGCK--PPIIHRDVKTANIL 739
              G+L   +   TKE   L  +  L++       L+  H        ++HRD+K AN+ 
Sbjct: 89  CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 740 LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVL 799
           L+ K   KL DFG ++I     ++  + + VGT  Y+ PE        EKSD++S G +L
Sbjct: 149 LDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 800 LELITGLP 807
            EL   +P
Sbjct: 207 YELCALMP 214

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 614 LGKGGFGTVYHGYLADGSEVAI-KMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + S +A  K++   S +  + +  E  +L    H N+  L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
              N+ ++ E+ A G +   +  E +  L+     QI V   Q L+ L++     IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRLTE-- 788
           +K  NIL       KLADFG S    A++   I    S +GT  ++ PE        +  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 789 ---KSDVYSFGIVLLEL 802
              K+DV+S GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 628 ADGSEVAIKMLS-ASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGL--VYEY 683
           +DG  +  K L   S ++  KQ   +E  LL  + H N+        D  N  L  V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 684 MAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLHHGCK--PPIIHRDVKTANIL 739
              G+L   +   TKE   L  +  L++       L+  H        ++HRD+K AN+ 
Sbjct: 89  CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 740 LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVL 799
           L+ K   KL DFG ++I     ++  + + VGT  Y+ PE        EKSD++S G +L
Sbjct: 149 LDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 800 LELITGLP 807
            EL   +P
Sbjct: 207 YELCALMP 214

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G      +V AIK++    +    +  + E  +L +     +    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                + ++ EY+  G+    L     DET+ A        I  +  +GL+YLH   K  
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-------TILREILKGLDYLHSEKK-- 125
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS-IVGTVGYLDPEYYASNRL 786
            IHRD+K AN+LL+E  + KLADFG +      +++ I  +  VGT  ++ PE    +  
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             K+D++S GI  +EL  G P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 614 LGKGGFGTVYHGYLADGSEVAI-KMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + S +A  K++   S +  + +  E  +L    H N+  L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
              N+ ++ E+ A G +   +  E +  L+     QI V   Q L+ L++     IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRLTE-- 788
           +K  NIL       KLADFG S    A++   I    S +GT  ++ PE        +  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 789 ---KSDVYSFGIVLLEL 802
              K+DV+S GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR-TEAQLLMRVHHRNL----ASLV 668
           +GKG +G V+ G    G  VA+K+ S+   +    FR TE    + + H N+    AS +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDM 72
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH------H 722
              +    + L+  Y   G+L  YL   T + +S    L+I +  A GL +LH       
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 129
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS---IVGTVGYLDPE 779
           G KP I HRD+K+ NIL+ +  Q  +AD G + +  ++S + +       VGT  Y+ PE
Sbjct: 130 G-KPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 780 YYASNRLTE------KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
                   +      + D+++FG+VL E+        R  +N  + +   PF +      
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR------RMVSNGIVEDYKPPFYD------ 235
Query: 834 IV--DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC 879
           +V  DP  E   D   V  V +     +P+  F  PT++ +   +K+C
Sbjct: 236 VVPNDPSFE---DMRKVVCVDQQRPN-IPNRWFSDPTLTSLAKLMKEC 279

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 613 ILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQF--RT---EAQLLMRVHHRNLAS 666
            LG+G F TVY     + ++ VAIK +        K    RT   E +LL  + H N+  
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+       N+ LV+++M      + +  +    L+        +   QGLEYLH     
Sbjct: 77  LLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            I+HRD+K  N+LL+E    KLADFG +K F + + ++    +  T  Y  PE     R+
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARM 189
Query: 787 TEKS-DVYSFGIVLLELITGLP 807
                D+++ G +L EL+  +P
Sbjct: 190 YGVGVDMWAVGCILAELLLRVP 211

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 46/288 (15%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR-TEAQLLMRVHHRNL----ASLV 668
           +GKG +G V+ G    G  VA+K+ S+   +    FR TE    + + H N+    AS +
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDM 72
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH------H 722
              +    + L+  Y   G+L  YL   T + +S    L+I +  A GL +LH       
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 129
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS---IVGTVGYLDPE 779
           G KP I HRD+K+ NIL+ +  Q  +AD G + +  ++S + +       VGT  Y+ PE
Sbjct: 130 G-KPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 780 YYASNRLTE------KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
                   +      + D+++FG+VL E+        R  +N  + +   PF +      
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR------RMVSNGIVEDYKPPFYD------ 235
Query: 834 IV--DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC 879
           +V  DP  E   D   V    +     +P+  F  PT++ +   +K+C
Sbjct: 236 VVPNDPSFE---DMRKV-VCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC--- 724
           N D G    + LV +Y  +G+L  YL    +  ++ +  +++A+  A GL +LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 725 --KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDPEY 780
             KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 781 YASN------RLTEKSDVYSFGIVLLEL 802
              +         +++D+Y+ G+V  E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +GKG F  V    ++  G EVA+K++  +   SS   K FR E ++   ++H N+  L
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF----DETKEALSWKDRLQIAVDAAQGLEYLHHG 723
                    + LV EY + G +  YL      + KEA   + + +  V A Q   Y H  
Sbjct: 79  FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA---RAKFRQIVSAVQ---YCHQK 132
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+K  N+LL+     K+ADFGFS  F   +  +   +  G   Y  PE +  
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSNEF---TFGNKLDAFCGAPPYAAPELFQG 186
Query: 784 NRLT-EKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVR 832
            +    + DV+S G++L  L++G LP    G N   +  RV     RG  R
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLP--FDGQNLKELRERVL----RGKYR 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 614 LGKGGFGTVYHGYL---ADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG+V  G         +VAIK+L   + +   ++   EAQ++ ++ +  +  L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + LV E    G L ++L  + +E +   +  ++    + G++YL    +   +
Sbjct: 78  VCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRLT 787
           HRD+   N+LL  +  AK++DFG SK   A+ +S+ +    G   + +  PE     + +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 788 EKSDVYSFGIVLLELIT 804
            +SDV+S+G+ + E ++
Sbjct: 192 SRSDVWSYGVTMWEALS 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC- 724
           N D G    + LV +Y  +G+L  YL  +  T E +     +++A+  A GL +LH    
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 122
Query: 725 ----KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDP 778
               KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ P
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 779 EYYASN------RLTEKSDVYSFGIVLLEL 802
           E    +         +++D+Y+ G+V  E+
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 628 ADGSEVAIKMLS-ASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGL--VYEY 683
           +DG  +  K L   S ++  KQ   +E  LL  + H N+        D  N  L  V EY
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 684 MAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLHHGCK--PPIIHRDVKTANIL 739
              G+L   +   TKE   L  +  L++       L+  H        ++HRD+K AN+ 
Sbjct: 89  CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 740 LNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVL 799
           L+ K   KL DFG ++I   + +   +   VGT  Y+ PE        EKSD++S G +L
Sbjct: 149 LDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 800 LELITGLP 807
            EL   +P
Sbjct: 207 YELCALMP 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC- 724
           N D G    + LV +Y  +G+L  YL  +  T E +     +++A+  A GL +LH    
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 121
Query: 725 ----KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDP 778
               KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 779 EYYASN------RLTEKSDVYSFGIVLLEL 802
           E    +         +++D+Y+ G+V  E+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR-TEAQLLMRVHHRNL----ASLV 668
           +GKG +G V+ G    G  VA+K+ S+   +    FR TE    + + H N+    AS +
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDM 101
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH------H 722
              +    + L+  Y   G+L  YL   T + +S    L+I +  A GL +LH       
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 158
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS---IVGTVGYLDPE 779
           G KP I HRD+K+ NIL+ +  Q  +AD G + +  ++S + +       VGT  Y+ PE
Sbjct: 159 G-KPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 780 YYASNRLTE------KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
                   +      + D+++FG+VL E+        R  +N  + +   PF +      
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR------RMVSNGIVEDYKPPFYD------ 264
Query: 834 IV--DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC 879
           +V  DP  E   D   V  V +     +P+  F  PT++ +   +K+C
Sbjct: 265 VVPNDPSFE---DMRKVVCVDQQRPN-IPNRWFSDPTLTSLAKLMKEC 308

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC--- 724
           N D G    + LV +Y  +G+L  YL    +  ++ +  +++A+  A GL +LH      
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 725 --KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDPEY 780
             KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ PE 
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 781 YASN------RLTEKSDVYSFGIVLLEL 802
              +         +++D+Y+ G+V  E+
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           N+F  HRI+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 665 ASLV--GYC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            SLV  G C          +    +  + + M  G+L  +L        S  D    A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
              GLE++H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGT 353
Query: 773 VGYLDPEYYASNRLTEKS-DVYSFGIVLLELITG 805
            GY+ PE        + S D +S G +L +L+ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           N+F  HRI+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 665 ASLV--GYC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            SLV  G C          +    +  + + M  G+L  +L        S  D    A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
              GLE++H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGT 353
Query: 773 VGYLDPEYYASNRLTEKS-DVYSFGIVLLELITG 805
            GY+ PE        + S D +S G +L +L+ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           N+F  HRI+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 241
Query: 665 ASLV--GYC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            SLV  G C          +    +  + + M  G+L  +L        S  D    A +
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 299
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
              GLE++H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGT 352
Query: 773 VGYLDPEYYASNRLTEKS-DVYSFGIVLLELITG 805
            GY+ PE        + S D +S G +L +L+ G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC- 724
           N D G    + LV +Y  +G+L  YL  +  T E +     +++A+  A GL +LH    
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 127
Query: 725 ----KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDP 778
               KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ P
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 779 EYYASN------RLTEKSDVYSFGIVLLEL 802
           E    +         +++D+Y+ G+V  E+
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHRNLASLVGYC 671
           +GKG FG V+ G    G EVA+K+ S   S+  + +  EA++   V   H N+   +   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 672 N-DGG---NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC--- 724
           N D G    + LV +Y  +G+L  YL    +  ++ +  +++A+  A GL +LH      
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 725 --KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES--HISTSIVGTVGYLDPEY 780
             KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+ PE 
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 781 YASN------RLTEKSDVYSFGIVLLEL 802
              +         +++D+Y+ G+V  E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           N+F  HRI+G+GGFG VY    AD G   A+K L        K+ + +    + ++ R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 665 ASLV--GYC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            SLV  G C          +    +  + + M  G+L  +L        S  D    A +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAE 300
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
              GLE++H+     +++RD+K ANILL+E    +++D G +  F ++ + H S   VGT
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGT 353
Query: 773 VGYLDPEYYASNRLTEKS-DVYSFGIVLLELITG 805
            GY+ PE        + S D +S G +L +L+ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           NF +I G+G  G V        G +VA+K +     Q  +    E  ++   HH N+  +
Sbjct: 49  NFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                 G  + +V E++  G L   +   T   ++ +    + +   + L YLH+     
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQG--- 161
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +     
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KXLVGTPYWMAPEVISRLPYG 219
Query: 788 EKSDVYSFGIVLLELITGLP 807
            + D++S GI+++E+I G P
Sbjct: 220 TEVDIWSLGIMVIEMIDGEP 239

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL        
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 247

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL        
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 247

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 16/223 (7%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPA-ESESHISTSIVGTVGYLDPEYYASNRLT 787
           +HRD+   N+LL  +  AK++DFG SK   A E+     T     V +  PE     + +
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
            KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 231

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 614 LGKGGFGTVYH------GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH---HRNL 664
           +G G +GTVY       G+      V +          P     E  LL R+    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 665 ASLVGYCNDGGN-----VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
             L+  C          V LV+E++   +L+ YL       L  +    +     +GL++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           LH  C   I+HRD+K  NIL+      KLADFG ++I+   S     T +V T+ Y  PE
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAPE 189
Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
               +      D++S G +  E+    P
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 146
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 206 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEKGE 245

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQL--LMRVHHRNLAS-LVG 669
           ++G+G +G VY G L D   VA+K+ S ++ Q    F  E  +  +  + H N+A  +VG
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVG 75
Query: 670 ---YCNDGG-NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC- 724
                 DG     LV EY   G+L +YL   T +   W    ++A    +GL YLH    
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRLAHSVTRGLAYLHTELP 132
Query: 725 -----KPPIIHRDVKTANILLNEKMQAKLADFGFSK-------IFPAESESHISTSIVGT 772
                KP I HRD+ + N+L+       ++DFG S        + P E E + + S VGT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE-EDNAAISEVGT 191
Query: 773 VGYLDPEYY--ASNRLTEKS-----DVYSFGIVLLELI 803
           + Y+ PE    A N    +S     D+Y+ G++  E+ 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V     +  G E A K+++    S++  ++   EA++   + H N+  L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G+  L+++ +  G L + +    +E  S  D         Q LE + H  +  ++H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCI---QQILEAVLHCHQMGVVH 144
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           RD+K  N+LL  K++    KLADFG +     E E        GT GYL PE    +   
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 203 KPVDLWACGVILYILLVGYP 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 614 LGKGGFGTVYHGYLADGSEVAI-KMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + S +A  K++   S +  + +  E  +L    H N+  L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
              N+ ++ E+ A G +   +  E +  L+     QI V   Q L+ L++     IIHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLT---ESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRLTE-- 788
           +K  NIL       KLADFG S    A++   I      +GT  ++ PE        +  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 789 ---KSDVYSFGIVLLEL 802
              K+DV+S GI L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 132
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 192 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 126
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 186 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + G+  A K++   S +  + +  E ++L    H  +  L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
             G + ++ E+   G +   +  E    L+     QI V   Q LE L+      IIHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIML-ELDRGLT---EPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYASNRLTE-- 788
           +K  N+L+  +   +LADFG S    A++   +    S +GT  ++ PE      + +  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 789 ---KSDVYSFGIVLLEL 802
              K+D++S GI L+E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 138
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 237

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL    +   
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG VY     + G+  A K++   S +  + +  E ++L    H  +  L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
             G + ++ E+   G +   +  E    L+     QI V   Q LE L+      IIHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIML-ELDRGLT---EPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYASNRLTE-- 788
           +K  N+L+  +   +LADFG S    A++   +    S +GT  ++ PE      + +  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 789 ---KSDVYSFGIVLLEL 802
              K+D++S GI L+E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVH---HRNLASL 667
           +G G +GTVY       G  VA+K +   + +   P     E  LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 668 VGYCNDGGN-----VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           +  C          V LV+E++   +L+ YL       L  +    +     +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            C   I+HRD+K  NIL+      KLADFG ++I+   S       +V T+ Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTLWYRAPEVLL 184
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
            +      D++S G +  E+    P
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL        
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 490
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 550 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEKGE 589

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 112/253 (44%), Gaps = 24/253 (9%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKS--DNQQFT-----YSEIVDITNN-------FHRILGK 616
           KR+R   ++      + +G++ S  DN  F      Y + V+I ++        H  LG 
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 617 GGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG 675
           G FG V+     A G+  A K +        +  R E Q +  + H  L +L     D  
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 676 NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKT 735
            + ++YE+M+ G L + + DE  + +S  + ++      +GL ++H       +H D+K 
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 283
Query: 736 ANILLNEKM--QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
            NI+   K   + KL DFG +     +    ++T   GT  +  PE      +   +D++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMW 340
Query: 794 SFGIVLLELITGL 806
           S G++   L++GL
Sbjct: 341 SVGVLSYILLSGL 353

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           ++G GGFG V+   +  DG    I+ +  ++ +  +    E + L ++ H N+    G C
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVHYNG-C 73
Query: 672 NDGGN------------------------------VGLVYEYMAYGNLKQYLFDETKEAL 701
            DG +                              + +  E+   G L+Q++     E L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 702 SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
                L++     +G++Y+H      +IHRD+K +NI L +  Q K+ DFG       + 
Sbjct: 134 DKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELI 803
           +    T   GT+ Y+ PE  +S    ++ D+Y+ G++L EL+
Sbjct: 191 K---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASLV 668
           LG G FGTV  GY  +    +     +  + +  P    +   EA ++ ++ +  +  ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL        
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN---F 491
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HRD+   N+LL  +  AK++DFG SK   A+ E++      G   V +  PE     + 
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD 830
           + KSDV+SFG+++ E  +      RG   +     V   LE+G+
Sbjct: 551 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEKGE 590

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVH---HRNLASL 667
           +G G +GTVY       G  VA+K +   + +   P     E  LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 668 VGYCNDGGN-----VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           +  C          V LV+E++   +L+ YL       L  +    +     +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            C   I+HRD+K  NIL+      KLADFG ++I+   S       +V T+ Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTLWYRAPEVLL 184
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
            +      D++S G +  E+    P
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 112/253 (44%), Gaps = 37/253 (14%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LGKG +G V+       G  VA+K +     +S+   + FR    L     H N+ +L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 670 Y--CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
               ++  +V LV++YM   +L   +     E +    +  +     + ++YLH G    
Sbjct: 77  VLRADNDRDVYLVFDYME-TDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHSGG--- 129
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPA-------------------ESESHISTS 768
           ++HRD+K +NILLN +   K+ADFG S+ F                     + +  I T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 769 IVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNR---VCP 824
            V T  Y  PE    S + T+  D++S G +L E++ G P I  G +  + + R   V  
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP-IFPGSSTMNQLERIIGVID 248
Query: 825 FLERGDVRSIVDP 837
           F    DV SI  P
Sbjct: 249 FPSNEDVESIQSP 261

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 112/253 (44%), Gaps = 24/253 (9%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKS--DNQQFT-----YSEIVDITNN-------FHRILGK 616
           KR+R   ++      + +G++ S  DN  F      Y + V+I ++        H  LG 
Sbjct: 2   KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 61
Query: 617 GGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG 675
           G FG V+     A G+  A K +        +  R E Q +  + H  L +L     D  
Sbjct: 62  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 121
Query: 676 NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKT 735
            + ++YE+M+ G L + + DE  + +S  + ++      +GL ++H       +H D+K 
Sbjct: 122 EMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 177
Query: 736 ANILLNEKM--QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVY 793
            NI+   K   + KL DFG +     +    ++T   GT  +  PE      +   +D++
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMW 234
Query: 794 SFGIVLLELITGL 806
           S G++   L++GL
Sbjct: 235 SVGVLSYILLSGL 247

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR-TEAQLLMRVHHRNLASLVGYCN 672
           +GKG +G V+ G    G +VA+K+    +++    FR TE    + + H N+   +    
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFF--TTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 673 DGG----NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC---- 724
            G      + L+ +Y   G+L  YL   T +A   K  L++A  +  GL +LH       
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDA---KSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 725 -KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES-ESHISTSI-VGTVGYLDPEYY 781
            KP I HRD+K+ NIL+ +     +AD G +  F +++ E  I  +  VGT  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 782 --ASNRLTEKS----DVYSFGIVLLEL 802
             + NR   +S    D+YSFG++L E+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVH---HRNLASL 667
           +G G +GTVY       G  VA+K +   + +   P     E  LL R+    H N+  L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 668 VGYCNDGGN-----VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           +  C          V LV+E++   +L+ YL       L  +    +     +GL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            C   I+HRD+K  NIL+      KLADFG ++I+   S       +V T+ Y  PE   
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLL 184
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
            +      D++S G +  E+    P
Sbjct: 185 QSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 614 LGKGGFGTVYHGYL---ADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG+V  G         +VAIK+L   + +   ++   EAQ++ ++ +  +  L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + LV E    G L ++L  + +E +   +  ++    + G++YL    +   +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYYASNRLTE 788
           HR++   N+LL  +  AK++DFG SK   A+   + + S     + +  PE     + + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 789 KSDVYSFGIVLLELIT 804
           +SDV+S+G+ + E ++
Sbjct: 519 RSDVWSYGVTMWEALS 534

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 20/277 (7%)
Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIK-MLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           ++G+G +G V      D G  VAIK  L +   +  K+    E +LL ++ H NL +L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C       LV+E++ +  L     +     L ++   +       G+ + H      II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQKYLFQIINGIGFCH---SHNII 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN-RLTE 788
           HRD+K  NIL+++    KL DFGF++   A  E  +    V T  Y  PE    + +  +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGK 204
Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
             DV++ G ++ E+  G P +  G ++   +  +   L        + PR +  F+ N V
Sbjct: 205 AVDVWAIGCLVTEMFMGEP-LFPGDSDIDQLYHIMMCLGN------LIPRHQELFNKNPV 257
Query: 849 WK-VAETAMECVPSISFQRPTMSHVVTEL-KKCLEME 883
           +  V    ++    +  + P +S VV +L KKCL ++
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASL 667
           F   LG G F  V      A G   A+K +   + +G +     E  +L ++ H N+ +L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEA--LSWKDRLQIAVDAAQGLEYLHHGCK 725
                   ++ LV + ++ G L    FD   E    + KD   +       + YLH   +
Sbjct: 86  EDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH---R 138
Query: 726 PPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             I+HRD+K  N+L    +E+ +  ++DFG SK+   E +  + ++  GT GY+ PE  A
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVLA 195
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
               ++  D +S G++   L+ G P
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYP 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 32  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 145
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 202
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEP 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV 659
           +   NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           +H N+  L+   +    + LV+E++ + +LK+++       +             QGL +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE
Sbjct: 126 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 180
Query: 780 YYASNRLTEKS-DVYSFGIVLLELIT 804
                +    + D++S G +  E++T
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  +G G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EYM  G++  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   K+ADFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 610 FHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           F  +LG G F  V+       G   A+K +  S +        E  +L ++ H N+ +L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKE--ALSWKDRLQIAVDAAQGLEYLHHGCKP 726
                  +  LV + ++ G L    FD   E    + KD   +       ++YLH     
Sbjct: 73  DIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN--- 125
Query: 727 PIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            I+HRD+K  N+L     E  +  + DFG SK+     ++ I ++  GT GY+ PE  A 
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
              ++  D +S G++   L+ G P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYP 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 154 DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 267
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 268 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 324
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEP 345

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  +G G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EYM  G++  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   K+ADFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 34  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 147
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 204
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEP 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 603 IVDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLM 657
           +VD+  NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL 
Sbjct: 3   LVDM-ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL 717
            ++H N+  L+   +    + LV+E++ + +LK+++       +             QGL
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
            + H      ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  
Sbjct: 121 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRA 175
Query: 778 PE------YYASNRLTEKSDVYSFGIVLLELIT 804
           PE      YY++       D++S G +  E++T
Sbjct: 176 PEILLGCKYYST-----AVDIWSLGCIFAEMVT 203

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 23  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 136
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 193
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEP 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 176
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV 659
           +   NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           +H N+  L+   +    + LV+E++ + +LK+++       +             QGL +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE
Sbjct: 126 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 180
Query: 780 YYASNRLTEKS-DVYSFGIVLLELIT 804
                +    + D++S G +  E++T
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
           E+ ++     R+L +GGF  VY    +  G E A+K L ++  +  +    E   + ++ 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 661 -HRNL------ASLVGYCNDGGNVG-LVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAV 711
            H N+      AS+    +D G    L+   +  G L ++L   E++  LS    L+I  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 712 DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI---FPAESESHISTS 768
              + ++++H   KPPIIHRD+K  N+LL+ +   KL DFG +     +P  S S    +
Sbjct: 144 QTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 769 IV-------GTVGYLDPE---YYASNRLTEKSDVYSFGIVL 799
           +V        T  Y  PE    Y++  + EK D+++ G +L
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 176
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 112/252 (44%), Gaps = 39/252 (15%)
Query: 614 LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G+G  G V        G +VA+KM+     Q  +    E  ++    H N+  +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA-QGLEYLHHGCKPPIIHR 731
            G  + ++ E++  G L     D   +    ++++    +A  Q L YLH      +IHR
Sbjct: 113 VGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHR 165
Query: 732 DVKTANILLNEKMQAKLADFGF----SKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           D+K+ +ILL    + KL+DFGF    SK  P          +VGT  ++ PE  + +   
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK------XLVGTPYWMAPEVISRSLYA 219
Query: 788 EKSDVYSFGIVLLELITGLP---------AIIR-------GYNNTHIVNRVC-PFLERGD 830
            + D++S GI+++E++ G P         A+ R          N+H V+ V   FLER  
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 831 VRSIVDPRLEAN 842
           VR   DP+  A 
Sbjct: 280 VR---DPQERAT 288

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 27  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 140
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 197
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEP 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMR-VHHRNLASLVGY 670
           LG+G +G V    ++  G  +A+K + A+ +SQ  K+   +  + MR V      +  G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL-QIAVDAAQGLEYLHHGCKPPII 729
               G+V +  E M     K Y     K     +D L +IAV   + LE+LH   K  +I
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 176
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY----YASNR 785
           HRDVK +N+L+N   Q K+ DFG S       +S   T   G   Y+ PE          
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIR-GYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
            + KSD++S GI ++EL     AI+R  Y++        PF +   V     P+L A  D
Sbjct: 234 YSVKSDIWSLGITMIEL-----AILRFPYDSWG-----TPFQQLKQVVEEPSPQLPA--D 281
Query: 845 TNSVWKVAETAMECVPSISFQRPT 868
             S   V  T+ +C+   S +RPT
Sbjct: 282 KFSAEFVDFTS-QCLKKNSKERPT 304

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +GKG F  V     L  G E A K+++    S++  ++   EA++   + H N+  L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G   LV++ +  G L + +    +E  S  D         Q LE + H  +  ++H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCI---QQILEAVLHCHQMGVVH 126
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           RD+K  N+LL  K +    KLADFG +     + +        GT GYL PE        
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKEAYG 184
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 185 KPVDIWACGVILYILLVGYP 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 177
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 176
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 175
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASL 667
           R+LG+GGFG V+   + A G   A K L+    +   G +    E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA--AQGLEYLHHGCK 725
                   ++ LV   M  G+++ ++++  ++   +++   I   A    GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  N+LL++    +++D G +    A      +    GT G++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEE 365
Query: 786 LTEKSDVYSFGIVLLELITGL-PAIIRG--YNNTHIVNRV 822
                D ++ G+ L E+I    P   RG    N  +  RV
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASL 667
           R+LG+GGFG V+   + A G   A K L+    +   G +    E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA--AQGLEYLHHGCK 725
                   ++ LV   M  G+++ ++++  ++   +++   I   A    GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  N+LL++    +++D G +    A      +    GT G++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEE 365
Query: 786 LTEKSDVYSFGIVLLELITGL-PAIIRG--YNNTHIVNRV 822
                D ++ G+ L E+I    P   RG    N  +  RV
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V     +  G E A K+++    S++  ++   EA++   + H N+  L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G   LV++ +  G L + +    +E  S  D         Q LE ++H     I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCI---QQILESVNHCHLNGIVH 126
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           RD+K  N+LL  K +    KLADFG +     + +        GT GYL PE    +   
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 185 KPVDMWACGVILYILLVGYP 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 175
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASL 667
           R+LG+GGFG V+   + A G   A K L+    +   G +    E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA--AQGLEYLHHGCK 725
                   ++ LV   M  G+++ ++++  ++   +++   I   A    GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  N+LL++    +++D G +    A      +    GT G++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEE 365
Query: 786 LTEKSDVYSFGIVLLELITGL-PAIIRG--YNNTHIVNRV 822
                D ++ G+ L E+I    P   RG    N  +  RV
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ---GPKQFRTEAQLLMRVHHRNLASL 667
           R+LG+GGFG V+   + A G   A K L+    +   G +    E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA--AQGLEYLHHGCK 725
                   ++ LV   M  G+++ ++++  ++   +++   I   A    GLE+LH   +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---Q 307
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  N+LL++    +++D G +    A      +    GT G++ PE      
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEE 365
Query: 786 LTEKSDVYSFGIVLLELITGL-PAIIRG--YNNTHIVNRV 822
                D ++ G+ L E+I    P   RG    N  +  RV
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 176
Query: 783 SNRLTEKS-DVYSFGIVLLELIT 804
             +    + D++S G +  E++T
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +NF +I G+G  G V    + + G  VA+K +     Q  +    E  ++    H N+  
Sbjct: 77  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           +      G  + +V E++  G L   +   T   ++ +    + +   Q L  LH     
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 190
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +IHRD+K+ +ILL    + KL+DFGF      E        +VGT  ++ PE  +    
Sbjct: 191 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPY 247
Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D++S GI+++E++ G P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEP 268

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG V+   +   G +VA+K +L  +  +G P     E ++L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 671 CNDG--------GNVGLVYEYMAY---GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           C           G++ LV+++  +   G L   L   T   +  K  +Q+ ++   GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLYY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLD 777
           +H      I+HRD+K AN+L+      KLADFG ++ F     S+ +   + V T+ Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 778 PEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTH---IVNRVC 823
           PE     R      D++  G ++ E+ T  P I++G    H   +++++C
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQHQLALISQLC 246

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V     +  G E A K+++    S++  ++   EA++   + H N+  L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G   LV++ +  G L + +    +E  S  D         Q LE ++H     I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCI---QQILESVNHCHLNGIVH 126
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           RD+K  N+LL  K +    KLADFG +     + +        GT GYL PE    +   
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 185 KPVDMWACGVILYILLVGYP 204

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 21/231 (9%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV----AIKMLSASS----SQGPKQFR 650
           ++E V I N    ++LG G +G V+      G +     A+K+L  ++    ++  +  R
Sbjct: 47  HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 651 TEAQLLMRVHHRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
           TE Q+L  +        + Y       + L+ +Y+  G L  +L    +E  + +  +QI
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFT-EHEVQI 163
Query: 710 AV-DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
            V +    LE+LH   K  II+RD+K  NILL+      L DFG SK F A+ E+  +  
Sbjct: 164 YVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD 219
Query: 769 IVGTVGYLDPEYY--ASNRLTEKSDVYSFGIVLLELITGL-PAIIRGYNNT 816
             GT+ Y+ P+      +   +  D +S G+++ EL+TG  P  + G  N+
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 270

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 31/249 (12%)
Query: 586 KKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSE-VAIKMLSASSS 643
           +K+G  ++D Q    +EI           G+G +G V+    L +G   VA+K +   + 
Sbjct: 2   EKDGLCRADQQYECVAEI-----------GEGAYGKVFKARDLKNGGRFVALKRVRVQTG 50
Query: 644 QGPKQFRTEAQLLMRVH-----HRNLASLVGYC-----NDGGNVGLVYEYMAYGNLKQYL 693
           +      T  ++ +  H     H N+  L   C     +    + LV+E++   +L  YL
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL 109
Query: 694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF 753
               +  +  +    +     +GL++LH      ++HRD+K  NIL+    Q KLADFG 
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY 813
           ++I+   S     TS+V T+ Y  PE    +      D++S G +  E+    P + RG 
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP-LFRGS 222
Query: 814 NNTHIVNRV 822
           ++   + ++
Sbjct: 223 SDVDQLGKI 231

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V     +  G E A  +++    S++  ++   EA++   + H N+  L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G+  L+++ +  G L + +    +E  S  D         Q LE + H  +  ++H
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCI---QQILEAVLHCHQMGVVH 133
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           R++K  N+LL  K++    KLADFG +     E E        GT GYL PE    +   
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 191
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 192 KPVDLWACGVILYILLVGYP 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 614 LGKGGFGTVYHGYLA-DGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G G +G V        G++VAIK L     S    K+   E +LL  + H N+  L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 671 ------CNDGGNVGLVYEYMA--YGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLH 721
                  +D  +  LV  +M    G L ++      E L  +DR+Q  V    +GL Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKH------EKLG-EDRIQFLVYQMLKGLRYIH 145
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 IIHRD+K  N+ +NE  + K+ DFG ++    +++S +   +V T  Y  PE  
Sbjct: 146 AAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMXGXVV-TRWYRAPEVI 197
Query: 782 AS-NRLTEKSDVYSFGIVLLELITG 805
            +  R T+  D++S G ++ E+ITG
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG V+   +   G +VA+K +L  +  +G P     E ++L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 671 CNDG--------GNVGLVYEYMAY---GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           C           G++ LV+++  +   G L   L   T   +  K  +Q+ ++   GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLYY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLD 777
           +H      I+HRD+K AN+L+      KLADFG ++ F     S+ +   + V T+ Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 778 PEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTH---IVNRVC 823
           PE     R      D++  G ++ E+ T  P I++G    H   +++++C
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQHQLALISQLC 246

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG V+   +   G +VA+K +L  +  +G P     E ++L  + H N+ +L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 671 CNDG--------GNVGLVYEYMAY---GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           C           G++ LV+++  +   G L   L   T   +  K  +Q+ ++   GL Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLYY 139
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLD 777
           +H      I+HRD+K AN+L+      KLADFG ++ F     S+ +   + V T+ Y  
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 778 PEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTH---IVNRVC 823
           PE     R      D++  G ++ E+ T  P I++G    H   +++++C
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQHQLALISQLC 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y     + VAIK +S    Q   Q RT  E Q+L+R  H N+  +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQ-RTLREIQILLRFRHENVIGIRDI 109
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+L+N     K+ DFG ++I  P    +   T  V T  Y  PE   +++   
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 227 KSIDIWSVGCILAEMLSNRP 246

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 119/265 (44%), Gaps = 29/265 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMR-VHHRNLASLVGY 670
           LG+G +G V    ++  G  +A+K + A+ +SQ  K+   +  + MR V      +  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL-QIAVDAAQGLEYLHHGCKPPII 729
               G+V +  E M     K Y     K     +D L +IAV   + LE+LH   K  +I
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVI 132
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY----YASNR 785
           HRDVK +N+L+N   Q K+ DFG S     +    I     G   Y+ PE          
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKG 189
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIR-GYNNTHIVNRVCPFLERGDVRSIVDPRLEAN-F 843
            + KSD++S GI ++EL     AI+R  Y++        PF +   V     P+L A+ F
Sbjct: 190 YSVKSDIWSLGITMIEL-----AILRFPYDSWG-----TPFQQLKQVVEEPSPQLPADKF 239
Query: 844 DTNSVWKVAETAMECVPSISFQRPT 868
               V    +   +C+   S +RPT
Sbjct: 240 SAEFV----DFTSQCLKKNSKERPT 260

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 174
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 107/251 (42%), Gaps = 40/251 (15%)
Query: 575 AARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVA 634
             +LN  +  +K    L SD +     EI   TN   +++G G FG V+   L +  EVA
Sbjct: 12  GVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNC--KVIGNGSFGVVFQAKLVESDEVA 68
Query: 635 IKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVGYCNDGGN------VGLVYEYMA-- 685
           IK +        K+F+  E Q++  V H N+  L  +    G+      + LV EY+   
Sbjct: 69  IKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 686 -------YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
                  Y  LKQ +             L I +   Q L  L +     I HRD+K  N+
Sbjct: 124 VYRASRHYAKLKQTM-----------PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172
Query: 739 LLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEY-YASNRLTEKSDVYSFG 796
           LL+      KL DFG +KI  A      + S + +  Y  PE  + +   T   D++S G
Sbjct: 173 LLDPPSGVLKLIDFGSAKILIA---GEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 797 IVLLELITGLP 807
            V+ EL+ G P
Sbjct: 230 CVMAELMQGQP 240

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 174
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 176
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 31/249 (12%)
Query: 586 KKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSE-VAIKMLSASSS 643
           +K+G  ++D Q    +EI           G+G +G V+    L +G   VA+K +   + 
Sbjct: 2   EKDGLCRADQQYECVAEI-----------GEGAYGKVFKARDLKNGGRFVALKRVRVQTG 50
Query: 644 QGPKQFRTEAQLLMRVH-----HRNLASLVGYC-----NDGGNVGLVYEYMAYGNLKQYL 693
           +      T  ++ +  H     H N+  L   C     +    + LV+E++   +L  YL
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL 109
Query: 694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF 753
               +  +  +    +     +GL++LH      ++HRD+K  NIL+    Q KLADFG 
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY 813
           ++I+   S     TS+V T+ Y  PE    +      D++S G +  E+    P + RG 
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP-LFRGS 222
Query: 814 NNTHIVNRV 822
           ++   + ++
Sbjct: 223 SDVDQLGKI 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRT---EAQLLMRVHHRNLASL 667
           R +GKG FG V      D  ++ A+K ++        + R    E Q++  + H  L +L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL--QIAVDAAQGLEYLHHGCK 725
                D  ++ +V + +  G+L+ +L    ++ + +K+        +    L+YL +   
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ-- 134
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             IIHRD+K  NILL+E     + DF  + + P E++    T++ GT  Y+ PE ++S +
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRK 190
Query: 786 LTEKS---DVYSFGIVLLELITG 805
               S   D +S G+   EL+ G
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRG 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 176
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 609 NFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMR-VHHRN 663
           +F +++GKG FG V    + A+    A+K+L   +    +  K   +E  +L++ V H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHH 722
           L  L         +  V +Y+  G L  +L    +E    + R +  A + A  L YLH 
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS 157
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEY 780
                I++RD+K  NILL+ +    L DFG  K    E+  H ST  +  GT  YL PE 
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
                     D +  G VL E++ GLP
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 174
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 173
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E+++  +LK+++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 176
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 173
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 174
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+     +  GT  YL PE    
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 175
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E+++  +LK+++       +             QGL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 175
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 178
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+     +  GT  YL PE    
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 210

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 614 LGKGGFGTVYHGYLADGS-EVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V        + E A K+++    S++  ++   EA++   + H N+  L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            ++ G   LV++ +  G L + +    +E  S  D         Q LE ++H  +  I+H
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCI---HQILESVNHIHQHDIVH 153
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           RD+K  N+LL  K +    KLADFG +     + E        GT GYL PE    +   
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPEVLRKDPYG 211
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 212 KPVDIWACGVILYILLVGYP 231

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 31/249 (12%)
Query: 586 KKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSE-VAIKMLSASSS 643
           +K+G  ++D Q    +EI           G+G +G V+    L +G   VA+K +   + 
Sbjct: 2   EKDGLCRADQQYECVAEI-----------GEGAYGKVFKARDLKNGGRFVALKRVRVQTG 50
Query: 644 QGPKQFRTEAQLLMRVH-----HRNLASLVGYC-----NDGGNVGLVYEYMAYGNLKQYL 693
           +      T  ++ +  H     H N+  L   C     +    + LV+E++   +L  YL
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL 109
Query: 694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF 753
               +  +  +    +     +GL++LH      ++HRD+K  NIL+    Q KLADFG 
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166
Query: 754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY 813
           ++I+   S     TS+V T+ Y  PE    +      D++S G +  E+    P + RG 
Sbjct: 167 ARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP-LFRGS 222
Query: 814 NNTHIVNRV 822
           ++   + ++
Sbjct: 223 SDVDQLGKI 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 11  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 125
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+     +  GT  YL PE    
Sbjct: 126 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 182
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 175
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVA--IKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY        EV    K+   + ++G P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE--- 779
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 176
Query: 780 ---YYASNRLTEKSDVYSFGIVLLELIT 804
              YY++       D++S G +  E++T
Sbjct: 177 GCKYYST-----AVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVA--IKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY        EV    K+   + ++G P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE--- 779
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 175
Query: 780 ---YYASNRLTEKSDVYSFGIVLLELIT 804
              YY++       D++S G +  E++T
Sbjct: 176 GCKYYST-----AVDIWSLGCIFAEMVT 198

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E+++  +LK ++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK+++       +             QGL + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 175
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK ++       +             QGL + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 174
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  +G G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   K+ADFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V    +   G E A K+++    S++  ++   EA++  ++ H N+  L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             +     LV++ +  G L + +    +E  S  D         + + Y H      I+H
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVH 128
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           R++K  N+LL  K +    KLADFG +      ++S       GT GYL PE    +  +
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 186 KPVDIWACGVILYILLVGYP 205

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V    +   G E A K+++    S++  ++   EA++  ++ H N+  L   
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             +     LV++ +  G L + +    +E  S  D         + + Y H      I+H
Sbjct: 73  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVH 127
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           R++K  N+LL  K +    KLADFG +      ++S       GT GYL PE    +  +
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 185 KPVDIWACGVILYILLVGYP 204

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+        GT  YL PE    
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 210

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK ++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E+++  +LK ++       +             QGL + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 176
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 140
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++E+   ++ DFGF+K          +  + GT  YL
Sbjct: 141 FEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 192
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 13  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 127
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+        GT  YL PE    
Sbjct: 128 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 184
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++ + +LK ++       +             QGL + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE--- 779
                ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 175
Query: 780 ---YYASNRLTEKSDVYSFGIVLLELIT 804
              YY++       D++S G +  E++T
Sbjct: 176 GCKYYST-----AVDIWSLGCIFAEMVT 198

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+        GT  YL PE    
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 210

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V    +   G E A K+++    S++  ++   EA++  ++ H N+  L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             +     LV++ +  G L + +    +E  S  D         + + Y H      I+H
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVH 128
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           R++K  N+LL  K +    KLADFG +      ++S       GT GYL PE    +  +
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 186 KPVDIWACGVILYILLVGYP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           LGKG F  V    +   G E A K+++    S++  ++   EA++  ++ H N+  L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             +     LV++ +  G L + +    +E  S  D         + + Y H      I+H
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVH 151
Query: 731 RDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           R++K  N+LL  K +    KLADFG + I   +SE+       GT GYL PE    +  +
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAW--HGFAGTPGYLSPEVLKKDPYS 208
Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D+++ G++L  L+ G P
Sbjct: 209 KPVDIWACGVILYILLVGYP 228

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 18/215 (8%)
Query: 609 NFHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNL 664
           ++ ++LGKG FG V      A G   A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHG 723
            +L         +  V EY   G L    F  ++E +  ++R +    +    LEYLH  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               +++RD+K  N++L++    K+ DFG  K     S+        GT  YL PE    
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 784 NRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
           N      D +  G+V+ E++ G LP     YN  H
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDH 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 112/260 (43%), Gaps = 29/260 (11%)
Query: 571 KRKRAARLNV------DNSHSKK-EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVY 623
           K++ AA ++       DNS +++ E SL     + T +E       + ++LGKG FG V 
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF-----EYLKLLGKGTFGKVI 165
Query: 624 H-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVGYCNDGGNVGL 679
                A G   A+K+L         +     TE ++L    H  L +L         +  
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225
Query: 680 VYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
           V EY   G L    F  ++E +  +DR +    +    L+YLH   +  +++RD+K  N+
Sbjct: 226 VMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENL 280
Query: 739 LLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIV 798
           +L++    K+ DFG  K      +     +  GT  YL PE    N      D +  G+V
Sbjct: 281 MLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 799 LLELITG-LPAIIRGYNNTH 817
           + E++ G LP     YN  H
Sbjct: 339 MYEMMCGRLPF----YNQDH 354

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 611 HRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLL-MRVHHRNLA 665
           H++LGKG FG V+       ++  AIK L                E ++L +   H  L 
Sbjct: 23  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYL 720
            +        N+  V EY+  G+L  ++     FD ++           A +   GL++L
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-------YAAEIILGLQFL 135
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI----STSIVGTVGYL 776
           H      I++RD+K  NILL++    K+ADFG  K      E+ +    +    GT  Y+
Sbjct: 136 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNEFCGTPDYI 186
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITG 805
            PE     +     D +SFG++L E++ G
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 40/224 (17%)
Query: 614 LGKGGFGTVYHGYLA-DGSEVAIKMLSAS-------------------------SSQGP- 646
           +GKG +G V   Y   D +  A+K+LS                             +GP 
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 647 KQFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMAYGNLKQYLFDETKEALSWK 704
           +Q   E  +L ++ H N+  LV   +D    ++ +V+E +  G + +     T + LS  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSED 137
Query: 705 DRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
                  D  +G+EYLH+     IIHRD+K +N+L+ E    K+ADFG S  F   S++ 
Sbjct: 138 QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-SDAL 193
Query: 765 ISTSIVGTVGYLDPEYYASNR--LTEKS-DVYSFGIVLLELITG 805
           +S + VGT  ++ PE  +  R   + K+ DV++ G+ L   + G
Sbjct: 194 LSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG V  G +   G +VA+K+L+    +      + + E Q L    H ++  L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
             +   +  +V EY++ G L  Y+    + E +  +   Q  + A   ++Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA---VDYCH---RHMV 132
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+K  N+LL+  M AK+ADFG S +    S+     +  G+  Y  PE   S RL  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAPE-VISGRLYA 188
Query: 789 --KSDVYSFGIVLLELITG 805
             + D++S G++L  L+ G
Sbjct: 189 GPEVDIWSCGVILYALLCG 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 611 HRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR---TEAQLL-MRVHHRNLA 665
           H++LGKG FG V+       ++  AIK L                E ++L +   H  L 
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYL 720
            +        N+  V EY+  G+L  ++     FD ++           A +   GL++L
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-------YAAEIILGLQFL 134
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI----STSIVGTVGYL 776
           H      I++RD+K  NILL++    K+ADFG  K      E+ +    +    GT  Y+
Sbjct: 135 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNXFCGTPDYI 185
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITG 805
            PE     +     D +SFG++L E++ G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 139
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          + ++ GT  YL
Sbjct: 140 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYL 191
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 23/244 (9%)
Query: 581 DNSHSKK-EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYH-GYLADGSEVAIKML 638
           DNS +++ E SL     + T +E       + ++LGKG FG V      A G   A+K+L
Sbjct: 130 DNSGAEEMEVSLAKPKHRVTMNEF-----EYLKLLGKGTFGKVILVKEKATGRYYAMKIL 184
Query: 639 SASSSQGPKQFR---TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD 695
                    +     TE ++L    H  L +L         +  V EY   G L    F 
Sbjct: 185 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFH 241
Query: 696 ETKEALSWKDRLQI-AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
            ++E +  +DR +    +    L+YLH   +  +++RD+K  N++L++    K+ DFG  
Sbjct: 242 LSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 299
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGY 813
           K      +     +  GT  YL PE    N      D +  G+V+ E++ G LP     Y
Sbjct: 300 K--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----Y 353
Query: 814 NNTH 817
           N  H
Sbjct: 354 NQDH 357

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G +G VY      G   A+K   L       P     E  +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+E++   +LK+ L D  +  L         +    G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 732 DVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L+N + + K+ADFG ++ F  P    +H     V T+ Y  P+    S + + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYRAPDVLMGSKKYST 180
Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  E++ G P
Sbjct: 181 TIDIWSVGCIFAEMVNGTP 199

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 29/230 (12%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIK-MLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G FG V+   +   G +VA+K +L  +  +G P     E ++L  + H N+ +L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 671 CNDGGN--------VGLVYEYMAY---GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
           C    +        + LV+++  +   G L   L   T   +  K  +Q+ ++   GL Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLYY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLD 777
           +H      I+HRD+K AN+L+      KLADFG ++ F     S+ +   + V T+ Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 778 PEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTH---IVNRVC 823
           PE     R      D++  G ++ E+ T  P I++G    H   +++++C
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQHQLALISQLC 246

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V    L +  +V A+K+L+        +   FR E  +L+    + + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF---DETKEALS--WKDRLQIAVDAAQGLEYLHH 722
                D  N+ LV +Y   G+L   L    D   E ++  +   + IA+D+   L Y   
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY--- 196
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                 +HRD+K  NIL++     +LADFG S +   E  +  S+  VGT  Y+ PE   
Sbjct: 197 ------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 783 S-----NRLTEKSDVYSFGIVLLELITG 805
           +      R   + D +S G+ + E++ G
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG V  G +   G +VA+K+L+     S     + + E Q L    H ++  L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
             +   +  +V EY++ G L  Y+    + E +  +   Q  + A   ++Y H   +  +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA---VDYCH---RHMV 132
Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+K  N+LL+  M AK+ADFG S +    S+        G+  Y  PE   S RL  
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRDSCGSPNYAAPE-VISGRLYA 188
Query: 789 --KSDVYSFGIVLLELITG 805
             + D++S G++L  L+ G
Sbjct: 189 GPEVDIWSCGVILYALLCG 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G +G VY      G   A+K   L       P     E  +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+E++   +LK+ L D  +  L         +    G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 732 DVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L+N + + K+ADFG ++ F  P    +H    IV T+ Y  P+    S + + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGSKKYST 180
Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  E++ G P
Sbjct: 181 TIDIWSVGCIFAEMVNGTP 199

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
           +G+G +G VY      G   A+K   L       P     E  +L  + H N+  L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHR 731
           +    + LV+E++   +LK+ L D  +  L         +    G+ Y H      ++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 732 DVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPE-YYASNRLTE 788
           D+K  N+L+N + + K+ADFG ++ F  P    +H     V T+ Y  P+    S + + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EVVTLWYRAPDVLMGSKKYST 180
Query: 789 KSDVYSFGIVLLELITGLP 807
             D++S G +  E++ G P
Sbjct: 181 TIDIWSVGCIFAEMVNGAP 199

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          + ++ GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL----- 667
           LG GG G V+     D    VAIK +  +  Q  K    E +++ R+ H N+  +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 668 ---------VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
                    VG   +  +V +V EYM   +L   L  E    L    RL       +GL+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL--EQGPLLEEHARL-FMYQLLRGLK 134
Query: 719 YLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAE--SESHISTSIVGTVGY 775
           Y+H      ++HRD+K AN+ +N E +  K+ DFG ++I       + H+S  +V T  Y
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWY 190
Query: 776 LDPEYYAS-NRLTEKSDVYSFGIVLLELITG 805
             P    S N  T+  D+++ G +  E++TG
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLAS 666
           NF   L +   G ++ G    G+++ +K+L     S++  + F  E   L    H N+  
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 667 LVGYCND--GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           ++G C      +  L+  +M YG+L   L + T   +     ++ A+D A+G+ +L H  
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL-HTL 130
Query: 725 KPPIIHRDVKTANILLNEKMQAK--LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           +P I    + + +++++E M A+  +AD  FS  F +    +    +        PE   
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFS--FQSPGRMYAPAWVAPEALQKKPE--D 186
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
           +NR    +D++SF ++L EL+T
Sbjct: 187 TNR--RSADMWSFAVLLWELVT 206

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           + LG+G FG V   Y    G +VA+K+     L+ S  QG  +   E   L  + H ++ 
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHII 67
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L         + +V EY A   L  Y+    K  +S ++  +        +EY H   +
Sbjct: 68  KLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 121
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL+E +  K+ADFG S I    ++ +   +  G+  Y  PE  +   
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 786 LT-EKSDVYSFGIVL 799
               + DV+S G++L
Sbjct: 179 YAGPEVDVWSCGVIL 193

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           + LG+G FG V   Y    G +VA+K+     L+ S  QG  +   E   L  + H ++ 
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHII 77
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L         + +V EY A   L  Y+    K  +S ++  +        +EY H   +
Sbjct: 78  KLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 131
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL+E +  K+ADFG S I    ++ +   +  G+  Y  PE  +   
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 786 LT-EKSDVYSFGIVL 799
               + DV+S G++L
Sbjct: 189 YAGPEVDVWSCGVIL 203

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 14/232 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 87
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 144
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 789 KS-DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---ERGDVRSIVD 836
           KS D++S G +L E+++  P I  G +    +N +   L   E+ D+  I++
Sbjct: 205 KSIDIWSVGCILAEMLSNRP-IFPGKHYLDQLNHILGILGSPEQEDLNCIIN 255

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           + LG+G FG V   Y    G +VA+K+     L+ S  QG  +   E   L  + H ++ 
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHII 76
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L         + +V EY A   L  Y+    K  +S ++  +        +EY H   +
Sbjct: 77  KLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 130
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL+E +  K+ADFG S I    ++ +   +  G+  Y  PE  +   
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 786 LT-EKSDVYSFGIVL 799
               + DV+S G++L
Sbjct: 188 YAGPEVDVWSCGVIL 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
           + LG+G FG V   Y    G +VA+K+     L+ S  QG  +   E   L  + H ++ 
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHII 71
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L         + +V EY A   L  Y+    K  +S ++  +        +EY H   +
Sbjct: 72  KLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCH---R 125
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL+E +  K+ADFG S I    ++ +   +  G+  Y  PE  +   
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 786 LT-EKSDVYSFGIVL 799
               + DV+S G++L
Sbjct: 183 YAGPEVDVWSCGVIL 197

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 148
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 149 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 200
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 207 KSIDIWSVGCILAEMLSNRP 226

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 207 KSIDIWSVGCILAEMLSNRP 226

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
            NF ++  +G+G +G VY       G  VA+K   L   +   P     E  LL  ++H 
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           N+  L+   +    + LV+E++   +LK+++       +             QGL + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDPEY 780
                ++HRD+K  N+L+N +   KLADFG ++ F  P  +  H     V T+ Y  PE 
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXH----EVVTLWYRAPEI 177
Query: 781 YASNRLTEKS-DVYSFGIVLLELIT 804
               +    + D++S G +  E++T
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 91
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 209 KSIDIWSVGCILAEMLSNRP 228

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 174
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          + ++ GT  YL
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYL 226
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 207 KSIDIWSVGCILAEMLSNRP 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 605 DITNNFHRI---LGKGGFGTVYHGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRV 659
           D  ++F  +   LG+G    VY      G++   A+K+L  +  +  K  RTE  +L+R+
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRL 105
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA----Q 715
            H N+  L         + LV E +  G L    FD   E   + +R   A DA     +
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSER--DAADAVKQILE 159
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNE---KMQAKLADFGFSKIFPAESESHISTSIVGT 772
            + YLH      I+HRD+K  N+L          K+ADFG SKI   +    +  ++ GT
Sbjct: 160 AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGT 213
Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
            GY  PE         + D++S GI+   L+ G 
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF 247

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 97
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 154
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 215 KSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 207 KSIDIWSVGCILAEMLSNRP 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 109
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 227 KSIDIWSVGCILAEMLSNRP 246

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 89
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 207 KSIDIWSVGCILAEMLSNRP 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 94
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 151
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 212 KSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 95
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 152
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 213 KSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 86
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 143
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 204 KSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 87
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 144
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 205 KSIDIWSVGCILAEMLSNRP 224

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 174
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 226
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 11/213 (5%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +GTV+     +  E VA+K   L       P     E  LL  + H+N+  L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            +    + LV+E+    +LK+Y FD     L  +          +GL + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCD-QDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+K  N+L+N   + KLADFG ++ F      +  ++ V T+ Y  P+     +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 791 -DVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            D++S G +  EL      +  G +    + R+
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQLKRI 215

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIIISKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASL--- 667
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 109
Query: 668 --VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
                     +V LV   M   +L + L     + LS            +GL+Y+H    
Sbjct: 110 IRAPTIEQMKDVYLVTHLMG-ADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASN 784
             ++HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   ++
Sbjct: 165 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 785 RLTEKS-DVYSFGIVLLELITGLP 807
           +   KS D++S G +L E+++  P
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSAS-----SSQGPKQFR----TEAQLLMRVH-H 661
           ILG+G    V    +     E A+K++  +     S++  ++ R     E  +L +V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
            N+  L           LV++ M  G L  YL +  K  LS K+  +I     + +  LH
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH 141
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEY 780
              K  I+HRD+K  NILL++ M  KL DFGFS ++ P E       S+ GT  YL PE 
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LRSVCGTPSYLAPEI 194
Query: 781 YASNR------LTEKSDVYSFGIVLLELITGLP 807
              +         ++ D++S G+++  L+ G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ ++  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYQMAAGYP 236

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 134
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE   +  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 55/302 (18%)
Query: 628 ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY 686
           A   E A+K++   S + P +   E ++L+R   H N+ +L    +DG +V LV E M  
Sbjct: 50  ATNMEYAVKVID-KSKRDPSE---EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG 105
Query: 687 GNL-----KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
           G L     +Q  F E + +        +     + +EYLH      ++HRD+K +NIL  
Sbjct: 106 GELLDKILRQKFFSEREASF-------VLHTIGKTVEYLH---SQGVVHRDLKPSNILYV 155
Query: 742 EKMQ----AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGI 797
           ++       ++ DFGF+K   AE+   ++     T  ++ PE        E  D++S GI
Sbjct: 156 DESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGCDIWSLGI 213
Query: 798 VLLELITGLPAIIRGYNNT--HIVNRV--CPFLERGDVRSIVDPRLEANFDTNSVWKVAE 853
           +L  ++ G      G ++T   I+ R+    F   G            N++T     V+E
Sbjct: 214 LLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSG-----------GNWNT-----VSE 257
Query: 854 TAMECVPSI----SFQRPTMSHV-----VTELKKCLEMETAREQIQRTKSQMLSLSSSVD 904
           TA + V  +      QR T   V     VT+  K  + + + + +Q  K  M +  S+++
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317
Query: 905 IS 906
            S
Sbjct: 318 SS 319

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 131/324 (40%), Gaps = 53/324 (16%)
Query: 579 NVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTV-YHGYLADGSEVAIKM 637
           N+DN  ++ E  +K        +E  D+     +++G+G FG V    + A     A+K+
Sbjct: 52  NIDNFLNRYEKIVKKIRGLQMKAEDYDVV----KVIGRGAFGEVQLVRHKASQKVYAMKL 107
Query: 638 LSASS---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL- 693
           LS            F  E  ++   +   +  L     D   + +V EYM  G+L   + 
Sbjct: 108 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 167
Query: 694 -FD-ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF 751
            +D   K A  +   + +A+DA   +          +IHRDVK  N+LL++    KLADF
Sbjct: 168 NYDVPEKWAKFYTAEVVLALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADF 218
Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITG-- 805
           G           H  T+ VGT  Y+ PE   S         + D +S G+ L E++ G  
Sbjct: 219 GTCMKMDETGMVHCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 277
Query: 806 ---LPAIIRGYN-----------------NTHIVNRVCPFLERGDV---RSIVDPRLEAN 842
                +++  Y+                 + H  N +C FL   +V   R+ V+   +  
Sbjct: 278 PFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 337
Query: 843 FDTNSVW---KVAETAMECVPSIS 863
           F  N  W    + ETA   VP +S
Sbjct: 338 FFKNDQWNWDNIRETAAPVVPELS 361

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 22/229 (9%)
Query: 589 GSLKSDNQQ---FTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSEVAIKML-SASSS 643
           G LK   +Q   FT  ++ D+       +G+G +G+V    +   G  +A+K + S    
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGE-----IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 644 QGPKQFRTEAQLLMRVHH-RNLASLVGYCNDGGNVGLVYEYMA--YGNLKQYLFDETKEA 700
           +  KQ   +  ++MR      +    G     G+  +  E M+  +    +Y++    + 
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121
Query: 701 LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE 760
           +  +   +I +   + L +L    K  IIHRD+K +NILL+     KL DFG S      
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--- 176
Query: 761 SESHISTSIVGTVGYLDPEYYASNRLTE----KSDVYSFGIVLLELITG 805
            +S   T   G   Y+ PE    +   +    +SDV+S GI L EL TG
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 28/247 (11%)
Query: 574 RAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE- 632
           R ++++ D   SK    + +  Q     + V  T+   +++G G FG VY   L D  E 
Sbjct: 2   RGSKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT--KVIGNGSFGVVYQAKLCDSGEL 59
Query: 633 VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVGYCNDGGN------VGLVYEYM- 684
           VAIK +        K+F+  E Q++ ++ H N+  L  +    G       + LV +Y+ 
Sbjct: 60  VAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 114
Query: 685 --AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE 742
              Y   + Y     K+ L             + L Y+H      I HRD+K  N+LL+ 
Sbjct: 115 ETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP 169
Query: 743 KMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEY-YASNRLTEKSDVYSFGIVLL 800
                KL DFG +K      E ++S   + +  Y  PE  + +   T   DV+S G VL 
Sbjct: 170 DTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 801 ELITGLP 807
           EL+ G P
Sbjct: 227 ELLLGQP 233

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 80  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 134
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE   +  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAI+ +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 146
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 198
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 51/300 (17%)
Query: 628 ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY 686
           A   E A+K++   S + P +   E ++L+R   H N+ +L    +DG +V LV E M  
Sbjct: 50  ATNMEYAVKVID-KSKRDPSE---EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRG 105
Query: 687 GNL-----KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
           G L     +Q  F E + +        +     + +EYLH      ++HRD+K +NIL  
Sbjct: 106 GELLDKILRQKFFSEREASF-------VLHTIGKTVEYLH---SQGVVHRDLKPSNILYV 155
Query: 742 EKMQ----AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGI 797
           ++       ++ DFGF+K   AE+   ++     T  ++ PE        E  D++S GI
Sbjct: 156 DESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGCDIWSLGI 213
Query: 798 VLLELITGLPAIIRGYNNT--HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETA 855
           +L  ++ G      G ++T   I+ R+      G  +  +      N++T     V+ETA
Sbjct: 214 LLYTMLAGYTPFANGPSDTPEEILTRI------GSGKFTLS---GGNWNT-----VSETA 259
Query: 856 MECVPSI----SFQRPTMSHV-----VTELKKCLEMETAREQIQRTKSQMLSLSSSVDIS 906
            + V  +      QR T   V     VT+  K  + + + + +Q  K  M +  S+++ S
Sbjct: 260 KDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSS 319

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L         +     TE ++L    H  L +L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY   G L    F  ++E +  +DR +    +    L+YLH   + 
Sbjct: 76  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +++RD+K  N++L++    K+ DFG  K      +        GT  YL PE    N  
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDY 188
Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-------YAAQIVLT 146
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 198
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L         +     TE ++L    H  L +L
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY   G L    F  ++E +  +DR +    +    L+YLH   + 
Sbjct: 74  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 128
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +++RD+K  N++L++    K+ DFG  K      +        GT  YL PE    N  
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDY 186
Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 214

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYH-GYLADGSEVAIKMLSA 640
            S  K+ G L    Q++  +EI D+ N     +G G  G V+   +   G  +A+K +  
Sbjct: 4   GSSGKQTGYLTIGGQRYQ-AEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 641 SSSQGP-KQFRTEAQLLMRVHH-RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETK 698
           S ++   K+   +  ++++ H    +    G      +V +  E M  G   + L    +
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQ 118
Query: 699 EALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP 758
             +  +   ++ V   + L YL    K  +IHRDVK +NILL+E+ Q KL DFG S    
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 759 AESESHISTSIVGTVGYLDPEYYASNRLTE-----KSDVYSFGIVLLELITG 805
            +     S    G   Y+ PE       T+     ++DV+S GI L+EL TG
Sbjct: 177 DDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 86/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 140
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE   +  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           ++LGKG FG V      A G   A+K+L         +     TE ++L    H  L +L
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKP 726
                    +  V EY   G L    F  ++E +  +DR +    +    L+YLH   + 
Sbjct: 75  KYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 129
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +++RD+K  N++L++    K+ DFG  K      +        GT  YL PE    N  
Sbjct: 130 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDNDY 187
Query: 787 TEKSDVYSFGIVLLELITG-LPAIIRGYNNTH 817
               D +  G+V+ E++ G LP     YN  H
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPF----YNQDH 215

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           F+  LG+G F  ++ G   +         +EV +K+L  +     + F   A ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           ++L    G C  G    LV E++ +G+L  YL  + K  ++   +L++A   A  + +L 
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAWAMHFLE 130
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT------VGY 775
                 +IH +V   NILL  +   K  +  F K+    S+  IS +++        + +
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL----SDPGISITVLPKDILQERIPW 183
Query: 776 LDPEYYASNR-LTEKSDVYSFGIVLLELITG 805
           + PE   + + L   +D +SFG  L E+ +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           F+  LG+G F  ++ G   +         +EV +K+L  +     + F   A ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           ++L    G C  G    LV E++ +G+L  YL  + K  ++   +L++A   A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT------VGY 775
                 +IH +V   NILL  +   K  +  F K+    S+  IS +++        + +
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL----SDPGISITVLPKDILQERIPW 183
Query: 776 LDPEYYASNR-LTEKSDVYSFGIVLLELITG 805
           + PE   + + L   +D +SFG  L E+ +G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 154
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFGF+K          +  + GT  YL
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR-----TWXLCGTPEYL 206
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
           R LG G FG V    +   G+  A+K+L        KQ      E ++   V+   L  L
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                D  N+ +V EY   G +  +L     F E             A       EYLH 
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLTFEYLH- 159
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                +I+RD+K  N+L++++   K+ADFGF+K          +  + GT  YL PE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 212
Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
           S    +  D ++ G+++ E+  G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            P    S    +  D ++ G+++ E+  G P
Sbjct: 206 APAIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+  G +  +L     F E             A      
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 174
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT  YL
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 226
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 85/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 76  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 130
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   +  +          +  PE   +  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 93
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +      V T  Y  PE   +++   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 211 KSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R  H N+  +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGINDI 94
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 151
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +      V T  Y  PE   +++   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 212 KSIDIWSVGCILAEMLSNRP 231

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSAS-----SSQGPKQFR----TEAQLLMRVH-H 661
           ILG+G    V    +     E A+K++  +     S++  ++ R     E  +L +V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
            N+  L           LV++ M  G L  YL +  K  LS K+  +I     + +  LH
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH 141
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEY 780
              K  I+HRD+K  NILL++ M  KL DFGFS ++ P E        + GT  YL PE 
Sbjct: 142 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEI 194
Query: 781 YASNR------LTEKSDVYSFGIVLLELITGLP 807
              +         ++ D++S G+++  L+ G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL-V 668
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI------AVDAAQGLEYLHH 722
            + + G    +VY  +    + + ++   +     K  L +           + L Y+H 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 723 GCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPEY- 780
                I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE  
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPELI 194
Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
           + +   T   DV+S G VL EL+ G P
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSAS-----SSQGPKQFR----TEAQLLMRVH-H 661
           ILG+G    V    +     E A+K++  +     S++  ++ R     E  +L +V  H
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
            N+  L           LV++ M  G L  YL +  K  LS K+  +I     + +  LH
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH 128
Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEY 780
              K  I+HRD+K  NILL++ M  KL DFGFS ++ P E        + GT  YL PE 
Sbjct: 129 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEI 181
Query: 781 YASNR------LTEKSDVYSFGIVLLELITGLP 807
              +         ++ D++S G+++  L+ G P
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 85/217 (39%), Gaps = 13/217 (5%)
Query: 614 LGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLAS 666
           LG G FG V  G     S     VA+K L       P+    F  E   +  + HRNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L G       + +V E    G+L   L       L      + AV  A+G+ YL      
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLE---SK 140
Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT-VGYLDPEYYASNR 785
             IHRD+   N+LL  +   K+ DFG  +  P   +  +          +  PE   +  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            +  SD + FG+ L E+ T       G N + I++++
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLS----ASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V        G E A K +     +SS +G   ++   E  +L  + H N+ +
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L +  KE+L+  +  Q       G+ YLH     
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SK 127
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +K     + KL DFG +    A +E     +I GT  ++ PE   
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 184
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 185 YEPLGLEADMWSIGVITYILLSG 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSASS-SQGPKQFRTEAQL--LMRVHHRNLASLVG 669
           LG+G FG V    +     +VA+K +S     +     R E ++  L  + H ++  L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                 ++ +V EY A G L  Y+ ++ +       R    +  A  +EY H   +  I+
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCH---RHKIV 130
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT-E 788
           HRD+K  N+LL++ +  K+ADFG S I    ++ +   +  G+  Y  PE          
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIM---TDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 789 KSDVYSFGIVLLELITG 805
           + DV+S GIVL  ++ G
Sbjct: 188 EVDVWSCGIVLYVMLVG 204

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 211
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 200
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G G +G+V        G +VAIK LS    S    K+   E  LL  + H N+  L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPII 729
                ++   Y++       Q    +       ++++Q  V    +GL+Y+H      ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VV 148
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTE 788
           HRD+K  N+ +NE  + K+ DFG ++   AE      T  V T  Y  PE   S     +
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQ 203
Query: 789 KSDVYSFGIVLLELITG 805
             D++S G ++ E++TG
Sbjct: 204 TVDIWSVGCIMAEMLTG 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 226
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G G +G+V        G +VAIK LS    S    K+   E  LL  + H N+  L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGCKPPII 729
                ++   Y++       Q    +       ++++Q  V    +GL+Y+H      ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VV 166
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTE 788
           HRD+K  N+ +NE  + K+ DFG ++   AE      T  V T  Y  PE   S     +
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQ 221
Query: 789 KSDVYSFGIVLLELITG 805
             D++S G ++ E++TG
Sbjct: 222 TVDIWSVGCIMAEMLTG 238

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+   H N+  +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLAFRHENIIGINDI 91
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 209 KSIDIWSVGCILAEMLSNRP 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLS----ASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V        G E A K +     +SS +G   ++   E  +L  + H N+ +
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L +  KE+L+  +  Q       G+ YLH     
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +K     + KL DFG +    A +E     +I GT  ++ PE   
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 191
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 192 YEPLGLEADMWSIGVITYILLSG 214

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 193
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 204
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +     QG K F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYC 671
           LG+GGFG V+      D    AIK +   + +   ++   E + L ++ H     +V Y 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH---PGIVRYF 69
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFDET----KEALS-W---------KDR---LQIAVDAA 714
           N         E +   + K YL+ +     KE L  W         ++R   L I +  A
Sbjct: 70  NAWLEKNTT-EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI--------- 765
           + +E+LH      ++HRD+K +NI        K+ DFG       + E            
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 766 -STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELI 803
             T  VGT  Y+ PE    N  + K D++S G++L EL+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    +   G+  A+K+L        KQ      E ++L  V+ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY+A G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N+L++++   ++ DFGF+K          +  + GT   L
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEAL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 205
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 226
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 167 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 220
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           +G+G +GTV+     +  E VA+K   L       P     E  LL  + H+N+  L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
            +    + LV+E+    +LK+Y FD     L  +          +GL + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCD-QDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS 790
           RD+K  N+L+N   + KLA+FG ++ F      +  ++ V T+ Y  P+     +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 791 -DVYSFGIVLLEL 802
            D++S G +  EL
Sbjct: 183 IDMWSAGCIFAEL 195

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAIK++S        A  +       TE ++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 126
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 217

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   +    G  VA+K LS    + +   + +R E  LL  V+H+N+ SL+ 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 88
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  E   E +S+     +      G+++LH 
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHS 142
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++     S + + T  V T  Y  PE   
Sbjct: 143 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVIL 196
Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
                E  D++S G ++ EL+ G   I +G ++    N+V
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKG-SVIFQGTDHIDQWNKV 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 175 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 228
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++S   + +  Y  PE
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSX--ICSRYYRAPE 196
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +     QG K F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 23/230 (10%)
Query: 587 KEGSLKSDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSAS--- 641
           KE S + +      S  + I N  F R+LGKG FG V    + + G   A+K+L      
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 642 SSQGPKQFRTEAQLL-MRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL-----KQYLFD 695
                +   TE ++L +  +H  L  L         +  V E++  G+L     K   FD
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 696 ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           E +           A +    L +LH      II+RD+K  N+LL+ +   KLADFG  K
Sbjct: 123 EARARF-------YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
                     + +  GT  Y+ PE           D ++ G++L E++ G
Sbjct: 173 --EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +     QG K F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 192
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAIK++S        A  +       TE ++L +++H 
Sbjct: 15  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 74
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 75  CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 125
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 126 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 179
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 180 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 216

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAIK++S        A  +       TE ++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 126
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAIK++S        A  +       TE ++L +++H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 76  CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 126
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 217

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 177 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 230
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 609 NFHRILGKGGFGTVYHGYLAD--GSE--VAIKMLSAS---SSQGPKQFRTEAQLLMRVHH 661
           NF  +LGKG FG V    LAD  G+E   AIK+L           +    E ++L  +  
Sbjct: 22  NFLMVLGKGSFGKVM---LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 662 RNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI--AVDAAQGLE 718
               + +  C      +  V EY+  G+L  ++    ++   +K+   +  A + + GL 
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISIGLF 134
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           +LH   K  II+RD+K  N++L+ +   K+ADFG  K    +  +  +    GT  Y+ P
Sbjct: 135 FLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAP 189
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  A     +  D +++G++L E++ G P
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQP 218

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGY 670
           +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+   H N+  +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLAFRHENIIGINDI 91
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETK-EALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                   +   Y+    ++  L+   K + LS            +GL+Y+H      ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y  PE   +++   
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 789 KS-DVYSFGIVLLELITGLP 807
           KS D++S G +L E+++  P
Sbjct: 209 KSIDIWSVGCILAEMLSNRP 228

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 144 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 197
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 628 ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY 686
           A   E A+K++   S + P +   E ++L+R   H N+ +L    +DG  V +V E M  
Sbjct: 45  ATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-- 744
           G L   +  +  +  S ++   +     + +EYLH      ++HRD+K +NIL  ++   
Sbjct: 101 GELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 745 --QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
               ++ DFGF+K   AE+   ++     T  ++ PE           D++S G++L  +
Sbjct: 156 PESIRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 803 ITGLPAIIRGYNNT 816
           +TG      G ++T
Sbjct: 214 LTGYTPFANGPDDT 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLS----ASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V        G E A K +      SS +G   ++   E  +L  + H N+ +
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L +  KE+L+  +  Q       G+ YLH     
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SK 148
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +K     + KL DFG +    A +E     +I GT  ++ PE   
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 205
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 206 YEPLGLEADMWSIGVITYILLSG 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
           +++G G FG VY   L D  E VAIK +        K+F+  E Q++ ++ H N+  L  
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 670 YCNDGGN------VGLVYEYM---AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
           +    G       + LV +Y+    Y   + Y     K+ L             + L Y+
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H      I HRD+K  N+LL+      KL DFG +K      E ++  S + +  Y  PE
Sbjct: 218 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNV--SYICSRYYRAPE 271
Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
             + +   T   DV+S G VL EL+ G P
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 670 YCNDGGNVGLVYE-YMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGCKPP 727
                 ++    + Y+    +   L +  K A    D +Q  +    +GL+Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA---D 141
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRL 786
           IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE   +    
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 196
Query: 787 TEKSDVYSFGIVLLELITG 805
            +  D++S G ++ EL+TG
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        K+      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   K+ DFG +K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAIK++S        A  +       TE ++L +++H 
Sbjct: 22  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 81
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 82  CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 132
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 133 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 186
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 187 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 31/215 (14%)
Query: 608 NNFHRI----LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR 662
           NNF+ +    LG+G F  V      + G E A K L        K+ R +      +H  
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK-------KRRRGQDCRAEILHEI 79
Query: 663 NLASLVGYC----------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            +  L   C           +   + L+ EY A G +      E  E +S  D +++   
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKM---QAKLADFGFSKIFPAESESHISTSI 769
             +G+ YLH      I+H D+K  NILL+        K+ DFG S+      E      I
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EI 193
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           +GT  YL PE    + +T  +D+++ GI+   L+T
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPK 647
           GS      Q   + I+D      ++LG G  G V   +     E  A+KML     Q   
Sbjct: 1   GSHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCP 55
Query: 648 QFRTEAQLLMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALS 702
           + R E +L  R     H   +  +      G    L V E +  G L   + D   +A +
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT 115
Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPA 759
            ++  +I     + ++YLH      I HRDVK  N+L   K      KL DFGF+K    
Sbjct: 116 EREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---- 168
Query: 760 ESESHIS-TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E+ SH S T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 592 KSDNQQFTYSEIVD----ITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLS---AS 641
           K DNQ F   E+ D    +   + ++  +G G  G V   +    G  VA+K LS    +
Sbjct: 5   KVDNQ-FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN 63
Query: 642 SSQGPKQFRTEAQLLMRVHHRNLASLVGY------CNDGGNVGLVYEYMAYGNLKQYLFD 695
            +   + +R E  LL  V+H+N+ SL+          +  +V LV E M   NL Q +  
Sbjct: 64  QTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHM 121
Query: 696 ET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           E   E +S+     +      G+++LH      IIHRD+K +NI++      K+ DFG +
Sbjct: 122 ELDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +       + + T  V T  Y  PE           D++S G ++ EL+ G   I +G +
Sbjct: 174 R---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGC-VIFQGTD 229
Query: 815 NTHIVNRV 822
           +    N+V
Sbjct: 230 HIDQWNKV 237

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K+ L+ +  +  +   A+G+E+L        IHRD+   NILL+EK   K+ DFG +
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +    + +          + ++ PE       T +SDV+SFG++L E+ + L A    Y 
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYP 297
Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              I    C  L+ G        R+ A ++ T  ++   +T ++C      QRPT S +V
Sbjct: 298 GVKIDEEFCRRLKEGT-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELV 347
Query: 874 TELKKCLE 881
             L   L+
Sbjct: 348 EHLGNLLQ 355

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K+ L+ +  +  +   A+G+E+L        IHRD+   NILL+EK   K+ DFG +
Sbjct: 189 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 245
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +    + +          + ++ PE       T +SDV+SFG++L E+ + L A    Y 
Sbjct: 246 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYP 302
Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              I    C  L+ G        R+ A ++ T  ++   +T ++C      QRPT S +V
Sbjct: 303 GVKIDEEFCRRLKEGT-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELV 352
Query: 874 TELKKCLE 881
             L   L+
Sbjct: 353 EHLGNLLQ 360

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K+ L+ +  +  +   A+G+E+L        IHRD+   NILL+EK   K+ DFG +
Sbjct: 191 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 247
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +    + +          + ++ PE       T +SDV+SFG++L E+ + L A    Y 
Sbjct: 248 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYP 304
Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              I    C  L+ G        R+ A ++ T  ++   +T ++C      QRPT S +V
Sbjct: 305 GVKIDEEFCRRLKEGT-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELV 354
Query: 874 TELKKCLE 881
             L   L+
Sbjct: 355 EHLGNLLQ 362

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAI+++S        A  +       TE ++L +++H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 251
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 305
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 342

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 695 DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS 754
           D  K+ L+ +  +  +   A+G+E+L        IHRD+   NILL+EK   K+ DFG +
Sbjct: 182 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 238
Query: 755 KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYN 814
           +    + +          + ++ PE       T +SDV+SFG++L E+ + L A    Y 
Sbjct: 239 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGA--SPYP 295
Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              I    C  L+ G        R+ A ++ T  ++   +T ++C      QRPT S +V
Sbjct: 296 GVKIDEEFCRRLKEGT-------RMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELV 345
Query: 874 TELKKCLE 881
             L   L+
Sbjct: 346 EHLGNLLQ 353

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLS-- 639
           SHS++  +        T  E+ +   N   + G G +G+V   +    G  VA+K LS  
Sbjct: 2   SHSQERPTFYRQELNKTIWEVPERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 640 -ASSSQGPKQFRTEAQLLMRVHHRNLASLVGY------CNDGGNVGLVYEYMA--YGNLK 690
             S     + +R E +LL  + H N+  L+          +  +V LV   M     N+ 
Sbjct: 61  FQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 119
Query: 691 --QYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL 748
             Q L D+  + L ++          +GL+Y+H      IIHRD+K +N+ +NE  + K+
Sbjct: 120 KCQKLTDDHVQFLIYQ--------ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 168
Query: 749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITG 805
            DFG ++    E      T  V T  Y  PE   +     +  D++S G ++ EL+TG
Sbjct: 169 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 7   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 61
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 62  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 121
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 122 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 174
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 175 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRVHHR 662
           + LG G  G V   +      +VAI+++S        A  +       TE ++L +++H 
Sbjct: 155 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 214
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET------KEALSWKDRLQIAVDAAQG 716
            +  +  +  D  +  +V E M  G L    FD+       KEA       Q+ +     
Sbjct: 215 CIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL----A 265
Query: 717 LEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      IIHRD+K  N+LL+   E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 266 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 319
Query: 774 GYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLP 807
            YL PE   S      NR     D +S G++L   ++G P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAV---DCWSLGVILFICLSGYP 356

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E M      Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 75  VIRLLDWFERPDSFVLILERM---EPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 130
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 186
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGY 670
           +LG+G +  V     L +G E A+K++   +     +   E + L +   ++N+  L+ +
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
             D     LV+E +  G++  ++  + ++  + ++  ++  D A  L++LH      I H
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVAAALDFLH---TKGIAH 134
Query: 731 RDVKTANILLN--EKMQ-AKLADFGF-SKIFPAESESHIST----SIVGTVGYLDPEYYA 782
           RD+K  NIL    EK+   K+ DF   S +    S + I+T    +  G+  Y+ PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 783 --SNRLT---EKSDVYSFGIVLLELITGLPAIIR------GYNNTHIVNRVC 823
             +++ T   ++ D++S G+VL  +++G P  +       G++   +  RVC
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVC-RVC 245

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 8   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 62
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 63  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 122
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 123 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 175
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 176 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 53  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 107
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 220
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 15  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 69
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 70  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 129
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 130 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 182
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 183 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 9   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 63
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 124 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 176
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 177 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 13  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 67
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 68  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 127
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 128 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 180
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 181 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
                    +  +V LV   M        L +  K      D +Q  +    +GL+Y+H 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE   
Sbjct: 144 A---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 783 S-NRLTEKSDVYSFGIVLLELITG 805
           +     +  D++S G ++ EL+TG
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 14  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 68
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 69  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 128
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 129 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 181
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 182 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 59  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 113
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 114 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 173
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 174 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 226
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 227 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 150
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 151 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 202
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   Y +  G ++A+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 670 YCNDGGNVGLVYE-YMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHHGCKPP 727
                 ++    + Y+    +   L +  K      D +Q  +    +GL+Y+H      
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---D 174
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS-NRL 786
           IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE   +    
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY 229
Query: 787 TEKSDVYSFGIVLLELITG 805
               D++S G ++ EL+TG
Sbjct: 230 NMTVDIWSVGCIMAELLTG 248

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
                    +  +V LV   M        L +  K      D +Q  +    +GL+Y+H 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE   
Sbjct: 144 A---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 195
Query: 783 S-NRLTEKSDVYSFGIVLLELITG 805
           +     +  D++S G ++ EL+TG
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 613 ILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH---------- 661
           +LG+G FG V     A D    AIK +   + +      +E  LL  ++H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 662 ---RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQ 715
              RN    +        + +  EY   G L   +  E    +    W+   QI     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-------IFPAESE-----S 763
            L Y+H      IIHRD+K  NI ++E    K+ DFG +K       I   +S+     S
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 764 HISTSIVGTVGYLDPEYY-ASNRLTEKSDVYSFGIVLLELI 803
              TS +GT  Y+  E    +    EK D+YS GI+  E+I
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLV 668
           R +G G +G+V   Y A    +VA+K LS          RT  E +LL  + H N+  L+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 669 GY------CNDGGNVGLVYEYMAYGNLK-----QYLFDETKEALSWKDRLQIAVDAAQGL 717
                     D   V LV   M   +L      Q L DE  + L ++          +GL
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQ--------LLRGL 136
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           +Y+H      IIHRD+K +N+ +NE  + ++ DFG ++   A+ E    T  V T  Y  
Sbjct: 137 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEE---MTGYVATRWYRA 188
Query: 778 PEYYAS-NRLTEKSDVYSFGIVLLELITG 805
           PE   +     +  D++S G ++ EL+ G
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 145
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G+++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 23  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 77
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 78  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 137
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 138 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 190
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 191 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 608 NNFHRI--LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMRVHH 661
           + F RI  LG G FG V    ++  G+  A+K+L        K+      E ++L  V+ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQG 716
             L  L     D  N+ +V EY   G +  +L     F E             A      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-------YAAQIVLT 153
Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
            EYLH      +I+RD+K  N++++++   ++ DFG +K          +  + GT  YL
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYL 205
Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE   S    +  D ++ G+++ E+  G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 136
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 188
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYA-SNRLTEKSDVYSFGIVLLELITG 805
               +    +  D++S G ++ EL+TG
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 22/221 (9%)
Query: 597 QFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRTEAQL 655
           Q   + I+D      ++LG G  G V   +     E  A+KML     Q   + R E +L
Sbjct: 7   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 61
Query: 656 LMRV----HHRNLASLVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
             R     H   +  +      G    L V E +  G L   + D   +A + ++  +I 
Sbjct: 62  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 121
Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHIS- 766
               + ++YLH      I HRDVK  N+L   K      KL DFGF+K    E+ SH S 
Sbjct: 122 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSHNSL 174
Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T    T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 175 TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 147
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 147
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 147
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE 199
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 145
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 139
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 140 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 191
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 145
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSAS---SSQG--PKQFRTEAQLLMRVHHRNLAS 666
           ++GKG F  V      + G + A+K++  +   SS G   +  + EA +   + H ++  
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+   +  G + +V+E+M   +L   +         + + +       Q LE L +    
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-MRQILEALRYCHDN 149
Query: 727 PIIHRDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            IIHRDVK  N+LL  K  +   KL DFG + I   ES   ++   VGT  ++ PE    
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGES-GLVAGGRVGTPHFMAPEVVKR 207
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
               +  DV+  G++L  L++G
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLV 668
           R +G G +G+V   Y A    +VA+K LS          RT  E +LL  + H N+  L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 669 GY------CNDGGNVGLVYEYMA--YGNL--KQYLFDETKEALSWKDRLQIAVDAAQGLE 718
                     D   V LV   M     N+   Q L DE  + L ++          +GL+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQ--------LLRGLK 145
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           Y+H      IIHRD+K +N+ +NE  + ++ DFG ++   A+ E    T  V T  Y  P
Sbjct: 146 YIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEE---MTGYVATRWYRAP 197
Query: 779 EYYAS-NRLTEKSDVYSFGIVLLELITG 805
           E   +     +  D++S G ++ EL+ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 146
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 159
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 211
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 147
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 199
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 145
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 197
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTAN 737
           ++ E M  G L   + +   +A + ++  +I  D    +++LH H     I HRDVK  N
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPEN 158
Query: 738 ILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYS 794
           +L   K +    KL DFGF+K    E+  +   +   T  Y+ PE     +  +  D++S
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 795 FGIVLLELITGLPAIIRGYNNT 816
            G+++  L+ G P     Y+NT
Sbjct: 215 LGVIMYILLCGFPPF---YSNT 233

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 142
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 160
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 212
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 137
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 189
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 142
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 137
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 189
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 15/142 (10%)
Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTAN 737
           ++ E M  G L   + +   +A + ++  +I  D    +++LH H     I HRDVK  N
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPEN 139
Query: 738 ILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYS 794
           +L   K +    KL DFGF+K    E+  +   +   T  Y+ PE     +  +  D++S
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 195
Query: 795 FGIVLLELITGLPAIIRGYNNT 816
            G+++  L+ G P     Y+NT
Sbjct: 196 LGVIMYILLCGFPPF---YSNT 214

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 136
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 188
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  E   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G+++ E+I G
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 146
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 138
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 139 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 190
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 151
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPE 203
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 152
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 153 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 152
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 153 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 151
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 203
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSA---SSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 152
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 153 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 204
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 146
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV-DAAQGLEYLHH 722
                    +  +V LV   M        L +  K      D +Q  +    +GL+Y+H 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKSQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +N+ +NE  + K+ DFG  +    E      T  V T  Y  PE   
Sbjct: 144 A---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIML 195
Query: 783 S-NRLTEKSDVYSFGIVLLELITG 805
           +     +  D++S G ++ EL+TG
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 159
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 211
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 160
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 212
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 163
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 164 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPE 215
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E         V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 142
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPE 194
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPK------QFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G E A K +    S+  +      +   E  +L +V H N+ +
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E ++ G L  +L    KE+LS ++          G+ YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 727 PIIHRDVKTANILLNEKM----QAKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYY 781
            I H D+K  NI+L +K       KL DFG +     E E  +   +I GT  ++ PE  
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH----EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
               L  ++D++S G++   L++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 146
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E      T  V T  Y  PE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPE 198
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLV 668
           R +G G +G+V   Y A    +VA+K LS          RT  E +LL  + H N+  L+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 669 GY------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLE 718
                     D   V LV   M     N+   Q L DE  + L ++          +GL+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQ--------LLRGLK 145
Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           Y+H      IIHRD+K +N+ +NE  + ++ DFG ++   A+ E    T  V T  Y  P
Sbjct: 146 YIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEE---MTGYVATRWYRAP 197
Query: 779 EYYAS-NRLTEKSDVYSFGIVLLELITG 805
           E   +     +  D++S G ++ EL+ G
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E         V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 136
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E         V T  Y  PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPE 188
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 18/129 (13%)
Query: 690 KQYLFDETKEALSWKDR-----LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM 744
           K+ L D      S +DR     L I +  A+ +E+LH      ++HRD+K +NI      
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDD 201
Query: 745 QAKLADFGF-SKIFPAESESHISTSI---------VGTVGYLDPEYYASNRLTEKSDVYS 794
             K+ DFG  + +   E E  + T +         VGT  Y+ PE    N  + K D++S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 795 FGIVLLELI 803
            G++L EL+
Sbjct: 262 LGLILFELL 270

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHS 137
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 138 AG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 163
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DFG ++    E   +++T       Y  PE
Sbjct: 164 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPE 215
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 113/265 (42%), Gaps = 29/265 (10%)
Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSAS-SSQGPKQFRTEAQLLMR-VHHRNLASLVGY 670
           LG+G +G V    ++  G   A+K + A+ +SQ  K+   +  +  R V      +  G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL-QIAVDAAQGLEYLHHGCKPPII 729
               G+V +  E       K Y     K     +D L +IAV   + LE+LH   K  +I
Sbjct: 102 LFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVI 159
Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY----YASNR 785
           HRDVK +N+L+N   Q K  DFG S     +    I     G   Y  PE          
Sbjct: 160 HRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA---GCKPYXAPERINPELNQKG 216
Query: 786 LTEKSDVYSFGIVLLELITGLPAIIR-GYNNTHIVNRVCPFLERGDVRSIVDPRLEAN-F 843
            + KSD++S GI  +EL     AI+R  Y++        PF +   V     P+L A+ F
Sbjct: 217 YSVKSDIWSLGITXIEL-----AILRFPYDSWG-----TPFQQLKQVVEEPSPQLPADKF 266
Query: 844 DTNSVWKVAETAMECVPSISFQRPT 868
               V    +   +C+   S +RPT
Sbjct: 267 SAEFV----DFTSQCLKKNSKERPT 287

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           ++GKG FG VYHG      EVAI+++     +    K F+ E     +  H N+   +G 
Sbjct: 40  LIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           C    ++ ++   +  G     +  + K  L      QIA +  +G+ YLH      I+H
Sbjct: 98  CMSPPHLAIITS-LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 731 RDVKTANILLNEKMQAKLADFGF---SKIFPAESESHISTSIVGTVGYLDPEYY------ 781
           +D+K+ N+  +   +  + DFG    S +  A           G + +L PE        
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 782 -ASNRL--TEKSDVYSFGIVLLEL 802
              ++L  ++ SDV++ G +  EL
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 160
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG---YL 776
           +H      IIHRD+K +N+ +NE  + K+ DFG ++        H    + G V    Y 
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVATRWYR 209
Query: 777 DPEYYAS-NRLTEKSDVYSFGIVLLELITG 805
            PE   +     +  D++S G ++ EL+TG
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 649 FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ 708
           F+ E Q++  + +    +  G   +   V ++YEYM   ++ +  FDE    L       
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK--FDEYFFVLDKNYTCF 147
Query: 709 IAVDAAQ--------GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE 760
           I +   +           Y+H+  +  I HRDVK +NIL+++  + KL+DFG       E
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFG-------E 198
Query: 761 SESHISTSIVGTVG---YLDPEYYA--SNRLTEKSDVYSFGIVL 799
           SE  +   I G+ G   ++ PE+++  S+    K D++S GI L
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 101/236 (42%), Gaps = 30/236 (12%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQL---LMRVHHRNLASL 667
           R+ G+G FGTV  G   + G  VAIK +     Q P+    E Q+   L  +HH N+  L
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH----- 722
             Y    G       Y+    + +Y+ D          R Q+A        +L       
Sbjct: 85  QSYFYTLGERDRRDIYLNV--VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142
Query: 723 GC----KPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           GC       + HRD+K  N+L+NE     KL DFG +K     S S  + + + +  Y  
Sbjct: 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---SPSEPNVAYICSRYYRA 199
Query: 778 PEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT---HIVNRV--CPFLE 827
           PE  + +   T   D++S G +  E++ G P I RG N+    H + RV  CP  E
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEP-IFRGDNSAGQLHEIVRVLGCPSRE 254

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ D+G ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 41/293 (13%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRIL---GKGGFGTVYHGYL 627
           K   AA+    +  S   G+   D    + +E + +    + IL   G GG   V+    
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 628 ADGSEVAIKM--LSASSSQGPKQFRTEAQLL--MRVHHRNLASLVGY-CNDGGNVGLVYE 682
                 AIK   L  + +Q    +R E   L  ++ H   +  L  Y   D      +Y 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YIYM 133
Query: 683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLN 741
            M  GN+    + + K+++   +R     +  + +  +H HG    I+H D+K AN L+ 
Sbjct: 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 189
Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY---YASNR--------LTEKS 790
           + M  KL DFG +     ++ S +  S VGTV Y+ PE     +S+R        ++ KS
Sbjct: 190 DGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 791 DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
           DV+S G +L  +  G            I+N++        + +I+DP  E  F
Sbjct: 249 DVWSLGCILYYMTYGKTPF------QQIINQI------SKLHAIIDPNHEIEF 289

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLAS 666
           NF   L +   G ++ G    G+++ +K+L     S++  + F  E   L    H N+  
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 667 LVGYCND--GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           ++G C      +  L+  +  YG+L   L + T   +     ++ A+D A+G  +L H  
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL-HTL 130
Query: 725 KPPIIHRDVKTANILLNEKMQAKL--ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           +P I    + + ++ ++E   A++  AD  FS  F +    +    +        PE   
Sbjct: 131 EPLIPRHALNSRSVXIDEDXTARISXADVKFS--FQSPGRXYAPAWVAPEALQKKPE--D 186
Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
           +NR +  +D +SF ++L EL+T
Sbjct: 187 TNRRS--ADXWSFAVLLWELVT 206

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 16/194 (8%)
Query: 628 ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAY 686
           A   E A+K++   S + P +   E ++L+R   H N+ +L    +DG  V +V E    
Sbjct: 45  ATNXEFAVKIID-KSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKG 100
Query: 687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-- 744
           G L   +  +  +  S ++   +     + +EYLH      ++HRD+K +NIL  ++   
Sbjct: 101 GELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 745 --QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
               ++ DFGF+K   AE+   +  +   T  ++ PE           D++S G++L   
Sbjct: 156 PESIRICDFGFAKQLRAENG--LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTX 213
Query: 803 ITGLPAIIRGYNNT 816
           +TG      G ++T
Sbjct: 214 LTGYTPFANGPDDT 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRT--EAQLLMRV 659
           D+ + +  I  +G G +G V        G +VAIK +  +        RT  E ++L   
Sbjct: 52  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF 111
Query: 660 HHRNLASL-------VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            H N+ ++       V Y  +  +V +V + M   +L Q +   + + L+ +        
Sbjct: 112 KHDNIIAIKDILRPTVPY-GEFKSVYVVLDLME-SDLHQII--HSSQPLTLEHVRYFLYQ 167
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---PAESESHISTSI 769
             +GL+Y+H      +IHRD+K +N+L+NE  + K+ DFG ++     PAE + +  T  
Sbjct: 168 LLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ-YFMTEY 223
Query: 770 VGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELIT 804
           V T  Y  PE   S +  T+  D++S G +  E++ 
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/259 (22%), Positives = 110/259 (42%), Gaps = 29/259 (11%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG G FG V+     A G     K ++          + E  ++ ++HH  L +L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
           D   + L+ E+++ G L   +  E  + +S  + +     A +GL+++H      I+H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 733 VKTANILLNEKMQA--KLADFGF-SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           +K  NI+   K  +  K+ DFG  +K+ P E    I      T  +  PE      +   
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFY 230
Query: 790 SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD-PRLEANFDTNSV 848
           +D+++ G++   L++GL                 PF    D+ ++ +  R +  FD ++ 
Sbjct: 231 TDMWAIGVLGYVLLSGL----------------SPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 849 WKVAETAMECVPSISFQRP 867
             V+  A + + ++  + P
Sbjct: 275 SSVSPEAKDFIKNLLQKEP 293

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  E   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQG--PKQFRTEAQLLMRVHHR 662
           + + RI  LG+G +G VY       +E VAIK +     +   P     E  LL  + HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH- 721
           N+  L    +    + L++EY A  +LK+Y+  +    +S +           G+ + H 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEY-AENDLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 722 HGCKPPIIHRDVKTANILL-----NEKMQAKLADFGFSKIF--PAESESHISTSIVGTVG 774
             C    +HRD+K  N+LL     +E    K+ DFG ++ F  P    +H    I+ T+ 
Sbjct: 151 RRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLW 202
Query: 775 YLDPEYYASNRLTEKS-DVYSFGIVLLELITGLP 807
           Y  PE    +R    S D++S   +  E++   P
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 76  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 131
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 90  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 145
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 201
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 71  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 126
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 75  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 130
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 186
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
           +V E +  G L   + D   +A + ++  +I     + ++YLH      I HRDVK  N+
Sbjct: 136 IVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPENL 192
Query: 739 LLNEKMQ---AKLADFGFSKIFPAESESHIS-TSIVGTVGYLDPEYYASNRLTEKSDVYS 794
           L   K      KL DFGF+K    E+ SH S T+   T  Y+ PE     +  +  D +S
Sbjct: 193 LYTSKRPNAILKLTDFGFAK----ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 795 FGIVLLELITGLP 807
            G++   L+ G P
Sbjct: 249 LGVIXYILLCGYP 261

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 76  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 131
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 90  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 145
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 201
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 76  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 131
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 187
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 74  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 129
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 185
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 222

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 71  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 126
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           R +G G FG +Y G  +A G EVAIK L    ++ P Q   E+++   +        + +
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP-QLHIESKIYKMMQGGVGIPTIRW 72
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           C   G+  ++   +   +L+  LF+      S K  L +A      +EY+H       IH
Sbjct: 73  CGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128
Query: 731 RDVKTANILLNEKMQAKLA---DFGFSKIF-PAESESHI----STSIVGTVGYLDPEYYA 782
           RDVK  N L+    +  L    DFG +K +  A +  HI    + ++ GT  Y     + 
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188
Query: 783 SNRLTEKSDVYSFGIVLLELITG-LP 807
               + + D+ S G VL+    G LP
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 89
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 90  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 143
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 144 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 198 GMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 91  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 146
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 202
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 103 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 158
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 214
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 251

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 91  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 146
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 202
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 41/293 (13%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRIL---GKGGFGTVYHGYL 627
           K   AA+    +  S   G+   D    + +E + +    + IL   G GG   V+    
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 628 ADGSEVAIKM--LSASSSQGPKQFRTEAQLL--MRVHHRNLASLVGY-CNDGGNVGLVYE 682
                 AIK   L  + +Q    +R E   L  ++ H   +  L  Y   D      +Y 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YIYM 133
Query: 683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLN 741
            M  GN+    + + K+++   +R     +  + +  +H HG    I+H D+K AN L+ 
Sbjct: 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 189
Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY---YASNR--------LTEKS 790
           + M  KL DFG +     ++ S +  S VGTV Y+ PE     +S+R        ++ KS
Sbjct: 190 DGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 791 DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
           DV+S G +L  +  G            I+N++        + +I+DP  E  F
Sbjct: 249 DVWSLGCILYYMTYGKTPF------QQIINQI------SKLHAIIDPNHEIEF 289

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 91  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 146
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 202
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 118 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 173
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 229
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 91
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 145
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 137
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 613 ILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH---------- 661
           +LG+G FG V     A D    AIK +   + +      +E  LL  ++H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 662 ---RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQ 715
              RN    +        + +  EY     L   +  E    +    W+   QI     +
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-------IFPAESE-----S 763
            L Y+H      IIHRD+K  NI ++E    K+ DFG +K       I   +S+     S
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 764 HISTSIVGTVGYLDPEYY-ASNRLTEKSDVYSFGIVLLELI 803
              TS +GT  Y+  E    +    EK D+YS GI+  E+I
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 91
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 145
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 84
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 138
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFR------TEAQLLMRVH----H 661
           +LGKGGFGTV+ G+ L D  +VAIK++  +   G            E  LL +V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             +  L+ +        LV E        Q LFD   E     +         Q +  + 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCF-FGQVVAAIQ 153
Query: 722 HGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
           H     ++HRD+K  NIL++  +  AKL DFG   +   E      T   GT  Y  PE+
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEW 209
Query: 781 YASNRLTE-KSDVYSFGIVLLELITG 805
            + ++     + V+S GI+L +++ G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 118 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 173
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 229
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 84
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 138
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 193 GMGYKENVDIWSVGCIMGEMV 213

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 110 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 165
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 221
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           R +G G FG +Y G  +A G EVAIK L    ++ P Q   E+++   +        + +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP-QLHIESKIYKMMQGGVGIPTIRW 70
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           C   G+  ++   +   +L+  LF+      S K  L +A      +EY+H       IH
Sbjct: 71  CGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 731 RDVKTANILLNEKMQAKLA---DFGFSKIF-PAESESHI----STSIVGTVGYLDPEYYA 782
           RDVK  N L+    +  L    DFG +K +  A +  HI    + ++ GT  Y     + 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 783 SNRLTEKSDVYSFGIVLLELITG-LP 807
               + + D+ S G VL+    G LP
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLP 212

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 182
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRT--EAQLLMRV 659
           D+ + +  I  +G G +G V        G +VAIK +  +        RT  E ++L   
Sbjct: 51  DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF 110
Query: 660 HHRNLASL-------VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
            H N+ ++       V Y  +  +V +V + M   +L Q +   + + L+ +        
Sbjct: 111 KHDNIIAIKDILRPTVPY-GEFKSVYVVLDLME-SDLHQII--HSSQPLTLEHVRYFLYQ 166
Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---PAESESHISTSI 769
             +GL+Y+H      +IHRD+K +N+L+NE  + K+ DFG ++     PAE + +  T  
Sbjct: 167 LLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ-YFMTEY 222
Query: 770 VGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELIT 804
           V T  Y  PE   S +  T+  D++S G +  E++ 
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           R +G G FG +Y G  +A G EVAIK L    ++ P Q   E++    +        + +
Sbjct: 15  RKIGSGSFGDIYLGANIASGEEVAIK-LECVKTKHP-QLHIESKFYKMMQGGVGIPSIKW 72
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
           C   G+  ++   +   +L+  LF+      S K  L +A      +EY+H       IH
Sbjct: 73  CGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 128
Query: 731 RDVKTANILLNEKMQAKLA---DFGFSKIF-PAESESHI----STSIVGTVGYLDPEYYA 782
           RDVK  N L+    +  L    DFG +K +  A +  HI    + ++ GT  Y     + 
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188
Query: 783 SNRLTEKSDVYSFGIVLLELITG-LP 807
               + + D+ S G VL+    G LP
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 90/196 (45%), Gaps = 13/196 (6%)
Query: 614 LGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           LG+G F           ++  A+K++S       ++  T  +L     H N+  L    +
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 673 DGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRD 732
           D  +  LV E +  G L + +  + K+  S  +   I       + ++H      ++HRD
Sbjct: 77  DQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRD 131
Query: 733 VKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           +K  N+L    N+ ++ K+ DFGF+++ P +++   +     T+ Y  PE    N   E 
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGYDES 189
Query: 790 SDVYSFGIVLLELITG 805
            D++S G++L  +++G
Sbjct: 190 CDLWSLGVILYTMLSG 205

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+ SL+ 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V LV E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 182
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 183 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ DF  ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 103 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 158
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 214
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 104 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 159
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 215
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 104 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 159
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 215
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 104 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 159
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 215
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 103 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 158
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 214
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 103 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 158
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 214
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 98  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 153
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 209
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 246

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 104 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 159
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 215
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 123 VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 178
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 234
Query: 783 SNRLTEKS-DVYSFGIVLLELITG-LP-----AIIRG 812
            +R   +S  V+S GI+L +++ G +P      IIRG
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 271

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRT--EAQLLMRVH--HRN 663
           +LG GGFG+VY G  ++D   VAIK +     +   + P   R   E  LL +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+ +     +  L+ E        Q LFD   E  + ++ L  +    Q LE + H 
Sbjct: 71  VIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSF-FWQVLEAVRHC 126
Query: 724 CKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
               ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE+  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 783 SNRLTEKS-DVYSFGIVLLELITG 805
            +R   +S  V+S GI+L +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 91
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 145
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLV 668
           +++G+G FG V         +V A+K+LS      +    F  E + +M   +      +
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 669 GYC-NDGGNVGLVYEYMAYGNLKQYL--FD-ETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
            Y   D   + +V EYM  G+L   +  +D   K A  +   + +A+DA   + +     
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 189
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
               IHRDVK  N+LL++    KLADFG       E      T+ VGT  Y+ PE   S 
Sbjct: 190 ----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQ 244
Query: 785 ----RLTEKSDVYSFGIVLLELITG 805
                   + D +S G+ L E++ G
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYLFDET-KEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  E   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+  FG ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLV 668
           +++G+G FG V         +V A+K+LS      +    F  E + +M   +      +
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 669 GYC-NDGGNVGLVYEYMAYGNLKQYL--FD-ETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
            Y   D   + +V EYM  G+L   +  +D   K A  +   + +A+DA   + +     
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF----- 194
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
               IHRDVK  N+LL++    KLADFG       E      T+ VGT  Y+ PE   S 
Sbjct: 195 ----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQ 249
Query: 785 ----RLTEKSDVYSFGIVLLELITG 805
                   + D +S G+ L E++ G
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 579 NVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV-AIKM 637
           N+DN  S+ + ++         +E  ++     +++G+G FG V         +V A+K+
Sbjct: 51  NIDNFLSRYKDTINKIRDLRMKAEDYEVV----KVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 638 LSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYL- 693
           LS      +    F  E + +M   +      + Y   D   + +V EYM  G+L   + 
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 166
Query: 694 -FD-ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF 751
            +D   K A  +   + +A+DA   + +         IHRDVK  N+LL++    KLADF
Sbjct: 167 NYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADF 217
Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASN----RLTEKSDVYSFGIVLLELITG 805
           G       E      T+ VGT  Y+ PE   S         + D +S G+ L E++ G
Sbjct: 218 GTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 144
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ D G ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    ++  ++         E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ D G ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 698 KEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
           KE ++ +D +  +   A+G+E+L    C    IHRD+   NILL+E    K+ DFG ++ 
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSRKC----IHRDLAARNILLSENNVVKICDFGLARD 248
Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYN 814
                +          + ++ PE       + KSDV+S+G++L E+ +  G P     Y 
Sbjct: 249 IYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP-----YP 303
Query: 815 NTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              +    C  L  G        R+ A  + T  ++++    ++C      +RP  + +V
Sbjct: 304 GVQMDEDFCSRLREG-------MRMRAPEYSTPEIYQI---MLDCWHRDPKERPRFAELV 353
Query: 874 TELKKCL 880
            +L   L
Sbjct: 354 EKLGDLL 360

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGY 670
           +LG+G    V     L    E A+K++         +   E ++L +   HRN+  L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 671 CNDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
             +     LV+E M  G++     K+  F+E + ++       +  D A  L++LH+   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALDFLHN--- 129
Query: 726 PPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESE-SHIST----SIVGTVGYLD 777
             I HRD+K  NIL    N+    K+ DFG         + S IST    +  G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 778 PEYY-----ASNRLTEKSDVYSFGIVLLELITGLPAII 810
           PE        ++   ++ D++S G++L  L++G P  +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V    + +   + A+K+L+        +   FR E  +L+    + + +L
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF---DETKEALS--WKDRLQIAVDAAQGLEYLHH 722
                D  ++ LV +Y   G+L   L    D+  E ++  +   + +A+D+   L Y   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYY 781
                 +HRD+K  N+LL+     +LADFG         +  + +S+ VGT  Y+ PE  
Sbjct: 197 ------VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 782 AS-----NRLTEKSDVYSFGIVLLELITG 805
            +      +   + D +S G+ + E++ G
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 606 ITNNFHRI----LGKGGFGTV--YHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           I +N H +    LG+GGF  V    G L DG   A+K +     Q  ++ + EA +    
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 660 HHRNLASLVGYC----NDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDA 713
           +H N+  LV YC           L+  +   G L   +    +    L+    L + +  
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG-- 771
            +GLE +H        HRD+K  NILL ++ Q  L D G       ++  H+  S     
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN----QACIHVEGSRQALT 196
Query: 772 ---------TVGYLDPEYYASNR---LTEKSDVYSFGIVLLELITG 805
                    T+ Y  PE ++      + E++DV+S G VL  ++ G
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G +G+V   +    G  VA+K LS    S     + +R E +LL  + H N+  L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 670 Y------CNDGGNVGLVYEYMA--YGNLK--QYLFDETKEALSWKDRLQIAVDAAQGLEY 719
                    +  +V LV   M     N+   Q L D+  + L ++          +GL+Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--------ILRGLKY 140
Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           +H      IIHRD+K +N+ +NE  + K+ D G ++    E      T  V T  Y  PE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPE 192
Query: 780 YYAS-NRLTEKSDVYSFGIVLLELITG 805
              +     +  D++S G ++ EL+TG
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 92
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 93  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 146
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S +    V T  Y  PE   
Sbjct: 147 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
                E  D++S G ++ E+I G
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           +++G+G FG V    + +   + A+K+L+        +   FR E  +L+    + + +L
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLF---DETKEALS--WKDRLQIAVDAAQGLEYLHH 722
                D  ++ LV +Y   G+L   L    D+  E ++  +   + +A+D+   L Y   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI-VGTVGYLDPEYY 781
                 +HRD+K  N+LL+     +LADFG         +  + +S+ VGT  Y+ PE  
Sbjct: 213 ------VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 782 AS-----NRLTEKSDVYSFGIVLLELITG 805
            +      +   + D +S G+ + E++ G
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRIL---GKGGFGTVYHGYL 627
           K   AA+    +  S   G+   D    + +E + +    + IL   G GG   V+    
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 628 ADGSEVAIKM--LSASSSQGPKQFRTEAQLL--MRVHHRNLASLVGY-CNDGGNVGLVYE 682
                 AIK   L  + +Q    +R E   L  ++ H   +  L  Y   D      +Y 
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----YIYM 133
Query: 683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLN 741
            M  GN+    + + K+++   +R     +  + +  +H HG    I+H D+K AN L+ 
Sbjct: 134 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV 189
Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY---YASNR--------LTEKS 790
           + M  KL DFG +     ++ S +  S VG V Y+ PE     +S+R        ++ KS
Sbjct: 190 DGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 791 DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
           DV+S G +L  +  G            I+N++        + +I+DP  E  F
Sbjct: 249 DVWSLGCILYYMTYGKTPF------QQIINQI------SKLHAIIDPNHEIEF 289

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    ++  ++         E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 55/264 (20%)
Query: 594 DNQQFTYSEIVDITNNFHR--ILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQ--GPK- 647
           +N  F    ++++   +H    +G+G +G V          + AIK+++ +  +   PK 
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL----KQYLFDET---- 697
             + +TE +L+ ++HH N+A L     D   + LV E    G+L      ++ D T    
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 698 --------------------------KEALSWKDRLQIAVDAAQ----GLEYLHHGCKPP 727
                                     +E+L +  R ++  +  +     L YLH+     
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QG 188
Query: 728 IIHRDVKTANILL--NEKMQAKLADFGFSKIFPA--ESESHISTSIVGTVGYLDPEYYAS 783
           I HRD+K  N L   N+  + KL DFG SK F      E +  T+  GT  ++ PE   +
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 784 NRLT--EKSDVYSFGIVLLELITG 805
              +   K D +S G++L  L+ G
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL--VGY 670
           +G+G +G VY     DG +     L      G       E  LL  + H N+ SL  V  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLEYLHHGC 724
            +    V L+++Y  +       F    +A     +L       +      G+ YLH   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 725 KPPIIHRDVKTANILL----NEKMQAKLADFGFSKIF--PAESESHISTSIVGTVGYLDP 778
              ++HRD+K ANIL+     E+ + K+AD GF+++F  P +  + +   +V T  Y  P
Sbjct: 149 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAP 204
Query: 779 EYYASNR-LTEKSDVYSFGIVLLELITGLP 807
           E     R  T+  D+++ G +  EL+T  P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 190 YEPLGLEADMWSIGVITYILLSG 212

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 601 SEIVDITNNFHRIL---GKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQL 655
           +E + +    + IL   G GG   V+          AIK   L  + +Q    +R E   
Sbjct: 4   NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 63
Query: 656 L--MRVHHRNLASLVGY-CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
           L  ++ H   +  L  Y   D      +Y  M  GN+    + + K+++   +R     +
Sbjct: 64  LNKLQQHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 119
Query: 713 AAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
             + +  +H HG    I+H D+K AN L+ + M  KL DFG +     ++ S +  S VG
Sbjct: 120 MLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 174
Query: 772 TVGYLDPEY---YASNR--------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN 820
           TV Y+ PE     +S+R        ++ KSDV+S G +L  +  G            I+N
Sbjct: 175 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIIN 228
Query: 821 RVCPFLERGDVRSIVDPRLEANF 843
           ++        + +I+DP  E  F
Sbjct: 229 QI------SKLHAIIDPNHEIEF 245

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 190 YEPLGLEADMWSIGVITYILLSG 212

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSAS------------------SSQGPKQF 649
           NF  +LGKG FG V         E+ A+K+L                     +  G   F
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
            T+     +   R L  ++ Y N G    L+Y     G  K+        A+ +      
Sbjct: 404 LTQLHSCFQTMDR-LYFVMEYVNGGD---LMYHIQQVGRFKE------PHAVFY------ 447
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK--IFPAESESHIST 767
           A + A GL +L       II+RD+K  N++L+ +   K+ADFG  K  I+    +   + 
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW----DGVTTK 500
Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
              GT  Y+ PE  A     +  D ++FG++L E++ G
Sbjct: 501 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 645 GPKQFRTEAQLLMRVHHRNLASLVG--YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALS 702
           G    + E QLL R+ H+N+  LV   Y  +   + +V EY   G   Q + D   E   
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG--MQEMLDSVPEK-- 104
Query: 703 WKDRLQIA------VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK- 755
              R  +            GLEYLH      I+H+D+K  N+LL      K++  G ++ 
Sbjct: 105 ---RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158
Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTE----KSDVYSFGIVLLELITGL 806
           + P  ++    TS  G+  +  PE   +N L      K D++S G+ L  + TGL
Sbjct: 159 LHPFAADDTCRTS-QGSPAFQPPE--IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSAS------------------SSQGPKQF 649
           NF  +LGKG FG V         E+ A+K+L                     +  G   F
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
            T+     +   R L  ++ Y N G    L+Y     G  K+        A+ +      
Sbjct: 83  LTQLHSCFQTMDR-LYFVMEYVNGGD---LMYHIQQVGRFKE------PHAVFY------ 126
Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
           A + A GL +L       II+RD+K  N++L+ +   K+ADFG  K      +   +   
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF 181
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            GT  Y+ PE  A     +  D ++FG++L E++ G
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 106/247 (42%), Gaps = 38/247 (15%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLL--MRVHHRNLASLVG 669
           +G GG   V+          AIK   L  + +Q    +R E   L  ++ H   +  L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 670 Y-CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
           Y   D      +Y  M  GN+    + + K+++   +R     +  + +  +H HG    
Sbjct: 96  YEITDQ----YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY---YASN 784
           I+H D+K AN L+ + M  KL DFG +     ++ S +  S VGTV Y+ PE     +S+
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 785 R--------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
           R        ++ KSDV+S G +L  +  G            I+N++        + +I+D
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQI------SKLHAIID 254
Query: 837 PRLEANF 843
           P  E  F
Sbjct: 255 PNHEIEF 261

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 112/263 (42%), Gaps = 41/263 (15%)
Query: 601 SEIVDITNNFHRIL---GKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQL 655
           +E + +    + IL   G GG   V+          AIK   L  + +Q    +R E   
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60
Query: 656 L--MRVHHRNLASLVGY-CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVD 712
           L  ++ H   +  L  Y   D      +Y  M  GN+    + + K+++   +R     +
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN 116
Query: 713 AAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
             + +  +H HG    I+H D+K AN L+ + M  KL DFG +     ++ S +  S VG
Sbjct: 117 MLEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 772 TVGYLDPEY---YASNR--------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN 820
           TV Y+ PE     +S+R        ++ KSDV+S G +L  +  G            I+N
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIIN 225
Query: 821 RVCPFLERGDVRSIVDPRLEANF 843
           ++        + +I+DP  E  F
Sbjct: 226 QI------SKLHAIIDPNHEIEF 242

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 111/262 (42%), Gaps = 41/262 (15%)
Query: 602 EIVDITNNFHRIL---GKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLL 656
           E + +    + IL   G GG   V+          AIK   L  + +Q    +R E   L
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 657 --MRVHHRNLASLVGY-CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
             ++ H   +  L  Y   D      +Y  M  GN+    + + K+++   +R     + 
Sbjct: 61  NKLQQHSDKIIRLYDYEITDQ----YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNM 116
Query: 714 AQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
            + +  +H HG    I+H D+K AN L+ + M  KL DFG +     ++ S +  S VGT
Sbjct: 117 LEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 171
Query: 773 VGYLDPEY---YASNR--------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNR 821
           V Y+ PE     +S+R        ++ KSDV+S G +L  +  G            I+N+
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQ 225
Query: 822 VCPFLERGDVRSIVDPRLEANF 843
           +        + +I+DP  E  F
Sbjct: 226 I------SKLHAIIDPNHEIEF 241

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLAD---GSEVAIKMLSASSSQGPKQFRTEAQ 654
           + Y E V    +  R LG+G FG V+   + D   G + A+K +        + FR E  
Sbjct: 86  YEYREEVHWATHQLR-LGRGSFGEVHR--MEDKQTGFQCAVKKVRL------EVFRAEEL 136
Query: 655 L-LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
           +    +    +  L G   +G  V +  E +  G+L Q + ++    L     L     A
Sbjct: 137 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQA 194
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILL-NEKMQAKLADFGFSKIFPAESESH---ISTSI 769
            +GLEYLH      I+H DVK  N+LL ++   A L DFG +     +           I
Sbjct: 195 LEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            GT  ++ PE         K DV+S   ++L ++ G
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 614 LGKGGFGTVYH-GYLADGSEVAIKML----SASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           LG G F  V      + G + A K +    + SS +G   +    E  +L  + H N+ +
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L     +  +V L+ E +A G L  +L +  KE+L+ ++  +       G+ YLH     
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 727 PIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
            I H D+K  NI+L +    K + K+ DFG +      +E     +I GT  ++ PE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 783 SNRLTEKSDVYSFGIVLLELITG 805
              L  ++D++S G++   L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 598 FTYSEIVDITNNFHRILGKGGFGTVYHGYLAD---GSEVAIKMLSASSSQGPKQFRTEAQ 654
           + Y E V    +  R LG+G FG V+   + D   G + A+K +        + FR E  
Sbjct: 67  YEYREEVHWATHQLR-LGRGSFGEVHR--MEDKQTGFQCAVKKVRL------EVFRAEEL 117
Query: 655 L-LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
           +    +    +  L G   +G  V +  E +  G+L Q + ++    L     L     A
Sbjct: 118 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQA 175
Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILL-NEKMQAKLADFGFSKIFPAESESH---ISTSI 769
            +GLEYLH      I+H DVK  N+LL ++   A L DFG +     +           I
Sbjct: 176 LEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            GT  ++ PE         K DV+S   ++L ++ G
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 84
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 85  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 138
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 139 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 193 GMGYKENVDLWSVGCIMGEMV 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           +G G  G V   Y A     VAIK LS    + +   + +R E  L+  V+H+N+  L+ 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 95
Query: 670 Y------CNDGGNVGLVYEYMAYGNLKQYL-FDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                    +  +V +V E M   NL Q +  +   E +S+     +      G+++LH 
Sbjct: 96  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS 149
Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 150 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 783 SNRLTEKSDVYSFGIVLLELI 803
                E  D++S G ++ E++
Sbjct: 204 GMGYKENVDLWSVGCIMGEMV 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGY 670
           +LG+G    V     L    E A+K++         +   E ++L +   HRN+  L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 671 CNDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
             +     LV+E M  G++     K+  F+E + ++       +  D A  L++LH+   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALDFLHN--- 129
Query: 726 PPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESE-SHIST----SIVGTVGYLD 777
             I HRD+K  NIL    N+    K+ DF          + S IST    +  G+  Y+ 
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 778 PEYY-----ASNRLTEKSDVYSFGIVLLELITGLPAII 810
           PE        ++   ++ D++S G++L  L++G P  +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 24/255 (9%)
Query: 603 IVDITNNFH--RILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQ--GPKQFRTEAQLLM 657
           + +I+++F    +LG+G +G V    +   G  VAIK +          +  R E ++L 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL 717
              H N+ ++               Y+    ++  L       +   D +Q  +      
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---------PAESESHISTS 768
             + HG    +IHRD+K +N+L+N     K+ DFG ++I          P   +S + T 
Sbjct: 125 VKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TE 181
Query: 769 IVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH----IVNRVC 823
            V T  Y  PE    S + +   DV+S G +L EL    P I  G +  H    I   + 
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP-IFPGRDYRHQLLLIFGIIG 240
Query: 824 PFLERGDVRSIVDPR 838
                 D+R I  PR
Sbjct: 241 TPHSDNDLRCIESPR 255

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSAS---SSQG--PKQFRTEAQLLMRVHHRNLAS 666
           ++GKG F  V      + G + A+K++  +   SS G   +  + EA +   + H ++  
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+   +  G + +V+E+M   +L   +         + + +  +    Q LE L +    
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-SHYMRQILEALRYCHDN 149
Query: 727 PIIHRDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            IIHRDVK   +LL  K  +   KL  FG + I   ES   ++   VGT  ++ PE    
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGES-GLVAGGRVGTPHFMAPEVVKR 207
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
               +  DV+  G++L  L++G
Sbjct: 208 EPYGKPVDVWGCGVILFILLSG 229

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHR------ 662
           +++GKG FG V   Y       VA+KM+     +  K+F  +A   +R+  H R      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 663 --NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
             N+  ++       ++ + +E ++  NL + +     +  S     + A    Q L+ L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           H   K  IIH D+K  NILL ++ ++  K+ DFG S          + T I     Y  P
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTXIQSRF-YRAP 268
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
           E     R     D++S G +L EL+TG P +
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 85/221 (38%), Gaps = 38/221 (17%)
Query: 613 ILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH---------- 661
           +LG+G FG V     A D    AIK +   + +      +E  LL  ++H          
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 662 ---RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDET---KEALSWKDRLQIAVDAAQ 715
              RN             + +  EY     L   +  E    +    W+   QI     +
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----E 127
Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-------IFPAESE-----S 763
            L Y+H      IIHR++K  NI ++E    K+ DFG +K       I   +S+     S
Sbjct: 128 ALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 764 HISTSIVGTVGYLDPEYY-ASNRLTEKSDVYSFGIVLLELI 803
              TS +GT  Y+  E    +    EK D YS GI+  E I
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 24/255 (9%)
Query: 603 IVDITNNFH--RILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQ--GPKQFRTEAQLLM 657
           + +I+++F    +LG+G +G V    +   G  VAIK +          +  R E ++L 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGL 717
              H N+ ++               Y+    ++  L       +   D +Q  +      
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 718 EYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---------PAESESHISTS 768
             + HG    +IHRD+K +N+L+N     K+ DFG ++I          P   +S + T 
Sbjct: 125 VKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TE 181
Query: 769 IVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH----IVNRVC 823
            V T  Y  PE    S + +   DV+S G +L EL    P I  G +  H    I   + 
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP-IFPGRDYRHQLLLIFGIIG 240
Query: 824 PFLERGDVRSIVDPR 838
                 D+R I  PR
Sbjct: 241 TPHSDNDLRCIESPR 255

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRV--HHR------ 662
           +++GKG FG V   Y       VA+KM+     +  K+F  +A   +R+  H R      
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 663 --NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
             N+  ++       ++ + +E ++  NL + +     +  S     + A    Q L+ L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           H   K  IIH D+K  NILL ++ ++  K+ DFG S          + T I     Y  P
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTXIQSRF-YRAP 268
Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAI 809
           E     R     D++S G +L EL+TG P +
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIKMLSAS---SSQG--PKQFRTEAQLLMRVHHRNLAS 666
           ++GKG F  V      + G + A+K++  +   SS G   +  + EA +   + H ++  
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           L+   +  G + +V+E+M   +L   +         + + +  +    Q LE L +    
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-SHYMRQILEALRYCHDN 151
Query: 727 PIIHRDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            IIHRDVK   +LL  K  +   KL  FG + I   ES   ++   VGT  ++ PE    
Sbjct: 152 NIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGES-GLVAGGRVGTPHFMAPEVVKR 209
Query: 784 NRLTEKSDVYSFGIVLLELITG 805
               +  DV+  G++L  L++G
Sbjct: 210 EPYGKPVDVWGCGVILFILLSG 231

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 38/247 (15%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLL--MRVHHRNLASLVG 669
           +G GG   V+          AIK   L  + +Q    +R E   L  ++ H   +  L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 670 Y-CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
           Y   D      +Y  M  GN+    + + K+++   +R     +  + +  +H HG    
Sbjct: 96  YEITDQ----YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY---YASN 784
           I+H D+K AN L+ + M  KL DFG +     +    +  S VGTV Y+ PE     +S+
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 785 R--------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
           R        ++ KSDV+S G +L  +  G            I+N++        + +I+D
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQI------SKLHAIID 254
Query: 837 PRLEANF 843
           P  E  F
Sbjct: 255 PNHEIEF 261

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 79/200 (39%), Gaps = 17/200 (8%)
Query: 614 LGKGGFGTVYHGYLAD-GSEVAIKMLSASSS------QGPK--QFRTEAQLLMRVHHRNL 664
           LG G FG V+     +   EV +K +           + PK  +   E  +L RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             ++    + G   LV E    G L  + F +    L       I       + YL    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK- 149
Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              IIHRD+K  NI++ E    KL DFG +          +  +  GT+ Y  PE    N
Sbjct: 150 --DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 785 RLT-EKSDVYSFGIVLLELI 803
                + +++S G+ L  L+
Sbjct: 205 PYRGPELEMWSLGVTLYTLV 224
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	919
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-154
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-123
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-122
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-70
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-58
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-54
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-44
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-42
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-38
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-32
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-21
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-21
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-20
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-19
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-17
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-10
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-11
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-14
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-04
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	8e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-07
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-07
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-07
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-07
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-06
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-06
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  455 bits (1172), Expect = e-154
 Identities = 120/318 (37%), Positives = 182/318 (57%), Gaps = 9/318 (2%)

Query: 572 RKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGYLAD 629
            K +   N  N        +  ++ +    ++ + TNNF    ++G G FG VY G L D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 630 GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
           G++VA+K  +  SSQG ++F TE + L    H +L SL+G+C++   + L+Y+YM  GNL
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 690 KQYLF--DETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK 747
           K++L+  D    ++SW+ RL+I + AA+GL YLH      IIHRDVK+ NILL+E    K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + DFG SK      ++H+ST + GT+GY+DPEY+   RLTEKSDVYSFG+VL E++    
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

Query: 808 AII--RGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQ 865
           AI+        ++          G +  IVDP L       S+ K  +TA++C+   S  
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299

Query: 866 RPTMSHVVTELKKCLEME 883
           RP+M  V+ +L+  L ++
Sbjct: 300 RPSMGDVLWKLEYALRLQ 317

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  375 bits (965), Expect = e-123
 Identities = 113/291 (38%), Positives = 180/291 (61%), Gaps = 10/291 (3%)

Query: 596 QQFTYSEIVDITNNFHR--ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTE 652
           ++F+  E+   ++NF    ILG+GGFG VY G LADG+ VA+K L    +QG + QF+TE
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIA 710
            +++    HRNL  L G+C       LVY YMA G++   L +  E++  L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
           + +A+GL YLH  C P IIHRDVK ANILL+E+ +A + DFG +K+     ++H++T++ 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVR 196

Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAI----IRGYNNTHIVNRVCPFL 826
           GT+G++ PEY ++ + +EK+DV+ +G++LLELITG  A     +   ++  +++ V   L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
           +   + ++VD  L+ N+    V ++ + A+ C  S   +RP MS VV  L+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  371 bits (955), Expect = e-122
 Identities = 101/302 (33%), Positives = 167/302 (55%), Gaps = 20/302 (6%)

Query: 593 SDNQQFTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA---- 640
           +    F++ E+ ++TNNF           +G+GGFG VY GY+ + + VA+K L+A    
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68

Query: 641 SSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKE 699
           ++ +  +QF  E +++ +  H NL  L+G+ +DG ++ LVY YM  G+L   L   +   
Sbjct: 69  TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 700 ALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA 759
            LSW  R +IA  AA G+ +LH       IHRD+K+ANILL+E   AK++DFG ++    
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV 819
            +++ +++ IVGT  Y+ PE      +T KSD+YSFG+VLLE+ITGLPA+        ++
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 820 NRVCPFL-ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
           +       E   +   +D ++  + D+ SV  +   A +C+     +RP +  V   L++
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 879 CL 880
             
Sbjct: 304 MT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  262 bits (672), Expect = 1e-80
 Identities = 74/317 (23%), Positives = 119/317 (37%), Gaps = 31/317 (9%)

Query: 593 SDNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFR 650
           S         +   +       +  +G FG V+   L     VA+K+      Q   Q  
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNE 66

Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDR 706
            E   L  + H N+   +G    G +V     L+  +   G+L  +L       +SW + 
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNEL 123

Query: 707 LQIAVDAAQGLEYLHH-------GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA 759
             IA   A+GL YLH        G KP I HRD+K+ N+LL   + A +ADFG +  F A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 760 ESESHISTSIVGTVGYLDPEY-----YASNRLTEKSDVYSFGIVLLELITGLPAI--IRG 812
              +  +   VGT  Y+ PE              + D+Y+ G+VL EL +   A      
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

Query: 813 YNNTHIVNRVCPFLERGDVRSIV-----DPRLEANFDTNSV-WKVAETAMECVPSISFQR 866
                    +       D++ +V      P L   +  ++    + ET  EC    +  R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

Query: 867 PTMSHVVTELKKCLEME 883
            +   V   + +   + 
Sbjct: 304 LSAGCVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  234 bits (599), Expect = 3e-70
 Identities = 83/313 (26%), Positives = 150/313 (47%), Gaps = 27/313 (8%)

Query: 570 YKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLAD 629
           +    +        +   +G++  D+    + ++          +G G FGTV+      
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-----IKEKIGAGSFGTVHRAEW-H 59

Query: 630 GSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYG 687
           GS+VA+K+L      ++   +F  E  ++ R+ H N+   +G      N+ +V EY++ G
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 688 NLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA 746
           +L + L     +E L  + RL +A D A+G+ YLH+   PPI+HR++K+ N+L+++K   
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG- 805
           K+ DFG S++  +   S  S S  GT  ++ PE        EKSDVYSFG++L EL T  
Sbjct: 179 KVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236

Query: 806 LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQ 865
            P      N   +V  V    +R ++   ++P++            A     C  +  ++
Sbjct: 237 QP--WGNLNPAQVVAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWK 282

Query: 866 RPTMSHVVTELKK 878
           RP+ + ++  L+ 
Sbjct: 283 RPSFATIMDLLRP 295

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  218 bits (557), Expect = 6e-65
 Identities = 59/281 (20%), Positives = 119/281 (42%), Gaps = 31/281 (11%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLAS 666
           NF   L +   G ++ G    G+++ +K+L     S++  + F  E   L    H N+  
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 667 LVGYCND--GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           ++G C      +  L+  +M YG+L   L + T   +     ++ A+D A+G+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE---YY 781
           +P I    + + +++++E M A+++       F        S   +    ++ PE     
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKK 183

Query: 782 ASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
             +     +D++SF ++L EL+T  +P      +N  I  +V     R  +   + P + 
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP--FADLSNMEIGMKVALEGLRPTIPPGISPHVS 241

Query: 841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                    K+ +  M   P+   +RP    +V  L+K  +
Sbjct: 242 ---------KLMKICMNEDPA---KRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  216 bits (552), Expect = 5e-64
 Identities = 85/305 (27%), Positives = 140/305 (45%), Gaps = 46/305 (15%)

Query: 592 KSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGP---- 646
           KS       +EI      + + +GKGGFG V+ G  + D S VAIK L    S+G     
Sbjct: 10  KSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64

Query: 647 ---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSW 703
              ++F+ E  ++  ++H N+  L G  ++     +V E++  G+L   L D+    + W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP-IKW 121

Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-----MQAKLADFGFSKIFP 758
             +L++ +D A G+EY+ +   PPI+HRD+++ NI L        + AK+ADFG S+   
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-- 178

Query: 759 AESESHISTSIVGTVGYLDPE--YYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNN 815
                H  + ++G   ++ PE         TEK+D YSF ++L  ++TG  P     Y+ 
Sbjct: 179 ---SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSY 233

Query: 816 THI--VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
             I  +N +     R  +     PRL                  C      +RP  S++V
Sbjct: 234 GKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIV 281

Query: 874 TELKK 878
            EL +
Sbjct: 282 KELSE 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  217 bits (555), Expect = 8e-64
 Identities = 75/332 (22%), Positives = 129/332 (38%), Gaps = 46/332 (13%)

Query: 597 QFTYSEI-VDITN-NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQ 654
           +   SE  +D+ N     ++G+G +G VY G L D   VA+K+ S ++ Q    F  E  
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKN 57

Query: 655 --LLMRVHHRNLASLVGYCNDGGNVG-----LVYEYMAYGNLKQYLFDETKEALSWKDRL 707
              +  + H N+A  +         G     LV EY   G+L +YL   T     W    
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSC 114

Query: 708 QIAVDAAQGLEYLH------HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---- 757
           ++A    +GL YLH         KP I HRD+ + N+L+       ++DFG S       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 758 --PAESESHISTSIVGTVGYLDPEY-------YASNRLTEKSDVYSFGIVLLELITGLPA 808
                 E + + S VGT+ Y+ PE               ++ D+Y+ G++  E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 809 IIRGYNNTHIV----NRVCPFLERGDVRSIVD-----PRLEANFDTNSV--WKVAETAME 857
           +  G +           V       D++ +V      P+    +  NS+    + ET  +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 858 CVPSISFQRPTMSHVVTELKKCLEMETAREQI 889
           C    +  R T       + + + +    + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  214 bits (547), Expect = 2e-63
 Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 40/292 (13%)

Query: 600 YSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS----SSQGPKQFRTEAQL 655
           ++E+         I+G GGFG VY  +   G EVA+K          SQ  +  R EA+L
Sbjct: 6   FAELT-----LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKL 59

Query: 656 LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
              + H N+ +L G C    N+ LV E+   G L + L   + + +     +  AV  A+
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQ--------AKLADFGFSKIFPAESESHIST 767
           G+ YLH     PIIHRD+K++NIL+ +K++         K+ DFG ++    E       
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKM 172

Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFL 826
           S  G   ++ PE   ++  ++ SDV+S+G++L EL+TG +P   RG +   +   V    
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNK 230

Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
               + S                  A+   +C       RP+ ++++ +L  
Sbjct: 231 LALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQLTT 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  211 bits (538), Expect = 8e-62
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 600 YSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           Y EI         ++G+G FG V         +VAIK + + S +  K F  E + L RV
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRV 58

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLE 718
           +H N+  L G C +   V LV EY   G+L   L   E     +    +   +  +QG+ 
Sbjct: 59  NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQ-AKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           YLH      +IHRD+K  N+LL       K+ DFG +            T+  G+  ++ 
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMA 171

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITG 805
           PE +  +  +EK DV+S+GI+L E+IT 
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITR 199

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (523), Expect = 6e-60
 Identities = 79/275 (28%), Positives = 138/275 (50%), Gaps = 23/275 (8%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASL 667
             + +G G FGTVY G      +VA+KML+ +  + Q  + F+ E  +L +  H N+   
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +GY      + +V ++    +L  +L    +     K  + IA   A+G++YLH      
Sbjct: 86  MGYSTAP-QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKS 140

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE---YYASN 784
           IIHRD+K+ NI L+E    K+ DFG +      S SH    + G++ ++ PE      SN
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 785 RLTEKSDVYSFGIVLLELITG-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
             + +SDVY+FGIVL EL+TG LP     Y+N +  +++   + RG +   +  ++ +N 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGSLSPDL-SKVRSNC 254

Query: 844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
                 ++     EC+     +RP+   ++ E+++
Sbjct: 255 PK----RMKRLMAECLKKKRDERPSFPRILAEIEE 285

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  204 bits (520), Expect = 5e-59
 Identities = 78/337 (23%), Positives = 131/337 (38%), Gaps = 45/337 (13%)

Query: 580 VDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLS 639
           ++ S S   GS      Q T ++   I     + +GKG +G V+ G    G +VA+K+  
Sbjct: 15  IEQSQSSGSGSGLPLLVQRTIAK--QIQ--MVKQIGKGRYGEVWMGKW-RGEKVAVKVFF 69

Query: 640 ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG----LVYEYMAYGNLKQYLFD 695
            +         TE    + + H N+   +     G        L+ +Y   G+L  YL  
Sbjct: 70  TTEEAS-WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-- 126

Query: 696 ETKEALSWKDRLQIAVDAAQGLEYLH-----HGCKPPIIHRDVKTANILLNEKMQAKLAD 750
                L  K  L++A  +  GL +LH        KP I HRD+K+ NIL+ +     +AD
Sbjct: 127 -KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185

Query: 751 FGFSKIFPAESESH--ISTSIVGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLEL 802
            G +  F +++        + VGT  Y+ PE           +    +D+YSFG++L E+
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

Query: 803 ITGLPAIIRGYNNTHIVNRVCPFLER-------GDVRSIVD-----PRLEANFDTNSVWK 850
                   R  +   +     P+ +         D+R IV      P     + ++   +
Sbjct: 246 AR------RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR 299

Query: 851 -VAETAMECVPSISFQRPTMSHVVTELKKCLEMETAR 886
            + +   EC       R T   V   L K  E +  +
Sbjct: 300 QMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  202 bits (517), Expect = 1e-58
 Identities = 62/315 (19%), Positives = 115/315 (36%), Gaps = 43/315 (13%)

Query: 581 DNSHSKKEGSLKSDNQQFT--YSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML 638
             S  +K        Q++   + ++         ++GKG FG VYHG      EVAI+++
Sbjct: 11  ARSFPRKASQTSIFLQEWDIPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLI 63

Query: 639 SAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
                +    K F+ E     +  H N+   +G C    ++ ++        L   + D 
Sbjct: 64  DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
            K  L      QIA +  +G+ YLH      I+H+D+K+ N+  +   +  + DFG   I
Sbjct: 124 -KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSI 178

Query: 757 FPAESESHIS---TSIVGTVGYLDPEYYASNRL---------TEKSDVYSFGIVLLELIT 804
                            G + +L PE                ++ SDV++ G +  EL  
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238

Query: 805 G-LPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSIS 863
              P   +      I+ ++      G   ++      +           +  + C     
Sbjct: 239 REWP--FKTQPAEAIIWQM----GTGMKPNL------SQIGMGKEIS--DILLFCWAFEQ 284

Query: 864 FQRPTMSHVVTELKK 878
            +RPT + ++  L+K
Sbjct: 285 EERPTFTKLMDMLEK 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  202 bits (516), Expect = 1e-58
 Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 30/300 (10%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
            +LGKG FG      +   G  + +K L     +  + F  E +++  + H N+   +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
                 +  + EY+  G L+  +         W  R+  A D A G+ YLH      IIH
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131

Query: 731 RDVKTANILLNEKMQAKLADFGFSKIFPAESES------------HISTSIVGTVGYLDP 778
           RD+ + N L+ E     +ADFG +++   E                   ++VG   ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
           E        EK DV+SFGIVL E+I  + A      +            RG +       
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNVRGFL------D 241

Query: 839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLS 898
                +    +      + C      +RP+   +   L+  L M  A       + + L 
Sbjct: 242 RYCPPNCPPSF--FPITVRCCDLDPEKRPSFVKLEHWLET-LRMHLAGHLPLGPQLEQLD 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  196 bits (500), Expect = 1e-56
 Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 51/304 (16%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQL--LMRVHHRNLASL 667
               +GKG +G V+ G    G  VA+K+ S   S+  K +  E +L   + + H N+   
Sbjct: 12  LLECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67

Query: 668 VGYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-- 721
           +       +      L+  Y   G+L  YL       L     L+I +  A GL +LH  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 722 ---HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH--ISTSIVGTVGYL 776
                 KP I HRD+K+ NIL+ +  Q  +AD G + +    +      +   VGT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 777 DPE------YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER-- 828
            PE              ++ D+++FG+VL E+        R  +N  + +   PF +   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR------RMVSNGIVEDYKPPFYDVVP 238

Query: 829 -----GDVRSIVD-----PRLEANFDTNSVWK-VAETAMEC---VPSISFQRPTMSHVVT 874
                 D+R +V      P +   + ++     +A+   EC    PS    R T   +  
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS---ARLTALRIKK 295

Query: 875 ELKK 878
            L K
Sbjct: 296 TLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (487), Expect = 2e-54
 Identities = 68/304 (22%), Positives = 127/304 (41%), Gaps = 41/304 (13%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEA--QLLMRVHHRNLASL 667
               +GKG FG V+ G    G EVA+K+ S   S+  + +  EA     + + H N+   
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGF 101

Query: 668 VGYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-- 721
           +   N          LV +Y  +G+L  YL    +  ++ +  +++A+  A GL +LH  
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 722 ---HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH--ISTSIVGTVGYL 776
                 KP I HRD+K+ NIL+ +     +AD G +    + +++        VGT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 777 DPE------YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV--NRVCPFLER 828
            PE              +++D+Y+ G+V  E+     +I   + +  +   + V      
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSV 277

Query: 829 GDVRSIVD-----PRLEANFDTNSVWK-VAETAMEC---VPSISFQRPTMSHVVTELKKC 879
            ++R +V      P +   + +    + +A+   EC     +    R T   +   L + 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA---ARLTALRIKKTLSQL 334

Query: 880 LEME 883
            + E
Sbjct: 335 SQQE 338

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  160 bits (408), Expect = 3e-44
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 21/235 (8%)

Query: 586 KKEGSLKSDNQQFTYSEIVDITNN-----FHRILGKGGFGTVYHGY-LADGSEVAIK--M 637
           ++E + + D+ +   ++ V ++N+     F   +G+G F TVY G       EVA     
Sbjct: 1   QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60

Query: 638 LSASSSQGPKQFRTEAQLLMRVHHRN----LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
               +    ++F+ EA++L  + H N      S          + LV E M  G LK YL
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFG 752
               K  +  K          +GL++LH    PPIIHRD+K  NI +       K+ D G
Sbjct: 121 -KRFK-VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            + +      +  + +++GT  ++ PE Y   +  E  DVY+FG+ +LE+ T   
Sbjct: 178 LATL----KRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEY 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  156 bits (397), Expect = 1e-42
 Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 41/299 (13%)

Query: 610 FHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
               LG G +G VY G     S  VA+K L   + +  ++F  EA ++  + H NL  L+
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPP 727
           G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL        
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASN 784
            IHRD+   N L+ E    K+ADFG S++          T+  G    + +  PE  A N
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 785 RLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN 842
           + + KSDV++FG++L E+ T    P    G + + +   +    E+         R+E  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELL----EKDY-------RMERP 234

Query: 843 FD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQM 896
                 V+++    M  C    PS    RP+ + +    +   +  +  +++++   + 
Sbjct: 235 EGCPEKVYEL----MRACWQWNPS---DRPSFAEIHQAFETMFQESSISDEVEKELGKR 286

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  162 bits (411), Expect = 1e-42
 Identities = 69/291 (23%), Positives = 125/291 (42%), Gaps = 21/291 (7%)

Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
               LG G +G VY G +      VA+K L   + +  ++F  EA ++  + H NL  L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
           G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 339

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
            IHR++   N L+ E    K+ADFG S++                + +  PE  A N+ +
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS 847
            KSDV++FG++L E+ T   +   G + + +   +    E+         R+E       
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDY-------RMERPEGCPE 446

Query: 848 VWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLS 898
             KV E    C       RP+ + +    +   +  +  +++++   +  +
Sbjct: 447 --KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 495

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (401), Expect = 3e-42
 Identities = 80/282 (28%), Positives = 118/282 (41%), Gaps = 31/282 (10%)

Query: 610 FHRILGKGGFGTVYHGYL-ADGSEVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLASL 667
               +G+G FG V+ G L AD + VA+K            +F  EA++L +  H N+  L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +G C     + +V E +  G+   +L  E    L  K  LQ+  DAA G+EYL       
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKC 233

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT----VGYLDPEYYAS 783
            IHRD+   N L+ EK   K++DFG S+    E    +  +  G     V +  PE    
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 784 NRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
            R + +SDV+SFGI+L E  +    P      +N      V    E+G        RL  
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP--YPNLSNQQTREFV----EKGG-------RLPC 336

Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME 883
                    V     +C      QRP+ S +  EL+   +  
Sbjct: 337 PELCPD--AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  159 bits (405), Expect = 3e-42
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 37/281 (13%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 670 YC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPP 727
               + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL  +     
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASN 784
            +HRD+   N+L++E   AK++DFG +K          S++       V +  PE     
Sbjct: 311 -VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREK 361

Query: 785 RLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN 842
           + + KSDV+SFGI+L E+ +   +P          +V RV    E+G        +++A 
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRV----EKGY-------KMDAP 408

Query: 843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME 883
                   V +    C    +  RPT   +  +L+     E
Sbjct: 409 DGCPP--AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  155 bits (393), Expect = 9e-42
 Identities = 81/319 (25%), Positives = 129/319 (40%), Gaps = 44/319 (13%)

Query: 610 FHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           +   LGKG FG+V            G+ VA+K L  S     + F+ E Q+L  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 665 ASLVGYCNDGGN--VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH- 721
               G     G   + LV EY+  G L+ +L    +  L     L  +    +G+EYL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGS 145

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDP 778
             C    +HRD+   NIL+  +   K+ADFG +K+ P + + ++          + +  P
Sbjct: 146 RRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQSPIFWYAP 199

Query: 779 EYYASNRLTEKSDVYSFGIVLLELIT----------GLPAIIRGYNNTHIVNRVCPFLER 828
           E  + N  + +SDV+SFG+VL EL T              ++    +   ++R+   LE 
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 829 GDVRSIVDPRLEANFD-TNSVWKVAETAM-ECVPSISFQRPTMSHVVTELKKCLEMETAR 886
           G        RL A       V ++    M  C       RP+ S +  +L          
Sbjct: 260 GQ-------RLPAPPACPAEVHEL----MKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

Query: 887 EQIQRT---KSQMLSLSSS 902
           E    T   + +  SLS S
Sbjct: 309 ETHAFTAHPEGKHHSLSFS 327

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  152 bits (387), Expect = 3e-41
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 22/231 (9%)

Query: 589 GSLKSDNQQFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-----DGSEVAIKML-S 639
           G + S+ +  T  +            R LG+G FG V            G +VA+K L  
Sbjct: 1   GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60

Query: 640 ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGN--VGLVYEYMAYGNLKQYLFDET 697
            S        + E ++L  ++H N+    G C + G   + L+ E++  G+LK+YL    
Sbjct: 61  ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN- 119

Query: 698 KEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
           K  ++ K +L+ AV   +G++YL         +HRD+   N+L+  + Q K+ DFG +K 
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKA 175

Query: 757 FPAESESHISTSIVGT---VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
              + E +           V +  PE    ++    SDV+SFG+ L EL+T
Sbjct: 176 IETDKEYYTVKD--DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  152 bits (385), Expect = 4e-41
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 610 FHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V            G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 665 ASLVGYCNDGGN--VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH- 721
               G C   G   + L+ EY+ YG+L+ YL    KE +     LQ      +G+EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT 132

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDP 778
                  IHRD+ T NIL+  + + K+ DFG +K+ P + E             + +  P
Sbjct: 133 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIFWYAP 186

Query: 779 EYYASNRLTEKSDVYSFGIVLLELIT 804
           E    ++ +  SDV+SFG+VL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  151 bits (384), Expect = 5e-41
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 22/201 (10%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G
Sbjct: 25  LLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 670 YC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPP 727
               + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL  +     
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHIS---TSIVGTVGYLDPEYYAS 783
            +HRD+   N+L++E   AK++DFG +K     +    +    T+         PE    
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALRE 188

Query: 784 NRLTEKSDVYSFGIVLLELIT 804
            + + KSDV+SFGI+L E+ +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  150 bits (382), Expect = 5e-41
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 14/199 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           F + +G G FG V+ GY  +  +VAIK +   +    + F  EA+++M++ H  L  L G
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
            C +   + LV E+M +G L  YL    +   + +  L + +D  +G+ YL         
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEACV---- 125

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           IHRD+   N L+ E    K++DFG ++           TS  GT   V +  PE ++ +R
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPVKWASPEVFSFSR 181

Query: 786 LTEKSDVYSFGIVLLELIT 804
            + KSDV+SFG+++ E+ +
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  151 bits (384), Expect = 1e-40
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 610 FHRILGKGGFGTVYHGYL-----ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
           F + LGKG FG+V            G  VA+K L  S+ +  + F  E ++L  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 665 ASLVGYCNDGGN--VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH- 721
               G C   G   + L+ EY+ YG+L+ YL    KE +     LQ      +G+EYL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGT 163

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDP 778
                  IHRD+ T NIL+  + + K+ DFG +K+ P + E +           + +  P
Sbjct: 164 KRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--PGESPIFWYAP 217

Query: 779 EYYASNRLTEKSDVYSFGIVLLELIT 804
           E    ++ +  SDV+SFG+VL EL T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  150 bits (381), Expect = 3e-40
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKML--SASSSQGPKQFRTEAQLLMRVHHRN 663
             R+LGKG FG+V    L         VA+KML     +S   ++F  EA  +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 664 LASLVGYCNDGGNVG------LVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDA 713
           +A LVG        G      ++  +M +G+L  +L      E    L  +  ++  VD 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 714 AQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIV 770
           A G+EYL   +      IHRD+   N +L E M   +ADFG S KI+  +          
Sbjct: 147 ACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR------Q 195

Query: 771 GTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
           G    L       E  A N  T  SDV++FG+ + E++T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  148 bits (375), Expect = 5e-40
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             + LG G FG V  G      +VA+KM+   S     +F  EAQ +M++ H  L    G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
            C+    + +V EY++ G L  YL     + L     L++  D  +G+ +L  H      
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQF---- 125

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           IHRD+   N L++  +  K++DFG ++            S VGT   V +  PE +   +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 786 LTEKSDVYSFGIVLLELIT 804
            + KSDV++FGI++ E+ +
Sbjct: 182 YSSKSDVWAFGILMWEVFS 200

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  152 bits (387), Expect = 6e-40
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 21/280 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPI 728
             ++   + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+         
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 301

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD++ ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           KSDV+SFGI+L EL T       G  N  ++++V    ERG        R+    +    
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGY-------RMPCPPECPE- 408

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
             + +   +C      +RPT  ++   L+        + Q
Sbjct: 409 -SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  149 bits (378), Expect = 6e-40
 Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 610 FHRILGKGGFGTVYHGYL-----ADGSEVAIKML-SASSSQGPKQFRTEAQLLMRVHHRN 663
             R LG+G FG V            G  VA+K L + +  Q    ++ E  +L  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 664 LASLVGYCNDGGN--VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           +    G C D G   + LV EY+  G+L+ YL    + ++     L  A    +G+ YLH
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLD 777
                   IHRD+   N+LL+     K+ DFG +K  P   E +           V +  
Sbjct: 152 AQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE--DGDSPVFWYA 205

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELIT 804
           PE     +    SDV+SFG+ L EL+T
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  148 bits (375), Expect = 7e-40
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           F + LG G FG V +G      +VAIKM+   S     +F  EA+++M + H  L  L G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
            C     + ++ EYMA G L  YL  E +     +  L++  D  + +EYL         
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---- 141

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           +HRD+   N L+N++   K++DFG S+           TS VG+   V +  PE    ++
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSK 197

Query: 786 LTEKSDVYSFGIVLLELIT 804
            + KSD+++FG+++ E+ +
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (376), Expect = 1e-39
 Identities = 76/324 (23%), Positives = 132/324 (40%), Gaps = 59/324 (18%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
             R LG+G FG VY G      +      VAIK ++ ++S     +F  EA ++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------FDETKEALSWKDRLQIAVDAA 714
           ++  L+G  + G    ++ E M  G+LK YL         +      S    +Q+A + A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 715 QGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGT 772
            G+ YL+ +      +HRD+   N ++ E    K+ DFG +  I+  +          G 
Sbjct: 149 DGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR------KGG 198

Query: 773 VGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPF 825
            G L      PE       T  SDV+SFG+VL E+ T    P   +G +N     +V  F
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSN----EQVLRF 252

Query: 826 LERGDVRSIVDPRLEANFDT-NSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCL 880
           +  G         L+   +  + ++++    M  C    P     RP+   +++ +K+ +
Sbjct: 253 VMEGG-------LLDKPDNCPDMLFEL----MRMCWQYNPK---MRPSFLEIISSIKEEM 298

Query: 881 EMETAREQIQRTKSQMLSLSSSVD 904
           E          ++   L     +D
Sbjct: 299 EPGFREVSFYYSEENKLPEPEELD 322

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  147 bits (373), Expect = 2e-39
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 43/296 (14%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLAS 666
           R++GKG FG VYHG   D ++     AIK L   +  Q  + F  E  L+  ++H N+ +
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 667 LVGYCNDGGNVGL-VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGC 724
           L+G       +   +  YM +G+L Q++    +   + KD +   +  A+G+EYL     
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKF 145

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYY 781
               +HRD+   N +L+E    K+ADFG ++    + E +           V +   E  
Sbjct: 146 ----VHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALESL 200

Query: 782 ASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
            + R T KSDV+SFG++L EL+T    P   R  +   + +    FL +G        RL
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDPFDLTH----FLAQGR-------RL 247

Query: 840 EANFD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLEMETAREQIQ 890
                  +S+++V    M +C    P+    RPT   +V E+++ +        +Q
Sbjct: 248 PQPEYCPDSLYQV----MQQCWEADPA---VRPTFRVLVGEVEQIVSALLGDHYVQ 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (374), Expect = 2e-39
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKML--SASSSQGPKQFRTEAQLLMRVHHRN 663
             +ILG+G FG+V  G L         VA+K +    SS +  ++F +EA  +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 664 LASLVGYCNDGGNVG-----LVYEYMAYGNLKQYL----FDETKEALSWKDRLQIAVDAA 714
           +  L+G C +  + G     ++  +M YG+L  YL     +   + +  +  L+  VD A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 715 QGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVG 771
            G+EYL   +      +HRD+   N +L + M   +ADFG SK I+  +          G
Sbjct: 158 LGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR------QG 206

Query: 772 TVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
            +  +       E  A    T KSDV++FG+ + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (382), Expect = 3e-39
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             + LG G FG V+       ++VA+K +   S    + F  EA ++  + H  L  L  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA 250

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
                  + ++ E+MA G+L  +L  +          +  +   A+G+ ++         
Sbjct: 251 VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---- 305

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           IHRD++ ANIL++  +  K+ADFG +++     E +  T+  G    + +  PE      
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 786 LTEKSDVYSFGIVLLELIT 804
            T KSDV+SFGI+L+E++T
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  146 bits (371), Expect = 3e-39
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 16/203 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
             LG GG  TVY         +VAIK +     +     K+F  E     ++ H+N+ S+
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
           +    +     LV EY+    L +Y+  E+   LS    +        G+++ H      
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMR--- 131

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI--STSIVGTVGYLDPEYYASN 784
            I+HRD+K  NIL++     K+ DFG +K   A SE+ +  +  ++GTV Y  PE     
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
              E +D+YS GIVL E++ G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  152 bits (386), Expect = 4e-39
 Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 27/283 (9%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               LG+G FG V+ G     + VAIK L   +   P+ F  EAQ++ ++ H  L  L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPI 728
             ++   + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+         
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 384

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD++ ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           KSDV+SFGI+L EL T       G  N  ++++V    ERG        R+    +    
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGY-------RMPCPPECPE- 491

Query: 849 WKVAETAMEC---VPSISFQRPTMSHVVTELKKCLEMETAREQ 888
             + +   +C    P    +RPT  ++   L+        + Q
Sbjct: 492 -SLHDLMCQCWRKEPE---ERPTFEYLQAFLEDYFTSTEPQYQ 530

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (371), Expect = 6e-39
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
             +I+G G  G V +G L    +    VAIK L +  + +  + F +EA ++ +  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHG 723
             L G    G    +V EYM  G+L  +L        +    + +      G+ YL   G
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEY 780
                +HRD+   N+L++  +  K++DFG S++   + ++  +T+  G    + +  PE 
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAPEA 225

Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
            A    +  SDV+SFG+V+ E++ 
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (372), Expect = 6e-39
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 46/287 (16%)

Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G      E     VAIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGC 724
            L+G C     V L+ + M +G L  Y+ +  K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYY 781
               +HRD+   N+L+      K+ DFG +K+  AE E        G    + ++  E  
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAE--GGKVPIKWMALESI 191

Query: 782 ASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                T +SDV+S+G+ + EL+T    P    G   + I + +    E+G+       RL
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL----EKGE-------RL 238

Query: 840 EANFD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLE 881
                 T  V+ +    M +C          RP    ++ E  K   
Sbjct: 239 PQPPICTIDVYMI----MRKCWMIDAD---SRPKFRELIIEFSKMAR 278

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  145 bits (368), Expect = 6e-39
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               LG G FG V+ GY    ++VA+K L   S   P  F  EA L+ ++ H+ L  L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA 75

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
                  + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++         
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---- 130

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           IHRD++ ANIL+++ +  K+ADFG +++     E +  T+  G    + +  PE      
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 786 LTEKSDVYSFGIVLLELIT 804
            T KSDV+SFGI+L E++T
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (368), Expect = 9e-39
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 22/209 (10%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQG-PKQFRTEAQLLMRVHHRN 663
           +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 664 LASLVGYCNDG-GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH- 721
           + SL+G C    G+  +V  YM +G+L+ ++ +E     + KD +   +  A+G++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK-IFPAESESHISTSIVGTVGYL---- 776
                  +HRD+   N +L+EK   K+ADFG ++ ++  E  S  +     T   L    
Sbjct: 147 KKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLPVKW 198

Query: 777 -DPEYYASNRLTEKSDVYSFGIVLLELIT 804
              E   + + T KSDV+SFG++L EL+T
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  145 bits (367), Expect = 1e-38
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
           R++G+GG G VY          VA+K++S + S  P    + + EA+   R+   ++  +
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
             +    G + +    +   +L   L    +  L+    + I       L+  H  G   
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAAG--- 154

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST--SIVGTVGYLDPEYYASN 784
              HRDVK  NIL++    A L DFG +    A ++  ++   + VGT+ Y+ PE ++ +
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
             T ++D+Y+   VL E +TG P
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  145 bits (368), Expect = 2e-38
 Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 51/303 (16%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKML-SASSSQGPKQFRTEAQLLMRV-HH 661
           F + LG G FG V         +      VA+KML S + +   +   +E +++  +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL------------FDETKEALSWKDRLQI 709
            N+ +L+G C  GG V ++ EY  YG+L  +L            F       S +D L  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
           +   AQG+ +L    C    IHRDV   N+LL     AK+ DFG ++    +S   +  +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFL 826
               V ++ PE       T +SDV+S+GI+L E+ +    P     Y    + ++    +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-----YPGILVNSKFYKLV 280

Query: 827 ERGDVRSIVDPRLEA-NFDTNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLE 881
           + G        ++    F   +++ +    M  C    P+    RPT   + + L++  +
Sbjct: 281 KDGY-------QMAQPAFAPKNIYSI----MQACWALEPT---HRPTFQQICSFLQEQAQ 326

Query: 882 MET 884
            + 
Sbjct: 327 EDR 329

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  145 bits (368), Expect = 2e-38
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE-----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRN 663
             +++G G FG VY G L   S      VAIK L +  + +    F  EA ++ +  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HH 722
           +  L G  +    + ++ EYM  G L ++L  E     S    + +    A G++YL + 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPE 779
                 +HRD+   NIL+N  +  K++DFG S++   + E+  +TS  G    + +  PE
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPE 220

Query: 780 YYASNRLTEKSDVYSFGIVLLELIT 804
             +  + T  SDV+SFGIV+ E++T
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  145 bits (369), Expect = 3e-38
 Identities = 80/324 (24%), Positives = 134/324 (41%), Gaps = 58/324 (17%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
             +++G G FG V  G L   S+    VAIK L    + +  + F  EA ++ +  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHG 723
             L G       V +V EYM  G+L  +L     +  +    + +    A G++YL   G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMG 167

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEY 780
                +HRD+   NIL+N  +  K++DFG  ++   + E+  +T   G    + +  PE 
Sbjct: 168 Y----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEA 221

Query: 781 YASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
            A  + T  SDV+S+GIVL E+++    P      +N  ++  V    + G        R
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSNQDVIKAV----DEGY-------R 268

Query: 839 LEANFDTNSVWKVAETAMECVPSI-----------SFQRPTMSHVVTELKKCLEMETARE 887
           L                M+C  ++              RP    +V+ L K +    + +
Sbjct: 269 LPP-------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLK 315

Query: 888 QIQRTK---SQMLSLSSSVDISAV 908
            I       S +L   S+VDI+  
Sbjct: 316 IITSAAARPSNLLLDQSNVDITTF 339

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (367), Expect = 5e-38
 Identities = 82/371 (22%), Positives = 151/371 (40%), Gaps = 45/371 (12%)

Query: 540 KKEKRNSVMPVVAASVSLLVILIAL-LVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQF 598
                  ++P  +  +  +  +  L    +             N+      +L  +  Q 
Sbjct: 19  ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78

Query: 599 TYSEIVDITNN---FHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQG-PKQFR 650
               ++  ++    F+ ++G+G FG VYHG L D        A+K L+  +  G   QF 
Sbjct: 79  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138

Query: 651 TEAQLLMRVHHRNLASLVGYCNDG-GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQI 709
           TE  ++    H N+ SL+G C    G+  +V  YM +G+L+ ++ +E     + KD +  
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGF 197

Query: 710 AVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
            +  A+G+++L         +HRD+   N +L+EK   K+ADFG ++    +    +   
Sbjct: 198 GLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 769 IVGT--VGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCP 824
                 V ++  E   + + T KSDV+SFG++L EL+T    P      N   I      
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITV---- 307

Query: 825 FLERGDVRSIVDPRLEANFD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKC 879
           +L +G        RL       + +++V    M +C          RP+ S +V+ +   
Sbjct: 308 YLLQGR-------RLLQPEYCPDPLYEV----MLKCWHPKAE---MRPSFSELVSRISAI 353

Query: 880 LEMETAREQIQ 890
                    + 
Sbjct: 354 FSTFIGEHYVH 364

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  143 bits (363), Expect = 6e-38
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
            ILG GG   V+    L D  +VA+K+L A  ++ P    +FR EAQ    ++H  + ++
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 668 VGYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
                     G    +V EY+    L+  +   T+  ++ K  +++  DA Q L + H +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST-SIVGTVGYLDPEYY 781
           G    IIHRDVK ANI+++     K+ DFG ++       S   T +++GT  YL PE  
Sbjct: 136 G----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 782 ASNRLTEKSDVYSFGIVLLELITG 805
             + +  +SDVYS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  142 bits (361), Expect = 8e-38
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQFRTEAQLLMRVHHRN 663
             R LG+G FG V+     + S       VA+K L   +    K F+ EA+LL  + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQI 709
           +    G C DG  + +V+EYM +G+L ++L                + K  L     L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 710 AVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST 767
           A   A G+ YL   H      +HRD+ T N L+   +  K+ DFG S+   +     +  
Sbjct: 139 ASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193

Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
             +  + ++ PE     + T +SDV+SFG++L E+ T
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (361), Expect = 1e-37
 Identities = 74/322 (22%), Positives = 133/322 (41%), Gaps = 40/322 (12%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE-----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRN 663
             ++LG G FGTV+ G      E     V IK++   S  Q  +        +  + H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           +  L+G C  G ++ LV +Y+  G+L  ++    + AL  +  L   V  A+G+ YL  H
Sbjct: 77  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           G     +HR++   N+LL    Q ++ADFG + + P + +  + +     + ++  E   
Sbjct: 135 GM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 783 SNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
             + T +SDV+S+G+ + EL+T    P    G     + + +    E+G+       RL 
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEVPDLL----EKGE-------RLA 237

Query: 841 ANFD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQ 895
                T  V+ V    M +C     +    RPT   +  E  +          I+R    
Sbjct: 238 QPQICTIDVYMV----MVKCWMIDEN---IRPTFKELANEFTRMARDPPRYLVIKRESGP 290

Query: 896 MLSLSSSVDISAVEVETEMGPE 917
            ++          +   E+  E
Sbjct: 291 GIAPGPEPHGLTNKKLEEVELE 312

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  142 bits (360), Expect = 2e-37
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQFRTEAQLLMRVHHRN 663
               LG+G FG V+     +         VA+K L  +S    + F+ EA+LL  + H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL-------------FDETKEALSWKDRLQIA 710
           +    G C +G  + +V+EYM +G+L ++L              D     L     L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 711 VDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
              A G+ YL   H      +HRD+ T N L+ + +  K+ DFG S+   +     +   
Sbjct: 165 SQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219

Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
            +  + ++ PE     + T +SDV+SFG+VL E+ T
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (357), Expect = 4e-37
 Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 20/214 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           + LG+GGF  V     L DG   A+K +     Q  ++ + EA +    +H N+  LV Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 671 C----NDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
           C           L+  +   G L   +    +    L+    L + +   +GLE +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV-------GTVGYLD 777
                HRD+K  NILL ++ Q  L D G         E       +        T+ Y  
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 778 PE---YYASNRLTEKSDVYSFGIVLLELITGLPA 808
           PE     +   + E++DV+S G VL  ++ G   
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  140 bits (355), Expect = 4e-37
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)

Query: 611 HRILGKGGFGTVYHGYLADGS---EVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLA 665
            + LG G FGTV  GY         VA+K+L   A+      +   EA ++ ++ +  + 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGC 724
            ++G C +  +  LV E    G L +YL  +    +  K+ +++    + G++YL     
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYY 781
               +HRD+   N+LL  +  AK++DFG SK   A+   + + +       V +  PE  
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPECI 192

Query: 782 ASNRLTEKSDVYSFGIVLLELIT 804
              + + KSDV+SFG+++ E  +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (359), Expect = 4e-37
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 14/232 (6%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKM- 637
           + H      +    +   +  +      + R+  +G+G FG         DG +  IK  
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57

Query: 638 -LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
            +S  SS+  ++ R E  +L  + H N+        + G++ +V +Y   G+L + +  +
Sbjct: 58  NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI 756
                     L   V     L+++H      I+HRD+K+ NI L +    +L DFG +++
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPA 808
               S   ++ + +GT  YL PE   +     KSD+++ G VL EL T   A
Sbjct: 175 L--NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  141 bits (357), Expect = 5e-37
 Identities = 62/233 (26%), Positives = 96/233 (41%), Gaps = 63/233 (27%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE---VAIKML-SASSSQGPKQFRTEAQLLMRV-HHRNL 664
           F  ++G+G FG V    +         AIK +   +S    + F  E ++L ++ HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQIA 710
            +L+G C   G + L  EY  +GNL  +L               + T   LS +  L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 711 VDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
            D A+G++YL         IHRD+   NIL+ E   AK+ADFG S+              
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190

Query: 770 VGTVGYLDPEYYAS------------------NRLTEKSDVYSFGIVLLELIT 804
                    E Y                    +  T  SDV+S+G++L E+++
Sbjct: 191 -------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (354), Expect = 5e-37
 Identities = 62/294 (21%), Positives = 123/294 (41%), Gaps = 37/294 (12%)

Query: 614 LGKGGFGTVYHGYLADGSE---VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG+V  G      +   VAIK+L   +     ++   EAQ++ ++ +  +  L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
            C     + LV E    G L ++L  + +E +   +  ++    + G++YL         
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNF---- 131

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYASNR 785
           +HRD+   N+LL  +  AK++DFG SK   A+   + + S       + +  PE     +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRK 189

Query: 786 LTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
            + +SDV+S+G+ + E ++    P   +      ++  +    E+G        R+E   
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFI----EQGK-------RMECPP 236

Query: 844 D-TNSVWKVAETAM-ECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQ 895
           +    ++ +    M +C       RP    V   ++ C     ++ +       
Sbjct: 237 ECPPELYAL----MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 286

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  140 bits (355), Expect = 6e-37
 Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHR 662
             + LG+G FG V                VA+KML  ++S    +   +E  +L +V+H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----------------------FDETKEA 700
           ++  L G C+  G + L+ EY  YG+L+ +L                          + A
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 701 LSWKDRLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIF 757
           L+  D +  A   +QG++YL         ++HRD+   NIL+ E  + K++DFG S  ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 758 PAESESHISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
                    + +  + G +       E    +  T +SDV+SFG++L E++T
Sbjct: 202 ------EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  140 bits (355), Expect = 6e-37
 Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 64/314 (20%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRV-HH 661
             + LG+G FG V         +      VA+KML   ++    +   +E ++L+ + HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 662 RNLASLVGYCNDGGN-VGLVYEYMAYGNLKQYL--------------FDETKEALSWKDR 706
            N+ +L+G C   G  + ++ E+  +GNL  YL               D  K+ L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 707 LQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
           +  +   A+G+E+L    C    IHRD+   NILL+EK   K+ DFG ++    + +   
Sbjct: 151 ICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--- 203

Query: 766 STSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHI 818
              +      L      PE       T +SDV+SFG++L E+ +    P     Y    I
Sbjct: 204 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKI 256

Query: 819 VNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAM-EC---VPSISFQRPTMSHVV 873
               C  L+ G        R+ A ++ T  +++     M +C    PS   QRPT S +V
Sbjct: 257 DEEFCRRLKEGT-------RMRAPDYTTPEMYQT----MLDCWHGEPS---QRPTFSELV 302

Query: 874 TELKKCLEMETARE 887
             L   L+    ++
Sbjct: 303 EHLGNLLQANAQQD 316

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (356), Expect = 7e-37
 Identities = 78/316 (24%), Positives = 133/316 (42%), Gaps = 40/316 (12%)

Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G      E     VAIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGC 724
            L+G C     V L+ + M +G L  Y+ +  K+ +  +  L   V  A+G+ YL     
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
               +HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E     
Sbjct: 139 ----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 785 RLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN 842
             T +SDV+S+G+ + EL+T    P    G   + I + +    E+G+       RL   
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSIL----EKGE-------RLPQP 241

Query: 843 FD-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQML 897
              T  V+ +    M +C          RP    ++ E  K          IQ  +   L
Sbjct: 242 PICTIDVYMI----MVKCWMIDAD---SRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 294

Query: 898 SLSSSVDISAVEVETE 913
              +  +     ++ E
Sbjct: 295 PSPTDSNFYRALMDEE 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (350), Expect = 1e-36
 Identities = 55/235 (23%), Positives = 98/235 (41%), Gaps = 22/235 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
             +G G +G        +DG  +  K     + +    +   +E  LL  + H N+   V
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI---V 68

Query: 669 GYCN-----DGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLH 721
            Y +         + +V EY   G+L   +    + ++ L  +  L++       L+  H
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 722 HGCKPP--IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                   ++HRD+K AN+ L+ K   KL DFG ++I     ++  + + VGT  Y+ PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPE 186

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
                   EKSD++S G +L EL   +P     ++   +  ++      G  R I
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIR----EGKFRRI 236

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  146 bits (370), Expect = 1e-36
 Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 25/205 (12%)

Query: 612 RILGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASL- 667
             +  GG G +Y       +G  V +K L  S     +     E Q L  V H ++  + 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 668 -VGYCNDGGNVGLVY---EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-H 722
                 D     + Y   EY+   +LK+       + L   + +   ++    L YLH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHSI 201

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           G    +++ D+K  NI+L E+ Q KL D G      +         + GT G+  PE   
Sbjct: 202 G----LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPEI-V 249

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
               T  +D+Y+ G  L  L   LP
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (350), Expect = 2e-36
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
            +RILG+G FG VY G   +       VA+K      +    ++F +EA ++  + H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHG 723
             L+G   +     ++ E   YG L  YL    K +L     +  ++   + + YL    
Sbjct: 76  VKLIGII-EEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEY 780
           C    +HRD+   NIL+      KL DFG S+    E E +   S   T   + ++ PE 
Sbjct: 134 C----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKAS--VTRLPIKWMSPES 185

Query: 781 YASNRLTEKSDVYSFGIVLLELIT 804
               R T  SDV+ F + + E+++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  139 bits (353), Expect = 2e-36
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 43/227 (18%)

Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQ-FRTEAQLLMRV- 659
             + LG+G FG V                  VA+KML   +++       +E +++  + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKD 705
            H+N+ +L+G C   G + ++ EY + GNL++YL                  +E +++KD
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 706 RLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESE 762
            +      A+G+EYL          IHRD+   N+L+ E    K+ADFG +  I      
Sbjct: 159 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDIN----- 208

Query: 763 SHISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
            +I      T G L      PE       T +SDV+SFG+++ E+ T
Sbjct: 209 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (349), Expect = 2e-36
 Identities = 53/206 (25%), Positives = 78/206 (37%), Gaps = 19/206 (9%)

Query: 610 FHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
               LG G FG V  G     S     VA+K L       P+    F  E   +  + HR
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-H 721
           NL  L G       + +V E    G+L   L    +         + AV  A+G+ YL  
Sbjct: 82  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDP 778
                  IHRD+   N+LL  +   K+ DFG  +  P   + ++            +  P
Sbjct: 140 KRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193

Query: 779 EYYASNRLTEKSDVYSFGIVLLELIT 804
           E   +   +  SD + FG+ L E+ T
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (349), Expect = 4e-36
 Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 36/247 (14%)

Query: 584 HSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGYLADGSEVAIKM--LS 639
           H      +    +   +  +      +  +  +G GG   V+          AIK   L 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63

Query: 640 ASSSQGPKQFRTEAQLLMRVHHRNLA--SLVGYCNDGGNVGLVYEYMAYGNLKQYL---- 693
            + +Q    +R E   L ++   +     L  Y      + +V E     +L  +L    
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122

Query: 694 -FDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADF 751
             D  +    WK    +     + +  +H HG    I+H D+K AN L+ + M  KL DF
Sbjct: 123 SIDPWERKSYWK---NML----EAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDF 170

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPE-----------YYASNRLTEKSDVYSFGIVLL 800
           G +     ++ S +  S VGTV Y+ PE             + ++++ KSDV+S G +L 
Sbjct: 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 801 ELITGLP 807
            +  G  
Sbjct: 231 YMTYGKT 237

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  138 bits (349), Expect = 4e-36
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 55/307 (17%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQG-PKQFRTEAQLLMRV-HH 661
           F + LG G FG V         +      VA+KML  S+     +   +E ++L  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----------------FDETKEALSWKD 705
            N+ +L+G C  GG   ++ EY  YG+L  +L                 ++ + AL  +D
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 706 RLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH 764
            L  +   A+G+ +L    C    IHRD+   NILL      K+ DFG ++    +S   
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRV 822
           +  +    V ++ PE   +   T +SDV+S+GI L EL +    P     Y    + ++ 
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKF 257

Query: 823 CPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELK 877
              ++ G        R+ +       ++ +    M  C    P    +RPT   +V  ++
Sbjct: 258 YKMIKEGF-------RMLSPEHAPAEMYDI----MKTCWDADPL---KRPTFKQIVQLIE 303

Query: 878 KCLEMET 884
           K +   T
Sbjct: 304 KQISEST 310

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  137 bits (346), Expect = 5e-36
 Identities = 60/318 (18%), Positives = 105/318 (33%), Gaps = 82/318 (25%)

Query: 610 FHRILGKGGFGTVYHGYLADGS--------EVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           F+  LG+G F  ++ G   +          EV +K+L  +     + F   A ++ ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL- 720
           ++L    G C  G    LV E++ +G+L  YL    K  ++   +L++A   A  + +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE 130

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQ--------AKLADFGFSKIFPAESESHISTSIVGT 772
            +      IH +V   NILL  +           KL+D G S                  
Sbjct: 131 ENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------------- 171

Query: 773 VGYLDPEYYA-------------SNRLTEKSDVYSFGIVLLELITG----LPAIIRGYNN 815
              L  +                   L   +D +SFG  L E+ +G    L       ++
Sbjct: 172 ---LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS----ALDS 224

Query: 816 THIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMEC---VPSISFQRPTMSHV 872
              +       E          +L A         +A     C    P     RP+   +
Sbjct: 225 QRKLQFY----EDRH-------QLPAPKAAE----LANLINNCMDYEPD---HRPSFRAI 266

Query: 873 VTELKKCLEMETAREQIQ 890
           + +L      +       
Sbjct: 267 IRDLNSLFTPDLVPRGSH 284

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (349), Expect = 5e-36
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 34/218 (15%)

Query: 610 FHRILGKGGFGTVYHGYLADGS------EVAIKMLSA-SSSQGPKQFRTEAQLLMRVHHR 662
             R LG G FG VY G ++         +VA+K L    S Q    F  EA ++ + +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGL 717
           N+   +G         ++ E MA G+LK +L           +L+  D L +A D A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 718 EYL--HHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSK-IFPAESESHISTSIVG 771
           +YL  +H      IHRD+   N LL        AK+ DFG ++ I+ A           G
Sbjct: 154 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR------KG 202

Query: 772 TVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
               L      PE +     T K+D +SFG++L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  137 bits (347), Expect = 5e-36
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHR 662
           F   LG+  FG VY G+L   +       VAIK L   +    ++ FR EA L  R+ H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKDRLQ 708
           N+  L+G       + +++ Y ++G+L ++L                  K AL   D + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 709 IAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST 767
           +    A G+EYL  H      +H+D+ T N+L+ +K+  K++D G  +   A     +  
Sbjct: 133 LVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
           + +  + ++ PE     + +  SD++S+G+VL E+ +
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  139 bits (352), Expect = 6e-36
 Identities = 83/317 (26%), Positives = 135/317 (42%), Gaps = 70/317 (22%)

Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKML-SASSSQGPKQFRTEAQLLMRV- 659
             + LG+G FG V                  VA+KML   ++ +      +E +++  + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKD 705
            H+N+ +L+G C   G + ++ EY + GNL++YL                  +E +++KD
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 706 RLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESE 762
            +      A+G+EYL          IHRD+   N+L+ E    K+ADFG +  I      
Sbjct: 205 LVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDIN----- 254

Query: 763 SHISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNN 815
            +I      T G L      PE       T +SDV+SFG+++ E+ T  G P    G   
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV 311

Query: 816 THIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAM-EC---VPSISFQRPTMS 870
                 +   L+ G        R++     TN ++ +    M +C   VPS   QRPT  
Sbjct: 312 ----EELFKLLKEGH-------RMDKPANCTNELYMM----MRDCWHAVPS---QRPTFK 353

Query: 871 HVVTELKKCLEMETARE 887
            +V +L + L + T  E
Sbjct: 354 QLVEDLDRILTLTTNEE 370

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 1e-35
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 19/202 (9%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G           VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCK 725
           L+G       V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRF- 137

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT---VGYLDPEYYA 782
              +HRD+   N+L++     KL DFG S+    E  ++   S       + ++ PE   
Sbjct: 138 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKAS--KGKLPIKWMAPESIN 190

Query: 783 SNRLTEKSDVYSFGIVLLELIT 804
             R T  SDV+ FG+ + E++ 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 2e-35
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 11/203 (5%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIK---MLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
           + +G+G F  VY    L DG  VA+K   +     ++       E  LL +++H N+   
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
                +   + +V E    G+L + +  F + K  +  +   +  V     LE++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+K AN+ +      KL D G  + F   S++  + S+VGT  Y+ PE    N 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENG 212

Query: 786 LTEKSDVYSFGIVLLELITGLPA 808
              KSD++S G +L E+      
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP 235

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  137 bits (348), Expect = 2e-35
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 41/226 (18%)

Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKML-SASSSQGPKQFRTEAQLLMRV- 659
             + LG+G FG V                ++VA+KML S ++ +      +E +++  + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALSWKD 705
            H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 706 RLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESES 763
            +  A   A+G+EYL    C    IHRD+   N+L+ E    K+ADFG +  I       
Sbjct: 193 LVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242

Query: 764 HISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
           HI      T G L      PE       T +SDV+SFG++L E+ T
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (340), Expect = 3e-35
 Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN- 663
            +F  I  +G GGFG V+      DG    IK +  ++    ++   E + L ++ H N 
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 664 ---------------LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ 708
                           +S     +    + +  E+   G L+Q++     E L     L+
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 709 IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
           +     +G++Y+H      +I+RD+K +NI L +  Q K+ DFG       + +    T 
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTR 180

Query: 769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             GT+ Y+ PE  +S    ++ D+Y+ G++L EL+    
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  136 bits (344), Expect = 3e-35
 Identities = 66/232 (28%), Positives = 100/232 (43%), Gaps = 48/232 (20%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHR 662
           + R +G+G FG V+               VA+KML   +S   +  F+ EA L+    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----------------------FDETKEA 700
           N+  L+G C  G  + L++EYMAYG+L ++L                             
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 701 LSWKDRLQIAVDAAQGLEYL--HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFS-KIF 757
           LS  ++L IA   A G+ YL          +HRD+ T N L+ E M  K+ADFG S  I+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

Query: 758 PAESESHISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
                             +      PE    NR T +SDV+++G+VL E+ +
Sbjct: 226 ------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  141 bits (356), Expect = 4e-35
 Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 14/198 (7%)

Query: 614 LGKGGFGTVYHGYLADGSE---VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG+V  G      +   VAIK+L   +     ++   EAQ++ ++ +  +  L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-HHGCKPPI 728
            C     + LV E    G L ++L  + +E +   +  ++    + G++YL         
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNF---- 457

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT--VGYLDPEYYASNRL 786
           +HR++   N+LL  +  AK++DFG SK   A+ +S+ +    G   + +  PE     + 
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 787 TEKSDVYSFGIVLLELIT 804
           + +SDV+S+G+ + E ++
Sbjct: 517 SSRSDVWSYGVTMWEALS 534

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  136 bits (344), Expect = 5e-35
 Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 34/218 (15%)

Query: 610 FHRILGKGGFGTVYHGYLADGS------EVAIKMLSASSS-QGPKQFRTEAQLLMRVHHR 662
             R LG G FG VY G ++         +VA+K L    S Q    F  EA ++ + +H+
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGL 717
           N+   +G         ++ E MA G+LK +L           +L+  D L +A D A G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 718 EYL--HHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSK-IFPAESESHISTSIVG 771
           +YL  +H      IHRD+   N LL        AK+ DFG ++ I+ A           G
Sbjct: 195 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR------KG 243

Query: 772 TVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT 804
               L      PE +     T K+D +SFG++L E+ +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  135 bits (342), Expect = 6e-35
 Identities = 71/317 (22%), Positives = 130/317 (41%), Gaps = 70/317 (22%)

Query: 610 FHRILGKGGFGTVYHGYLADGSE------VAIKMLSASSSQGPKQ-FRTEAQLLMRV-HH 661
           F ++LG G FG V +      S+      VA+KML   +    ++   +E +++ ++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL---------------------FDETKEA 700
            N+ +L+G C   G + L++EY  YG+L  YL                      +E    
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 701 LSWKDRLQIAVDAAQGLEYL-HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA 759
           L+++D L  A   A+G+E+L    C    +HRD+   N+L+      K+ DFG ++   +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 760 ESESHISTSIVGTVGYL-----DPEYYASNRLTEKSDVYSFGIVLLELIT--GLPAIIRG 812
           +S   +  +       L      PE       T KSDV+S+GI+L E+ +    P     
Sbjct: 225 DSNYVVRGN-----ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----- 274

Query: 813 YNNTHIVNRVCPFLERGDVRSIVDPRLEA-NFDTNSVWKVAETAM-EC---VPSISFQRP 867
           Y    +       ++ G        +++   + T  ++ +    M  C         +RP
Sbjct: 275 YPGIPVDANFYKLIQNGF-------KMDQPFYATEEIYII----MQSCWAFDSR---KRP 320

Query: 868 TMSHVVTELKKCLEMET 884
           +  ++ + L   L    
Sbjct: 321 SFPNLTSFLGCQLADAE 337

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 2e-34
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 27/226 (11%)

Query: 601 SEIVDITNN---FHRILGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQL 655
           +E + +        + +G GG   V+          AIK   L  + +Q    +R E   
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 60

Query: 656 LMRVHHRNLA--SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA 713
           L ++   +     L  Y      + +V E     +L  +L  + K+++   +R     + 
Sbjct: 61  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNM 117

Query: 714 AQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
            + +  +H HG    I+H D+K AN L+ + M  KL DFG +     ++ S +  S VGT
Sbjct: 118 LEAVHTIHQHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 773 VGYLDPE-----------YYASNRLTEKSDVYSFGIVLLELITGLP 807
           V Y+ PE             + ++++ KSDV+S G +L  +  G  
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (340), Expect = 3e-34
 Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 37/263 (14%)

Query: 569 TYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG 625
             K   AA+    +  S   G+   D    + +E + +        + +G GG   V+  
Sbjct: 16  GMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV 75

Query: 626 YLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLA--SLVGYCNDGGNVGLVY 681
                   AIK   L  + +Q    +R E   L ++   +     L  Y      + +V 
Sbjct: 76  LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135

Query: 682 EYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKT 735
           E     +L  +L      D  +    WK    +     + +  +H HG    I+H D+K 
Sbjct: 136 EC-GNIDLNSWLKKKKSIDPWERKSYWK---NML----EAVHTIHQHG----IVHSDLKP 183

Query: 736 ANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-----------YYASN 784
           AN L+ + M  KL DFG +     ++ S +  S VG V Y+ PE             + +
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
           +++ KSDV+S G +L  +  G  
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKT 265

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  137 bits (347), Expect = 8e-34
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 40/285 (14%)

Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
           R +G+G FG V+ G           VAIK     +S   ++ F  EA  + +  H ++  
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCK 725
           L+G       V ++ E    G L+ +L    K +L     +  A   +  L YL      
Sbjct: 456 LIGVI-TENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKRF- 512

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
              +HRD+   N+L++     KL DFG S+     +    S   +  + ++ PE     R
Sbjct: 513 ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRR 568

Query: 786 LTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
            T  SDV+ FG+ + E++     P   +G  N  ++ R+    E G+       RL    
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRI----ENGE-------RLPMPP 615

Query: 844 D-TNSVWKVAETAM-EC---VPSISFQRPTMSHVVTELKKCLEME 883
           +   +++ +    M +C    PS   +RP  + +  +L   LE E
Sbjct: 616 NCPPTLYSL----MTKCWAYDPS---RRPRFTELKAQLSTILEEE 653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  129 bits (327), Expect = 3e-33
 Identities = 58/272 (21%), Positives = 92/272 (33%), Gaps = 39/272 (14%)

Query: 568 WTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHG 625
               + R      + S + +         +  + +      +F R+  LG G +G V+  
Sbjct: 23  MHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ------SFQRLSRLGHGSYGEVFKV 76

Query: 626 -YLADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVY 681
               DG   A+K  M      +   +   E     +V  H     L     +GG + L  
Sbjct: 77  RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136

Query: 682 EYMAYGNLKQYLFDETK---EALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTAN 737
           E     +L+Q+         EA  W        D    L +LH  G    ++H DVK AN
Sbjct: 137 ELCG-PSLQQHCEAWGASLPEAQVWG----YLRDTLLALAHLHSQG----LVHLDVKPAN 187

Query: 738 ILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-----YYASNRLTEKSDV 792
           I L  + + KL DFG          +       G   Y+ PE     Y         +DV
Sbjct: 188 IFLGPRGRCKLGDFGLLVEL---GTAGAGEVQEGDPRYMAPELLQGSY------GTAADV 238

Query: 793 YSFGIVLLELITGLPAIIRGYNNTHIVNRVCP 824
           +S G+ +LE+   +     G     +     P
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGYLP 270

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  128 bits (324), Expect = 7e-33
 Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 44/231 (19%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
            +F  I  LG+GGFG V+      D    AIK +   + +  ++    E + L ++ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 664 LASLVGY------------CNDGGNVGLVY---EYMAYGNLKQYL-----FDETKEALSW 703
           +   V Y                     +Y   +     NLK ++      +E + ++  
Sbjct: 65  I---VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 704 KDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI------- 756
              LQIA    + +E+LH      ++HRD+K +NI        K+ DFG           
Sbjct: 122 HIFLQIA----EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 757 ---FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT 804
                        T  VGT  Y+ PE    N  + K D++S G++L EL+ 
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 9e-33
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 32/232 (13%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG 669
           R+L +GGF  VY    +  G E A+K L ++  +  +    E   + ++  H N+     
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 670 YC-------NDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLH 721
                    + G    L+   +  G L ++L   E++  LS    L+I     + ++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF---PAESESHISTSIV-------G 771
              KPPIIHRD+K  N+LL+ +   KL DFG +      P  S S    ++V        
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 772 TVGYLDPE---YYASNRLTEKSDVYSFGIVLLELITG-LP-------AIIRG 812
           T  Y  PE    Y++  + EK D+++ G +L  L     P        I+ G
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  129 bits (324), Expect = 2e-32
 Identities = 24/278 (8%), Positives = 62/278 (22%), Gaps = 50/278 (17%)

Query: 570 YKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGY- 626
           Y R+ A +       +        + +    S +            L  G    V+    
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83

Query: 627 LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASLVGYCN----------- 672
           +    + A+K+ +  +       ++         R+   +                    
Sbjct: 84  VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143

Query: 673 ---------------DGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVD 712
                             N  L+    +  +L+            +          +   
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 713 AAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVG 771
             +    L   G    ++H      N+ +    +  L D                 +   
Sbjct: 203 LIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSV 253

Query: 772 TVGYLDPEYYASNRL--TEKSDVYSFGIVLLELITGLP 807
            V Y   E+  ++    T   + +  G+ +  +     
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  130 bits (328), Expect = 2e-32
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 20/208 (9%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASL 667
               +LG G  GT+ +  + D  +VA+K +         +   E QLL     H N+   
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRY 83

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
                D     +  E  A   L++Y+ ++   A    + + +      GL +LH      
Sbjct: 84  FCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138

Query: 727 PIIHRDVKTANILLNEK-----MQAKLADFGFSKIFPAESES-HISTSIVGTVGYLDPEY 780
            I+HRD+K  NIL++       ++A ++DFG  K       S    + + GT G++ PE 
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 781 YASN---RLTEKSDVYSFGIVLLELITG 805
            + +     T   D++S G V   +I+ 
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (320), Expect = 3e-32
 Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 32/241 (13%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHG-YLADGSEVAIKML 638
            S  K+ G L    Q++         N+   +  +G G  G V+   +   G  +A+K +
Sbjct: 4   GSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 639 SASSSQGP-KQFRTEAQLLMR-VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--- 693
             S ++   K+   +  ++++      +    G      +V +  E M     K      
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118

Query: 694 --FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADF 751
               E           ++ V   + L YL       +IHRDVK +NILL+E+ Q KL DF
Sbjct: 119 GPIPERILG-------KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE-----KSDVYSFGIVLLELITGL 806
           G S       +        G   Y+ PE       T+     ++DV+S GI L+EL TG 
Sbjct: 170 GISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

Query: 807 P 807
            
Sbjct: 227 F 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  126 bits (318), Expect = 3e-32
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)

Query: 590 SLKSDNQQFTYSEIVDITNNFHR-----ILGKGGFGTVYHGY-LADGSEVAIKMLSASSS 643
           S++S  +    S++++    +       +LGKG +G VY G  L++   +AIK +    S
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 644 QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSW 703
           +  +    E  L   + H+N+   +G  ++ G + +  E +  G+L   L   +K     
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL--RSKWGPLK 118

Query: 704 KDRLQIAVDAAQ---GLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPA 759
            +   I     Q   GL+YLH      I+HRD+K  N+L+N      K++DFG SK    
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 760 ESESHISTSIVGTVGYLDPE--YYASNRLTEKSDVYSFGIVLLELITGLP 807
            +    + +  GT+ Y+ PE          + +D++S G  ++E+ TG P
Sbjct: 176 INPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  126 bits (319), Expect = 5e-32
 Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 33/254 (12%)

Query: 569 TYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHR--ILGKGGFGTVYHGY 626
           T+    A    +       EG L ++  +    E  +  +       +G+G FG V+   
Sbjct: 19  TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78

Query: 627 -LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA 685
               G + A+K +     +       E      +    +  L G   +G  V +  E + 
Sbjct: 79  DKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 686 YGNLKQYL-----FDETKEALSWKDRLQIAVDAAQ---GLEYLHHGCKPPIIHRDVKTAN 737
            G+L Q +       E           +      Q   GLEYLH      I+H DVK  N
Sbjct: 134 GGSLGQLIKQMGCLPED----------RALYYLGQALEGLEYLHTRR---ILHGDVKADN 180

Query: 738 ILLNEK-MQAKLADFGFSKIFPAESESHIST---SIVGTVGYLDPEYYASNRLTEKSDVY 793
           +LL+    +A L DFG +     +           I GT  ++ PE         K D++
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240

Query: 794 SFGIVLLELITGLP 807
           S   ++L ++ G  
Sbjct: 241 SSCCMMLHMLNGCH 254

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 6e-32
 Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 25/217 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLAS 666
               ILG+G    V+ G     G   AIK+ +  S   P      E ++L +++H+N+  
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 667 L--VGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           L  +       +  L+ E+   G+L   L +      L   + L +  D   G+ +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 723 GCKPPIIHRDVKTANILL----NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           G    I+HR++K  NI+     + +   KL DFG ++      +     S+ GT  YL P
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHP 184

Query: 779 EYYASNRL--------TEKSDVYSFGIVLLELITGLP 807
           + Y    L            D++S G+      TG  
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 7e-32
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 28/241 (11%)

Query: 577 RLNVDNSHSKK-EGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHG-YLADGSE 632
            L +D    K+ E  L    +     +     ++F +I  LG G  G V+   +   G  
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 633 VAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQ 691
           +A K++          Q   E Q+L   +   +    G     G + +  E+M  G+L Q
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 692 YL-----FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA 746
            L       E           ++++   +GL YL    K  I+HRDVK +NIL+N + + 
Sbjct: 121 VLKKAGRIPEQILG-------KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEI 171

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           KL DFG S     +    ++ S VGT  Y+ PE       + +SD++S G+ L+E+  G 
Sbjct: 172 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

Query: 807 P 807
            
Sbjct: 228 Y 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (313), Expect = 1e-31
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           R LGKG FG VY          +A+K+L  +    +    Q R E ++   + H N+  L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH- 721
            GY +D   V L+ EY   G + + L     FDE + A           + A  L Y H 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSYCHS 127

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 +IHRD+K  N+LL    + K+ADFG+S      + S   T + GT+ YL PE  
Sbjct: 128 KR----VIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI 179

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                 EK D++S G++  E + G P
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  126 bits (318), Expect = 3e-31
 Identities = 30/237 (12%), Positives = 67/237 (28%), Gaps = 46/237 (19%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMR--------- 658
            +LG+              G    + +   +        KQ + E   L           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 659 -------------VHHRNLASLVGYCNDGGNVGLVYEYMAY-------GNLKQYLFD--E 696
                        V       ++    D  ++ ++  +  Y           + L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           T ++L    RLQ+ +   + L  LH +G    ++H  ++  +I+L+++    L  F    
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 756 IFPAESESHISTSIVGTVGYLDPE-----YYASNRLTEKSDVYSFGIVLLELITGLP 807
              A + S                      +    +T   D ++ G+ +  +     
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (311), Expect = 4e-31
 Identities = 59/249 (23%), Positives = 92/249 (36%), Gaps = 53/249 (21%)

Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
              +LG+G FG V       D    AIK +  +  +      +E  LL  ++H+ +    
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVRYY 68

Query: 669 GYCNDGGNVG-------------LVYEYMAYGNLKQYLFDE---TKEALSWKDRLQIAVD 712
               +  N               +  EY   G L   +  E    +    W+   QI   
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126

Query: 713 AAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS----- 766
             + L Y+H  G    IIHRD+K  NI ++E    K+ DFG +K      +         
Sbjct: 127 --EALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 767 -------TSIVGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGY 813
                  TS +GT  Y+  E      +Y      EK D+YS GI+  E+I        G 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYPFST---GM 232

Query: 814 NNTHIVNRV 822
              +I+ ++
Sbjct: 233 ERVNILKKL 241

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (316), Expect = 4e-31
 Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 25/217 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLAS 666
               ILG+G    V+ G     G   AIK+ +  S   P      E ++L +++H+N+  
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 667 L--VGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLH-H 722
           L  +       +  L+ E+   G+L   L +      L   + L +  D   G+ +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 723 GCKPPIIHRDVKTANILL----NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           G    I+HR++K  NI+     + +   KL DFG ++      +     S+ GT  YL P
Sbjct: 132 G----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHP 184

Query: 779 EYYASNRL--------TEKSDVYSFGIVLLELITGLP 807
           + Y    L            D++S G+      TG  
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  124 bits (312), Expect = 6e-31
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 32/221 (14%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLS-----------------ASSSQGPKQFRTEAQ 654
           R L +G F  +      D    A+K                     S       F+ E Q
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDA- 713
           ++  + +    +  G   +   V ++YEYM   ++ ++         ++   + I V   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 714 -----AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS 768
                     Y+H+  +  I HRDVK +NIL+++  + KL+DFG S+      +  I  S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKGS 210

Query: 769 IVGTVGYLDPEYYASNRLT--EKSDVYSFGIVLLELITGLP 807
             GT  ++ PE++++       K D++S GI L  +   + 
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 8e-31
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASL 667
            +LGKG F  VY    +  G EVAIKM+   +        + + E ++  ++ H ++  L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK---EALSWKDRLQIAVDAAQGLEYLH-HG 723
             Y  D   V LV E    G + +YL +  K   E  +     QI      G+ YLH HG
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG 132

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               I+HRD+  +N+LL   M  K+ADFG +       E H   ++ GT  Y+ PE    
Sbjct: 133 ----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPEIATR 186

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           +    +SDV+S G +   L+ G P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRP 210

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (321), Expect = 1e-30
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASL 667
               LG GGFG V        G +VAIK      S   ++ +  E Q++ +++H N+ S 
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 668 V------GYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYL 720
                            L  EY   G+L++YL   E    L       +  D +  L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 721 H-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           H +     IIHRD+K  NI+L    +++  K+ D G++K      +  + T  VGT+ YL
Sbjct: 138 HENR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYL 190

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE     + T   D +SFG +  E ITG  
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  122 bits (308), Expect = 1e-30
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 22/234 (9%)

Query: 586 KKEGSLKSDNQQ---FTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA- 640
           +  G LK   +Q   FT  ++ D+       +G+G +G+V        G  +A+K + + 
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 641 SSSQGPKQFRTEAQLLMR-VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQY--LFDET 697
              +  KQ   +  ++MR      +    G     G+  +  E M+    K Y  ++   
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118

Query: 698 KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF 757
            + +  +   +I +   + L +L    K  IIHRD+K +NILL+     KL DFG S   
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176

Query: 758 PAESESHISTSIVGTVGYLDPEYYASNRL----TEKSDVYSFGIVLLELITGLP 807
               +S   T   G   Y+ PE    +        +SDV+S GI L EL TG  
Sbjct: 177 ---VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  125 bits (316), Expect = 2e-30
 Identities = 66/234 (28%), Positives = 99/234 (42%), Gaps = 23/234 (9%)

Query: 585 SKKEGSLKSDNQQFTYSEIVDITN--NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSAS 641
              +G L++    F  S+   ++      + LG G +G V          E AIK++  +
Sbjct: 14  LYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT 73

Query: 642 --SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--T 697
             S+    +   E  +L  + H N+  L  +  D  N  LV E    G     LFDE   
Sbjct: 74  SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIH 129

Query: 698 KEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQA---KLADFGF 753
           +   +  D   I      G+ YLH H     I+HRD+K  N+LL  K +    K+ DFG 
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGL 185

Query: 754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           S +F            +GT  Y+ PE     +  EK DV+S G++L  L+ G P
Sbjct: 186 SAVF---ENQKKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (304), Expect = 3e-30
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
            F  +LG G F  V+       G   A+K +  S +        E  +L ++ H N+ +L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HGC 724
                   +  LV + ++ G     LFD    +   + KD   +       ++YLH +G 
Sbjct: 72  EDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENG- 126

Query: 725 KPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              I+HRD+K  N+L     E  +  + DFG SK+     ++ I ++  GT GY+ PE  
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVL 179

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
           A    ++  D +S G++   L+ G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYP 205

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (303), Expect = 3e-30
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 614 LGKGGFGTVYHG-YLADGSEVAIKMLSA-SSSQGPKQFRTEAQLLMR-VHHRNLASLVGY 670
           LG+G +G V    ++  G  +A+K + A  +SQ  K+   +  + MR V      +  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL------QIAVDAAQGLEYLHHGC 724
               G+V +  E M     K Y     K+ +     +      +IAV   + LE+LH   
Sbjct: 75  LFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE----Y 780
              +IHRDVK +N+L+N   Q K+ DFG S       +        G   Y+ PE     
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPE 184

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
                 + KSD++S GI ++EL     
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRF 211

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (301), Expect = 6e-30
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 25/203 (12%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCN 672
           +G+G  GTVY    +A G EVAI+ ++       +    E  ++    + N+ + +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 673 DGGNVGLVYEYMAYGNL----KQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCK 725
            G  + +V EY+A G+L     +   DE           QIA    +  Q LE+LH    
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLH---S 134

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEYYASN 784
             +IHRD+K+ NILL      KL DFGF  +I P +S+    +++VGT  ++ PE     
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 191

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
               K D++S GI+ +E+I G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEP 214

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  123 bits (311), Expect = 6e-30
 Identities = 67/230 (29%), Positives = 99/230 (43%), Gaps = 24/230 (10%)

Query: 590 SLKSDNQQFTYSEIVDITN--NFHRILGKGGFGTVYHGY-LADGSEVAIKMLS---ASSS 643
            L +    F        ++     R+LGKG FG V        G E A+K++S       
Sbjct: 8   HLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK 67

Query: 644 QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEAL 701
              +    E QLL ++ H N+  L  +  D G   LV E    G     LFD   +++  
Sbjct: 68  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRF 123

Query: 702 SWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQA---KLADFGFSKIF 757
           S  D  +I      G+ Y+H +     I+HRD+K  N+LL  K +    ++ DFG S  F
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

Query: 758 PAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
                S      +GT  Y+ PE        EK DV+S G++L  L++G P
Sbjct: 180 ---EASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (300), Expect = 6e-30
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
           R LGKG FG VY      +   +A+K+L  S         Q R E ++   + H N+  +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK--EALSWKDRLQIAVDAAQGLEYLH-HGC 724
             Y +D   + L+ E+   G L + L    +  E  S     ++A      L Y H    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHYCHERK- 134

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              +IHRD+K  N+L+  K + K+ADFG+S      + S    ++ GT+ YL PE     
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYLPPEMIEGK 187

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
              EK D++  G++  E + G+P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMP 210

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  121 bits (305), Expect = 8e-30
 Identities = 33/243 (13%), Positives = 69/243 (28%), Gaps = 57/243 (23%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS---SSQGPKQFRTEAQ------------- 654
            +LG+              G    + +   +    S   KQ + E               
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 655 ------------LLMRVHHRNLASLVGYCNDGGNVGLVYEYMA----YGNLKQYLFD--E 696
                       L+     + +  +     D   +   + Y           + L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           T ++L    RLQ+ +   + L  LH +G    ++H  ++  +I+L+++    L  F    
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASN-----------RLTEKSDVYSFGIVLLELIT 804
                           + G+  PE  A              +T   D ++ G+V+  +  
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 805 GLP 807
              
Sbjct: 309 ADL 311

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (300), Expect = 9e-30
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 26/204 (12%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYC 671
           +GKG FG V+ G        VAIK++    ++   +  + E  +L +     +    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 672 NDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGC 724
                + ++ EY+  G+    L+    DET          QIA    +  +GL+YLH   
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDET----------QIATILREILKGLDYLHSEK 139

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEYYAS 783
           K   IHRD+K AN+LL+E  + KLADFG + ++   + +     + VGT  ++ PE    
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMAPEVIKQ 193

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           +    K+D++S GI  +EL  G P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEP 217

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (300), Expect = 1e-29
 Identities = 58/250 (23%), Positives = 107/250 (42%), Gaps = 31/250 (12%)

Query: 573 KRAARLNVDNSHSKKEGSLKSDNQ-QFTYSEIVDITN---NFHRI--LGKGGFGTVYHGY 626
             ++ +++   +   +  + +  Q +     +VD  +          +G+G  G V    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 627 -LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA 685
               G +VA+KM+     Q  +    E  ++    H N+  +      G  + ++ E++ 
Sbjct: 66  EKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125

Query: 686 YGNL----KQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPIIHRDVKTANI 738
            G L     Q   +E           QIA       Q L YLH      +IHRD+K+ +I
Sbjct: 126 GGALTDIVSQVRLNEE----------QIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172

Query: 739 LLNEKMQAKLADFGFS-KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGI 797
           LL    + KL+DFGF  +I     +     S+VGT  ++ PE  + +    + D++S GI
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

Query: 798 VLLELITGLP 807
           +++E++ G P
Sbjct: 230 MVIEMVDGEP 239

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  119 bits (301), Expect = 2e-29
 Identities = 60/277 (21%), Positives = 99/277 (35%), Gaps = 57/277 (20%)

Query: 584 HSKKEGSLKSDNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKM--- 637
           H     S   +N  F    ++++   +H    +G+G +G V         +  AIK+   
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61

Query: 638 --LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD 695
             +   + +  ++ +TE +L+ ++HH N+A L     D   + LV E    G+L   L  
Sbjct: 62  NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121

Query: 696 ETKEALSWKDRLQIAV-------------------------------DAA-------QGL 717
              ++        +                                   +         L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPA--ESESHISTSIVGT 772
            YLH  G    I HRD+K  N L +       KL DFG SK F      E +  T+  GT
Sbjct: 182 HYLHNQG----ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 773 VGYLDPE--YYASNRLTEKSDVYSFGIVLLELITGLP 807
             ++ PE     +     K D +S G++L  L+ G  
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (297), Expect = 2e-29
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASL 667
           R LGKGGF   +           A K++  S    P    +   E  +   + H+++   
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDR---LQIAVDAAQGLEY 719
            G+  D   V +V E     +L +         E  EA     R    QI      G +Y
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEA-----RYYLRQIV----LGCQY 130

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           LH +     +IHRD+K  N+ LNE ++ K+ DFG +     + E      + GT  Y+ P
Sbjct: 131 LHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAP 184

Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  +    + + DV+S G ++  L+ G P
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (307), Expect = 2e-29
 Identities = 64/256 (25%), Positives = 96/256 (37%), Gaps = 44/256 (17%)

Query: 579 NVDNSHSKKEGSLKSDNQQFTYSEIVDITNN--FHRILGKGGFGTVYHGY-LADGSEVAI 635
           +     +     +  +   +   +   I  +    R LG G +G V         SE AI
Sbjct: 7   HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66

Query: 636 KMLS-------------ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE 682
           K++               +  +  ++   E  LL  + H N+  L     D     LV E
Sbjct: 67  KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126

Query: 683 YMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANIL 739
           +   G     LF+    +      D   I      G+ YLH H     I+HRD+K  NIL
Sbjct: 127 FYEGGE----LFEQIINRHKFDECDAANIMKQILSGICYLHKHN----IVHRDIKPENIL 178

Query: 740 LNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPE-----YYASNRLTEKSD 791
           L  K      K+ DFG S  F   S+ +     +GT  Y+ PE     Y       EK D
Sbjct: 179 LENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYIAPEVLKKKY------NEKCD 229

Query: 792 VYSFGIVLLELITGLP 807
           V+S G+++  L+ G P
Sbjct: 230 VWSCGVIMYILLCGYP 245

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (298), Expect = 3e-29
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHRNLASL 667
           R LGKGGF   +           A K++  S    P    +   E  +   + H+++   
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDR---LQIAVDAAQGLEY 719
            G+  D   V +V E     +L +         E  EA     R    QI      G +Y
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEA-----RYYLRQIV----LGCQY 156

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           LH +     +IHRD+K  N+ LNE ++ K+ DFG +     + E      + GT  Y+ P
Sbjct: 157 LHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAP 210

Query: 779 EYYASNRLTEKSDVYSFGIVLLELITGLP 807
           E  +    + + DV+S G ++  L+ G P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (296), Expect = 4e-29
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 22/235 (9%)

Query: 583 SHSKKEGSLKSDNQQFTYSEIV---DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK 636
           S    +       Q     E          F  +  LG+G +G+VY       G  VAIK
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 637 MLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
            +        ++   E  ++ +    ++    G      ++ +V EY   G++   +   
Sbjct: 61  QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRL 117

Query: 697 TKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF 753
             + L      +IA       +GLEYLH       IHRD+K  NILLN +  AKLADFG 
Sbjct: 118 RNKTL---TEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 754 S-KIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + ++    ++     +++GT  ++ PE          +D++S GI  +E+  G P
Sbjct: 172 AGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 7e-29
 Identities = 51/226 (22%), Positives = 82/226 (36%), Gaps = 37/226 (16%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASL 667
              +ILG G  GTV       G  VA+K +             E +LL     H N+   
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVIRY 74

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQGLEYLH- 721
                    + +  E     NL+  +      DE  +     + + +    A G+ +LH 
Sbjct: 75  YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 722 HGCKPPIIHRDVKTANILLNEK-------------MQAKLADFGFSKIFPAESESHIST- 767
                 IIHRD+K  NIL++               ++  ++DFG  K   +   S  +  
Sbjct: 134 LK----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 768 -SIVGTVGYLDPE-------YYASNRLTEKSDVYSFGIVLLELITG 805
            +  GT G+  PE            RLT   D++S G V   +++ 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  116 bits (294), Expect = 8e-29
 Identities = 71/211 (33%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 609 NFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQF---RTEAQLLMRVHHRNL 664
            F +ILG+G F TV     LA   E AIK+L         +      E  ++ R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIA--VDAAQGL 717
             L     D   +     Y   G L +Y+     FDET        R   A  V A   L
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT------RFYTAEIVSA---L 143

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           EYLH  G    IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + S VGT  Y+
Sbjct: 144 EYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE        + SD+++ G ++ +L+ GLP
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (294), Expect = 1e-28
 Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 23/242 (9%)

Query: 610 FHRILGKGGFGTVYHGY------LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRN 663
            H +LG+G F  VY           +  +  +K+   ++           + L       
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL---FDETKEALSWKDRLQIAVDAAQGLEYL 720
                          LV E  +YG L   +    +  ++ +     +  A+     +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQA-----------KLADFGFSKIFPAESESHISTSI 769
           H      IIH D+K  N +L                  L D G S       +  I T+ 
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 770 VGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG 829
             T G+   E  ++     + D +     +  ++ G    ++          +   L   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHL 305

Query: 830 DV 831
           D+
Sbjct: 306 DM 307

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (291), Expect = 1e-28
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 24/231 (10%)

Query: 590 SLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP 646
           S++   +       +D    +  +  LG G FG VY       G+  A K++   S +  
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60

Query: 647 KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR 706
           + +  E ++L    H  +  L+G     G + ++ E+   G +   +  E    L     
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL---TE 116

Query: 707 LQIAV---DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES 763
            QI V      + L +LH       IHRD+K  N+L+  +   +LADFG S    A++  
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVS----AKNLK 169

Query: 764 HIS--TSIVGTVGYLDPEYYASNRLTE-----KSDVYSFGIVLLELITGLP 807
            +    S +GT  ++ PE      + +     K+D++S GI L+E+    P
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  115 bits (290), Expect = 2e-28
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLA 665
           +    LGKG F  V        G E A K++     S++  ++   EA++  ++ H N+ 
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-H 722
            L     +     LV++ +  G     LF++   +E  S  D         + + Y H +
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 723 GCKPPIIHRDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           G    I+HR++K  N+LL  K +    KLADFG +      ++S       GT GYL PE
Sbjct: 125 G----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 177

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
               +  ++  D+++ G++L  L+ G P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYP 205

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (290), Expect = 2e-28
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYC 671
           +G G    V   Y      +VAIK ++    Q        E Q + + HH N+ S     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 672 NDGGNVGLVYEYMAYG---NLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLH-HGC 724
                + LV + ++ G   ++ +++  + +      D   IA    +  +GLEYLH +G 
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG- 141

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFS-KIFPAESESHIS--TSIVGTVGYLDPE-- 779
               IHRDVK  NILL E    ++ADFG S  +      +      + VGT  ++ PE  
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 780 ----YYASNRLTEKSDVYSFGIVLLELITGLP 807
                Y       K+D++SFGI  +EL TG  
Sbjct: 199 EQVRGY-----DFKADIWSFGITAIELATGAA 225

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  117 bits (294), Expect = 2e-28
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 22/237 (9%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNN--FHRILGKGGFGTVYHGY-LADGSEVAIKML 638
           +  S   G       +F  +     ++N      LGKG F  V        G E A K++
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 639 SASSSQGP--KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
           +         ++   EA++  ++ H N+  L     +     LV++ +  G     LF++
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFED 118

Query: 697 --TKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQA---KLAD 750
              +E  S  D         + + Y H +G    I+HR++K  N+LL  K +    KLAD
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           FG +       +S       GT GYL PE    +  ++  D+++ G++L  L+ G P
Sbjct: 175 FGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (299), Expect = 2e-28
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 38/241 (15%)

Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNN--FHRILGKGGFGTVYHGY-LADGSEVAIKMLS 639
            H        S  +   +              +LGKG FG V          E A+K+++
Sbjct: 2   HHHHHH---SSGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56

Query: 640 AS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD-- 695
            +   ++       E +LL ++ H N+  L     D  +  +V E    G     LFD  
Sbjct: 57  KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEI 112

Query: 696 ETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADF 751
             ++  S  D  +I      G+ Y+H H     I+HRD+K  NILL    +    K+ DF
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDF 168

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPE-----YYASNRLTEKSDVYSFGIVLLELITGL 806
           G S  F    ++      +GT  Y+ PE     Y       EK DV+S G++L  L++G 
Sbjct: 169 GLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGT 219

Query: 807 P 807
           P
Sbjct: 220 P 220

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (294), Expect = 2e-28
 Identities = 52/282 (18%), Positives = 91/282 (32%), Gaps = 42/282 (14%)

Query: 614 LGKG--GFGTVYHGY-LADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           +GKG     TV        G  V ++   L A S++     + E  +    +H N+    
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 669 GYCNDGGNVGLVYEYMAYGN----LKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLH 721
                   + +V  +MAYG+    +  +  D   E         IA       + L+Y+H
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL-------AIAYILQGVLKALDYIH 145

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE-----SESHISTSIVGTVGY 775
             G     +HR VK ++IL++   +  L+    +    +               V  + +
Sbjct: 146 HMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 776 LDPEYYASNRL--TEKSDVYSFGIVLLELITGLPAIIRGYNNTH-------IVNRVCPFL 826
           L PE    N      KSD+YS GI   EL  G       + +          +N   P L
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP----FKDMPATQMLLEKLNGTVPCL 257

Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPT 868
                    +  +  +    +               +   P+
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  114 bits (287), Expect = 3e-28
 Identities = 48/211 (22%), Positives = 79/211 (37%), Gaps = 29/211 (13%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
                +G+G +G V            A K +     +   +F+ E +++  + H N+  L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HGC 724
                D  ++ LV E    G     LF+    K      D  +I  D    + Y H    
Sbjct: 72  YETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN- 126

Query: 725 KPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-- 779
              + HRD+K  N L    +     KL DFG +  F       +  + VGT  Y+ P+  
Sbjct: 127 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQVL 180

Query: 780 ---YYASNRLTEKSDVYSFGIVLLELITGLP 807
              Y        + D +S G+++  L+ G P
Sbjct: 181 EGLY------GPECDEWSAGVMMYVLLCGYP 205

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  114 bits (287), Expect = 4e-28
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 35/232 (15%)

Query: 592 KSDNQQFTYSEIVDITNN--FHRILGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGP 646
            S  +   +              +LGKG FG V          E A+K+++ +   ++  
Sbjct: 8   SSGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 647 KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWK 704
                E +LL ++ H N+  L     D  +  +V E    G     LFDE   ++  S  
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEH 121

Query: 705 DRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAE 760
           D  +I      G+ Y+H H     I+HRD+K  NILL    +    K+ DFG S  F   
Sbjct: 122 DAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--- 174

Query: 761 SESHISTSIVGTVGYLDPE-----YYASNRLTEKSDVYSFGIVLLELITGLP 807
            ++      +GT  Y+ PE     Y       EK DV+S G++L  L++G P
Sbjct: 175 QQNTKMKDRIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTP 220

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (285), Expect = 6e-28
 Identities = 61/270 (22%), Positives = 102/270 (37%), Gaps = 41/270 (15%)

Query: 593 SDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FR 650
           S  +   +   +D    F R LG G FG V+     + G E  IK ++   SQ P +   
Sbjct: 9   SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68

Query: 651 TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL--- 707
            E ++L  + H N+  +     D  N+ +V E    G     L +    A +    L   
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEG 124

Query: 708 ---QIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAE 760
              ++       L Y H       ++H+D+K  NIL    +     K+ DFG +++F   
Sbjct: 125 YVAELMKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--- 177

Query: 761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVN 820
                ST+  GT  Y+ PE +  + +T K D++S G+V+  L+TG               
Sbjct: 178 KSDEHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCL------------- 223

Query: 821 RVCPFLERGDVRSIVDPRLEANFDTNSVWK 850
              PF        +         +     +
Sbjct: 224 ---PFTGTSL-EEVQQKATYKEPNYAVECR 249

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (289), Expect = 1e-27
 Identities = 50/253 (19%), Positives = 93/253 (36%), Gaps = 31/253 (12%)

Query: 572 RKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITN-------NFHRILGKGGFGTVYH 624
                R   D            D  +    + V++         +    LG G FG V+ 
Sbjct: 10  HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR 69

Query: 625 GY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY 683
               A G     K ++          + E  ++ ++HH  L +L     D   + L+ E+
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129

Query: 684 MAYGNL------KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTA 736
           ++ G L      + Y   E +     +   Q      +GL+++H H     I+H D+K  
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVINYMR---QA----CEGLKHMHEHS----IVHLDIKPE 178

Query: 737 NILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYS 794
           NI+   K  +  K+ DFG +      +   I      T  +  PE      +   +D+++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 235

Query: 795 FGIVLLELITGLP 807
            G++   L++GL 
Sbjct: 236 IGVLGYVLLSGLS 248

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  114 bits (288), Expect = 1e-27
 Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 32/258 (12%)

Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNN--FHRILGKGGFGTVYHG-YL 627
           + K+        + +    S+  +++   ++   +         ++G+G    V    + 
Sbjct: 57  EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116

Query: 628 ADGSEVAIKMLSASSSQGPKQ--------FRTEAQLLMRVH-HRNLASLVGYCNDGGNVG 678
           A G E A+K++  ++ +   +         R E  +L +V  H ++ +L+        + 
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 679 LVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKT 735
           LV++ M  G L    FD    K ALS K+   I     + + +LH +     I+HRD+K 
Sbjct: 177 LVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN----IVHRDLKP 228

Query: 736 ANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE------YYASNRLTEK 789
            NILL++ MQ +L+DFGFS              + GT GYL PE              ++
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285

Query: 790 SDVYSFGIVLLELITGLP 807
            D+++ G++L  L+ G P
Sbjct: 286 VDLWACGVILFTLLAGSP 303

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (284), Expect = 1e-27
 Identities = 57/218 (26%), Positives = 85/218 (38%), Gaps = 31/218 (14%)

Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQ---------FRTEAQLLMRV 659
              ILG+G    V    +     E A+K++  +                   E  +L +V
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 660 -HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQG 716
             H N+  L           LV++ M  G L    FD    K  LS K+  +I     + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEV 136

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           +  LH       I+HRD+K  NILL++ M  KL DFGFS              + GT  Y
Sbjct: 137 ICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 189

Query: 776 LDPE------YYASNRLTEKSDVYSFGIVLLELITGLP 807
           L PE              ++ D++S G+++  L+ G P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  114 bits (287), Expect = 1e-27
 Identities = 47/214 (21%), Positives = 81/214 (37%), Gaps = 26/214 (12%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKM-----LSASSSQGPKQFRTEAQLLMRVHHRN 663
              ++GKG F  V        G + A+K+      ++S     +  + EA +   + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE------TKEALSWKDRLQIAVDAAQGL 717
           +  L+   +  G + +V+E+M   +    L  E           S            + L
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 718 EYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
            Y H +     IIHRDVK   +LL         KL  FG +          ++   VGT 
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTP 197

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            ++ PE        +  DV+  G++L  L++G  
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (281), Expect = 2e-27
 Identities = 40/233 (17%), Positives = 77/233 (33%), Gaps = 39/233 (16%)

Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV 659
             T  FH +  +G G FG+V+      DG   AIK      + S   +    E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 660 -HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FDETKEALSWKDRLQIAVDAAQG 716
             H ++        +  ++ +  EY   G+L   +             +   + +   +G
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNE-------------------KMQAKLADFGFSKI 756
           L Y+H       ++H D+K +NI ++                    K+  K+ D G    
Sbjct: 128 LRYIHSMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 757 FPAESESHISTSIVGTVGYLDPEYYASNRL-TEKSDVYSFGIVLLELITGLPA 808
             +           G   +L  E    N     K+D+++  + ++      P 
Sbjct: 184 ISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  112 bits (283), Expect = 3e-27
 Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 18/235 (7%)

Query: 584 HSKKEGSLKSDNQQFTYSEIVDITNNF---HRILGKGGFGTVYHGY-LADGSEVAIKML- 638
           H      +    +   +  + +  N +    + LG+G F  V      + G E A K L 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63

Query: 639 -SASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
                     +   E  +L        + +L     +   + L+ EY A G +      E
Sbjct: 64  KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123

Query: 697 TKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFG 752
             E +S  D +++     +G+ YLH +     I+H D+K  NILL         K+ DFG
Sbjct: 124 LAEMVSENDVIRLIKQILEGVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFG 179

Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            S+       +     I+GT  YL PE    + +T  +D+++ GI+   L+T   
Sbjct: 180 MSRKI---GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (279), Expect = 7e-27
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHH 661
           +    LG G F  V      + G E A K +    S+  ++         E  +L +V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEY 719
            N+ +L     +  +V L+ E ++ G     LFD    KE+LS ++          G+ Y
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 720 LH-HGCKPPIIHRDVKTANILLNEK----MQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           LH       I H D+K  NI+L +K       KL DFG +       +     +I GT  
Sbjct: 131 LHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           ++ PE      L  ++D++S G++   L++G  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (286), Expect = 8e-27
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 19/207 (9%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ--FRTEAQLLMRVHHRNLAS 666
               LGKG F  V     +  G E A  +++              EA++   + H N+  
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HG 723
           L    ++ G+  L+++ +  G     LF++   +E  S  D         + + + H  G
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 724 CKPPIIHRDVKTANILLNEKMQA---KLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
               ++HR++K  N+LL  K++    KLADFG +     E E        GT GYL PE 
Sbjct: 131 ----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLSPEV 184

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLP 807
              +   +  D+++ G++L  L+ G P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYP 211

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  111 bits (280), Expect = 3e-26
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRV 659
              + LG G  G V   +      +VAI+++S        A  +       TE ++L ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGL 717
           +H  +  +  + +   +  +V E M  G L    FD+    + L               +
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAESESHISTSIVGTV 773
           +YLH +G    IIHRD+K  N+LL+ +      K+ DFG SKI     E+ +  ++ GT 
Sbjct: 253 QYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 305

Query: 774 GYLDPE---YYASNRLTEKSDVYSFGIVLLELITGLP 807
            YL PE      +       D +S G++L   ++G P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (273), Expect = 3e-26
 Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 25/213 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHH 661
                LG G F  V        G E A K +        ++         E  +L  + H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEY 719
            N+ +L     +  +V L+ E ++ G     LFD    KE+L+  +  Q       G+ Y
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQA----KLADFGFSKIFPAESESHISTSIVGTVG 774
           LH       I H D+K  NI+L +K       KL DFG +         +   +I GT  
Sbjct: 124 LHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFGTPE 176

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           ++ PE      L  ++D++S G++   L++G  
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  110 bits (276), Expect = 3e-26
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMR-VHHRNLAS 666
                +G G +         A   E A+K++  S          E ++L+R   H N+ +
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HG 723
           L    +DG  V +V E M  G L     D+   ++  S ++   +     + +EYLH  G
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136

Query: 724 CKPPIIHRDVKTANILLNEKMQA----KLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
               ++HRD+K +NIL  ++       ++ DFGF+K     +E+ +  +   T  ++ PE
Sbjct: 137 ----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPCYTANFVAPE 190

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                      D++S G++L  ++TG  
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYT 218

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (276), Expect = 3e-26
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHH 661
           +    LG G F  V      + G E A K +    S+  ++         E  +L +V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEY 719
            N+ +L     +  +V L+ E ++ G     LFD    KE+LS ++          G+ Y
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 720 LH-HGCKPPIIHRDVKTANILLNEK----MQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           LH       I H D+K  NI+L +K       KL DFG +       +     +I GT  
Sbjct: 131 LHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPE 183

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           ++ PE      L  ++D++S G++   L++G  
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 4e-26
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG-- 669
           +G G +G VY G  +  G   AIK++  +     ++ + E  +L +  HHRN+A+  G  
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90

Query: 670 ----YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHH 722
                      + LV E+   G++   + +     L       IA    +  +GL +LH 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGLSHLHQ 147

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEY 780
                 IHRD+K  N+LL E  + KL DFG S    A+ +  +    + +GT  ++ PE 
Sbjct: 148 HKV---IHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTPYWMAPEV 200

Query: 781 YASNRLTE-----KSDVYSFGIVLLELITGLP 807
            A +   +     KSD++S GI  +E+  G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  109 bits (275), Expect = 4e-26
 Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 20/205 (9%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
               LG+G    VY           A+K+L  +  +  K  RTE  +L+R+ H N+  L 
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLK 114

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HGCK 725
                   + LV E +  G     LFD    K   S +D         + + YLH +G  
Sbjct: 115 EIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168

Query: 726 PPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             I+HRD+K  N+L          K+ADFG SKI        +  ++ GT GY  PE   
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILR 223

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
                 + D++S GI+   L+ G  
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFE 248

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (275), Expect = 5e-26
 Identities = 70/251 (27%), Positives = 100/251 (39%), Gaps = 30/251 (11%)

Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRI--LGKGGFGTVYHGY-L 627
                 +  +D   +        D          D    F  +  +G G FG VY    +
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76

Query: 628 ADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM 684
            +   VAIK +S     S++  +    E + L ++ H N     G         LV EY 
Sbjct: 77  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136

Query: 685 AYGNLKQYLFDETKEALSWKDRLQIAV---DAAQGLEYLHHGCKPPIIHRDVKTANILLN 741
             G+    L +  K+ L     ++IA     A QGL YLH      +IHRDVK  NILL+
Sbjct: 137 L-GSASD-LLEVHKKPL---QEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 188

Query: 742 EKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDPEYYASNRLTE---KSDVYSFG 796
           E    KL DFG +        S ++   S VGT  ++ PE   +    +   K DV+S G
Sbjct: 189 EPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240

Query: 797 IVLLELITGLP 807
           I  +EL    P
Sbjct: 241 ITCIELAERKP 251

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 7e-26
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMRVHH 661
           +    LG G F  V      + G + A K +    ++  ++         E  +L  + H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEY 719
            N+ +L     +  +V L+ E +A G     LFD    KE+L+ ++  +       G+ Y
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQA----KLADFGFSKIFPAESESHISTSIVGTVG 774
           LH       I H D+K  NI+L ++       K+ DFG +         +   +I GT  
Sbjct: 130 LHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPE 182

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           ++ PE      L  ++D++S G++   L++G  
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (279), Expect = 1e-25
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 13/241 (5%)

Query: 571 KRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LAD 629
           + K     N DN              +  +  ++D   + H  LG G FG V+     A 
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRVTERAT 181

Query: 630 GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
           G+  A K +        +  R E Q +  + H  L +L     D   + ++YE+M+ G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241

Query: 690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQA-- 746
            + + DE    +S  + ++      +GL ++H +      +H D+K  NI+   K     
Sbjct: 242 FEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN----YVHLDLKPENIMFTTKRSNEL 296

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           KL DFG +                GT  +  PE      +   +D++S G++   L++GL
Sbjct: 297 KLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353

Query: 807 P 807
            
Sbjct: 354 S 354

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (267), Expect = 2e-25
 Identities = 21/201 (10%), Positives = 50/201 (24%), Gaps = 46/201 (22%)

Query: 614 LGKGGFGTVYHGYLAD---GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
            G       +     D     +VA+  +               +    L R+    +A +
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
           +   +      +V E++  G+L++        + S    ++     A   +  H  G   
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHRAG--- 149

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
            +       + + ++      LA                          +          
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179

Query: 787 TEKSDVYSFGIVLLELITGLP 807
             + D+   G  L  L+    
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  108 bits (272), Expect = 2e-25
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 611 HRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             ILG G FG V+     A G ++A K++     +  ++ + E  ++ ++ H NL  L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFD---ETKEALSWKDRLQIAVDAAQGLEYLH-HGCK 725
                 ++ LV EY+  G     LFD   +    L+  D +       +G+ ++H     
Sbjct: 154 AFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY-- 207

Query: 726 PPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
             I+H D+K  NIL   +     K+ DFG ++ +             GT  +L PE    
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNY 262

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           + ++  +D++S G++   L++GL 
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLS 286

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (267), Expect = 3e-25
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 30/217 (13%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLS--------ASSSQGPKQFRTEAQLLMRV 659
              + LG G  G V   +      +VAIK++S        A  +       TE ++L ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGL 717
           +H  +  +  + +   +  +V E M  G L    FD+    + L               +
Sbjct: 73  NHPCIIKIKNFFDAE-DYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 718 EYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           +YLH +G    IIHRD+K  N+LL    E    K+ DFG SKI     E+ +  ++ GT 
Sbjct: 128 QYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180

Query: 774 GYLDPE---YYASNRLTEKSDVYSFGIVLLELITGLP 807
            YL PE      +       D +S G++L   ++G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  106 bits (267), Expect = 3e-25
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG 669
           + LG+G F               A+K++S          + E   L     H N+  L  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHE 73

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKDRLQIAVDAAQGLEYLH-HGCKP 726
             +D  +  LV E +  G L    F+    K+  S  +   I       + ++H  G   
Sbjct: 74  VFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--- 126

Query: 727 PIIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
            ++HRD+K  N+L    N+ ++ K+ DFGF+++ P +++     +   T+ Y  PE    
Sbjct: 127 -VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQ 183

Query: 784 NRLTEKSDVYSFGIVLLELITGLP 807
           N   E  D++S G++L  +++G  
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQV 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (266), Expect = 4e-25
 Identities = 36/206 (17%), Positives = 83/206 (40%), Gaps = 19/206 (9%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
                LG+G FG V+     +       K +           + E  +L    HRN+  L
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHL 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFD---ETKEALSWKDRLQIAVDAAQGLEYLH-HG 723
                    + +++E+++  +    +F+    +   L+ ++ +       + L++LH H 
Sbjct: 67  HESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 724 CKPPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
               I H D++  NI+   +  +  K+ +FG ++             +     Y  PE +
Sbjct: 123 ----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
             + ++  +D++S G ++  L++G+ 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  103 bits (258), Expect = 4e-24
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 26/213 (12%)

Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGY 670
           +LG+G    V     L    E A+K++         +   E ++L +   HRN+  L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPP 727
             +     LV+E M  G++          +   +  +   +  D A  L++LH  G    
Sbjct: 80  FEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNKG---- 131

Query: 728 IIHRDVKTANILL---NEKMQAKLADFGFSKIFPAESESHISTS-----IVGTVGYLDPE 779
           I HRD+K  NIL    N+    K+ DF          +    ++       G+  Y+ PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 780 -----YYASNRLTEKSDVYSFGIVLLELITGLP 807
                   ++   ++ D++S G++L  L++G P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  106 bits (267), Expect = 5e-24
 Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 17/251 (6%)

Query: 566 VFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNN---FHRILGKGGFGTV 622
           +F    R     L+V       +    +   Q+ + E   +T N    +R+LGKGGFG V
Sbjct: 141 LFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200

Query: 623 YHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYC-NDGGNV 677
               +    ++ A K L        +G      E Q+L +V+ R + SL  Y       +
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDAL 259

Query: 678 GLVYEYMAYGNLKQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKPPIIHRDVKTA 736
            LV   M  G+LK +++   +     + R    A +   GLE LH   +  I++RD+K  
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLH---RERIVYRDLKPE 315

Query: 737 NILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFG 796
           NILL++    +++D G +   P   E       VGTVGY+ PE   + R T   D ++ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372

Query: 797 IVLLELITGLP 807
            +L E+I G  
Sbjct: 373 CLLYEMIAGQS 383

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (253), Expect = 2e-23
 Identities = 38/186 (20%), Positives = 69/186 (37%), Gaps = 24/186 (12%)

Query: 639 SASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL----- 693
             SS         + + +     +N    +   +    + +  +     NLK ++     
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 694 FDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFG 752
            ++ +  +     +QIA    + +E+LH  G    ++HRD+K +NI        K+ DFG
Sbjct: 158 LEDREHGVCLHIFIQIA----EAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 753 FSKI----------FPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLEL 802
                                   T  VGT  Y+ PE    N  + K D++S G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

Query: 803 ITGLPA 808
           +     
Sbjct: 270 LYSFST 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 15/60 (25%), Positives = 27/60 (45%), Gaps = 4/60 (6%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
            +F  I  +G+GGFG V+      D    AIK +   + +  ++    E + L ++ H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (251), Expect = 3e-23
 Identities = 52/212 (24%), Positives = 84/212 (39%), Gaps = 26/212 (12%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS----ASSSQGPKQFRTEAQLLMRVHHRNLAS 666
            +LG+G +G V            A+K+L          G    + E QLL R+ H+N+  
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 667 L--VGYCNDGGNVGLVYEYMAYGNLKQYLFDET-----KEALSWKDRLQIAVDAAQGLEY 719
           L  V Y  +   + +V EY   G  +  + D           +     Q+      GLEY
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLI----DGLEY 124

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           LH  G    I+H+D+K  N+LL      K++  G ++     +      +  G+  +  P
Sbjct: 125 LHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 779 EYYASNRLTE--KSDVYSFGIVLLELITG-LP 807
           E           K D++S G+ L  + TG  P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.7 bits (249), Expect = 6e-23
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKML------SASSSQGPKQFRTEAQLLMRVHHR-- 662
            +LG GGFG+VY G  ++D   VAIK +               +   E  LL +V     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGLEYL 720
            +  L+ +     +  L+ E        Q LFD    + AL  +          + + + 
Sbjct: 109 GVIRLLDWFERPDSFVLILER---PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165

Query: 721 H-HGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           H  G    ++HRD+K  NIL++  + + KL DFG   +     ++  +    GT  Y  P
Sbjct: 166 HNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDF-DGTRVYSPP 217

Query: 779 EYYASNRLT-EKSDVYSFGIVLLELITG-LP 807
           E+   +R     + V+S GI+L +++ G +P
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 8e-23
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNL 664
              R+LG+GGFG V+   +    ++ A K L+       +G +    E ++L +VH R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 665 ASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ---GLEYL 720
            SL  Y      ++ LV   M  G+++ ++++  ++   +++  +     AQ   GLE+L
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHL 305

Query: 721 H-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
           H       II+RD+K  N+LL++    +++D G +    A      +    GT G++ PE
Sbjct: 306 HQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
                      D ++ G+ L E+I    
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARG 387

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS-------ASSSQGPKQFRTEAQLLMRVH--- 660
            +LGKGGFGTV+ G+ L D  +VAIK++        +  S        E  LL +V    
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGG 95

Query: 661 -HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--ETKEALSWKDRLQIAVDAAQGL 717
            H  +  L+ +        LV E        Q LFD    K  L               +
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           ++ H  G    ++HRD+K  NIL++ +   AKL DFG   +     +   +    GT  Y
Sbjct: 153 QHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDF-DGTRVY 204

Query: 776 LDPEYYASNRLT-EKSDVYSFGIVLLELITG-LP 807
             PE+ + ++     + V+S GI+L +++ G +P
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVG 669
           + LG+G +G V           VA+K++    +   P+  + E  +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ--------GLEYLH 721
           +  +G    L  EY + G L    FD     +     +      AQ        G+ YLH
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDR----IEPDIGMP--EPDAQRFFHQLMAGVVYLH 122

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE- 779
             G    I HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE 
Sbjct: 123 GIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 780 -----YYASNRLTEKSDVYSFGIVLLELITG-LP 807
                ++A        DV+S GIVL  ++ G LP
Sbjct: 179 LKRREFHAE-----PVDVWSCGIVLTAMLAGELP 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 49/236 (20%), Positives = 93/236 (39%), Gaps = 23/236 (9%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSA 640
           + H      +     +     + D      ++LG G  G V   +    G + A+K+L  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64

Query: 641 SSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVG----LVYEYMAYGNLKQYLFD 695
           S      + R E     +     ++  ++    +  +      ++ E M  G L   + +
Sbjct: 65  S-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE 119

Query: 696 ETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADF 751
              +A + ++  +I  D    +++LH H     I HRDVK  N+L     +    KL DF
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDF 175

Query: 752 GFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           GF+K     +      +   T  Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (253), Expect = 4e-22
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 36/256 (14%)

Query: 568 WTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNF--HRILGKGGFGTVYHG 625
               R    +  +++    +    K+       +      N+F  HRI+G+GGFG VY  
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTM-----NDFSVHRIIGRGGFGEVYGC 208

Query: 626 YLADGSEV-AIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASLVG--YCN-DGGNVG 678
             AD  ++ A+K L     +  +       E  +L  V   +   +V   Y       + 
Sbjct: 209 RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268

Query: 679 LVYEYMAYGNLKQYL-----FDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKPPIIHRD 732
            + + M  G+L  +L     F E          ++  A +   GLE++H      +++RD
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSE--------ADMRFYAAEIILGLEHMH---NRFVVYRD 317

Query: 733 VKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKS-D 791
           +K ANILL+E    +++D G +  F  +       + VGT GY+ PE        + S D
Sbjct: 318 LKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSAD 373

Query: 792 VYSFGIVLLELITGLP 807
            +S G +L +L+ G  
Sbjct: 374 WFSLGCMLFKLLRGHS 389

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 45/231 (19%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--------------------------ASSSQ 644
             +GKG +G V   Y   D +  A+K+LS                               
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 645 GPKQFRTEAQLLMRVHHRNLASL--VGYCNDGGNVGLVYEYMAYGNLKQYLFD-ETKEAL 701
             +Q   E  +L ++ H N+  L  V    +  ++ +V+E +  G +     +  T + L
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPL 134

Query: 702 SWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE 760
           S         D  +G+EYLH       IIHRD+K +N+L+ E    K+ADFG S  F   
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KG 189

Query: 761 SESHISTSIVGTVGYLDPEYYASNRLT---EKSDVYSFGIVLLELITG-LP 807
           S++ +S + VGT  ++ PE  +  R     +  DV++ G+ L   + G  P
Sbjct: 190 SDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.2 bits (245), Expect = 5e-22
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 28/229 (12%)

Query: 593 SDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQFR 650
           S    F  +E V+  +    R +GKG FG V      D  ++ A+K ++        + R
Sbjct: 1   SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60

Query: 651 ---TEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL-----KQYLFDETKEALS 702
               E Q++  + H  L +L     D  ++ +V + +  G+L     +   F E      
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV--- 117

Query: 703 WKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
              +L I  +    L+YL        IIHRD+K  NILL+E     + DF  + + P E+
Sbjct: 118 ---KLFIC-ELVMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

Query: 762 ESHISTSIVGTVGYLDPEYYASNRLTEKS---DVYSFGIVLLELITGLP 807
           +    T++ GT  Y+ PE ++S +    S   D +S G+   EL+ G  
Sbjct: 170 Q---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 54/217 (24%), Positives = 77/217 (35%), Gaps = 38/217 (17%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKML--------SASSSQGPKQFRTEAQLLMRVHHR 662
             LG G FG V+         EV +K +                 +   E  +L RV H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL----------QIAVD 712
           N+  ++    + G   LV E    G     LF      +    RL          Q+   
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG---LDLFAF----IDRHPRLDEPLASYIFRQLV-- 140

Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
               + YL       IIHRD+K  NI++ E    KL DFG +     E      T   GT
Sbjct: 141 --SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTF-CGT 192

Query: 773 VGYLDPEYYASNRLT-EKSDVYSFGIVLLELITG-LP 807
           + Y  PE    N     + +++S G+ L  L+    P
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 7e-22
 Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 22/246 (8%)

Query: 572 RKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADG 630
                         +          Q   + I+D      ++LG G  G V   +     
Sbjct: 28  LPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ 87

Query: 631 SEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGG----NVGLVYEYMA 685
            + A+KML         + R E +L  R     ++  +V    +       + +V E + 
Sbjct: 88  EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142

Query: 686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILL---N 741
            G L   + D   +A + ++  +I     + ++YLH       I HRDVK  N+L     
Sbjct: 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKR 198

Query: 742 EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLE 801
                KL DFGF+K   +    +  T+   T  Y+ PE     +  +  D++S G+++  
Sbjct: 199 PNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255

Query: 802 LITGLP 807
           L+ G P
Sbjct: 256 LLCGYP 261

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLV 668
           + +GKG F  V     +  G EVAIK++  +  +    ++   E +++  ++H N+  L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRL----------QIAVDAAQGLE 718
                   + L+ EY + G +  YL            R+          QI       ++
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVA--------HGRMKEKEARSKFRQIV----SAVQ 128

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           Y H      I+HRD+K  N+LL+  M  K+ADFGFS  F       +     G   Y  P
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF-CGAPPYAAP 182

Query: 779 EYYASNRLT-EKSDVYSFGIVLLELITG-LP 807
           E +   +    + DV+S G++L  L++G LP
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVG 669
           + LG+G +G V           VA+K++    +   P+  + E  +   ++H N+    G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ--------GLEYLH 721
           +  +G    L  EY + G L    FD     +     +      AQ        G+ YLH
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDR----IEPDIGMP--EPDAQRFFHQLMAGVVYLH 122

Query: 722 -HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE- 779
             G    I HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE 
Sbjct: 123 GIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 780 -----YYASNRLTEKSDVYSFGIVLLELITG-LP 807
                ++A        DV+S GIVL  ++ G LP
Sbjct: 179 LKRREFHAE-----PVDVWSCGIVLTAMLAGELP 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.5 bits (236), Expect = 3e-21
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVAIKMLS-ASSSQG-PKQFRTEAQLLMRVHHRN 663
             + ++  +G+G +G VY    + G  VA+K +   +  +G P     E  LL  +HH N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----LQIAVDAAQGLEY 719
           + SL+   +    + LV+E+M   +LK+ L DE K  L          Q+     +G+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLL----RGVAH 134

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      I+HRD+K  N+L+N     KLADFG ++ F         T  V T+ Y  P+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWYRAPD 189

Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
               S + +   D++S G +  E+ITG P
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 93.8 bits (234), Expect = 6e-21
 Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 34/148 (22%)

Query: 398 EPTDQDDVNAIMDIK--LSYDLG-KGWQGD-PCSPMYYSWDGLNCSYNGYKPPKIISLNL 453
           E  +  D  A++ IK  L        W     C     +W G+ C  +  +  ++ +L+L
Sbjct: 1   ELCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN--RTWLGVLCDTDT-QTYRVNNLDL 57

Query: 454 TSEGL---------------------------TGKISPSLSNLKSLENLDLSNNSLTGSI 486
           +   L                            G I P+++ L  L  L +++ +++G+I
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           P+FLSQ+  L  L+   N LSG++P S+
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSI 145

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 93.0 bits (232), Expect = 1e-20
 Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 4/88 (4%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
               ++L    L   +   +   K+L  LDL NN + G++P+ L+QL  L  LN+  N L
Sbjct: 222 NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 507 SGSVPTSLVARSQNGSLLLSIGRNPDLC 534
            G +P     +  +   + +   N  LC
Sbjct: 281 CGEIPQGGNLQRFD---VSAYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 26/69 (37%), Positives = 43/69 (62%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L +T   ++G I   LS +K+L  LD S N+L+G++P  +S LP L  +  DGN+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 506 LSGSVPTSL 514
           +SG++P S 
Sbjct: 161 ISGAIPDSY 169

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 24/87 (27%), Positives = 39/87 (44%), Gaps = 9/87 (10%)

Query: 436 LNCSYN---GYKPPKIISLNLT----SE-GLTGKISPSLSNLKSLENLDLSNNSLTGSIP 487
           +  S N   G  PP   +LNL     S   L G  S    + K+ + + L+ NSL   + 
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 488 EFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           + +     L  L+L  N++ G++P  L
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGL 264

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 75.6 bits (187), Expect = 8e-15
 Identities = 19/64 (29%), Positives = 31/64 (48%), Gaps = 1/64 (1%)

Query: 448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
             S+ ++   LTGKI P+ +NL +L  +DLS N L G            + ++L  N L+
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 508 GSVP 511
             + 
Sbjct: 235 FDLG 238

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 75.3 bits (186), Expect = 8e-15
 Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 2/70 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSL-ENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P ++ +      ++G I  S  +   L  ++ +S N LTG IP   + L  L  ++L  N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207

Query: 505 KLSGSVPTSL 514
            L G      
Sbjct: 208 MLEGDASVLF 217

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 21/67 (31%), Positives = 32/67 (47%), Gaps = 2/67 (2%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
               +  L+L +  + G +   L+ LK L +L++S N+L G IP+    L    V     
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300

Query: 504 NK-LSGS 509
           NK L GS
Sbjct: 301 NKCLCGS 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 8e-21
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 608 NNFHRI--LGKGGFGTVYHG-YLADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRN 663
             + ++  LG+G + TVY G      + VA+K +     +G P     E  LL  + H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----LQIAVDAAQGLEY 719
           + +L    +   ++ LV+EY+   +LKQYL D+    ++  +      Q+     +GL Y
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLL----RGLAY 115

Query: 720 LHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
            H      ++HRD+K  N+L+NE+ + KLADFG ++     ++++   + V T+ Y  P+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

Query: 780 Y-YASNRLTEKSDVYSFGIVLLELITGLP 807
               S   + + D++  G +  E+ TG P
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 1e-20
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 23/211 (10%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHR 662
             +  +  +G+G +G V        G  VAIK    S       K    E +LL ++ H 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD----RLQIAVDAAQGLE 718
           NL +L+  C       LV+E++ +  +   L +     L ++       QI      G+ 
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQII----NGIG 138

Query: 719 YLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLD 777
           + H H     IIHRD+K  NIL+++    KL DFGF++   A  E +     V T  Y  
Sbjct: 139 FCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRA 192

Query: 778 PEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
           PE      +  +  DV++ G ++ E+  G P
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 59/252 (23%), Positives = 100/252 (39%), Gaps = 43/252 (17%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITN---------------NFHRILGKGGFGTVYHGY 626
           N+ + K+GS +   ++F      D                  +  + LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 627 LADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE 682
             +     A+K+L        KQ      E ++L  V+   L  L     D  N+ +V E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 683 YMAYGNLKQYL-----FDETKEALSWKDRLQI-AVDAAQGLEYLH-HGCKPPIIHRDVKT 735
           Y+A G +  +L     F E           +  A       EYLH       +I+RD+K 
Sbjct: 122 YVAGGEMFSHLRRIGRFSE--------PHARFYAAQIVLTFEYLHSLD----LIYRDLKP 169

Query: 736 ANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSF 795
            N+L++++   ++ DFGF+K          + ++ GT   L PE   S    +  D ++ 
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224

Query: 796 GIVLLELITGLP 807
           G+++ E+  G P
Sbjct: 225 GVLIYEMAAGYP 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.1 bits (234), Expect = 2e-20
 Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 30/216 (13%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNL 664
              +++G+G FG V    L +  +V A+K+L+        +   FR E  +L+    + +
Sbjct: 77  EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL------FDETKEALSWKDRLQI-AVDAAQGL 717
            +L     D  N+ LV +Y   G+L   L        E        +  +    +    +
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE--------EMARFYLAEMVIAI 188

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           + +H        +HRD+K  NIL++     +LADFG       +     S+  VGT  Y+
Sbjct: 189 DSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 243

Query: 777 DPEYYASNRLTEKS-----DVYSFGIVLLELITGLP 807
            PE   +    +       D +S G+ + E++ G  
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.9 bits (229), Expect = 3e-20
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 25/218 (11%)

Query: 604 VDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRT---EAQLL 656
           +  ++ F ++  LG G + TVY G     G  VA+K +   S +G P    T   E  L+
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP---STAIREISLM 57

Query: 657 MRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA-- 714
             + H N+  L    +    + LV+E+M   +LK+Y+  +++   +    L++ +     
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM--DSRTVGNTPRGLELNLVKYFQ 114

Query: 715 ----QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
               QGL + H      I+HRD+K  N+L+N++ Q KL DFG ++ F     +   +S V
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEV 169

Query: 771 GTVGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
            T+ Y  P+    S   +   D++S G +L E+ITG P
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 92.3 bits (230), Expect = 3e-20
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ------FRTEAQLLMR 658
             + ++  LG+G F TVY          VAIK +        K        R E +LL  
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQE 68

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----LQIAVDAA 714
           + H N+  L+       N+ LV+++M   +L+  +  +    L+        L       
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTL---- 122

Query: 715 QGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTV 773
           QGLEYLH H     I+HRD+K  N+LL+E    KLADFG +K F   S +   T  V T 
Sbjct: 123 QGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTR 176

Query: 774 GYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
            Y  PE  + +       D+++ G +L EL+  +P
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 606 ITNNFHRI--LGKGGFGTVYHG-YLADGSEVAIKM--LSASSSQGPK-QFRTEAQLLMRV 659
           +   + +I  +G+G +G V+       G  VAIK    S       K   R E ++L ++
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQL 59

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEY 719
            H NL +L+        + LV+EY  +  +   L D  +  +       I     Q + +
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
            H H      IHRDVK  NIL+ +    KL DFGF+++    S+ +     V T  Y  P
Sbjct: 118 CHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSP 171

Query: 779 EY-YASNRLTEKSDVYSFGIVLLELITGLP 807
           E      +     DV++ G V  EL++G+P
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.0 bits (237), Expect = 4e-20
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 3/87 (3%)

Query: 448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           +  LNL    ++G I   + +L+ L  LDLS+N L G IP+ +S L +L  ++L  N LS
Sbjct: 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717

Query: 508 GSVPTSLVARSQNGSLLLSIGRNPDLC 534
           G +P      +   +       NP LC
Sbjct: 718 GPIPEMGQFETFPPA---KFLNNPGLC 741

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.4 bits (225), Expect = 1e-18
 Identities = 31/70 (44%), Positives = 38/70 (54%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
              +  L L + G TGKI P+LSN   L +L LS N L+G+IP  L  L  LR L L  N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 505 KLSGSVPTSL 514
            L G +P  L
Sbjct: 453 MLEGEIPQEL 462

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.4 bits (220), Expect = 5e-18
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 4/86 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            +++SL+L+   L+G I  SL +L  L +L L  N L G IP+ L  +  L  L LD N 
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477

Query: 506 LSGSVPTSLVARSQNGSL-LLSIGRN 530
           L+G +P+ L   S   +L  +S+  N
Sbjct: 478 LTGEIPSGL---SNCTNLNWISLSNN 500

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.4 bits (220), Expect = 5e-18
 Identities = 28/69 (40%), Positives = 40/69 (57%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + +L L    LTG+I   LSN  +L  + LSNN LTG IP+++ +L  L +L L  N 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 506 LSGSVPTSL 514
            SG++P  L
Sbjct: 526 FSGNIPAEL 534

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 87.7 bits (218), Expect = 7e-18
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 16/97 (16%)

Query: 421 WQG--DPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLT---GKISPSLSNLKSLENL 475
           W    +PC+     +DG+ C  +     K+ S++L+S+ L      +S SL +L  LE+L
Sbjct: 33  WSSNKNPCT-----FDGVTCR-DD----KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPT 512
            LSN+ + GS+  F      L  L+L  N LSG V T
Sbjct: 83  FLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTT 118

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 86.9 bits (216), Expect = 1e-17
 Identities = 19/69 (27%), Positives = 36/69 (52%), Gaps = 1/69 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+++S   +  I P L +  +L++LD+S N L+G     +S    L++LN+  N+
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258

Query: 506 LSGSVPTSL 514
             G +P   
Sbjct: 259 FVGPIPPLP 267

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 85.0 bits (211), Expect = 6e-17
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 2/75 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+++   L+G  S ++S    L+ L++S+N   G IP     L  L+ L+L  NK
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENK 280

Query: 506 LSGSVPTSLVARSQN 520
            +G +P  L      
Sbjct: 281 FTGEIPDFLSGACDT 295

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.6 bits (210), Expect = 7e-17
 Identities = 26/69 (37%), Positives = 38/69 (55%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
                 N+TS    G  SP+  N  S+  LD+S N L+G IP+ +  +P L +LNL  N 
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667

Query: 506 LSGSVPTSL 514
           +SGS+P  +
Sbjct: 668 ISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.2 bits (209), Expect = 8e-17
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 7/95 (7%)

Query: 437 NCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLL 496
           NC+        +  ++L++  LTG+I   +  L++L  L LSNNS +G+IP  L     L
Sbjct: 488 NCT-------NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540

Query: 497 RVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNP 531
             L+L+ N  +G++P ++  +S   +     G+  
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY 575

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 84.2 bits (209), Expect = 1e-16
 Identities = 26/69 (37%), Positives = 36/69 (52%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            K+  L L    L G+I   L  +K+LE L L  N LTG IP  LS    L  ++L  N+
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501

Query: 506 LSGSVPTSL 514
           L+G +P  +
Sbjct: 502 LTGEIPKWI 510

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.0 bits (206), Expect = 2e-16
 Identities = 24/82 (29%), Positives = 44/82 (53%), Gaps = 6/82 (7%)

Query: 439 SYNGYKPPKI------ISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQ 492
            Y G+  P        + L+++   L+G I   + ++  L  L+L +N ++GSIP+ +  
Sbjct: 619 VYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGD 678

Query: 493 LPLLRVLNLDGNKLSGSVPTSL 514
           L  L +L+L  NKL G +P ++
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAM 700

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 82.6 bits (205), Expect = 3e-16
 Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 13/105 (12%)

Query: 442 GYKPPKIISLNLTSEGLTGKISPSLSN--LKSLENLDLSNNSLTGSIPEFLSQLPLLRVL 499
                 +++L+L+S   +G I P+L      +L+ L L NN  TG IP  LS    L  L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423

Query: 500 NLDGNKLSGSVPTSLVARSQ-----------NGSLLLSIGRNPDL 533
           +L  N LSG++P+SL + S+            G +   +     L
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.1 bits (201), Expect = 8e-16
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 446 PKIISLNLTSEGLTGKISP--SLSNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLD 502
             + SL+L+   L+G ++   SL +   L+ L++S+N+L          +L  L VL+L 
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159

Query: 503 GNKLSGSVPTSLVARSQNGSL-LLSIGRN 530
            N +SG+     V     G L  L+I  N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGN 188

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 80.7 bits (200), Expect = 1e-15
 Identities = 27/83 (32%), Positives = 37/83 (44%), Gaps = 2/83 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLS-NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L+L     TG+I   LS    +L  LDLS N   G++P F     LL  L L  N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328

Query: 505 KLSGSVPTSLVARSQN-GSLLLS 526
             SG +P   + + +    L LS
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLS 351

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 79.6 bits (197), Expect = 2e-15
 Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 2/87 (2%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPL-LRVLNLDG 503
             + SL L+S   +G++   +L  ++ L+ LDLS N  +G +PE L+ L   L  L+L  
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377

Query: 504 NKLSGSVPTSLVARSQNGSLLLSIGRN 530
           N  SG +  +L    +N    L +  N
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNN 404

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 77.6 bits (192), Expect = 1e-14
 Identities = 28/70 (40%), Positives = 37/70 (52%), Gaps = 3/70 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS-QLPLLRVLNLDGN 504
            ++  LN++S    G I P    LKSL+ L L+ N  TG IP+FLS     L  L+L GN
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 505 KLSGSVPTSL 514
              G+VP   
Sbjct: 305 HFYGAVPPFF 314

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 72.6 bits (179), Expect = 3e-13
 Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 4/70 (5%)

Query: 446 PKIISLNLTSEGLTGKIS-PSLSNLKSLENLDLSNNSLTGSIPE---FLSQLPLLRVLNL 501
             +  LN++S  L           L SLE LDLS NS++G+             L+ L +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185

Query: 502 DGNKLSGSVP 511
            GNK+SG V 
Sbjct: 186 SGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.7 bits (174), Expect = 1e-12
 Identities = 16/85 (18%), Positives = 31/85 (36%), Gaps = 4/85 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L L++   +G I   L + +SL  LDL+ N   G+IP  + +        +  N 
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANF 569

Query: 506 LSGSVPTSLVARSQNGSLLLSIGRN 530
           ++G     +           +    
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLL 594

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.1 bits (222), Expect = 1e-19
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 12/205 (5%)

Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVAIKMLSASSSQ-G-PKQFRTEAQLLMRVHHRN 663
             +H +  +G+G +G VY      G   A+K +       G P     E  +L  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L    +    + LV+E++   +LK+ L D  +  L         +    G+ Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY-YA 782
               ++HRD+K  N+L+N + + K+ADFG ++ F         T  + T+ Y  P+    
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 783 SNRLTEKSDVYSFGIVLLELITGLP 807
           S + +   D++S G +  E++ G P
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP 199

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.7 bits (221), Expect = 2e-19
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLS-ASSSQG-PKQFRTEAQLLMRVHHR 662
             + ++  +G+G +GTV+          VA+K +      +G P     E  LL  + H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----LQIAVDAAQGLE 718
           N+  L    +    + LV+E+    +LK+Y  D     L  +       Q+     +GL 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLL----KGLG 115

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           + H      ++HRD+K  N+L+N   + KLA+FG ++ F      +  ++ V T+ Y  P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPP 170

Query: 779 EY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNN 815
           +  + +   +   D++S G +  EL      +  G + 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 28/209 (13%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
             LG G FG V  G     G +VA+K+L+     S     + + E Q L    H ++  L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK--EALSWKDRLQIAVDAAQGLEYLH-HGC 724
               +   +  +V EY++ G L  Y+    +  E  + +   QI       ++Y H H  
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM- 131

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE----- 779
              ++HRD+K  N+LL+  M AK+ADFG S +        + TS  G+  Y  PE     
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAPEVISGR 185

Query: 780 YYASNRLTEKSDVYSFGIVLLELITG-LP 807
            YA      + D++S G++L  L+ G LP
Sbjct: 186 LYAG----PEVDIWSCGVILYALLCGTLP 210

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 32/212 (15%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRVHHRNL 664
              R LG G FG V+           A+K+L        KQ      E  +L  V H  +
Sbjct: 9   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRLQIAVDAAQ---G 716
             + G   D   + ++ +Y+  G L   L     F             +    AA+    
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--------PVAKFY--AAEVCLA 118

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           LEYLH       II+RD+K  NILL++    K+ DFGF+K  P      ++ ++ GT  Y
Sbjct: 119 LEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDY 169

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + PE  ++    +  D +SFGI++ E++ G  
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 89.7 bits (223), Expect = 4e-19
 Identities = 63/245 (25%), Positives = 96/245 (39%), Gaps = 39/245 (15%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSAS 641
           N        +K         E  +I     +++G G FG V+   L +  EVAIK +   
Sbjct: 16  NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV--- 72

Query: 642 SSQGPKQFRT----EAQLLMRVHHRNLASL------VGYCNDGGNVGLVYEYMAYGNLKQ 691
                 Q +     E Q++  V H N+  L       G   D   + LV EY+    + +
Sbjct: 73  -----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR 126

Query: 692 YLFDETKEALSWKDRL------QIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLN-EK 743
                 K   +    L      Q+     + L Y+H  G    I HRD+K  N+LL+   
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSIG----ICHRDIKPQNLLLDPPS 178

Query: 744 MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLEL 802
              KL DFG +KI         + S + +  Y  PE  + +   T   D++S G V+ EL
Sbjct: 179 GVLKLIDFGSAKIL---IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235

Query: 803 ITGLP 807
           + G P
Sbjct: 236 MQGQP 240

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.4 bits (222), Expect = 6e-19
 Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 34/219 (15%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNL 664
              +++G+G F  V    +    +V A+K+++        +   FR E  +L+    R +
Sbjct: 64  EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 665 ASLVGYC-NDGGNVGLVYEYMAYGNLKQYL------FDETKEALSWKDRLQI-AVDAAQG 716
             L  +   D   + LV EY   G+L   L                 +  +    +    
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--------EMARFYLAEIVMA 174

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           ++ +H  G     +HRD+K  NILL+     +LADFG      A+     S   VGT  Y
Sbjct: 175 IDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDY 229

Query: 776 LDPEYYASNRLTEKSDVY-------SFGIVLLELITGLP 807
           L PE   +      +  Y       + G+   E+  G  
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 87.6 bits (218), Expect = 8e-19
 Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 39/242 (16%)

Query: 580 VDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVY---HGYLADGSEV-AI 635
           +  +H  KEG  K+D  QF             ++LG+G FG V+       +D  ++ A+
Sbjct: 8   IAITHHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAM 57

Query: 636 KMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYC-NDGGNVGLVYEYMAYGNL--- 689
           K+L  ++ +   + RT  E  +L+ V+H  +  L  Y     G + L+ +++  G+L   
Sbjct: 58  KVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116

Query: 690 --KQYLFDETKEALSWKDRLQI-AVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQ 745
             K+ +F E        + ++    + A  L++LH  G    II+RD+K  NILL+E+  
Sbjct: 117 LSKEVMFTE--------EDVKFYLAELALALDHLHSLG----IIYRDLKPENILLDEEGH 164

Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            KL DFG SK      +   + S  GTV Y+ PE       T+ +D +SFG+++ E++TG
Sbjct: 165 IKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

Query: 806 LP 807
             
Sbjct: 223 TL 224

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 53/213 (24%), Positives = 81/213 (38%), Gaps = 27/213 (12%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNL 664
              +++G+G FG V         +V A+K+LS            F  E  ++   +   +
Sbjct: 72  EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL----FDETKEALSWKDRLQI-AVDAAQGLEY 719
             L     D   + +V EYM  G+L   +      E           +    +    L+ 
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--------KWARFYTAEVVLALDA 183

Query: 720 LH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           +H  G     IHRDVK  N+LL++    KLADFG       E       + VGT  Y+ P
Sbjct: 184 IHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISP 238

Query: 779 EYYASNRLTEK----SDVYSFGIVLLELITGLP 807
           E   S           D +S G+ L E++ G  
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
             LG+G FG V          +VA+K +S      S    +   E   L  + H ++  L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK--EALSWKDRLQIAVDAAQGLEYLHHGCK 725
                   ++ +V EY A G L  Y+ ++ +  E    +   QI       +EY H    
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRHK- 128

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL++ +  K+ADFG S I      + + TS  G+  Y  PE   + +
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS-CGSPNYAAPEVI-NGK 182

Query: 786 LTE--KSDVYSFGIVLLELITG-LP 807
           L    + DV+S GIVL  ++ G LP
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.5 bits (217), Expect = 3e-18
 Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 25/239 (10%)

Query: 581 DNSHSKKEGSLKSDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV-AIKML 638
             S S   G+ + +         V +    + ++LGKG FG V            A+K+L
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181

Query: 639 SASSSQGPKQF---RTEAQLLMRVHHRNLASLVGYC-NDGGNVGLVYEYMAYGNL----- 689
                    +     TE ++L    H  L +L  Y       +  V EY   G L     
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS 240

Query: 690 KQYLFDETKEALSWKDRLQI-AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKL 748
           ++ +F E        DR +    +    L+YLH   +  +++RD+K  N++L++    K+
Sbjct: 241 RERVFSE--------DRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKI 290

Query: 749 ADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            DFG  K      +     +  GT  YL PE    N      D +  G+V+ E++ G  
Sbjct: 291 TDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 609 NFHRILGKGGFGTVY---HGYLADGSEV-AIKMLS-ASSSQGPKQF---RTEAQLLMRVH 660
              R+LGKGG+G V+       A+  ++ A+K+L  A   +  K     + E  +L  V 
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 661 HRNLASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDA 713
           H  +  L+ Y    GG + L+ EY++ G L     ++ +F E        D       + 
Sbjct: 80  HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFME--------DTACFYLAEI 130

Query: 714 AQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGT 772
           +  L +LH  G    II+RD+K  NI+LN +   KL DFG  K    +     + +  GT
Sbjct: 131 SMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGT 184

Query: 773 VGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + Y+ PE    +      D +S G ++ +++TG P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.8 bits (215), Expect = 6e-18
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
             LG G FG V  G     G +VA+K+L+     S     + R E Q L    H ++  L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETK--EALSWKDRLQIAVDAAQGLEYLH-HGC 724
               +   ++ +V EY++ G L  Y+    +  E  S +   QI      G++Y H H  
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM- 136

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              ++HRD+K  N+LL+  M AK+ADFG S +        + TS  G+  Y  PE   S 
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS-CGSPNYAAPEVI-SG 189

Query: 785 RLTE--KSDVYSFGIVLLELITG-LP 807
           RL    + D++S G++L  L+ G LP
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.0 bits (213), Expect = 7e-18
 Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 48/224 (21%)

Query: 614 LGKGGFGTVY---HGYLADGSEVAIKMLSA----SSSQGPKQFRTEAQLLMRVHHRNLAS 666
           +G+G +G VY        D  + A+K +       S+        E  LL  + H N+ S
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82

Query: 667 LVGYCNDGGN--VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA--------QG 716
           L        +  V L+++Y  + +L   +    + + + K  +Q+              G
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 717 LEYLH-HGCKPPIIHRDVKTANILL----NEKMQAKLADFGFSKIF--PAESESHISTSI 769
           + YLH +     ++HRD+K ANIL+     E+ + K+AD GF+++F  P +  + +   +
Sbjct: 141 IHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 770 VGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLP 807
           V T  Y  PE      +Y     T+  D+++ G +  EL+T  P
Sbjct: 197 V-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSEP 234

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 37/220 (16%)

Query: 609 NFHRILGKGGFGTVY---HGYLADGSEV-AIKMLS-ASSSQGPKQF---RTEAQLLMRV- 659
              ++LG G +G V+        D  ++ A+K+L  A+  Q  K     RTE Q+L  + 
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 660 HHRNLASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQIAVDA 713
               L +L  Y       + L+ +Y+  G L     ++  F E          +QI    
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTE--------HEVQIY--V 165

Query: 714 AQ---GLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
            +    LE+LH  G    II+RD+K  NILL+      L DFG SK F    E+  +   
Sbjct: 166 GEIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDF 220

Query: 770 VGTVGYLDPEYYASNRL--TEKSDVYSFGIVLLELITGLP 807
            GT+ Y+ P+          +  D +S G+++ EL+TG  
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 34/211 (16%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           + +G G FG             VA+K +   ++   +  + E      + H N+      
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84

Query: 671 CNDGGNVGLVYEYMAYGNLKQYL-----FDETKEALSWKDRL---QIAVDAAQGLEYLH- 721
                ++ ++ EY + G L + +     F E  EA     R    Q+      G+ Y H 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSE-DEA-----RFFFQQLL----SGVSYCHS 134

Query: 722 HGCKPPIIHRDVKTANILL--NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                 I HRD+K  N LL  +   + K+ DFG+SK       S   ++ VGT  Y+ PE
Sbjct: 135 MQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKST-VGTPAYIAPE 187

Query: 780 YYASNRLTE--KSDVYSFGIVLLELITG-LP 807
                +  +   +DV+S G+ L  ++ G  P
Sbjct: 188 VL-LRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 67/261 (25%), Positives = 105/261 (40%), Gaps = 43/261 (16%)

Query: 589 GSLKSDNQQFTYSEIVD----ITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSAS 641
           GS    +  F   EI D    +   +  +  +G G  G V   Y       VAIK LS  
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-- 59

Query: 642 SSQGPKQFRTEAQ-------LLMRVHHRNLASLV------GYCNDGGNVGLVYEYMA--- 685
               P Q +T A+       L+  V+H+N+  L+          +  +V +V E M    
Sbjct: 60  ---RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116

Query: 686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQ 745
              ++  L  E    L +    Q+      G+++LH      IIHRD+K +NI++     
Sbjct: 117 CQVIQMELDHERMSYLLY----QML----CGIKHLHSAG---IIHRDLKPSNIVVKSDCT 165

Query: 746 AKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
            K+ DFG +        S + T  V T  Y  PE        E  D++S G ++ E+I G
Sbjct: 166 LKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

Query: 806 LPAIIRGYNNTHIVNRVCPFL 826
              +  G ++    N+V   L
Sbjct: 223 GV-LFPGTDHIDQWNKVIEQL 242

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 45/230 (19%), Positives = 81/230 (35%), Gaps = 44/230 (19%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSA--SSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             +G+GGFG +Y   +     V                   TE +   R           
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 670 YCNDGGNVGL--------------VYEYMA---YG-NLKQYLFDETKEALSWKDRLQIAV 711
                  +G+               Y +M    +G +L Q +++   +  S K  LQ+++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL-QKIYEANAKRFSRKTVLQLSL 159

Query: 712 DAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK--LADFGFSKIF-PAESESHIS-- 766
                LEY+H       +H D+K +N+LLN K   +  L D+G +  + P       +  
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 767 --TSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLLELITG-LP 807
                 GT+       + S         + + D+   G  +++ +TG LP
Sbjct: 217 PKRCHDGTI------EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 33/218 (15%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLS-ASSSQG-PKQFRT---EAQLLMRV 659
           + + RI  LG+G +G VY          VAIK +      +G P    T   E  LL  +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLKEL 90

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----LQIAVDAAQ 715
            HRN+  L    +    + L++EY    +LK+Y+  +    +S +       Q+      
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLI----N 143

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLN-----EKMQAKLADFGFSKIFPAESESHISTSIV 770
           G+ + H       +HRD+K  N+LL+     E    K+ DFG ++ F         T  +
Sbjct: 144 GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEI 198

Query: 771 GTVGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
            T+ Y  PE    S   +   D++S   +  E++   P
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 5e-17
 Identities = 63/224 (28%), Positives = 91/224 (40%), Gaps = 56/224 (25%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT----EAQLLMRVHHRNLAS 666
           +++G G FG VY   L D G  VAIK +         Q +     E Q++ ++ H N+  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKV--------LQDKRFKNRELQIMRKLDHCNIVR 111

Query: 667 L------VGYCNDGGNVGLVYEYM---------AYGNLKQYLFDETKEALSWKDRLQIAV 711
           L       G   D   + LV +Y+          Y   KQ L     +   +    Q+  
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY----QLF- 166

Query: 712 DAAQGLEYLH-HGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSI 769
              + L Y+H  G    I HRD+K  N+LL+ +    KL DFG +K          + S 
Sbjct: 167 ---RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSY 216

Query: 770 VGTVGYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLP 807
           + +  Y  PE       Y     T   DV+S G VL EL+ G P
Sbjct: 217 ICSRYYRAPELIFGATDY-----TSSIDVWSAGCVLAELLLGQP 255

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 6e-17
 Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 23/225 (10%)

Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
            R L S+    +   +  +  + ++    ++   D  K+ L+ +  +  +   A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
                   IHRD+   NILL+EK   K+ DFG ++    + +          + ++ PE 
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266

Query: 781 YASNRLTEKSDVYSFGIVLLELIT--GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR 838
                 T +SDV+SFG++L E+ +    P     Y    I    C  L+ G        R
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDEEFCRRLKEGT-------R 314

Query: 839 LEA-NFDTNSVWKVAETAM-ECVPSISFQRPTMSHVVTELKKCLE 881
           + A ++ T  +++     M +C      QRPT S +V  L   L+
Sbjct: 315 MRAPDYTTPEMYQT----MLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 18/155 (11%)

Query: 610 FHRILGKGGFGTVYHGYL------ADGSEVAIKML-SASSSQGPKQFRTEAQLLMRV-HH 661
             + LG+G FG V           A    VA+KML   ++    +   +E ++L+ + HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 662 RNLASLVGYCND-GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
            N+ +L+G C   GG + ++ E+  +GNL  YL            R +      +G  + 
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFR 136

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
                   I  D+K     +     +  + F   K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLS-ASSSQGPKQF-----RTEAQLLMR 658
           + +  +  +G G +GTVY       G  VA+K +   +   G         R E  LL R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRR 67

Query: 659 VH---HRNLASLV-----GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIA 710
           +    H N+  L+        +    V LV+E++   +L+ YL       L  +    + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 711 VDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIV 770
               +GL++LH  C   I+HRD+K  NIL+      KLADFG ++I+   S     T +V
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVV 180

Query: 771 GTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            T+ Y  PE    +      D++S G +  E+    P
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 66/260 (25%), Positives = 105/260 (40%), Gaps = 43/260 (16%)

Query: 590 SLKSDNQQFTYSEIVD----ITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASS 642
           S    + QF   E+ D    +   +   + +G G  G V   Y       VAIK LS   
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--- 96

Query: 643 SQGPKQFRTEAQ-------LLMRVHHRNLASLV------GYCNDGGNVGLVYEYMA---Y 686
              P Q +T A+       L+  V+H+N+ SL+          +  +V LV E M     
Sbjct: 97  --RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 154

Query: 687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA 746
             ++  L  E    L +    Q+      G+++LH      IIHRD+K +NI++      
Sbjct: 155 QVIQMELDHERMSYLLY----QMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTL 203

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           K+ DFG ++       S + T  V T  Y  PE        E  D++S G ++ E++   
Sbjct: 204 KILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

Query: 807 PAIIRGYNNTHIVNRVCPFL 826
             +  G +     N+V   L
Sbjct: 261 I-LFPGRDYIDQWNKVIEQL 279

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 37/229 (16%)

Query: 601 SEIVDITNNF--HRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLM 657
             ++ +  NF   + +G G FG +  G  L     VAIK+    S     Q   E +   
Sbjct: 3   GVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYK 59

Query: 658 RVHH-RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
           ++     +  +  +   G    +V E +   +L+  LFD      S K  L IA+     
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISR 117

Query: 717 LEYLH-HGCKPPIIHRDVKTANILL-----NEKMQAKLADFGFSKIF-PAESESHI---- 765
           +EY+H        I+RDVK  N L+       +    + DF  +K +   E++ HI    
Sbjct: 118 MEYVHSKNL----IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 766 STSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLLELITG-LP 807
             S+ GT        Y S         + + D+ + G + +  + G LP
Sbjct: 174 HKSLTGTA------RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRVHHRNL 664
           ++ ++LGKG FG V            A+K+L         +     TE+++L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 665 ASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQGL 717
            +L  Y       +  V EY   G L     ++ +F E        +R +    +    L
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--------ERARFYGAEIVSAL 118

Query: 718 EYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYL 776
           EYLH       +++RD+K  N++L++    K+ DFG  K   ++  +    +  GT  YL
Sbjct: 119 EYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 172

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            PE    N      D +  G+V+ E++ G  
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)

Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK-MLSASSSQGPKQFRT----EAQLLMRV 659
           + + ++  +G+G FG V+       G +VA+K +L  +  +G   F      E ++L  +
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 660 HHRNLASLVG--------YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR----L 707
            H N+ +L+         Y    G++ LV+++  + +L   L        +  +      
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQ 131

Query: 708 QIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF--PAESESHI 765
            +      GL Y+H      I+HRD+K AN+L+      KLADFG ++ F     S+ + 
Sbjct: 132 MLL----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 766 STSIVGTVGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
            T+ V T+ Y  PE            D++  G ++ E+ T  P
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 50/224 (22%)

Query: 612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQF-------RT--EAQLLMRVHH 661
           R+ G+G FGTV  G     G  VAIK          K         R     Q L  +HH
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQDLAVLHH 78

Query: 662 RNLASL--VGYCNDGGN-----VGLVYEYM---------AYGNLKQYLFDETKEALSWKD 705
            N+  L    Y     +     + +V EY+          Y   +        +   +  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF-- 136

Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAESESH 764
             Q+     + +  LH      + HRD+K  N+L+NE     KL DFG +K     S S 
Sbjct: 137 --QLI----RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---SPSE 186

Query: 765 ISTSIVGTVGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLP 807
            + + + +  Y  PE  + +   T   D++S G +  E++ G P
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH-RNLASLVG 669
           R +G+G FG ++ G  L +  +VAIK     S     Q R E +    +     + ++  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
           +  +G +  LV + +   +L + L D      S K     A      ++ +H      ++
Sbjct: 74  FGQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 128

Query: 730 HRDVKTANILLNEKMQAK-----LADFGFSKIF-PAESESHI----STSIVGTVGYLDPE 779
           +RD+K  N L+            + DFG  K +    ++ HI      ++ GT       
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA------ 182

Query: 780 YYAS------NRLTEKSDVYSFGIVLLELITG-LP 807
            Y S         + + D+ + G V +  + G LP
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 31/248 (12%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQF---------RT--EAQLLMRVH 660
           R +  G +G V  G  ++G  VAIK +  + S G             R   E +LL   H
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 661 HRNLASLV-----GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDAA 714
           H N+  L              + LV E M   +L Q + D+ +  +S    +Q       
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ-RIVIS-PQHIQYFMYHIL 144

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            GL  LH      ++HRD+   NILL +     + DF  ++   A++     T  V    
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRW 198

Query: 775 YLDPEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---ERGD 830
           Y  PE        T+  D++S G V+ E+      + RG    + +N++   +   +  D
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA-LFRGSTFYNQLNKIVEVVGTPKIED 257

Query: 831 VRSIVDPR 838
           V     P 
Sbjct: 258 VVMFSSPS 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 19/165 (11%)

Query: 601 SEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
           + I+D      ++LG G  G V   +      + A+KML         + R E +L  R 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67

Query: 660 -HHRNLASLVGYCNDGG----NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAA 714
               ++  +V    +       + +V E +  G L   + D   +A + ++  +I     
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 715 QGLEYLH-HGCKPPIIHRDVKTANILL---NEKMQAKLADFGFSK 755
           + ++YLH       I HRDVK  N+L          KL DFGF+K
Sbjct: 128 EAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 45/229 (19%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           + +G GGFG +Y  +      + A  ++     +      +E +   RV  ++       
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG-PLFSELKFYQRVAKKDCIKKWIE 101

Query: 671 CNDGGNVGLVYEYMAYGNLK------------------QYLFDETKEALSWKDRLQIAVD 712
                 +G +  +   G  +                  Q +  +          LQ+ + 
Sbjct: 102 RKQLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159

Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK--LADFGFSKIF-PAESESHIS--- 766
               LEY+H       +H D+K AN+LL  K   +  LAD+G S  + P  +        
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 767 -TSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLLELITG-LP 807
                GT+       + S        L+ +SDV   G  +L  + G LP
Sbjct: 217 RKGHNGTI------EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 1e-15
 Identities = 22/139 (15%), Positives = 46/139 (33%), Gaps = 11/139 (7%)

Query: 413 LSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSL 472
                G  W  +    M+ +  G++ + NG    ++  L+L   G +G++  ++  L  L
Sbjct: 52  FGTQPGANWNFNKELDMWGAQPGVSLNSNG----RVTGLSLEGFGASGRVPDAIGQLTEL 107

Query: 473 ENLDLSNNSLTG----SIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIG 528
           E L L ++          P+ +S                 +          +  +   I 
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167

Query: 529 RNPDLCLSAPCKKEKRNSV 547
            +P        KK  R ++
Sbjct: 168 SDP---QQKSIKKSSRITL 183

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.4 bits (178), Expect = 3e-13
 Identities = 24/138 (17%), Positives = 40/138 (28%), Gaps = 16/138 (11%)

Query: 397 QEPTDQDDVNAIMDIKLSYD-----LGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISL 451
              TD   V   +     Y      L + W          + +G N S  G+      + 
Sbjct: 10  NALTDDAIVPIKLSRTAEYIKDYLALKEIWD---------ALNGKNWSQQGFGTQPGANW 60

Query: 452 NLTSE--GLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           N   E      +   SL++   +  L L     +G +P+ + QL  L VL L  +    +
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 510 VPTSLVARSQNGSLLLSI 527
                             
Sbjct: 121 ERLFGPKGISANMSDEQK 138

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 4e-13
 Identities = 15/102 (14%), Positives = 30/102 (29%), Gaps = 9/102 (8%)

Query: 436 LNCSYN---GYKPPKIISL-NLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS 491
                +        +     N               NLK L ++++ N      +P FL 
Sbjct: 211 FYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270

Query: 492 QLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
            LP ++++N+  N+       S      +   L        +
Sbjct: 271 ALPEMQLINVACNRG-----ISGEQLKDDWQALADAPVGEKI 307

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 71.2 bits (175), Expect = 8e-13
 Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 16/85 (18%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL 495
           +   YN          NL     T  +  SL  +K L  L+   N L G +P F      
Sbjct: 310 IYIGYN----------NLK----TFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIK 354

Query: 496 LRVLNLDGNKLSGSVPTSLVARSQN 520
           L  LNL  N+++  +P +    ++ 
Sbjct: 355 LASLNLAYNQITE-IPANFCGFTEQ 378

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.5 bits (173), Expect = 1e-12
 Identities = 10/84 (11%), Positives = 27/84 (32%), Gaps = 3/84 (3%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
            +        +    ++   SL  L + +N +     +       + VL++  N      
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISID 603

Query: 511 PTSLVARSQNGSLLLSIGRNPDLC 534
            + +    + G  +L   +  D+ 
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIR 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.8 bits (166), Expect = 1e-11
 Identities = 19/73 (26%), Positives = 31/73 (42%), Gaps = 2/73 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            K+  L      L GK+ P+  +   L +L+L+ N +T     F      +  L+   NK
Sbjct: 330 KKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388

Query: 506 LSGSVPTSLVARS 518
           L   +P    A+S
Sbjct: 389 LK-YIPNIFDAKS 400

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 1e-11
 Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 14/98 (14%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL 495
           ++ SYN         +          + P+     ++ +++LSNN ++    E  S    
Sbjct: 407 IDFSYN--------EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 496 LRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
           L  +NL GN L+       + ++       +      L
Sbjct: 459 LSSINLMGNMLTE------IPKNSLKDENENFKNTYLL 490

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 65.4 bits (160), Expect = 5e-11
 Identities = 11/89 (12%), Positives = 26/89 (29%), Gaps = 7/89 (7%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
            +I   + S+     I  S         +   +N++T  + + + +L  LR   +  +  
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPF 218

Query: 507 SGSVP------TSLVARSQNGSLLLSIGR 529
                       +     Q  +  L    
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDN 247

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 14/78 (17%), Positives = 30/78 (38%), Gaps = 8/78 (10%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSL-TGSIPEFLSQLP 494
           +N + N     + IS     +             + ++ + +  N+L T  +   L ++ 
Sbjct: 278 INVACN-----RGISGEQLKDDWQ--ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330

Query: 495 LLRVLNLDGNKLSGSVPT 512
            L +L    N+L G +P 
Sbjct: 331 KLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 8/86 (9%)

Query: 452 NLTS--EGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSG 508
            LT   +      + +  N   L ++DL  N LT    +F  + LP L  ++L  N  S 
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527

Query: 509 SVPTSLVARSQNGSL-LLSIGRNPDL 533
             PT       + +L    I    D 
Sbjct: 528 -FPTQP---LNSSTLKGFGIRNQRDA 549

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.8 bits (153), Expect = 3e-10
 Identities = 13/75 (17%), Positives = 26/75 (34%), Gaps = 8/75 (10%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLE------NLDLSNNSLTGSIPEFLSQLPLLRVL 499
           P ++ ++L+    +        N  +L+        D   N      PE ++  P L  L
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571

Query: 500 NLDGNKLSGSVPTSL 514
            +  N +   V   +
Sbjct: 572 QIGSNDIR-KVNEKI 585

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 58.5 bits (142), Expect = 7e-09
 Identities = 12/87 (13%), Positives = 23/87 (26%), Gaps = 20/87 (22%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-------------------SIP 487
           K   +   S  +T  +S ++  L  L    + N+                       +  
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242

Query: 488 EFLSQLPLLRVLNLDGNKLSGSVPTSL 514
                L  L  + +        +PT L
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFL 269

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 7/60 (11%), Positives = 18/60 (30%), Gaps = 7/60 (11%)

Query: 462 ISPSLSNLKSLENLDLSNNSLTG-------SIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
                 ++  +  +D S N +          +     +   +  +NL  N++S       
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 5/67 (7%), Positives = 15/67 (22%), Gaps = 3/67 (4%)

Query: 450 SLNLTSEGLTGKISPSLSNLK--SLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
                                   L    ++++    SI +          +    N ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 508 GSVPTSL 514
             V  ++
Sbjct: 197 -FVSKAV 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH-RNLASLVG 669
           R +G G FG +Y G  +A G EVAIK+    +     Q   E+++   +     + ++  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
              +G    +V E +   +L+  LF+      S K  L +A      +EY+H       I
Sbjct: 73  CGAEGDYNVMVMELLGP-SLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 730 HRDVKTANILLNEKMQAK---LADFGFSKIF-PAESESHI----STSIVGTVGYLDPEYY 781
           HRDVK  N L+    +     + DFG +K +  A +  HI    + ++ GT        Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA------RY 181

Query: 782 AS---NRLTEKS---DVYSFGIVLLELITG-LP 807
           AS   +   E+S   D+ S G VL+    G LP
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 608 NNFHRI--LGKGGFGTVYHG--YLADGSEVAIKMLS-ASSSQG-PKQFRT---EAQLLMR 658
             +  +  +G+G +G V+        G  VA+K +   +  +G P    +   E  +L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRH 67

Query: 659 VH---HRNLASL-----VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDR---- 706
           +    H N+  L     V   +    + LV+E++   +L  YL    +  +  +      
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
            Q+     +GL++LH      ++HRD+K  NIL+    Q KLADFG ++I+   S     
Sbjct: 127 FQLL----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 176

Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           TS+V T+ Y  PE    +      D++S G +  E+    P
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQ-LLMRVHHRN 663
           +F +++GKG FG V            A+K+L   +    K+     +E   LL  V H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQG 716
           L  L  +       +  V +Y+  G L     ++  F E         R +  A + A  
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE--------PRARFYAAEIASA 151

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           L YLH       I++RD+K  NILL+ +    L DFG  K     + +  +++  GT  Y
Sbjct: 152 LGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           L PE           D +  G VL E++ GLP
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 29/235 (12%)

Query: 587 KEGSLKSDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQ 644
           KE S + +      S  + I N  F R+LGKG FG V    + +  ++ A+K+L      
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62

Query: 645 GPKQF---RTEAQLLMRV-HHRNLASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLF 694
                    TE ++L    +H  L  L   C      +  V E++  G+L     K   F
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF 121

Query: 695 DETKEALSWKDRLQI-AVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFG 752
           DE         R +  A +    L +LH  G    II+RD+K  N+LL+ +   KLADFG
Sbjct: 122 DE--------ARARFYAAEIISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFG 169

Query: 753 FSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
             K       +  + +  GT  Y+ PE           D ++ G++L E++ G  
Sbjct: 170 MCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 37/253 (14%)

Query: 605 DITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMR 658
           ++   +     +G G +G+V        G +VAIK LS    S     + +R E  LL  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKH 79

Query: 659 VHHRNLASLV------GYCNDGGNVGLVYEYMA---YGNLKQYLFDETKEALSWKDRLQI 709
           + H N+  L+          +  +  LV  +M       +     +E  + L +    Q+
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----QM 135

Query: 710 AVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSI 769
                +GL+Y+H      ++HRD+K  N+ +NE  + K+ DFG      A       T  
Sbjct: 136 L----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-----ARHADAEMTGY 183

Query: 770 VGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL-- 826
           V T  Y  PE   +     +  D++S G ++ E++TG   + +G +    + ++      
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGV 242

Query: 827 -ERGDVRSIVDPR 838
                V+ + D  
Sbjct: 243 PGTEFVQKLNDKA 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.7 bits (191), Expect = 6e-15
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVG 669
           R +G G FG +Y G  +    EVAIK+ +  +     Q   E+++   +     + ++  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
           +  +G    LV + +   +L+  LF+     LS K  L +A      +E++H       +
Sbjct: 71  FGVEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FL 125

Query: 730 HRDVKTANILLNEKMQAK---LADFGFSKIF-PAESESHI----STSIVGTVGYLDPEYY 781
           HRD+K  N L+    +A    + DFG +K +    +  HI    + ++ GT        Y
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA------RY 179

Query: 782 ASNR------LTEKSDVYSFGIVLLELITG-LP 807
           AS         + + D+ S G VL+  + G LP
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 77.8 bits (192), Expect = 8e-15
 Identities = 18/84 (21%), Positives = 27/84 (32%), Gaps = 6/84 (7%)

Query: 437 NCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
            C    +       P    +L+L+   L    S S  +   L+ LDLS   +        
Sbjct: 13  QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
             L  L  L L GN +      + 
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAF 96

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.2 bits (188), Expect = 2e-14
 Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 3/87 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L+   L      + ++L SL+ L++S+N+           L  L+VL+   N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529

Query: 506 LSGSVPTSLVARSQNGSL-LLSIGRNP 531
           +  S    L  +    SL  L++ +N 
Sbjct: 530 IMTSKKQEL--QHFPSSLAFLNLTQND 554

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.7 bits (171), Expect = 2e-12
 Identities = 13/69 (18%), Positives = 25/69 (36%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P++  L+L+   +      +  +L  L  L L+ N +        S L  L+ L      
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 506 LSGSVPTSL 514
           L+      +
Sbjct: 112 LASLENFPI 120

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.7 bits (171), Expect = 3e-12
 Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 9/94 (9%)

Query: 436 LNCSYNG--------YKPPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSI 486
           L+ S+NG            ++  L+     L      S   +L++L  LD+S+     + 
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQN 520
               + L  L VL + GN    +    +    +N
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.3 bits (170), Expect = 3e-12
 Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 1/70 (1%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L +          P   + L++L  LDLS   L    P   + L  L+VLN+  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 505 KLSGSVPTSL 514
                     
Sbjct: 505 NFFSLDTFPY 514

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.4 bits (165), Expect = 1e-11
 Identities = 15/75 (20%), Positives = 26/75 (34%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + +L LT   +      + S L SL+ L     +L       +  L  L+ LN+  N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 506 LSGSVPTSLVARSQN 520
           +         +   N
Sbjct: 136 IQSFKLPEYFSNLTN 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 61.2 bits (149), Expect = 1e-09
 Identities = 23/77 (29%), Positives = 33/77 (42%), Gaps = 3/77 (3%)

Query: 446 PKIISLNLTSEGLT--GKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
           P +  L+L+  GL+  G  S S     SL+ LDLS N +      FL  L  L  L+   
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQH 405

Query: 504 NKLSGSVPTSLVARSQN 520
           + L      S+    +N
Sbjct: 406 SNLKQMSEFSVFLSLRN 422

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.8 bits (148), Expect = 1e-09
 Identities = 24/76 (31%), Positives = 35/76 (46%), Gaps = 3/76 (3%)

Query: 436 LNCSYNGYKPPKIISL-NLTSEGLTGKISPSLSNLKSLENLDLSNNSLT--GSIPEFLSQ 492
           +NC +  +   K+ SL  LT     G  + S  +L SLE LDLS N L+  G   +    
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 493 LPLLRVLNLDGNKLSG 508
              L+ L+L  N +  
Sbjct: 372 TTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 59.7 bits (145), Expect = 3e-09
 Identities = 19/74 (25%), Positives = 33/74 (44%), Gaps = 5/74 (6%)

Query: 446 PKIISLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRV----LN 500
             +  LN+    +   K+    SNL +LE+LDLS+N +       L  L  + +    L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 501 LDGNKLSGSVPTSL 514
           L  N ++   P + 
Sbjct: 184 LSLNPMNFIQPGAF 197

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 3/88 (3%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
           P   +SL+L+   +   I P       L  L L NN  + ++ +  +  L  L V  L  
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 504 NKLSGSVPTSLVARSQNGSL-LLSIGRN 530
            +           +S    L  L+I   
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEF 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 12/72 (16%), Positives = 27/72 (37%), Gaps = 3/72 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNL-KSLENLDLSNNSLTGSIP--EFLSQLPLLRVLNLD 502
             +  L+ +   +       L +   SL  L+L+ N    +     FL  +   R L ++
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577

Query: 503 GNKLSGSVPTSL 514
             ++  + P+  
Sbjct: 578 VERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.0 bits (107), Expect = 9e-05
 Identities = 19/98 (19%), Positives = 32/98 (32%), Gaps = 8/98 (8%)

Query: 447 KIISLNLTSEGLTGKIS-PSLSNLKSLENLDLSNNSLT------GSIPEFLSQLPLLRVL 499
           ++  L L      G +     S L+ L NL +    L         I +  + L  +   
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287

Query: 500 NLDGNKLSGSVPTSLVARSQNGSLL-LSIGRNPDLCLS 536
           +L    +      S     Q+  L+    G+ P L L 
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 11/63 (17%), Positives = 18/63 (28%), Gaps = 2/63 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + S +L S  +        S     ++L+L N          L  L  L   +  G  
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339

Query: 506 LSG 508
              
Sbjct: 340 AFS 342

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 26/250 (10%)

Query: 605 DITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRV 659
           D+   +     +G+G +G V   Y   +   VAIK +S    Q   Q RT  E ++L+R 
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRF 82

Query: 660 HHRNLASLV-----GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDA 713
            H N+  +             +V +V + M   +L + L     + LS  D +       
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLS-NDHICYFLYQI 137

Query: 714 AQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI-FPAESESHISTSIVGT 772
            +GL+Y+H      ++HRD+K +N+LLN     K+ DFG +++  P    +   T  V T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 773 VGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---ER 828
             Y  PE    S   T+  D++S G +L E+++  P I  G +    +N +   L    +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP-IFPGKHYLDQLNHILGILGSPSQ 253

Query: 829 GDVRSIVDPR 838
            D+  I++ +
Sbjct: 254 EDLNCIINLK 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRV-HHRN 663
             H++LGKG FG V+       ++  AIK L                E ++L     H  
Sbjct: 20  ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQG 716
           L  +         N+  V EY+  G+L       + FD          R    A +   G
Sbjct: 80  LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--------SRATFYAAEIILG 130

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           L++LH  G    I++RD+K  NILL++    K+ADFG  K          + +  GT  Y
Sbjct: 131 LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 184

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + PE     +     D +SFG++L E++ G  
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 47/212 (22%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRV-HHRN 663
           +  R++G+G +  V    L     + A+K++        +     +TE  +  +  +H  
Sbjct: 12  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQG 716
           L  L   C      +  V EY+  G+L     +Q    E        +  +  + + +  
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--------EHARFYSAEISLA 122

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           L YLH  G    II+RD+K  N+LL+ +   KL D+G  K      ++  +++  GT  Y
Sbjct: 123 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 176

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + PE           D ++ G+++ E++ G  
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 28/212 (13%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGPKQF---RTEAQLLMRV-HHRN 663
           NF  +LGKG FG V         E+ A+K+L                E ++L        
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNL-----KQYLFDETKEALSWKDRLQI-AVDAAQG 716
           L  L   C      +  V EY+  G+L     +   F E              A + A G
Sbjct: 83  LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE--------PHAVFYAAEIAIG 133

Query: 717 LEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
           L +L   G    II+RD+K  N++L+ +   K+ADFG  K    +  +  + +  GT  Y
Sbjct: 134 LFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 187

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           + PE  A     +  D ++FG++L E++ G  
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 76.0 bits (186), Expect = 3e-14
 Identities = 99/665 (14%), Positives = 192/665 (28%), Gaps = 174/665 (26%)

Query: 277 VDSQYR-LPSAVMKTAVKPMNVNDSLDF----------DFEIGDPTLQFYVYMHFAELES 325
              QY+ + S      V   +  D  D           D  I            F  L S
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73

Query: 326 RQGNQYREFSIE-LNGN---LWEKSVVPEYLQSKTISSTQPARGSKLNFSLCK----TSN 377
           +Q    ++F  E L  N   L         ++++     QP+  +++ +   +      N
Sbjct: 74  KQEEMVQKFVEEVLRINYKFLMSP------IKTEQR---QPSMMTRM-YIEQRDRLYNDN 123

Query: 378 STLPPI-LNAIEIYI-LTDTLQEPTDQDDVNAI--MDIKLSYDLGKGW-----------Q 422
                  ++ ++ Y+ L   L E     +V  I  +        GK W           Q
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGV-----LGSGKTWVALDVCLSYKVQ 177

Query: 423 GDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNS 481
                 ++  W  LN        P+ +   L    L  +I P+  S      N+ L  +S
Sbjct: 178 CKMDFKIF--W--LNLKN--CNSPETVLEMLQK--LLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 482 LTGSIPEFLSQLPLLRVL-NLDG-------NKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
           +   +   L   P    L  L         N  + S    L  R +  +  LS      +
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 534 CLSAPCKK-EKRNSV-------------MPVVAASVSLLVI-LIALLV-----FWTYKRK 573
            L                          +P    + +   + +IA  +      W   + 
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349

Query: 574 RAARLNVDNSHSKKEGS---LKSDNQQFTYSEI------VDITNNFHRILGKGGFGTVYH 624
               +N D   +  E S   L+    +  +  +        I      ++        + 
Sbjct: 350 ----VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI--------WF 397

Query: 625 GYLADGSEVAIKMLSASS--SQGPKQFRTE---AQLLMRVHHRNLASLVGYCNDGGNVGL 679
             +     V +  L   S   + PK+         L ++V   N  +L        +  +
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL--------HRSI 449

Query: 680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL-----HHGCKPPIIHRDVK 734
           V  Y    N+ +  FD       + D            +Y      HH        R   
Sbjct: 450 VDHY----NIPKT-FDSDDLIPPYLD------------QYFYSHIGHHLKNIEHPERMTL 492

Query: 735 TANILLNEKMQAKLADFGF--SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDV 792
              + L         DF F   KI    +  + S SI+ T+     ++Y    + +    
Sbjct: 493 FRMVFL---------DFRFLEQKIRHDSTAWNASGSILNTL--QQLKFY-KPYICDNDPK 540

Query: 793 YSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVA 852
           Y    ++  ++  LP I       +++     +        ++  R+    +  ++++ A
Sbjct: 541 YE--RLVNAILDFLPKI-----EENLIC--SKYT------DLL--RIALMAEDEAIFEEA 583

Query: 853 ETAME 857
              ++
Sbjct: 584 HKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.3 bits (153), Expect = 3e-10
 Identities = 97/737 (13%), Positives = 199/737 (27%), Gaps = 267/737 (36%)

Query: 98  NKNISSKFMSANLQNTYATVRSFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDYDDEDKL 157
            + +  KF+   L+  Y  + S           R P    + Y+ +   +Y D     K 
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMS-----PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY 129

Query: 158 PEFDLYIGVNRWDSIKFDNASHVVIKEIIHSALMDEINVCL---LNTGKGTPFISALELR 214
                   V+R             +++ +   L    NV +   L +GK     + +   
Sbjct: 130 N-------VSRLQPYL-------KLRQALLE-LRPAKNVLIDGVLGSGK-----TWV--- 166

Query: 215 HFHNATYRTQSGALVLYRRLDVGSTTTQIIRFKDDHYDRI-WVPYPGFPGSASINTSFII 273
                       AL +     V          +     +I W+         ++      
Sbjct: 167 ------------ALDVCLSYKV----------QCKMDFKIFWL---------NLKNCNSP 195

Query: 274 DSLVDSQYRLPSAVMKTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYRE 333
           +++++   +L   +        + + ++          L+         L+S+    Y  
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-------LKSK---PYEN 245

Query: 334 FSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIYILT 393
             + L  N+                       +  N S CK                +LT
Sbjct: 246 CLLVLL-NVQNAKAW-----------------NAFNLS-CKI---------------LLT 271

Query: 394 DTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNL 453
              ++ TD         I L          D    +   +  L+C             +L
Sbjct: 272 TRFKQVTDFLSAATTTHISLD-HHSMTLTPDEVKSLLLKY--LDCRPQ----------DL 318

Query: 454 TSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLL--RVLNLDGNKLSGSVP 511
             E L    +P   ++                I E +           +++ +KL+  + 
Sbjct: 319 PREVL--TTNPRRLSI----------------IAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 512 TSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRN-----SVMPV-VAASVSLLVILIALL 565
           +SL       ++L      P          E R      SV P        LL ++    
Sbjct: 361 SSL-------NVL-----EPA---------EYRKMFDRLSVFPPSAHIPTILLSLI---- 395

Query: 566 VFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG 625
             W    K    + V+  H      ++   ++ T S                    +   
Sbjct: 396 --WFDVIKSDVMVVVNKLHKY--SLVEKQPKESTIS--------------------IPSI 431

Query: 626 YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL----ASLVGYCNDGGNV---- 677
           YL       +K           +   E  L     HR++         + +D        
Sbjct: 432 YL------ELK----------VKLENEYAL-----HRSIVDHYNIPKTFDSDDLIPPYLD 470

Query: 678 GLVYEYMAYGNLKQ-------------YL---FDETK---EALSWKDRLQIAVDAAQGLE 718
              Y ++ + +LK              +L   F E K   ++ +W     I  +  Q L+
Sbjct: 471 QYFYSHIGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL-NTLQQLK 528

Query: 719 -YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGY 775
            Y  + C            N    E++   + DF    +   E     S  T ++  +  
Sbjct: 529 FYKPYICD-----------NDPKYERLVNAILDF----LPKIEENLICSKYTDLL-RIAL 572

Query: 776 LDPE---YYASNRLTEK 789
           +  +   +  +++  ++
Sbjct: 573 MAEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 8e-10
 Identities = 71/466 (15%), Positives = 130/466 (27%), Gaps = 167/466 (35%)

Query: 33  TVLASDATSSGKSEKFVGHKHARRKLDDIGGDISIDCGVPAGFMYLDEKTQLSYKSDEEF 92
           T +A D                            + C +     +L+ K   +  S E  
Sbjct: 164 TWVALDVCL----------------------SYKVQCKMDFKIFWLNLK---NCNSPETV 198

Query: 93  IRTGVNKNISSKFMSANLQNTYATVR-SFPEGNRNCYSLRPPEGKAKTYLTRASFMYGDY 151
           +                LQ     +  ++   + +  +++      +  L R       Y
Sbjct: 199 L--------------EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPY 243

Query: 152 -------DD-EDK--LPEFDL---------YIGVNRWDSIKFDNASHVVIKEIIHSALMD 192
                   + ++      F+L         +  V   D +     +H+ +     +   D
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT--DFLSAATTTHISLDHHSMTLTPD 301

Query: 193 E-INVCLLNTG-----------KGTPF-IS--ALELRHFHNATYRTQSGALVLYRRLDVG 237
           E  ++ L                  P  +S  A  +R          +     ++ ++  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA---TWDN-----WKHVNCD 353

Query: 238 STTTQIIRFKD--------DHYDRIWVPYPGFPGSASI---------------NTSFIID 274
             TT I    +          +DR+ V    FP SA I               +   +++
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVN 409

Query: 275 -----SLVDSQ-----YRLPSAVMKTAVKPMNV-----------NDSLDFDFE-IGDPTL 312
                SLV+ Q       +PS  ++  VK  N            N    FD + +  P L
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469

Query: 313 QFYVYMHFAE--LESRQGNQYREFS-IELNGNLWEKSVVPEYLQSKTISSTQP--ARGSK 367
             Y Y H            +   F  + L+   +        L+ K    +    A GS 
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-F--------LEQKIRHDSTAWNASGSI 520

Query: 368 LNFSLCKTSNSTLPPILNAIEIY---ILTDTLQEPTDQDDVNAIMD 410
           LN              L  ++ Y   I      +P  +  VNAI+D
Sbjct: 521 LN-------------TLQQLKFYKPYI---CDNDPKYERLVNAILD 550

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 49/240 (20%), Positives = 99/240 (41%), Gaps = 29/240 (12%)

Query: 582 NSHSKKEGSLKSDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV-AIKMLS 639
            S  ++E    +  +    S  + + + +  R++G+G +  V    L     + A++++ 
Sbjct: 27  GSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86

Query: 640 ASSSQGPKQF---RTEAQLLMRV-HHRNLASLVGYC-NDGGNVGLVYEYMAYGNL----- 689
                  +     +TE  +  +  +H  L  L   C      +  V EY+  G+L     
Sbjct: 87  KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ 145

Query: 690 KQYLFDETKEALSWKDRLQI-AVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAK 747
           +Q    E        +  +  + + +  L YLH  G    II+RD+K  N+LL+ +   K
Sbjct: 146 RQRKLPE--------EHARFYSAEISLALNYLHERG----IIYRDLKLDNVLLDSEGHIK 193

Query: 748 LADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           L D+G  K      ++  +++  GT  Y+ PE           D ++ G+++ E++ G  
Sbjct: 194 LTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.4 bits (185), Expect = 4e-14
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 29/241 (12%)

Query: 581 DNSHSKKEGSLKSDNQQFTYSEIVDITN-NFHRILGKGGFGTVYHGYLADGSEV-AIKML 638
             +  +K  +  S        + + +T+ NF  +LGKG FG V         E+ A+K+L
Sbjct: 315 TKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL 374

Query: 639 SASSSQGPKQF---RTEAQLLMRV-HHRNLASLVGYC-NDGGNVGLVYEYMAYGNL---- 689
                           E ++L        L  L   C      +  V EY+  G+L    
Sbjct: 375 KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 690 -KQYLFDETKEALSWKDRLQI-AVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQA 746
            +   F E              A + A GL +L   G    II+RD+K  N++L+ +   
Sbjct: 434 QQVGRFKE--------PHAVFYAAEIAIGLFFLQSKG----IIYRDLKLDNVMLDSEGHI 481

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           K+ADFG  K    +  +  + +  GT  Y+ PE  A     +  D ++FG++L E++ G 
Sbjct: 482 KIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

Query: 807 P 807
            
Sbjct: 540 A 540

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.4 bits (186), Expect = 5e-14
 Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 6/85 (7%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
            +CS+          P  I  LNLT   L    + + +    L +LD+  N+++   PE 
Sbjct: 9   ADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSL 514
             +LP+L+VLNL  N+LS     + 
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTF 93

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.3 bits (178), Expect = 4e-13
 Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 3/90 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  LNL S G          +L  L+ +DL  N+L        +    L+ LNL  N 
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595

Query: 506 LSGSVPTSLVARSQNGSL-LLSIGRNPDLC 534
           ++              +L  L +  NP  C
Sbjct: 596 ITSVEKKVF--GPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 2e-12
 Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 2/88 (2%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
              +  L+L S  +    +      K+L  LDLS+N L+ +      QL  L+ L L  N
Sbjct: 96  CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

Query: 505 KLSGSVPTSLVARSQNGSLL-LSIGRNP 531
           K+   + +  +    N SL  L +  N 
Sbjct: 156 KIQA-LKSEELDIFANSSLKKLELSSNQ 182

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.6 bits (163), Expect = 2e-11
 Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 3/88 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLK--SLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
             +  L L++  +    S  L      SL+ L+LS+N +    P     +  L  L L+ 
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204

Query: 504 NKLSGSVPTSLVARSQNGSLL-LSIGRN 530
            +L  S+   L     N S+  LS+  +
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNS 232

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.2 bits (162), Expect = 3e-11
 Identities = 16/69 (23%), Positives = 27/69 (39%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P +  LNL    L+     + +   +L  L L +NS+         +   L  L+L  N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 506 LSGSVPTSL 514
           LS +   + 
Sbjct: 133 LSSTKLGTQ 141

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.2 bits (162), Expect = 3e-11
 Identities = 12/69 (17%), Positives = 26/69 (37%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++ SL++    ++         L  L+ L+L +N L+    +  +    L  L+L  N 
Sbjct: 49  SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

Query: 506 LSGSVPTSL 514
           +        
Sbjct: 109 IQKIKNNPF 117

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 65.4 bits (160), Expect = 5e-11
 Identities = 11/64 (17%), Positives = 24/64 (37%), Gaps = 1/64 (1%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L+L    +  +++      L+++  + LS N          + +P L+ L L   
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464

Query: 505 KLSG 508
            L  
Sbjct: 465 ALKN 468

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 20/71 (28%), Positives = 33/71 (46%), Gaps = 2/71 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLK--SLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
             I +L+L++  L+   + +   LK  +L  LDLS N+L     +  + LP L    L+ 
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281

Query: 504 NKLSGSVPTSL 514
           N +      SL
Sbjct: 282 NNIQHLFSHSL 292

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.3 bits (152), Expect = 4e-10
 Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 2/85 (2%)

Query: 448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
               +++   L      S   LK LE+L++ +N + G      + L  L+ L+L  +  S
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 508 GSVPTSLVARSQNGSLL--LSIGRN 530
               T+    S   S L  L++ +N
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKN 391

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.2 bits (149), Expect = 1e-09
 Identities = 14/63 (22%), Positives = 22/63 (34%)

Query: 452 NLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVP 511
            L      G     L  L  L  L+L +N       E    L  L++++L  N L+    
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 512 TSL 514
           +  
Sbjct: 578 SVF 580

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.8 bits (148), Expect = 2e-09
 Identities = 18/70 (25%), Positives = 28/70 (40%)

Query: 442 GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL 501
           G K   +  L+L+   L    + S + L  LE   L  N++       L  L  +R LNL
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 502 DGNKLSGSVP 511
             +    S+ 
Sbjct: 304 KRSFTKQSIS 313

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 19/64 (29%), Positives = 28/64 (43%), Gaps = 2/64 (3%)

Query: 446 PKIISLNLTSEGLTG--KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
           P +  L L    L            L++L  LDLSNN++     + L  L  L +L+L  
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQH 513

Query: 504 NKLS 507
           N L+
Sbjct: 514 NNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.6 bits (145), Expect = 4e-09
 Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 3/74 (4%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS---QLPLLRVLN 500
               +  L L+S  +          +  L  L L+N  L  S+ E L        +R L+
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228

Query: 501 LDGNKLSGSVPTSL 514
           L  ++LS +  T+ 
Sbjct: 229 LSNSQLSTTSNTTF 242

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.2 bits (136), Expect = 4e-08
 Identities = 16/69 (23%), Positives = 31/69 (44%), Gaps = 2/69 (2%)

Query: 447 KIISLNLTSEGLTGKISPSLSNL--KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           K +SL+ +   L    + +  +L    L  L+L+ N ++    +  S L  L VL+L  N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 505 KLSGSVPTS 513
           ++   +   
Sbjct: 416 EIGQELTGQ 424

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 5/74 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLS---NLKSLENLDLSNNSLTGSIPEFLSQLPL--LRVLN 500
            ++  L L +  L   ++  L       S+ NL LSN+ L+ +       L    L +L+
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254

Query: 501 LDGNKLSGSVPTSL 514
           L  N L+     S 
Sbjct: 255 LSYNNLNVVGNDSF 268

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 9e-08
 Identities = 16/78 (20%), Positives = 26/78 (33%), Gaps = 9/78 (11%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN---------SLTGSIPEFLSQLPLL 496
           P++    L    +    S SL  L ++  L+L  +         SL          L  L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 497 RVLNLDGNKLSGSVPTSL 514
             LN++ N + G      
Sbjct: 332 EHLNMEDNDIPGIKSNMF 349

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 21/73 (28%), Positives = 31/73 (42%), Gaps = 4/73 (5%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN--SLTGSIPEFLSQLPL--LRVLNL 501
             +  LN+    + G  S   + L +L+ L LSN+  SL     E    L    L +LNL
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 502 DGNKLSGSVPTSL 514
             NK+S     + 
Sbjct: 389 TKNKISKIESDAF 401

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 50/260 (19%), Positives = 85/260 (32%), Gaps = 76/260 (29%)

Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRT---EAQLLM 657
           E      +  + LG G FG V   +  + G   A+K +        +  R    E  ++ 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMK 55

Query: 658 RVHHRNLASL--VGYCNDGGNVG------------------------------------L 679
            + H N+  L    Y                                            +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 680 VYEYM---------AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH-HGCKPPII 729
           + EY+         ++    + +         +    Q+     + + ++H  G    I 
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIY----QLF----RAVGFIHSLG----IC 163

Query: 730 HRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE-YYASNRLT 787
           HRD+K  N+L+N +    KL DFG +K       S  S + + +  Y  PE    +   T
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKL---IPSEPSVAYICSRFYRAPELMLGATEYT 220

Query: 788 EKSDVYSFGIVLLELITGLP 807
              D++S G V  ELI G P
Sbjct: 221 PSIDLWSIGCVFGELILGKP 240

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 44/248 (17%), Positives = 88/248 (35%), Gaps = 59/248 (23%)

Query: 603 IVDITNNFHRI---LGKGGFGTVYHGY---------LADGSEVAIKMLSASS-------- 642
           + D +    ++     +   G +Y                 + ++K+ +           
Sbjct: 36  LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95

Query: 643 ---SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA---YG-NLKQYLFD 695
              +  P Q     +L        + + +G+          Y ++     G +L Q   D
Sbjct: 96  FQRAAKPLQVNKWKKL-YSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSL-QSALD 149

Query: 696 ET-KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAK--LADFG 752
            + K  LS +  LQ+A      LE+LH       +H +V   NI ++ + Q++  LA +G
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206

Query: 753 FSKIFPAESESHI------STSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLL 800
           F+  +   S  H+       +   G +       + S         + +SD+ S G  +L
Sbjct: 207 FAFRY-CPSGKHVAYVEGSRSPHEGDL------EFISMDLHKGCGPSRRSDLQSLGYCML 259

Query: 801 ELITG-LP 807
           + + G LP
Sbjct: 260 KWLYGFLP 267

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 33/226 (14%)

Query: 605 DITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRV 659
           D+ + +   + LG GG G V+          VAIK +  +  Q  K      E +++ R+
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALREIKIIRRL 65

Query: 660 HHRNLASL--------------VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD 705
            H N+  +              VG   +  +V +V EYM   +L   L    +  L  ++
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLL-EE 120

Query: 706 RLQ-IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIF-PAESE 762
             +       +GL+Y+H      ++HRD+K AN+ +N E +  K+ DFG ++I  P  S 
Sbjct: 121 HARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 763 SHISTSIVGTVGYLDPE-YYASNRLTEKSDVYSFGIVLLELITGLP 807
               +  + T  Y  P    + N  T+  D+++ G +  E++TG  
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 38/265 (14%)

Query: 596 QQFTYSEIVDITNNFH--------RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP 646
             F   E+      +         + +G G +G V        G++VAIK L        
Sbjct: 9   SGFYRQEVTKTA--WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66

Query: 647 KQFRT--EAQLLMRVHHRNLASLV------GYCNDGGNVGLVYEYMAYGNLKQYLFDETK 698
              R   E +LL  + H N+  L+         +D  +  LV  +M   +L + +     
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM---KH 122

Query: 699 EALSWKDRLQ-IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF 757
           E L  +DR+Q +     +GL Y+H      IIHRD+K  N+ +NE  + K+ DFG     
Sbjct: 123 EKLG-EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL---- 174

Query: 758 PAESESHISTSIVGTVGYLDPEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT 816
            A       T  V T  Y  PE      R T+  D++S G ++ E+ITG   + +G ++ 
Sbjct: 175 -ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHL 232

Query: 817 HIVNRVCPFL---ERGDVRSIVDPR 838
             +  +           V+ +    
Sbjct: 233 DQLKEIMKVTGTPPAEFVQRLQSDE 257

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 32/249 (12%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLV 668
            +LG+G +G V        G  VAIK +           RT  E ++L    H N+ ++ 
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENIITIF 75

Query: 669 -----GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDAAQGLEYLHH 722
                    +   V ++ E M   +L + +   + + LS  D +Q       + ++ LH 
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQT-DLHRVI---STQMLS-DDHIQYFIYQTLRAVKVLHG 130

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--------TSIVGTVG 774
                +IHRD+K +N+L+N     K+ DFG ++I    +  +             V T  
Sbjct: 131 SN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187

Query: 775 YLDPEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL----ERG 829
           Y  PE    S + +   DV+S G +L EL    P I  G +  H +  +   +       
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP-IFPGRDYRHQLLLIFGIIGTPHSDN 246

Query: 830 DVRSIVDPR 838
           D+R I  PR
Sbjct: 247 DLRCIESPR 255

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 51/227 (22%), Positives = 99/227 (43%), Gaps = 32/227 (14%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLL--MRVHHRNLASL- 667
           R LG+G +  V+    + +  +V +K+L     +  K  R E ++L  +R    N+ +L 
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKR-EIKILENLR-GGPNIITLA 97

Query: 668 -VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKD----RLQIAVDAAQGLEYLH- 721
            +          LV+E++   + KQ       + L+  D      +I     + L+Y H 
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL----KALDYCHS 148

Query: 722 HGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
            G    I+HRDVK  N++++ E  + +L D+G ++ +            V +  +  PE 
Sbjct: 149 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPEL 201

Query: 781 YASNRLTEKS-DVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL 826
               ++ + S D++S G +L  +I        G++N   + R+   L
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 28/242 (11%)

Query: 611 HRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASL 667
              +G G +G+V   +    G  VA+K LS          RT  E +LL  + H N+  L
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 93

Query: 668 V------GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDAAQGLEYL 720
           +          +  +V LV   M   +L   +     + L+  D +Q +     +GL+Y+
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV---KCQKLT-DDHVQFLIYQILRGLKYI 148

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE- 779
           H      IIHRD+K +N+ +NE  + K+ DFG      A   +   T  V T  Y  PE 
Sbjct: 149 HSA---DIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTADEMTGYVATRWYRAPEI 200

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL---ERGDVRSIVD 836
                   +  D++S G ++ EL+TG   +  G ++   +  +   +       ++ I  
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 837 PR 838
             
Sbjct: 260 ES 261

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 37/221 (16%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV--------HHR 662
           R LG G F TV+    + + + VA+K++        +    E +LL RV           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 663 NLASLVG------YCNDGGN-VGLVYEYMA---YGNLKQYLFDETKEALSWKDRLQIAVD 712
               ++       +    G  V +V+E +       +K+Y        +      QI+  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQ 139

Query: 713 AAQGLEYLHHGCKPPIIHRDVKTANILLNE------KMQAKLADFGFSKIFPAESESHIS 766
              GL+Y+H  C   IIH D+K  N+L+         +Q K+AD G +  +         
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACW----YDEHY 192

Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           T+ + T  Y  PE          +D++S   ++ ELITG  
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 56/261 (21%), Positives = 97/261 (37%), Gaps = 41/261 (15%)

Query: 585 SKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSS 643
           S +E       +     +   I      ++G+G +G VY  Y       VAIK ++    
Sbjct: 9   SGRENLYFQGIKNVHVPDNYIIK----HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 644 QGPKQFRT--EAQLLMRVHHRNLASLV-----GYCNDGGNVGLVYEYMAYGNLKQYLFDE 696
                 R   E  +L R+    +  L              + +V E     +LK+    +
Sbjct: 65  DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF--K 121

Query: 697 TKEALSWKDRLQ-IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK 755
           T   L+ ++ ++ I  +   G  ++H      IIHRD+K AN LLN+    K+ DFG ++
Sbjct: 122 TPIFLT-EEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

Query: 756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTE--------------------KS-DVYS 794
              +E +++I   +               +LT                     KS D++S
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237

Query: 795 FGIVLLELITGLPAIIRGYNN 815
            G +  EL+  L + I    N
Sbjct: 238 TGCIFAELLNMLQSHINDPTN 258

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 3e-12
 Identities = 19/85 (22%), Positives = 27/85 (31%), Gaps = 6/85 (7%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
            NC   G        P     L  +   L    + + S L +L  LDL+   +     + 
Sbjct: 17  YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSL 514
                 L  L L  N L     T+L
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETAL 101

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.0 bits (159), Expect = 7e-11
 Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 6/88 (6%)

Query: 446 PKIISLNLTS---EGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLD 502
           P +  LNL          + + SL  L  LE L LS   L+       + L ++  ++L 
Sbjct: 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508

Query: 503 GNKLSGSVPTSLVARSQNGSLLLSIGRN 530
            N+L+ S   +L   S    + L++  N
Sbjct: 509 HNRLTSSSIEAL---SHLKGIYLNLASN 533

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.9 bits (156), Expect = 1e-10
 Identities = 19/87 (21%), Positives = 35/87 (40%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P  +  L     G++      L N K+LE+L L +N ++            L+VL+   N
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163

Query: 505 KLSGSVPTSLVARSQNGSLLLSIGRNP 531
            +       + +  Q  +L L++  N 
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGND 190

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 2/87 (2%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P++  L+L    L  K + S   NL  L+ L+LS++ L  S  +    LP L+ LNL GN
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459

Query: 505 KLSGSVPTSLVARSQNGSL-LLSIGRN 530
                      +    G L +L +   
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFC 486

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.5 bits (155), Expect = 2e-10
 Identities = 15/69 (21%), Positives = 26/69 (37%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++ +L LT+  L      +LS  K+L++L      ++      L     L  L L  N 
Sbjct: 81  HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140

Query: 506 LSGSVPTSL 514
           +S       
Sbjct: 141 ISSIKLPKG 149

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 61.2 bits (149), Expect = 1e-09
 Identities = 28/86 (32%), Positives = 46/86 (53%), Gaps = 3/86 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L L+   L+     + ++LK + ++DLS+N LT S  E LS L  +  LNL  N 
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534

Query: 506 LSGSVPTSLVARSQNGSLLLSIGRNP 531
           +S  +P+ L   SQ  ++ L   +NP
Sbjct: 535 ISIILPSLLPILSQQRTINLR--QNP 558

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.0 bits (146), Expect = 2e-09
 Identities = 14/69 (20%), Positives = 23/69 (33%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+LT   +      +  +   L+ L L+ N L       LS    L+ L      
Sbjct: 57  INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116

Query: 506 LSGSVPTSL 514
           +S      L
Sbjct: 117 ISSIDFIPL 125

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 59.3 bits (144), Expect = 4e-09
 Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 1/68 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+LT+  L+ ++   L  L +L+ L LS N          S  P L  L++ GN 
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336

Query: 506 LSGSVPTS 513
               + T 
Sbjct: 337 KRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.1 bits (141), Expect = 1e-08
 Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 1/74 (1%)

Query: 441 NGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLN 500
            G     + S+NL         S +      L+ LDL+   L+  +P  L  L  L+ L 
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307

Query: 501 LDGNKLSGSVPTSL 514
           L  NK       S 
Sbjct: 308 LSANKFENLCQISA 321

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 1/69 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSI-PEFLSQLPLLRVLNLDGN 504
             +  L L++         S SN  SL +L +  N+    +    L  L  LR L+L  +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 505 KLSGSVPTS 513
            +  S   +
Sbjct: 361 DIETSDCCN 369

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 16/67 (23%), Positives = 23/67 (34%), Gaps = 3/67 (4%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSI---PEFLSQLPLLRVLNL 501
              +  LNL+   L          L +L++L+L  N            L  L  L +L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 502 DGNKLSG 508
               LS 
Sbjct: 484 SFCDLSS 490

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 56.6 bits (137), Expect = 3e-08
 Identities = 17/71 (23%), Positives = 30/71 (42%), Gaps = 2/71 (2%)

Query: 446 PKIISLNLTSEGLT--GKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
             +  L+L+ + +      +  L NL  L++L+LS N       E   + P L +L+L  
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409

Query: 504 NKLSGSVPTSL 514
            +L      S 
Sbjct: 410 TRLKVKDAQSP 420

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 1/64 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  ++L+   LT     +LS+LK +  L+L++N ++  +P  L  L   R +NL  N 
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558

Query: 506 LSGS 509
           L  +
Sbjct: 559 LDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.9 bits (117), Expect = 7e-06
 Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
            ++  E ++  +   L  + S+E+++L  +               L+ L+L    LS  +
Sbjct: 236 EDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293

Query: 511 PTSL 514
           P+ L
Sbjct: 294 PSGL 297

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 12/86 (13%), Positives = 28/86 (32%), Gaps = 3/86 (3%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL--LRVLNLDGN 504
             +SLNL    + G I P   +    ++L+         I + L    +  L +   +  
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 505 KLSGSVPTSLVARSQNGSLLLSIGRN 530
                 P       +     +++ ++
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKH 264

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 12/69 (17%), Positives = 19/69 (27%), Gaps = 4/69 (5%)

Query: 450 SLNLTSEGLTGKISPSLSN--LKSLENLDLSNNSLTGSIPEFLSQLPL--LRVLNLDGNK 505
           SLN         I   L N  ++SL      +       P     L    +  +NL  + 
Sbjct: 206 SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

Query: 506 LSGSVPTSL 514
                  + 
Sbjct: 266 FFNISSNTF 274

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 5e-12
 Identities = 44/236 (18%), Positives = 90/236 (38%), Gaps = 35/236 (14%)

Query: 572 RKRAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFH--RILGKGGFGTVYHGY-LA 628
            ++  +    +  SK   S+   +  +       I + +    ++G G +G V   Y   
Sbjct: 23  SQQEGQQRKQHHSSKPTASMPRPHSDW------QIPDRYEIRHLIGTGSYGHVCEAYDKL 76

Query: 629 DGSEVAIKMLS--ASSSQGPKQFRT--EAQLLMRVHHRNLASLV-----GYCNDGGNVGL 679
           +   VAIK +          K  R   E  +L R++H ++  ++             + +
Sbjct: 77  EKRVVAIKKILRVFEDLIDCK--RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134

Query: 680 VYEYMAYGNLKQYLFDETKEALSWKDRLQ-IAVDAAQGLEYLH-HGCKPPIIHRDVKTAN 737
           V E     + K+     T   L+ +  ++ +  +   G++Y+H  G    I+HRD+K AN
Sbjct: 135 VLEIADS-DFKKLF--RTPVYLT-ELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPAN 186

Query: 738 ILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR-----LTE 788
            L+N+    K+ DFG ++        +    I      ++   +   +     LT 
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 68.0 bits (166), Expect = 9e-12
 Identities = 22/124 (17%), Positives = 46/124 (37%), Gaps = 8/124 (6%)

Query: 414 SYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLE 473
           +      W  +    M+    G++   NG    ++  L+L   G  G++  ++  L  L+
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNG----RVTGLSLAGFGAKGRVPDAIGQLTELK 350

Query: 474 NLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL----LSIGR 529
            L    +S T S   F  +     +     +++        +   Q  +L      +I R
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410

Query: 530 NPDL 533
           NP++
Sbjct: 411 NPEM 414

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 67.2 bits (164), Expect = 2e-11
 Identities = 18/59 (30%), Positives = 26/59 (44%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
             N            S SNLK L +++L N      +P+FL  LP L+ LN+  N+   
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 62.2 bits (151), Expect = 7e-10
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 8/89 (8%)

Query: 433 WDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT-------GS 485
              ++CS + YK     ++ L+   +    +   +    +  + LSNN +T         
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKP 719

Query: 486 IPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
                    LL  ++L  NKL+ S+    
Sbjct: 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDF 747

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 16/101 (15%), Positives = 31/101 (30%)

Query: 432 SWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS 491
           +W   + + N        + N   +    +    L N   +  L L+     G +P+ + 
Sbjct: 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG 344

Query: 492 QLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPD 532
           QL  L+VL+   +  + S                   R   
Sbjct: 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.1 bits (143), Expect = 5e-09
 Identities = 10/56 (17%), Positives = 19/56 (33%)

Query: 452 NLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            + SEG     S       +   + LS N +     E  +    +  + L  N ++
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.1 bits (143), Expect = 5e-09
 Identities = 16/116 (13%), Positives = 35/116 (30%), Gaps = 28/116 (24%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLE------NLDLSNNSLTGSIPEFLSQLPLLRVL 499
           P + +++++    +        N   L+        D   N +    P  ++  P L  L
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811

Query: 500 NLDGNKLSG--------------------SVP-TSLVARSQNGSLLLSIGRNPDLC 534
            +  N +                      S+  TS+    + G  +L   +  D+ 
Sbjct: 812 QIGSNDIRKVDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIR 867

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.3 bits (141), Expect = 1e-08
 Identities = 13/73 (17%), Positives = 27/73 (36%), Gaps = 7/73 (9%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLP 494
           LN + N     + IS        T +++        ++   +  N+L        L ++ 
Sbjct: 520 LNIACN-----RGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573

Query: 495 LLRVLNLDGNKLS 507
            L +L+   NK+ 
Sbjct: 574 KLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.8 bits (137), Expect = 3e-08
 Identities = 17/77 (22%), Positives = 32/77 (41%), Gaps = 10/77 (12%)

Query: 446 PKIISLNLTSEGLTGKISPSL--SNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL-- 501
             + +++L    LT  +S     + L  L N+D+S N  + S P        L+   +  
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRH 785

Query: 502 ----DGNKLSGSVPTSL 514
               +GN++    PT +
Sbjct: 786 QRDAEGNRILRQWPTGI 802

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 1/55 (1%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARS 518
            +      L +L L  N +     +F +    +  L    NKL   +P    A+S
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 9e-08
 Identities = 13/84 (15%), Positives = 25/84 (29%), Gaps = 20/84 (23%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-------------------SIPEFL 490
            +   +  +T  IS ++  L  L+ +  +N+  T                    +     
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
           S L  L  + L        +P  L
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 50.3 bits (120), Expect = 3e-06
 Identities = 10/94 (10%), Positives = 24/94 (25%), Gaps = 15/94 (15%)

Query: 436 LNCSYN---------GYKPPKIISLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTGS 485
           L   YN              ++  L  +   L       +  ++  + ++D S N +   
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSE 659

Query: 486 IPEFLSQLPL-----LRVLNLDGNKLSGSVPTSL 514
                  +          + L  N++        
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 7e-06
 Identities = 8/94 (8%), Positives = 29/94 (30%), Gaps = 9/94 (9%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG------SIPEFLSQLPLLRV 498
             ++   +L  + +    +P +  +K    + L +  +         I + + +L  L++
Sbjct: 395 DQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452

Query: 499 LNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPD 532
           +    +  +     ++     N            
Sbjct: 453 IYFANSPFTY-DNIAVDWEDANSDYAKQYENEEL 485

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.7 bits (166), Expect = 1e-11
 Identities = 21/85 (24%), Positives = 29/85 (34%), Gaps = 6/85 (7%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
             C            P    +++L+   L    S S SN   L+ LDLS   +     + 
Sbjct: 16  YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSL 514
              L  L  L L GN +    P S 
Sbjct: 76  WHGLHHLSNLILTGNPIQSFSPGSF 100

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 65.1 bits (159), Expect = 6e-11
 Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
              +  L+L+   L          L  L+ L++S+N+L        +QL  L  L+   N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 505 KLSGSVPTSLVARSQNGSL-LLSIGRNP 531
           ++  S            SL   ++  N 
Sbjct: 532 RIETSKGILQ---HFPKSLAFFNLTNNS 556

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.7 bits (158), Expect = 8e-11
 Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 1/83 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGN 504
             + +L      L    S  +  L +L+ L++++N +    +P + S L  L  ++L  N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 505 KLSGSVPTSLVARSQNGSLLLSI 527
            +       L    +N  + LS+
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSL 186

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.4 bits (152), Expect = 4e-10
 Identities = 18/63 (28%), Positives = 25/63 (39%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + +L LT   +      S S L SLENL      L       + QL  L+ LN+  N 
Sbjct: 80  HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139

Query: 506 LSG 508
           +  
Sbjct: 140 IHS 142

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 61.6 bits (150), Expect = 7e-10
 Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 1/76 (1%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
            ++  L+     L      S   +L+ L  LD+S  +           L  L  L + GN
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

Query: 505 KLSGSVPTSLVARSQN 520
               +  +++ A + N
Sbjct: 459 SFKDNTLSNVFANTTN 474

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 61.6 bits (150), Expect = 8e-10
 Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 1/70 (1%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             + +L +           +  +N  +L  LDLS   L          L  L++LN+  N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 505 KLSGSVPTSL 514
            L     +  
Sbjct: 508 NLLFLDSSHY 517

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 61.2 bits (149), Expect = 9e-10
 Identities = 15/69 (21%), Positives = 25/69 (36%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L+L+   +      +   L  L NL L+ N +    P   S L  L  L     K
Sbjct: 56  SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 506 LSGSVPTSL 514
           L+      +
Sbjct: 116 LASLESFPI 124

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 58.1 bits (141), Expect = 9e-09
 Identities = 16/62 (25%), Positives = 24/62 (38%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  LN++   L    S   + L SL  LD S N +  S          L   NL  N 
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556

Query: 506 LS 507
           ++
Sbjct: 557 VA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 3/87 (3%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLK--SLENLDLSNNSLTGSIPEFLSQL 493
            + S+     P +  L+L+   L+     S S+L   SL +LDLS N     +      L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398

Query: 494 PLLRVLNLDGNKLSGSVPTSLVARSQN 520
             L+ L+   + L      S     + 
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEK 425

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 51.6 bits (124), Expect = 8e-07
 Identities = 15/67 (22%), Positives = 27/67 (40%), Gaps = 5/67 (7%)

Query: 446 PKIISLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQL----PLLRVLN 500
             +  LN+    +   K+    SNL +L ++DLS N +       L  L     +   L+
Sbjct: 128 ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187

Query: 501 LDGNKLS 507
           +  N + 
Sbjct: 188 MSLNPID 194

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 27/91 (29%), Positives = 35/91 (38%), Gaps = 10/91 (10%)

Query: 425 PCSPMYYSWDGLNCSYN------GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLS 478
              P ++ W  L+              P + SL LT    +  IS     L SL  LDLS
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS 358

Query: 479 NNSLTGSIPEFLSQLPL--LRVLNLDGNKLS 507
            N+L+ S     S L    LR L+L  N   
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 17/91 (18%), Positives = 27/91 (29%), Gaps = 2/91 (2%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLD 502
            P   +SL+++   +   I         L  L L  N  + +I +  L  L  L V  L 
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237

Query: 503 GNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
             +        +   S    L         L
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.9 bits (112), Expect = 3e-05
 Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 5/81 (6%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           SL++    L         +L  L++L L+ N  +    + ++ LP L  L+L  N LS S
Sbjct: 311 SLSIIRCQLK---QFPTLDLPFLKSLTLTMNKGS-ISFKKVA-LPSLSYLDLSRNALSFS 365

Query: 510 VPTSLVARSQNGSLLLSIGRN 530
              S      N    L +  N
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFN 386

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 2/67 (2%)

Query: 448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           I    LT              L ++  + L+  S+   + +   +    + L++   +L 
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDV-PKHFKWQSLSIIRCQLK 320

Query: 508 GSVPTSL 514
                 L
Sbjct: 321 QFPTLDL 327

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 6/93 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLK----SLENLDLSNNSLTGSIPEFLSQLPLLRVLNL 501
             ++ ++L+   +       L  L+       +LD+S N +     +    +  L  L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTL 211

Query: 502 DGNKLSGSVPTSLVARSQNGSLL-LSIGRNPDL 533
            GN  S ++  + +       +  L +G   D 
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 20/215 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR------NL 664
           +++GKG FG V   Y       VA+KM+  +  +  +Q   E ++L  +  +      N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             ++       ++ + +E ++  NL + +     +  S     + A    Q L+ LH   
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217

Query: 725 KPPIIHRDVKTANILLNEKMQA--KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
           K  IIH D+K  NILL ++ ++  K+ DFG S  +    E     + + +  Y  PE   
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCY----EHQRVYTYIQSRFYRAPEVIL 272

Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTH 817
             R     D++S G +L EL+TG P ++ G +   
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYP-LLPGEDEGD 306

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 24/255 (9%)

Query: 582 NSHSKKEGSLKS--DNQQFTYSEIVD--ITNNFH--RILGKGGFGTVYHGY-LADGSEVA 634
           +SH K+        D+  + Y         + +    ++GKG FG V   Y   +   VA
Sbjct: 24  SSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVA 83

Query: 635 IKMLSASSSQGPKQFRTEAQLLMRVHHR------NLASLVGYCNDGGNVGLVYEYMAYGN 688
           IK++  +      Q + E +LL  ++         +  L  +     ++ LV+E ++Y N
Sbjct: 84  IKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-N 141

Query: 689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL--NEKMQA 746
           L   L +     +S     + A      L +L    +  IIH D+K  NILL   ++   
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           K+ DFG S               + +  Y  PE           D++S G +L+E+ TG 
Sbjct: 201 KIVDFG-SSCQ----LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

Query: 807 PAIIRGYNNTHIVNR 821
           P +  G N    +N+
Sbjct: 256 P-LFSGANEVDQMNK 269

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 17/71 (23%), Positives = 30/71 (42%), Gaps = 3/71 (4%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
             P  ++L L S  L  +       L  L+++ +    L   +P+ + Q   L  L L  
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 504 NKLSGSVPTSL 514
           N L  ++P S+
Sbjct: 137 NPLR-ALPASI 146

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 10/100 (10%)

Query: 436 LNCSYNGYK--PPKI------ISLNLTSEGLTGKISPSLSNLKSLENLDLSN-NSLTGSI 486
           L    +      P I        L+L          P       L+ L L + ++L  ++
Sbjct: 211 LKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TL 269

Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLS 526
           P  + +L  L  L+L G      +P+ +     N  +L+ 
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 2/65 (3%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           SL L   G+   +  S++NL++L++L + N+ L+ ++   +  LP L  L+L G     +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244

Query: 510 VPTSL 514
            P   
Sbjct: 245 YPPIF 249

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.5 bits (124), Expect = 7e-07
 Identities = 13/56 (23%), Positives = 23/56 (41%), Gaps = 3/56 (5%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN---KLSGSVPTSLVA 516
             +  L  LE LDL        +P  ++QLP   ++ +  +   +L    P +  A
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 19/96 (19%)

Query: 436 LNCSYNGYK--PPKI------ISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIP 487
           +     G    P  +       +L L    L   +  S+++L  L  L +        +P
Sbjct: 109 MTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167

Query: 488 EFLSQLPL---------LRVLNLDGNKLSGSVPTSL 514
           E L+             L+ L L+   +  S+P S+
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 11/83 (13%), Positives = 30/83 (36%), Gaps = 6/83 (7%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTG--KISPSLSNLKS--LENLDLSNNSLTGSIPEFLS 491
            N  ++ ++     +  + +         +  L +        L+L +  L    P+   
Sbjct: 43  RNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101

Query: 492 QLPLLRVLNLDGNKLSGSVPTSL 514
           +L  L+ + +D   L   +P ++
Sbjct: 102 RLSHLQHMTIDAAGLM-ELPDTM 123

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 61.8 bits (151), Expect = 3e-10
 Identities = 22/81 (27%), Positives = 31/81 (38%), Gaps = 5/81 (6%)

Query: 436 LNCSYNG-YKPPKIISL-NLTSEGLTG-KIS--PSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L    N       +  L  L    +   +IS    L+NL  L +L L+NN L     E +
Sbjct: 248 LEIGTNQISDINAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVI 307

Query: 491 SQLPLLRVLNLDGNKLSGSVP 511
             L  L  L L  N ++   P
Sbjct: 308 GGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++ SL L +  L  +    +  L +L  L LS N +T   P  L+ L  +   +     
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

Query: 506 LS 507
           + 
Sbjct: 345 IK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 55.2 bits (134), Expect = 4e-08
 Identities = 15/66 (22%), Positives = 27/66 (40%), Gaps = 3/66 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L L  + ++      L+NL  + +L+L  N    S    LS +  L  L +  +K
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK 166

Query: 506 LSGSVP 511
           +    P
Sbjct: 167 VKDVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 7e-08
 Identities = 16/87 (18%), Positives = 38/87 (43%), Gaps = 8/87 (9%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L + +  ++  I+  + +L  L+ L++ +N ++      L+ L  L  L L+ N+
Sbjct: 243 SQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQ 298

Query: 506 LSGSVPTSLVARSQNGSL-LLSIGRNP 531
           L       +       +L  L + +N 
Sbjct: 299 LGNEDMEVI---GGLTNLTTLFLSQNH 322

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.1 bits (131), Expect = 1e-07
 Identities = 19/62 (30%), Positives = 29/62 (46%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             I  L +  E +   I   +  L +LE L+L+ N +T   P  LS L  L  L +  NK
Sbjct: 44  ESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99

Query: 506 LS 507
           ++
Sbjct: 100 IT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 53.3 bits (129), Expect = 2e-07
 Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 8/82 (9%)

Query: 436 LNCSYNGY--KPPKIISL-NLTSEGLTG-KIS--PSLSNLKSLENLDLSNNSLTGSIPEF 489
           LN   N        + ++  L    +T  K+     ++NL  L +L L+ N +    P  
Sbjct: 137 LNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISP-- 194

Query: 490 LSQLPLLRVLNLDGNKLSGSVP 511
           L+ L  L       N+++   P
Sbjct: 195 LASLTSLHYFTAYVNQITDITP 216

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 14/63 (22%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +         +T      ++N+  L +L + NN +T   P  L+ L  L  L +  N+
Sbjct: 199 TSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ 254

Query: 506 LSG 508
           +S 
Sbjct: 255 ISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.8 bits (125), Expect = 6e-07
 Identities = 16/66 (24%), Positives = 29/66 (43%), Gaps = 4/66 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            + I   L    +T     +   L+S+  L ++   +  SI   +  L  L  LNL+GN+
Sbjct: 22  AEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQ 77

Query: 506 LSGSVP 511
           ++   P
Sbjct: 78  ITDISP 83

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 47.5 bits (114), Expect = 1e-05
 Identities = 11/58 (18%), Positives = 23/58 (39%), Gaps = 4/58 (6%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           +L      +  +I P  ++L       L   S+T  +     +L  +  L + G K++
Sbjct: 4   TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 53/232 (22%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQ------LLMR--VHHR 662
           + LGKG +G V+       G  VA+K +         Q  T+AQ      +++     H 
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIF-----DAFQNSTDAQRTFREIMILTELSGHE 69

Query: 663 NLASL--VGYCNDGGNVGLVYEYMAYGNLK-----QYLFDETKEALSWKDRLQIAVDAAQ 715
           N+ +L  V   ++  +V LV++YM   +L        L    K+ + +    Q+     +
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVY----QLI----K 120

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            ++YLH G    ++HRD+K +NILLN +   K+ADFG S+ F        +  +      
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 776 LDP--------EYYA------------SNRLTEKSDVYSFGIVLLELITGLP 807
            +         +Y A            S + T+  D++S G +L E++ G P
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 2/79 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            K+ +L+L+S  L   + P   +   +  + L NN L   I + L     L   +L GN 
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248

Query: 506 LSGSVPTSLVARSQNGSLL 524
                     +++Q    +
Sbjct: 249 FHCGTLRDFFSKNQRVQTV 267

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.9 bits (138), Expect = 9e-09
 Identities = 15/57 (26%), Positives = 25/57 (43%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
             +T   L   ++    +  +++ LDLS N L+      L+    L +LNL  N L 
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 17/62 (27%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L+   L+   +  L+    LE L+LS+N L     +    L  LR L+L+ N 
Sbjct: 34  WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNY 91

Query: 506 LS 507
           + 
Sbjct: 92  VQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 6/76 (7%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL 523
                   L+ LDLS+N L   +         +  ++L  NKL   +  +L     + +L
Sbjct: 185 KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL---RFSQNL 239

Query: 524 -LLSIGRNPDLCLSAP 538
               +  N   C +  
Sbjct: 240 EHFDLRGNGFHCGTLR 255

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 12/59 (20%), Positives = 22/59 (37%), Gaps = 1/59 (1%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGNKLS 507
           ++ L +  +T            ++ LDL  N +   +  E  +    L  LNL  N + 
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 18/89 (20%), Positives = 37/89 (41%), Gaps = 7/89 (7%)

Query: 436 LNCSYNG----YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS 491
           L+ + N        P I +L+  +  ++ ++S S    +  +N+ L+NN +T        
Sbjct: 85  LDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEG 141

Query: 492 QLPLLRVLNLDGNKLSGSVPTSLVARSQN 520
               ++ L+L  N++       L A S  
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDT 170

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 9/40 (22%), Positives = 19/40 (47%)

Query: 468 NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           N    +   ++++SL  ++         ++ L+L GN LS
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 2/79 (2%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            K+ +L+L+S  L   + P   +   +  + L NN L   I + L     L   +L GN 
Sbjct: 191 AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248

Query: 506 LSGSVPTSLVARSQNGSLL 524
                     +++Q    +
Sbjct: 249 FHCGTLRDFFSKNQRVQTV 267

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.1 bits (143), Expect = 4e-09
 Identities = 15/58 (25%), Positives = 25/58 (43%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
             +T   L   ++    +  +++ LDLS N L+      L+    L +LNL  N L  
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 6/76 (7%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL 523
                   L+ LDLS+N L   +         +  ++L  NKL   +  +L     + +L
Sbjct: 185 KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL---RFSQNL 239

Query: 524 -LLSIGRNPDLCLSAP 538
               +  N   C +  
Sbjct: 240 EHFDLRGNGFHCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 17/62 (27%), Positives = 29/62 (46%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L+   L+   +  L+    LE L+LS+N L     +    L  LR L+L+ N 
Sbjct: 34  WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNY 91

Query: 506 LS 507
           + 
Sbjct: 92  VQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 2/66 (3%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGNKLSG 508
           ++ L +  +T            ++ LDL  N +   +  E  +    L  LNL  N +  
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 509 SVPTSL 514
            V   +
Sbjct: 183 DVKGQV 188

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 16/75 (21%), Positives = 33/75 (44%), Gaps = 3/75 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P I +L+  +  ++ ++S S    +  +N+ L+NN +T            ++ L+L  N+
Sbjct: 99  PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155

Query: 506 LSGSVPTSLVARSQN 520
           +       L A S  
Sbjct: 156 IDTVNFAELAASSDT 170

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 10/47 (21%), Positives = 20/47 (42%)

Query: 468 NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           N    +   ++++SL  ++         ++ L+L GN LS      L
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL 54

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 12/82 (14%), Positives = 23/82 (28%), Gaps = 1/82 (1%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           +L       T ++     N      +D         I +   +      L      L   
Sbjct: 316 ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375

Query: 510 VPTSLVA-RSQNGSLLLSIGRN 530
           V     A    +G+L  ++G+ 
Sbjct: 376 VSNGRRAHAELDGTLQQAVGQI 397

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 20/78 (25%), Positives = 35/78 (44%), Gaps = 7/78 (8%)

Query: 436 LNCSYNG---YKP----PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L  +      Y P      +  L +  + +T    P+LS L SL  LD+S+++   SI  
Sbjct: 71  LTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 489 FLSQLPLLRVLNLDGNKL 506
            ++ LP +  ++L  N  
Sbjct: 131 KINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 17/86 (19%), Positives = 32/86 (37%), Gaps = 9/86 (10%)

Query: 436 LNCSYNGYKP-------PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           +  +               I  L + +   T   +P +S L +LE L +    +T     
Sbjct: 49  ITLANINVTDLTGIEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIP 106

Query: 489 FLSQLPLLRVLNLDGNKLSGSVPTSL 514
            LS L  L +L++  +    S+ T +
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKI 132

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 14/62 (22%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+++       I   ++ L  + ++DLS N     I   L  LP L+ LN+  + 
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170

Query: 506 LS 507
           + 
Sbjct: 171 VH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 3/63 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           PK+ S++L+  G    I P L  L  L++L++  + +       +   P L  L      
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQT 192

Query: 506 LSG 508
           + G
Sbjct: 193 IGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 6/43 (13%), Positives = 20/43 (46%), Gaps = 2/43 (4%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           + + + SL  + L+N ++T  +   +     ++ L ++    +
Sbjct: 39  TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT 79

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.2 bits (145), Expect = 2e-09
 Identities = 37/235 (15%), Positives = 66/235 (28%), Gaps = 10/235 (4%)

Query: 275 SLVDSQYRLPSAVMKTAVKPMNVNDSLD-FDFEIGDPTLQFYVYMHFAELESRQGNQYRE 333
           +L+      P +V        N    +   D        Q   +            +   
Sbjct: 273 TLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECV 332

Query: 334 FSIELNGNLWEKSVVPEYLQSKTISSTQPARGSKLNFSLCK-TSNSTLPPILNAIEIYIL 392
              +        S   E L    +S  +         S  +               I ++
Sbjct: 333 LLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLM 392

Query: 393 TDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLN 452
                   +++ +     +K    +   +  D  S        L   Y   +      L+
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR-----VLH 447

Query: 453 LTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           L  + LT  +   L  L  + +LDLS+N L  ++P  L+ L  L VL    N L 
Sbjct: 448 LAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.3 bits (135), Expect = 4e-08
 Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 6/87 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L+   L   + P+L+ L+ LE L  S+N+L  ++   ++ LP L+ L L  N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519

Query: 506 LSGSVPTSLVARSQNGSL-LLSIGRNP 531
           L      ++        L LL++  N 
Sbjct: 520 LQQ--SAAIQPLVSCPRLVLLNLQGNS 544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 24/79 (30%), Positives = 37/79 (46%), Gaps = 7/79 (8%)

Query: 436 LNCSYNGYK--PPKIISL-NLTSEGLTG-KIS--PSLSNLKSLENLDLSNNSLTG-SIPE 488
           L+ S+N  +  PP + +L  L     +   +     ++NL  L+ L L NN L   +  +
Sbjct: 468 LDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQ 527

Query: 489 FLSQLPLLRVLNLDGNKLS 507
            L   P L +LNL GN L 
Sbjct: 528 PLVSCPRLVLLNLQGNSLC 546

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 18/77 (23%), Positives = 26/77 (33%), Gaps = 6/77 (7%)

Query: 437 NCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
            C    +       P    +L+L+   L    S S  +   L+ LDLS   +        
Sbjct: 13  QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 491 SQLPLLRVLNLDGNKLS 507
             L  L  L L GN + 
Sbjct: 73  QSLSHLSTLILTGNPIQ 89

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.6 bits (142), Expect = 7e-09
 Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 5/88 (5%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L +          P   + L++L  LDLS   L    P   + L  L+VLN+  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 505 KLSGSVPTSLVARSQNGSLL-LSIGRNP 531
           +L  SVP  +  R    SL  + +  NP
Sbjct: 505 QLK-SVPDGIFDR--LTSLQKIWLHTNP 529

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 18/88 (20%), Positives = 33/88 (37%), Gaps = 9/88 (10%)

Query: 436 LNCSYNG--------YKPPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSI 486
           L+ S+NG            ++  L+     L      S   +L++L  LD+S+     + 
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
               + L  L VL + GN    +    +
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 3/91 (3%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT-GSIPEFLSQLPLLRVLNLD 502
               +  L      L    +  + +LK+L+ L++++N +    +PE+ S L  L  L+L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 503 GNKLSGSVPTSL--VARSQNGSLLLSIGRNP 531
            NK+     T L  + +    +L L +  NP
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 13/62 (20%), Positives = 24/62 (38%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P++  L+L+   +      +  +L  L  L L+ N +        S L  L+ L      
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 506 LS 507
           L+
Sbjct: 112 LA 113

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 14/62 (22%), Positives = 24/62 (38%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + +L LT   +      + S L SL+ L     +L       +  L  L+ LN+  N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 506 LS 507
           + 
Sbjct: 136 IQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.0 bits (125), Expect = 7e-07
 Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 7/96 (7%)

Query: 425 PCSPMYYSWDGLNCSYNGYKPPKIISL-NLTSEGLTG---KISPSLSNLKSLENLDLSNN 480
                 + W  L      +     + L +L     T      + S  +L SLE LDLS N
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357

Query: 481 SLT--GSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
            L+  G   +       L+ L+L  N +  ++ ++ 
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 3/81 (3%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLT--GKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQL 493
              +++    P +  L+L+  GL+  G  S S     SL+ LDLS N +  ++      L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395

Query: 494 PLLRVLNLDGNKLSGSVPTSL 514
             L  L+   + L      S+
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSV 416

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 11/45 (24%), Positives = 22/45 (48%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           + ++L SL+ L++++N L         +L  L+ + L  N    S
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 446 PKIISLNLTSEGLT-GKISPSLSNLKSLENLDLSNNSLTGSIPE---FLSQLPLLRV-LN 500
             +  LN+    +   K+    SNL +LE+LDLS+N +          L Q+PLL + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 501 LDGNKLS 507
           L  N ++
Sbjct: 184 LSLNPMN 190

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 20/65 (30%), Positives = 25/65 (38%), Gaps = 2/65 (3%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLSGS 509
            N   E  +G  S   +    L+ LDLS+NSL  +           L  LNL    L   
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267

Query: 510 VPTSL 514
           VP  L
Sbjct: 268 VPKGL 272

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 23/65 (35%), Positives = 31/65 (47%), Gaps = 5/65 (7%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P ++ SLNL+  GL  ++   L     L  LDLS N L    P    +LP +  L+L GN
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGN 306

Query: 505 KLSGS 509
               S
Sbjct: 307 PFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 22/92 (23%), Positives = 32/92 (34%), Gaps = 7/92 (7%)

Query: 442 GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLS----QLPLLR 497
            +  P +  L++            +    +L  LDLS+N   G      +    + P L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 498 VLNLDGNK---LSGSVPTSLVARSQNGSLLLS 526
           VL L        SG       AR Q   L LS
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLS 236

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 12/75 (16%), Positives = 22/75 (29%), Gaps = 3/75 (4%)

Query: 449 ISLNLTSEGLTGKISPSLSNLKSLENLDLSNN---SLTGSIPEFLSQLPLLRVLNLDGNK 505
           +S N          +       +L+ L L N    + +G      +    L+ L+L  N 
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239

Query: 506 LSGSVPTSLVARSQN 520
           L  +           
Sbjct: 240 LRDAAGAPSCDWPSQ 254

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 7/91 (7%)

Query: 447 KIISLNLTSEGLTGKISPSLS---NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
            +  L + +  +  +I         +  L+ L L N  +TG+ P  L +     +  L+ 
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 504 NKLSGSVPTSLVARSQNGSLL----LSIGRN 530
             +S +   + +A  Q         LSI + 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 18/82 (21%), Positives = 29/82 (35%), Gaps = 9/82 (10%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNL--KSLENLDLSNNSLTGSIPEFLSQL-----PLLRV 498
             +  L L +  +TG   P L       L  L+L N S       +L++L     P L+V
Sbjct: 95  SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKV 153

Query: 499 LNLDGNKLSGSVPTSLVARSQN 520
           L++       +     V     
Sbjct: 154 LSIAQAHSL-NFSCEQVRVFPA 174

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 24/77 (31%), Positives = 33/77 (42%), Gaps = 10/77 (12%)

Query: 436 LNCSYN-----GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L  S N        P ++  L ++   LT  +    S L SL    +  N LT  +PE L
Sbjct: 226 LIVSGNRLTSLPVLPSELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESL 280

Query: 491 SQLPLLRVLNLDGNKLS 507
             L     +NL+GN LS
Sbjct: 281 IHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 8/84 (9%)

Query: 450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
            LN+   GLT  +   L     +  L + +N+LT S+P    +   LR L + GN+L+ S
Sbjct: 44  VLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT-S 95

Query: 510 VPTSLVARSQNGSLLLSIGRNPDL 533
           +P       +       +   P L
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLPAL 119

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 14/84 (16%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L+ S N        P ++  L   +  LT  +    S LK L    +S N LT S+P   
Sbjct: 186 LSVSDNQLASLPTLPSELYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRLT-SLPVLP 240

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
           S+   L+ L + GN+L+ S+P   
Sbjct: 241 SE---LKELMVSGNRLT-SLPMLP 260

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 7e-06
 Identities = 17/84 (20%), Positives = 27/84 (32%), Gaps = 14/84 (16%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L    N        PP++ +L ++   LT  +      L  L         L        
Sbjct: 66  LVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-- 122

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
                L  L + GN+L+ S+P   
Sbjct: 123 -----LCKLWIFGNQLT-SLPVLP 140

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 20/84 (23%), Positives = 32/84 (38%), Gaps = 14/84 (16%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L+   N        P  +  L +    LT  +      L   + L +S+N L  S+P   
Sbjct: 106 LSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPGL---QELSVSDNQLA-SLPALP 160

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
           S+   L  L    N+L+ S+P   
Sbjct: 161 SE---LCKLWAYNNQLT-SLPMLP 180

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 22/84 (26%), Positives = 33/84 (39%), Gaps = 11/84 (13%)

Query: 436 LNCSYNG-----YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L+ S N        P ++  L   +  LT  +    S L+ L    +S+N L  S+P   
Sbjct: 146 LSVSDNQLASLPALPSELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLP 200

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
           S+L  L   N     L    P+ L
Sbjct: 201 SELYKLWAYNNRLTSLPAL-PSGL 223

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 6/70 (8%)

Query: 436 LNCSYNG-----YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L  S N        P  ++SL++    LT ++  SL +L S   ++L  N L+    + L
Sbjct: 246 LMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304

Query: 491 SQLPLLRVLN 500
            ++      +
Sbjct: 305 REITSAPGYS 314

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.4 bits (134), Expect = 5e-08
 Identities = 21/83 (25%), Positives = 35/83 (42%), Gaps = 11/83 (13%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L     G            +  +N ++  LT  I+P L NL  L ++ ++NN +    P 
Sbjct: 51  LQADRLGIKSIDGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADITP- 107

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
            L+ L  L  L L  N+++   P
Sbjct: 108 -LANLTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.4 bits (134), Expect = 5e-08
 Identities = 21/77 (27%), Positives = 36/77 (46%), Gaps = 6/77 (7%)

Query: 436 LNCSYNGYKPPKIISL-NLTSEGLTG-KIS--PSLSNLKSLENLDLSNNSLTGSIPEFLS 491
           L+          + +L  L    ++  K+S    L+ L +LE+L  +NN ++   P  L 
Sbjct: 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LG 218

Query: 492 QLPLLRVLNLDGNKLSG 508
            L  L  L+L+GN+L  
Sbjct: 219 ILTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.4 bits (134), Expect = 6e-08
 Identities = 22/83 (26%), Positives = 34/83 (40%), Gaps = 11/83 (13%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L+ + N            K+  L L +  ++      L+ L +L NL+L+ N L    P 
Sbjct: 248 LDLANNQISNLAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP- 304

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
            +S L  L  L L  N +S   P
Sbjct: 305 -ISNLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 11/83 (13%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L  + N             +  L L    ++  ISP +S+L  L+ L   NN ++     
Sbjct: 292 LELNENQLEDISPISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFFYNNKVSD--VS 347

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
            L+ L  +  L+   N++S   P
Sbjct: 348 SLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 4/66 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L    L   I   L++L +L +LDL+NN ++   P  LS L  L  L L  N+
Sbjct: 221 TNLDELSLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276

Query: 506 LSGSVP 511
           +S   P
Sbjct: 277 ISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.4 bits (116), Expect = 8e-06
 Identities = 9/60 (15%), Positives = 21/60 (35%), Gaps = 3/60 (5%)

Query: 448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           + S  +T +    +I    + L       L   ++T ++    + L  +  L  D   + 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 9e-06
 Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 5/63 (7%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L L+S  ++     +LS L SL+ L   N  +T   P  L+ L  L  L++  NK
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNK 188

Query: 506 LSG 508
           +S 
Sbjct: 189 VSD 191

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 12/83 (14%)

Query: 436 LNCSYN---GYKP----PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           +  + N      P      +  L L +  +T      L NL +L  L+LS+N+++     
Sbjct: 95  ILMNNNQIADITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--IS 150

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
            LS L  L+ L+  GN+++   P
Sbjct: 151 ALSGLTSLQQLSF-GNQVTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.5 bits (111), Expect = 3e-05
 Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 16/96 (16%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L    N             I  L+     ++  ++P L+NL  +  L L++ + T +   
Sbjct: 336 LFFYNNKVSDVSSLANLTNINWLSAGHNQISD-LTP-LANLTRITQLGLNDQAWTNAPVN 393

Query: 489 FLSQLPLLR-VLNLDGNKLSGSVPTSLVARSQNGSL 523
           + + + +   V N+ G  ++   P ++   S  GS 
Sbjct: 394 YKANVSIPNTVKNVTGALIA---PATI---SDGGSY 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.5 bits (134), Expect = 6e-08
 Identities = 16/81 (19%), Positives = 32/81 (39%), Gaps = 1/81 (1%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L++    L   +S   S L+ ++ + + N+ +      F   L  L  L+L  N +    
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 511 PTSLVARSQNGSL-LLSIGRN 530
             +   +    SL  L + +N
Sbjct: 351 LKNSACKGAWPSLQTLVLSQN 371

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 14/102 (13%)

Query: 436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           LN S  G        P  +  L++++  L    S  L  L+ L    +S N L  ++P+ 
Sbjct: 415 LNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDA 469

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNP 531
            S  P+L V+ +  N+L  SVP  +  R  +    + +  NP
Sbjct: 470 -SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQ-KIWLHTNP 508

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 21/79 (26%), Positives = 32/79 (40%), Gaps = 15/79 (18%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL 495
           L  S N      + S+  T E         L  LK+L +LD+S N+    +P+       
Sbjct: 366 LVLSQN-----HLRSMQKTGE--------ILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411

Query: 496 LRVLNLDGNKLSGSVPTSL 514
           +R LNL    +   V T +
Sbjct: 412 MRFLNLSSTGIR-VVKTCI 429

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 6/78 (7%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
            +     +          + SL+L+   +T      L    +L+ L L ++ +     + 
Sbjct: 10  CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 490 LSQLPLLRVLNLDGNKLS 507
              L  L  L+L  N LS
Sbjct: 70  FYSLGSLEHLDLSDNHLS 87

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 17/65 (26%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSI---PEFLSQLPLLRVLNLD 502
            K+  + + +  +         +LKSLE LDLS N +              P L+ L L 
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369

Query: 503 GNKLS 507
            N L 
Sbjct: 370 QNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 21/63 (33%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L L S  +   I   +  +L SLE+LDLS+N L+     +   L  L+ LNL GN
Sbjct: 50  ANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN 108

Query: 505 KLS 507
              
Sbjct: 109 PYQ 111

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.7 bits (119), Expect = 4e-06
 Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 15/80 (18%)

Query: 436 LNCSYNG--------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIP 487
           L+ S N           P K+  LNL+S G+   +   +   ++LE LD+SNN+L  S  
Sbjct: 392 LDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFS 447

Query: 488 EFLSQLPLLRVLNLDGNKLS 507
            FL +L   + L +  NKL 
Sbjct: 448 LFLPRL---QELYISRNKLK 464

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 11/63 (17%), Positives = 25/63 (39%), Gaps = 1/63 (1%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             + +L + +     +I     + L SL  L++   SL     + L  +  +  L L  +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182

Query: 505 KLS 507
           + +
Sbjct: 183 ESA 185

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 2/64 (3%)

Query: 446 PKIISLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
             +  LNL         ++    NL +L+ L + N      I     + L  L  L +  
Sbjct: 98  SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157

Query: 504 NKLS 507
             L 
Sbjct: 158 LSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 5/69 (7%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             + SL+++       +  S    + +  L+LS+  +   +   +     L VL++  N 
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNN 442

Query: 506 LSGSVPTSL 514
           L  S    L
Sbjct: 443 LD-SFSLFL 450

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 14/63 (22%), Positives = 25/63 (39%), Gaps = 3/63 (4%)

Query: 451 LNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGNKLSG 508
           L+L+   L+  +S S    L SL+ L+L  N      +      L  L+ L +   +   
Sbjct: 79  LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137

Query: 509 SVP 511
            + 
Sbjct: 138 EIR 140

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 16/83 (19%), Positives = 30/83 (36%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L + +  L    S SL +++ + +L L  +     +  F   L  +R L L    L+   
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212

Query: 511 PTSLVARSQNGSLLLSIGRNPDL 533
            + L     +  +     R   L
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVL 235

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 9/72 (12%), Positives = 27/72 (37%), Gaps = 7/72 (9%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL 495
            +C+ NG     +   N +   +  ++        ++  L +    L   +    S L  
Sbjct: 259 DDCTLNG-----LGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 496 LRVLNLDGNKLS 507
           ++ + ++ +K+ 
Sbjct: 312 VKRITVENSKVF 323

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 73/280 (26%)

Query: 578 LNVDNSHSKKEGSLKS--DNQQFTYSEIVD--ITNNFH--RILGKGGFGTVYHGY-LADG 630
           ++  + HS    +L    D++   +S      + N F   R +G G FG V     + + 
Sbjct: 1   MHHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK 60

Query: 631 SEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN-- 688
              A+K++        K++   A++   +    L  +     +  N+   +    Y +  
Sbjct: 61  KYYAVKVVRNI-----KKYTRSAKIEADI----LKKIQNDDINNNNIVKYHGKFMYYDHM 111

Query: 689 ------LKQYLFDETKE----ALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI 738
                 L   L++            +D     ++  + L YL       + H D+K  NI
Sbjct: 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MS--LTHTDLKPENI 168

Query: 739 LLNEKMQA-------------------------KLADFGFSKIFPAESESHISTSIVGTV 773
           LL++                             KL DFG    F  +S+ H   SI+ T 
Sbjct: 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATF--KSDYH--GSIINTR 223

Query: 774 GYLDPE------YYASNRLTEKSDVYSFGIVLLELITGLP 807
            Y  PE      +         SD++SFG VL EL TG  
Sbjct: 224 QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGSL 257

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 9/92 (9%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
            K+  L L    +   I   SLS L +L  L L NN L+  +P  L  L LL+V+ L  N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274

Query: 505 KLSGSVP----TSLVARSQNGSL-LLSIGRNP 531
            ++  V       +    +      +S+  NP
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 11/87 (12%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE 488
           + CS  G K       P    L+L +  ++ ++       L+ L  L L NN ++  I E
Sbjct: 38  VQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHE 95

Query: 489 F-LSQLPLLRVLNLDGNKLSGSVPTSL 514
              S L  L+ L +  N L   +P +L
Sbjct: 96  KAFSPLRKLQKLYISKNHLV-EIPPNL 121

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 26/72 (36%), Positives = 32/72 (44%), Gaps = 5/72 (6%)

Query: 445 PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLD 502
           P  +  L+L    +   I    L     L  L L +N +   I    LS LP LR L+LD
Sbjct: 192 PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLD 249

Query: 503 GNKLSGSVPTSL 514
            NKLS  VP  L
Sbjct: 250 NNKLS-RVPAGL 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 48.1 bits (115), Expect = 8e-06
 Identities = 14/69 (20%), Positives = 30/69 (43%), Gaps = 9/69 (13%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-------FLSQLPLLRV 498
           P +  L+L +  L+ ++   L +LK L+ + L  N++T  +         F  +      
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNG 298

Query: 499 LNLDGNKLS 507
           ++L  N + 
Sbjct: 299 ISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 44.6 bits (106), Expect = 8e-05
 Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 5/63 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             + +L L +  ++ KI   + S L+ L+ L +S N L   IP  L     L  L +  N
Sbjct: 78  QHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDN 133

Query: 505 KLS 507
           ++ 
Sbjct: 134 RIR 136

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.5 bits (98), Expect = 8e-04
 Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 4/72 (5%)

Query: 445 PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLT-GSIPEFLSQLPLLRVLNLD 502
           P  ++ L +    +  K+     S L+++  +++  N L              L  L + 
Sbjct: 122 PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180

Query: 503 GNKLSGSVPTSL 514
             KL+  +P  L
Sbjct: 181 EAKLT-GIPKDL 191

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 25/177 (14%), Positives = 56/177 (31%), Gaps = 28/177 (15%)

Query: 229 VLYRRLDVGSTTTQIIRFKDDHYDRIWVPYPGFPGSASINTSFIIDSLVDSQYRLPSAVM 288
           V++  ++ G  +        D +   +   P   G     + + +   +         + 
Sbjct: 6   VIWA-VNAGGESHV------DVHGIHYRKDPLE-GRVGRASDYGMKLPILRSNPEDQVLY 57

Query: 289 KTAVKPMNVNDSLDFDFEIGDPTLQFYVYMHFAELESRQGNQYREFSIELNGNLWEKS-- 346
           +T        DS  +D  I     ++ + + FAE+   Q  Q + F + +NG+   K   
Sbjct: 58  QTER---YNEDSFGYDIPI-KEEGEYVLVLKFAEVYFAQSQQ-KVFDVRVNGHTVVKDLD 112

Query: 347 -------------VVPEYLQSKTISSTQPARGSKLNFSLCKTSNSTLPPILNAIEIY 390
                        ++P  ++   +S            S+         P + A+ I 
Sbjct: 113 IFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIM 169

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.2 bits (133), Expect = 9e-08
 Identities = 16/79 (20%), Positives = 30/79 (37%), Gaps = 8/79 (10%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSI-PE 488
               +               L L+   +   ++  S   L+ L+ L+L +     +I  E
Sbjct: 9   AFYRFCNLTQVPQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKE 67

Query: 489 FLSQLPLLRVLNLDGNKLS 507
               LP LR+L+L  +K+ 
Sbjct: 68  AFRNLPNLRILDLGSSKIY 86

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 3/104 (2%)

Query: 446 PKIISLNLTSEGLTGKISPS--LSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLD 502
             +  L L   GL+  +       NLK+L  LDLS N +    +     +L  L+ ++  
Sbjct: 97  FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156

Query: 503 GNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNS 546
            N++       L           S+  N      +    +  N 
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 29/112 (25%), Positives = 40/112 (35%), Gaps = 21/112 (18%)

Query: 436 LNCSYNG----------YKPPKIISLNLTSEGLTGKISPSL-----SNLKSLENLDLSNN 480
           L  + N            + P +  L L    L       L       L  L+ L L++N
Sbjct: 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL-LLSIGRNP 531
            L    P   S L  LR L+L+ N+L     T L       +L +L I RN 
Sbjct: 491 YLNSLPPGVFSHLTALRGLSLNSNRL-----TVLSHNDLPANLEILDISRNQ 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 1/66 (1%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
            ++  L L S+     I   +  NL +L  LDL ++ +    P+    L  L  L L   
Sbjct: 48  EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107

Query: 505 KLSGSV 510
            LS +V
Sbjct: 108 GLSDAV 113

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSI--PEFLSQLPLLRVLNLD 502
           P +  L+L S  +   + P     L  L  L L    L+ ++    +   L  L  L+L 
Sbjct: 73  PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131

Query: 503 GNKLS 507
            N++ 
Sbjct: 132 KNQIR 136

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 2/67 (2%)

Query: 450 SLNLTSEGLTG-KISPSLSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGNKLS 507
            ++L+   L    I   L  +  L+ L L+ N  +  S  +  S+ P L  L L  N L 
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464

Query: 508 GSVPTSL 514
            +  T L
Sbjct: 465 LAWETEL 471

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 14/62 (22%), Positives = 25/62 (40%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  LNL    +      +   L +L+ L+LS N L          LP +  ++L  N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 506 LS 507
           ++
Sbjct: 350 IA 351

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 15/62 (24%), Positives = 25/62 (40%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  LNL+   L    S +   L  +  +DL  N +     +    L  L+ L+L  N 
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373

Query: 506 LS 507
           L+
Sbjct: 374 LT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 2/72 (2%)

Query: 437 NCSYNGYKPPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPL 495
             ++ G     +  L+L+   +   ++      LK L+ L+L+ N +     E    L  
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315

Query: 496 LRVLNLDGNKLS 507
           L+VLNL  N L 
Sbjct: 316 LQVLNLSYNLLG 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 30/174 (17%), Positives = 58/174 (33%), Gaps = 25/174 (14%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQL------------ 493
             +  L+L S  LT           +LE LD+S N L    P+    L            
Sbjct: 504 TALRGLSLNSNRLTV--LSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561

Query: 494 -----PLLRVLNLDGNKLSG--SVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNS 546
                  +  LN     ++G  +    +   S +G  L S+  + + C      K  + S
Sbjct: 562 ECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSL--STEGCDEEEVLKSLKFS 619

Query: 547 VMPVVAASVSLLVILIALLVFWTYKRKRAARLNVDNSHSKKEGSLKSDNQQFTY 600
           +   +  +V+L + L+ +L    ++               K+    ++   + Y
Sbjct: 620 L--FIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKY 671

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 18/62 (29%), Positives = 33/62 (53%), Gaps = 3/62 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            + + L+     +  K+  +LS LK+ ++L LS N++   I   LS +  LR+L+L  N 
Sbjct: 25  AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81

Query: 506 LS 507
           + 
Sbjct: 82  IK 83

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 13/82 (15%)

Query: 436 LNCSYNGYK--------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIP 487
           L+   N  K           +  L ++   +   +S  +  L +L  L +SNN +T +  
Sbjct: 75  LSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT-NWG 131

Query: 488 EF--LSQLPLLRVLNLDGNKLS 507
           E   L+ L  L  L L GN L 
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLY 153

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 11/77 (14%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L    N  K     PP +  L +++  L     P L N   L+ +D+ NNSL   +P+  
Sbjct: 116 LLVDNNNLKALSDLPPLLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLP 172

Query: 491 SQLPLLRVLNLDGNKLS 507
                L  +    N+L 
Sbjct: 173 PS---LEFIAAGNNQLE 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 20/100 (20%), Positives = 37/100 (37%), Gaps = 24/100 (24%)

Query: 436 LNCSYNG-----YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG------ 484
           L  +  G       PP + SL  +   LT ++     +LKSL   + +  +L+       
Sbjct: 76  LELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLE 134

Query: 485 ----------SIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
                      +PE       L+++++D N L   +P   
Sbjct: 135 YLGVSNNQLEKLPEL-QNSSFLKIIDVDNNSLK-KLPDLP 172

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 14/84 (16%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L+ S N +      PP +  LN +S  +   +     +L+ L   ++SNN L   +P   
Sbjct: 282 LDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALP 336

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
            +   L  L    N L+  VP   
Sbjct: 337 PR---LERLIASFNHLA-EVPELP 356

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 28/103 (27%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           ++   N  K     PP +  +   +  L  ++ P L NL  L  +   NNSL   +P+  
Sbjct: 158 IDVDNNSLKKLPDLPPSLEFIAAGNNQLE-EL-PELQNLPFLTAIYADNNSLK-KLPDLP 214

Query: 491 SQL-------------------PLLRVLNLDGNKLSGSVPTSL 514
             L                   P L  +  D N L  ++P   
Sbjct: 215 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 12/84 (14%)

Query: 436 LNCSYNGYK--PPKIISL---NLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           +    N  K  P   +SL      +  L     P L NL  L  +   NN L  ++P+  
Sbjct: 200 IYADNNSLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP 256

Query: 491 SQLPLLRVLNLDGNKLSGSVPTSL 514
                L  LN+  N L+  +P   
Sbjct: 257 PS---LEALNVRDNYLT-DLPELP 276

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.4 bits (108), Expect = 7e-05
 Identities = 8/72 (11%), Positives = 22/72 (30%), Gaps = 1/72 (1%)

Query: 462 ISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNG 521
           I+P   +   L+     +++LT  +P     +          ++   + P     + +  
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 522 SLLLSIGRNPDL 533
              L    +   
Sbjct: 62  VSRLRDCLDRQA 73

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 45.0 bits (107), Expect = 9e-05
 Identities = 14/88 (15%), Positives = 25/88 (28%), Gaps = 19/88 (21%)

Query: 445 PPKIISLNLTSEGLTG-----KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPL---- 495
            P+ +S     E L       ++     N+KS      + +    + P    +       
Sbjct: 4   NPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63

Query: 496 ---------LRVLNLDGNKLSGSVPTSL 514
                       L L+   LS S+P   
Sbjct: 64  RLRDCLDRQAHELELNNLGLS-SLPELP 90

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 21/101 (20%), Positives = 35/101 (34%), Gaps = 28/101 (27%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNL-----------------KSLE 473
           +    N  K     PP + +LN+    LT  +     +L                  +L 
Sbjct: 242 IYADNNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLY 300

Query: 474 NLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
            L+ S+N +  S+ +       L  LN+  NKL   +P   
Sbjct: 301 YLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALP 336

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.4 bits (103), Expect = 3e-04
 Identities = 20/100 (20%), Positives = 32/100 (32%), Gaps = 27/100 (27%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           LN S N        PP++  L  +   L  ++     NLK L    +  N L    P+  
Sbjct: 322 LNVSNNKLIELPALPPRLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIP 376

Query: 491 SQLPL----------------LRVLNLDGNKLSGSVPTSL 514
             +                  L+ L+++ N L    P   
Sbjct: 377 ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.4 bits (103), Expect = 3e-04
 Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 20/92 (21%)

Query: 436 LNCSYNGYK--PPKIISL-NLTSEGLTGKISPSLSNLK-----------------SLENL 475
           L+  YN  +  P    S+ +L       ++     NLK                 S+E+L
Sbjct: 362 LHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDL 421

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            +++  +             L     + +   
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 7/85 (8%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           + C    +       P +   L+L    +        ++   LE L+L+ N ++   P  
Sbjct: 16  VLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSL 514
            + L  LR L L  N+L   +P  +
Sbjct: 76  FNNLFNLRTLGLRSNRLK-LIPLGV 99

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 24/64 (37%), Positives = 30/64 (46%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDG 503
             + SL +    L   IS  + S L SLE L L   +LT SIP   LS L  L VL L  
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH 185

Query: 504 NKLS 507
             ++
Sbjct: 186 LNIN 189

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 17/64 (26%), Positives = 28/64 (43%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
            ++  + L    L   + P +   L  L  L++S N LT ++ E     +  L  L LD 
Sbjct: 272 LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329

Query: 504 NKLS 507
           N L+
Sbjct: 330 NPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 4/60 (6%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFL-SQLPLLRVLNLDGNKLS 507
           +L L S  L   I     + L +L  LD+S N +   + +++   L  L+ L +  N L 
Sbjct: 84  TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 18/60 (30%), Positives = 33/60 (55%), Gaps = 4/60 (6%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
           SL++T   LT  +   ++ +L  L  L+LS N ++ +I    L +L  L+ + L G +L+
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +I L L    +   I   S   L  L+ L++S+     ++         L  L++   
Sbjct: 176 HGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234

Query: 505 KLSGSVP 511
            L+ +VP
Sbjct: 235 NLT-AVP 240

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 2/82 (2%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             +  L L    LT  I   +LS+L  L  L L + ++         +L  L+VL +   
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210

Query: 505 KLSGSVPTSLVARSQNGSLLLS 526
               ++  + +      SL ++
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSIT 232

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 9/86 (10%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE 488
           + CS  G +      PP    L+L +  +T +I      NLK+L  L L NN ++   P 
Sbjct: 36  VQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPG 94

Query: 489 FLSQLPLLRVLNLDGNKLSGSVPTSL 514
             + L  L  L L  N+L   +P  +
Sbjct: 95  AFAPLVKLERLYLSKNQLK-ELPEKM 119

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 5/72 (6%)

Query: 445 PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLD 502
           PP +  L+L    +T K+   SL  L +L  L LS NS++ ++    L+  P LR L+L+
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248

Query: 503 GNKLSGSVPTSL 514
            NKL   VP  L
Sbjct: 249 NNKLV-KVPGGL 259

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 13/69 (18%), Positives = 32/69 (46%), Gaps = 9/69 (13%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-------FLSQLPLLRV 498
           P +  L+L +  L  K+   L++ K ++ + L NN+++ +I         + ++      
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSG 297

Query: 499 LNLDGNKLS 507
           ++L  N + 
Sbjct: 298 VSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 12/73 (16%), Positives = 27/73 (36%), Gaps = 5/73 (6%)

Query: 445 PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSI--PEFLSQLPLLRVLNL 501
           P  +  L +    +T K+     + L  +  ++L  N L  S         +  L  + +
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178

Query: 502 DGNKLSGSVPTSL 514
               ++ ++P  L
Sbjct: 179 ADTNIT-TIPQGL 190

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 19/63 (30%), Positives = 33/63 (52%), Gaps = 5/63 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
             + +L L +  ++ KISP + + L  LE L LS N L   +PE +     L+ L +  N
Sbjct: 76  KNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHEN 131

Query: 505 KLS 507
           +++
Sbjct: 132 EIT 134

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 18/81 (22%), Positives = 31/81 (38%), Gaps = 17/81 (20%)

Query: 436 LNCSYNGYKPPKIISLNLTS---------EGLTGKISPSLSNLKSLENLDLSNNSLTGSI 486
           L+C         ++ ++LT          EG        +++   L  LD     +T  +
Sbjct: 259 LHCIQT-----DLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL 312

Query: 487 PEFLSQLPLLRVLNLDGNKLS 507
              LSQ P L  L L+  +L+
Sbjct: 313 D--LSQNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 11/78 (14%)

Query: 436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           LNC+ N           ++  L+             ++    L  LD S N +T  +   
Sbjct: 132 LNCARNTLTEIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD-- 186

Query: 490 LSQLPLLRVLNLDGNKLS 507
           +SQ  LL  LN D N ++
Sbjct: 187 VSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 26/111 (23%), Positives = 38/111 (34%), Gaps = 20/111 (18%)

Query: 436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           L C+ N        +   +  L   S  LT   +  ++ L  L  L+   N LT  +   
Sbjct: 69  LICTSNNITTLDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT-KLD-- 122

Query: 490 LSQLPLLRVLNLDGNKLSGSVP-------TSLVARSQNGSLLLSIGRNPDL 533
           +SQ PLL  LN   N L+  +        T L          L +     L
Sbjct: 123 VSQNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVTPQTQL 172

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 20/104 (19%), Positives = 33/104 (31%), Gaps = 17/104 (16%)

Query: 436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           LNC  N        +  ++  L+ +S  LT      ++ L  L   D S N LT  +   
Sbjct: 196 LNCDTNNITKLDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLT-ELD-- 249

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
           +S L  L  L+     L       +        +         +
Sbjct: 250 VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKI 288

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 6e-06
 Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 5/61 (8%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
             ++     +      + S   L +L +LD  N+S+T  +     +L  L  L    N +
Sbjct: 22  SEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNI 76

Query: 507 S 507
           +
Sbjct: 77  T 77

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 19/101 (18%), Positives = 42/101 (41%), Gaps = 15/101 (14%)

Query: 436 LNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           L+C   G       + PK++ L L +  LT ++   +S+   L++L   N  +       
Sbjct: 302 LDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS- 356

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRN 530
           + ++P L        +   ++P   +    N SL +++  +
Sbjct: 357 VGKIPALNNNFEAEGQTI-TMPKETL---TNNSLTIAVSPD 393

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.0 bits (126), Expect = 2e-07
 Identities = 28/188 (14%), Positives = 48/188 (25%), Gaps = 47/188 (25%)

Query: 614 LGKGGFGTVYHGYLADGSEVAIKML--------SASSSQGPKQFRTEAQLLMRVH----- 660
           +G+G FG V+    AD + VAIK++        + S  +  ++   E  +   +      
Sbjct: 28  IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 661 ----HRNLASLVG---------------------------YCNDGGNVGLVYEYMAYGNL 689
                     L                                D      ++  + +   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA 749
              L     +  S      I       L            HRD+   N+LL +    KL 
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 750 DFGFSKIF 757
                K  
Sbjct: 205 YTLNGKSS 212

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 21/62 (33%), Positives = 35/62 (56%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L+  + GLT  I+ +L  L  L+ L+LS+N ++G +     + P L  LNL GNK
Sbjct: 42  EELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99

Query: 506 LS 507
           + 
Sbjct: 100 IK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 19/77 (24%), Positives = 32/77 (41%), Gaps = 8/77 (10%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG-SIP 487
           L+    G        K  K+  L L+   ++G +        +L +L+LS N +   S  
Sbjct: 47  LSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI 106

Query: 488 EFLSQLPLLRVLNLDGN 504
           E L +L  L+ L+L   
Sbjct: 107 EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 18/49 (36%), Positives = 24/49 (48%), Gaps = 2/49 (4%)

Query: 460 GKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
           GK+       + LE L   N  LT SI   L +L  L+ L L  N++SG
Sbjct: 32  GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 55/268 (20%), Positives = 97/268 (36%), Gaps = 74/268 (27%)

Query: 605 DITNNFHRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQFRTEAQLLMRV- 659
           D+ N  + ++ K G+G     +L+        VA+K++ ++     +    E +LL  V 
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVR 91

Query: 660 ----HHRNLASLVGYCND-------GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQ 708
               +  N   +V   +D       G ++ +V+E + + +L +++     + L      +
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK 150

Query: 709 IAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN--------------------------- 741
           I     QGL+YLH  C+  IIH D+K  NILL+                           
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 742 ----------------------EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                                 EK++ K+AD G      A       T  + T  Y   E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN-----ACWVHKHFTEDIQTRQYRSLE 263

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLP 807
               +     +D++S   +  EL TG  
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDY 291

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 12/84 (14%), Positives = 28/84 (33%), Gaps = 5/84 (5%)

Query: 424 DPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT 483
            P  P Y   D  N  Y+         +++  +            L + + +   N+++ 
Sbjct: 4   KPRQPEYKCID-SNLQYDCV----FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 58

Query: 484 GSIPEFLSQLPLLRVLNLDGNKLS 507
                 L     + +LNL+  ++ 
Sbjct: 59  KLPAALLDSFRQVELLNLNDLQIE 82

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 16/62 (25%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  L L    LT   +  L N   L  +DLS N L   +     ++  L  L +  N+
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 506 LS 507
           L 
Sbjct: 284 LV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 18/71 (25%), Positives = 35/71 (49%), Gaps = 5/71 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
            ++  LNL    +  +I   + +   +++ L +  N++   +P      +PLL VL L+ 
Sbjct: 69  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLER 126

Query: 504 NKLSGSVPTSL 514
           N LS S+P  +
Sbjct: 127 NDLS-SLPRGI 136

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 17/62 (27%), Positives = 27/62 (43%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P +  L+L+   L   +  +      LENL L +NS+  ++   LS    L+ L L  N 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 350

Query: 506 LS 507
             
Sbjct: 351 WD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 8/66 (12%), Positives = 27/66 (40%), Gaps = 3/66 (4%)

Query: 450 SLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
            +   +  +  K+  + L + + +E L+L++  +        +    ++ L +  N +  
Sbjct: 49  IVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 106

Query: 509 SVPTSL 514
            +P  +
Sbjct: 107 YLPPHV 112

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFL-SQLPLLRVLNLDG 503
             I  L +    +   + P    N+  L  L L  N L+ S+P  +    P L  L++  
Sbjct: 93  HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 150

Query: 504 NKLS 507
           N L 
Sbjct: 151 NNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 5/63 (7%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           PK+ +L++++  L  +I         SL+NL LS+N LT  +   LS +P L   N+  N
Sbjct: 141 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196

Query: 505 KLS 507
            LS
Sbjct: 197 LLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 17/64 (26%), Positives = 27/64 (42%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLDG 503
           P +  L L    L+  +   +  N   L  L +SNN+L   I  +       L+ L L  
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 174

Query: 504 NKLS 507
           N+L+
Sbjct: 175 NRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 15/62 (24%), Positives = 28/62 (45%), Gaps = 8/62 (12%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P +   N++   L+     +L+   ++E LD S+NS+   +         L +L L  N 
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 237

Query: 506 LS 507
           L+
Sbjct: 238 LT 239

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
               ++SLN++S  LT  I   L     ++ LDL +N +  SIP+ + +L  L+ LN+  
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453

Query: 504 NKLSGSVPTSLVARSQNGSL-LLSIGRNP 531
           N+L  SVP  +  R    SL  + +  NP
Sbjct: 454 NQLK-SVPDGIFDRLT--SLQKIWLHTNP 479

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 18/57 (31%), Positives = 23/57 (40%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            N T  G         S +    +LD SNN LT ++ E    L  L  L L  N+L 
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.3 bits (115), Expect = 8e-06
 Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 12/91 (13%)

Query: 436 LNCSYNGYK--PPKIIS-------LNLTSEGLT--GKISPSLSNLKSLENLDLSNNSLTG 484
           L+ S N       +          L L    L    KI+   + +KSL+ LD+S NS++ 
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388

Query: 485 SIP-EFLSQLPLLRVLNLDGNKLSGSVPTSL 514
                  S    L  LN+  N L+ ++   L
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 18/83 (21%), Positives = 33/83 (39%), Gaps = 9/83 (10%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPE 488
           ++ S NG          K   LN++   ++ ++  S + +L  L  L +S+N +      
Sbjct: 5   VDRSKNGLIHVPKDLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
                  L  L+L  NKL   + 
Sbjct: 64  VFKFNQELEYLDLSHNKLV-KIS 85

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 4/62 (6%)

Query: 451 LNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           L+++   ++        S  KSL +L++S+N LT +I   L   P ++VL+L  NK+  S
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435

Query: 510 VP 511
           +P
Sbjct: 436 IP 437

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 19/85 (22%), Positives = 40/85 (47%), Gaps = 3/85 (3%)

Query: 451 LNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGS 509
           L+L+   L  ++SP + ++L SL+ L++S+N+           L  L+VL+   N +  +
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-T 237

Query: 510 VPTSLVARSQNGSLLLSIGRNPDLC 534
                +    +    L++ +N   C
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 14/64 (21%), Positives = 28/64 (43%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE--FLSQLPLLRVLNLDG 503
             +  L+L+  G+   +S +   L+ LE+LD  +++L   + E      L  L  L++  
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 135

Query: 504 NKLS 507
               
Sbjct: 136 THTR 139

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 14/70 (20%), Positives = 28/70 (40%), Gaps = 1/70 (1%)

Query: 446 PKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
            ++  L+     L      S+  +L++L  LD+S+     +     + L  L VL + GN
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160

Query: 505 KLSGSVPTSL 514
               +    +
Sbjct: 161 SFQENFLPDI 170

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 3/71 (4%)

Query: 446 PKIISLNLTSEGLTGK--ISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG 503
            ++  L+L+S GL+ K   S S     SL+ LDLS N +  ++      L  L  L+   
Sbjct: 52  TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110

Query: 504 NKLSGSVPTSL 514
           + L      S+
Sbjct: 111 SNLKQMSEFSV 121

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 4/71 (5%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
             +I L+++             + L SLE L ++ NS   +      ++L  L  L+L  
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 504 NKLSGSVPTSL 514
            +L   +  + 
Sbjct: 185 CQLE-QLSPTA 194

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 7/86 (8%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
            + + + +   L+   + SL    +  N+ +++ SL   + + L+Q+  L  L    N+L
Sbjct: 233 DLDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 507 SGSVPTSLVARSQNGSL-LLSIGRNP 531
             SVP  +  R    SL  + +  NP
Sbjct: 290 K-SVPDGIFDR--LTSLQKIWLHTNP 312

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 4/87 (4%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLS 507
            L + +  L     P SL +++++ +L L        + E F+     +  L L    L 
Sbjct: 178 ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235

Query: 508 GSVPTSLVARSQNGSLLLSIGRNPDLC 534
               + L     N  +     RN  + 
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKIT 262

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 5/86 (5%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLS 507
           +L LTS G+   I   S S+L SLE+LDLS N L+ ++   +   L  L  LNL GN   
Sbjct: 80  ALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK 137

Query: 508 GSVPTSLVARSQNGSLLLSIGRNPDL 533
            ++  + +        +L +G     
Sbjct: 138 -TLGETSLFSHLTKLQILRVGNMDTF 162

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 3/57 (5%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKL 506
           + +T E L  ++   L+ +  L  L+ S N L  S+P+    +L  L+ + L  N  
Sbjct: 259 VKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 13/64 (20%), Positives = 23/64 (35%), Gaps = 3/64 (4%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDG 503
            K+  L + +     KI     + L  LE L++  + L  S     L  +  +  L L  
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHM 207

Query: 504 NKLS 507
            +  
Sbjct: 208 KQHI 211

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 25/78 (32%), Positives = 36/78 (46%), Gaps = 10/78 (12%)

Query: 436 LNCSYN------GYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           L+ + N      G     +  L L +  L       L +LK+LE L + NN L  SI   
Sbjct: 90  LSVNRNRLKNLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VM 145

Query: 490 LSQLPLLRVLNLDGNKLS 507
           L  L  L VL+L GN+++
Sbjct: 146 LGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 12/62 (19%), Positives = 28/62 (45%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
              +  NL  + +T  +      L  ++N +  N+++  S+   +     L+ L+L  N+
Sbjct: 19  ANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQ 74

Query: 506 LS 507
           +S
Sbjct: 75  IS 76

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 18/79 (22%), Positives = 33/79 (41%), Gaps = 12/79 (15%)

Query: 436 LNCSYNGYK-------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
            N   +  +          +  L+L+   ++  +SP L +L  LE L ++ N L  ++  
Sbjct: 46  FNGDNSNIQSLAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NL-N 101

Query: 489 FLSQLPLLRVLNLDGNKLS 507
            +     L  L LD N+L 
Sbjct: 102 GIPSAC-LSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 8/47 (17%), Positives = 19/47 (40%), Gaps = 3/47 (6%)

Query: 461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           ++ P    L +    +L   S+T  +     +L  ++  N D + + 
Sbjct: 11  QVFP-DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ 54

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 3/63 (4%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P ++ L+L        IS  +   L +L+ L+L   ++   +P   + L  L  L + GN
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEELEMSGN 228

Query: 505 KLS 507
              
Sbjct: 229 HFP 231

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 23/90 (25%), Positives = 32/90 (35%), Gaps = 13/90 (14%)

Query: 426 CSPMYYSWDGLNCSYNGYK------PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLS 478
           CS  +     + C+  G        P     LNL    +   I   +  +L  LE L L 
Sbjct: 52  CSNQFSK---VVCTRRGLSEVPQGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLG 107

Query: 479 NNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
            NS+   I     + L  L  L L  N L+
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT 136

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 23/72 (31%), Positives = 31/72 (43%), Gaps = 6/72 (8%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL 523
           S   L SL+ L + N+ ++  I       L  L  LNL  N LS S+P  L        L
Sbjct: 237 SFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFT--PLRYL 292

Query: 524 L-LSIGRNPDLC 534
           + L +  NP  C
Sbjct: 293 VELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 13/45 (28%), Positives = 22/45 (48%), Gaps = 2/45 (4%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
           P+L+ L  LE L++S N     I       L  L+ L +  +++S
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 42.4 bits (100), Expect = 6e-04
 Identities = 20/65 (30%), Positives = 30/65 (46%), Gaps = 5/65 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNL-D 502
             + +L L    LT  I   +   L  L  L L NN +  SIP +  +++P L  L+L +
Sbjct: 123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGE 180

Query: 503 GNKLS 507
             KL 
Sbjct: 181 LKKLE 185

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 22/102 (21%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF 489
           L  +           PP+I  L +T   L   +    ++L   E LD  +N L+ ++PE 
Sbjct: 64  LQLNRLNLSSLPDNLPPQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPEL 118

Query: 490 LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL-LLSIGRN 530
            +    L+ L++D N+L+  +P           L  ++   N
Sbjct: 119 PAS---LKHLDVDNNQLT-MLPELP------ALLEYINADNN 150

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 16/66 (24%), Positives = 26/66 (39%), Gaps = 5/66 (7%)

Query: 450 SLNLTSEGLTGKIS-PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
              L  E     +S      +     L L+  +L+ S+P+ L   P + VL +  N L  
Sbjct: 38  KQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI- 93

Query: 509 SVPTSL 514
           S+P   
Sbjct: 94  SLPELP 99

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 24/105 (22%), Positives = 43/105 (40%), Gaps = 17/105 (16%)

Query: 436 LNCSYNGYK--PPKIISL---NLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           +N   N     P    SL   ++ +  LT    P L   +SLE LD+S N L  S+P   
Sbjct: 145 INADNNQLTMLPELPTSLEVLSVRNNQLTF--LPEL--PESLEALDVSTNLLE-SLPAVP 199

Query: 491 SQLPLLR----VLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNP 531
            +               N+++  +P ++++     +++L    NP
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE--DNP 241

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 45.3 bits (107), Expect = 8e-05
 Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 19/109 (17%)

Query: 436 LNCSYNGYK-----PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFL 490
           L+   N        P  +  L++ +  LT  +    + L   E ++  NN LT  +PE  
Sbjct: 105 LDACDNRLSTLPELPASLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELP 159

Query: 491 SQLPLLRVLNLDGNKLSG--SVPTSL----VARSQNGSLLLSIGRNPDL 533
           +    L VL++  N+L+    +P SL    V+ +   SL     RN   
Sbjct: 160 TS---LEVLSVRNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHS 205

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +  L+L + GL   +S  L  L  L+ L+LS N + G +     +LP L  LNL GNK
Sbjct: 49  VNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106

Query: 506 LS 507
           L 
Sbjct: 107 LK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 21/69 (30%), Positives = 30/69 (43%), Gaps = 3/69 (4%)

Query: 441 NGYKPPKIISLNLTSEGLT-GKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVL 499
               P  +  L L +     GKI    +   +LE L L N  L  S+   L +LP L+ L
Sbjct: 19  RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKL 76

Query: 500 NLDGNKLSG 508
            L  N++ G
Sbjct: 77  ELSENRIFG 85

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 26/67 (38%), Positives = 38/67 (56%), Gaps = 4/67 (5%)

Query: 445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
              I+ LNL+S  LTG +   L     ++ LDL NN +  SIP+ ++ L  L+ LN+  N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483

Query: 505 KLSGSVP 511
           +L  SVP
Sbjct: 484 QLK-SVP 489

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 12/94 (12%)

Query: 436 LNCSYNGYK--PPKIIS-------LNLTSEGLT--GKISPSLSNLKSLENLDLSNNSLTG 484
           LN + N +     +  S       L L   GL    K++    N+ SLE LD+S NSL  
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417

Query: 485 SIPEFLSQLPL-LRVLNLDGNKLSGSVPTSLVAR 517
              +        + VLNL  N L+GSV   L  +
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK 451

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 13/61 (21%), Positives = 21/61 (34%), Gaps = 1/61 (1%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
             L+             +  S   L+ + N  T S+ +  S L  L+ L L  N L  + 
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392

Query: 511 P 511
            
Sbjct: 393 F 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 18/86 (20%), Positives = 33/86 (38%), Gaps = 11/86 (12%)

Query: 437 NCSYNGYK-----PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-- 488
            C   G       P  +  ++L+   +  +++  S S L+ L+ L +   +    I    
Sbjct: 16  ICINRGLHQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNT 74

Query: 489 FLSQLPLLRVLNLDGNKLSGSVPTSL 514
           F   L  L +L LD N+    + T  
Sbjct: 75  F-RGLSSLIILKLDYNQFL-QLETGA 98

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 20/78 (25%), Positives = 35/78 (44%), Gaps = 7/78 (8%)

Query: 437 NCSYNGYKPPKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIPE--FLSQL 493
           N ++ G +   + + +L+   +   +  S+ S+   LE L L+ N +   I +  F   L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF-WGL 322

Query: 494 PLLRVLNLDGNKLSGSVP 511
             L  LNL  N L  S+ 
Sbjct: 323 THLLKLNLSQNFLG-SID 339

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 22/89 (24%), Positives = 33/89 (37%), Gaps = 3/89 (3%)

Query: 451 LNLTSEGLTGKISP--SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLS 507
           L LT   L G +        L SLE L L +N++    P  F   +    VL+L  NK+ 
Sbjct: 108 LTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167

Query: 508 GSVPTSLVARSQNGSLLLSIGRNPDLCLS 536
                 L+        LL +       ++
Sbjct: 168 SICEEDLLNFQGKHFTLLRLSSITLQDMN 196

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 16/67 (23%), Positives = 23/67 (34%), Gaps = 3/67 (4%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
             +  L +  +     I   +   L SL  L L  N     +     + L  L VL L  
Sbjct: 54  QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQ 112

Query: 504 NKLSGSV 510
             L G+V
Sbjct: 113 CNLDGAV 119

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 25/67 (37%), Positives = 34/67 (50%), Gaps = 3/67 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGN 504
             ++ LNL+   L    S    NL  LE LDLS N +  ++ +     LP L+ L LD N
Sbjct: 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTN 381

Query: 505 KLSGSVP 511
           +L  SVP
Sbjct: 382 QLK-SVP 387

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
            L+L+   L+  I P S   L  L+ L +  + +   I       L  L  +NL  N L+
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268

Query: 508 GSVPTSLVARSQNGSLL-LSIGRNPDLC 534
             +P  L   +    L  + +  NP  C
Sbjct: 269 -LLPHDLF--TPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 20/63 (31%), Positives = 29/63 (46%), Gaps = 3/63 (4%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           P +  L+L        IS  +   L +L  L+L+  +L   IP   + L  L  L+L GN
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGN 217

Query: 505 KLS 507
            LS
Sbjct: 218 HLS 220

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 22/90 (24%), Positives = 33/90 (36%), Gaps = 13/90 (14%)

Query: 426 CSPMYYSWDGLNCSYNGYK------PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLS 478
           CS  +     + C     +            LNL    +   I   S  +L+ LE L LS
Sbjct: 41  CSNQFSK---VICVRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLS 96

Query: 479 NNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
            N +  +I     + L  L  L L  N+L+
Sbjct: 97  RNHIR-TIEIGAFNGLANLNTLELFDNRLT 125

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 19/71 (26%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
             +  L L+   +   I   + + L +L  L+L +N LT +IP      L  L+ L L  
Sbjct: 88  RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRN 145

Query: 504 NKLSGSVPTSL 514
           N +  S+P+  
Sbjct: 146 NPIE-SIPSYA 155

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 2/45 (4%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLS 507
           P+L+ L  L+ LDLS N L+ +I       L  L+ L +  +++ 
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 5/65 (7%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFL-SQLPLLRVLNL-D 502
             + +L L    LT  I   +   L  L+ L L NN +  SIP +  +++P LR L+L +
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGE 169

Query: 503 GNKLS 507
             +LS
Sbjct: 170 LKRLS 174

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 24/62 (38%), Positives = 37/62 (59%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            K+ SL+L   G++  I+  L +L  LE+L L NN +T  I   LS+L  L  L+L+ N+
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQ 167

Query: 506 LS 507
           +S
Sbjct: 168 IS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P++ SL L +  +T  I+  LS L  L+ L L +N ++  I   L+ L  L+ L L  N 
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH 189

Query: 506 LS 507
           +S
Sbjct: 190 IS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 21/79 (26%), Positives = 33/79 (41%), Gaps = 11/79 (13%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L  + N             +  L L    +   +S  L +LK L++L L +N ++  I  
Sbjct: 73  LFLNGNKLTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-N 128

Query: 489 FLSQLPLLRVLNLDGNKLS 507
            L  LP L  L L  NK++
Sbjct: 129 GLVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            + I  NL  + +T       + L S++ +  +N+ +  S+ + +  LP +  L L+GNK
Sbjct: 24  AETIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 79

Query: 506 LS 507
           L+
Sbjct: 80  LT 81

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 5/47 (10%), Positives = 17/47 (36%), Gaps = 3/47 (6%)

Query: 461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           +I             +L   S+T ++    ++L  +  +  + + + 
Sbjct: 16  QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 20/74 (27%), Positives = 31/74 (41%), Gaps = 5/74 (6%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPE----FLSQLPLLRVLNLDGNKLSGSVPTSLVARSQN 520
           +  ++  L+ L LS N ++   P       ++LP L +L+L  NKL     T L      
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189

Query: 521 GSLLLSIGRNPDLC 534
               L +  NP  C
Sbjct: 190 VKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 21/64 (32%), Positives = 29/64 (45%), Gaps = 5/64 (7%)

Query: 450 SLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLDGNKLS 507
           SL L+   L   IS  +   + +L  LDLS+N L  ++     S L  L VL L  N + 
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125

Query: 508 GSVP 511
             V 
Sbjct: 126 -VVD 128

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 22/85 (25%), Positives = 37/85 (43%), Gaps = 12/85 (14%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISP--SLSNLKSLENLDLSNNSLTGSIP 487
           L+CS           P     L+L+   L+ ++    + + L +L +L LS+N L   I 
Sbjct: 23  LSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80

Query: 488 E-FLSQLPLLRVLNLDGNKLSGSVP 511
                 +P LR L+L  N L  ++ 
Sbjct: 81  SEAFVPVPNLRYLDLSSNHLH-TLD 104

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 13/85 (15%), Positives = 30/85 (35%), Gaps = 7/85 (8%)

Query: 424 DPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT 483
            P  P Y   D  N  Y+         +++  +            L + + +   N+++ 
Sbjct: 10  KPRQPEYKCID-SNLQYDCV----FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 484 GSIP-EFLSQLPLLRVLNLDGNKLS 507
             +P   L     + +LNL+  ++ 
Sbjct: 65  -KLPAALLDSFRQVELLNLNDLQIE 88

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 17/63 (26%), Positives = 25/63 (39%), Gaps = 4/63 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGN 504
            ++  L L    LT   +  L N   L  +DLS N L   I      ++  L  L +  N
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNN 288

Query: 505 KLS 507
           +L 
Sbjct: 289 RLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 20/84 (23%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTG------------KISPSLSNLKSLENLDLSNNSLT 483
           L  S N     ++++LNL  + +               +  +      LENL L +NS+ 
Sbjct: 283 LYISNN-----RLVALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV 337

Query: 484 GSIPEFLSQLPLLRVLNLDGNKLS 507
            ++   LS    L+ L L  N   
Sbjct: 338 -TLK--LSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
            ++  LNL    +  +I   + +   +++ L +  N++    P     +PLL VL L+ N
Sbjct: 75  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133

Query: 505 KLS 507
            LS
Sbjct: 134 DLS 136

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 9/71 (12%), Positives = 29/71 (40%), Gaps = 5/71 (7%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDG 503
                +   +  +  K+  + L + + +E L+L++  +   I  +  +    ++ L +  
Sbjct: 51  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108

Query: 504 NKLSGSVPTSL 514
           N +   +P  +
Sbjct: 109 NAIR-YLPPHV 118

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 5/63 (7%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN 504
           PK+ +L++++  L  +I         SL+NL LS+N LT  +   LS +P L   N+  N
Sbjct: 147 PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202

Query: 505 KLS 507
            LS
Sbjct: 203 LLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 5/71 (7%)

Query: 446 PKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLDG 503
           P +  L L    L+  +   +  N   L  L +SNN+L   I  +       L+ L L  
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 180

Query: 504 NKLSGSVPTSL 514
           N+L+  V  SL
Sbjct: 181 NRLT-HVDLSL 190

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 15/62 (24%), Positives = 28/62 (45%), Gaps = 8/62 (12%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P +   N++   L+     +L+   ++E LD S+NS+   +         L +L L  N 
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 243

Query: 506 LS 507
           L+
Sbjct: 244 LT 245

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 20/79 (25%), Positives = 33/79 (41%), Gaps = 11/79 (13%)

Query: 436 LNCSYNGY-------KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L+ +               +  L L    +T  ISP L+ L +L+ L + N  ++  +  
Sbjct: 112 LDLTSTQITDVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DL-T 167

Query: 489 FLSQLPLLRVLNLDGNKLS 507
            L+ L  L  L  D NK+S
Sbjct: 168 PLANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 21/62 (33%), Positives = 36/62 (58%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            KI  L L+   L   +S  ++ L+S++ LDL++  +T   P  L+ L  L+VL LD N+
Sbjct: 85  TKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQ 140

Query: 506 LS 507
           ++
Sbjct: 141 IT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
             +I L L    +T  ++P L NL  +  L+LS N L  ++   ++ L  ++ L+L   +
Sbjct: 63  NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQ 118

Query: 506 LS 507
           ++
Sbjct: 119 IT 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 12/62 (19%), Positives = 25/62 (40%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
              I +      +T   + + ++L  +  L      +T +I E +  L  L  L L  N+
Sbjct: 19  ANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQ 74

Query: 506 LS 507
           ++
Sbjct: 75  IT 76

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 7/47 (14%), Positives = 19/47 (40%), Gaps = 3/47 (6%)

Query: 461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            I P    L +   +    +++T ++    + L  +  L+  G  ++
Sbjct: 11  VIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT 54

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 47/228 (20%)

Query: 612 RILGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR------N 663
             LG+G FG V          S+VA+K++        +  R E  +L ++  +       
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARLEINVLKKIKEKDKENKFL 83

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
              +  + N  G++ + +E +   N  ++L +   +         +A      L +LH  
Sbjct: 84  CVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE- 141

Query: 724 CKPPIIHRDVKTANILLNEKMQA-------------------KLADFGFSKIFPAESESH 764
            +  + H D+K  NIL                          ++ADFG S  F  + E H
Sbjct: 142 NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF--DHEHH 196

Query: 765 ISTSIVGTVGYLDPE-----YYASNRLTEKSDVYSFGIVLLELITGLP 807
             T+IV T  Y  PE      +      +  DV+S G +L E   G  
Sbjct: 197 --TTIVATRHYRPPEVILELGW-----AQPCDVWSIGCILFEYYRGFT 237

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 11/84 (13%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPE 488
           +NC            P     L+L+   L    S + L     L  L+L    LT  +  
Sbjct: 15  VNCDKRNLTALPPDLPKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQV 72

Query: 489 FLSQLPLLRVLNLDGNKLSGSVPT 512
               LP+L  L+L  N+L  S+P 
Sbjct: 73  D-GTLPVLGTLDLSHNQLQ-SLPL 94

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 22/62 (35%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            ++  LNL    LT         L  L  LDLS+N L  S+P     LP L VL++  N+
Sbjct: 55  TRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111

Query: 506 LS 507
           L+
Sbjct: 112 LT 113

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 13/89 (14%)

Query: 436 LNCSYNGYK--P------PKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSI 486
           L+ S+N  +  P      P +  L+++   LT  +       L  L+ L L  N L  ++
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TL 139

Query: 487 PE-FLSQLPLLRVLNLDGNKLSGSVPTSL 514
           P   L+  P L  L+L  N L+  +P  L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPAGL 167

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 21/79 (26%), Positives = 33/79 (41%), Gaps = 11/79 (13%)

Query: 436 LNCSYNG-------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE 488
           L  + N             +  L L    +   +S  L +LK L++L L +N ++  I  
Sbjct: 70  LFLNGNKLTDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-N 125

Query: 489 FLSQLPLLRVLNLDGNKLS 507
            L  LP L  L L  NK++
Sbjct: 126 GLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 16/62 (25%), Positives = 32/62 (51%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            + I  NL  + +T       + L S++ +  +N+ +  S+ + +  LP +  L L+GNK
Sbjct: 21  AETIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 76

Query: 506 LS 507
           L+
Sbjct: 77  LT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 4/62 (6%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           P++ SL L +  +T  I+  LS L  L+ L L +N ++  I   L+ L  L+ L L  N 
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNH 186

Query: 506 LS 507
           +S
Sbjct: 187 IS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.8 bits (100), Expect = 5e-04
 Identities = 6/47 (12%), Positives = 18/47 (38%), Gaps = 3/47 (6%)

Query: 461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           +I P           +L   S+T ++    ++L  +  +  + + + 
Sbjct: 13  QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)

Query: 446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
            +  +++ +   +  K+      L+ L+ L ++NN +          LP L  L L  N 
Sbjct: 42  DQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99

Query: 506 LS 507
           L 
Sbjct: 100 LV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 10/57 (17%), Positives = 21/57 (36%), Gaps = 3/57 (5%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
           + LT+E +  +     +N      LDL    +   I    + L     ++   N++ 
Sbjct: 2   VKLTAELIE-QA-AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR 55

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 11/67 (16%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 441 NGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLN 500
                 +   L+L    +   I    + L   + +D S+N +   + +    L  L+ L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 501 LDGNKLS 507
           ++ N++ 
Sbjct: 71  VNNNRIC 77

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 28/121 (23%), Positives = 40/121 (33%), Gaps = 16/121 (13%)

Query: 424 DPCSPMYYSWDGLNCSYNGYK--PPKIISL-NLTSEGLTG-----KISP-SLSNLKSLEN 474
           D C P  +   GL C+ +G       +    NLT   +        +    L  L  L N
Sbjct: 3   DACCP--HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 475 LDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
           L +  + L   +        P L  LNL  N L      ++   S      L +  NP  
Sbjct: 61  LTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE---LVLSGNPLH 116

Query: 534 C 534
           C
Sbjct: 117 C 117

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 19/64 (29%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
            ++ +L+L   GL  ++ P     L +L+ L L +N+L  ++P+     L  L  L L G
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162

Query: 504 NKLS 507
           N++S
Sbjct: 163 NRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 8/83 (9%)

Query: 436 LNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE- 488
            +C   G +      P     + L    ++   + S    ++L  L L +N L   I   
Sbjct: 16  TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74

Query: 489 FLSQLPLLRVLNLDGNKLSGSVP 511
             + L LL  L+L  N    SV 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVD 97

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 20/72 (27%), Positives = 31/72 (43%), Gaps = 6/72 (8%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL 523
           +   L SL+ L L  N +   +       L  L  L L  N LS ++PT  +  +   +L
Sbjct: 172 AFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL--APLRAL 227

Query: 524 -LLSIGRNPDLC 534
             L +  NP +C
Sbjct: 228 QYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 4/68 (5%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLDG 503
             +  L L S  L  +I   + + L  LE LDLS+N+   S+       L  L  L+LD 
Sbjct: 56  RNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114

Query: 504 NKLSGSVP 511
             L   + 
Sbjct: 115 CGLQ-ELG 121

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 4/64 (6%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDG 503
             +  L L    L   +   +  +L +L +L L  N ++ S+PE     L  L  L L  
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186

Query: 504 NKLS 507
           N+++
Sbjct: 187 NRVA 190

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 16/61 (26%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDG 503
             +  L L    +   + P +  +L  L  L L  N+L+ ++P   L+ L  L+ L L+ 
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234

Query: 504 N 504
           N
Sbjct: 235 N 235

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 6e-06
 Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 8/94 (8%)

Query: 446 PKIISLNLTSEGLTGKISPSLSN---LKSLENLDLSNNSLTGS----IPEFLSQLPLLRV 498
           P +  L +        +         L  LE +D+S   LT      + + + ++  L+ 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 499 LNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPD 532
           +N+  N LS  +   L  +S    + +S  +  D
Sbjct: 312 INMKYNYLSDEMKKEL-QKSLPMKIDVSDSQEYD 344

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 9e-06
 Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 63/236 (26%)

Query: 612 RILGKGGFGTVYHGY--LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             LG+G FG V       A G  VA+K++         ++   A+  ++V    L  L  
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQV----LEHLNT 70

Query: 670 YCNDG--------------GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
              +               G++ +V+E +   +   ++ +            ++A    +
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQA-------------------KLADFGFSKI 756
            + +LH   K  + H D+K  NIL  +                       K+ DFG S  
Sbjct: 130 SVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT 185

Query: 757 FPAESESHISTSIVGTVGYLDPE-----YYASNRLTEKSDVYSFGIVLLELITGLP 807
           +  + E H  +++V T  Y  PE      +     ++  DV+S G +L+E   G  
Sbjct: 186 Y--DDEHH--STLVSTRHYRAPEVILALGW-----SQPCDVWSIGCILIEYYLGFT 232

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 14/76 (18%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG----SIPEFLS 491
           +    NG          +  EG+   +   L+  + L+ LDL +N+ T     ++   L 
Sbjct: 192 VKMVQNG----------IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241

Query: 492 QLPLLRVLNLDGNKLS 507
             P LR L L+   LS
Sbjct: 242 SWPNLRELGLNDCLLS 257

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 7e-04
 Identities = 12/77 (15%), Positives = 27/77 (35%), Gaps = 16/77 (20%)

Query: 436 LNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLT-----GSIPEFL 490
           + C  N           L +  +    + +  + + L  + +  N +        + E L
Sbjct: 164 IICGRN----------RLENGSMKE-WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212

Query: 491 SQLPLLRVLNLDGNKLS 507
           +    L+VL+L  N  +
Sbjct: 213 AYCQELKVLDLQDNTFT 229

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 3/90 (3%)

Query: 446 PKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIP-EFLSQLPLLRVLNLDG 503
           P I  + ++ +    ++   S  NL  + ++++ N      I  + L +LPLL+ L +  
Sbjct: 55  PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114

Query: 504 NKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
             L    P      S +   +L I  NP +
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 462 ISPS-LSNLKSLENLDLSNNSLTGSIPE--FLSQLPLLRVLNLDGNKLSGSVPTSLVARS 518
           I P  L  L  L+ L + N  L    P+   +    +  +L +  N    S+P +     
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154

Query: 519 QNGSLLLSIGRN 530
            N +L L +  N
Sbjct: 155 CNETLTLKLYNN 166

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 8/93 (8%)

Query: 446 PKIISLNLTSEGLTGKISP--SLSNLKSLENLDLSNNSLTGSIPE--FLSQLPLLRVLNL 501
           P +  L + + GL         + +      L++++N    SIP   F         L L
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163

Query: 502 DGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLC 534
             N  + SV       ++  ++ L+  +N  L 
Sbjct: 164 YNNGFT-SVQGYAFNGTKLDAVYLN--KNKYLT 193

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 13/87 (14%)

Query: 437 NCSYNGYK------PPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSNNSLTGSIPE- 488
           +C   G        P  I  + L    +   I P + S  K L  +DLSNN ++  +   
Sbjct: 17  DCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPD 74

Query: 489 -FLSQLPLLRVLNLDGNKLSGSVPTSL 514
            F   L  L  L L GNK++  +P SL
Sbjct: 75  AF-QGLRSLNSLVLYGNKIT-ELPKSL 99

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 22/85 (25%), Positives = 34/85 (40%), Gaps = 13/85 (15%)

Query: 437 NCSYNGYK------PPKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSNNSLTGSIPE- 488
           +CS           P     L+L S  L+  +       L  L  L L++N L  ++P  
Sbjct: 22  DCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79

Query: 489 -FLSQLPLLRVLNLDGNKLSGSVPT 512
            F  +L  L  L +  NKL  ++P 
Sbjct: 80  IF-KELKNLETLWVTDNKLQ-ALPI 102

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 17/73 (23%), Positives = 30/73 (41%), Gaps = 8/73 (10%)

Query: 444 KPPKIISLNLTSEGLTGKISPSL-SNLKSLENLDLSNNSLTGSIPE---FLSQLPLLRVL 499
               +  L      L   +      +LK+L+ L++++N +  S      F S L  L  L
Sbjct: 98  GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYF-SNLTNLEHL 154

Query: 500 NLDGNKLSGSVPT 512
           +L  NK+  S+  
Sbjct: 155 DLSSNKIQ-SIYC 166

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 6/91 (6%)

Query: 446 PKIISLNLTSEGLTGKISPS-LSNLKSLENLDLSN-NSLTGSIP-EFLSQLPLLRVLNLD 502
             +  + ++   +   I     SNL  L  + +   N+L   I  E    LP L+ L + 
Sbjct: 54  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLIS 112

Query: 503 GNKLSGSVPTSLVARSQNGSLLLSIGRNPDL 533
              +   +P      S    +LL I  N ++
Sbjct: 113 NTGIK-HLPDVHKIHSLQ-KVLLDIQDNINI 141

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 14/85 (16%)

Query: 437 NCSYNGYK------PPKIISLNLTSEGLTGKISPS--LSNLKSLENLDLSNNSLTGSIPE 488
           +CS           P     L L +   T  +  +     L  L  ++ SNN +T  I E
Sbjct: 17  DCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEE 74

Query: 489 --FLSQLPLLRVLNLDGNKLSGSVP 511
             F      +  + L  N+L  +V 
Sbjct: 75  GAF-EGASGVNEILLTSNRLE-NVQ 97

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	919
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-63
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	6e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	7e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 2e-66
 Identities = 78/274 (28%), Positives = 126/274 (45%), Gaps = 21/274 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLASL 667
             + +G G FGTVY G      +VA+KML  +A + Q  + F+ E  +L +  H N+   
Sbjct: 12  VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +GY      + +V ++    +L  +L    +        + IA   AQG++YLH      
Sbjct: 70  MGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KS 124

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY---ASN 784
           IIHRD+K+ NI L+E +  K+ DFG + +    S SH    + G++ ++ PE       N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
             + +SDVY+FGIVL EL+TG        N   I+  V         R  + P L     
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------RGYLSPDLS-KVR 235

Query: 845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
           +N    +     EC+     +RP    ++  ++ 
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 7e-63
 Identities = 70/280 (25%), Positives = 131/280 (46%), Gaps = 20/280 (7%)

Query: 603 IVDITN-NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           ++D +   F + +G G FG V+ GY  +  +VAIK +    +   + F  EA+++M++ H
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSH 59

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L  L G C +   + LV+E+M +G L  YL  +     + +  L + +D  +G+    
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGM---A 115

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
           +  +  +IHRD+   N L+ E    K++DFG ++    + +   ST     V +  PE +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 174

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
           + +R + KSDV+SFG+++ E+ +         +N+ +V  +           +  PRL +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLAS 228

Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
                    V +    C       RP  S ++ +L +  E
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 5e-62
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 19/269 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               LG G FG V+ GY    ++VA+K L    S  P  F  EA L+ ++ H+ L  L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
                  + ++ EYM  G+L  +L   +   L+    L +A   A+G+ ++        I
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           HRD++ ANIL+++ +  K+ADFG +++   ++E          + +  PE       T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 790 SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW 849
           SDV+SFGI+L E++T       G  N  ++  +               R+      N   
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-----------GYRMV--RPDNCPE 237

Query: 850 KVAETAMECVPSISFQRPTMSHVVTELKK 878
           ++ +    C       RPT  ++ + L+ 
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 9e-60
 Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 36/303 (11%)

Query: 598 FTYSEIVDITNNFH-----------RILGKGGFGTVYHGYLADGSE----VAIKML-SAS 641
           FT+ +  +    F            +++G G FG V  G+L    +    VAIK L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 642 SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEAL 701
           + +  + F +EA ++ +  H N+  L G       V ++ E+M  G+L  +L     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 702 SWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES 761
           +    + +    A G++YL        +HRD+   NIL+N  +  K++DFG S+    ++
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 762 ESHISTSIVG---TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHI 818
                TS +G    + +  PE     + T  SDV+S+GIV+ E+++          N  +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK 878
           +N +             D RL    D  S   + +  ++C       RP    +V  L K
Sbjct: 243 INAIEQ-----------DYRLPPPMDCPS--ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289

Query: 879 CLE 881
            + 
Sbjct: 290 MIR 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 9e-60
 Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 19/269 (7%)

Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
            F + LG G FG V +G      +VAIKM+    S    +F  EA+++M + H  L  L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
           G C     + ++ EYMA G L  YL +        +  L++  D  + +EYL        
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+   N L+N++   K++DFG S+    + E   S      V +  PE    ++ + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           KSD+++FG+++ E+ +        + N+     +   L       +  P L +       
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------LYRPHLASE------ 228

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELK 877
            KV      C    + +RPT   +++ + 
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (517), Expect = 9e-60
 Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 19/284 (6%)

Query: 609 NFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
                LG G +G VY G        VA+K L   + +  ++F  EA ++  + H NL  L
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
           +G C       ++ E+M YGNL  YL +  ++ +S    L +A   +  +EYL    K  
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 135

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
            IHRD+   N L+ E    K+ADFG S++                + +  PE  A N+ +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS 847
            KSDV++FG++L E+ T   +   G + + +               +++           
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------------LLEKDYRMERPEGC 241

Query: 848 VWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQR 891
             KV E    C       RP+ + +    +   +  +  +++++
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-59
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 25/298 (8%)

Query: 607 TNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
            ++F +I  LG G  G V+       G  +A K++          Q   E Q+L   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
            +    G     G + +  E+M  G+L Q L    +  +  +   ++++   +GL YL  
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE 122

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
             K  I+HRDVK +NIL+N + + KL DFG S          ++ S VGT  Y+ PE   
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176

Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC-----PFLERGDVRSIVDP 837
               + +SD++S G+ L+E+  G   I         +   C             R+   P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 838 RLEANFDTNSVWKVAETAMECV--PSISFQRPTMSHVVTEL-KKCLEME-----TARE 887
                 D+     + E     V  P         S    +   KCL          ++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-59
 Identities = 63/298 (21%), Positives = 119/298 (39%), Gaps = 29/298 (9%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               +GKG FG V+ G    G EVA+K+ S+   +       E    + + H N+   + 
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 670 YCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC- 724
             N          LV +Y  +G+L  YL    +  ++ +  +++A+  A GL +LH    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 725 ----KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE--SHISTSIVGTVGYLDP 778
               KP I HRD+K+ NIL+ +     +AD G +    + ++         VGT  Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 779 EYYASN------RLTEKSDVYSFGIVLLELITGLP------AIIRGYNNTHIVNRVCPFL 826
           E    +         +++D+Y+ G+V  E+                Y +    +     +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 827 ERGDVRSIVDPRLEANFDT-NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME 883
            +      + P +   + +  ++  +A+   EC  +    R T   +   L +  + E
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (508), Expect = 3e-58
 Identities = 74/302 (24%), Positives = 127/302 (42%), Gaps = 45/302 (14%)

Query: 609 NFHRILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHH 661
            + R +G+G FG V+             + VA+KML   +S      F+ EA L+    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKE---------------------- 699
            N+  L+G C  G  + L++EYMAYG+L ++L   +                        
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 700 ALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA 759
            LS  ++L IA   A G+ YL        +HRD+ T N L+ E M  K+ADFG S+   +
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV 819
                   +    + ++ PE    NR T +SDV+++G+VL E+ +       G  +  ++
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252

Query: 820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC 879
             V      G++ +  +         N   ++      C   +   RP+   +   L++ 
Sbjct: 253 YYV----RDGNILACPE---------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

Query: 880 LE 881
            E
Sbjct: 300 CE 301

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-58
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 19/271 (7%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
               LG+G FG V+ G     + VAIK L    +  P+ F  EAQ++ ++ H  L  L  
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
             ++   + +V EYM+ G+L  +L  ET + L     + +A   A G+ Y+        +
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEK 789
           HRD++ ANIL+ E +  K+ADFG +++   ++E          + +  PE     R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 790 SDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVW 849
           SDV+SFGI+L EL T       G  N  ++++             V+             
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------VERGYRMPCPPECPE 241

Query: 850 KVAETAMECVPSISFQRPTMSHVVTELKKCL 880
            + +   +C      +RPT  ++   L+   
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-58
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 25/298 (8%)

Query: 605 DITNNFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQG-PKQFRTEAQLLMRV 659
            +  +F+ ++G+G FG VYHG L D        A+K L+  +  G   QF TE  ++   
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 660 HHRNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
            H N+ SL+G C    G+  +V  YM +G+L+ ++ +ET    + KD +   +  A+G+ 
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM- 143

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES--ESHISTSIVGTVGYL 776
                     +HRD+   N +L+EK   K+ADFG ++    +     H  T     V ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 777 DPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD 836
             E   + + T KSDV+SFG++L EL+T         N   I   +         R ++ 
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGRRLLQ 255

Query: 837 PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKS 894
           P             + E  ++C    +  RP+ S +V+ +            +    +
Sbjct: 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-58
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 25/275 (9%)

Query: 610 FHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVG 669
             + +GKG FG V  G    G++VA+K +   ++   + F  EA ++ ++ H NL  L+G
Sbjct: 11  LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 67

Query: 670 YC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
               + G + +V EYMA G+L  YL    +  L     L+ ++D  + +EYL        
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
           +HRD+   N+L++E   AK++DFG +K       S    +    V +  PE     + + 
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFST 179

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           KSDV+SFGI+L E+ +             +V RV    E+G      D    A       
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGCPPA------- 228

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLEME 883
             V E    C    +  RP+   +  +L+     E
Sbjct: 229 --VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 8e-56
 Identities = 63/286 (22%), Positives = 118/286 (41%), Gaps = 24/286 (8%)

Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLA 665
           +++G G FG VY G L   S      VAIK L A  ++     F  EA ++ +  H N+ 
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L G  +    + ++ EYM           E     S    + +    A G+    +   
Sbjct: 73  RLEGVISKYKPMMIITEYM-ENGALDKFLREKDGEFSVLQLVGMLRGIAAGM---KYLAN 128

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE-SHISTSIVGTVGYLDPEYYASN 784
              +HRD+   NIL+N  +  K++DFG S++   + E ++ ++     + +  PE  +  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
           + T  SDV+SFGIV+ E++T         +N  ++               ++        
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-------------AINDGFRLPTP 235

Query: 845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQ 890
            +    + +  M+C      +RP  + +V+ L K +    + + + 
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-55
 Identities = 59/280 (21%), Positives = 117/280 (41%), Gaps = 23/280 (8%)

Query: 614 LGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVG 669
           LG G FG+V  G         +VAIK+L   + +   ++   EAQ++ ++ +  +  L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 670 YCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPII 729
            C     + LV E    G L ++L  + +E +   +  ++    + G++YL        +
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFV 131

Query: 730 HRDVKTANILLNEKMQAKLADFGFSKIFPA-ESESHISTSIVGTVGYLDPEYYASNRLTE 788
           HRD+   N+LL  +  AK++DFG SK   A +S     ++    + +  PE     + + 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV 848
           +SDV+S+G+ + E ++      +      ++  +    +R +      P L         
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPEL--------- 241

Query: 849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQ 888
                   +C       RP    V   ++ C     ++ +
Sbjct: 242 ---YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-55
 Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 28/272 (10%)

Query: 610 FHRILGKGGFGTVYHGYLAD-GSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLAS 666
           F   +G+G F TVY G   +   EVA   L     +    ++F+ EA++L  + H N+  
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 667 LVGYC----NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                         + LV E M  G LK YL     + +  K          +GL++LH 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 723 GCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
              PPIIHRD+K  NI +       K+ D G + +      +  + +++GT  ++ PE Y
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY 185

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
              +  E  DVY+FG+ +LE+ T         N   I  RV   ++      +  P ++ 
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 243

Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
                   ++ E  +        +R ++  ++
Sbjct: 244 --------EIIEGCIRQNKD---ERYSIKDLL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 5e-55
 Identities = 73/318 (22%), Positives = 127/318 (39%), Gaps = 42/318 (13%)

Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ 644
           D  Q  Y    +   N   F + LG G FG V                VA+KML  S+  
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67

Query: 645 G-PKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------- 693
              +   +E ++L  + +H N+ +L+G C  GG   ++ EY  YG+L  +L         
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 694 -------FDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQA 746
                   ++ + AL  +D L  +   A+G+ +L        IHRD+   NILL      
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184

Query: 747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGL 806
           K+ DFG ++    +S   +  +    V ++ PE   +   T +SDV+S+GI L EL +  
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 807 PAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQR 866
            +   G        +            ++          ++  ++ +    C  +   +R
Sbjct: 245 SSPYPGMPVDSKFYK------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 867 PTMSHVVTELKKCLEMET 884
           PT   +V  ++K +   T
Sbjct: 293 PTFKQIVQLIEKQISEST 310

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 8e-55
 Identities = 69/335 (20%), Positives = 134/335 (40%), Gaps = 55/335 (16%)

Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNN-----------FHRILGKGGFGTVYHGYLADGS 631
           S  +      S + ++ Y +  +   +           F ++LG G FG V +      S
Sbjct: 3   SQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGIS 62

Query: 632 E------VAIKMLSASSSQG-PKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY 683
           +      VA+KML   +     +   +E +++ ++  H N+ +L+G C   G + L++EY
Sbjct: 63  KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122

Query: 684 MAYGNLKQYLF---------------------DETKEALSWKDRLQIAVDAAQGLEYLHH 722
             YG+L  YL                      +E    L+++D L  A   A+G+E+L  
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                 +HRD+   N+L+      K+ DFG ++   ++S   +  +    V ++ PE   
Sbjct: 183 ---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239

Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN 842
               T KSDV+S+GI+L E+ +       G                 +   ++    + +
Sbjct: 240 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP------------VDANFYKLIQNGFKMD 287

Query: 843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
               +  ++      C    S +RP+  ++ + L 
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 1e-54
 Identities = 80/325 (24%), Positives = 141/325 (43%), Gaps = 42/325 (12%)

Query: 603 IVDITN-NFHRILGKGGFGTVYHGYLADGS---EVAIKMLS-ASSSQGPKQFRTEAQLLM 657
           ++D  +  F  ++G+G FG V    +       + AIK +   +S    + F  E ++L 
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 658 RV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL--------------FDETKEALS 702
           ++ HH N+ +L+G C   G + L  EY  +GNL  +L               + T   LS
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
            +  L  A D A+G++YL    +   IHRD+   NIL+ E   AK+ADFG S+      +
Sbjct: 126 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
               T     V ++  E    +  T  SDV+S+G++L E+++       G     +  ++
Sbjct: 183 ---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239

Query: 823 CPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM 882
                          RLE     N   +V +   +C     ++RP+ + ++  L + LE 
Sbjct: 240 PQ-----------GYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

Query: 883 ETAREQIQRTKSQMLSLSSSVDISA 907
              +  +  T  +  +  + +D SA
Sbjct: 287 R--KTYVNTTLYEKFT-YAGIDCSA 308

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-54
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 25/274 (9%)

Query: 609 NFHRILGKGGFGTVYHGY-LADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLA 665
                +G G +G        +DG  +  K L   S      +   +E  LL  + H N+ 
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 666 SLVGYCND--GGNVGLVYEYMAYGNLKQYLFDETKE--ALSWKDRLQIAVDAAQGLEYLH 721
                  D     + +V EY   G+L   +   TKE   L  +  L++       L+  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 722 --HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                   ++HRD+K AN+ L+ K   KL DFG ++I     ++  + + VGT  Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPE 184

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL 839
                   EKSD++S G +L EL   +P     ++   +  +         +R     R+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMP-PFTAFSQKELAGK---------IREGKFRRI 234

Query: 840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVV 873
              +  + + ++    +         RP++  ++
Sbjct: 235 PYRYS-DELNEIITRMLNLKDY---HRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-53
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 8/216 (3%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASL 667
             + LG+G +G V           VA+K++    +   P+  + E  +   ++H N+   
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
            G+  +G    L  EY + G L   +  +    +   D  +       G+ YLH      
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG---IG 123

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL- 786
           I HRD+K  N+LL+E+   K++DFG + +F   +   +   + GT+ Y+ PE        
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 787 TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRV 822
            E  DV+S GIVL  ++ G     +  ++    +  
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 2e-53
 Identities = 77/308 (25%), Positives = 118/308 (38%), Gaps = 35/308 (11%)

Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMR 658
           D    F  +  +G G FG VY    + +   VAIK +S S  Q     +    E + L +
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
           + H N     G         LV EY              K+ L   +   +   A QGL 
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLA 129

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           YLH      +IHRDVK  NILL+E    KL DFG + I         + S VGT  ++ P
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAP 180

Query: 779 EYYAS---NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV 835
           E   +    +   K DV+S GI  +EL    P  +   N    +  +     + +  ++ 
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNAMSALYHIA----QNESPALQ 235

Query: 836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTE--LKKCLEMETAREQIQRTK 893
                  F         ++ ++ +P     RPT   ++    + +        + IQRTK
Sbjct: 236 SGHWSEYFR-----NFVDSCLQKIPQ---DRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

Query: 894 SQMLSLSS 901
             +  L +
Sbjct: 288 DAVRELDN 295

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-53
 Identities = 54/204 (26%), Positives = 81/204 (39%), Gaps = 12/204 (5%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
               LG G FG VY           A K++   S +  + +  E  +L    H N+  L+
Sbjct: 16  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
                  N+ ++ E+ A G +   + +  +  L+      +       L YLH      I
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL-- 786
           IHRD+K  NIL       KLADFG S       +     S +GT  ++ PE         
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKD 189

Query: 787 ---TEKSDVYSFGIVLLELITGLP 807
                K+DV+S GI L+E+    P
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEP 213

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 9e-53
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 25/272 (9%)

Query: 612 RILGKGGFGTVYHGYLAD---GSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLAS 666
           + LG G FGTV  GY         VA+K+L   ++      +   EA ++ ++ +  +  
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 667 LVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKP 726
           ++G C     + LV E    G L +YL       +  K+ +++    + G++YL      
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 727 PIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE-SESHISTSIVGTVGYLDPEYYASNR 785
             +HRD+   N+LL  +  AK++DFG SK   A+ +     T     V +  PE     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT 845
            + KSDV+SFG+++ E  +      RG   + +   +               R+      
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----------GERMG--CPA 233

Query: 846 NSVWKVAETAMECVPSISFQRPTMSHVVTELK 877
               ++ +    C       RP  + V   L+
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-52
 Identities = 73/308 (23%), Positives = 127/308 (41%), Gaps = 24/308 (7%)

Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLS-ASSSQGPKQFRTEAQLLMRVHHRNLA 665
           ++LG G FGTVY G      E     VAIK L  A+S +  K+   EA ++  V + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+G C     V L+ + M +G L  Y+ +  K+ +  +  L   V  A+G+ YL     
Sbjct: 75  RLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED--- 129

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             ++HRD+   N+L+      K+ DFG +K+  AE + + +      + ++  E      
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT 845
            T +SDV+S+G+ + EL+T       G   + I + +               RL      
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-----------GERLP--QPP 236

Query: 846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQIQRTKSQMLSLSSSVDI 905
                V    ++C    +  RP    ++ E  K          IQ  +   L   +  + 
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 296

Query: 906 SAVEVETE 913
               ++ E
Sbjct: 297 YRALMDEE 304

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-52
 Identities = 70/268 (26%), Positives = 106/268 (39%), Gaps = 28/268 (10%)

Query: 610 FHRILGKGGFGTVYHGYL-ADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLA 665
             R LGKG FG VY          +A+K+L       +    Q R E ++   + H N+ 
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L GY +D   V L+ EY   G + + L   +K     +       + A  L Y H    
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---S 124

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             +IHRD+K  N+LL    + K+ADFG+S      + S   T++ GT+ YL PE      
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT 845
             EK D++S G++  E + G P             R+            V          
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKP-PFEANTYQETYKRISR--VEFTFPDFVTEGAR----- 232

Query: 846 NSVWKVAETAMECVPSISFQRPTMSHVV 873
                +    ++  PS   QRP +  V+
Sbjct: 233 ----DLISRLLKHNPS---QRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-51
 Identities = 63/282 (22%), Positives = 115/282 (40%), Gaps = 24/282 (8%)

Query: 610 FHRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNL 664
             R +G+G FG V+ G           VAIK     +S    ++F  EA  + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             L+G   +   V ++ E    G L+ +L      +L     +  A   +  L YL    
Sbjct: 71  VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE--- 125

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
               +HRD+   N+L++     KL DFG S+    +S  + ++     + ++ PE     
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184

Query: 785 RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
           R T  SDV+ FG+ + E++       +G  N  ++ R         + +     +  N  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---------IENGERLPMPPNCP 235

Query: 845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAR 886
             +++ +        PS   +RP  + +  +L   LE E A+
Sbjct: 236 -PTLYSLMTKCWAYDPS---RRPRFTELKAQLSTILEEEKAQ 273

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 1e-51
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 11/206 (5%)

Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
           D    + R   +G+G  GTVY    +A G EVAI+ ++       +    E  ++    +
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
            N+ + +     G  + +V EY+A G+L   +    +  +       +  +  Q LE+LH
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH 133

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
                 +IHRD+K+ NILL      KL DFGF        E    +++VGT  ++ PE  
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVV 188

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
                  K D++S GI+ +E+I G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEP 214

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 3e-51
 Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 31/287 (10%)

Query: 610 FHRILGKGGFGTVYHGYL------ADGSEVAIKMLS-ASSSQGPKQFRTEAQLLMRVHHR 662
             R LG+G FG VY G           + VAIK ++ A+S +   +F  EA ++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF--------DETKEALSWKDRLQIAVDAA 714
           ++  L+G  + G    ++ E M  G+LK YL         +      S    +Q+A + A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 715 QGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
            G+ YL+       +HRD+   N ++ E    K+ DFG ++              +  V 
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
           ++ PE       T  SDV+SFG+VL E+ T      +G +N  ++  V      G +   
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EGGLLDK 256

Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
            D   +          + E    C       RP+   +++ +K+ +E
Sbjct: 257 PDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-51
 Identities = 62/218 (28%), Positives = 92/218 (42%), Gaps = 10/218 (4%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNLA 665
           F +ILG+G F TV     LA   E AIK+L                E  ++ R+ H    
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L     D   +     Y   G L +Y+                    A+ +  L +   
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDET---CTRFYTAEIVSALEYLHG 126

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             IIHRD+K  NILLNE M  ++ DFG +K+   ES+   + S VGT  Y+ PE      
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 786 LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
             + SD+++ G ++ +L+ GLP   R  N   I  ++ 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKII 223

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 63/278 (22%), Positives = 96/278 (34%), Gaps = 25/278 (8%)

Query: 610 FHRILGKGGFGTVYHGYL----ADGSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHR 662
               LG G FG V  G           VA+K L     S  +    F  E   +  + HR
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
           NL  L G       + +V E    G+L   L              + AV  A+G+ YL  
Sbjct: 72  NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 129

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI-STSIVGTVGYLDPEYY 781
                 IHRD+   N+LL  +   K+ DFG  +  P   + ++          +  PE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA 841
            +   +  SD + FG+ L E+ T       G N + I++++    ER          +  
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI-- 244

Query: 842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC 879
                  + V        P     RPT   +   L + 
Sbjct: 245 -------YNVMVQCWAHKPE---DRPTFVALRDFLLEA 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 8e-49
 Identities = 72/297 (24%), Positives = 131/297 (44%), Gaps = 40/297 (13%)

Query: 610 FHRILGKGGFGTVYHGYL--------ADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV- 659
             + LG+G FG V                ++VA+KML + +++       +E +++  + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFD--------------ETKEALSWKD 705
            H+N+ +L+G C   G + ++ EY + GNL++YL                  +E LS KD
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
            +  A   A+G+EYL        IHRD+   N+L+ E    K+ADFG ++          
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF 825
           +T+    V ++ PE       T +SDV+SFG++L E+ T   +   G     +   +   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE- 252

Query: 826 LERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM 882
                       R++    +N   ++     +C  ++  QRPT   +V +L + + +
Sbjct: 253 ----------GHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  173 bits (440), Expect = 2e-48
 Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 13/224 (5%)

Query: 605 DITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
            + +++     LG G FG V+     A G+  A K +        +  R E Q +  + H
Sbjct: 23  HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 82

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L +L     D   + ++YE+M+ G L + + DE    +S  + ++      +GL ++H
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 722 HGCKPPIIHRDVKTANILLNEKM--QAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                  +H D+K  NI+   K   + KL DFG +                GT  +  PE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPE 195

Query: 780 YYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
                 +   +D++S G++   L++GL     G N+   +  V 
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLS-PFGGENDDETLRNVK 238

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 3e-48
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 38/295 (12%)

Query: 610 FHRILGKGGFGTVYHGY------LADGSEVAIKMLSASSSQGP-KQFRTEAQLLMR-VHH 661
             + LG+G FG V           A    VA+KML   ++    +   +E ++L+   HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 662 RNLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLF--------------DETKEALSWKDR 706
            N+ +L+G C   GG + ++ E+  +GNL  YL               D  K+ L+ +  
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 707 LQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS 766
           +  +   A+G+E+L        IHRD+   NILL+EK   K+ DFG ++    + +    
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL 826
                 + ++ PE       T +SDV+SFG++L E+ +   +   G        R     
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---- 249

Query: 827 ERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE 881
               ++     R           ++ +T ++C      QRPT S +V  L   L+
Sbjct: 250 ----LKEGTRMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (424), Expect = 3e-46
 Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 10/201 (4%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
               LG G FG V+     A G     K ++          + E  ++ ++HH  L +L 
Sbjct: 33  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
               D   + L+ E+++ G L   +  E    +S  + +     A +GL+++H   +  I
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSI 148

Query: 729 IHRDVKTANILL--NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRL 786
           +H D+K  NI+    +    K+ DFG +      +   I      T  +  PE      +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 787 TEKSDVYSFGIVLLELITGLP 807
              +D+++ G++   L++GL 
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLS 226

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (414), Expect = 8e-46
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 606 ITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRV 659
           +++ +    ILG GG   V+    L    +VA+K+L A  ++ P    +FR EAQ    +
Sbjct: 5   LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64

Query: 660 HHRNLASLVGYCNDGGNVG----LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
           +H  + ++          G    +V EY+    L+  +  E    ++ K  +++  DA Q
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQ 122

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST-SIVGTVG 774
            L +     +  IIHRDVK ANI+++     K+ DFG ++       S   T +++GT  
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           YL PE    + +  +SDVYS G VL E++TG P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 1e-45
 Identities = 49/228 (21%), Positives = 96/228 (42%), Gaps = 10/228 (4%)

Query: 600 YSEIVDITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQL 655
           + +  DI + +    +LG G F  V           VAIK ++  + +G       E  +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 656 LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
           L ++ H N+ +L      GG++ L+ + ++ G L   +    K   + +D  ++      
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLD 118

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGY 775
            ++YLH         +        L+E  +  ++DFG SK+   E    + ++  GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 175

Query: 776 LDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
           + PE  A    ++  D +S G++   L+ G P      N+  +  ++ 
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP-PFYDENDAKLFEQIL 222

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  158 bits (401), Expect = 1e-43
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 14/202 (6%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLA 665
             R LG G FG V+      +G   A+K+L        KQ      E  +L  V H  + 
Sbjct: 8   ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            + G   D   + ++ +Y+  G L   L                   AA+    L +   
Sbjct: 68  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS 122

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             II+RD+K  NILL++    K+ DFGF+K  P      ++ ++ GT  Y+ PE  ++  
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKP 177

Query: 786 LTEKSDVYSFGIVLLELITGLP 807
             +  D +SFGI++ E++ G  
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 2e-43
 Identities = 36/215 (16%), Positives = 87/215 (40%), Gaps = 12/215 (5%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
             LG+G FG V+     +       K +    +      + E  +L    HRN+  L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69

Query: 671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIH 730
                 + +++E+++  ++ + + + +   L+ ++ +       + L++LH      I H
Sbjct: 70  FESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 731 RDVKTANILLNEK--MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTE 788
            D++  NI+   +     K+ +FG ++             +     Y  PE +  + ++ 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 789 KSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
            +D++S G ++  L++G+        N  I+  + 
Sbjct: 183 ATDMWSLGTLVYVLLSGIN-PFLAETNQQIIENIM 216

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (391), Expect = 9e-43
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 25/215 (11%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSS---------QGPKQFRTEAQLLMRV 659
              ILG+G    V          E A+K++  +           +  +    E  +L +V
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 660 H-HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
             H N+  L           LV++ M  G L  YL    K  LS K+  +I     + + 
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVIC 124

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
            LH   K  I+HRD+K  NILL++ M  KL DFGFS              + GT  YL P
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAP 178

Query: 779 EYYASNRL------TEKSDVYSFGIVLLELITGLP 807
           E    +         ++ D++S G+++  L+ G P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-42
 Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 12/203 (5%)

Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQ---FRTEAQLLMRV-HHRNL 664
            H++LGKG FG V+   +       AIK L                E ++L     H  L
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGC 724
             +        N+  V EY+  G+L  ++    K           A +   GL++L    
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL---H 120

Query: 725 KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
              I++RD+K  NILL++    K+ADFG  K            +  GT  Y+ PE     
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQ 178

Query: 785 RLTEKSDVYSFGIVLLELITGLP 807
           +     D +SFG++L E++ G  
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQS 201

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-42
 Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 29/289 (10%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-----PKQFRTEAQLLMRVHHRNLA 665
             LG+G F TVY          VAIK +             +    E +LL  + H N+ 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
            L+       N+ LV+++M        +  +    L+        +   QGLEYLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 726 PPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR 785
             I+HRD+K  N+LL+E    KLADFG +K F + + ++  T  V T  Y  PE     R
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176

Query: 786 L-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD 844
           +     D+++ G +L EL+  +P  + G ++   + R+          ++  P  E   D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVP-FLPGDSDLDQLTRI--------FETLGTPTEEQWPD 227

Query: 845 TNSVWKVAETAMECVPSISFQRPTMSHVVTEL-KKCLEME-----TARE 887
             S+             +          + +L +           TA +
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (381), Expect = 3e-41
 Identities = 50/287 (17%), Positives = 99/287 (34%), Gaps = 32/287 (11%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASL 667
             R +G+G FG ++ G  L +  +VAIK     S     Q R E +    +     + ++
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNV 66

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
             +  +G +  LV + +  G   + L D      S K     A      ++ +H      
Sbjct: 67  YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 728 IIHRDVKTANILLNEKMQ-----AKLADFGFSKIFPAESES-----HISTSIVGTVGYLD 777
           +++RD+K  N L+            + DFG  K +               ++ GT  Y+ 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 778 PEYYASNRLTEKSDVYSFGIVLLELITG--LPAIIRGYNNTHIVNRVCPFLERGDVRSIV 835
              +     + + D+ + G V +  + G      ++   N     R+    +   +R + 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 836 DPRLEANFDTNSVWKVAETAMECVPSISF-QRPTMSHVVTELKKCLE 881
                         +     M    +++F   P   ++     K LE
Sbjct: 242 A----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-41
 Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 17/290 (5%)

Query: 602 EIVDITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLM 657
           ++ D+   +     +G+G +G V   Y   +   VAIK +S    Q   ++   E ++L+
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKE-ALSWKDRLQIAVDAAQG 716
           R  H N+  +           +   Y+    +   L+   K   LS            +G
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIF-PAESESHISTSIVGTVGY 775
           L+Y+H      ++HRD+K +N+LLN     K+ DFG +++  P    +   T  V T  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 776 LDPEY-YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSI 834
             PE    S   T+  D++S G +L E+++  P I  G +    +N +   L      S 
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP-IFPGKHYLDQLNHILGIL-----GSP 232

Query: 835 VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL-KKCLEME 883
               L    +  +   +     +     +   P       +L  K L   
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 55/289 (19%), Positives = 108/289 (37%), Gaps = 22/289 (7%)

Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRN 663
             +H +  +G+G +G VY      G   A+K +         P     E  +L  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L    +    + LV+E++        L D  +  L             Q L  + + 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESV---TAKSFLLQLLNGIAYC 116

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               ++HRD+K  N+L+N + + K+ADFG ++ F      +    IV            S
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGS 175

Query: 784 NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
            + +   D++S G +  E++ G P +  G +    + R+   L   + ++  +      +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTP-LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME-----TARE 887
           D N            +  +          +  L K L+++     TA++
Sbjct: 235 DPNFTVYEPLPWESFLKGLD------ESGIDLLSKMLKLDPNQRITAKQ 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  150 bits (380), Expect = 2e-40
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 19/208 (9%)

Query: 608 NNFH--RILGKGGFGTVYHGYLAD-GSEVAIKMLS---ASSSQGPKQFRTE---AQLLMR 658
           N+F   RI+G+GGFG VY    AD G   A+K L        QG      E     L+  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLE 718
                +  +    +    +  + + M  G+L  +L        S  D    A +   GLE
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLE 121

Query: 719 YLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDP 778
           ++H+     +++RD+K ANILL+E    +++D G +  F  +       + VGT GY+ P
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAP 174

Query: 779 EYYASNR-LTEKSDVYSFGIVLLELITG 805
           E           +D +S G +L +L+ G
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRG 202

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-40
 Identities = 60/290 (20%), Positives = 117/290 (40%), Gaps = 24/290 (8%)

Query: 609 NFHRI--LGKGGFGTVYHGY-LADGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRN 663
           NF ++  +G+G +G VY       G  VA+K +     +   P     E  LL  ++H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG 723
           +  L+   +    + LV+E++ + +LK+++       +             QGL +    
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118

Query: 724 CKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYAS 783
               ++HRD+K  N+L+N +   KLADFG ++ F     ++  T  V T+ Y  PE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 176

Query: 784 NR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN 842
            +  +   D++S G +  E++T    +  G +    + R+   L   D           +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME-----TARE 887
           +  +      +   + VP +           + L + L  +     +A+ 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLD------EDGRSLLSQMLHYDPNKRISAKA 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 9e-40
 Identities = 57/290 (19%), Positives = 99/290 (34%), Gaps = 26/290 (8%)

Query: 606 ITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR 662
           + N +   R +G G FG +Y G  +A G EVAIK+    +     Q   E+++   +   
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGG 62

Query: 663 NLASLVGYC-NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
                + +C  +G    +V E +  G   + LF+      S K  L +A      +EY+H
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 722 HGCKPPIIHRDVKTANILLNEK---MQAKLADFGFSKIFPAESES-----HISTSIVGTV 773
                  IHRDVK  N L+          + DFG +K +             + ++ GT 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS 833
            Y     +     + + D+ S G VL+    G          T          ++    S
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---MS 234

Query: 834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME 883
                L   +  +                   +P  S++    +     +
Sbjct: 235 TPIEVLCKGYP-SEFATYLNFCRSLRFD---DKPDYSYLRQLFRNLFHRQ 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-39
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 23/214 (10%)

Query: 606 ITNNFH---RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-H 660
           I +++    ++LG G  G V   +      + A+KML         + R E +L  R   
Sbjct: 9   IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQ 63

Query: 661 HRNLASLVGYCND----GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQG 716
             ++  +V    +       + +V E +  G L   + D   +A + ++  +I     + 
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 717 LEYLHHGCKPPIIHRDVKTANILLNEKMQ---AKLADFGFSKIFPAESESHISTSIVGTV 773
           ++YLH      I HRDVK  N+L   K      KL DFGF+K   + +      +   T 
Sbjct: 124 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177

Query: 774 GYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
            Y+ PE     +  +  D++S G+++  L+ G P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 63/292 (21%), Positives = 108/292 (36%), Gaps = 31/292 (10%)

Query: 612 RILGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMR---VHHRNL 664
             +G+G +G V+        G  VA+K +   + +   P     E  +L       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 665 ASLVGYCNDGGNVGLVYEYM----AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
             L   C            +       +L  YL    +  +  +    +     +GL++L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
           H      ++HRD+K  NIL+    Q KLADFG ++I+   S     TS+V T+ Y  PE 
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186

Query: 781 YASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE 840
              +      D++S G +  E+    P + RG ++   + ++        +  I  P  E
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKP-LFRGSSDVDQLGKI--------LDVIGLPGEE 237

Query: 841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME-----TARE 887
                 ++ + A  +    P   F           L KCL        +A  
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 8e-39
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 13/206 (6%)

Query: 608 NNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP---KQFRTEAQLLMRVHH 661
           N+F   ++LGKG FG V      A G   A+K+L               TE+++L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
             L +L         +  V EY   G L  +L  E     + +         A+ +  L 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYG---AEIVSALE 119

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
           +     +++RD+K  N++L++    K+ DFG  K   ++  +    +  GT  YL PE  
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVL 177

Query: 782 ASNRLTEKSDVYSFGIVLLELITGLP 807
             N      D +  G+V+ E++ G  
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 19/209 (9%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP------KQFRTEAQLLMRVH-- 660
              +LG GGFG+VY G  ++D   VAIK +               +   E  LL +V   
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
              +  L+ +     +  L+ E             E + AL  +          + + + 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC 126

Query: 721 HHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPE 779
                  ++HRD+K  NIL++  + + KL DFG   +     +  + T   GT  Y  PE
Sbjct: 127 ---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179

Query: 780 YYASNRL-TEKSDVYSFGIVLLELITGLP 807
           +   +R     + V+S GI+L +++ G  
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-38
 Identities = 63/295 (21%), Positives = 120/295 (40%), Gaps = 28/295 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG--PKQFRTEAQLLMRVHHRNLASLV 668
             +G+G FG V+       G +VA+K +   + +   P     E ++L  + H N+ +L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 669 GYCNDG--------GNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
             C           G++ LV+++  +           K  LS   R+         L  L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGL 130

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS--TSIVGTVGYLDP 778
           ++  +  I+HRD+K AN+L+      KLADFG ++ F     S  +  T+ V T+ Y  P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 779 EYYASNRL-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP 837
           E     R      D++  G ++ E+ T  P I++G    H +  +      G +   V P
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSP-IMQGNTEQHQLALISQLC--GSITPEVWP 247

Query: 838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME-----TARE 887
            ++ N++     ++ +     V           + +  + K L ++      + +
Sbjct: 248 NVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 9e-38
 Identities = 53/285 (18%), Positives = 103/285 (36%), Gaps = 22/285 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKML--SASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
             +G+G +GTV+          VA+K +         P     E  LL  + H+N+  L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPI 728
              +    + LV+E+      K +                      Q L+ L       +
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122

Query: 729 IHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNR-LT 787
           +HRD+K  N+L+N   + KLA+FG ++ F      +  ++ V T+ Y  P+     +  +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYS 180

Query: 788 EKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS 847
              D++S G +  EL      +  G +    + R+   L               ++    
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 848 VWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME-----TARE 887
           ++    + +  VP ++      +     L+  L+       +A E
Sbjct: 241 MYPATTSLVNVVPKLN------ATGRDLLQNLLKCNPVQRISAEE 279

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 9e-38
 Identities = 70/314 (22%), Positives = 107/314 (34%), Gaps = 40/314 (12%)

Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLAD-GSEVAIKMLSASSSQGPK 647
           G      Q+ +Y++         +++G G FG VY   L D G  VAIK +     Q  +
Sbjct: 11  GQGPDRPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKR 58

Query: 648 QFRTEAQLLMRVHHRNLASLVGYCNDGGN------VGLVYEYMAYGNLKQYL-FDETKEA 700
               E Q++ ++ H N+  L  +    G       + LV +Y+     +    +   K+ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 701 LSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKIFPA 759
           L             + L Y+H      I HRD+K  N+LL+      KL DFG +K    
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-- 173

Query: 760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIV 819
                  + I           + +   T   DV+S G VL EL+ G P I  G +    +
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP-IFPGDSGVDQL 232

Query: 820 NRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTEL-KK 878
             +   L       I +             K         P     RP        L  +
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIK-------AHPWTKVFRPRTPPEAIALCSR 285

Query: 879 CLEME-----TARE 887
            LE       T  E
Sbjct: 286 LLEYTPTARLTPLE 299

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 21/214 (9%)

Query: 605 DITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGP------KQFRTEAQL 655
           ++ + +     LG G F  V      + G + A K +    ++        +    E  +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66

Query: 656 LMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
           L  + H N+ +L     +  +V L+ E +A G L  +L +  KE+L+ ++  +      Q
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEF---LKQ 121

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLNE----KMQAKLADFGFSKIFPAESESHISTSIVG 771
            L  +++     I H D+K  NI+L +    K + K+ DFG +      +E      I G
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 178

Query: 772 TVGYLDPEYYASNRLTEKSDVYSFGIVLLELITG 805
           T  ++ PE      L  ++D++S G++   L++G
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 1e-35
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 14/200 (7%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASL 667
           + LG G FG V        G+  A+K+L        KQ      E ++L  V+   L  L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPP 727
                D  N+ +V EY+A G +  +L    +   S       A       EYLH      
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLD 161

Query: 728 IIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLT 787
           +I+RD+K  N+L++++   ++ DFGF+K          + ++ GT   L PE   S    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPEIILSKGYN 216

Query: 788 EKSDVYSFGIVLLELITGLP 807
           +  D ++ G+++ E+  G P
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  132 bits (332), Expect = 3e-34
 Identities = 61/294 (20%), Positives = 119/294 (40%), Gaps = 33/294 (11%)

Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASL 667
             R LG+G +  V+    + +  +V +K+L        K+ + E ++L  +    N+ +L
Sbjct: 39  LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITL 95

Query: 668 VGYCND--GGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCK 725
                D       LV+E++   + KQ       + L+  D      +  + L+Y H    
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 726 PPIIHRDVKTANILL-NEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASN 784
             I+HRDVK  N+++ +E  + +L D+G ++ +    E ++    V +  +  PE     
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLVDY 204

Query: 785 RL-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF 843
           ++     D++S G +L  +I        G++N   + R+   L   D+   +D   + N 
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID---KYNI 261

Query: 844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTE-----LKKCLEME-----TARE 887
           + +  +              F      H+V+      L K L  +     TARE
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 6e-34
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 26/225 (11%)

Query: 598 FTYSEIVDITNNFH------RILGKGGFGTVYHGY-LADGSEVAIKML--SASSSQGPKQ 648
           F   E+              + +G G +G V        G++VAIK L     S    K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 649 FRTEAQLLMRVHHRNLASLVGYCNDGGNVG------LVYEYMAYGNLKQYLFDETKEALS 702
              E +LL  + H N+  L+        +       LV  +M  G     L    K  L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LG 119

Query: 703 WKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE 762
                 +     +GL Y+H      IIHRD+K  N+ +NE  + K+ DFG ++    +++
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QAD 172

Query: 763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           S ++  +V              R T+  D++S G ++ E+ITG  
Sbjct: 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-33
 Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 15/208 (7%)

Query: 610 FHRILGKGGFGTVYHGYLA----DGSEVAIKMLS----ASSSQGPKQFRTEAQLLMRV-H 660
             ++LG G +G V+          G   A+K+L        ++  +  RTE Q+L  +  
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYL 720
              L +L         + L+ +Y+  G L  +L    +         ++ +   + +  L
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLAL 142

Query: 721 HHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEY 780
            H  K  II+RD+K  NILL+      L DFG SK F A+                    
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 781 YASNR-LTEKSDVYSFGIVLLELITGLP 807
              +    +  D +S G+++ EL+TG  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-30
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 21/221 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLS--ASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
           + +G G  G V   Y       VAIK LS    +    K+   E  L+  V+H+N+ SL+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 669 GYC------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHH 722
                     +  +V LV E M     +    +        +    +      G+++LH 
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137

Query: 723 GCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYA 782
                IIHRD+K +NI++      K+ DFG ++       S + T  V T  Y  PE   
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 191

Query: 783 SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
                E  D++S G ++ E++     +  G +     N+V 
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKI-LFPGRDYIDQWNKVI 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 7e-28
 Identities = 47/238 (19%), Positives = 94/238 (39%), Gaps = 19/238 (7%)

Query: 597 QFTYSEI----VDITNNFH--RILGKGGFGTVYHGY-LADGSEVAIKMLSAS--SSQGPK 647
            F   E+     ++   +     +G G +G+V   +    G  VA+K LS    S    K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 648 QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDE--TKEALSWKD 705
           +   E +LL  + H N+  L+       ++    +     +L     +     + L+   
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122

Query: 706 RLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI 765
              +     +GL+Y+H        HRD+K +N+ +NE  + K+ DFG ++    E   ++
Sbjct: 123 VQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179

Query: 766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVC 823
           +T                    +  D++S G ++ EL+TG   +  G ++   +  + 
Sbjct: 180 AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLIL 232

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 5e-27
 Identities = 49/213 (23%), Positives = 81/213 (38%), Gaps = 21/213 (9%)

Query: 612 RILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
           R LG G F TV+    + + + VA+K++        +    E +LL RV+  +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 671 C---------------NDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQ 715
                            +G +V +V+E +    L      E +         QI+     
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISKQLLL 136

Query: 716 GLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAESESHISTSIVGTVG 774
           GL+Y+H  C   IIH D+K  N+L+        L     + +  A       T+ + T  
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 775 YLDPEYYASNRLTEKSDVYSFGIVLLELITGLP 807
           Y  PE          +D++S   ++ ELITG  
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.9 bits (230), Expect = 3e-22
 Identities = 36/200 (18%), Positives = 68/200 (34%), Gaps = 24/200 (12%)

Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSS----------QGPKQFRTEAQLLMRVHH 661
           +++G+G    V++ Y     E  +K      +           G   F   A    R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLH 721
           R L  L      G  V  VY +     L + +  +    +  ++  ++     + +   +
Sbjct: 66  RALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 722 HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYY 781
           H     I+H D+   N+L++E     + DF  S     E    I    V  +      Y+
Sbjct: 121 H---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI----ITYF 172

Query: 782 ASNRLTEKSDVYSFGIVLLE 801
            S     + D+ S    +L+
Sbjct: 173 -SRTYRTEKDINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.2 bits (170), Expect = 2e-13
 Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 1/91 (1%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
              +                       +  L+L +  + G +   L+ LK L +L++S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSGSVP 511
           +L G IP+    L    V     NK     P
Sbjct: 279 NLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.2 bits (152), Expect = 4e-11
 Identities = 19/59 (32%), Positives = 30/59 (50%), Gaps = 3/59 (5%)

Query: 476 DLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLC 534
           DL NN + G++P+ L+QL  L  LN+  N L G +P     +  +   + +   N  LC
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD---VSAYANNKCLC 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 25/111 (22%), Positives = 37/111 (33%), Gaps = 35/111 (31%)

Query: 401 DQDDVNAIMDIK--LSYDLG-KGWQ--GDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTS 455
           +  D  A++ IK  L        W    D C+    +W G+ C  +              
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTD-------------- 46

Query: 456 EGLTGKISPSLSNLKSLENLDLSNNSLTG--SIPEFLSQLPLLRVLNLDGN 504
                      +    + NLDLS  +L     IP  L+ LP L  L + G 
Sbjct: 47  -----------TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.7 bits (151), Expect = 7e-11
 Identities = 20/143 (13%), Positives = 46/143 (32%), Gaps = 11/143 (7%)

Query: 369 NFSLCKTSNSTLPPILNAIEIYILTDTLQEPTDQDDVNAIMDIKLSYDLGKGWQGDPCSP 428
           +  L     S L P+    ++  L     + ++   +  +  +          +      
Sbjct: 245 DLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304

Query: 429 MYYSWDGLNCSYNGY-------KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNS 481
              +   L   +N            K+  L   +  ++     SL+NL ++  L   +N 
Sbjct: 305 NLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362

Query: 482 LTGSIPEFLSQLPLLRVLNLDGN 504
           ++   P  L+ L  +  L L+  
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.4 bits (145), Expect = 4e-10
 Identities = 15/91 (16%), Positives = 33/91 (36%), Gaps = 4/91 (4%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
                 + +  + + L           +  L L    ++      +S+L  L+ L  +NN
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANN 339

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSGSVP 511
            ++      L+ L  +  L+   N++S   P
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 2e-06
 Identities = 13/65 (20%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
           + +   L    +T  +S   ++L  +  L      +  SI + +  L  L  +N   N+L
Sbjct: 23  EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQL 78

Query: 507 SGSVP 511
           +   P
Sbjct: 79  TDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 9e-05
 Identities = 14/54 (25%), Positives = 23/54 (42%), Gaps = 4/54 (7%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLN 500
           ++ +L     G+   I   +  L +L  ++ SNN LT   P  L  L  L  + 
Sbjct: 45  QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 58.1 bits (139), Expect = 1e-09
 Identities = 23/83 (27%), Positives = 33/83 (39%), Gaps = 6/83 (7%)

Query: 432 SWDGLNCSYNGYK------PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGS 485
               + CS  G +      PP    L+L +  +T        NLK+L  L L NN ++  
Sbjct: 11  HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 486 IPEFLSQLPLLRVLNLDGNKLSG 508
            P   + L  L  L L  N+L  
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKE 93

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.2 bits (95), Expect = 4e-04
 Identities = 20/78 (25%), Positives = 38/78 (48%), Gaps = 3/78 (3%)

Query: 437 NCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLL 496
              +NG     ++ L       +G  + +   +K L  + +++ ++T +IP+ L   P L
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 173

Query: 497 RVLNLDGNKLSGSVPTSL 514
             L+LDGNK++     SL
Sbjct: 174 TELHLDGNKITKVDAASL 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.3 bits (90), Expect = 0.002
 Identities = 7/47 (14%), Positives = 21/47 (44%), Gaps = 6/47 (12%)

Query: 467 SNLKSLENLDLSNNSLTG------SIPEFLSQLPLLRVLNLDGNKLS 507
           ++ K ++ + L NN+++         P + ++      ++L  N + 
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.5 bits (134), Expect = 8e-09
 Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 5/81 (6%)

Query: 450 SLNLTSEGLTGK-ISPSLSNLKSLENLDLSNNSLTG----SIPEFLSQLPLLRVLNLDGN 504
           SL++  E L+    +  L  L+  + + L +  LT      I   L   P L  LNL  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 505 KLSGSVPTSLVARSQNGSLLL 525
           +L       ++   Q  S  +
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 7e-08
 Identities = 21/111 (18%), Positives = 33/111 (29%), Gaps = 16/111 (14%)

Query: 415 YDLGKGWQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLEN 474
            D G                 L  +            +++       ++ +L    SL  
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADC----------DVSDSSC-SSLAATLLANHSLRE 401

Query: 475 LDLSNNSLTGSIPEFLSQ-----LPLLRVLNLDGNKLSGSVPTSLVARSQN 520
           LDLSNN L  +    L +       LL  L L     S  +   L A  ++
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 17/64 (26%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 466 LSNLKSLENLDLSNNSLTG----SIPEFLSQLPLLRVLNLDGNKLSGSVPTSLV-ARSQN 520
                 L  L L++  ++     S+   L     LR L+L  N L  +    LV +  Q 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 521 GSLL 524
           G LL
Sbjct: 425 GCLL 428

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 13/63 (20%), Positives = 28/63 (44%), Gaps = 3/63 (4%)

Query: 471 SLENLDLSNNSLTGS-IPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL--LSI 527
            +++LD+    L+ +   E L  L   +V+ LD   L+ +    + +  +    L  L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 528 GRN 530
             N
Sbjct: 63  RSN 65

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 15/68 (22%), Positives = 25/68 (36%), Gaps = 9/68 (13%)

Query: 446 PKIISLNLTSEGLTGK----ISPSLSNLKSLENLDLSNNSLTGSIPEFLSQL-----PLL 496
            +   + L   GLT      IS +L    +L  L+L +N L       + Q        +
Sbjct: 27  QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86

Query: 497 RVLNLDGN 504
           + L+L   
Sbjct: 87  QKLSLQNC 94

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 8e-09
 Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 10/96 (10%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
               P +  Y +            PP +  LN+++  L  ++      L   E L  S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFN 314

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSG--SVPTSL 514
            L   +PE    L   + L+++ N L     +P S+
Sbjct: 315 HLA-EVPELPQNL---KQLHVEYNPLREFPDIPESV 346

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 9e-06
 Identities = 21/112 (18%), Positives = 33/112 (29%), Gaps = 12/112 (10%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
           +  D                      ++          + +I        SLE L++SNN
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL-LLSIGRNP 531
            L   +P    +   L  L    N L+  VP          +L  L +  NP
Sbjct: 295 KLI-ELPALPPR---LERLIASFNHLA-EVPELP------QNLKQLHVEYNP 335

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 2e-04
 Identities = 12/45 (26%), Positives = 19/45 (42%), Gaps = 5/45 (11%)

Query: 470 KSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           +    L+L+N  L+ S+PE       L  L    N L+  +P   
Sbjct: 38  RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELP 77

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 21/61 (34%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV 510
           L L + GL+  +     +L+SL     S NSLT  +PE    L  L V N +   LS   
Sbjct: 43  LELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 97

Query: 511 P 511
           P
Sbjct: 98  P 98

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.5 bits (116), Expect = 1e-06
 Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 6/93 (6%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISP-SLSNLKSLENLDLSN 479
                      +      S+   +   +    L++ G    +   S      L+ L L  
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282

Query: 480 NSLTGSIPEFL-----SQLPLLRVLNLDGNKLS 507
           N +       L      ++P L  L L+GN+ S
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 9/60 (15%), Positives = 21/60 (35%), Gaps = 5/60 (8%)

Query: 451 LNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG----SIPEFLSQLPLLRVLNLDGNKL 506
             +T+E     +   L    S++ + LS N++       + E ++    L +        
Sbjct: 13  DAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 6e-06
 Identities = 7/44 (15%), Positives = 15/44 (34%), Gaps = 1/44 (2%)

Query: 463 SPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
           +   +N      LDL    +   I    + L     ++   N++
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 7e-06
 Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 8/90 (8%)

Query: 433 WDGLNCSYNGYKP---PKIISLNLT----SEGLTGKISPSLSNLKSLENLDLSNNSLTG- 484
           W  L+ +     P    +++S  +           +      +   ++++DLSN+ +   
Sbjct: 2   WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 485 SIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
           ++   LSQ   L+ L+L+G +LS  +  +L
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTL 91

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 0.001
 Identities = 10/94 (10%), Positives = 30/94 (31%), Gaps = 4/94 (4%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
                 S      +     +      + +SL+   + +  +    L  + +L+ L +   
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD-IIPETLLELGEIPTLKTLQVFGI 235

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
              G++      LP L++     +  +     ++
Sbjct: 236 VPDGTLQLLKEALPHLQINC---SHFTTIARPTI 266

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 7e-06
 Identities = 8/41 (19%), Positives = 11/41 (26%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
                     LD+S   +       L  L  LR  +    K
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 15/62 (24%), Positives = 31/62 (50%), Gaps = 4/62 (6%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
           + I  NL  + +T  ++   + L S++ +  +N+ +       +  LP +  L L+GNKL
Sbjct: 25  ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80

Query: 507 SG 508
           + 
Sbjct: 81  TD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 8e-05
 Identities = 13/38 (34%), Positives = 19/38 (50%), Gaps = 2/38 (5%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL 501
             L+ L  L+NL LS N ++  +    + L  L VL L
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLEL 207

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 10/38 (26%), Positives = 19/38 (50%), Gaps = 2/38 (5%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL 501
             L++L +L  + L NN ++   P  L+    L ++ L
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 2/48 (4%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVP 511
             L+NL  L  L   +N ++   P  L+ LP L  ++L  N++S   P
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 12/60 (20%), Positives = 24/60 (40%), Gaps = 4/60 (6%)

Query: 447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKL 506
             I +      +T  ++   ++L  +  L      +T +I E +  L  L  L L  N++
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 5/40 (12%), Positives = 17/40 (42%), Gaps = 2/40 (5%)

Query: 468 NLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS 507
            L +   +    +++T ++    + L  +  L+  G  ++
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT 54

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 17/57 (29%), Positives = 21/57 (36%), Gaps = 3/57 (5%)

Query: 449 ISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNK 505
           + +N     LT  + P L   K    L LS N L       L     L  LNLD  +
Sbjct: 13  LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 21/86 (24%), Positives = 33/86 (38%), Gaps = 1/86 (1%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
                   +  +             PK+  L+L +  LT   +  L+ L++L+ L L  N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKL 506
           SL  +IP+      LL    L GN  
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 13/62 (20%), Positives = 26/62 (41%), Gaps = 3/62 (4%)

Query: 465 SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL 524
            +S + S   ++    +LT ++P  L       +L+L  N L      +L+  ++   L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 525 LS 526
           L 
Sbjct: 62  LD 63

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 20/66 (30%), Positives = 30/66 (45%), Gaps = 3/66 (4%)

Query: 464 PSLSNLKSLENLDLSNNSLTG-SIPEFLSQLPLLRVLNLDGNKLSG--SVPTSLVARSQN 520
             ++NL  L+ L L NN L   +  + L   P L +LNL GN L     +   L     +
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 521 GSLLLS 526
            S +L+
Sbjct: 119 VSSILT 124

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 13/36 (36%), Positives = 21/36 (58%), Gaps = 2/36 (5%)

Query: 464 PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVL 499
             L+NL +LE LD+S+N ++      L++L  L  L
Sbjct: 166 KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 4e-04
 Identities = 23/102 (22%), Positives = 41/102 (40%), Gaps = 6/102 (5%)

Query: 449 ISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTG--SIPEFLSQLPLLRVLNLDGNKL 506
           + LN  S      +     N+  L +L+LSNN L     +   + + P L++LNL GN+L
Sbjct: 45  VVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 103

Query: 507 SGSVPTSLVARSQNGSLLLSIGRNPDLCLSAPCKKEKRNSVM 548
                   +   +   L L    N  L  +   +    +++ 
Sbjct: 104 KSERELDKIKGLKLEELWLD--GNS-LSDTFRDQSTYISAIR 142

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 22/78 (28%), Positives = 34/78 (43%), Gaps = 2/78 (2%)

Query: 444 KPPKIISLNLTSEGLTGK--ISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNL 501
             P+++SLNL++  L     +S  +    +L+ L+LS N L         +   L  L L
Sbjct: 63  NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 502 DGNKLSGSVPTSLVARSQ 519
           DGN LS +        S 
Sbjct: 123 DGNSLSDTFRDQSTYISA 140

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 39.7 bits (91), Expect = 7e-04
 Identities = 18/60 (30%), Positives = 30/60 (50%), Gaps = 8/60 (13%)

Query: 447 KIISLNLTSEGLTGKISP------SLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLN 500
            +++       L G I P      +LS LK+ ++L LS N++   I   LS +  LR+L+
Sbjct: 19  SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILS 76

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 0.001
 Identities = 12/88 (13%), Positives = 25/88 (28%), Gaps = 4/88 (4%)

Query: 421 WQGDPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNN 480
                   ++ +      +        +  L L           +      L+    S++
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSS 258

Query: 481 SLTGSIPEFLSQLPLLRVLNLDGNKLSG 508
            +  S+P+ L+   L     L  N L G
Sbjct: 259 EVPCSLPQRLAGRDL---KRLAANDLQG 283

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	919
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.84
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.33
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.09
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.02
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.91
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.89
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.72
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.71
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.66
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.63
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.61
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.59
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.36
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.32
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.29
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.24
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.19
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.09
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.07
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.05
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.9
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.77
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.66
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.5
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.44
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.22
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.19
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.99
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.81
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.78
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.74
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	96.13
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.03
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.75
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.48
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	90.13

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=363.81  Aligned_cols=269  Identities=24%  Similarity=0.424  Sum_probs=213.4

Q ss_pred             CCCHHHHHHHHHHH-----------CCEECEECCEEEEEEEECC-CC---EEEEEEEECCCCC-CCHHHHHHHHHHHHCC
Q ss_conf             44887999987533-----------1412020747999999769-98---9999995058998-9133368999987403
Q 002461          597 QFTYSEIVDITNNF-----------HRILGKGGFGTVYHGYLAD-GS---EVAIKMLSASSSQ-GPKQFRTEAQLLMRVH  660 (919)
Q Consensus       597 ~~~~~el~~~t~~f-----------~~~LG~G~fG~Vyka~~~~-g~---~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~  660 (919)
                      .++++++.+++.+|           .+.||+|+||+||+|.+.. ++   .||||.+...... ..+.|.+|+.+|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC
T ss_conf             88879899999604622080042785698027882999999957997889999999784459899999999999998579


Q ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEE
Q ss_conf             76031687676339908999983468882344200123468967699999999999999881699993530364330785
Q 002461          661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILL  740 (919)
Q Consensus       661 H~NIv~l~g~~~~~~~~~LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILl  740 (919)
                      |||||+++|++...+..++||||+++|+|.+++... ...++|..++.++.|+++||.|||   +++++||||||+|||+
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CCCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEE
T ss_conf             988861899996288779999722798530021045-679999999999999999889885---2798357615044898


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf             8898489960376423488878743---115545865337443247889941468999999999992-999753487862
Q 002461          741 NEKMQAKLADFGFSKIFPAESESHI---STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNT  816 (919)
Q Consensus       741 d~~~~vkI~DFGla~~~~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~  816 (919)
                      +.++.+||+|||+++.+........   .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~  240 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQ  240 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HH
T ss_pred             CCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-HH
T ss_conf             89991998884431575677776536502566688300387888369978612144535789999867999999999-99


Q ss_pred             CHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             0001223322368742233620004899367999999999529899899999999999999977557
Q 002461          817 HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       817 ~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      .+...+..    +         .+...+.+....+.+++.+||+.+|++||+|.||++.|+++++..
T Consensus       241 ~~~~~i~~----~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         241 DVINAIEQ----D---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             HHHHHHHT----T---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHHHHC----C---------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf             99999973----7---------889997422699999999975879768929999999999984186

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=365.70  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=216.7

Q ss_pred             HHHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             7533141202074799999976-998999999505899891333689999874037603168767633990899998346
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      .+.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++|+||++
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEECCC
T ss_conf             939865982088808999999999969999997776-1039999999999986799988267752745785478763146


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858898489960376423488878743
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++.......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~  172 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA  172 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SSEE
T ss_pred             CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC-CCEE
T ss_conf             760677753035541579999999999999788898---789305760457689989992898324454653788-7221


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf             11554586533744324788994146899999999999299975348786200012233223687422336200048993
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDT  845 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~  845 (919)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+..+.+...+.+.+..    +         .....+.
T Consensus       173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----~---------~~~~~~~  239 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----D---------YRMERPE  239 (287)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----T---------CCCCCCT
T ss_pred             ECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----C---------CCCCCCC
T ss_conf             03556654666927872799981043021789999998679988774259999999855----8---------8888874


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
Q ss_conf             67999999999529899899999999999999977557879999
Q 002461          846 NSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETAREQI  889 (919)
Q Consensus       846 ~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~~~~~~  889 (919)
                      .....+.+++.+||..+|++||+|.|+++.|+.+.+.....+..
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~~~~i  283 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV  283 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCHHHHH
T ss_pred             CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCHHH
T ss_conf             33099999999975779768939999999999998757777475

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.59  Aligned_cols=254  Identities=27%  Similarity=0.471  Sum_probs=209.7

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCCCC
Q ss_conf             33141202074799999976998999999505899891333689999874037603168767633990899998346888
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~Gs  688 (919)
                      .+.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++||||++++|+|...+..++|+||+++|+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCCCC
T ss_conf             888898208882999999889999999998788-6768999999999996689975653524315993379998369991


Q ss_pred             HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             23442001234689676999999999999998816999935303643307858898489960376423488878743115
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++... ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...... ......
T Consensus        87 L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~  161 (263)
T d1sm2a_          87 LSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG  161 (263)
T ss_dssp             HHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             HHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC-CEEECC
T ss_conf             89975201-347889999999999999877653---1643104431532666688776865532100236887-335043


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf             54586533744324788994146899999999999299975348786200012233223687422336200048993679
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNSV  848 (919)
Q Consensus       769 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~~~  848 (919)
                      ..|+..|+|||++.+..++.++|||||||++|||+|+..|+........+.+.+..    +.         +...+....
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~----~~---------~~~~p~~~~  228 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GF---------RLYKPRLAS  228 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH----TC---------CCCCCTTSC
T ss_pred             EECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH----CC---------CCCCCCCCC
T ss_conf             00176667857860799984033210599999998789888778999999999980----68---------889954367


Q ss_pred             HHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             999999995298998999999999999999775
Q 002461          849 WKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       849 ~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ..+.+++.+||+.+|++||+|+||++.|+++.+
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             999999999765797689199999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.86  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=209.1

Q ss_pred             HHHHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             75331412020747999999769989999995058998913336899998740376031687676339908999983468
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      .+.+.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++||||++++|++.+ +..++||||+++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEECCC
T ss_conf             93886798107982899999999999999998647-6888999999999986799988578731045-976999995789


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++.......+++..+++++.|+++||.|||   +++++||||||+|||++.++.+||+|||+++.... ......
T Consensus        92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~~~  167 (272)
T d1qpca_          92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAR  167 (272)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEECC
T ss_pred             CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCC-CCCCCC
T ss_conf             82888875147898878899999999999999997---48954675642251562024404234101477358-864420


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf             15545865337443247889941468999999999992999753487862000122332236874223362000489936
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~  846 (919)
                      ....|+..|+|||++.+..++.++|||||||++|||+||+.|+..........+.+..    +.         +...+..
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~----~~---------~~~~p~~  234 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GY---------RMVRPDN  234 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TC---------CCCCCTT
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH----CC---------CCCCCCC
T ss_conf             3567744445828983799982456452579999999689888888899999999970----68---------8889655


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             7999999999529899899999999999999977
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       847 ~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ....+.+++.+||+.+|++||||.+|+++|+++.
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             7199999999975889768939999999861132

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.74  Aligned_cols=257  Identities=30%  Similarity=0.494  Sum_probs=204.4

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             3314120207479999997699899999950589--98913336899998740376031687676339908999983468
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      .+.+.||+|+||+||+|.++  ..||||+++...  ....+.|.+|+.++++++||||++++|++.+ +..++|+||+++
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~   87 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG   87 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred             EEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCCC
T ss_conf             99889830788589999999--989999997346998999999999999984799878645679715-589999965899


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++... ...+++..++.++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++...........
T Consensus        88 g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          88 SSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             EEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             CCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCCCC
T ss_conf             8889998523-578999999999999999988875---099951614789979818997887500221333556776312


Q ss_pred             CCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             15545865337443247---889941468999999999992999753487862000122332236874223362000489
Q 002461          767 TSIVGTVGYLDPEYYAS---NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                      ....||+.|+|||++.+   ..++.++|||||||++|||+||+.||........+...+..    +.    ..+.+. ..
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----~~----~~p~~~-~~  234 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GY----LSPDLS-KV  234 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----TS----CCCCGG-GS
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----CC----CCCCCH-HC
T ss_conf             5665574317999995056899995315163599999999788998998969999999965----88----898600-03


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             93679999999995298998999999999999999775
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .......+.+++.+||..+|++||||.|+++.|+.+.+
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             65554999999999758897689299999999999997

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.38  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=206.7

Q ss_pred             HHHHCCEECEECCEEEEEEEECC-C-----CEEEEEEEECC-CCCCCHHHHHHHHHHHHC-CCCCEEEEEEEEECCCEEE
Q ss_conf             75331412020747999999769-9-----89999995058-998913336899998740-3760316876763399089
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD-G-----SEVAIKMLSAS-SSQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~~-g-----~~VAVK~l~~~-~~~~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~~~~~~  678 (919)
                      ...+.+.||+|+||+||+|.... +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf             93970198307881999999857885542049999996633587899999999999997158996868778886299589


Q ss_pred             EEEEECCCCCHHHHHHCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCE
Q ss_conf             9998346888234420012---------------------3468967699999999999999881699993530364330
Q 002461          679 LVYEYMAYGNLKQYLFDET---------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTAN  737 (919)
Q Consensus       679 LV~E~~~~GsL~~~L~~~~---------------------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~N  737 (919)
                      +||||+++|+|.++++...                     ...+++..++.++.|+++||+|||   +++|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHC
T ss_conf             9997279995999998625777510221000012220012577899999999999999999997---3990505270321


Q ss_pred             EEECCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf             7858898489960376423488878743115545865337443247889941468999999999992-999753487862
Q 002461          738 ILLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNT  816 (919)
Q Consensus       738 ILld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~  816 (919)
                      ||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             CCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             44345982898514222204577861562343578765783887279999633030003999999838999999989899


Q ss_pred             CHHCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             00012233223687422336200048993679999999995298998999999999999999
Q 002461          817 HIVNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       817 ~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      .+.+.+.    .+         .+...+......+.+++.+||+.+|++||||.||++.|..
T Consensus       275 ~~~~~~~----~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         275 NFYKLIQ----NG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             HHHHHHH----TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHH----CC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             9999985----69---------9899887678999999999758896689399999999748

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.44  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=208.5

Q ss_pred             HHCCEECEECCEEEEEEEECCC-----CEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             3314120207479999997699-----89999995058998-91333689999874037603168767633990899998
Q 002461          609 NFHRILGKGGFGTVYHGYLADG-----SEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g-----~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      ...++||+|+||+||+|.++..     ..||||+++..... ...+|.+|+.++++++||||++++|++.+....++|+|
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEE
T ss_conf             86159811779099999996899878799999998844596899999999999985689878323677833880389997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             34688823442001234689676999999999999998816999935303643307858898489960376423488878
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 ~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~  762 (919)
                      |+.+|++.+.+.. ....++|..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.+.....
T Consensus        90 ~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          90 YMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             CCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             ECCCCCCHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCCCC
T ss_conf             2135740222102-3454208999999999998541212---12342576564427888998499845510300357876


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             -7431155458653374432478899414689999999999929997534878620001223322368742233620004
Q 002461          763 -SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       763 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~  841 (919)
                       ........||..|+|||++.+..++.++|||||||++|||++|..|+........+.+.+..-             .+.
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------------~~~  232 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------------FRL  232 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------------CCC
T ss_pred             CCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-------------CCC
T ss_conf             5267426777734348888704999973556344898999996798865568999999998635-------------789


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             899367999999999529899899999999999999977557
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       842 ~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                      ..+......+.+++.+||..+|++||+|.||+++|+.+++..
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             985045799999999977679768939999999999986695

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.12  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=202.3

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             533141202074799999976-998999999505899-891333689999874037603168767633990899998346
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      +++.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCC
T ss_conf             08998972174809999999999979999998456641279999999999985799888469654046743679886458


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858898489960376423488878743
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++.  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        87 gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          87 GGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCC
T ss_conf             980899975--3799999999999999999999999---75983575468997887899879832314224046886531


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             115545865337443247889-9414689999999999929997534878620001223322368742233620004899
Q 002461          766 STSIVGTVGYLDPEYYASNRL-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~  844 (919)
                      .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+..........   ....         ....
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~---~~~~---------~~~~  229 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKTY---------LNPW  229 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT---TCTT---------STTG
T ss_pred             CCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC---CCCC---------CCCC
T ss_conf             113255747428728618999997101617379999998299788889859999999863---8887---------8864


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             367999999999529899899999999999
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|++.+|++||++.|+++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             469999999999976799668909999961

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.09  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=210.8

Q ss_pred             HHHHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             75331412020747999999769989999995058998913336899998740376031687676339908999983468
Q 002461          607 TNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      .+.+.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|+.++++++|+|||+++|++.+ +..++|+||+++
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECCC
T ss_conf             97984699307980999999999999999998804-4888999999999986666788689999823-975999994479


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++.......++|..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... ......
T Consensus        96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~~~  171 (285)
T d1fmka3          96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTAR  171 (285)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---HHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCC-CCCEEE
T ss_conf             94354200003553059999999999999999875---41143353123079998999299844255542568-873352


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf             15545865337443247889941468999999999992999753487862000122332236874223362000489936
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~  846 (919)
                      ....|+..|+|||++....++.++||||||+++|||++|+.|+............+....             ....+..
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-------------~~~~~~~  238 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPE  238 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------CCCCCTT
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-------------CCCCCCC
T ss_conf             454556654580898379989177413235899999868999998888999999998268-------------9999832


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             7999999999529899899999999999999977
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       847 ~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ....+.+++.+||+.+|++||+|.+|+++|++..
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             3799999999975669758919999999876662

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.34  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=202.7

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             53314120207479999997-69989999995058998913336899998740376031687676339908999983468
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +.+.+.||+|+||+||+|.. .+|+.||+|+++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             CEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECCC
T ss_conf             38878981285829999999899989999998430172799999999999867999880585779889998999970379


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++..   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+....  ...
T Consensus       102 g~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  173 (293)
T d1yhwa1         102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  173 (293)
T ss_dssp             CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred             CCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--CCC
T ss_conf             808988641---59999999999999999999999---8797226776888688789968642515641321366--644


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf             15545865337443247889941468999999999992999753487862000122332236874223362000489936
Q 002461          767 TSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~  846 (919)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||........+...    ...+.. .     +  ..+..
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~-~-----~--~~~~~  241 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTP-E-----L--QNPEK  241 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSC-C-----C--SSGGG
T ss_pred             CCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HHCCCC-C-----C--CCCCC
T ss_conf             4444477736826644799880120313729999980488998997999999999----857999-8-----8--88553


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7999999999529899899999999999
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       847 ~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....+.+++.+|+..+|++||++.|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7999999999986699668909999964

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.09  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=207.0

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCCCC
Q ss_conf             33141202074799999976998999999505899891333689999874037603168767633990899998346888
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGN  688 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~Gs  688 (919)
                      .+.+.||+|+||+||+|+++++..||||+++... ...++|.+|+..+++++||||++++|+|.+.+..++|+||+++|+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCCCC
T ss_conf             9968982078839999998899899999987475-778999999999996689860158899850781699997048993


Q ss_pred             HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             23442001234689676999999999999998816999935303643307858898489960376423488878743115
Q 002461          689 LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHISTS  768 (919)
Q Consensus       689 L~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~~  768 (919)
                      |.+++... ...+++..+.+++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+++..... .......
T Consensus        86 l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~  160 (258)
T d1k2pa_          86 LLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVG  160 (258)
T ss_dssp             HHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCC
T ss_pred             HHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC-CCEEECC
T ss_conf             88864102-467768999999999999999875---468434665413588769984798861442023578-7225246


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf             545865337443247889941468999999999992-9997534878620001223322368742233620004899367
Q 002461          769 IVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTNS  847 (919)
Q Consensus       769 ~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~~  847 (919)
                      ..|+..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...+...+.    .+.         +...+...
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~----~~~---------~~~~p~~~  226 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIA----QGL---------RLYRPHLA  226 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHH----TTC---------CCCCCTTC
T ss_pred             CCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC-HHHHHHHHH----HCC---------CCCCCCCC
T ss_conf             5788775780786379988521033643246739755999988999-999999998----079---------78996546


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             9999999995298998999999999999999
Q 002461          848 VWKVAETAMECVPSISFQRPTMSHVVTELKK  878 (919)
Q Consensus       848 ~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~  878 (919)
                      ...+.+++.+||+.+|++||++.++++.|.+
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             5999999999766897689399999987418

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.11  Aligned_cols=249  Identities=25%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             CEECEECCEEEEEEEECC---CCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             412020747999999769---989999995058998--913336899998740376031687676339908999983468
Q 002461          612 RILGKGGFGTVYHGYLAD---GSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       612 ~~LG~G~fG~Vyka~~~~---g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +.||+|+||+||+|.+++   ++.||||+++.....  ..++|.+|+.++++++||||++++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC-CC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787-43
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-HI  765 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~-~~  765 (919)
                      |+|.+++.  ....+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.+...... ..
T Consensus        92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf             96899975--2257899999999999999976687---479556777611310235675123413453313432344322


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             115545865337443247889941468999999999992-9997534878620001223322368742233620004899
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~  844 (919)
                      .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+...+    ..+.         +...+
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~~~~~~~i----~~~~---------~~~~p  232 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAML----EKGE---------RMGCP  232 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHH----HTTC---------CCCCC
T ss_pred             CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC-HHHHHHHH----HCCC---------CCCCC
T ss_conf             4456778420391665379998434430340313289658999999989-99999999----8289---------99998


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             367999999999529899899999999999999977
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCL  880 (919)
Q Consensus       845 ~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~  880 (919)
                      ......+.+++.+||..+|++||+|.+|+++|+...
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf             656799999999975889768909899999852887

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.65  Aligned_cols=252  Identities=23%  Similarity=0.416  Sum_probs=201.9

Q ss_pred             CC-EECEECCEEEEEEEEC---CCCEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             14-1202074799999976---9989999995058998-91333689999874037603168767633990899998346
Q 002461          611 HR-ILGKGGFGTVYHGYLA---DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       611 ~~-~LG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      .+ .||+|+||+||+|.++   ++..||||+++..... ..++|.+|+.++++++||||++++|++.. +..++||||++
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~   91 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG   91 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEECC
T ss_conf             78487306080999999960897689999998820397899999999999986799888068656036-80799998078


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC-C
Q ss_conf             888234420012346896769999999999999988169999353036433078588984899603764234888787-4
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES-H  764 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~-~  764 (919)
                      +|+|.+++.. .+..+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.+...... .
T Consensus        92 ~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  167 (285)
T d1u59a_          92 GGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  167 (285)
T ss_dssp             TEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             CCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCCC
T ss_conf             9968997521-2569999999999999999878998---68810576764660454688542033134211554343211


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             3115545865337443247889941468999999999992-999753487862000122332236874223362000489
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       765 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                      ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.... ...+...+    ..+..         ...
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i----~~~~~---------~~~  233 (285)
T d1u59a_         168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFI----EQGKR---------MEC  233 (285)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHH----HTTCC---------CCC
T ss_pred             CCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC-HHHHHHHH----HCCCC---------CCC
T ss_conf             35621137433586887279999541232201789999938999999979-99999999----81899---------999


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             93679999999995298998999999999999999775
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      +......+.+++.+||..+|++||+|.+|++.|+.+..
T Consensus       234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             97678999999999757797689099999999999999

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=346.20  Aligned_cols=258  Identities=29%  Similarity=0.474  Sum_probs=209.3

Q ss_pred             HHHCCEECEECCEEEEEEEEC------CCCEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             533141202074799999976------9989999995058998-913336899998740376031687676339908999
Q 002461          608 NNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      .++.+.||+|+||+||+|++.      +++.||||+++..... ..++|.+|++++++++|+||++++++|......+++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEEEE
T ss_conf             38867982078839999998887657788299999988210857999999999999966899765524666059803899


Q ss_pred             EEECCCCCHHHHHHCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEE
Q ss_conf             98346888234420012----------------------34689676999999999999998816999935303643307
Q 002461          681 YEYMAYGNLKQYLFDET----------------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANI  738 (919)
Q Consensus       681 ~E~~~~GsL~~~L~~~~----------------------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NI  738 (919)
                      +|++++|+|.+++....                      ...+++..++.++.|++.||+|||   +++++||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCEEEEEECCCCE
T ss_conf             981589929999985275542100001110012103467889899999999999999855413---57868548840116


Q ss_pred             EECCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf             85889848996037642348887874311554586533744324788994146899999999999299975348786200
Q 002461          739 LLNEKMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHI  818 (919)
Q Consensus       739 Lld~~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~l  818 (919)
                      |++.++.+||+|||+++.+.............|+..|+|||.+.+..++.++|||||||++|||++|..|+..+.+....
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             EECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf             89899928983314421136776411157777676767989972688980563025236299998068999999899999


Q ss_pred             HCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             012233223687422336200048993679999999995298998999999999999999775
Q 002461          819 VNRVCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       819 v~~v~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ...+.    .+....         .+......+.+++.+||+.+|++||+|.||+++|+++.+
T Consensus       252 ~~~v~----~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         252 IYYVR----DGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHHH----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHH----CCCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             99997----399788---------873252999999999748896579399999999998429

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.04  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=205.8

Q ss_pred             HHHCCEECEECCEEEEEEEECCC----CEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
Q ss_conf             53314120207479999997699----8999999505899-891333689999874037603168767633-99089999
Q 002461          608 NNFHRILGKGGFGTVYHGYLADG----SEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGLVY  681 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~~g----~~VAVK~l~~~~~-~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~-~~~~~LV~  681 (919)
                      .+|.++||+|+||+||+|.+.++    ..||||+++.... ...++|.+|++++++++||||++++|++.. ++..++|+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             52666981368809999999779987999999998843697899999999999986789998678678980699438999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             83468882344200123468967699999999999999881699993530364330785889848996037642348887
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~  761 (919)
                      ||+++|+|.+++.. ....+++..+++++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++......
T Consensus       109 E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         109 PYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             ECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEECCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             87406741442101-3454048999999999887652003---3676257766875767799988991065232255665


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf             87--4311554586533744324788994146899999999999299975348786200012233223687422336200
Q 002461          762 ES--HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       762 ~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l  839 (919)
                      ..  .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.......+...++.    .+.-.       
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~----~g~~~-------  253 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRRL-------  253 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----TTCCC-------
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----CCCCC-------
T ss_conf             5531002565556455676887437999745746619999999978999988899999999998----08988-------


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             048993679999999995298998999999999999999775
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       840 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                        ..+......+.+++.+||..+|++||+|.||++.|+.+++
T Consensus       254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             --9964475999999999768897689399999999999997

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.54  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=201.0

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             533141202074799999976-9989999995058998913336899998740376031687676339908999983468
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +++.+.||+|+||+||+|... ++..||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf             59847993077819999999999939999998728999999999999999867999988498898009958999962799


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      |+|.+++... ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        94 g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~  167 (288)
T d2jfla1          94 GAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  167 (288)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHH
T ss_pred             CCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC--CCCC
T ss_conf             8188999862-899999999999999999999999---889887140700314878999899716123035778--6410


Q ss_pred             CCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             1554586533744324-----78899414689999999999929997534878620001223322368742233620004
Q 002461          767 TSIVGTVGYLDPEYYA-----SNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~  841 (919)
                      ....||+.|+|||++.     ...++.++|||||||++|||++|+.||........+....     .+....+.      
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-----~~~~~~~~------  236 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-----KSEPPTLA------  236 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-----HSCCCCCS------
T ss_pred             CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----CCCCCCCC------
T ss_conf             0102562647999983202578888806657878999999820889999989999999997-----07998777------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             899367999999999529899899999999999
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                       .+......+.+++.+||+.+|++|||+.|+++
T Consensus       237 -~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 -QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -65669999999999976699668919999962

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.78  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=204.0

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCC----EEEEEEEECC-CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             533141202074799999976-998----9999995058-9989133368999987403760316876763399089999
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGS----EVAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      +.+.+.||+|+||+||+|.+. +|+    .||+|+++.. .....++|.+|+.++++++||||++++|+|.+. ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEE
T ss_conf             9783198208992999999958998898999999965134979999999999999867998881589999619-836999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             83468882344200123468967699999999999999881699993530364330785889848996037642348887
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~  761 (919)
                      |++.+|+|.+++... ...+++..+++++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++......
T Consensus        90 e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          90 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             ECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCC
T ss_conf             842687401011133-457999999999999999999998---7695047621203116799875860255222335444


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             8743115545865337443247889941468999999999992-999753487862000122332236874223362000
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~  840 (919)
                      .........||..|+|||++.++.++.++|||||||++|||+| |++||.. .....+...+    ..+         .+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i----~~~---------~~  231 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSIL----EKG---------ER  231 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHH----HHT---------CC
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH----HCC---------CC
T ss_conf             532236510586446708874699983565440799999999779999999-9989999999----759---------98


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             48993679999999995298998999999999999999775
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       841 ~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      ...+......+.+++.+||..+|++||+|.|+++.|+.+..
T Consensus       232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             99985568999999998478993469199999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.82  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             53314120207479999997-69989999995058998-91333689999874037603168767633990899998346
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      +...+.||+|+||+||+|.. .+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+.++.++||||++
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             88978971277809999999899969999998754097899999999999986799999949999998999999997679


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858898489960376423488878743
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~  765 (919)
                      +|+|.+++..  ...+++..+..++.|++.||.|||+  +.+|+||||||+|||++.++.+||+|||+|+.+..    ..
T Consensus        88 gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~  159 (322)
T d1s9ja_          88 GGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM  159 (322)
T ss_dssp             TEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HT
T ss_pred             CCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC----CC
T ss_conf             9868998742--4999999999999999999999998--59997144577994687899899954877625678----86


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCC---------------
Q ss_conf             11554586533744324788994146899999999999299975348786200012233223687---------------
Q 002461          766 STSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---------------  830 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~---------------  830 (919)
                      .....||..|+|||++.+..++.++||||+||++|||++|+.||.....................               
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             21113771411946875899894888998999999999888998998878999999887517754577421233322111


Q ss_pred             ----------CCCCCCCCCC---CCCC-HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             ----------4223362000---4899-367999999999529899899999999999--9999
Q 002461          831 ----------VRSIVDPRLE---ANFD-TNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKK  878 (919)
Q Consensus       831 ----------l~~iiD~~l~---~~~~-~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~--~Le~  878 (919)
                                ..+..+....   ...+ ......+.+++.+|+..+|++|||+.|+++  .+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf             1222354134778876650268766764448999999999986899467908999960986476

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.02  Aligned_cols=246  Identities=28%  Similarity=0.458  Sum_probs=193.7

Q ss_pred             HHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEEC----CCEEEEEE
Q ss_conf             33141202074799999976-998999999505899--891333689999874037603168767633----99089999
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCND----GGNVGLVY  681 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~----~~~~~LV~  681 (919)
                      .|.+.||+|+||+||+|... ++..||+|++.....  ...+.+.+|++++++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf             85169700828499999999999599999985122798999999999999985799985069999840334588899999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEEC-CCCCEEEECCCCCCCCCCC
Q ss_conf             834688823442001234689676999999999999998816999935303643307858-8984899603764234888
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN-EKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld-~~~~vkI~DFGla~~~~~~  760 (919)
                      ||+++|+|.+++..  ...+++..+..++.|+++||+|||+. ..+|+||||||+|||++ +++.+||+|||+++.... 
T Consensus        92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  167 (270)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             ECCCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC-
T ss_conf             57898948999751--35546999999999999999999978-997996876743511667999889800576542368-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             78743115545865337443247889941468999999999992999753487862000122332236874223362000
Q 002461          761 SESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       761 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~  840 (919)
                         .......||+.|+|||++.+ .++.++|||||||++|||++|+.||....+...+.+.+..    +...    +.+.
T Consensus       168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----~~~~----~~~~  235 (270)
T d1t4ha_         168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----GVKP----ASFD  235 (270)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT----TCCC----GGGG
T ss_pred             ---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC----CCCC----CCCC
T ss_conf             ---76677553813008988478-9998671100799999998788999876559999999973----8998----6567


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             4899367999999999529899899999999999
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                          ......+.+++.+|+..+|++|||+.|+++
T Consensus       236 ----~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 ----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ----557899999999976379758929999967

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.24  Aligned_cols=243  Identities=28%  Similarity=0.429  Sum_probs=200.7

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             533141202074799999976-9989999995058---998913336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +.+.+.||+|+||+||+|... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
T ss_conf             69988985177858999999899949999998168856768999999999999856888888599999989998999850


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.....   
T Consensus        88 ~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          88 APLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             CCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC---
T ss_conf             479858988750--489999999999999999999999---889465220234414668998711555633544888---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.    .+..          .+
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~----~~~~----------~~  223 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS----RVEF----------TF  223 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHH----TTCC----------CC
T ss_pred             -CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHH----CCCC----------CC
T ss_conf             -5235578876349999758998931440467599999832999988899-999999997----1899----------99


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9367999999999529899899999999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++.+|+..+|++|||+.|+++
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             8668999999999976479768909999971

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.99  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=206.1

Q ss_pred             HHCCEECEECCEEEEEEEECC-CC--EEEEEEEECCC-CCCCHHHHHHHHHHHHC-CCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             331412020747999999769-98--99999950589-98913336899998740-376031687676339908999983
Q 002461          609 NFHRILGKGGFGTVYHGYLAD-GS--EVAIKMLSASS-SQGPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~-g~--~VAVK~l~~~~-~~~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      ++.+.||+|+||+||+|.+.+ +.  .||||+++... ....+.|.+|++++.++ +||||++++|++...+..++|+||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
T ss_conf             88779820788289999998999699999999782338579999999999998622899883678888418736999980


Q ss_pred             CCCCCHHHHHHCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEE
Q ss_conf             4688823442001--------------23468967699999999999999881699993530364330785889848996
Q 002461          684 MAYGNLKQYLFDE--------------TKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLA  749 (919)
Q Consensus       684 ~~~GsL~~~L~~~--------------~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~  749 (919)
                      +++|+|.++++..              ....+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCCEEEC
T ss_conf             2898699998640355555123101234578999999999999999987663---0895455505204898688763874


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCC
Q ss_conf             03764234888787431155458653374432478899414689999999999929997534878620001223322368
Q 002461          750 DFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG  829 (919)
Q Consensus       750 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~  829 (919)
                      |||+++.....   .......|+..|+|||.+....++.++||||||+++|||++|..|+..+.+...+.+.+.+-.   
T Consensus       170 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~---  243 (309)
T d1fvra_         170 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  243 (309)
T ss_dssp             CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC---
T ss_pred             CCCCCCCCCCC---CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC---
T ss_conf             34432244422---345530137755553875269999622153138899999836899999999999999998268---


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             7422336200048993679999999995298998999999999999999775
Q 002461          830 DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       830 ~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                                +...+......+.+++.+||+.+|++||+|.||++.|+.+++
T Consensus       244 ----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         244 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             ----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ----------888876678999999999767896689499999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=338.39  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=201.6

Q ss_pred             HHHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             753314120207479999997-6998999999505899891333689999874037603168767633990899998346
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      .+.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             75898898407681999999889998999999845243169999999999986799799929999998999999998579


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECC--CCCEEEECCCCCCCCCCCCCC
Q ss_conf             888234420012346896769999999999999988169999353036433078588--984899603764234888787
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE--KMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~--~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +|+|.+++... ...+++..+..++.|++.||.|||   +.+++||||||+|||++.  ++.+||+|||+++.+...   
T Consensus       107 gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---  179 (350)
T d1koaa2         107 GGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---  179 (350)
T ss_dssp             SCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---
T ss_pred             CCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC---
T ss_conf             98899999762-378999999999999999999997---56976000154673641688986999545210442565---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..    ....  .+....   
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~----~~~~--~~~~~~---  249 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRNVKS----CDWN--MDDSAF---  249 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH----TCCC--SCCGGG---
T ss_pred             CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHH----CCCC--CCCCCC---
T ss_conf             43200068624218899758998726765546599999985989989979-9999999984----7889--894223---


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9367999999999529899899999999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                       ......+.+++.+|+..+|++|||+.|+++
T Consensus       250 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         250 -SGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -589999999999975689667908999862

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.65  Aligned_cols=249  Identities=29%  Similarity=0.447  Sum_probs=205.4

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEECCCC
Q ss_conf             33141202074799999976998999999505899891333689999874037603168767633-99089999834688
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND-GGNVGLVYEYMAYG  687 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~-~~~~~LV~E~~~~G  687 (919)
                      .+.+.||+|+||.||+|.++ |+.||||+++..  ...+.+.+|+.++++++||||++++|+|.+ .+..++|+||+++|
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             EEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCCCC
T ss_conf             88579820798089999999-909999998857--779999999999986789898549878872389289999636999


Q ss_pred             CHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf             82344200123468967699999999999999881699993530364330785889848996037642348887874311
Q 002461          688 NLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIST  767 (919)
Q Consensus       688 sL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~~  767 (919)
                      +|.+++.......++|..+++++.|++.||.|||   +.+++||||||+|||++.++.+|++|||+++.....     ..
T Consensus        87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~  158 (262)
T d1byga_          87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QD  158 (262)
T ss_dssp             EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             CHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCC-----CC
T ss_conf             8999987457888899999999999985232113---376553666567601468997763245600344787-----76


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf             5545865337443247889941468999999999992-999753487862000122332236874223362000489936
Q 002461          768 SIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFDTN  846 (919)
Q Consensus       768 ~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~~~  846 (919)
                      ...++..|+|||++.+..++.++||||||+++|||+| |++|+.. .+..++..++..    +.         +...+..
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~----~~---------~~~~~~~  224 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK----GY---------KMDAPDG  224 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT----TC---------CCCCCTT
T ss_pred             CCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHC----CC---------CCCCCCC
T ss_conf             556664677817872798885887775799999999789999999-999999999980----89---------9999765


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             799999999952989989999999999999997755
Q 002461          847 SVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       847 ~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      ....+.+++.+||..+|.+||+|.+++++|+.++..
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             799999999997566976893999999999999867

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.16  Aligned_cols=247  Identities=27%  Similarity=0.401  Sum_probs=204.1

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             53314120207479999997-69989999995058---998913336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +.+.+.||+|+||+||+|.. .+++.||||+++..   .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEC
T ss_conf             78988985087909999999899979999998657755777899999999999876888861799999989988999970


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++.  ..+.+++.....++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.+......
T Consensus        90 ~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          90 AKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCCCHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf             48987777653--1599999999999999999997621---650884767741236688853886032102422567764


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+...+.    .+..          .+
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~----~~~~----------~~  229 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIFQKII----KLEY----------DF  229 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH----TTCC----------CC
T ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH----CCCC----------CC
T ss_conf             333555677552584400268989666230456999998038899899599-99999997----1899----------99


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9367999999999529899899999999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      +......+.+++.+|++.+|++|||+.|+..
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             8547999999999985579768919789737

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=335.84  Aligned_cols=249  Identities=19%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             53314120207479999997-69989999995058998913336899998740376031687676339908999983468
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +++.+.||+|+||.||+|.. .+|+.||+|+++.........+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCCC
T ss_conf             59989993177829999999899979999998872646799999999999867997989199999989999999982899


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEEC--CCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             8823442001234689676999999999999998816999935303643307858--89848996037642348887874
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN--EKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld--~~~~vkI~DFGla~~~~~~~~~~  764 (919)
                      |+|.+.+.. ....+++.....++.|++.||.|||   +.+|+||||||+|||++  .++.+||+|||+++.+...   .
T Consensus       111 g~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~  183 (352)
T d1koba_         111 GELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---E  183 (352)
T ss_dssp             CBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---S
T ss_pred             CHHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC---C
T ss_conf             808888986-3899899999999999999999999---77926513144553113467884899525630343788---7


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             31155458653374432478899414689999999999929997534878620001223322368742233620004899
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~  844 (919)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.    .+..      .......
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~----~~~~------~~~~~~~  252 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVK----RCDW------EFDEDAF  252 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHH----HCCC------CCCSSTT
T ss_pred             CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH----HCCC------CCCCCCC
T ss_conf             20100476453489997479989763338989999999968899899799-99999998----4788------9893002


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             367999999999529899899999999999
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ......+.+++.+|+..+|.+||++.|+++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             479999999999975699668918999960

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.63  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             HHHHCCEECEECCEEEEEEEEC------CCCEEEEEEEECCCCC-CCHHHHHHHHHHHHC-CCCCEEEEEEEEECCCEEE
Q ss_conf             7533141202074799999976------9989999995058998-913336899998740-3760316876763399089
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~~~~~~  678 (919)
                      .+.+.+.||+|+||.||+|.+.      .++.||||+++..... ....|.+|+.++..+ +||||++++|+|......+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~  103 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             96985498206882999999806644778869999998742487799999999999876269998878998983199789


Q ss_pred             EEEEECCCCCHHHHHHCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECC
Q ss_conf             9998346888234420012----------------346896769999999999999988169999353036433078588
Q 002461          679 LVYEYMAYGNLKQYLFDET----------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE  742 (919)
Q Consensus       679 LV~E~~~~GsL~~~L~~~~----------------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~  742 (919)
                      +++||+++|+|.++++...                ...+++..+..++.|+++||+|||   +++++||||||+|||++.
T Consensus       104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred             EEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCC
T ss_conf             99973799879999985356654444453322233458899999999999999999887---579266624102100002


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC-CHHCC
Q ss_conf             98489960376423488878743115545865337443247889941468999999999992999753487862-00012
Q 002461          743 KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT-HIVNR  821 (919)
Q Consensus       743 ~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~-~lv~~  821 (919)
                      ++.+|++|||+++...............|++.|+|||++.+..++.++||||||+++|||+|++.|+....... .+.+.
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~  260 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             CCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf             57521023401023367886158620135968767788617999974001025899999985899887789989999999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             2332236874223362000489936799999999952989989999999999999997755
Q 002461          822 VCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       822 v~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      +             +...+...+......+.+++.+||+.+|++||+|.+|+++|++.+..
T Consensus       261 i-------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         261 I-------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             H-------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-------------HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             8-------------66898898543659999999997577965792999999999876534

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.89  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             HHHHCCEECEECCEEEEEEEEC------CCCEEEEEEEECCCCC-CCHHHHHHHHHHHHC-CCCCEEEEEEEEECC-CEE
Q ss_conf             7533141202074799999976------9989999995058998-913336899998740-376031687676339-908
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDG-GNV  677 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~~-~~~  677 (919)
                      .+.+.+.||+|+||.||+|...      +++.||||+++..... ..+.+..|...+.++ +|+||+.+++++... ...
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEE
T ss_conf             97984498416783999999867775557839999998600171789999999999886149984997411540479757


Q ss_pred             EEEEEECCCCCHHHHHHCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCC
Q ss_conf             99998346888234420012--------------3468967699999999999999881699993530364330785889
Q 002461          678 GLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK  743 (919)
Q Consensus       678 ~LV~E~~~~GsL~~~L~~~~--------------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~  743 (919)
                      ++|+||+++|+|.++++...              ...+++..++.++.|+++||.|||   +++|+||||||+|||++.+
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGG
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCC
T ss_conf             9999845899299999853666665322202332146899999999999999999887---3797178677310657799


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCCCCCCHHCCC
Q ss_conf             8489960376423488878743115545865337443247889941468999999999992999-753487862000122
Q 002461          744 MQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLP-AIIRGYNNTHIVNRV  822 (919)
Q Consensus       744 ~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~-p~~~~~~~~~lv~~v  822 (919)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|.. ||........+...+
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf             82898457520011356652224751667210203686468899663221367899999868899998999899999999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             332236874223362000489936799999999952989989999999999999997755
Q 002461          823 CPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       823 ~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                          ..+..         ...+......+.+++.+||+.+|++||+|.|+++.|+++++.
T Consensus       251 ----~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         251 ----KEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HCCCC---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----63898---------888865789999999997677966791999999999799867

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.62  Aligned_cols=269  Identities=23%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             HHHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHH--HHHHHHHCCCCCEEEEEEEEECCC----EEEEEE
Q ss_conf             53314120207479999997699899999950589989133368--999987403760316876763399----089999
Q 002461          608 NNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGG----NVGLVY  681 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~--Ei~~L~~l~H~NIv~l~g~~~~~~----~~~LV~  681 (919)
                      +-+.+.||+|+||.||+|++ +|+.||||+++...   ...+..  |+..+..++||||++++++|...+    ..++|+
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             99988982078819999999-99899999987200---467999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEECCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf             834688823442001234689676999999999999998816-----999935303643307858898489960376423
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHG-----CKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~-----~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~  756 (919)
                      ||+++|+|.++++.   ..++|..+++++.|+|.||.|||+.     .+++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ECCCCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
T ss_conf             64669898999865---899989999999999999999887665204689866153173135786887768876386623


Q ss_pred             CCCCCCC--CCCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCC---
Q ss_conf             4888787--4311554586533744324788------9941468999999999992999753487862000122332---
Q 002461          757 FPAESES--HISTSIVGTVGYLDPEYYASNR------LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPF---  825 (919)
Q Consensus       757 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~------~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~---  825 (919)
                      .......  .......||+.|+|||++....      ++.++|||||||++|||+||..|+................   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             CCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCH
T ss_conf             46777620013552503547678221056545467776750122015999999962899887663112410122556430


Q ss_pred             ---CCCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             ---236874223362000489-9367999999999529899899999999999999977557
Q 002461          826 ---LERGDVRSIVDPRLEANF-DTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       826 ---~~~~~l~~iiD~~l~~~~-~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                         ..........+|.+.... ..+....+.+++.+||..+|++||+|.||++.|+++.+.+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             99999987502468887765577689999999999976069858959999999999888865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=336.29  Aligned_cols=248  Identities=21%  Similarity=0.377  Sum_probs=200.8

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             533141202074799999976-998999999505899-891333689999874037603168767633990899998346
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      +++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             69988994065839999999999989999998157731289999999999986799899919899998998889885268


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEEC---CCCCEEEECCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858---898489960376423488878
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld---~~~~vkI~DFGla~~~~~~~~  762 (919)
                      +|+|.+++..  ...+++.....++.|++.||.|||   +.+++||||||+|||+.   +++.+||+|||+++.....  
T Consensus        91 gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--  163 (307)
T d1a06a_          91 GGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--  163 (307)
T ss_dssp             SCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC--
T ss_conf             9848886530--367887899999999999987524---130556870463001104688824998315435872589--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             74311554586533744324788994146899999999999299975348786200012233223687422336200048
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~  842 (919)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..    +..      .....
T Consensus       164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~----~~~------~~~~~  231 (307)
T d1a06a_         164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-AKLFEQILK----AEY------EFDSP  231 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHT----TCC------CCCTT
T ss_pred             -CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHC----CCC------CCCCC
T ss_conf             -704400328422591887379998078734515999999859799999899-999999861----687------77876


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             99367999999999529899899999999999
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ........+.+++.+|+..+|++|||+.|+++
T Consensus       232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             66678999999999976089757918999862

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=336.25  Aligned_cols=243  Identities=29%  Similarity=0.378  Sum_probs=195.2

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCC---CHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             53314120207479999997-699899999950589989---13336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +...+.||+|+||+||+|.. .+++.||||+++......   .+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf             67627970188809999999899939999998444435889999999999999977899982389999989988999980


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +++|+|..++.  ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....    
T Consensus        97 ~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          97 CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             CCCCCHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC----
T ss_conf             69994578997--3799999999999999999999998---68976667884217987999789844365334677----


Q ss_pred             CCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247---889941468999999999992999753487862000122332236874223362000
Q 002461          764 HISTSIVGTVGYLDPEYYAS---NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~  840 (919)
                        .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ ...+   .. +...     .+.
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i---~~-~~~~-----~~~  235 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHI---AQ-NESP-----ALQ  235 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHH---HH-SCCC-----CCS
T ss_pred             --CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH---HH-CCCC-----CCC
T ss_conf             --8731347663688998346788867214545589999999878899999799999-9999---82-8999-----888


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             4899367999999999529899899999999999
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       841 ~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                         .......+.+++.+|+..+|++|||+.|+++
T Consensus       236 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ---7888999999999977379657918999971

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.82  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=199.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCEEEEEEE
Q ss_conf             53314120207479999997-69989999995058998--91333689999874037603168767633--990899998
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCND--GGNVGLVYE  682 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~--~~~~~LV~E  682 (919)
                      +++.+.||+|+||+||+|.. .+|+.||+|.++.....  ..+.+.+|++++++++||||+++++++.+  .+..++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf             79967983088919999999999979999998746579799999999999999778999824899999178998999995


Q ss_pred             ECCCCCHHHHHHCCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEEECCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf             346888234420012--346896769999999999999988169--9993530364330785889848996037642348
Q 002461          683 YMAYGNLKQYLFDET--KEALSWKDRLQIAVDAAQGLEYLHHGC--KPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       683 ~~~~GsL~~~L~~~~--~~~ls~~~~~~ia~qia~aL~yLH~~~--~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~  758 (919)
                      |+++|+|.+++....  ...+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEECC
T ss_conf             68999389999851545789999999999999999999999716778878858676542574788857980010003224


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCC
Q ss_conf             88787431155458653374432478899414689999999999929997534878620001223322368742233620
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       759 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~  838 (919)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+    ..+....     
T Consensus       166 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i----~~~~~~~-----  233 (269)
T d2java1         166 HD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKI----REGKFRR-----  233 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHH----HHTCCCC-----
T ss_pred             CC--CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC-HHHHHHHH----HCCCCCC-----
T ss_conf             57--775566778823279999839999938988752789999801889989989-99999999----7189988-----


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             004899367999999999529899899999999999
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       839 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                          .+......+.+++.+|+..+|++||++.|+++
T Consensus       234 ----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 ----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ----97435999999999976799557918999972

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.11  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             HHHHCCEECEECCEEEEEEEECC----CCEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             75331412020747999999769----989999995058998-9133368999987403760316876763399089999
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD----GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+++.+.||+|+||.||+|.+..    +..||+|.++..... ..+.|.+|+.++++++||||++++|++. .+..++|+
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEE
T ss_conf             96987799307882999999936996449999999365668799999999999998689999856988995-37479999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             83468882344200123468967699999999999999881699993530364330785889848996037642348887
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~  761 (919)
                      ||+++|+|.+++.. ....+++..++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++..... 
T Consensus        87 E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-  161 (273)
T d1mp8a_          87 ELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-  161 (273)
T ss_dssp             ECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC-
T ss_conf             84069807765422-4789999999999999987752302---267441410265532067896787650342133677-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             8743115545865337443247889941468999999999992-999753487862000122332236874223362000
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLE  840 (919)
Q Consensus       762 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~  840 (919)
                      .........|++.|+|||++.+..++.++|||||||++|||++ |.+||.... ...+...+.    .+...        
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~~~i~----~~~~~--------  228 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE----NGERL--------  228 (273)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH----TTCCC--------
T ss_pred             CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-HHHHHHHHH----CCCCC--------
T ss_conf             62330540058310326675169988745244424789999826999988899-999999998----18999--------


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf             489936799999999952989989999999999999997755787
Q 002461          841 ANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEMETA  885 (919)
Q Consensus       841 ~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~~~  885 (919)
                       ..+......+.+++.+||..+|++||++.||++.|+.+++.+.+
T Consensus       229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~  272 (273)
T d1mp8a_         229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  272 (273)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHC
T ss_conf             -89877799999999997687976892999999999999778617

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.32  Aligned_cols=259  Identities=28%  Similarity=0.456  Sum_probs=208.2

Q ss_pred             HHHHCCEECEECCEEEEEEEECC--------CCEEEEEEEECCCCC-CCHHHHHHHHHHHHC-CCCCEEEEEEEEECCCE
Q ss_conf             75331412020747999999769--------989999995058998-913336899998740-37603168767633990
Q 002461          607 TNNFHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQ-GPKQFRTEAQLLMRV-HHRNLASLVGYCNDGGN  676 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~~~~  676 (919)
                      .+.+.+.||+|+||.||+|....        +..||||+++..... ...++.+|...+.++ +||||++++++|.+.+.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCCE
T ss_conf             96970098516782899999857875556675499999988112868899999999999981399969734652201886


Q ss_pred             EEEEEEECCCCCHHHHHHCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECC
Q ss_conf             899998346888234420012--------------346896769999999999999988169999353036433078588
Q 002461          677 VGLVYEYMAYGNLKQYLFDET--------------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE  742 (919)
Q Consensus       677 ~~LV~E~~~~GsL~~~L~~~~--------------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~  742 (919)
                      .++||||+++|+|.+++....              ...+++..++.++.|++.||.|||   +.+++||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred             EEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCEEECC
T ss_conf             89999736999099999860677643222334574346799999999999999998766---379786302210224547


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCC
Q ss_conf             98489960376423488878743115545865337443247889941468999999999992-99975348786200012
Q 002461          743 KMQAKLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNR  821 (919)
Q Consensus       743 ~~~vkI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~  821 (919)
                      ++.+||+|||+++...............|+..|+|||.+.++.++.++||||||+++|||++ |.+||.. .....+.+.
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~  249 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKL  249 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHH
T ss_pred             CCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-CCHHHHHHH
T ss_conf             8976762211101135555543146678884663266751798882555477588888740179898999-999999999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             2332236874223362000489936799999999952989989999999999999997755
Q 002461          822 VCPFLERGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEM  882 (919)
Q Consensus       822 v~~~~~~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~  882 (919)
                      +    ..+.         ....+......+.+++.+||+.+|++|||+.||++.|++++.+
T Consensus       250 i----~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         250 L----KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             H----HTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H----HCCC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             9----7288---------8898743529999999997667976793999999999888604

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.98  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=207.9

Q ss_pred             HHCCEECEECCEEEEEEEEC------CCCEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             33141202074799999976------9989999995058998-9133368999987403760316876763399089999
Q 002461          609 NFHRILGKGGFGTVYHGYLA------DGSEVAIKMLSASSSQ-GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVY  681 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~  681 (919)
                      .+.+.||+|+||+||+|.+.      +++.||||+++..... ....|.+|+.++++++||||++++|+|......++|+
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf             88359820788189999987864477896899999870128689999999999999769998841254784288106777


Q ss_pred             EECCCCCHHHHHHCCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCC
Q ss_conf             8346888234420012--------34689676999999999999998816999935303643307858898489960376
Q 002461          682 EYMAYGNLKQYLFDET--------KEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGF  753 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~--------~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGl  753 (919)
                      ||+++|+|.+++....        ...+++..+.+++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             EECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECEECCCCEEECCCCEEEEEECCC
T ss_conf             604899889998750332113444688799999999999999999876---47965432867754035996499942454


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCC
Q ss_conf             42348887874311554586533744324788994146899999999999299975348786200012233223687422
Q 002461          754 SKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRS  833 (919)
Q Consensus       754 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~  833 (919)
                      ++...............|++.|+|||.+.+..++.++||||||+++|||+||+.++..+.........+.    .+... 
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~----~~~~~-  254 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM----EGGLL-  254 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH----TTCCC-
T ss_pred             CEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH----HCCCC-
T ss_conf             2023577630313402316323788887369988333444378999999968999999989999999998----08888-


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             33620004899367999999999529899899999999999999977557
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLEME  883 (919)
Q Consensus       834 iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~~~  883 (919)
                              ..+......+.+++.+||+.+|++||+|.+|+++|++.++..
T Consensus       255 --------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         255 --------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCC
T ss_conf             --------886335399999999975779658939999999978761778

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.86  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             HHHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC------CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
Q ss_conf             753314120207479999997-69989999995058998------91333689999874037603168767633990899
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ------GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGL  679 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~L  679 (919)
                      .+++.+.||+|+||+||+|.. .+|+.||||+++.....      ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             77982798117895999999999998999999875663213406899999999999986799899938899997998999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCC----CEEEECCCCCC
Q ss_conf             99834688823442001234689676999999999999998816999935303643307858898----48996037642
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM----QAKLADFGFSK  755 (919)
Q Consensus       680 V~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~----~vkI~DFGla~  755 (919)
                      ||||+++|+|.+++..  .+.+++..+..++.|++.||+|||   +.+++||||||+|||++.++    .+|++|||+++
T Consensus        91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEECCCCCCCCCHHCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHH
T ss_conf             9986778643100103--564215578999999999987666---25422113330127982589866646964334421


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCC
Q ss_conf             34888787431155458653374432478899414689999999999929997534878620001223322368742233
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~ii  835 (919)
                      .....   .......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.    .+...  .
T Consensus       166 ~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~----~~~~~--~  235 (293)
T d1jksa_         166 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVS----AVNYE--F  235 (293)
T ss_dssp             ECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH----TTCCC--C
T ss_pred             HCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHH----HCCCC--C
T ss_conf             05777---631224777743099998189999766522140999999708899889999-99999998----16888--8


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             620004899367999999999529899899999999999
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       836 D~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      .+...    ......+.+++.+|+..+|++||++.|+++
T Consensus       236 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         236 EDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             70104----788999999999986389668919999961

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.21  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             53314120207479999997-69989999995058---998913336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +++.+.||+|+||.||+|+. .+|+.||+|++++.   .....+.+.+|+.+|+.++||||+++++++.+....++|+||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEEC
T ss_conf             28988983176849999999899989999998156544979999999999999867999887787640356421110003


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +++|+|.+++..  ...+++.....++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.....  .
T Consensus        87 ~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~  159 (337)
T d1o6la_          87 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G  159 (337)
T ss_dssp             CTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred             CCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC--C
T ss_conf             579860555532--567759999999999965211343---159622464777847658998888205652003567--8


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                      .......||+.|+|||++.+..++.++||||+||++|||++|++||..... ..+.+.+    ..+.+          .+
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i----~~~~~----------~~  224 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI----LMEEI----------RF  224 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH----HHCCC----------CC
T ss_pred             CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH-HHHHHHH----HCCCC----------CC
T ss_conf             620551008899666650489888333102230678899878999999699-9999998----52899----------89


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             9367999999999529899899999-----999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                      +......+.+++..|+..+|.+||+     +.|+++
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             866899999999866638934422565234999972

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=324.46  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             53314120207479999997-69989999995058---998913336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +++.+.||+|+||+||+|.. .+|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf             08888972076808999999899979999998457754889999999999999863696753303568528800567650


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +++|+|..++.  ....+++.....++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 ~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          86 IEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             CCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHC---CCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC---
T ss_conf             37863223432--2221110079999999987655412---476770556810503868998898317521671245---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.    .+..          .+
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~----~~~~----------~~  220 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKIL----NAEL----------RF  220 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHH----HCCC----------CC
T ss_pred             --CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH-HHHHHHHH----CCCC----------CC
T ss_conf             --6434576343599998389998043046533368999759899999699-99999997----0898----------89


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             936799999999952989989999-----9999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      +......+.+++.+|+..+|.+|+     ++.++++
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             977899999999999544997666431021999981

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=324.33  Aligned_cols=246  Identities=23%  Similarity=0.300  Sum_probs=191.4

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCC---CCCCHHHHHH---HHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             533141202074799999976-99899999950589---9891333689---9998740376031687676339908999
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASS---SQGPKQFRTE---AQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|   +.+++.++||||+++++++...+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
T ss_conf             85101884288909999999999979999998458754266799999999999998508998588999999989988999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             98346888234420012346896769999999999999988169999353036433078588984899603764234888
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~  760 (919)
                      |||+++|+|.+++..  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.+...
T Consensus        86 mE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             ECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCC
T ss_conf             991489838999873--255327899999999999999999---779622044422167858896798220102333788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf             78743115545865337443247-88994146899999999999299975348786200012233223687422336200
Q 002461          761 SESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRL  839 (919)
Q Consensus       761 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l  839 (919)
                          ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ... +........      .  
T Consensus       161 ----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-~~~~~~~~~------~--  226 (364)
T d1omwa3         161 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-IDRMTLTMA------V--  226 (364)
T ss_dssp             ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHH-HHHHSSSCC------C--
T ss_pred             ----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-HHH-HHHHCCCCC------C--
T ss_conf             ----64331134554216876038999844104677899999985999888899899-999-998604688------8--


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             04899367999999999529899899999-----999999
Q 002461          840 EANFDTNSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       840 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                        ..+......+.+++.+|+..+|++||+     ++|+++
T Consensus       227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             --78877899999999998566988808874357999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.53  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=193.4

Q ss_pred             CCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHC-CCCCEEEEEEEEEC----CCEEEEEEEEC
Q ss_conf             14120207479999997-69989999995058998913336899998740-37603168767633----99089999834
Q 002461          611 HRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVGYCND----GGNVGLVYEYM  684 (919)
Q Consensus       611 ~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l-~H~NIv~l~g~~~~----~~~~~LV~E~~  684 (919)
                      .++||+|+||.||+|.. .+++.||||+++.     ...+.+|+.++.++ +||||+++++++.+    ....++||||+
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECC
T ss_conf             0796545486999999889998999999897-----47799999999986699997829899950346897899999778


Q ss_pred             CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECC---CCCEEEECCCCCCCCCCCC
Q ss_conf             6888234420012346896769999999999999988169999353036433078588---9848996037642348887
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE---KMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~---~~~vkI~DFGla~~~~~~~  761 (919)
                      ++|+|.+++.......+++.....++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||+++......
T Consensus        92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf             9984999998627877579999999999999999999---7698644410022011355556631135455123336888


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             87431155458653374432478899414689999999999929997534878620001223322368742233620004
Q 002461          762 ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEA  841 (919)
Q Consensus       762 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~  841 (919)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......+... ...+.   
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i~~~~~~-~~~~~---  240 (335)
T d2ozaa1         169 ---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYE-FPNPE---  240 (335)
T ss_dssp             ---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSSS-CCTTH---
T ss_pred             ---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHHCCCCC-CCCCC---
T ss_conf             ---6432267756379277748988888888764516778865889988988778-899999998538888-89854---


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             899367999999999529899899999999999
Q 002461          842 NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       842 ~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                        .......+.+++.+|+..+|++||++.|+++
T Consensus       241 --~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         241 --WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             --3469999999999975699657909999970

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=330.60  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=201.3

Q ss_pred             HHHCCEECEECCEEEEEEEECC--C--CEEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             5331412020747999999769--9--8999999505899---8913336899998740376031687676339908999
Q 002461          608 NNFHRILGKGGFGTVYHGYLAD--G--SEVAIKMLSASSS---QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~~--g--~~VAVK~l~~~~~---~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.+.+.||+|+||+||+|.+..  +  ..||||+++....   ...++|.+|+.++++++||||++++|++.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHHEE
T ss_conf             1997898038883999999988999079999999983555798999999999999986899998789877740-100114


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             98346888234420012346896769999999999999988169999353036433078588984899603764234888
Q 002461          681 YEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       681 ~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~  760 (919)
                      +||+++|++.+.+... ...+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          89 TELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             EEEECCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCC
T ss_conf             6542386125444212-689999999999999999998752---178752056688815655654332561155530358


Q ss_pred             CCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCC
Q ss_conf             7874-3115545865337443247889941468999999999992-9997534878620001223322368742233620
Q 002461          761 SESH-ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELIT-GLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       761 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELlt-G~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~  838 (919)
                      .... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||... +......++..   .+.        
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~---~~~--------  232 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDK---EGE--------  232 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHT---SCC--------
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHH---CCC--------
T ss_conf             875265476325731079999837999942156614899999996899999996-99999999984---799--------


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             00489936799999999952989989999999999999997
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKC  879 (919)
Q Consensus       839 l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~  879 (919)
                       +..........+.+++.+||..+|++||+|.||.+.|++.
T Consensus       233 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             -9998544539999999997688966792999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=322.59  Aligned_cols=257  Identities=25%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCC---CHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EEEE
Q ss_conf             53314120207479999997-699899999950589989---133368999987403760316876763399----0899
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNLASLVGYCNDGG----NVGL  679 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~----~~~L  679 (919)
                      +.+.+.||+|+||.||+|.. .+|+.||+|+++......   ...+.+|+.+++.++||||+++++++....    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf             69868996089929999999999989999998556646989999999999999856999887311435432688766999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf             99834688823442001234689676999999999999998816999935303643307858898489960376423488
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~  759 (919)
                      ||||+++|+|.+++.  ..+.+++.....++.|++.||+|||   +.+++||||||+|||++.+...+++|||.+.....
T Consensus        89 vmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEECCCCCEEHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf             997788987101120--3589999999999999999999998---57952763467556657543201003444322123


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCC
Q ss_conf             87-87431155458653374432478899414689999999999929997534878620001223322368742233620
Q 002461          760 ES-ESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPR  838 (919)
Q Consensus       760 ~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~  838 (919)
                      .. .........||+.|+|||++.+..++.++||||+||++|||++|+.||..........    .....+...    + 
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~~~~~~~~~----~-  234 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIP----P-  234 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHCCCCC----G-
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCCCCC----C-
T ss_conf             5443333464257624369999839999966320265289999976979989969999999----998469999----7-


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf             00489936799999999952989989999-9999999999977
Q 002461          839 LEANFDTNSVWKVAETAMECVPSISFQRP-TMSHVVTELKKCL  880 (919)
Q Consensus       839 l~~~~~~~~~~~l~~li~~Cl~~~P~~RP-sm~eVv~~Le~~~  880 (919)
                        ..........+.+++.+|+..+|++|| +++++.+.|..++
T Consensus       235 --~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             --10034789999999999866797677739999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=322.09  Aligned_cols=242  Identities=23%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECC---CCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             533141202074799999976-9989999995058---998913336899998740376031687676339908999983
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEY  683 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~  683 (919)
                      +++.+.||+|+||.||+|... +|+.||||+++..   .....+.+.+|+.+++.++||||+++++++......++|+|+
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf             08988961176808999999899989999998267745889999999999999974877274034444322222322223


Q ss_pred             CCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             46888234420012346896769999999999999988169999353036433078588984899603764234888787
Q 002461          684 MAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESES  763 (919)
Q Consensus       684 ~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~  763 (919)
                      +.+|+|.+++..  ...+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.+...   
T Consensus       123 ~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         123 VAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             CCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC---
T ss_conf             346622666751--589899999999999999899998---599861767999936077897886101033322566---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             43115545865337443247889941468999999999992999753487862000122332236874223362000489
Q 002461          764 HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANF  843 (919)
Q Consensus       764 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~  843 (919)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.    .+..          ..
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~----~~~~----------~~  257 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----SGKV----------RF  257 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH----HCCC----------CC
T ss_pred             --CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-HHHHHHHHH----CCCC----------CC
T ss_conf             --643367635678899717998853311450078999975889989959-999999986----1798----------89


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             936799999999952989989999-----9999999
Q 002461          844 DTNSVWKVAETAMECVPSISFQRP-----TMSHVVT  874 (919)
Q Consensus       844 ~~~~~~~l~~li~~Cl~~~P~~RP-----sm~eVv~  874 (919)
                      +......+.+++..|+..+|.+|+     ++.++++
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             766899999999998340998606553454999971

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.11  Aligned_cols=254  Identities=25%  Similarity=0.295  Sum_probs=194.0

Q ss_pred             CEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC-----CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             4120207479999997-69989999995058998-----91333689999874037603168767633990899998346
Q 002461          612 RILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ-----GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       612 ~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~-----~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      ++||+|+||+||+|.. .+|+.||||+++.....     ..+.+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHHC
T ss_conf             38512728299999999999699999984202124567999999999999986799998689854225874022045534


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858898489960376423488878743
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~  765 (919)
                      ++.+....  .....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......  ..
T Consensus        84 ~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~  156 (299)
T d1ua2a_          84 TDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA  156 (299)
T ss_dssp             EEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred             CHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf             50776554--12667789999999999999998863---1635503577625885377841146576100057875--54


Q ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCC------------
Q ss_conf             1155458653374432478-899414689999999999929997534878620001223322368742------------
Q 002461          766 STSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR------------  832 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~------------  832 (919)
                      .....||..|+|||++... .++.++||||+||++|||++|++||....+ .+....+.+........            
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCH-HHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf             33020473336399972677888056436304289999859699999999-99999999851899725452100021344


Q ss_pred             ---CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---233620004899367999999999529899899999999999
Q 002461          833 ---SIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ---~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ......+.. ........+.+++.+|+..+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCHHH-HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             303478988678-56568999999999976389456908999967

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.16  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECC---CCCCCHHHHHHHHHHH-HCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             533141202074799999976-9989999995058---9989133368999987-4037603168767633990899998
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSAS---SSQGPKQFRTEAQLLM-RVHHRNLASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~L~-~l~H~NIv~l~g~~~~~~~~~LV~E  682 (919)
                      +.+.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++||||+++++++.+++..++|+|
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf             18865894087828999999999989999998055533848999999999999984799968789889704983167775


Q ss_pred             ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             34688823442001234689676999999999999998816999935303643307858898489960376423488878
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       683 ~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~  762 (919)
                      |+++|+|.+++..  ...+++.....++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.....  
T Consensus        84 y~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--  156 (320)
T d1xjda_          84 YLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--  156 (320)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred             ECCCCCHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC--
T ss_conf             0379808998640--478999999999999999999998---689340347654044448996301555302323566--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             74311554586533744324788994146899999999999299975348786200012233223687422336200048
Q 002461          763 SHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEAN  842 (919)
Q Consensus       763 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~  842 (919)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+...+    ..+.      +    .
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i----~~~~------~----~  221 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSI----RMDN------P----F  221 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHH----HHCC------C----C
T ss_pred             CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHH----HCCC------C----C
T ss_conf             533454578777689999827998832320112278989873889999989-99999999----7189------9----8


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             9936799999999952989989999999-9999
Q 002461          843 FDTNSVWKVAETAMECVPSISFQRPTMS-HVVT  874 (919)
Q Consensus       843 ~~~~~~~~l~~li~~Cl~~~P~~RPsm~-eVv~  874 (919)
                      ++......+.+++.+|+..+|++||++. ++++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             975679999999999654489878388999980

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=314.89  Aligned_cols=248  Identities=25%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCC---------CHHHHHHHHHHHHCC-CCCEEEEEEEEECCCE
Q ss_conf             53314120207479999997-699899999950589989---------133368999987403-7603168767633990
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQG---------PKQFRTEAQLLMRVH-HRNLASLVGYCNDGGN  676 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~---------~~~f~~Ei~~L~~l~-H~NIv~l~g~~~~~~~  676 (919)
                      +++.+.||+|+||+||+|+. .+|+.+|||+++......         .+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf             88852884176849999999999989999999624464114788899999999999999985079974799762146760


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf             89999834688823442001234689676999999999999998816999935303643307858898489960376423
Q 002461          677 VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       677 ~~LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~  756 (919)
                      .++||||+++|+|.+++..  ...+++..+..++.|+++||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf             5999976898668999986--599999999999999999999998---75994323462548986899838712403167


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCC
Q ss_conf             488878743115545865337443247------88994146899999999999299975348786200012233223687
Q 002461          757 FPAESESHISTSIVGTVGYLDPEYYAS------NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD  830 (919)
Q Consensus       757 ~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~  830 (919)
                      .....   ......|+..|+|||.+.+      ..++.++||||+||++|||++|+.||...... ...+.+    ..+.
T Consensus       160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~~~i----~~~~  231 (277)
T d1phka_         160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMI----MSGN  231 (277)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH----HHTC
T ss_pred             CCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-HHHHHH----HHCC
T ss_conf             26887---213452467888988860534456788992331856560231032288898899999-999999----8189


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             42233620004899367999999999529899899999999999
Q 002461          831 VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ..      ............+.+++.+|++.+|++||++.|+++
T Consensus       232 ~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CC------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             88------898543468999999999976589668919999973

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=317.69  Aligned_cols=248  Identities=16%  Similarity=0.258  Sum_probs=197.4

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             533141202074799999976-9989999995058998913336899998740376031687676339908999983468
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +.+.+.||+|+||+||+|... +++.||+|+++... .....+.+|+.+|+.++||||+++++++.+.+..++||||+++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf             588789831778399999998999699999975786-6599999999999857997989098999889988999953899


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCC--CCEEEECCCCCCCCCCCCCCC
Q ss_conf             882344200123468967699999999999999881699993530364330785889--848996037642348887874
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK--MQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~--~~vkI~DFGla~~~~~~~~~~  764 (919)
                      |+|.+++... ...+++.....++.|++.||.|||   +.+|+||||||+|||++.+  ..+||+|||+++.....   .
T Consensus        86 g~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~  158 (321)
T d1tkia_          86 LDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---D  158 (321)
T ss_dssp             CBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---C
T ss_pred             CCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC---C
T ss_conf             8088998753-899999999999999999999998---76997513554443443788518997644111003467---7


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             31155458653374432478899414689999999999929997534878620001223322368742233620004899
Q 002461          765 ISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDPRLEANFD  844 (919)
Q Consensus       765 ~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~~l~~~~~  844 (919)
                      ......+++.|+|||...+..++.++||||+||++|||++|+.||..... ......+.    .+..  .++.....   
T Consensus       159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~~~~i~----~~~~--~~~~~~~~---  228 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIM----NAEY--TFDEEAFK---  228 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHH----HTCC--CCCHHHHT---
T ss_pred             CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH-HHHHHHHH----HCCC--CCCHHHCC---
T ss_conf             53212233222340210487778401130279999999828999999899-99999998----3899--98802236---


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             367999999999529899899999999999
Q 002461          845 TNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       845 ~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                       .....+.+++..|+..+|++||++.|+++
T Consensus       229 -~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         229 -EISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -78999999999986699668909999963

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=310.76  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=196.3

Q ss_pred             HHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             3314120207479999997-6998999999505899--891333689999874037603168767633990899998346
Q 002461          609 NFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS--QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      ...+.||+|+||+||+|.. .+|+.||+|+++....  .....+.+|+.++++++||||+++++++.+.++.++|+||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEECC
T ss_conf             76517723768099999999999799999980222575899999999999986799838874453322432037886237


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858898489960376423488878743
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHI  765 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~  765 (919)
                      + ++.+.+.......+++..+..++.|++.||.|||   +.+|+||||||+|||++.+..+||+|||+++.....  ...
T Consensus        85 ~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~  158 (298)
T d1gz8a_          85 Q-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT  158 (298)
T ss_dssp             E-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBC
T ss_pred             C-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCC--CCC
T ss_conf             7-4455544202568888999999999999999865---288992135711401134676210357861343688--641


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCC--CCC---CCCC------
Q ss_conf             11554586533744324788-99414689999999999929997534878620001223322--368---7422------
Q 002461          766 STSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFL--ERG---DVRS------  833 (919)
Q Consensus       766 ~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~--~~~---~l~~------  833 (919)
                      .....|+..|+|||.+.... ++.++||||+||++|+|++|+.||........+........  .+.   ....      
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCC
T ss_conf             00103652154112213665777422103333134279668799898899999999998328983331444222421243


Q ss_pred             ----CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----33620004899367999999999529899899999999999
Q 002461          834 ----IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       834 ----iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                          ........ ........+.+++.+|+..+|++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         239 SFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCHHH-HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             454322220444-16678999999999976399557918999967

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=306.25  Aligned_cols=259  Identities=20%  Similarity=0.313  Sum_probs=191.4

Q ss_pred             HHHCCEECEECCEEEEEEEE-CC-CCEEEEEEEECCC--CCCCHHHHHHHHHHHHC---CCCCEEEEEEEEEC-----CC
Q ss_conf             53314120207479999997-69-9899999950589--98913336899998740---37603168767633-----99
Q 002461          608 NNFHRILGKGGFGTVYHGYL-AD-GSEVAIKMLSASS--SQGPKQFRTEAQLLMRV---HHRNLASLVGYCND-----GG  675 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~L~~l---~H~NIv~l~g~~~~-----~~  675 (919)
                      +++.+.||+|+||+||+|.. .+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             79888992155869999999888998999999802324516799999999999987425898802366322146666674


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCC
Q ss_conf             08999983468882344200123468967699999999999999881699993530364330785889848996037642
Q 002461          676 NVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       676 ~~~LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~  755 (919)
                      ..++++|++.++.+.... ......+++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEEEEEECCCCCHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEECCCCCEEECCHHHHH
T ss_conf             699999740587144444-303789998999999999999999997---5889835798627898589975421000101


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCC---C---
Q ss_conf             3488878743115545865337443247889941468999999999992999753487862000122332236---8---
Q 002461          756 IFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---G---  829 (919)
Q Consensus       756 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~---~---  829 (919)
                      ....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||....+... ...+......   .   
T Consensus       165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSC
T ss_pred             HHCC---CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCHHCCC
T ss_conf             1002---3457776548511483100179888111000328999999878799899898999-99999840799611053


Q ss_pred             ---CCC-CC---CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---742-23---3620004899367999999999529899899999999999
Q 002461          830 ---DVR-SI---VDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       830 ---~l~-~i---iD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                         ... ..   ........+.......+.+++.+|+..+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2111103330223456454404458999999999987489667918999966

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=307.04  Aligned_cols=263  Identities=23%  Similarity=0.268  Sum_probs=191.6

Q ss_pred             HHHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEEEEEEEEC------CCEEEE
Q ss_conf             7533141202074799999976-998999999505899891333689999874037603168767633------990899
Q 002461          607 TNNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND------GGNVGL  679 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~------~~~~~L  679 (919)
                      +++..++||+|+||+||+|+.. +|+.||||+++...    ....+|+.++++++|+||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             7675169821768399999999999799999988160----689999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHHC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCC-CEEEECCCCCCCC
Q ss_conf             9983468882344200-1234689676999999999999998816999935303643307858898-4899603764234
Q 002461          680 VYEYMAYGNLKQYLFD-ETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIF  757 (919)
Q Consensus       680 V~E~~~~GsL~~~L~~-~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkI~DFGla~~~  757 (919)
                      |+||++++.+...... .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             9841688607888863103689999999999999999999998---6687645788603787358971167336605440


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCC---------
Q ss_conf             88878743115545865337443247-88994146899999999999299975348786200012233223---------
Q 002461          758 PAESESHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---------  827 (919)
Q Consensus       758 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~---------  827 (919)
                      ....   ......|+..|+|||.+.+ ..++.++||||+||++|||++|++||........+.... ....         
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~-~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII-KVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH-HHHCCCCHHHHHH
T ss_pred             CCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHH-HHHCCCHHHHHHH
T ss_conf             4776---53200255555682776404688821000246527785502879989879999999999-9748981776543


Q ss_pred             ------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHHH
Q ss_conf             ------68742233620004899367999999999529899899999999999--999977
Q 002461          828 ------RGDVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKCL  880 (919)
Q Consensus       828 ------~~~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~--~Le~~~  880 (919)
                            ...........+...........+.+++.+|+..+|++|||+.|+++  .++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf             0621011035544567444431568999999999997658955792999996698452466

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=306.12  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=197.2

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             3314120207479999997699899999950589--98913336899998740376031687676339908999983468
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAY  686 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~~~  686 (919)
                      +..+.||+|+||+||+|...+|+.||||+++...  ....+.+.+|+.++++++||||+++++++...+..++++|++.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             EECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEHH
T ss_conf             34318722778189999968999999999812326858999999999999867998687660120467731589974004


Q ss_pred             CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf             88234420012346896769999999999999988169999353036433078588984899603764234888787431
Q 002461          687 GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESHIS  766 (919)
Q Consensus       687 GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~~~  766 (919)
                      +.+..+.  ...+.+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||++.......  ...
T Consensus        85 ~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  157 (286)
T d1ob3a_          85 DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKY  157 (286)
T ss_dssp             EHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHHH--HHCCCCCHHHHHHHHHHHHHHHHHHC---CCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--CCC
T ss_conf             5678998--60477514456899999999999860---5748826787750568689978732366430114676--541


Q ss_pred             CCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCC------------C--
Q ss_conf             15545865337443247-88994146899999999999299975348786200012233223687------------4--
Q 002461          767 TSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD------------V--  831 (919)
Q Consensus       767 ~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~------------l--  831 (919)
                      ....++..|+|||.+.. ..++.++||||+||++|||++|+.||....+...+ ..+........            .  
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL-MRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             CEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHH-HHHHHHHCCCCHHHCCCHHHHHHCCC
T ss_conf             01024311013788717888884100211175899997797998988989999-99998638997110421233322143


Q ss_pred             -CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -2233620004899367999999999529899899999999999
Q 002461          832 -RSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       832 -~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                       .....+.............+.+++.+|+..+|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             33335676466651258999999999986689668909999856

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=309.92  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCC------CCCHHHHHHHHHHHHCC--CCCEEEEEEEEECCCEEE
Q ss_conf             53314120207479999997-6998999999505899------89133368999987403--760316876763399089
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS------QGPKQFRTEAQLLMRVH--HRNLASLVGYCNDGGNVG  678 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~~L~~l~--H~NIv~l~g~~~~~~~~~  678 (919)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++....      ....++.+|+.++++++  ||||+++++++.+.+..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEEE
T ss_conf             79967984087839999999999979999998568844334556799999999999974358988127999983099689


Q ss_pred             EEEEECCC-CCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCC-CCEEEECCCCCCC
Q ss_conf             99983468-882344200123468967699999999999999881699993530364330785889-8489960376423
Q 002461          679 LVYEYMAY-GNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEK-MQAKLADFGFSKI  756 (919)
Q Consensus       679 LV~E~~~~-GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~-~~vkI~DFGla~~  756 (919)
                      +|+|++.+ +++.+++.  ....+++..+..++.|++.||.|||   +.+++||||||+|||++.+ +.+||+|||+++.
T Consensus        86 lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          86 LILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEECCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf             99983368622899986--1589999999999999999999998---779755667611147744788489775465353


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCC
Q ss_conf             488878743115545865337443247889-9414689999999999929997534878620001223322368742233
Q 002461          757 FPAESESHISTSIVGTVGYLDPEYYASNRL-TEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIV  835 (919)
Q Consensus       757 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~ii  835 (919)
                      ....    ......||..|+|||++.+..+ +.++||||+||++|||++|+.||....   ....        +..    
T Consensus       161 ~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~i~~--------~~~----  221 (273)
T d1xwsa_         161 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EIIR--------GQV----  221 (273)
T ss_dssp             CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HHHH--------CCC----
T ss_pred             CCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH---HHHH--------CCC----
T ss_conf             2444----55665658774799998489978865332554034536756889988736---7761--------544----


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf             620004899367999999999529899899999999999--99997
Q 002461          836 DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKC  879 (919)
Q Consensus       836 D~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~--~Le~~  879 (919)
                        .+    .......+.+++.+|+..+|++|||+.|+++  .++++
T Consensus       222 --~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         222 --FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             --CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             --CC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             --77----87799999999999760897589399998539866788

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=298.37  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=192.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCC--CCCCHHHHHHHHHHHHCCCCCEEEEEEEEEC--------CCE
Q ss_conf             53314120207479999997-699899999950589--9891333689999874037603168767633--------990
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLASLVGYCND--------GGN  676 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~--------~~~  676 (919)
                      +...+.||+|+||+||+|.. .+|+.||||++....  .....++.+|+.+|++++|+|++++++.+..        ..+
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~   91 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   91 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCE
T ss_conf             88999972274829999999899979999998422246378999999999999835999660676540246544445763


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf             89999834688823442001234689676999999999999998816999935303643307858898489960376423
Q 002461          677 VGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       677 ~~LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~  756 (919)
                      .++++|++.++.+....  .....++......++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||+++.
T Consensus        92 ~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          92 IYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             EEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCCCCHHH--HCCCCCCCHHHHHHHHHHHHHHHHHC---CCCEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf             89998535787410122--20344330899999999999998852---29988567672220366899687631350022


Q ss_pred             CCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCC---CCC
Q ss_conf             488878--7431155458653374432478-8994146899999999999299975348786200012233223---687
Q 002461          757 FPAESE--SHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE---RGD  830 (919)
Q Consensus       757 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~---~~~  830 (919)
                      ......  ........||..|+|||++.+. .++.++||||+||++|||++|+.||....+... ...+.....   ...
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred             CCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHH
T ss_conf             3554443211356602497874289970799989178700678646617448799899899999-999998418998255


Q ss_pred             CCCC--------CCCCCCCCCCHH-------HHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             4223--------362000489936-------7999999999529899899999999999
Q 002461          831 VRSI--------VDPRLEANFDTN-------SVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       831 l~~i--------iD~~l~~~~~~~-------~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                      ....        ............       ....+.+++.+|+..+|++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             34432034443320133445550334044459989999999987389658909999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-45  Score=297.31  Aligned_cols=260  Identities=21%  Similarity=0.237  Sum_probs=194.1

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEEE-EEEEEECCCEEEEEEEECC
Q ss_conf             53314120207479999997-699899999950589989133368999987403760316-8767633990899998346
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLAS-LVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv~-l~g~~~~~~~~~LV~E~~~  685 (919)
                      +.+.+.||+|+||.||+|.. .+|+.||||++....  ...++..|+++++.++|+|++. +.++....+..++|+|++.
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEECC
T ss_conf             999689850788099999998899899999972100--588899999999970389960179999951987789998738


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEEC---CCCCEEEECCCCCCCCCCCCC
Q ss_conf             88823442001234689676999999999999998816999935303643307858---898489960376423488878
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLN---EKMQAKLADFGFSKIFPAESE  762 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld---~~~~vkI~DFGla~~~~~~~~  762 (919)
                       ++|.+.+.. ....+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+|++|||+++.+.....
T Consensus        87 -~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          87 -PSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             -CBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             -CCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCC
T ss_conf             -713332443-0688768999999999999999999---79944266787660643357776156504675134255445


Q ss_pred             C-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCC
Q ss_conf             7-----43115545865337443247889941468999999999992999753487862000122332236874223362
Q 002461          763 S-----HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVDP  837 (919)
Q Consensus       763 ~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD~  837 (919)
                      .     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. . ..... ....+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~-~-~~~~~-~~~~~  238 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-I-SEKKM-STPIE  238 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH-H-HHHHH-HSCHH
T ss_pred             CCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHH-H-HCCCC-CCCHH
T ss_conf             541000135776787353299999189989832188617789999849876655305779999998-5-23567-89835


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             00048993679999999995298998999999999999999775
Q 002461          838 RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       838 ~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                      .+.    ......+.+++..|+..+|++||++.++.+.|+.+..
T Consensus       239 ~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         239 VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             753----4788999999999843995579199999999999999

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-44  Score=294.91  Aligned_cols=258  Identities=18%  Similarity=0.213  Sum_probs=200.3

Q ss_pred             HHHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             533141202074799999976-998999999505899891333689999874037-603168767633990899998346
Q 002461          608 NNFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH-RNLASLVGYCNDGGNVGLVYEYMA  685 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H-~NIv~l~g~~~~~~~~~LV~E~~~  685 (919)
                      +.+.+.||+|+||+||+|... +|+.||||+++...  ....+.+|++.+..++| +|++.+++++......++|+|++ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC-
T ss_conf             699799841788299999998899799999975025--82999999999999648999877999960188117999964-


Q ss_pred             CCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECC-----CCCEEEECCCCCCCCCCC
Q ss_conf             888234420012346896769999999999999988169999353036433078588-----984899603764234888
Q 002461          686 YGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNE-----KMQAKLADFGFSKIFPAE  760 (919)
Q Consensus       686 ~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~-----~~~vkI~DFGla~~~~~~  760 (919)
                      +++|.+++.. ....+++.....++.|++.||.|||   +.+++||||||+|||++.     ++.+||+|||+++.+...
T Consensus        84 ~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHH-HCCCHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCC
T ss_conf             8887999975-2031106899999999999999999---77966266771315234754344795687236605771467


Q ss_pred             CCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCH--HCCCCCCCCCCCCCC
Q ss_conf             787-----4311554586533744324788994146899999999999299975348786200--012233223687422
Q 002461          761 SES-----HISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHI--VNRVCPFLERGDVRS  833 (919)
Q Consensus       761 ~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~l--v~~v~~~~~~~~l~~  833 (919)
                      ...     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ...+.........  
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--  237 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL--  237 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH--
T ss_pred             CCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCH--
T ss_conf             665411102467627751026798964888886999898319999998698767885302199999999705679995--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             336200048993679999999995298998999999999999999775
Q 002461          834 IVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVTELKKCLE  881 (919)
Q Consensus       834 iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~~Le~~~~  881 (919)
                         +.+..    ..+..+.+++..|+..+|++||+++.+.+.|+++++
T Consensus       238 ---~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         238 ---RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             ---HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---HHHCC----CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf             ---89657----998999999999843993008599999999999999

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=294.89  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf             53314120207479999997-69989999995058998--9133368999987403760316876763399089999834
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYM  684 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~~~~LV~E~~  684 (919)
                      ++..+.||+|+||+||+|+. .+++.||||+++.....  ....+.+|+.+++.++|+||+++++++......+++++++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf             78626971286819999999999969999998032178689999999999998567578882135444443115886302


Q ss_pred             CCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf             68882344200123468967699999999999999881699993530364330785889848996037642348887874
Q 002461          685 AYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAESESH  764 (919)
Q Consensus       685 ~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~~~~  764 (919)
                      .++.|..++.  ..+.+++..+..++.|++.||+|||   +.+|+||||||+|||++.+..+||+|||.++......  .
T Consensus        84 ~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~  156 (292)
T d1unla_          84 DQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R  156 (292)
T ss_dssp             SEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--S
T ss_pred             CCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHH---CCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC--C
T ss_conf             3322211212--3565403678999999999987743---3998600146761211337826652046011046887--5


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCC---C---CCCCC-
Q ss_conf             311554586533744324788-994146899999999999299975348786200012233223687---4---22336-
Q 002461          765 ISTSIVGTVGYLDPEYYASNR-LTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD---V---RSIVD-  836 (919)
Q Consensus       765 ~~~~~~gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~---l---~~iiD-  836 (919)
                      ......++..|+|||.+.... ++.++||||+||++|||++|+.||..+.+..+....+........   .   ....+ 
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCC
T ss_conf             10010344310146675069888804440265418899851899998899999999999861189973551344322211


Q ss_pred             --------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --------20004899367999999999529899899999999999
Q 002461          837 --------PRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       837 --------~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                              ..-...........+.+++.+|++.+|++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             3344454431043306568999999999986499668909999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=297.85  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=196.2

Q ss_pred             HHHCCEECEECCEEEEEEEEC----CCCEEEEEEEECC----CCCCCHHHHHHHHHHHHCCC-CCEEEEEEEEECCCEEE
Q ss_conf             533141202074799999976----9989999995058----99891333689999874037-60316876763399089
Q 002461          608 NNFHRILGKGGFGTVYHGYLA----DGSEVAIKMLSAS----SSQGPKQFRTEAQLLMRVHH-RNLASLVGYCNDGGNVG  678 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~~----~g~~VAVK~l~~~----~~~~~~~f~~Ei~~L~~l~H-~NIv~l~g~~~~~~~~~  678 (919)
                      +++.+.||+|+||+||+|...    +|+.||+|+++..    .....+.+.+|+.++++++| +||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf             59998983287839999998765887948999998367721016899999999999986467983999620002487300


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf             99983468882344200123468967699999999999999881699993530364330785889848996037642348
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~  758 (919)
                      +++||+.+|+|.+++..  ...+.......++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.+.
T Consensus       106 ~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEECCCCCHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf             12312341179999873--045437888888999999998851---4998965477320124699988874132022203


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCC
Q ss_conf             88787431155458653374432478--8994146899999999999299975348786200012233223687422336
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASN--RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVRSIVD  836 (919)
Q Consensus       759 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~~iiD  836 (919)
                      .. .........|+..|+|||.+.+.  .++.++||||+||++|||++|+.||................ ...       
T Consensus       181 ~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-~~~-------  251 (322)
T d1vzoa_         181 AD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKS-------  251 (322)
T ss_dssp             GG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-HHC-------
T ss_pred             CC-CCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC-CCC-------
T ss_conf             44-443221222333331068760577688713251777799999976899988887777999999833-568-------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             20004899367999999999529899899999-----999999
Q 002461          837 PRLEANFDTNSVWKVAETAMECVPSISFQRPT-----MSHVVT  874 (919)
Q Consensus       837 ~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----m~eVv~  874 (919)
                         ....+......+.+++.+|+..+|++||+     ++|+++
T Consensus       252 ---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             ---9988654799999999997445898819997450999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-44  Score=293.88  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=192.6

Q ss_pred             HHHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCEEEEEEEEEC--CCEEEEEEE
Q ss_conf             753314120207479999997-699899999950589989133368999987403-7603168767633--990899998
Q 002461          607 TNNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCND--GGNVGLVYE  682 (919)
Q Consensus       607 t~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~-H~NIv~l~g~~~~--~~~~~LV~E  682 (919)
                      .+.+.+.||+|+||+||+|+. .+|+.||+|+++..   ..+++.+|+.+|+.++ ||||+++++++..  ....++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf             718978983174819999998899979999998889---99999999999985157998767999998168771268886


Q ss_pred             ECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCC-CEEEECCCCCCCCCCCC
Q ss_conf             34688823442001234689676999999999999998816999935303643307858898-48996037642348887
Q 002461          683 YMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM-QAKLADFGFSKIFPAES  761 (919)
Q Consensus       683 ~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~-~vkI~DFGla~~~~~~~  761 (919)
                      |+.+++|....     +.+++..+..++.|++.||.|||   +.+|+||||||+|||++.+. .+||+|||+++......
T Consensus       113 ~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         113 HVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             ECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf             31798589974-----68999999999999999998876---43344345644123774899836641565426646887


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCC---------C--
Q ss_conf             87431155458653374432478-89941468999999999992999753487862000122332236---------8--
Q 002461          762 ESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLER---------G--  829 (919)
Q Consensus       762 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~---------~--  829 (919)
                         ......+|..|+|||.+.+. .++.++||||+|++++||++|+.||....+..+....+......         .  
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf             ---44432248642476102688888845232335455587604889998876018999999998788415555542254


Q ss_pred             ----CCCCCC--------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----742233--------620004899367999999999529899899999999999
Q 002461          830 ----DVRSIV--------DPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       830 ----~l~~ii--------D~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                          ......        ...............+.+++.+|+..+|++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             447430000033343311211552112448999999999986699568908999964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=299.18  Aligned_cols=260  Identities=21%  Similarity=0.296  Sum_probs=190.4

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCEEEEEEEEECCC----EEEEEE
Q ss_conf             53314120207479999997-6998999999505899-89133368999987403760316876763399----089999
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG----NVGLVY  681 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~----~~~LV~  681 (919)
                      +...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.+|+.++|||++++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             59978994064809999999999949999998031095899999999999997689898858889950564554149999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             83468882344200123468967699999999999999881699993530364330785889848996037642348887
Q 002461          682 EYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPAES  761 (919)
Q Consensus       682 E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~~~  761 (919)
                      +++.+|+|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          90 THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEECCCCHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf             96259865664405---89999999999999999999999---7898677787643788799977875457056504777


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCCCC-------
Q ss_conf             8-743115545865337443247-8899414689999999999929997534878620001223322368742-------
Q 002461          762 E-SHISTSIVGTVGYLDPEYYAS-NRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGDVR-------  832 (919)
Q Consensus       762 ~-~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~l~-------  832 (919)
                      . ........|+..|+|||++.. ..++.++||||+||+++||++|+.||........ ..............       
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTCCC
T ss_pred             CCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHHHHHH
T ss_conf             6410101102652000387860478887410100467013377669799788888999-998765206997566423433


Q ss_pred             ----CC--CCCCCCC----CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----23--3620004----899367999999999529899899999999999
Q 002461          833 ----SI--VDPRLEA----NFDTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       833 ----~i--iD~~l~~----~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                          ..  ..+....    .........+.+++.+|+..+|++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2222024467755778777837899999999999976489567908999861

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-45  Score=296.09  Aligned_cols=258  Identities=24%  Similarity=0.287  Sum_probs=192.6

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEECCC------EEE
Q ss_conf             53314120207479999997-69989999995058998--9133368999987403760316876763399------089
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDGG------NVG  678 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~~------~~~  678 (919)
                      +...+.||+|+||+||+|.. .+|+.||||+++.....  ..+.+.+|+.+|+.++||||+++++++...+      +.+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEE
T ss_conf             89988980177819999999999989999998522259699999999999998668987547999863576555541599


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCC
Q ss_conf             99983468882344200123468967699999999999999881699993530364330785889848996037642348
Q 002461          679 LVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFP  758 (919)
Q Consensus       679 LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~  758 (919)
                      +|+||+ +.+|.....   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||+++...
T Consensus       100 lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             EEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEECC-CCCHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCC
T ss_conf             998405-521899987---402269999999999999999987---3787645668511112100122113431022068


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCCC-------
Q ss_conf             88787431155458653374432478-8994146899999999999299975348786200012233223687-------
Q 002461          759 AESESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERGD-------  830 (919)
Q Consensus       759 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~~-------  830 (919)
                      ..     .+...|+..|+|||.+.+. .++.++||||+||++|||++|++||........+.... .......       
T Consensus       173 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         173 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM-KVTGTPPAEFVQRL  246 (346)
T ss_dssp             SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HHHCCCCHHHHHTC
T ss_pred             CC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHH-HCCCCCCHHHHHHH
T ss_conf             76-----3102455333588998178789965010300389999997869988897689999998-50378848888653


Q ss_pred             -----------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf             -----------42233620004899367999999999529899899999999999--99997
Q 002461          831 -----------VRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKKC  879 (919)
Q Consensus       831 -----------l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~--~Le~~  879 (919)
                                 +.+.....+.. ........+.+++.+|+..+|.+|||+.|+++  .++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCHHHHHHHCCCCCCCCCCHHH-HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf             0003443311578666556677-556899999999999772995579299999639623758

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-44  Score=289.49  Aligned_cols=254  Identities=24%  Similarity=0.240  Sum_probs=191.8

Q ss_pred             HHCCEECEECCEEEEEEEEC-CCCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEEC------CCEEEE
Q ss_conf             33141202074799999976-9989999995058998--91333689999874037603168767633------990899
Q 002461          609 NFHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCND------GGNVGL  679 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~------~~~~~L  679 (919)
                      ...++||+|+||+||+|... +|+.||||+++.....  ....+.+|+.+++.++||||+++++++..      ..+.++
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEEE
T ss_conf             99889621758599999999999899999988233697999999999999986489876489989702564345762699


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf             99834688823442001234689676999999999999998816999935303643307858898489960376423488
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~  759 (919)
                      |+||+.++ +.+.+.    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.+..+|++|||+++....
T Consensus       100 v~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         100 VMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEECCCHH-HHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCC
T ss_conf             98414467-787650----38999999999999999998865---22112456776321136544313201023211466


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCC------------
Q ss_conf             87874311554586533744324788994146899999999999299975348786200012233223------------
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLE------------  827 (919)
Q Consensus       760 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~------------  827 (919)
                         ........+|..|+|||++.+..++.++||||+||+++||++|+.||....+.... ..+.....            
T Consensus       172 ---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         172 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHTTSCH
T ss_pred             ---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_conf             ---65533221465555813314777787743335662578986598998889778899-99997205898799987656


Q ss_pred             -------C------CCCCCCCCCCCCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -------6------874223362000489---9367999999999529899899999999999
Q 002461          828 -------R------GDVRSIVDPRLEANF---DTNSVWKVAETAMECVPSISFQRPTMSHVVT  874 (919)
Q Consensus       828 -------~------~~l~~iiD~~l~~~~---~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~  874 (919)
                             .      ......+........   .......+.+++.+|+..+|++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             677776417543566642126433354321013337999999999987699457908999966

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=286.32  Aligned_cols=258  Identities=21%  Similarity=0.249  Sum_probs=190.8

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCEEEEEEEEECC-----CEEEE
Q ss_conf             53314120207479999997-69989999995058998--913336899998740376031687676339-----90899
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQ--GPKQFRTEAQLLMRVHHRNLASLVGYCNDG-----GNVGL  679 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~L~~l~H~NIv~l~g~~~~~-----~~~~L  679 (919)
                      +...+.||+|+||+||+|.. .+|+.||||+++.....  ..+.+.+|+.+|+.++|+|++++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEE
T ss_conf             18888983178839999999999979999998820028689999999999998668987425999996346456686499


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCCCCC
Q ss_conf             99834688823442001234689676999999999999998816999935303643307858898489960376423488
Q 002461          680 VYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKIFPA  759 (919)
Q Consensus       680 V~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~~~~  759 (919)
                      +++++.+|+|.+++..   +.+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||++.....
T Consensus       100 i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCC
T ss_conf             9996258862320022---45309999999999999999997---38876516677633455432200132100012575


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHCCCCCCCCCC---------
Q ss_conf             8787431155458653374432478-899414689999999999929997534878620001223322368---------
Q 002461          760 ESESHISTSIVGTVGYLDPEYYASN-RLTEKSDVYSFGIVLLELITGLPAIIRGYNNTHIVNRVCPFLERG---------  829 (919)
Q Consensus       760 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~~lv~~v~~~~~~~---------  829 (919)
                           ......|+..|+|||...+. .++.++||||+||++|+|++|+.||...... .....+.......         
T Consensus       174 -----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         174 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             -----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTCC
T ss_pred             -----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHHHHCC
T ss_conf             -----4444345435558355337756785512432058999997688997889889-9999999730799757732001


Q ss_pred             ---------CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHH
Q ss_conf             ---------742233620004899367999999999529899899999999999--9999
Q 002461          830 ---------DVRSIVDPRLEANFDTNSVWKVAETAMECVPSISFQRPTMSHVVT--ELKK  878 (919)
Q Consensus       830 ---------~l~~iiD~~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eVv~--~Le~  878 (919)
                               .........+... .......+.+++.+|+..+|++|||+.|+++  .+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHCCCCCCCCHHHH-CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             0244544430355787555662-6789999999999977588345938999855995487

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-39  Score=261.07  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=188.1

Q ss_pred             HHHCCEECEECCEEEEEEEE-CCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-----------CCCEEEEEEEEEC--
Q ss_conf             53314120207479999997-699899999950589989133368999987403-----------7603168767633--
Q 002461          608 NNFHRILGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-----------HRNLASLVGYCND--  673 (919)
Q Consensus       608 ~~f~~~LG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~-----------H~NIv~l~g~~~~--  673 (919)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++... .....+.+|+.+++.++           |+||+++++++..  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf             799899750778189999999999799999983431-3368999999999984014555554227676478998763125


Q ss_pred             CCEEEEEEEECCCCC-HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCC------CE
Q ss_conf             990899998346888-23442001234689676999999999999998816999935303643307858898------48
Q 002461          674 GGNVGLVYEYMAYGN-LKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKM------QA  746 (919)
Q Consensus       674 ~~~~~LV~E~~~~Gs-L~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~------~v  746 (919)
                      .....++++++..+. ............+.+..+..++.|++.||.|||+  ..+|+||||||+|||++.++      .+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECCCCCCCCCEE
T ss_conf             65202343200035420000012234678689999999999999888764--0586465677057056305765644305


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC------CHHC
Q ss_conf             9960376423488878743115545865337443247889941468999999999992999753487862------0001
Q 002461          747 KLADFGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLLELITGLPAIIRGYNNT------HIVN  820 (919)
Q Consensus       747 kI~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ELltG~~p~~~~~~~~------~lv~  820 (919)
                      +++|||.+.....     ......|+..|+|||++....++.++||||+||+++||++|+.||.......      .+..
T Consensus       172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             EEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
T ss_conf             6753144212344-----54223665210571321466777643201237899999878899898755432102689999


Q ss_pred             CCCCCCCC------------------C----CCCCC----CCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf             22332236------------------8----74223----362--00048993679999999995298998999999999
Q 002461          821 RVCPFLER------------------G----DVRSI----VDP--RLEANFDTNSVWKVAETAMECVPSISFQRPTMSHV  872 (919)
Q Consensus       821 ~v~~~~~~------------------~----~l~~i----iD~--~l~~~~~~~~~~~l~~li~~Cl~~~P~~RPsm~eV  872 (919)
                      .+. .+..                  .    .+...    ...  .............+.+++.+|+..+|.+|||++|+
T Consensus       247 ~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         247 IIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHH-HHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf             999-8379987886245322000132012202432357764442100015674358999999999877994579089999


Q ss_pred             HH--HHHHH
Q ss_conf             99--99997
Q 002461          873 VT--ELKKC  879 (919)
Q Consensus       873 v~--~Le~~  879 (919)
                      ++  .+++.
T Consensus       326 L~Hp~f~~~  334 (362)
T d1q8ya_         326 VNHPWLKDT  334 (362)
T ss_dssp             HTCGGGTTC
T ss_pred             HCCCCCCCC
T ss_conf             669340789

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=4.6e-22  Score=153.10  Aligned_cols=170  Identities=16%  Similarity=0.209  Sum_probs=117.4

Q ss_pred             HHCCEECEECCEEEEEEEECCCCEEEEEEEECCCCC-----C-------------CHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf             331412020747999999769989999995058998-----9-------------1333689999874037603168767
Q 002461          609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQ-----G-------------PKQFRTEAQLLMRVHHRNLASLVGY  670 (919)
Q Consensus       609 ~f~~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~-----~-------------~~~f~~Ei~~L~~l~H~NIv~l~g~  670 (919)
                      .+.+.||+|+||+||+|...+|+.||||+++.....     .             ......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             EECCCEEEEEEEECCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEECCCCCEEEECCCCCEEEEC
Q ss_conf             63399089999834688823442001234689676999999999999998816999935303643307858898489960
Q 002461          671 CNDGGNVGLVYEYMAYGNLKQYLFDETKEALSWKDRLQIAVDAAQGLEYLHHGCKPPIIHRDVKTANILLNEKMQAKLAD  750 (919)
Q Consensus       671 ~~~~~~~~LV~E~~~~GsL~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~~~~iiH~DLKp~NILld~~~~vkI~D  750 (919)
                      ..    .+++||++++..+.+         ++......++.|+++++.|||   +.+++|+||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             CC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHEEEECC-CEEEEE
T ss_conf             28----889999504565420---------015789999999999999982---6888983689036114289-899987


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             37642348887874311554586533744324788994146899999999
Q 002461          751 FGFSKIFPAESESHISTSIVGTVGYLDPEYYASNRLTEKSDVYSFGIVLL  800 (919)
Q Consensus       751 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDVwSlGviL~  800 (919)
                      ||++...........   ....... -.+.+ ...+..++|+||..--++
T Consensus       146 FG~a~~~~~~~~~~~---l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREI---LERDVRN-IITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHH---HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCCCHHH---HHHHHHH-HHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf             788430899870999---9877999-99997-578998446899999874

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.84  E-value=2.4e-21  Score=148.62  Aligned_cols=126  Identities=27%  Similarity=0.431  Sum_probs=108.5

Q ss_pred             CCCHHHHHHHHHHHHHCCC---CCCCC-C-CCCCCCCCCEEEEECCCCCCCCCCEEEEEEECCCCCC--CCCCCCCCCCC
Q ss_conf             9996579999999986899---99999-9-9999988842388808999899958999910699732--16712228899
Q 002461          399 PTDQDDVNAIMDIKLSYDL---GKGWQ-G-DPCSPMYYSWDGLNCSYNGYKPPKIISLNLTSEGLTG--KISPSLSNLKS  471 (919)
Q Consensus       399 ~t~~~d~~al~~~k~~~~~---~~~W~-g-dpC~~~~~~W~gv~C~~~~~~~~~i~~l~L~~n~l~G--~ip~~~~~l~~  471 (919)
                      =|.++|++||++||+.+..   ..+|. + |+|.   +.|+||+|+..+ ...||+.|+|++++++|  .||+++++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~---~~w~gv~C~~~~-~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~   77 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN---RTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPY   77 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT---TCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC---CCCCCEEEECCC-CCEEEEEEECCCCCCCCCCCCCHHHHCCCC
T ss_conf             9898999999999997799986778899999988---948896974899-947988998989988888879847846753


Q ss_pred             CCEEECCC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             98897768-8556677945899997309994799888987642000023685432468
Q 002461          472 LENLDLSN-NSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIG  528 (919)
Q Consensus       472 L~~L~Ls~-N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls~~  528 (919)
                      |+.|+|++ |+++|.||.++++|++|++|+|++|++.|.+|..+..+..+..++++.+
T Consensus        78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N  135 (313)
T d1ogqa_          78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN  135 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf             3520202654333002431145420011020356434433222220111001111224

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.33  E-value=3.6e-13  Score=97.23  Aligned_cols=92  Identities=28%  Similarity=0.411  Sum_probs=79.4

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      ..+.+..++++++.+.|.+| +++.+++|+.|+|++|+|+|.||..+++|++|+.|+|++|+|+|.||. ++++.++.. 
T Consensus       219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~-  295 (313)
T d1ogqa_         219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV-  295 (313)
T ss_dssp             TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCG-
T ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCH-
T ss_conf             22221112222222222222-222455444444765706660876884799999897958835166898-666799897-


Q ss_pred             CCCCCCCCCCCCC--CCC
Q ss_conf             3246889898889--874
Q 002461          524 LLSIGRNPDLCLS--APC  539 (919)
Q Consensus       524 ~ls~~~N~~lc~~--~~c  539 (919)
                       +++.+|+.+||.  ++|
T Consensus       296 -l~l~~N~~l~g~plp~c  312 (313)
T d1ogqa_         296 -SAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             -GGTCSSSEEESTTSSCC
T ss_pred             -HHHCCCCCCCCCCCCCC
T ss_conf             -88688950019898898

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.28  E-value=7.2e-12  Score=89.02  Aligned_cols=99  Identities=23%  Similarity=0.244  Sum_probs=81.9

Q ss_pred             CCEEEEECCCCC------CCCCCEEEEEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             842388808999------899958999910699732167-1222889998897768855667794589999730999479
Q 002461          431 YSWDGLNCSYNG------YKPPKIISLNLTSEGLTGKIS-PSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDG  503 (919)
Q Consensus       431 ~~W~gv~C~~~~------~~~~~i~~l~L~~n~l~G~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~  503 (919)
                      |+|..|.|+..+      ..|+.++.|+|++|.|++.++ ..|.++++|+.|+|++|++.+..+..+..+++|+.|+|++
T Consensus         8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_           8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEEECCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf             76999997089967029898978788984898775530200257876272130136322121212221122221010035


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             98889876420000236854324688
Q 002461          504 NKLSGSVPTSLVARSQNGSLLLSIGR  529 (919)
Q Consensus       504 N~l~G~iP~~l~~~~~l~~l~ls~~~  529 (919)
                      |++++..|..+..++++..|+|+.+.
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~  113 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             CCCCCCCHHHHHCCCCCCCCCCCCCC
T ss_conf             53443497998079746552457745

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=2.6e-10  Score=79.22  Aligned_cols=107  Identities=27%  Similarity=0.358  Sum_probs=82.4

Q ss_pred             CCCCCCCCCEEEEECCCCCC--------CCCCEEEEEEECCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf             99999888423888089998--------99958999910699-7321671222889998897768855667794589999
Q 002461          424 DPCSPMYYSWDGLNCSYNGY--------KPPKIISLNLTSEG-LTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLP  494 (919)
Q Consensus       424 dpC~~~~~~W~gv~C~~~~~--------~~~~i~~l~L~~n~-l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~  494 (919)
                      +.|++.  .+++|+|+..+.        ..++++.|+|.+|+ |+..-+..|.+|++|+.|+|++|+|+.--|..|..++
T Consensus         3 ~~C~c~--~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~   80 (156)
T d2ifga3           3 DACCPH--GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP   80 (156)
T ss_dssp             SSSCCS--SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred             CCCCCC--CCCEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf             978869--999698528997658600257656574316898664436921225666667216202124774201112455


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             73099947998889876420000236854324688989888
Q 002461          495 LLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDLCL  535 (919)
Q Consensus       495 ~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls~~~N~~lc~  535 (919)
                      +|+.|+|++|+++ .+|.......++.  .+.+.+||.-|.
T Consensus        81 ~L~~L~Ls~N~l~-~l~~~~~~~~~l~--~L~L~~Np~~C~  118 (156)
T d2ifga3          81 RLSRLNLSFNALE-SLSWKTVQGLSLQ--ELVLSGNPLHCS  118 (156)
T ss_dssp             CCCEEECCSSCCS-CCCSTTTCSCCCC--EEECCSSCCCCC
T ss_pred             CCCCEECCCCCCC-CCCHHHHCCCCCC--CCCCCCCCCCCC
T ss_conf             4333322678785-1574563353212--433579863388

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.02  E-value=3e-10  Score=78.87  Aligned_cols=90  Identities=26%  Similarity=0.385  Sum_probs=78.3

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      ..++++.|+|++|.+.+..+..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+..++++..+
T Consensus        52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l  131 (192)
T d1w8aa_          52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL  131 (192)
T ss_dssp             GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred             CCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
T ss_conf             87627213013632212121222112222101003553443497998079746552457745353597785687533420


Q ss_pred             CCCCCCCCCCCC
Q ss_conf             324688989888
Q 002461          524 LLSIGRNPDLCL  535 (919)
Q Consensus       524 ~ls~~~N~~lc~  535 (919)
                        .+.+|+..|.
T Consensus       132 --~L~~N~~~~~  141 (192)
T d1w8aa_         132 --NLASNPFNCN  141 (192)
T ss_dssp             --ECTTCCBCCS
T ss_pred             --CCCCCCCCCC
T ss_conf             --0036443435

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=6.7e-10  Score=76.65  Aligned_cols=89  Identities=27%  Similarity=0.269  Sum_probs=69.1

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      ...++..|++++|.+.+..+..+..+++|+.|++++|++++..|..+..+++|+.|+|++|+|+ .+|..+..+.++.. 
T Consensus       122 ~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~-  199 (266)
T d1p9ag_         122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF-  199 (266)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE-
T ss_pred             CCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCE-
T ss_conf             2211112212434210221233322111000000015652237200134212423430139785-56866777888999-


Q ss_pred             CCCCCCCCCCCC
Q ss_conf             324688989888
Q 002461          524 LLSIGRNPDLCL  535 (919)
Q Consensus       524 ~ls~~~N~~lc~  535 (919)
                       +.+.+||+.|.
T Consensus       200 -L~L~~Np~~Cd  210 (266)
T d1p9ag_         200 -AFLHGNPWLCN  210 (266)
T ss_dssp             -EECCSCCBCCS
T ss_pred             -EEECCCCCCCC
T ss_conf             -98369998788

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.93  E-value=1.9e-09  Score=73.76  Aligned_cols=97  Identities=26%  Similarity=0.268  Sum_probs=79.1

Q ss_pred             EEEECCCCC------CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf             388808999------89995899991069973216712228899988977688556677945899997309994799888
Q 002461          434 DGLNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS  507 (919)
Q Consensus       434 ~gv~C~~~~------~~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~  507 (919)
                      .-|+|+..+      ..|+.++.|+|++|.|++..+..|.++++|+.|+|++|+|+ .+|. ++.+++|+.|+|++|+++
T Consensus        13 ~~v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~   90 (266)
T d1p9ag_          13 LEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ   90 (266)
T ss_dssp             CEEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS
T ss_pred             EEEECCCCCCCEECCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCC-CCCCCCCCCCCCCCCCCC
T ss_conf             69980699988619675768898988499289859778634565522135665444-4311-111223211111222221


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             98764200002368543246889898
Q 002461          508 GSVPTSLVARSQNGSLLLSIGRNPDL  533 (919)
Q Consensus       508 G~iP~~l~~~~~l~~l~ls~~~N~~l  533 (919)
                       .+|..+..++++..++++.+....+
T Consensus        91 -~~~~~~~~l~~L~~L~l~~~~~~~~  115 (266)
T d1p9ag_          91 -SLPLLGQTLPALTVLDVSFNRLTSL  115 (266)
T ss_dssp             -SCCCCTTTCTTCCEEECCSSCCCCC
T ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf             -1111212222222222222311011

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.91  E-value=5.2e-09  Score=71.07  Aligned_cols=84  Identities=29%  Similarity=0.376  Sum_probs=66.3

Q ss_pred             CCEEEEECCCCC------CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf             842388808999------89995899991069973216712228899988977688556677945899997309994799
Q 002461          431 YSWDGLNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN  504 (919)
Q Consensus       431 ~~W~gv~C~~~~------~~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N  504 (919)
                      |.|++|+|+..+      ..++.++.|+|++|+|+...+..|.++++|+.|++++|.+....|..+..+++|+.|+|++|
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n   89 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN   89 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             ECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCC
T ss_conf             55999985599988519888999798978499189869657604656523112344344523566527985578315687


Q ss_pred             CCCCCCCCCCC
Q ss_conf             88898764200
Q 002461          505 KLSGSVPTSLV  515 (919)
Q Consensus       505 ~l~G~iP~~l~  515 (919)
                      +++ .+|..+.
T Consensus        90 ~l~-~l~~~~~   99 (305)
T d1xkua_          90 QLK-ELPEKMP   99 (305)
T ss_dssp             CCS-BCCSSCC
T ss_pred             CCC-CCCCCHH
T ss_conf             567-6764001

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=1.3e-09  Score=74.83  Aligned_cols=89  Identities=24%  Similarity=0.251  Sum_probs=78.8

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99589999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      .+.++.|+|++|+|++..+..|.++++|+.|+|++|++++..|..+..+++|+.|++++|++.+..|..+..+.++..  
T Consensus       152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~--  229 (284)
T d1ozna_         152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY--  229 (284)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE--
T ss_pred             CCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCE--
T ss_conf             340502231417656625666546563413142114346628167665320002333335221000002355465688--


Q ss_pred             CCCCCCCCCCC
Q ss_conf             24688989888
Q 002461          525 LSIGRNPDLCL  535 (919)
Q Consensus       525 ls~~~N~~lc~  535 (919)
                      +.+++||..|.
T Consensus       230 L~l~~N~l~C~  240 (284)
T d1ozna_         230 LRLNDNPWVCD  240 (284)
T ss_dssp             EECCSSCEECS
T ss_pred             EEECCCCCCCC
T ss_conf             98119988787

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.72  E-value=1.7e-08  Score=67.79  Aligned_cols=82  Identities=30%  Similarity=0.385  Sum_probs=59.9

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCCCC
Q ss_conf             995899991069973216712228899988977688556677945899997309994799888987-6420000236854
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSV-PTSLVARSQNGSL  523 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~i-P~~l~~~~~l~~l  523 (919)
                      .+.++.|+|++|.|+ .+|+.++.+++|+.|+|++|.++ .+|. +..+++|+.|++++|+++... +..+..++++..+
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L   95 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL   95 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEE
T ss_conf             898898979787168-65215655431354532432112-3574-12335557688889865888882565379999999


Q ss_pred             CCCCCCCC
Q ss_conf             32468898
Q 002461          524 LLSIGRNP  531 (919)
Q Consensus       524 ~ls~~~N~  531 (919)
                      ++  .+|+
T Consensus        96 ~l--~~N~  101 (124)
T d1dcea3          96 NL--QGNS  101 (124)
T ss_dssp             EC--TTSG
T ss_pred             EC--CCCC
T ss_conf             89--7996

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.71  E-value=1.1e-08  Score=69.08  Aligned_cols=76  Identities=33%  Similarity=0.425  Sum_probs=65.3

Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99991069973216712228899988977688556677945899997309994799888987642000023685432468
Q 002461          449 ISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIG  528 (919)
Q Consensus       449 ~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls~~  528 (919)
                      +.|+|++|+++ .++ .+..|++|+.|||++|+++ .+|..++.+++|+.|++++|+++ .+| .+..++++..++++.+
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf             98986899898-871-0105898898979787168-65215655431354532432112-357-4123355576888898


Q ss_pred             C
Q ss_conf             8
Q 002461          529 R  529 (919)
Q Consensus       529 ~  529 (919)
                      .
T Consensus        76 ~   76 (124)
T d1dcea3          76 R   76 (124)
T ss_dssp             C
T ss_pred             C
T ss_conf             6

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=2.4e-08  Score=66.88  Aligned_cols=82  Identities=17%  Similarity=0.199  Sum_probs=61.4

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      .+.+++.|+|++|+|+ .|+..+..+++|+.|||++|.++ .++. +..+++|+.|+|++|+++...+..+..++++..|
T Consensus        16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCC-CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             8574848978899788-65762004145998989799787-6477-4457613064310213457776322334534434


Q ss_pred             CCCCC
Q ss_conf             32468
Q 002461          524 LLSIG  528 (919)
Q Consensus       524 ~ls~~  528 (919)
                      +++.+
T Consensus        93 ~L~~N   97 (162)
T d1a9na_          93 ILTNN   97 (162)
T ss_dssp             ECCSC
T ss_pred             EECCC
T ss_conf             20300

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=3.5e-08  Score=65.89  Aligned_cols=85  Identities=19%  Similarity=0.176  Sum_probs=66.1

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      ....+..+++++|.|++..+..|..+++|+.|+|++|++++..|..+..+++|+.+++++|++++..|..+..++++..+
T Consensus       127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L  206 (284)
T d1ozna_         127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL  206 (284)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             HHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCC
T ss_conf             00012110200143144580574043405022314176566256665465634131421143466281676653200023


Q ss_pred             CCCCC
Q ss_conf             32468
Q 002461          524 LLSIG  528 (919)
Q Consensus       524 ~ls~~  528 (919)
                      +++.+
T Consensus       207 ~l~~N  211 (284)
T d1ozna_         207 YLFAN  211 (284)
T ss_dssp             ECCSS
T ss_pred             CCCCC
T ss_conf             33335

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=7.4e-07  Score=57.52  Aligned_cols=132  Identities=14%  Similarity=0.119  Sum_probs=90.6

Q ss_pred             EEC-CEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCEEEEEEEEECCCEEEEEEEECCCCCHHHHH
Q ss_conf             207-479999997699899999950589989133368999987403-760316876763399089999834688823442
Q 002461          616 KGG-FGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVH-HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL  693 (919)
Q Consensus       616 ~G~-fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~-H~NIv~l~g~~~~~~~~~LV~E~~~~GsL~~~L  693 (919)
                      +|. ...||+... +++.+.+|+...........+.+|...++.+. +-.+.+++++....+..++|+++.++.++.+..
T Consensus        23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~  101 (263)
T d1j7la_          23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY  101 (263)
T ss_dssp             CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred             CCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCC
T ss_conf             8998771899990-898699998488765325569999999998760699872899975089649999860433435433


Q ss_pred             HCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------------
Q ss_conf             0012346896769999999999999988169-------------------------------------------------
Q 002461          694 FDETKEALSWKDRLQIAVDAAQGLEYLHHGC-------------------------------------------------  724 (919)
Q Consensus       694 ~~~~~~~ls~~~~~~ia~qia~aL~yLH~~~-------------------------------------------------  724 (919)
                      .       +......++.++++.++.||+..                                                 
T Consensus       102 ~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         102 E-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             T-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             C-------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
T ss_conf             4-------402699999989999999855684214357644656555778998776555543033232005799999999


Q ss_pred             -------CCCEEEECCCCCEEEECCCCCEEEECCCCCC
Q ss_conf             -------9993530364330785889848996037642
Q 002461          725 -------KPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       725 -------~~~iiH~DLKp~NILld~~~~vkI~DFGla~  755 (919)
                             ...++|+|+.+.|||++++....|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             84498678178986004764236499659996023144

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.61  E-value=4.2e-08  Score=65.33  Aligned_cols=86  Identities=23%  Similarity=0.334  Sum_probs=65.5

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCC-CC------CC
Q ss_conf             995899991069973216712228899988977688556677945899997309994799888987642-00------00
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTS-LV------AR  517 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~-l~------~~  517 (919)
                      .+.++.|++++|.+.+..+..+.++++|+.|+|++|+|+ .||..+..+++|+.|+|++|+++ .|+.. +.      .+
T Consensus       194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~  271 (305)
T d1xkua_         194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK  271 (305)
T ss_dssp             CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCHHCCC
T ss_conf             341330154455332223454334433224302554002-46311033467898989898657-6381002672100215


Q ss_pred             CCCCCCCCCCCCCCCCC
Q ss_conf             23685432468898988
Q 002461          518 SQNGSLLLSIGRNPDLC  534 (919)
Q Consensus       518 ~~l~~l~ls~~~N~~lc  534 (919)
                      ..+.  .+.+.+||.-+
T Consensus       272 ~~L~--~L~L~~N~~~~  286 (305)
T d1xkua_         272 ASYS--GVSLFSNPVQY  286 (305)
T ss_dssp             CCCS--EEECCSSSSCG
T ss_pred             CCCC--EEECCCCCCCC
T ss_conf             8889--78898995766

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.59  E-value=2.7e-08  Score=66.57  Aligned_cols=76  Identities=24%  Similarity=0.305  Sum_probs=64.1

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99589999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      .+.++.|+|++|++++. + .+..+++|+.|+|++|+++ .+| .+.++++|+.|+|++|++++.+|  +.+++++..|+
T Consensus       306 ~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~  379 (384)
T d2omza2         306 LKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  379 (384)
T ss_dssp             CTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred             HCCCCEEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEE
T ss_conf             02467677778877898-4-5366898898989899899-974-67089999989897995899800--00399999963


Q ss_pred             CC
Q ss_conf             24
Q 002461          525 LS  526 (919)
Q Consensus       525 ls  526 (919)
                      ++
T Consensus       380 L~  381 (384)
T d2omza2         380 LN  381 (384)
T ss_dssp             CC
T ss_pred             CC
T ss_conf             97

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.36  E-value=6.2e-07  Score=58.00  Aligned_cols=74  Identities=31%  Similarity=0.360  Sum_probs=39.9

Q ss_pred             CEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             58999910699732167122288999889776885566779458999973099947998889876420000236854324
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLS  526 (919)
Q Consensus       447 ~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls  526 (919)
                      .+..+.+..|.+.+  ...+..+++++.|+|++|++++ ++. +..+++|+.|+|++|++++ +| .+..+++++.|+++
T Consensus       286 ~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~  359 (384)
T d2omza2         286 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAG  359 (384)
T ss_dssp             TCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECC
T ss_pred             CCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCC-CCC-CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECC
T ss_conf             22223323233333--2210000246767777887789-845-3668988989898998999-74-67089999989897

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.32  E-value=2.3e-07  Score=60.78  Aligned_cols=82  Identities=26%  Similarity=0.289  Sum_probs=64.7

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCEEEECCCCCCCCCCC--CCCCCCCCCC
Q ss_conf             995899991069973216712228899988977688556677945-8999973099947998889876--4200002368
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEF-LSQLPLLRVLNLDGNKLSGSVP--TSLVARSQNG  521 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-l~~l~~L~~L~Ls~N~l~G~iP--~~l~~~~~l~  521 (919)
                      .+.++.|+|++|.|+ .++ .+..|++|+.|+|++|+++. +|.. +..+++|+.|+|++|+++ .++  ..+..++++.
T Consensus        40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~  115 (162)
T d1a9na_          40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT  115 (162)
T ss_dssp             TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC
T ss_pred             CCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCC-CCCCCCCCCCCCCCCEECCCCCC-CCCCCCCCCCCCCCC
T ss_conf             145998989799787-647-74457613064310213457-77632233453443420300016-654211001365320


Q ss_pred             CCCCCCCCCCC
Q ss_conf             54324688989
Q 002461          522 SLLLSIGRNPD  532 (919)
Q Consensus       522 ~l~ls~~~N~~  532 (919)
                      .+.  +.+|+-
T Consensus       116 ~L~--l~~N~i  124 (162)
T d1a9na_         116 YLC--ILRNPV  124 (162)
T ss_dssp             EEE--CCSSGG
T ss_pred             HHH--CCCCCC
T ss_conf             664--079963

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.31  E-value=4.3e-07  Score=58.99  Aligned_cols=77  Identities=25%  Similarity=0.341  Sum_probs=62.1

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420000236854
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSL  523 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l  523 (919)
                      ..++++.|++++|.+.+..  .+.++++|+.|+|++|++++ +|. ++.+++|+.|+|++|++++ +| .+.+++.+..|
T Consensus       149 ~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L  222 (227)
T d1h6ua2         149 GLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIV  222 (227)
T ss_dssp             GCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEE
T ss_pred             CCCCCCCCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCC-CHH-HCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCEE
T ss_conf             0211100233333333100--10564633564458884177-853-4479999989795996899-80-20369998989


Q ss_pred             CCC
Q ss_conf             324
Q 002461          524 LLS  526 (919)
Q Consensus       524 ~ls  526 (919)
                      +++
T Consensus       223 ~ls  225 (227)
T d1h6ua2         223 TLT  225 (227)
T ss_dssp             EEE
T ss_pred             EEE
T ss_conf             712

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.29  E-value=6.1e-06  Score=51.76  Aligned_cols=130  Identities=15%  Similarity=0.097  Sum_probs=83.8

Q ss_pred             EECEECC-EEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCC--CEEEEEEEEECCCEEEEEEEECCCCCH
Q ss_conf             1202074-7999999769989999995058998913336899998740376--031687676339908999983468882
Q 002461          613 ILGKGGF-GTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHR--NLASLVGYCNDGGNVGLVYEYMAYGNL  689 (919)
Q Consensus       613 ~LG~G~f-G~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~--NIv~l~g~~~~~~~~~LV~E~~~~GsL  689 (919)
                      .+..|.. ..||+....++..+++|.....   ....+..|...++.+...  .+.++++++.+.+..++|++++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             767865477589999389878999958966---77689999999999986599988613222456615999874413554


Q ss_pred             HHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q ss_conf             34420012346896769999999999999988------------------------------------------------
Q 002461          690 KQYLFDETKEALSWKDRLQIAVDAAQGLEYLH------------------------------------------------  721 (919)
Q Consensus       690 ~~~L~~~~~~~ls~~~~~~ia~qia~aL~yLH------------------------------------------------  721 (919)
                      .+...       .   ....+.++++.|+-||                                                
T Consensus        94 ~~~~~-------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          94 LSSHL-------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTSCC-------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             CCCCC-------C---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf             32212-------6---8999999999999873688544887554124688999999875411011340112137999999


Q ss_pred             ---HC----CCCCEEEECCCCCEEEECCCCCEEEECCCCCC
Q ss_conf             ---16----99993530364330785889848996037642
Q 002461          722 ---HG----CKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       722 ---~~----~~~~iiH~DLKp~NILld~~~~vkI~DFGla~  755 (919)
                         ..    ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             99871876579567867888763577379658999853326

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=6e-07  Score=58.09  Aligned_cols=97  Identities=23%  Similarity=0.264  Sum_probs=65.6

Q ss_pred             CCEEEEECCCCC------CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEEECC-
Q ss_conf             842388808999------8999589999106997321671222889998897768855667794-58999973099947-
Q 002461          431 YSWDGLNCSYNG------YKPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLD-  502 (919)
Q Consensus       431 ~~W~gv~C~~~~------~~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~Ls-  502 (919)
                      |.+..|.|+..+      ..+..++.|+|++|.|+...+..|.++++|+.|+|++|.+...+|. .+..++.++.+.+. 
T Consensus         8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1           8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf             73999998189988768888998899987699189649668614643232110221124201001122222222211111


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             9988898764200002368543246
Q 002461          503 GNKLSGSVPTSLVARSQNGSLLLSI  527 (919)
Q Consensus       503 ~N~l~G~iP~~l~~~~~l~~l~ls~  527 (919)
                      .|++....+..+..++++..+.++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~  112 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISN  112 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEES
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf             2343222222122222222223421

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.19  E-value=1.7e-06  Score=55.22  Aligned_cols=79  Identities=23%  Similarity=0.207  Sum_probs=54.4

Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCC-CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             9991069973216712228899988977688-5566779-4589999730999479988898764200002368543246
Q 002461          450 SLNLTSEGLTGKISPSLSNLKSLENLDLSNN-SLTGSIP-EFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSI  527 (919)
Q Consensus       450 ~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N-~l~g~iP-~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls~  527 (919)
                      .++.+++++. .+|..+..+++|+.|+|++| .++ .|| ..|.++++|+.|+|++|+++...|..+..+++++.|+|+.
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-CCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf             6985289976-586002576565743168986644-36921225666667216202124774201112455433332267


Q ss_pred             CCC
Q ss_conf             889
Q 002461          528 GRN  530 (919)
Q Consensus       528 ~~N  530 (919)
                      +.-
T Consensus        90 N~l   92 (156)
T d2ifga3          90 NAL   92 (156)
T ss_dssp             SCC
T ss_pred             CCC
T ss_conf             878

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.09  E-value=4.7e-06  Score=52.47  Aligned_cols=73  Identities=30%  Similarity=0.382  Sum_probs=28.1

Q ss_pred             CEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             5899991069973216712228899988977688556677945899997309994799888987642000023685432
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLL  525 (919)
Q Consensus       447 ~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~l  525 (919)
                      .+..++++.|.+++  +..+.++++|+.+++++|++++ +++ +.++++|+.|+|++|+++ .+| .+..+++++.|++
T Consensus       135 ~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~L  207 (210)
T d1h6ta2         135 QLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLEL  207 (210)
T ss_dssp             TCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEE
T ss_pred             CCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEEC
T ss_conf             12221122233345--4310001332100134643025-645-367898999989799899-872-1169999899971

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.07  E-value=4.4e-06  Score=52.66  Aligned_cols=71  Identities=28%  Similarity=0.305  Sum_probs=30.3

Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             89999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          448 IISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       448 i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      ++.|+++++.+.. ++ .+..+++|+.|+|++|++++ +|. ++.+++|+.|++++|++++ +| .+..++++..+.
T Consensus        48 L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          48 IDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             CCEEECCCCCCCC-CH-HHHHCCCCCEEECCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf             4589782798887-44-47648998987698960258-601-1358621201433333212-22-121222111223

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.05  E-value=7.1e-06  Score=51.35  Aligned_cols=58  Identities=36%  Similarity=0.563  Sum_probs=28.8

Q ss_pred             CCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf             95899991069973216712228899988977688556677945899997309994799888
Q 002461          446 PKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS  507 (919)
Q Consensus       446 ~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~  507 (919)
                      ++++.|++++|.+. .++ .+..+++|+.|++++|++++ +++ ++++++|+.|+|++|+++
T Consensus       128 ~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~~-l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         128 TNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LKP-LANLTTLERLDISSNKVS  185 (199)
T ss_dssp             TTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred             HHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCC
T ss_conf             23677643111100-234-33321111112234555567-701-167998999978799799

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=0.00015  Score=43.03  Aligned_cols=76  Identities=18%  Similarity=0.169  Sum_probs=48.4

Q ss_pred             CEECEECCEEEEEEEECC-CCEEEEEEEECC-------CCCCCHHHHHHHHHHHHCC-C--CCEEEEEEEEECCCEEEEE
Q ss_conf             412020747999999769-989999995058-------9989133368999987403-7--6031687676339908999
Q 002461          612 RILGKGGFGTVYHGYLAD-GSEVAIKMLSAS-------SSQGPKQFRTEAQLLMRVH-H--RNLASLVGYCNDGGNVGLV  680 (919)
Q Consensus       612 ~~LG~G~fG~Vyka~~~~-g~~VAVK~l~~~-------~~~~~~~f~~Ei~~L~~l~-H--~NIv~l~g~~~~~~~~~LV  680 (919)
                      +.||.|....||+....+ ++.+++|.-...       -.....+...|.+.|+.+. +  ..+.+++.+.  ....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEEE
T ss_conf             98079852768999957998489996177130346777888778999999999986505798855289985--9887798


Q ss_pred             EEECCCCCH
Q ss_conf             983468882
Q 002461          681 YEYMAYGNL  689 (919)
Q Consensus       681 ~E~~~~GsL  689 (919)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EECCCCCCC
T ss_conf             713577653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.90  E-value=1.2e-05  Score=49.88  Aligned_cols=62  Identities=29%  Similarity=0.405  Sum_probs=50.4

Q ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf             99958999910699732167122288999889776885566779458999973099947998889876420
Q 002461          444 KPPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL  514 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l  514 (919)
                      .++.++.|+|++|.|+ .+|..   +++|+.|+|++|+|+ .||..   +++|+.|+|++|+++ .+|...
T Consensus       282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~  343 (353)
T d1jl5a_         282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP  343 (353)
T ss_dssp             CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC
T ss_pred             CCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCC
T ss_conf             6898898979799168-35665---487998989999687-54532---288898987699189-777652

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.88  E-value=2.4e-05  Score=48.07  Aligned_cols=57  Identities=26%  Similarity=0.462  Sum_probs=23.0

Q ss_pred             CEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf             5899991069973216712228899988977688556677945899997309994799888
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLS  507 (919)
Q Consensus       447 ~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~  507 (919)
                      .++.|++++++++ .++ .+..|++|+.|+|++|++++ +++ +.++++|+.|++++|.+.
T Consensus        41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred             CCCEEECCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCC
T ss_conf             8789989999997-752-02137886757545655667-640-167752231111222222

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.77  E-value=6e-05  Score=45.56  Aligned_cols=73  Identities=33%  Similarity=0.420  Sum_probs=47.2

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99589999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      +......++..+.+.+. +   ..+++|+.|+|++|+|+ .||..   +++|+.|+|++|+++ .+|..+.   +++.|+
T Consensus       263 ~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~~---~L~~L~  330 (353)
T d1jl5a_         263 PPNLYYLNASSNEIRSL-C---DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQ---NLKQLH  330 (353)
T ss_dssp             CTTCCEEECCSSCCSEE-C---CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCT---TCCEEE
T ss_pred             CCHHCCCCCCCCCCCCC-C---CCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCCC---CCCEEE
T ss_conf             30001233335753234-5---66898898979799168-35665---487998989999687-5453228---889898


Q ss_pred             CCCCCCC
Q ss_conf             2468898
Q 002461          525 LSIGRNP  531 (919)
Q Consensus       525 ls~~~N~  531 (919)
                      +  .+|+
T Consensus       331 L--~~N~  335 (353)
T d1jl5a_         331 V--EYNP  335 (353)
T ss_dssp             C--CSSC
T ss_pred             C--CCCC
T ss_conf             7--6991

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.75  E-value=2e-07  Score=61.08  Aligned_cols=79  Identities=23%  Similarity=0.252  Sum_probs=56.8

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99589999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      ...++.|+|++|+|+ .++ .+..|++|+.|+|++|.++ .+|.....+++|+.|++++|+++. ++ .+..++++..|+
T Consensus        47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~  121 (198)
T d1m9la_          47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred             CCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCC
T ss_conf             604615199446899-864-4247825357341353432-100003322123333333322222-22-222222341112


Q ss_pred             CCCC
Q ss_conf             2468
Q 002461          525 LSIG  528 (919)
Q Consensus       525 ls~~  528 (919)
                      ++.+
T Consensus       122 L~~N  125 (198)
T d1m9la_         122 MSNN  125 (198)
T ss_dssp             ESEE
T ss_pred             CCCC
T ss_conf             3410

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.66  E-value=7.1e-05  Score=45.08  Aligned_cols=72  Identities=24%  Similarity=0.335  Sum_probs=27.8

Q ss_pred             CEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             589999106997321671222889998897768855667794589999730999479988898764200002368543
Q 002461          447 KIISLNLTSEGLTGKISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLL  524 (919)
Q Consensus       447 ~i~~l~L~~n~l~G~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~  524 (919)
                      .+..+.++.+.+....  .+.++++|+.|++++|.+++ ++. +.++++|+.|+|++|++++ +|. +..++++..|+
T Consensus       130 ~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~-~~~-l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~  201 (227)
T d1h6ua2         130 NLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVH  201 (227)
T ss_dssp             TCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred             CHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCC-CHH-HCCCCCCEECCCCCCCCCC-CHH-HCCCCCCCEEE
T ss_conf             0122200000000000--00102111002333333331-001-0564633564458884177-853-44799999897

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.50  E-value=3.2e-06  Score=53.54  Aligned_cols=63  Identities=30%  Similarity=0.394  Sum_probs=40.8

Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             167122288999889776885566779458999973099947998889876420000236854324
Q 002461          461 KISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLS  526 (919)
Q Consensus       461 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls  526 (919)
                      .++.++..|++|+.|+|++|+++ .|+ .+..+++|+.|+|++|+++ .+|......+.+..|+++
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~  101 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECS
T ss_pred             HHHHHHHCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf             02467762604615199446899-864-4247825357341353432-100003322123333333

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.44  E-value=0.00013  Score=43.43  Aligned_cols=78  Identities=17%  Similarity=0.175  Sum_probs=48.8

Q ss_pred             CCCEEEEEEECCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCCC-CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             9958999910699732167122288999889-7768855667794-5899997309994799888987642000023685
Q 002461          445 PPKIISLNLTSEGLTGKISPSLSNLKSLENL-DLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGS  522 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~-~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~  522 (919)
                      +..+..|++.+|+++ .++....+.+++..+ ++++|+++ .||. .+.++++|+.|+|++|+++...+..+.++..+..
T Consensus       152 ~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  229 (242)
T d1xwdc1         152 SFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  229 (242)
T ss_dssp             BSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred             CCCCEEEECCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCC-CCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCC
T ss_conf             331001220012333-322222220111012123543246-424788668999998989799289459779737713414


Q ss_pred             CC
Q ss_conf             43
Q 002461          523 LL  524 (919)
Q Consensus       523 l~  524 (919)
                      ++
T Consensus       230 l~  231 (242)
T d1xwdc1         230 RS  231 (242)
T ss_dssp             SS
T ss_pred             CC
T ss_conf             76

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.44  E-value=0.0014  Score=36.99  Aligned_cols=157  Identities=13%  Similarity=0.126  Sum_probs=85.2

Q ss_pred             CCCHHHHHHHHHHHC-----CEEC-EECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCE--EEEE
Q ss_conf             448879999875331-----4120-2074799999976998999999505899891333689999874037603--1687
Q 002461          597 QFTYSEIVDITNNFH-----RILG-KGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL--ASLV  668 (919)
Q Consensus       597 ~~~~~el~~~t~~f~-----~~LG-~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NI--v~l~  668 (919)
                      .++.+.+..+.....     +++- .+.--.||++...+|..+++|+.+.. ....+++..|...+..+....+  +..+
T Consensus         7 ~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~   85 (325)
T d1zyla1           7 TLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPV   85 (325)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCE
T ss_conf             669799999999759997757232566120269998389997999984787-7889999999999999985599878752


Q ss_pred             E-----EEECCCEEEEEEEECCCCCHHH-----H---------HHCC-------CCCCCCH-------------------
Q ss_conf             6-----7633990899998346888234-----4---------2001-------2346896-------------------
Q 002461          669 G-----YCNDGGNVGLVYEYMAYGNLKQ-----Y---------LFDE-------TKEALSW-------------------  703 (919)
Q Consensus       669 g-----~~~~~~~~~LV~E~~~~GsL~~-----~---------L~~~-------~~~~ls~-------------------  703 (919)
                      .     .....+..+.++++.++..+..     +         ++..       .+..+++                   
T Consensus        86 ~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~  165 (325)
T d1zyla1          86 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  165 (325)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ECCCCEEEEEEEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCH
T ss_conf             06898056653479999865277688999999999989999998863035786556778978876656899987476998


Q ss_pred             HHHHHHHHHHHHHHHHHH----HCCCCCEEEECCCCCEEEECCCCCEEEECCCCCCC
Q ss_conf             769999999999999988----16999935303643307858898489960376423
Q 002461          704 KDRLQIAVDAAQGLEYLH----HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSKI  756 (919)
Q Consensus       704 ~~~~~ia~qia~aL~yLH----~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~~  756 (919)
                      ..+..+...+.+.+..+.    .....+++|+|+.+.|||++++  ..++||+-+..
T Consensus       166 ~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         166 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             89899999999999999984545687120247888042878389--35886520146

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.22  E-value=1.1e-05  Score=50.19  Aligned_cols=71  Identities=28%  Similarity=0.270  Sum_probs=40.5

Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             1671222889998897768855667--794589999730999479988898764200002368543246889898
Q 002461          461 KISPSLSNLKSLENLDLSNNSLTGS--IPEFLSQLPLLRVLNLDGNKLSGSVPTSLVARSQNGSLLLSIGRNPDL  533 (919)
Q Consensus       461 ~ip~~~~~l~~L~~L~Ls~N~l~g~--iP~~l~~l~~L~~L~Ls~N~l~G~iP~~l~~~~~l~~l~ls~~~N~~l  533 (919)
                      .++....++++|+.|+|++|+++..  ++..+..+++|+.|+|++|.++ .+++ +..+.......+.+.+||-.
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~-l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERE-LDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGG-HHHHTTCCCSSCCCTTSTTS
T ss_pred             HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHH-HHHHHCCCCCEEECCCCCCC
T ss_conf             6078897487878863777666677315889865885610004357213-4234-42220331042664899767

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.19  E-value=0.0036  Score=34.36  Aligned_cols=73  Identities=16%  Similarity=0.276  Sum_probs=48.3

Q ss_pred             CEECEECCEEEEEEEECCC--------CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCE-EEEEEEEECCCEEEEEEE
Q ss_conf             4120207479999997699--------8999999505899891333689999874037603-168767633990899998
Q 002461          612 RILGKGGFGTVYHGYLADG--------SEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL-ASLVGYCNDGGNVGLVYE  682 (919)
Q Consensus       612 ~~LG~G~fG~Vyka~~~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NI-v~l~g~~~~~~~~~LV~E  682 (919)
                      +.|+.|-.-.+|++...++        ..+.+++.. . ........+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             991785334348999688775445789817999659-9-61165899999999999757999808998189----56999


Q ss_pred             ECCCCCHH
Q ss_conf             34688823
Q 002461          683 YMAYGNLK  690 (919)
Q Consensus       683 ~~~~GsL~  690 (919)
                      |+++.++.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EECCCCCC
T ss_conf             73455488

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.99  E-value=9.2e-05  Score=44.37  Aligned_cols=17  Identities=35%  Similarity=0.450  Sum_probs=7.0

Q ss_pred             CCCCCCCCEEECCCCCC
Q ss_conf             22889998897768855
Q 002461          466 LSNLKSLENLDLSNNSL  482 (919)
Q Consensus       466 ~~~l~~L~~L~Ls~N~l  482 (919)
                      +..+++|+.|||++|.+
T Consensus        51 L~~~~~L~~LdLs~N~i   67 (460)
T d1z7xw1          51 LRVNPALAELNLRSNEL   67 (460)
T ss_dssp             HHTCTTCCEEECTTCCC
T ss_pred             HHCCCCCCEEECCCCCC
T ss_conf             85399988897959859

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.81  E-value=5.9e-05  Score=45.59  Aligned_cols=84  Identities=27%  Similarity=0.281  Sum_probs=54.6

Q ss_pred             CCCCEEEEEEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCC-CCCCC-CCCCCCCCCCC
Q ss_conf             999589999106997321-6712228899988977688556677945899997309994799-88898-76420000236
Q 002461          444 KPPKIISLNLTSEGLTGK-ISPSLSNLKSLENLDLSNNSLTGSIPEFLSQLPLLRVLNLDGN-KLSGS-VPTSLVARSQN  520 (919)
Q Consensus       444 ~~~~i~~l~L~~n~l~G~-ip~~~~~l~~L~~L~Ls~N~l~g~iP~~l~~l~~L~~L~Ls~N-~l~G~-iP~~l~~~~~l  520 (919)
                      .+.+++.|+|+++.++.. +..-+.++++|+.|+|+++.+++..+..++.+++|+.|+|+++ .++.. +..-...++++
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             CCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf             67878878898984577799999974877651452346798678999851899757151001341235540365788743


Q ss_pred             CCCCCCC
Q ss_conf             8543246
Q 002461          521 GSLLLSI  527 (919)
Q Consensus       521 ~~l~ls~  527 (919)
                      +.|+++.
T Consensus       124 ~~L~ls~  130 (284)
T d2astb2         124 DELNLSW  130 (284)
T ss_dssp             CEEECCC
T ss_pred             CCCCCCC
T ss_conf             5652245

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.79  E-value=0.011  Score=31.25  Aligned_cols=155  Identities=11%  Similarity=0.075  Sum_probs=81.3

Q ss_pred             CCHHHHHHHHHHH--C-----CEECEECCEEEEEEEECCCCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCEE--EEE
Q ss_conf             4887999987533--1-----412020747999999769989999995058998913336899998740376031--687
Q 002461          598 FTYSEIVDITNNF--H-----RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA--SLV  668 (919)
Q Consensus       598 ~~~~el~~~t~~f--~-----~~LG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~L~~l~H~NIv--~l~  668 (919)
                      ++.+|+.....++  .     +.|..|---+.|+....+| .+++|+.....  ...+...|...+..+...++.  ..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             8999999999867999856852378885267389997897-28999807899--98899999999875430255545564


Q ss_pred             E------EEECCCEEEEEEEECCCCCHHHHH--------------HCCC-------------------------CCCCCH
Q ss_conf             6------763399089999834688823442--------------0012-------------------------346896
Q 002461          669 G------YCNDGGNVGLVYEYMAYGNLKQYL--------------FDET-------------------------KEALSW  703 (919)
Q Consensus       669 g------~~~~~~~~~LV~E~~~~GsL~~~L--------------~~~~-------------------------~~~ls~  703 (919)
                      -      ..........++.+..+......-              +...                         ......
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHH-HCCCCCEEEECCCCCEEEECCCCCEEEECCCCCC
Q ss_conf             769999999999999988-1699993530364330785889848996037642
Q 002461          704 KDRLQIAVDAAQGLEYLH-HGCKPPIIHRDVKTANILLNEKMQAKLADFGFSK  755 (919)
Q Consensus       704 ~~~~~ia~qia~aL~yLH-~~~~~~iiH~DLKp~NILld~~~~vkI~DFGla~  755 (919)
                      ......+......+...+ .....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             12799999998764204855454503337863656402045412674222123

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.78  E-value=0.0005  Score=39.76  Aligned_cols=80  Identities=24%  Similarity=0.217  Sum_probs=38.9

Q ss_pred             CCEEEEEEECC--CCCCC-CCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCEEEECCC-CCCCCCCCCCCCCCCCC
Q ss_conf             95899991069--97321-6712228899988977688-55667794589999730999479-98889876420000236
Q 002461          446 PKIISLNLTSE--GLTGK-ISPSLSNLKSLENLDLSNN-SLTGSIPEFLSQLPLLRVLNLDG-NKLSGSVPTSLVARSQN  520 (919)
Q Consensus       446 ~~i~~l~L~~n--~l~G~-ip~~~~~l~~L~~L~Ls~N-~l~g~iP~~l~~l~~L~~L~Ls~-N~l~G~iP~~l~~~~~l  520 (919)
                      +.++.|+|++.  +++.. +..-+.++++|+.|+|+++ .+++..+..+..+++|++|+|++ +.+++.....+.+++++
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCC
T ss_conf             11101221355424444434342323222123553223477830333321357687798999997873789997269998


Q ss_pred             CCCCC
Q ss_conf             85432
Q 002461          521 GSLLL  525 (919)
Q Consensus       521 ~~l~l  525 (919)
                      ..|++
T Consensus       228 ~~L~l  232 (284)
T d2astb2         228 KTLQV  232 (284)
T ss_dssp             CEEEC
T ss_pred             CEEEE
T ss_conf             98964

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.74  E-value=2.4e-05  Score=48.05  Aligned_cols=79  Identities=30%  Similarity=0.246  Sum_probs=58.5

Q ss_pred             CCCEEEEEEECCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEEECCCCCCCCCCCCC-------C
Q ss_conf             99589999106997321--671222889998897768855667794-5899997309994799888987642-------0
Q 002461          445 PPKIISLNLTSEGLTGK--ISPSLSNLKSLENLDLSNNSLTGSIPE-FLSQLPLLRVLNLDGNKLSGSVPTS-------L  514 (919)
Q Consensus       445 ~~~i~~l~L~~n~l~G~--ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~l~~l~~L~~L~Ls~N~l~G~iP~~-------l  514 (919)
                      .+.++.|+|++|+|+..  ++..+..+++|+.|||++|+++ .++. ......+|+.|+|++|.+++.....       +
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~  142 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR  142 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred             CCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHH
T ss_conf             87878863777666677315889865885610004357213-42344222033104266489976767666156999999


Q ss_pred             CCCCCCCCCC
Q ss_conf             0002368543
Q 002461          515 VARSQNGSLL  524 (919)
Q Consensus       515 ~~~~~l~~l~  524 (919)
                      ..++++..|+
T Consensus       143 ~~~P~L~~LD  152 (162)
T d1koha1         143 ERFPKLLRLD  152 (162)
T ss_dssp             TTSTTCCEET
T ss_pred             HHCCCCCEEC
T ss_conf             9889978799

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.44  E-value=0.00011  Score=43.94  Aligned_cols=63  Identities=33%  Similarity=0.474  Sum_probs=34.3

Q ss_pred             CCEEEEEEECCCCCCC----CCCCCC-CCCCCCEEECCCCCCCCC----CCCCCCCCCCCEEEECCCCCCCC
Q ss_conf             9589999106997321----671222-889998897768855667----79458999973099947998889
Q 002461          446 PKIISLNLTSEGLTGK----ISPSLS-NLKSLENLDLSNNSLTGS----IPEFLSQLPLLRVLNLDGNKLSG  508 (919)
Q Consensus       446 ~~i~~l~L~~n~l~G~----ip~~~~-~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~G  508 (919)
                      +.++.|+|++|.|+..    +...+. ..++|+.|+|++|.++..    ++..+..+++|+.|+|++|+++.
T Consensus        55 ~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          55 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             998889795985972899999999843788778877888775432210121100003432002444332023

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.13  E-value=0.00051  Score=39.69  Aligned_cols=81  Identities=17%  Similarity=0.190  Sum_probs=48.1

Q ss_pred             CCEEEEEEECCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----------CCCCCCCCCCCEEEECCCCCCCCCC-
Q ss_conf             958999910699732----1671222889998897768855667----------7945899997309994799888987-
Q 002461          446 PKIISLNLTSEGLTG----KISPSLSNLKSLENLDLSNNSLTGS----------IPEFLSQLPLLRVLNLDGNKLSGSV-  510 (919)
Q Consensus       446 ~~i~~l~L~~n~l~G----~ip~~~~~l~~L~~L~Ls~N~l~g~----------iP~~l~~l~~L~~L~Ls~N~l~G~i-  510 (919)
                      ..++.|+|++|.+..    .+...+..+++|+.|+|+++.+...          +-..+...++|+.|+|++|.++..- 
T Consensus        31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf             99788978498377899999999998589988888877754334542106787999887547775633000013455433


Q ss_pred             ---CCCCCCCCCCCCCCCC
Q ss_conf             ---6420000236854324
Q 002461          511 ---PTSLVARSQNGSLLLS  526 (919)
Q Consensus       511 ---P~~l~~~~~l~~l~ls  526 (919)
                         ...+...+.+..|.++
T Consensus       111 ~~l~~~l~~~~~L~~L~l~  129 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLH  129 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECC
T ss_pred             CCHHHHHCCCCCCHHEECC
T ss_conf             3101110023432100000

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.03  E-value=0.0018  Score=36.24  Aligned_cols=17  Identities=35%  Similarity=0.575  Sum_probs=6.2

Q ss_pred             CCCCCCCCEEECCCCCC
Q ss_conf             22889998897768855
Q 002461          466 LSNLKSLENLDLSNNSL  482 (919)
Q Consensus       466 ~~~l~~L~~L~Ls~N~l  482 (919)
                      +..+++|+.|+|++|.+
T Consensus       211 l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         211 LAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             GGGCTTCCEEECCSSCC
T ss_pred             HCCHHHHCCCCCCCCCC
T ss_conf             21101211222333322

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.75  E-value=0.0099  Score=31.60  Aligned_cols=63  Identities=25%  Similarity=0.451  Sum_probs=28.2

Q ss_pred             CCEEEEEEECC-CCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCEEEECCCCCCCC
Q ss_conf             95899991069-97321----671222889998897768855667----79458999973099947998889
Q 002461          446 PKIISLNLTSE-GLTGK----ISPSLSNLKSLENLDLSNNSLTGS----IPEFLSQLPLLRVLNLDGNKLSG  508 (919)
Q Consensus       446 ~~i~~l~L~~n-~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~G  508 (919)
                      +.++.|+|+++ .++..    +-..+...+.|+.|+|++|.+...    +-..+...+.|+.|+|++|.++.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~   86 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP   86 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred             CCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCH
T ss_conf             998197827999989899999999976377645401201562156798875310002343300330102145

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.48  E-value=0.0066  Score=32.72  Aligned_cols=62  Identities=16%  Similarity=0.178  Sum_probs=48.1

Q ss_pred             CCEEEEEEECCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCEEEECCCCCCC
Q ss_conf             9589999106997321----671222889998897768855667----7945899997309994799888
Q 002461          446 PKIISLNLTSEGLTGK----ISPSLSNLKSLENLDLSNNSLTGS----IPEFLSQLPLLRVLNLDGNKLS  507 (919)
Q Consensus       446 ~~i~~l~L~~n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~  507 (919)
                      ..++.|+|++|.+...    +...+...+.|+.|+|++|.++..    +-..+...++|+.|+|++|.+.
T Consensus        44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf             7645401201562156798875310002343300330102145999999999984893898778877688

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=90.13  E-value=0.021  Score=29.53  Aligned_cols=85  Identities=18%  Similarity=0.234  Sum_probs=49.4

Q ss_pred             CCEEEEEEEC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCEEEECCCCCCCCCC----CC
Q ss_conf             9589999106-997321----671222889998897768855667----7945899997309994799888987----64
Q 002461          446 PKIISLNLTS-EGLTGK----ISPSLSNLKSLENLDLSNNSLTGS----IPEFLSQLPLLRVLNLDGNKLSGSV----PT  512 (919)
Q Consensus       446 ~~i~~l~L~~-n~l~G~----ip~~~~~l~~L~~L~Ls~N~l~g~----iP~~l~~l~~L~~L~Ls~N~l~G~i----P~  512 (919)
                      +.++.|+|++ +.++..    +-..+...++|+.|+|++|.++..    +-..+...++|+.+++++|.+....    -.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHH
T ss_conf             99868876899998989999999888419825743015896117789999987752122101210254322014788999


Q ss_pred             CCCCCCCCCCCCCCCCCC
Q ss_conf             200002368543246889
Q 002461          513 SLVARSQNGSLLLSIGRN  530 (919)
Q Consensus       513 ~l~~~~~l~~l~ls~~~N  530 (919)
                      .+...+.+..+.+....|
T Consensus        97 ~l~~~~~L~~l~L~l~~n  114 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQ  114 (166)
T ss_dssp             GGGGCSSCCEEECCCCSS
T ss_pred             HHHHCCCCCEEEECCCCC
T ss_conf             998486524773216778